<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
   xmlns:ao="http://www.w3.org/ns/oa#"
   xmlns:dailymed="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/"
   xmlns:dct="http://purl.org/dc/terms/"
   xmlns:dikbD2R="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/"
   xmlns:domeo="http://www.w3.org/ns/domeo#"
   xmlns:foafx="http://xmlns.com/foaf/0.1/"
   xmlns:pav="http://purl.org/pav/"
   xmlns:permissions="http://vocab.deri.ie/cpo#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns:sio="http://semanticscience.org/resource/"
>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A4E3BF0-E555-4B66-960D-DFAD328E40AB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:53:06 -0400</pav:createdOn>
    <domeo:uuid>6A4E3BF0-E555-4B66-960D-DFAD328E40AB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6A4E3BF0-E555-4B66-960D-DFAD328E40AB"/>
    <ao:suffix>tablets.</ao:suffix>
    <ao:prefix>oral solution is bioequivalent to </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/131B4E2A-B685-490F-A204-C1EF6BD31042">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>amlodipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/17767</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC6B8700-5CF9-4919-83CE-CD30B715AF09">
    <domeo:uuid>FC6B8700-5CF9-4919-83CE-CD30B715AF09</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC6B8700-5CF9-4919-83CE-CD30B715AF09"/>
    <pav:createdOn>2014-07-14 16:08:06 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Elderly: In healthy elderly subjects, renal clearance of both </ao:prefix>
    <ao:suffix>and 9-hydroxyrisperidone was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3096A47-93EA-42E0-AB4D-2714032C897B">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:05:22 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A22A7401-D44F-4B96-825C-D6B7A0326C39"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:05:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B6255E2A-6F5B-4EF8-94C7-E0ECE9F9449D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/185C1FAA-6E97-4CF5-A614-E00F7479C206"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5786A7D6-0AB4-4D44-B750-6F0EFA06B91D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11F0264D-23A5-4A18-B0D3-91DA654E6326">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F8DBE126-C96D-492C-8D5B-06E2619CDEFF"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/113BF3F9-340B-4E03-80E2-BB485F290F34">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:810d4247-b95c-46b5-a207-7b6e880ba4b3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:810d4247-b95c-46b5-a207-7b6e880ba4b3"/>
    <ao:prefix>Erythromycin: </ao:prefix>
    <ao:exact>Erythromycin</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> (500 mg, single dose) did not</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-192.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:09:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69F69FA8-3DE1-4421-91B8-02129972291A">
    <pav:createdOn>2014-07-14 15:21:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:79FE78F2-7123-4AEA-AD1B-5E5CDB703C66"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:22:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8648DC49-9892-477D-B72A-403D6F34EE07">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AD3F6DA3-AFE1-4CBA-9D1E-10378C1BEEA4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6DCBD3FC-FFAD-4910-91FC-FA2AA684B759"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE991691-BDFF-4ADF-9C96-0A0635EB225A">
    <ao:exact>morphine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE991691-BDFF-4ADF-9C96-0A0635EB225A"/>
    <ao:suffix>are administered over the course of several hours while the patient's condition and vital signs are under careful observation. (Intravenous hydrocortisone or prednisolone have been used to treat severe reactions, with the addition of intravenous chlorpro</ao:suffix>
    <pav:createdOn>2014-07-14 15:42:08 -0400</pav:createdOn>
    <domeo:uuid>BE991691-BDFF-4ADF-9C96-0A0635EB225A</domeo:uuid>
    <ao:prefix>. If a narcotic is needed in such patients, a sensitivity test should be performed in which repeated, small, incremental doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F">
    <ao:item rdf:resource="urn:domeoclient:uuid:AD8CE684-D437-4E97-A17B-32DDE469E97C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91E4A62D-D081-48ED-B0E9-BF74542B5243"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:939E6E39-63EA-4BDA-92CF-4473C5F8254A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:654E908A-332C-4C3B-B9E2-B799EF2947A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7842F04E-DAC6-4560-9470-E882DD2419F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4977430A-75B0-4EB8-B005-F04BD520C42B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F57D73A8-743F-47BA-B724-496E02303CBD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9EF1DCCA-C32E-478E-B1D6-13A65B80011A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5F2905F-D14C-4C3C-BCE5-81F7C2290A31"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2425CE75-E5F6-4449-BA5B-7E08F3E3E468"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A72BAEFC-1EC6-4248-889B-1624DD187092"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91B8AC57-1C0B-4BD7-A12E-1E11D8BA2E15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02DCE132-9725-4F90-89A3-DB8B43187944"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F26CC484-4EAA-4D86-AD6F-08AC326B1CEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EF843CCA-9BE0-4A0E-AA53-9AA6CB32F36C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8B07DC6-86DF-413F-A291-AA22B4CC9A6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1284E9CF-B8EE-488B-8CD1-506043FF5504"/>
    <pav:previousVersion>urn:domeoserver:annotationset:3B4F9958-F251-4717-8930-EEB6892FDDC3</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:B321CD6F-2C57-4243-9343-115D92773E59"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6077C77-F288-423E-95CF-9688004B9EA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A578511B-AD5F-4453-BCF7-B667E5B06A96"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5683C35-E3C0-4011-8950-F1D1EF689BC2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB73AA57-612F-4156-AD04-7AEC495B0653"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC9ACC5A-39AC-427B-805F-339CA9F6BDC1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B15B99CE-DBDC-432A-B3B1-5E3A1BD31AE2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A874C3BD-3499-4877-B489-584D8AE1F205"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70A02B0A-E2D3-4C76-A00D-07A21B7A4FA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54B90F5C-1D92-4337-8EC1-596F87DA0671"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8228F109-6A70-4C8B-BCAB-741F4BD594E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DB84529D-6E38-4ED9-A05C-BE5515EA7F80"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFB9848-5EF5-4473-9AB3-7135CF730A98"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:30500CEB-FE00-459F-91E6-CCCB5669463B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F75A828E-CBAD-47C8-BBC3-45B5E8A39C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA95F2B2-1968-4200-A5BB-7DA23D1DE9D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB08A3DA-622C-4B72-AF55-786567D870F7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B119365E-FA3A-4C81-A0DD-4035AD4A41BC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2E294FA4-87CC-456B-8D0D-7E0234FDF6B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65AD7458-085A-4A27-93DB-8F704670EFE4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7239942A-3971-4A3D-A133-94C5843F811E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B18EE4D7-99CC-41CB-817D-AE74A036FC32"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6E06164-F47E-4410-8D10-75C1F3E859BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA0AA67E-99A3-44AA-B89A-AED6D0DEA80D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EBBC3BF4-D014-4529-ACAF-B10B20BF3167"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA638B1B-85C2-4801-9004-5DAE5B879088"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7E37C4BC-BC85-4FA2-8CBE-51890DA9F6A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C38FFC84-55EB-4952-8F9D-079DC836F634"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:568E3662-0BF5-44C6-A624-F35646BE9C93"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:89A88D98-1294-4F80-A248-88FC6CE69FC2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33FB62B6-2A11-4637-8FA3-68B0BBD8B517"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:483B5894-871E-41EE-920E-148635088DD9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4ABE7DE-E61C-4D46-A3FE-379D9EA353C6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74C593C1-62E2-474F-8664-18E528C125D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FD5E204D-1584-45B4-B4BC-98D54BB50E09"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6D5E41F1-E9A0-4BB0-8282-60119CFA2048"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7B77D933-272C-43D1-B39C-FA16DC5AFB1F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7998E9DB-B8C4-467F-8FF0-00F310A2DDBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F29A5602-9739-4278-BA8A-DBBF58A6459C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EF0D417-70EE-4247-ADF5-6E19AA1B61AA"/>
    <pav:lastSavedOn>2014-07-14 14:48:58 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:48820B68-CAF4-4D1A-8572-BF79D1A8D37E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75CE840F-35C1-4DC3-A437-252E24866FE3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBD102BC-D765-4751-A1B4-5B1F1376AFC8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1544E0E4-4548-47A0-9A95-1B3624CB3D6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADC45253-A3D7-4B7C-9820-C7A411B89173"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4D28906-8A23-4ECA-B4D7-2550E551D75C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE7F178F-D344-411B-BAF8-9075ACE496DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:707031EA-7C19-401C-BBCC-48A2AB5E98C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3079DA6A-B893-4381-B554-F583232CB187"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9DE981F4-541F-4902-AC82-FCE6D2B02FA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7D64D1F-8DA7-4472-941E-8F193465EBC8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:716FE94B-EF89-4FA5-BDB5-34D9D634F049"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:272B9063-8E86-4EFB-AFF6-04EE69988B64"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7972E3FF-C889-40D0-BA5B-B52CA2B34BBB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDFF1064-0B94-4251-9EDD-83164C93EC74"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C1CE72E-EE74-438E-B925-8BDDA00E97F1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C06802B-8803-4873-95EF-26DCB9756032"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A530B793-9D12-4AA6-BE63-2960BB5CAAD5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:083BD2C5-441A-419A-AFA2-28C29EE6EF8F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C961A91-7FF4-46F4-852E-CB250589B873"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:25E1338C-0A22-4132-985C-BC19C6E09234"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAFF1DBA-4588-4DD0-9479-69F1D385CD4D"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:4AA5618D-E659-4A6A-8E7D-926CBB5C8EB6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF56FE4B-6224-4192-A64E-B4B91FF70A51"/>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:7120E47E-4F61-491A-B71C-522A35540598"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:078B790F-60D6-4853-B6CE-8B560D2343CD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AF77A136-EB98-4EA7-A892-A5B0FC6ADAA9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7726B9-F827-4F55-856D-E6D8235A718B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5B3E6D1-A159-4297-A53B-43BD0352DB0F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D99FDDDB-F0E0-44E5-BFF6-F7E22260E78C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EC29843-C5A8-40A5-93EE-2640705D81EB"/>
    <permissions:permissions rdf:nodeID="Nfe75f386b3364699a9f957fa8ca3081f"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7535A38-E3BB-4AED-AAB5-3E284F8F5D35"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E8A97BED-E65E-434A-92E5-9B9E3B8B801D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1359537D-E2F3-40E7-9BEE-88D45BB4D3FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F001C05-D2A7-4D62-BB98-D0CA63FB500A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDFC99BC-0293-453A-BE1C-C3205EB80DBD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65171858-7BDA-4D2C-8CBF-607CAC4FBCC0"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDEBBB06-8BD4-4F89-A187-A2C9DCE011D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04416B46-CC4F-42CD-9001-3BD556AF4E3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7FAA99DF-F0F3-4209-93DD-6B3C5F1E4E36"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E235B5A4-5738-4EE1-B721-55F30ABD99C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35DC6D04-1356-424A-958E-CB74DF00CEE6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4871EF5-CA78-4A31-B579-2BBD09C2EB35"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40D93E65-EFFA-4110-BB95-3F6525050777"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5CC5FB4-810F-46EE-9C08-31F9EEED4452"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED519FB5-4637-4314-B368-FC31635D7532"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD56A5E9-D5CC-4E12-A91A-8C14396A5B06"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94C25269-4810-41F4-A427-244868A8E338"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:28A340DD-B098-45BA-8CDE-2776C36F13B5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:38464E2F-D76E-485E-92D2-493EA6207953"/>
    <pav:createdOn>2014-07-14 14:05:27 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:86F2F338-DCD6-4C16-8C92-900AF2B1E865"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C1976E2-C29D-4A23-94A9-9A2B3531BC06"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:D9AFCED8-4216-4013-843A-1A805A229289"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:49059DD3-063E-440E-A478-00A3FD35C784"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63A87F56-A3EC-4533-8029-5C236DE26B7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">26</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:56BDA5D3-9924-46E2-BA2D-1F2D8C77CDF3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AFAB68BD-49C7-439D-A842-617C4AE3D9EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F697B7A2-4908-40D5-94D4-682B6261F32F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:6ED1B51A-5BBC-45C8-97C4-2CED36FE7F72"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1E29A9F-A024-4F8B-BE96-7C827681A402"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE25CF3B-9AF9-4457-81F6-F7034B3900E0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69A77863-6B21-463E-B248-090DBEAF2A77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3306C93E-D359-4AAC-9048-F57995B6A419"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D2367BD-3A38-43EB-A3B0-C110E67D40FD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1574BC9A-EE1F-4135-99B9-71A1BFEE0A19"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C789F60-840A-4189-AB01-0464184BB388"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:6E123EA8-4CB0-41ED-A5BC-BDAAECF21AB6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C403DADA-9061-432C-8227-51655C34C466"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:988CF1A5-0399-4784-9662-28B5815B5831"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54625714-C1D4-44A4-B970-A16C630AB9F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19A220B4-9579-4FC7-B16C-BE7A6723CC83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0EFC0480-98C5-44E3-8C41-3925C3D9A089"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32515912-017E-402F-A8DD-F5644EE84E4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:39C44C5B-5441-4761-8AF2-0B5F9F25161B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3D526E35-3C47-41BC-B59C-546638F50D9D">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:059304BF-0CE8-4FEB-8E08-B283296A3929"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/880C6585-3226-4C5B-ABE2-E5611B0C1FA7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>theophylline</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52DEC0C9-5A9A-4CD8-A621-36C5793DF7DF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52DEC0C9-5A9A-4CD8-A621-36C5793DF7DF"/>
    <domeo:uuid>52DEC0C9-5A9A-4CD8-A621-36C5793DF7DF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> metabolizers convert </ao:prefix>
    <ao:exact>risperidone </ao:exact>
    <ao:suffix>rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risper</ao:suffix>
    <pav:createdOn>2014-07-14 16:02:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/185C1FAA-6E97-4CF5-A614-E00F7479C206">
    <rdfs:label>ritonavir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C4E84CA0-FE12-4DA0-967D-F21854C66900">
    <pav:previousVersion>urn:domeoclient:uuid:afe84a08-06cb-4431-a6fc-5a78f5877c14</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:a12c625c-eafa-4490-bab9-a0b6a61b87f5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/1eb27493-2522-4c5d-abb7-079b275e7f59"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N2b164d9eece74629b75f1b304d616fdf"/>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 21:42:25 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:224B5795-48A6-41C5-8A03-42E676D48DCD"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-87.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc3bafe31481d42bd80638f2403b51ff6">
    <domeo:sets rdf:resource="urn:pddi:uuid:27F74D94-835C-4D62-9540-CB940FD4A1A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45B29599-C983-42A7-A3F1-3DF0980C5720">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45B29599-C983-42A7-A3F1-3DF0980C5720"/>
    <ao:prefix>with the long-acting </ao:prefix>
    <pav:createdOn>2014-07-14 15:01:54 -0400</pav:createdOn>
    <ao:suffix>did not have a significant effect on propranolol’s pharmacokinetics.</ao:suffix>
    <domeo:uuid>45B29599-C983-42A7-A3F1-3DF0980C5720</domeo:uuid>
    <ao:exact>propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A38F4267-C2F3-4669-9DDA-6CCFCBED3798">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189">
    <ao:item rdf:resource="urn:domeoclient:uuid:7C7473C1-3AD7-48FC-ACAF-AF71E873A853"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:983A278E-ECF2-4B9A-AFCF-4B5E560A3A74"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D344422-E49D-4A6D-A4EF-1F8DE7EC669E"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBFD3FC8-A46C-4FDB-803E-459F879788FE"/>
    <permissions:permissions rdf:nodeID="N29d129f828304189bc961463061538bf"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6BC95CE-8A3C-4155-B29E-23A3A869A07E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C172398-DC8A-4607-B1F6-6B8C6EACF2C5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:F55A34F9-4DAF-462C-B2A0-A6E31F3786AA"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:933191E0-98FC-4AED-BE77-500BD2A1480E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A22768E3-A426-444E-876F-EFC695201FAE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1AD5962F-9377-44EA-9537-7FD6E957079C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:0FEDA167-0373-4FCF-8DDE-B9BE3C63CAAB</pav:previousVersion>
    <pav:createdOn>2014-07-14 13:59:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:04:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0C5576A-85F0-440D-8AC8-7C176A634496">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdOn>2014-07-20 22:14:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:14:39 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B409FE5B-3157-4EDA-99FE-B679ADFE6155"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:83531713-BD51-4439-A04B-063A78646A82</pav:previousVersion>
    <ao:body rdf:nodeID="N2e223151816343aba14e24242a9f71cc"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:586A1A5A-2F81-4CCD-892E-FCD763AA2787">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B89B7BC8-E40C-4236-BF27-5D0A3E0B3199</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:44:08 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:44:08 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9FAB530E-2E79-4327-93D1-F62EDC7FD648"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:7CE009CE-9A28-417B-B003-33CDFDB4E8FF</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BFB4A22-7E1E-4883-89B5-129E3B3002B5">
    <pav:lineageUri>urn:domeoserver:annotation:84502BEF-FC65-42FD-B1D7-4DF753A806FE</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ned6aaa04d29143e49eb0b2d2a51f2a37"/>
    <pav:lastSavedOn>2014-07-20 22:29:24 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5E26D8B8-3109-4C14-B9D9-36AE9589E7A8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:29:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:98A2D657-E7D0-4451-8886-8EC8C12E22A0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1B8A19A-60AF-40EE-9D04-50544D59019F">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A1B8A19A-60AF-40EE-9D04-50544D59019F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A1B8A19A-60AF-40EE-9D04-50544D59019F</domeo:uuid>
    <pav:createdOn>2014-07-14 14:33:15 -0400</pav:createdOn>
    <ao:exact>Glyburide</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4452DAE2-DD46-4916-9432-8B794E524A8C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 21:52:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6BF318DE-8E9D-4574-832B-B631CEBCD037"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 21:52:37 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:AA9D1C59-63AC-40E7-94DB-52BB4730B491</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E44F8607-E886-4BD7-A4FB-E84256F75267">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 00:16:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:B2B3667B-3201-40EE-BDFC-327B76EBC35B"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB97FFC5-B995-4858-91DF-45F2675318E9</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 00:18:31 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:4C1BC3FD-BA71-4CEA-B3DA-507B9E262C73</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AAE83FD-A3FA-4118-A8CE-F534CC555020">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 21:52:37 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C046A6C6-31A9-4B54-A8A9-8D5D25A280A5</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DDE9A5F8-1276-49D2-B080-F3134B265370"/>
    <pav:createdOn>2014-07-20 21:52:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:517742CB-4DFD-4C81-AA9E-E37DD1F8D8DB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8C4AAA54-50A3-466F-9BD3-A508BFC15CD4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5E14082A-8F0B-463C-9316-F9DC45C11355"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C217FC2F-B5B6-45CC-8596-DD4F565DB7A0">
    <domeo:uuid>C217FC2F-B5B6-45CC-8596-DD4F565DB7A0</domeo:uuid>
    <ao:suffix>AUC by 41% and Cmax by 43%.</ao:suffix>
    <pav:createdOn>2014-07-14 15:21:46 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C217FC2F-B5B6-45CC-8596-DD4F565DB7A0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine </ao:exact>
    <ao:prefix>®1) decreased </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:822F77AE-2E7D-4534-B4E7-F8C6C5D1D1B2">
    <pav:createdOn>2014-07-13 23:59:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:66997FDA-ED9B-4429-9D7D-F08F78ADD03E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BF318DE-8E9D-4574-832B-B631CEBCD037">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6BF318DE-8E9D-4574-832B-B631CEBCD037</domeo:uuid>
    <pav:createdOn>2014-07-20 21:52:20 -0400</pav:createdOn>
    <ao:suffix>, 5α-tetrahydrolevonorgestrel and 16βhydroxylevonorgestrel. </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6BF318DE-8E9D-4574-832B-B631CEBCD037"/>
    <ao:prefix> are also present in plasma, along with much smaller amounts of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <ao:exact>3α</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7C38443-FAF5-44DE-A56A-E3B79DCCB5EC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:59A35842-09FF-485C-B13A-8ABBA487A4B7"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:39:47 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A81B116-EAE0-4CA0-8C37-F8F5710FAAB6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A81B116-EAE0-4CA0-8C37-F8F5710FAAB6"/>
    <pav:createdOn>2014-07-20 20:49:09 -0400</pav:createdOn>
    <ao:suffix> [see Dosage and Administration (2.1)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
    <ao:prefix>. After intravenous dosing, about 29% of the dose was excreted in the urine unchanged, and about 45% of the dose was excreted as </ao:prefix>
    <domeo:uuid>4A81B116-EAE0-4CA0-8C37-F8F5710FAAB6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E">
    <ao:item rdf:resource="urn:domeoclient:uuid:6BB45444-BC21-4F91-AD74-52A83BF2D105"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:30AFA474-E4E7-4C5A-ABF1-C9EC45F21378"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DB26F27A-D643-4980-9DBF-B3537C0D3D6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:39FC5D6C-2AC9-4A5A-A824-047ACF944440"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:49373B45-F6BE-435A-B987-90009A6BF72D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2686D0A-82A9-415D-81F8-10EB4F8C507E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:80115C95-2CA3-40D8-A6DA-4ED061B28DB2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33C973CD-EFB1-42B4-B1D8-5406520B9A3C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34AE2CE1-80BE-4B8D-A3D3-A7E0231146B3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AFC481A-FB29-476F-AAE6-47C17237FE11"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/400e0729-ff42-48b8-b64a-ca4598fee6ba"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E234B393-5FE6-4CFD-9138-E244B2D96757"/>
    <rdfs:label>NER Sets</rdfs:label>
    <permissions:permissions rdf:nodeID="N339b58f9dca74a6abdc6d2f122102843"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA703CD7-92EF-408F-88C1-7CABC81F4ECD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1996A40-CBAA-47DA-9FCD-A7DB2F8A8CED"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 22:23:09 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2D3876F-AC33-4A2B-B3DB-97296D114AE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4072B5D8-2FFC-4AAD-8EEB-C43C8CA94210"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42B2576B-2D8B-4075-9732-4694107207D5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:852FB01C-EE51-4C8B-AB5D-A557E28656B7</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD25FC56-73E5-4077-815F-65E4D28AF5F4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:27686EA6-093D-4F11-BCF2-8C755CF6E4F7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8FFC4712-D696-40A1-914B-B1BBE98E3CA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0C5576A-85F0-440D-8AC8-7C176A634496"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3D23DB3-B709-4C8F-ABC8-C512BB4BBDF5"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-07 08:09:17 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:3293CB2D-387F-4DA3-8639-E5F5AB7621E1"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35CBA4C1-DDB3-4254-9572-00A7C57054A3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C44D15C-34C7-4C2C-9997-221A4390017A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C41072DB-3941-43B5-9230-4489236E0433"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:1576A3E5-6684-42C5-B761-64F15EA02CA8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08357EC7-543C-42F8-8ED4-776EEDC7BAC2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C64610CC-A0C0-45CA-A872-B67AC5497E43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F4E366F-E035-400F-99C4-EA97163AB922"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76ED4D83-BD2C-4B6D-A45C-B1F016F94ADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8C545DA-9FDD-4C41-B839-2F0031E766AA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CED7EB1-D759-40C3-A5BE-250152053AEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32B2F675-54DA-43C7-9F4E-34FC3B29654D">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 20:22:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C6D52A0-BA79-4D38-87DE-8E3E185A35CC"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AB301DE-F7B3-49BC-BAD5-ADD02D903002">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N6c9b1ae298074402a50d9ec8e3345a6c"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:3EA476BA-103A-4964-8278-AE462906815B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:193686C3-0953-4EB0-B679-3CD8F00C64D7"/>
    <pav:lastSavedOn>2014-07-20 21:00:22 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 21:00:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBA50C9E-51D5-4418-9757-8D5148B012E1">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FBA50C9E-51D5-4418-9757-8D5148B012E1"/>
    <domeo:uuid>FBA50C9E-51D5-4418-9757-8D5148B012E1</domeo:uuid>
    <pav:createdOn>2014-07-14 15:38:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Plasma concentrations of meperidine and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/39A94FF0-9FCB-46BD-B664-CA5916E92D1F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB409338-703B-4C6B-A32D-933D72D9FF08">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:55:21 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE770B26-EFF8-465C-9F09-8F6D8EE12A07"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/43CA60C2-6C9B-4D6A-B869-369E04D7A0EA">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C0354CB-25CA-476B-B337-C7C45B4F528A">
    <ao:suffix>100 mg administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3C0354CB-25CA-476B-B337-C7C45B4F528A"/>
    <pav:createdOn>2014-07-07 09:39:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>3C0354CB-25CA-476B-B337-C7C45B4F528A</domeo:uuid>
    <ao:prefix>Single oral doses of </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7535A38-E3BB-4AED-AAB5-3E284F8F5D35">
    <pav:createdOn>2014-07-14 14:33:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A48C0A37-DA7A-4F0F-A0C3-981C7FF76E06"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C83D7098-A26D-484F-B852-C053E3EF8920">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3FD1AA0B-C794-409D-9E49-1F256BA00CDD"/>
    <pav:createdOn>2014-07-07 11:07:55 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:555798FB-0C2E-4051-B426-FD9DAA56F7B0">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:555798FB-0C2E-4051-B426-FD9DAA56F7B0"/>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <domeo:uuid>555798FB-0C2E-4051-B426-FD9DAA56F7B0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:58:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F2F93BCC-1924-4C9E-ABF5-542A48FE6909">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:54657A16-AB6D-4506-BE2A-81079A0AF29F"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/15EE846D-56EB-4183-91FC-C434E504D22D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42B2576B-2D8B-4075-9732-4694107207D5">
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3EE34468-D0A2-4A18-BC8D-991824787C67"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:11:24 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:483E875B-D447-49D9-B73A-93DFCCBD5D97</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:11:23 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N21fadbcc68474523a28c65479b569df4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45E70A06-7DB9-4245-A63B-21FFBD6833F0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45E70A06-7DB9-4245-A63B-21FFBD6833F0"/>
    <ao:prefix>. There was a mean ± SD increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>tolbutamide </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>45E70A06-7DB9-4245-A63B-21FFBD6833F0</domeo:uuid>
    <pav:createdOn>2014-07-14 00:06:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F94E16A-024F-416B-9422-E821C3961017">
    <pav:createdOn>2014-07-14 16:05:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F94E16A-024F-416B-9422-E821C3961017"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>9F94E16A-024F-416B-9422-E821C3961017</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4ECCFA2E-96CF-4E39-8D93-07103CEE402B">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9603BE1B-7FD7-4631-804C-D6FB0F060B00"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:55:22 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:54:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/226CFA8F-CFF2-405E-93CE-FF82D5380B26">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/126E527F-80E7-4641-B3E9-A725E45D7103">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D43D723-6A5D-49C8-9684-291C519A0C99">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D43D723-6A5D-49C8-9684-291C519A0C99"/>
    <domeo:uuid>4D43D723-6A5D-49C8-9684-291C519A0C99</domeo:uuid>
    <ao:suffix> are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix>are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:53:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9579423D-AA96-468E-B401-A4679754CF48">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9579423D-AA96-468E-B401-A4679754CF48</domeo:uuid>
    <pav:createdOn>2014-07-13 14:49:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix> dosing resulted in small increases in the mean AUCs of </ao:prefix>
    <ao:suffix> and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cau</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9579423D-AA96-468E-B401-A4679754CF48"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4274C027-B092-46B3-B4FB-8A59A3AC83EE">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4274C027-B092-46B3-B4FB-8A59A3AC83EE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 11:12:11 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>4274C027-B092-46B3-B4FB-8A59A3AC83EE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Concomitant administration of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg) did not affect the pharmacokinetics of sildenafil</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E05590F3-5B2D-4B59-94D7-EEEE42491D85">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/94475638-AF19-4A8F-A6B0-2AAABF65AC60"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CB5EDDF0-69AF-43EF-9F9D-11FA8690A1B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52A74600-0E76-4D41-AF58-7F4E323A1F24">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:02:33 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3DF675E2-C00D-4F68-BFA2-E7F750F7172B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34F54519-830D-46BC-B3E6-91AD60A447BE">
    <pav:createdOn>2014-07-14 16:06:53 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:A9E118A3-84A9-4EF3-9007-B65103DACCBD</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4703F4F8-4BAE-4BD3-B47F-AB840CA05806"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24E3D83E-9C5E-49DF-AB2D-C19982646DF4">
    <pav:createdOn>2014-07-14 15:34:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C695803C-F876-4316-8563-FFD22F9C8D2E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:35:21 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:073118E8-782E-429A-A1FF-5CA073116676"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B3804DF-439A-4567-A6D0-C1CEADAAE040">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <ao:body rdf:nodeID="Nb954198474ef4c779aa59c3bfccffef8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F3B4911-C04E-4909-BFC9-7737FBFD0C44"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:338D89FA-A2F3-4A78-82F4-B1B7A34C002A</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:01:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:01:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC2D793B-54AA-4D45-86A1-D42CA557334B">
    <pav:createdOn>2014-07-07 11:09:20 -0400</pav:createdOn>
    <ao:exact>atorvastatin</ao:exact>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>AC2D793B-54AA-4D45-86A1-D42CA557334B</domeo:uuid>
    <ao:prefix>or </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AC2D793B-54AA-4D45-86A1-D42CA557334B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89F7D02C-486F-47FE-B0D9-AF05F4BA971A">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 20:20:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA439B2C-7EAF-443F-BEB0-08193CD6CA8B"/>
    <pav:createdOn>2014-07-20 20:20:13 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:6e22c92c-7297-4e91-ba82-ac1dc0a550ab</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:607F7195-0BA5-4B52-AE2D-5D34139388BA">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:607F7195-0BA5-4B52-AE2D-5D34139388BA"/>
    <domeo:uuid>607F7195-0BA5-4B52-AE2D-5D34139388BA</domeo:uuid>
    <ao:exact>FLAGYL </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 13:55:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:prefix>and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25E1338C-0A22-4132-985C-BC19C6E09234">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3DF16459-E6DB-498D-9BF2-44EC35A17409"/>
    <pav:previousVersion>urn:domeoserver:annotationset:5C62A5E1-E846-4FFE-B0D2-F54E63A65412</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:13:42 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:15:09 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1DD2A3E-1394-4DAF-AD07-2985DF205731">
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B1F84D1E-3DE5-4DFC-B5D7-A3487C6036D9"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 23:50:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 23:50:41 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2CEA7D67-F9F8-4FE7-8D95-EBB184D52C09">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:51E1B74C-9C01-4628-830F-AC07648ED9CC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:03:34 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AEDF6EED-7EC2-4959-BE6B-8370EC949112">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CFFC5D6-2D2A-4C1B-8A07-494C53091242">
    <pav:createdOn>2014-07-14 00:24:09 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:60A4D5FB-7A8D-40DF-B1FF-0D6B7599C889"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:158806C8-EDEF-4315-8072-AB9961CEBF65">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8D13EEBF-6744-4949-89CE-47AD2806435E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6FC8FF68-89FE-4106-B69A-222A64D567C7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 16:05:40 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 16:05:39 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N0911aa1822624a159e7a54304e21756c"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D1AFC77-0930-41BE-8564-87038FCC0C62">
    <ao:suffix>is contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitors or those who have recently received such agents. Therapeutic doses of meperidine have occasionally precipitated unpredictable, severe, and occasionally fatal reactions in</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D1AFC77-0930-41BE-8564-87038FCC0C62"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:40:10 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>3D1AFC77-0930-41BE-8564-87038FCC0C62</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:exact>Meperidine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8209DD89-3405-4E3B-9DE0-854D524E41B8">
    <pav:createdOn>2014-07-20 20:39:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8209DD89-3405-4E3B-9DE0-854D524E41B8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8209DD89-3405-4E3B-9DE0-854D524E41B8"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Concomitant administration of propafenone and fluoxetine in extensive metabolizers increased the S propafenone Cmax and AUC by 39 and 50% and the R propafenone Cmax and AUC by 71 and 50%</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B204FD97-C00E-4CC9-9C3C-30F8B0CCFA98">
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:BDC4A353-FE12-4B22-879E-4CD3489B5876</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:48:57 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:48:58 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N9f2ee248124b421a829139d7c663ffff"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D869A491-1E47-4F2C-828D-B6518B4BB664"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FAA27D4-119A-4182-B1D3-9BDF13FE4AC6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1FAA27D4-119A-4182-B1D3-9BDF13FE4AC6"/>
    <pav:createdOn>2014-07-14 15:17:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>carbamazepine </ao:exact>
    <domeo:uuid>1FAA27D4-119A-4182-B1D3-9BDF13FE4AC6</domeo:uuid>
    <ao:suffix>reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>100 mg to 300 mg daily, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/32BDD969-DCD1-4A82-8447-E9785119F390">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8134</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenobarbital</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5489E53B-C365-4C9D-BA0A-9FA3E2E4EE43">
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5489E53B-C365-4C9D-BA0A-9FA3E2E4EE43</domeo:uuid>
    <ao:suffix>. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTI</ao:suffix>
    <pav:createdOn>2014-07-13 15:57:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5489E53B-C365-4C9D-BA0A-9FA3E2E4EE43"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix>AUC and a significant increase in apparent oral clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF77A136-EB98-4EA7-A892-A5B0FC6ADAA9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5840ED50-9DC2-4896-9799-FF7D2B94281E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:18:20 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4684A74-F0C3-456E-A817-27DCA1288D90">
    <ao:prefix>to interfere with metabolism of other drugs metabolized by </ao:prefix>
    <domeo:uuid>B4684A74-F0C3-456E-A817-27DCA1288D90</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4684A74-F0C3-456E-A817-27DCA1288D90"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:06:40 -0400</pav:createdOn>
    <ao:exact>CYP 2D6</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E77B5B61-8D0C-40C1-A89F-2FB849FFCAE0">
    <pav:lastSavedOn>2014-07-20 21:58:38 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2E10C4B4-CF29-40DD-A054-507F791D2E26"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N355c15d5dd264720bb02429757d421cd"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:501B0EDF-5539-44F6-99EA-4C741B335E54</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 21:58:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/453740CB-757C-4B86-851E-562C5B63714F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rosiglitazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:256DFC44-CA71-40A7-9682-83DEF643C7DC">
    <pav:createdOn>2014-07-20 21:14:30 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3FA0D293-6991-45B9-B139-8D36E8FDA33E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8DE072DC-2540-4985-9736-6C57CD3C5F15"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 21:15:07 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A2317AD6-F2D6-43E2-A50D-0BB94855D542">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:32695D30-116C-4B63-ABF4-77566437369D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BB84476-421D-44DB-9D68-3E10638DA849">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2BB84476-421D-44DB-9D68-3E10638DA849"/>
    <ao:prefix>and its metabolites. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <ao:exact>Diazepam </ao:exact>
    <domeo:uuid>2BB84476-421D-44DB-9D68-3E10638DA849</domeo:uuid>
    <pav:createdOn>2014-07-14 14:57:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F697B7A2-4908-40D5-94D4-682B6261F32F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:28:37 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:06F5477E-1CBF-4421-B40C-D43DEC150968"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A121296A-BFE9-431D-B5F0-5FBD4D494F16">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/68E2B300-8315-4FD1-B603-AB0DBDAA6D3B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/453740CB-757C-4B86-851E-562C5B63714F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBFD3FC8-A46C-4FDB-803E-459F879788FE">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:04:21 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF028FB5-C10E-454B-AB76-0E8AEB2FCCB3"/>
    <pav:lineageUri>urn:domeoserver:annotation:A8141CAA-B4F7-49D2-BE37-CC2FFCD3FC24</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-14 14:04:18 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Nc2ade50445eb4d5a941f90ad00b94762"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9615C85D-A507-4824-98F2-AF16E6C5176D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sertraline</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA703CD7-92EF-408F-88C1-7CABC81F4ECD">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nc6da84fc58e746cbad8e781a822c1e33"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DD960D41-A85D-4FD9-B88F-EF1BBF911F5C</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1530D396-91D1-4424-839A-534000E05771"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:23:09 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:22:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/58F2429E-AA5B-4989-BB2D-EFBB6F85E91F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluvastatin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CCD7AB8A-0CE0-4991-8CCD-894DDDCC7F32">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/55D858DF-A99C-4EF9-A070-F8D97817ADD6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31896681-6F81-4411-80C8-7455907DC3A1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DB2AB72-A10F-4DB7-861A-EAAEF3E26977">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3DB2AB72-A10F-4DB7-861A-EAAEF3E26977"/>
    <pav:createdOn>2014-07-14 14:44:26 -0400</pav:createdOn>
    <ao:exact>Acarbose</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>3DB2AB72-A10F-4DB7-861A-EAAEF3E26977</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:004698D0-124C-41AE-8A7F-D640A8C3CD3F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:40DCEDC8-8827-4C1A-AF10-FC10AB55BEDE</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 00:23:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:23:11 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:DDE9697B-4596-4560-B3CC-D852CBB6AF20</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7B5D92B-3E31-426E-A1D1-F5290C6499FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:988CF1A5-0399-4784-9662-28B5815B5831">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:28:39 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:C8764870-11A3-4087-A41D-E4F3424A4189"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A912A10-3A37-43D5-8572-60FE94EF052F">
    <ao:suffix>in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known en</ao:suffix>
    <ao:prefix>pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of </ao:prefix>
    <pav:createdOn>2014-07-14 16:03:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4A912A10-3A37-43D5-8572-60FE94EF052F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A912A10-3A37-43D5-8572-60FE94EF052F"/>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086">
    <pav:createdOn>2014-07-13 23:50:08 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1DD2A3E-1394-4DAF-AD07-2985DF205731"/>
    <pav:lastSavedOn>2014-07-13 23:53:02 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B530E20-E9BD-4FE9-9DB6-C2F0CC95B9BF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93BB24EB-1586-4941-99D5-2D6960DFF4BA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:864A7E17-993B-44F1-BEBF-8DA14B436612"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoclient:uuid:1C4EB1A3-EFC3-42E1-97AE-E94EB289BF24</pav:previousVersion>
    <permissions:permissions rdf:nodeID="Na50cd6786fd14b68b9a77b3b16a55f26"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3844856-EB1A-41E8-883A-716B53E41D87"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E0AFC0D-0B0C-4424-A049-69B15D7BBF07"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:02B3E468-88DF-4A12-9D2D-0D33BD7DF9F0"/>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8E7FCA2-29B2-4398-B95F-2DAEF9F9DF7A">
    <domeo:uuid>F8E7FCA2-29B2-4398-B95F-2DAEF9F9DF7A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:01:42 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8E7FCA2-29B2-4398-B95F-2DAEF9F9DF7A"/>
    <ao:exact>risperidone </ao:exact>
    <ao:prefix>. Consequently, the clinical effect of the drug results from the combined concentrations of </ao:prefix>
    <ao:suffix>plus 9-hydroxyrisperidone.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D653786A-F069-42B0-91A8-52DBEC720004">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D653786A-F069-42B0-91A8-52DBEC720004"/>
    <ao:exact>5-hydroxy metabolite</ao:exact>
    <domeo:uuid>D653786A-F069-42B0-91A8-52DBEC720004</domeo:uuid>
    <ao:prefix> elimination half-life ranges from 10-32 hours. Decreased ability to form the </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:suffix> of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:20:53 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FB3340D-F382-46CF-B042-DBEB5BDD4CC7">
    <pav:createdOn>2014-07-14 13:41:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:exact>Synercid </ao:exact>
    <ao:suffix>and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6FB3340D-F382-46CF-B042-DBEB5BDD4CC7"/>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6FB3340D-F382-46CF-B042-DBEB5BDD4CC7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7604DAB8-64E6-4865-8E64-717B6A4BFF43">
    <ao:context rdf:resource="urn:domeoclient:uuid:ACE16AEE-94A1-44D3-8155-5F29E6571424"/>
    <pav:previousVersion>urn:domeoserver:annotationset:4D204DA5-0CBE-4A3F-9794-CBE60388801A</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 11:14:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:body rdf:nodeID="N61605ee3260a43b7a1c5ba888beb5eed"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:14:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9379805F-EC1D-49FD-8C5D-3E99BD213C02">
    <ao:context rdf:resource="urn:domeoclient:uuid:958E3F8C-5E1F-49A9-99E2-C804B56FE22B"/>
    <pav:lineageUri>urn:domeoserver:annotation:764AD4C5-105C-4E17-8EBB-D6C277425C2B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:53:55 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:D67E4EBA-2902-4F1F-B709-6F53A4DE73E0</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:53:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0b30b981e3ec4dab8ee449dd213e0981">
    <domeo:sets rdf:resource="urn:pddi:uuid:7649EB48-4659-4BA7-B849-BA342E7DDF8B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:475F1D2C-51BA-49DA-BEE4-57DA6D1E02FC">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CCD7AB8A-0CE0-4991-8CCD-894DDDCC7F32"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C5E5596-217A-4C95-852D-2F0A6CD487EA">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C5E5596-217A-4C95-852D-2F0A6CD487EA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4C5E5596-217A-4C95-852D-2F0A6CD487EA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:47:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE726D8C-7F7E-43C2-BEA5-31259689A4A0">
    <pav:lastSavedOn>2014-07-20 21:21:42 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:4d867608-6034-4082-aeba-08fb4f0d59a4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-20 21:21:04 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2221B30-2A29-4C16-9090-4E75B7E0AEDD"/>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/36C11962-9D03-476B-98B8-E87892436CE6">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B482F83B-A318-449C-B864-C34A0F7D9EC0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:prefix>AUC by 127%, compared to the administration of </ao:prefix>
    <domeo:uuid>B482F83B-A318-449C-B864-C34A0F7D9EC0</domeo:uuid>
    <pav:createdOn>2014-07-14 14:28:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B482F83B-A318-449C-B864-C34A0F7D9EC0"/>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DD267561-23D9-4467-BC42-A0C76F4F087B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tolbutamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0769544F-AC1F-41EC-84A8-317A809A4452">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:874B7B64-6C2A-4267-AE28-70801AD41B84">
    <domeo:uuid>874B7B64-6C2A-4267-AE28-70801AD41B84</domeo:uuid>
    <ao:prefix>inhibits hepatic gluconeogenesis. The expression of the insulin-regulated glucose transporter GLUT-4 was increased in adipose tissue. </ao:prefix>
    <pav:createdOn>2014-07-14 14:08:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:874B7B64-6C2A-4267-AE28-70801AD41B84"/>
    <ao:suffix>did not induce hypoglycemia in animal models of type 2 diabetes and/or impaired glucose tolerance.</ao:suffix>
    <ao:exact>Rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E840C550-A3FA-4315-9644-0E54F7F3EA8F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E840C550-A3FA-4315-9644-0E54F7F3EA8F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:suffix> AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <pav:createdOn>2014-07-13 14:38:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E840C550-A3FA-4315-9644-0E54F7F3EA8F</domeo:uuid>
    <ao:prefix>. The mean increase in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D344422-E49D-4A6D-A4EF-1F8DE7EC669E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 13:59:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E299A69-7012-4228-8CC3-DC2F6A333380"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:548FEE08-2C12-4A6D-807D-15917CC4A9A5">
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:69B4CC3D-F889-485F-820B-1A78F72B1013</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:31:57 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:08006C31-AEF2-4A53-AB93-23C7606EE4AD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:67EF6373-65E8-44B4-BC03-21748A973E3E">
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/1ca7dc28-841a-49ed-9e2e-7567afd000a1"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 21:34:22 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:e0906d9f-40da-4766-b22a-18cfd5648862</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N218a3477749d40ab920fd6551d1612be"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-112.txt.html</ao:annotatesResource>
    <pav:previousVersion>urn:domeoclient:uuid:935991e5-ca1a-461f-b2ed-9c4f4082430d</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9EBF6B9D-30C7-425A-8E9E-B990CBABD166"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ADC3C789-70F1-4FE1-A8B7-219C2B42A48B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D01B81CE-09EA-4696-9C80-161065BB8C80">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C442770-348C-4AAB-8CE7-5AE43CBBEEEB"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:50FCED91-5F3D-4068-951D-13F3B60B4C62</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:25:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:25:20 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB60D2F5-F01F-4FED-9269-88A5958AF552">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB60D2F5-F01F-4FED-9269-88A5958AF552"/>
    <domeo:uuid>CB60D2F5-F01F-4FED-9269-88A5958AF552</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:38:59 -0400</pav:createdOn>
    <ao:suffix>e</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:exact>Cimetidin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49FB6983-E51C-4611-BCBF-B8EE2F771B88">
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:49ADF7D8-E82A-4905-A70E-977D1E43AA87"/>
    <pav:createdOn>2014-07-13 14:49:41 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:935A3E41-35EA-4680-AFD3-93EC7AE37C97">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:37:36 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:935A3E41-35EA-4680-AFD3-93EC7AE37C97"/>
    <ao:prefix>, therefore, increases </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation.</ao:suffix>
    <ao:exact>cGMP </ao:exact>
    <domeo:uuid>935A3E41-35EA-4680-AFD3-93EC7AE37C97</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C005D5B3-3371-44F5-A9A3-2AA59A112CC1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:38:28 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7EEC6BC-124A-48D0-8A0B-89DC26C3A2AC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F19A4698-7758-48BB-BA98-947783DF2EB6">
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 15:55:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B5E7563-69FB-47D8-851A-D0622887AAC1"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79B8A3C0-204E-4C8C-AB84-3DBEE919D050">
    <ao:body rdf:nodeID="N7bc5bf00555c458d972c4d6fb8d559fc"/>
    <pav:createdOn>2014-07-20 21:56:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:84F64974-6142-4275-AEE1-AF5D2FC01F05"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 21:56:47 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:058292D1-F68D-4213-BC3B-8D89F9C0500A</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:112550DE-F811-433C-9B7A-F824D4140201">
    <domeo:uuid>112550DE-F811-433C-9B7A-F824D4140201</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> 400 mg to six healthy male volunteers. After the administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:112550DE-F811-433C-9B7A-F824D4140201"/>
    <pav:createdOn>2014-07-13 15:54:38 -0400</pav:createdOn>
    <ao:exact>cimetidine</ao:exact>
    <ao:suffix>, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35DC6D04-1356-424A-958E-CB74DF00CEE6">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:33:32 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:033A02C1-428B-407E-AF6F-A0214E996ADB"/>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16AE6D16-D2D3-4D3D-96E9-107AB8AAA5D5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nb6e0f4138ce54821bff758fce8d7fdc6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:C695803C-F876-4316-8563-FFD22F9C8D2E</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:35:21 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-14 15:35:22 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:953C880A-3315-406F-9C98-B28D9ADE5BD7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E657762-1784-45DB-AD4F-2ADA2132AA07">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:44:01 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DA56E4A-6ADA-42D3-9A74-5E768F688858"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6D653F5-8672-4616-850F-7595FE4934A0">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:14:58 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Ncfd11d69529645278d6554ab5cb7e10f"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3435341E-7364-4F7A-8B30-06C2BF5C3AC2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:408FE757-3C82-4E9F-B650-3D447D4BBC7C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 15:54:45 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F175F7AF-622E-4079-BCD1-470178128C83"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5895DE06-4E3E-4F22-9346-B9DF978976AC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:10:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:AA1003BD-0D0B-4E6F-85C1-8D5BC43E5409</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:355E97C3-7B62-4B90-9BD2-37DBA2F13617"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28532EB6-2049-433D-A3BE-E723EF7A10A7">
    <pav:createdOn>2014-07-14 15:50:17 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8392E813-0E90-42C8-97AD-FAC2DDFCCB13"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/76ACE6B5-3D00-4147-905B-481C54B994FB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3364</dailymed:activeMoietyRxCUI>
    <rdfs:label>didanosine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BE1E166-79EF-4EA3-91A4-E33A8867A502">
    <ao:exact>Co-administration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine</ao:exact>
    <pav:createdOn>2014-07-14 00:14:01 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>7BE1E166-79EF-4EA3-91A4-E33A8867A502</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BE1E166-79EF-4EA3-91A4-E33A8867A502"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD">
    <ao:item rdf:resource="urn:domeoclient:uuid:24A0AFEC-D04E-4A9E-8F17-8C7F1A891B98"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F931F147-885D-41D0-852B-E34B0168B75C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF35217B-80CC-4C97-BCD6-03C1471E6786"/>
    <pav:lineageUri>urn:domeoserver:annotationset:15331652-C02A-42E7-B19F-9C0B6B766772</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCED36C6-B2BC-46B8-B71D-F0ADBB7CC685"/>
    <permissions:permissions rdf:nodeID="Nd5d62ab8910e4c51987888905565a0aa"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:C161CDA1-9B5D-42D6-81A6-A9E3FF049191"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E8C4F6-1F71-435F-A40E-2A8811775877"/>
    <pav:createdOn>2014-07-14 15:45:35 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:069C2CDC-9263-4759-A894-746542B86E88"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9EC80DFF-71D4-4B0F-88B9-A3BA543576EC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A58CFEE-CB47-4FAF-B2C3-F078F9107715">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A58CFEE-CB47-4FAF-B2C3-F078F9107715"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>require more than two weeks (up to four weeks) of drug administration.</ao:suffix>
    <ao:prefix> tablets should be taken shortly after a meal or light snack. Symptomatic relief may be seen during the first week, with optimal antidepressant effects typically evident within two weeks. Twenty-five percent of those who respond to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:hasSource>
    <domeo:uuid>4A58CFEE-CB47-4FAF-B2C3-F078F9107715</domeo:uuid>
    <pav:createdOn>2014-07-14 15:19:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0CF6529-B457-4866-8946-0E9C63BFB4EA">
    <pav:createdOn>2014-07-20 21:05:26 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E3D8E77-DD6B-4DEE-B1FA-368DAAA52068"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N15d729a406ca4b299c35d528bcb67c5d"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 21:05:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:73B3FB5F-25C5-439F-BCD2-31E69052EA41</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4C054237-B470-403C-A35B-AE535CC06BD0</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBD102BC-D765-4751-A1B4-5B1F1376AFC8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:8A66A3C5-1E5E-4EBF-8342-14A271B60E81</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:30AAE68F-C689-411E-BFF1-7C8B847A39AB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:45:11 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">23</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:44:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D028659-C4A2-45FC-84D5-9CF0E9391856">
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:body rdf:nodeID="Na12e13a2d507409fba2c6a486f5a61b3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:23:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:885098EE-12EB-405C-B70A-661E8D02785F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45C36CE1-788C-4B0E-89C7-BF221CF9D14A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8104CD3F-2809-464D-B7A0-56B934F97F82"/>
    <pav:createdOn>2014-07-14 15:25:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:25:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:50FCED91-5F3D-4068-951D-13F3B60B4C62</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:272B9063-8E86-4EFB-AFF6-04EE69988B64">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:783472EA-AC00-4D92-B9EB-E94774672A16"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:A7CF76A0-A5C2-4C16-A32F-635827C3D643</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:42:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:44:14 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0A3C798B-3140-4B7E-B30E-34637942D510">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BFEB82CF-CDE5-4E85-9B81-DC9BDD2A5563"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20E9BBCF-0B8E-4E32-A17B-036CC033AC70">
    <pav:createdOn>2014-07-13 15:57:39 -0400</pav:createdOn>
    <ao:prefix> after 15 days of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>20E9BBCF-0B8E-4E32-A17B-036CC033AC70</domeo:uuid>
    <ao:suffix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (ran</ao:suffix>
    <ao:exact>rifampin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20E9BBCF-0B8E-4E32-A17B-036CC033AC70"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB08A3DA-622C-4B72-AF55-786567D870F7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:5C62A5E1-E846-4FFE-B0D2-F54E63A65412</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:38854486-FAD6-4812-AE1A-68BC6BF47203"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:15:09 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:13:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04ccfbeb-b000-4a55-a4fa-a9d92008534b">
    <pav:createdOn>2014-07-07 08:09:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04ccfbeb-b000-4a55-a4fa-a9d92008534b"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>a single 800 mg oral dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:hasSource>
    <ao:suffix> on the pharmacokinetics of a </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5B667F9-05E2-4645-9230-F32EA6B4EA69">
    <ao:suffix> 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse event</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5B667F9-05E2-4645-9230-F32EA6B4EA69"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:prefix>. In two separate studies in healthy adult subjects, </ao:prefix>
    <domeo:uuid>A5B667F9-05E2-4645-9230-F32EA6B4EA69</domeo:uuid>
    <pav:createdOn>2014-07-14 15:26:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0C21289C-3482-4415-8AFE-F4EFDE31AFFE">
    <rdfs:label>zidovudine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA0AA67E-99A3-44AA-B89A-AED6D0DEA80D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F06559E-F01F-4AA8-AC27-A2D667F000FB"/>
    <pav:createdOn>2014-07-14 14:33:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA3AD80C-88A6-482F-9FC4-6DE41DEB8ECF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone (0.25 mg twice daily) did not show a clinically relevant effect on the pharmacokinetics of digoxin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA3AD80C-88A6-482F-9FC4-6DE41DEB8ECF"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <domeo:uuid>FA3AD80C-88A6-482F-9FC4-6DE41DEB8ECF</domeo:uuid>
    <pav:createdOn>2014-07-20 22:14:54 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78260399-4B48-4D6A-BB23-1F5C1DB11C63">
    <ao:context rdf:resource="urn:domeoclient:uuid:0645BCBF-7588-44D9-9F0F-259C54E9DB46"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:03:17 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00C40DBD-DDB8-4667-85A1-845FF6A0EC8D">
    <ao:prefix>The pattern of LDL and HDL changes following therapy with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:00C40DBD-DDB8-4667-85A1-845FF6A0EC8D"/>
    <pav:createdOn>2014-07-14 14:11:22 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <ao:suffix>in combination with other hypoglycemic agents were generally similar to those seen with AVANDIA in monotherapy.</ao:suffix>
    <domeo:uuid>00C40DBD-DDB8-4667-85A1-845FF6A0EC8D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1B65AAF-5FCC-4501-B613-7B375724DA27">
    <pav:lastSavedOn>2014-07-14 14:58:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:57:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:42A9228C-7605-4287-9210-CB0702357D4A"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63AA3B2B-C74B-423C-A470-42D9557E1562">
    <ao:suffix>200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax i</ao:suffix>
    <pav:createdOn>2014-07-13 23:59:17 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:exact>fluconazole </ao:exact>
    <ao:prefix>(6 mg/kg) before and after the oral administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:63AA3B2B-C74B-423C-A470-42D9557E1562"/>
    <domeo:uuid>63AA3B2B-C74B-423C-A470-42D9557E1562</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0D1B0F4-93D2-4F43-9CFA-E9DCB99FE550">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:08B4F0E2-7831-4C3F-872F-7908F013A5BA"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:AFBD4DF3-2F53-4791-8488-6668A4EB10FD</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:3BF4568D-5BF3-4DE3-935D-3B333D5A3EB7</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 13:54:28 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 13:57:24 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C46EE241-3381-4CEF-8D13-3BB2DF5618DC">
    <pav:previousVersion>urn:domeoserver:annotationset:A566DE70-C58C-4801-99C0-AB3D8A08BA18</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Ndd6a9600e1c4404a81d03cfedae0ea61"/>
    <pav:createdOn>2014-07-14 15:15:31 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:590FE9A8-9B3F-40EB-B85F-003E4A245F10"/>
    <pav:lastSavedOn>2014-07-14 15:15:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96D5C991-A5DC-456E-9D64-4DD7B52BE20B">
    <pav:createdOn>2014-07-20 21:13:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:c617ed29-a536-4a51-95a3-3f1cbb9e8b61</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 21:14:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:21DF0E35-5074-44B5-BE2E-39C734C23383"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:541CC392-EE3B-4E29-85AF-7380F847B755">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:body rdf:nodeID="N253b00d205d0427fa74c9ef7ef7862d1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:a44e2c8f-4b9e-4967-b8db-c857796f8ffa</pav:lineageUri>
    <pav:createdOn>2014-07-20 22:32:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:47a4b968-24ae-4f0f-a4a3-1e8147df3a8f</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:263ACF7F-CFA7-4427-8A35-2A3BDEAD47FD"/>
    <pav:lastSavedOn>2014-07-20 22:32:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8B07DC6-86DF-413F-A291-AA22B4CC9A6F">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7873A0EC-2F8C-4C58-84D1-48C318DA1582"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:42:17 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:A7CF76A0-A5C2-4C16-A32F-635827C3D643</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:44:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:af07b0f7-9cc5-4945-b389-197abde3ee14">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:af07b0f7-9cc5-4945-b389-197abde3ee14"/>
    <ao:prefix>The AUC and Cmax of </ao:prefix>
    <pav:createdOn>2014-07-07 08:09:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (2.5 mg single dose) were sig</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-30.txt.html</ao:hasSource>
    <ao:exact>glipizide</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E8903495-A0B0-4E81-A534-0B33FFE8CE47">
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8089CFAC-1281-4F58-A0F9-C39DB631F17F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:03:36 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:83AF2611-F71E-4896-90EE-6D866FF99775"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90535690-FF72-467C-BFC9-66E4C3B86FC3">
    <pav:createdOn>2014-07-20 21:40:54 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:4023C5A4-DE1E-44A1-977F-25FA31708758</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:41:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AF93E7BB-716E-4E64-BCE0-B1DA8CE4D2F9</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:27404F63-F3EB-4A7E-B804-35E19E45732A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1D2DFDBE-4A91-40A7-B6C8-FD17A4EE70CD">
    <rdfs:label>theophylline</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8B85EE2-490D-4FA9-BE2B-8697019FB457">
    <ao:exact>risperidone </ao:exact>
    <ao:prefix>is well absorbed. The absolute oral bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8B85EE2-490D-4FA9-BE2B-8697019FB457"/>
    <domeo:uuid>F8B85EE2-490D-4FA9-BE2B-8697019FB457</domeo:uuid>
    <pav:createdOn>2014-07-14 15:52:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83DEDFBA-3638-4B3C-87E9-3539366B8790">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 00:12:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C646526-BC6E-4925-8245-2EB52CCD51AB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:134D66B3-37AB-4023-9059-8ECD44307D68</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/13CD0FEE-854B-4A27-A144-8605128D6FD0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F001C05-D2A7-4D62-BB98-D0CA63FB500A">
    <pav:createdOn>2014-07-14 14:07:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC64C9D4-D56B-452A-813C-E1D9FAE070C1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A3BEEA0E-86E8-41AA-B260-FE3EF9BC49E2">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8134</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenobarbital</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/40674DF2-4AB0-4B72-BE36-B6179875DC94">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689">
    <pav:createdOn>2014-07-14 00:12:01 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81F532DC-0494-4D7E-A130-DF143CB81B08"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:986AC187-5D34-4867-AFBA-C8433F2C989A"/>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="Naf299516951c49ffb6fb03be90b40dec"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:83DEDFBA-3638-4B3C-87E9-3539366B8790"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A297685E-33BC-4DAD-920B-6220B0319A62"/>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4FF65FC1-23D5-4F70-A676-40AACF45649D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0AA4C48-41A9-43BD-8EE8-F31A4DCC7D18"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9B42688B-C600-40F5-9710-9FA6CB81930C</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C0FF29B5-3436-4FB1-937A-B10528573293">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tolbutamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0EB0A26-D479-42D5-8C52-187EBE17C0A4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-20 21:07:34 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3377CE81-F0D9-4690-A732-E96CA8DCBB25"/>
    <pav:lastSavedOn>2014-07-20 21:14:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:c617ed29-a536-4a51-95a3-3f1cbb9e8b61</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02">
    <ao:item rdf:resource="urn:domeoclient:uuid:4CF95123-8C3E-4AC8-8FE8-F0045B6D7338"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:25F374CE-1C77-42F4-9054-82A4A5CF1633"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD47852A-FBF5-4E76-B498-B105F27CF209"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA73FD81-BE36-452D-8AF7-36BF7EEACA6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0CADE04B-1D2F-4F33-A33D-05645A3A1368"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A3C8322-C58C-4824-9537-47749E4A77BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7C38443-FAF5-44DE-A56A-E3B79DCCB5EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C83D7098-A26D-484F-B852-C053E3EF8920"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:594745C0-2398-42CD-9D5F-73771B352E35"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5B049D20-0BF5-4A45-B4CF-1E997279A13C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C005D5B3-3371-44F5-A9A3-2AA59A112CC1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58C9619F-518B-44E5-A36D-530B8A48B4C7"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:18:20 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:AE8138E0-9D44-4B9F-8195-A6DC23914988</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B0AE6E9-2A4D-447C-8458-3B68FA9FA20C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:C0274940-28B6-44EC-9939-4E6325365E22"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C8A8132-167F-45D6-970D-50721AE732DA"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5AD781D5-79C0-4997-A8FE-2DA3F3BB2502"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:67E793B4-B7C1-4873-81F6-CDDC4A13B720"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90E91CE5-FB39-4968-8AF5-B7CDB511BF7F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:74DEB7D4-9543-4829-B272-BF59AA13AC97"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58F72512-576D-402B-A522-563246BFB1F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2DF66BC-423C-4819-9019-E9CB779C506E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35B872AD-CE76-475F-A13E-387450CA96D9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:710125B6-05F6-4D89-99C4-C24BBC6FC63F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1D32611-12A6-484E-AF7D-AD9FF1C038BB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7E04482-9101-4365-BD5F-E1F93FB2EB13"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8938DD8-F07C-4CCD-B376-DD381766E6E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B86BDB91-30BA-4D92-AD89-8E468545F774"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:593206DE-6B60-4404-B7C1-4F46BD29CB6E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:64504D98-005B-4ECB-AFA2-A4D9BB1CFCC3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0D091A8-A8A9-42CA-AB30-C1A370B5BF92"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:51255C4A-016D-4EC5-8FDD-638FE9C2A7E7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6AAA2938-667F-4834-8FB5-BD1C820B541F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71D837C7-D687-4607-95FF-4BD95F544864"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:499B3DF8-59D4-4E33-86BC-A4B323D8F805"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7604DAB8-64E6-4865-8E64-717B6A4BFF43"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:887DE4D9-4AEB-43CC-8197-17E3F102E6F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1201551D-97D3-42D5-94CA-CB103E9BF4BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DBCC441D-CC6D-43EF-9768-612425898015"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:740BE9BF-079B-434B-A7CE-DB1241AC5C51"/>
    <pav:createdOn>2014-07-07 09:34:47 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0E657762-1784-45DB-AD4F-2ADA2132AA07"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA2AC80A-9C85-4921-B302-367861299DA3"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA548A1D-68C2-4599-89EF-8C0B45EAA27B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:38E1F199-7B1C-40D5-8766-2CEADB62D668"/>
    <permissions:permissions rdf:nodeID="N232334f29216408497f9ae26eb7f0320"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA91473-653C-480F-9C91-6E28EE5C0D15"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:78F4A53A-48DF-47FD-B430-96D6F6DA5FAF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3956C85C-5ADE-4B49-853F-74AC124377EC"/>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C51B56B-3ED5-4D07-96A6-1858FE942795">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 14:49:26 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:80946A21-D6CC-4F00-BE40-C81A4D5974E3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A8A5BE3-9A8B-4E32-B698-3A155F1E8736">
    <pav:lineageUri>urn:domeoserver:annotation:EA0950EC-D24E-41B5-8542-B53F6A3BF2E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5FE461E0-58D7-4E9E-B5DE-69728C3EF270"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:17:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5F2905F-D14C-4C3C-BCE5-81F7C2290A31">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:661131FF-E5A2-4EE3-8C61-BCAF2C9423B9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:23:30 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAED9F67-B764-4379-BF32-C623F2400E01">
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0B3F136-A2DA-402C-966A-F651CF933AB6"/>
    <pav:createdOn>2014-07-14 15:12:51 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D57AA31-05E1-414A-82A5-F1465C9BD3A1">
    <domeo:uuid>4D57AA31-05E1-414A-82A5-F1465C9BD3A1</domeo:uuid>
    <ao:suffix>, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabo</ao:suffix>
    <pav:createdOn>2014-07-14 00:24:08 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>had no appreciable effect on the steady-state plasma concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D57AA31-05E1-414A-82A5-F1465C9BD3A1"/>
    <ao:exact>phenytoin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED3121E4-8B7C-4FB3-9B8D-35F3B6C92CD0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 22:02:23 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED3121E4-8B7C-4FB3-9B8D-35F3B6C92CD0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>ED3121E4-8B7C-4FB3-9B8D-35F3B6C92CD0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2C1A11E-24E0-405D-A5ED-B54DA23BE3A6">
    <pav:createdOn>2014-07-20 22:06:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2C1A11E-24E0-405D-A5ED-B54DA23BE3A6"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A2C1A11E-24E0-405D-A5ED-B54DA23BE3A6</domeo:uuid>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35CBA4C1-DDB3-4254-9572-00A7C57054A3">
    <ao:context rdf:resource="urn:domeoclient:uuid:73FC6F4E-B5BF-4EB0-856F-AF5AEB56DC10"/>
    <ao:body rdf:nodeID="N7d1fcdc71a664ad3b41d0805f9a0d59f"/>
    <pav:createdOn>2014-07-20 22:17:34 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:30B00218-F90E-4FF9-8E61-BA23A4380A3F</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 22:17:34 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3F7C3F1-AE92-43C1-9CA1-E5C138372093">
    <pav:lastSavedOn>2014-07-14 15:05:59 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6FAB58C-924E-4B34-86A6-41311AD57722"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:05:20 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF312A94-575B-4B8B-A18C-9AACB3205407">
    <pav:createdOn>2014-07-14 15:04:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF312A94-575B-4B8B-A18C-9AACB3205407"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BF312A94-575B-4B8B-A18C-9AACB3205407</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Co-administration of cholestyramine or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4DEDC71-1C2D-4DC8-830E-D12E97F1A902">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:AA04C9C9-75B9-4F98-8427-9C284456866B</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:01:48 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Ndab2583855c14b7b91e720ba51859bc2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FA21F32-D373-4CF9-ADFC-31F76BED0A67"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 22:02:03 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0764FFD-3129-4C37-9ABC-7401CA3304C4">
    <ao:prefix>, to parent drug ratio significantly decreased after the administration of </ao:prefix>
    <pav:createdOn>2014-07-13 23:55:19 -0400</pav:createdOn>
    <domeo:uuid>F0764FFD-3129-4C37-9ABC-7401CA3304C4</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0764FFD-3129-4C37-9ABC-7401CA3304C4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:63D66C0F-316A-45FD-A9F9-323DA47C4EEA</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:04:38 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:23F36509-0614-43F9-924D-7EF7B847092B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB178C28-C043-4B54-A75F-304283D5ED1D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DF80D84-8381-4449-9F22-4ABD6660C6AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6625C6B5-F306-45E9-A073-F5C64BA7B7AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE81CB3B-EBA6-42B3-B93D-9BF9CAEB0E8B"/>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N38335c204bfb4f2f8b927ddfc7719d66"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:2A44D91F-F86F-48CB-BFF5-CB7A3CDE8615"/>
    <pav:createdOn>2014-07-14 15:03:09 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F5CC3A3-C193-4A33-8427-3AA2F7A26581"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D0C75F6-6E68-4F8D-B2B1-A755E8E3425B">
    <ao:exact>The Cmax values of nifedipine in the presence of cimetidine were increased by factors ranging between 1.60 and 2.02</ao:exact>
    <domeo:uuid>1D0C75F6-6E68-4F8D-B2B1-A755E8E3425B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D0C75F6-6E68-4F8D-B2B1-A755E8E3425B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:hasSource>
    <ao:prefix>. </ao:prefix>
    <pav:createdOn>2014-07-20 21:33:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. The increase in exposure to</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30500CEB-FE00-459F-91E6-CCCB5669463B">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:105DA8CC-4801-42A7-B880-1FF45DF02C0F"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:11:13 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8FAE16C3-486C-42CF-BC58-8F7B8D40E38B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdfs:label>ethinyl estradiol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B97D060-A92E-4DE6-9631-D9431C40495A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:8C562F23-B46A-4331-8AF0-A6F4674F6797</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:217C265B-6D9D-4552-8330-D79644D90CAB"/>
    <pav:createdOn>2014-07-13 14:38:31 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2093A3B0-20D0-46F4-B2FB-FE5C8A4793C8">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-20 20:49:12 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:49:06 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7A214A93-2426-48A1-B636-1337A2D9E56A</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:325ED69B-8C49-4CD2-922D-266C897B186B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0BFD3ECF-0629-4897-AAA5-5FB5ABE39E8E">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C55AB560-FFE7-4925-ACA0-D74F8519F26F"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:52EA4F51-A88B-41B8-9E40-4E1A27AB19EC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E4066C2B-1A2B-4EB9-BEDD-5E2051FE9E5C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1B2D1779-276F-413D-AEC9-CC35B60FA0A4">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DAC237E6-032D-4F62-BE59-D442943F6A84"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:e6712706-f454-49c6-89a1-48570d61642c">
    <pav:createdOn>2014-07-07 08:08:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>conivaptan</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>increases in Cmax and AUC of </ao:prefix>
    <ao:suffix>, respectively [see Contraindi</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:e6712706-f454-49c6-89a1-48570d61642c"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDDC451D-DB10-45C3-916F-DE83B5FA894A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0764FFD-3129-4C37-9ABC-7401CA3304C4"/>
    <pav:createdOn>2014-07-13 23:55:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42526B14-2925-4E0A-B27E-F7AB349EFB23">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42526B14-2925-4E0A-B27E-F7AB349EFB23"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>P450 </ao:exact>
    <domeo:uuid>42526B14-2925-4E0A-B27E-F7AB349EFB23</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>enzymes at clinically relevant concentrations. In vitro data demonstrate that rosiglitazone is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokin</ao:suffix>
    <ao:prefix>does not inhibit any of the major </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:23:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:43094D9A-060D-4712-A34E-09F917644BF8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:147E9D8C-BB67-4DAB-A0AE-3250BFC6360E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:c4cc0b55-16cf-45eb-a692-55166c0ff571</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N41022670fd884fa2beac0f3999a0ba44"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-20 21:17:04 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/f16f4148-1c48-4f6f-9232-594b605319a6"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:09:18 -0400</pav:createdOn>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:93eba70d-6a1c-4636-ab05-083ee0087049</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-192.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C62C57C9-D3AF-48D4-8F17-2C1140FDF759">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:59:07 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:69162B97-85CE-4930-B176-2D9320EFABBE"/>
    <pav:lastSavedOn>2014-07-14 15:00:43 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:783472EA-AC00-4D92-B9EB-E94774672A16">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:783472EA-AC00-4D92-B9EB-E94774672A16"/>
    <ao:suffix>or rosiglitazone.</ao:suffix>
    <ao:prefix>(500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either </ao:prefix>
    <pav:createdOn>2014-07-14 14:42:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>metformin </ao:exact>
    <domeo:uuid>783472EA-AC00-4D92-B9EB-E94774672A16</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE425825-8F21-4D56-A182-F047657EBBED">
    <pav:createdOn>2014-07-20 21:32:35 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 21:32:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N1a394f8933854a15b68866a30e4f6038"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:831af861-283a-4830-a91e-c36b0a7b18d4</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:56075848-a02b-4727-b78e-3e46a3ebe240</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0CBA1D0E-EE21-43A4-A435-C10B50636A5C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:634D2AAB-74D7-4264-B8F7-545FA873F964"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD41230F-0741-4986-A669-0CA0975CADD9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:51:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N8d7d3daa1cce4cd48caf2f0504a14f75"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CEE1968C-30D8-4376-A0D9-107831DABF5A"/>
    <pav:lineageUri>urn:domeoserver:annotation:F6E22D8B-F9C8-42F3-ACB3-1D49E4AD30E0</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:16AF6B78-9915-4978-BA10-0534B7220A56</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:51:13 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94C25269-4810-41F4-A427-244868A8E338">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:37:20 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:1B2D1CB1-AF4A-4392-B9F9-E4972994FD93</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:936E07F0-EB98-40E1-A094-0BC98472D52C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:36:33 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:d637dee9-5167-42cc-880c-41448bf7c6c0">
    <ao:suffix>. Increased metoprolol plasma </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-81.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:exact>metoprolol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:d637dee9-5167-42cc-880c-41448bf7c6c0"/>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <ao:prefix> the beta-adrenergic blocker </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5DD10163-B459-4AF1-BDD3-4954A6197369">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/04B73200-8828-441C-8C58-84D06189FF0B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BD7C5FC2-BE60-48C0-8A69-2D4E224E0F98"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb412c1a555734327ad6d10a03b0dd895">
    <domeo:sets rdf:resource="urn:pddi:uuid:859AAAA8-FD74-4E07-98E4-F05008D361FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D0EBB027-3A62-405B-8549-2C1215178F0B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2BE79849-42A4-447A-9F36-9F940FDA7FD0"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7BBB7AA-7E29-4784-B124-0C1FF7BE4435">
    <ao:prefix> accounts for 14% and 74%, respectively, of the dose following oral administration. A second metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C7BBB7AA-7E29-4784-B124-0C1FF7BE4435"/>
    <pav:createdOn>2014-07-20 20:46:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C7BBB7AA-7E29-4784-B124-0C1FF7BE4435</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix> (AMT), has been identified in the plasma following single-dose intravenous (IV) administration of </ao:suffix>
    <ao:exact>3'-amino-3'-deoxythymidine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0509C8AA-EF81-4DE6-BE6D-A72681D9B74F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10502</dailymed:activeMoietyRxCUI>
    <rdfs:label>thioridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AE86C8F9-71A2-4E4D-AA99-632A91F221F6">
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:48CA2567-4617-464B-9D33-7985EBFDAF1B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B4C97892-60FE-45C6-B827-555B44457702"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A5ED559-DED3-41B0-8FCD-ED86B82E452D">
    <rdfs:label>paroxetine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/529D9ABE-231C-442F-94F5-98F1E4CC8A1E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E74D7F41-C3C5-4E58-B5FB-D30661810CA1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>gemfibrozil </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E74D7F41-C3C5-4E58-B5FB-D30661810CA1"/>
    <domeo:uuid>E74D7F41-C3C5-4E58-B5FB-D30661810CA1</domeo:uuid>
    <ao:prefix>Concomitant administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:28:17 -0400</pav:createdOn>
    <ao:suffix>(600 mg twice daily), an inhibitor of CYP2C8, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42F5C75D-314E-47EE-82D1-B11BDC6E1AF0">
    <ao:exact>PDE5</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>is selective for </ao:prefix>
    <domeo:uuid>42F5C75D-314E-47EE-82D1-B11BDC6E1AF0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42F5C75D-314E-47EE-82D1-B11BDC6E1AF0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:37:53 -0400</pav:createdOn>
    <ao:suffix>. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is impor</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1C268B5-6BC3-4678-A83F-B8577ABEEF6C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1C268B5-6BC3-4678-A83F-B8577ABEEF6C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>resulted in up to 50% decrease in </ao:prefix>
    <ao:exact>propranolol </ao:exact>
    <pav:createdOn>2014-07-14 15:03:14 -0400</pav:createdOn>
    <domeo:uuid>D1C268B5-6BC3-4678-A83F-B8577ABEEF6C</domeo:uuid>
    <ao:suffix>concentrations.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C49A99DB-6535-4834-8793-87F74FBE696B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3908C93B-3FA8-45E2-99DA-EE0516518457"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F53E5468-3974-4391-9325-89ACD826409D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE21E93E-223E-4EDB-BDBE-2A17DCAA138C">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:BCBC813C-26E8-4167-A861-2A127BD4B194"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:52:40 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F2ABA6C-3921-4F59-9D48-8E02DA9E1084">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F2ABA6C-3921-4F59-9D48-8E02DA9E1084"/>
    <ao:suffix>(2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:suffix>
    <domeo:uuid>2F2ABA6C-3921-4F59-9D48-8E02DA9E1084</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Concurrent administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-14 14:42:23 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D">
    <ao:item rdf:resource="urn:domeoclient:uuid:9B3804DF-439A-4567-A6D0-C1CEADAAE040"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:9372314C-A230-4A4C-8D91-E38EB06994EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:314A9916-550D-4E1C-8B93-378A6818577A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A41E5726-CB3A-4EB2-B011-D43D24A0CCB5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79B8A3C0-204E-4C8C-AB84-3DBEE919D050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21105C35-24BE-42D6-91BE-E8098A83CA63"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44D26FF0-9C88-425F-BD66-8CC2F3CB2B18"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:4EB5CCA0-E7A8-44DB-9A3D-A4FC0CCFCB59"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61726DE6-CCE8-4DFA-BA53-6657D2AE1361"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F40FD644-8BD9-4A38-AB84-DDB7EDF84363"/>
    <pav:previousVersion>urn:domeoserver:annotationset:0C3A23F3-692A-4072-8DFD-7B3A4BC00581</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:521F4DE2-CCEF-4D75-B5D8-2331E2C11BC6"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7203243A-1F22-4097-B0B6-2E6B9FD1DD0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD22DF06-EA15-4549-85B5-842A0F4D11C6"/>
    <permissions:permissions rdf:nodeID="N70fdf79a395841d48e696610bfb22fac"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5482918E-25A3-416A-9A0F-2447BC00CD12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE35E9E9-3163-4055-A3AF-F0F2DB4FEF84"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A78F5331-D727-4933-ACEB-25D18E39AA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:222293E7-679B-4BCE-ABED-0516BB481AE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7E743095-492B-413E-ACD5-5890ED7190FF"/>
    <pav:lastSavedOn>2014-07-20 22:03:36 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6EE65F7-6FA6-4781-8E7C-4CE575F0DF11"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA0BFC3-A990-495C-8705-283BD6015459"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5859887-8D70-4483-B3AB-D761286AB512"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD7ECD61-8E14-45F2-907A-0ABA6A22D947"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E77B5B61-8D0C-40C1-A89F-2FB849FFCAE0"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E8F4575A-6E81-41A7-9180-23E52174F1E7"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:04D5BE4C-3158-45A9-B8BC-540CC74E85B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:250650BC-CC4F-40A0-BD84-08622DA45BFC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F4ED9D3-5133-4145-9D5D-DE8F072ED4C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:894838DF-AC3A-4DFE-9080-DBC82491C758"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84C2CB34-1630-4D81-B99F-BE8565B74420"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4DEDC71-1C2D-4DC8-830E-D12E97F1A902"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/9d8f35a8-4978-4d7e-a9b3-ecacfc22eab5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE666A09-D3D2-40C5-8258-A66C8CB88000">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F262549B-5F75-4AD6-8B52-2A200E9E3368"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7C17198E-3C41-4F16-A801-28063E1C3E40</pav:previousVersion>
    <pav:createdOn>2014-07-20 20:29:29 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 20:29:30 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:body rdf:nodeID="N19451323bf344750ab441f5ccd3a761a"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C63B787E-B3A4-46FB-85F1-DF955887F744">
    <ao:exact>Repeated oral doses of risperidone (4 mg once daily) did not affect the pre-dose or average plasma concentrations and exposure (AUC) of valproate (1000 mg/day in three divided doses) compared to placebo (N=21)</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C63B787E-B3A4-46FB-85F1-DF955887F744"/>
    <ao:suffix>. However, there was a 20% increase in</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C63B787E-B3A4-46FB-85F1-DF955887F744</domeo:uuid>
    <pav:createdOn>2014-07-20 22:13:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CCAA2803-5EEB-4AA9-A4D5-E11BEDC5809E">
    <rdfs:label>fexofenadine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88924AE7-7FDD-4FE3-B89A-5414BFA6907E">
    <pav:createdOn>2014-07-13 14:58:44 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C66DD857-DBA8-47C6-949E-883D629C3B3F"/>
    <pav:lastSavedOn>2014-07-13 14:58:45 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:17F1ED56-07FD-4E2E-A59F-03B231459952</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N89016168d51047e7818270d29905c1f7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3630F892-8B97-4E54-83B6-89A8ABA5C1BB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 20:22:37 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E071D1FC-20CD-4D09-B79E-A18C918F0469"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7B4C48B-8305-4B8F-AF91-F60EC32F9052">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:36:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:749A982C-1C6F-4EC5-822D-5846D27D5A06"/>
    <pav:lastSavedOn>2014-07-14 15:38:08 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:261FBCCB-D709-4392-82BC-685600FA5428</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C95081B-328F-4E21-817A-D42CE8FEDE58">
    <domeo:uuid>2C95081B-328F-4E21-817A-D42CE8FEDE58</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:49:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:exact>In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d. with immediate-release metoprolol 50 mg t.i.d. resulted in two- to five-fold increases in the steady-state concentration of metoprolol</ao:exact>
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C95081B-328F-4E21-817A-D42CE8FEDE58"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:811DB7F2-5DD1-489F-B2C7-A89B8956DA8A">
    <ao:exact>Uricosuric drugs, such as probenecid and sulfinpyrazone, can inhibit renal tubular secretion of nitrofurantoin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:811DB7F2-5DD1-489F-B2C7-A89B8956DA8A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-36.txt.html</ao:hasSource>
    <domeo:uuid>811DB7F2-5DD1-489F-B2C7-A89B8956DA8A</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 23:20:40 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:22AD69A3-05C3-4F20-92A1-A29E166F01BF">
    <domeo:belongsToSet>urn:domeoserver:annotationset:ADA754D7-8F98-4A1B-A03A-7494BA24B16A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:26:56 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:26:55 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC9296A5-C566-49AE-BC1C-8A52E61ED7B2"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Nd1f6dd4d853c4d81ab7df9f745880175"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:4B9D5CAA-03B0-4029-B632-5D7519E7D7BB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1359537D-E2F3-40E7-9BEE-88D45BB4D3FA">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7FCDBA82-A0EA-4942-9FE8-ADFC6D2B6FE0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:A7CF76A0-A5C2-4C16-A32F-635827C3D643</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:44:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:42:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E4BC4F8D-E61A-4B30-B2B7-F3246B516D4C">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:08D4CE38-B274-4CA5-A6A7-8A31D9B99ED6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49373B45-F6BE-435A-B987-90009A6BF72D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:87b7c298-8ac5-448c-a8b6-3df7ca45b625</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:08:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:09:20 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Ned36fdfec9a0487980bc11939410a715"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:25EA107B-55E7-4F53-82DA-95E6E9308587"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4033ACE4-AA22-470E-BB24-5B38B949FF75">
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1201551D-97D3-42D5-94CA-CB103E9BF4BF">
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:09:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AC2D793B-54AA-4D45-86A1-D42CA557334B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:5BD6AA8F-46DC-4A84-891D-E3CE8ADADC9D">
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <permissions:permissions rdf:nodeID="N9ae2f5b8a8b04e63a417930d1ca19b13"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoclient:uuid:ace39cb5-a08d-4d82-af8c-9aa129b36f60</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:08:57 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDDB7D24-DB36-4290-8D46-E3A008DAB715"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-110.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/90d43cff-af53-450d-97c6-e286a4ddb4c3"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 21:30:35 -0400</pav:lastSavedOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:e9baa0ba-8ace-46bc-ad37-1407aba4cb5c</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14014694-722B-463D-8CFB-283D360F24E7">
    <domeo:uuid>14014694-722B-463D-8CFB-283D360F24E7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14014694-722B-463D-8CFB-283D360F24E7"/>
    <ao:suffix>has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) f</ao:suffix>
    <ao:prefix>acts as an antagonist at other receptors, but with lower potency. </ao:prefix>
    <pav:createdOn>2014-07-14 15:50:45 -0400</pav:createdOn>
    <ao:exact>Risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E3A0235-DCFD-459A-8F14-2890C2BE937C">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E3A0235-DCFD-459A-8F14-2890C2BE937C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <domeo:uuid>1E3A0235-DCFD-459A-8F14-2890C2BE937C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>quinupristin/dalfopristin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 21:21:08 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6C13FE5-66B6-4E94-9AE2-29A6538BF6E0">
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C6C13FE5-66B6-4E94-9AE2-29A6538BF6E0"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C6C13FE5-66B6-4E94-9AE2-29A6538BF6E0</domeo:uuid>
    <pav:createdOn>2014-07-20 22:03:13 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57089BDA-24A6-4128-85C0-8AB8591105EB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>57089BDA-24A6-4128-85C0-8AB8591105EB</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <pav:createdOn>2014-07-20 22:02:51 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57089BDA-24A6-4128-85C0-8AB8591105EB"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:027918B1-469E-419C-82BD-87C275C47917">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:027918B1-469E-419C-82BD-87C275C47917"/>
    <domeo:uuid>027918B1-469E-419C-82BD-87C275C47917</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 20:37:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F5F3635-63E8-45D6-A1D7-ED0A6A16E7B0">
    <domeo:uuid>4F5F3635-63E8-45D6-A1D7-ED0A6A16E7B0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F5F3635-63E8-45D6-A1D7-ED0A6A16E7B0"/>
    <ao:exact>propranolol</ao:exact>
    <ao:prefix>does not alter the pharmacokinetics of </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:57:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A81E644F-1C28-4C13-AA67-0D9F8F092B13">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <rdfs:label>norethindrone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C1D7D94-E8DC-4AD9-A34B-AB98CFC25DD2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 22:34:40 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5a52faba0d9f405d80d8454f3e2d1381"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:75881584-7AB7-48E9-BB30-9B332B3D1661"/>
    <pav:lineageUri>urn:domeoserver:annotation:70DB71CA-4C7E-414D-80FA-9BFC9064039B</pav:lineageUri>
    <pav:createdOn>2014-07-20 22:33:42 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBA0136A-E3AC-425E-AA53-0A9D099D4B69">
    <pav:createdOn>2014-07-20 23:02:04 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N683b8e9829854159a33a71d8e1896980"/>
    <pav:lastSavedOn>2014-07-20 23:02:32 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0152500B-ECCE-4E95-8F3F-B3FD831A70DF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:90649C44-B159-4B0F-9960-F57339980BA3</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96FC24C5-FC7C-4873-AD87-FCF9472681C5">
    <domeo:belongsToSet>urn:domeoclient:uuid:D67E4EBA-2902-4F1F-B709-6F53A4DE73E0</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nbecc0bf4d7bd45c0b439430a739b6f7e"/>
    <pav:createdOn>2014-07-14 14:53:57 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB42C0C7-E2EA-4FB1-9566-1CB2FBBEE7F0"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:3023776E-1AA6-400C-9B33-5E6883D00A5D</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:53:55 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FD1AA0B-C794-409D-9E49-1F256BA00CDD">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3FD1AA0B-C794-409D-9E49-1F256BA00CDD"/>
    <ao:exact>Sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 11:07:55 -0400</pav:createdOn>
    <ao:suffix>had no impact on the plasma levels of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg).</ao:suffix>
    <domeo:uuid>3FD1AA0B-C794-409D-9E49-1F256BA00CDD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F5C8BE47-13CA-4CE1-A05F-B1A4280B8693">
    <rdfs:label>nifedipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AABDB76F-19E8-4781-9E6B-ED84810D0E54">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:16:17 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N70372e2d52084e43948d63c14e9f4e51"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:36A43FFC-CDD5-44E8-9521-7E09FE1B21F2"/>
    <pav:createdOn>2014-07-14 15:16:19 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:EDCD6863-BD39-4E6C-A535-E4DCAE77B2A4</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8139538-CBBA-4CC7-BE1E-8A2ABF951A1A">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:22:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:20:48 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8C52EF1-5A65-4253-A293-005A68BF9C4E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:475DA2FE-928A-4FC5-8BF1-461E941EB8A4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:475DA2FE-928A-4FC5-8BF1-461E941EB8A4"/>
    <domeo:uuid>475DA2FE-928A-4FC5-8BF1-461E941EB8A4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>or </ao:prefix>
    <ao:suffix>. The findings of these studies are summarized in the following table:</ao:suffix>
    <pav:createdOn>2014-07-14 15:26:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2DF66BC-423C-4819-9019-E9CB779C506E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <ao:body rdf:nodeID="N5ba657e2acdf4c86a74cf89b2ad3e53a"/>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4274C027-B092-46B3-B4FB-8A59A3AC83EE"/>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:12:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4F2DD3F-7165-4015-A692-8A7AEEBC58F8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4F2DD3F-7165-4015-A692-8A7AEEBC58F8"/>
    <ao:suffix> [see Drug Interactions (7.1)]</ao:suffix>
    <pav:createdOn>2014-07-14 14:30:48 -0400</pav:createdOn>
    <ao:exact>Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced</ao:exact>
    <ao:prefix>. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B4F2DD3F-7165-4015-A692-8A7AEEBC58F8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16AF6B78-9915-4978-BA10-0534B7220A56">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:49:58 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N0309f2de9c0b42f6b9073bbac5aed890"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7DB5499-620B-464B-9769-D3E961A61EEB"/>
    <pav:lastSavedOn>2014-07-14 14:51:13 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:DD41230F-0741-4986-A669-0CA0975CADD9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:113E0FF8-269E-46B2-88C3-27D56B7CB970"/>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:24783CAA-6FF4-404B-A714-B835E876F141</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB87A9EF-7D85-4C94-B4C9-B9DDB2353518">
    <pav:createdOn>2014-07-14 14:54:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:exact>propranolol</ao:exact>
    <ao:suffix>.</ao:suffix>
    <ao:prefix>does not affect the pharmacokinetics of </ao:prefix>
    <domeo:uuid>CB87A9EF-7D85-4C94-B4C9-B9DDB2353518</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB87A9EF-7D85-4C94-B4C9-B9DDB2353518"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F8CB0DA6-E11A-42A8-BEA9-D0F8963B1ADE">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/202807</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>SEPTRA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B72196C6-8245-4C89-A5FC-0907252FF162">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B72196C6-8245-4C89-A5FC-0907252FF162"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>B72196C6-8245-4C89-A5FC-0907252FF162</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-85.txt.html</ao:hasSource>
    <ao:exact>In a study of 13 healthy, male volunteers, a single 40 mg dose of tacrine added to fluvoxamine 100 mg/day administered at steady-state was associated with five- and eight-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone</ao:exact>
    <ao:suffix>. Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:44:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:91D7CE6B-02D3-45FF-8E3E-11641C822319">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:82C0520F-2BA6-4B31-93EC-52EAFBA14FAC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:906C71AA-A68D-4B07-9173-8404D6AC0B88">
    <pav:lineageUri>urn:domeoserver:annotation:8DC2733A-B31E-4F4D-9B3F-8D021A1F35D0</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:11:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B458216-3F8B-417B-9505-2F5C6BBF2715"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5896BA13-194C-4FE4-B3C7-9D01720C79B1">
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:annotatesResource>
    <pav:previousVersion>urn:domeoserver:annotationset:AEC842B8-7767-4D1E-8C5C-E4352B7F4650</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE633226-2A2F-4C88-99A8-EE2BD0E3D987"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DAD668E7-4FE9-4E53-87DA-A40162094D4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F19A4698-7758-48BB-BA98-947783DF2EB6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:661631F1-239C-4984-A953-CCD787046D36"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C72F630F-0659-45FA-AD82-178873B7AB96"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A5C0B7D-E4B9-44CB-9047-E9015462CC2F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DBE6388-DF62-40C2-973C-F3FBD0E27179"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:408FE757-3C82-4E9F-B650-3D447D4BBC7C"/>
    <pav:lastSavedOn>2014-07-13 15:56:14 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-13 15:54:31 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N4c9931de075d4c20acfa7ed825afd4ba"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F6B5F1D-46CF-49E7-B31C-2D2D38DB56F6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50D09A15-B89D-498F-8E12-6C483F9122F3"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DD0A32F-ECBB-4255-88EE-2AFF24578DA2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:9579423D-AA96-468E-B401-A4679754CF48"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 14:49:22 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:946DC0F8-6735-4931-A702-523CADB1D8D6">
    <ao:suffix> decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatm</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of </ao:prefix>
    <domeo:uuid>946DC0F8-6735-4931-A702-523CADB1D8D6</domeo:uuid>
    <pav:createdOn>2014-07-13 14:50:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:946DC0F8-6735-4931-A702-523CADB1D8D6"/>
    <ao:exact>norethindrone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:568E3662-0BF5-44C6-A624-F35646BE9C93">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:18:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2816B7BF-8F3C-4670-8147-5D5698ACE0F4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:18:08 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:F743ABC6-D666-4FC3-A24D-5FCA56BC32ED</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D30DECC7-EF99-492F-9ADD-5A6A22F12DC4">
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FF147165-69C3-434A-84A5-D74FE2899769"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:59:04 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:00:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B0AE6E9-2A4D-447C-8458-3B68FA9FA20C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9EBC34EF-32AC-4F0E-884A-83E5DC6BC3E8"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdOn>2014-07-07 09:43:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F61456F1-3C46-41AF-8738-36A6475ABE3C">
    <domeo:uuid>F61456F1-3C46-41AF-8738-36A6475ABE3C</domeo:uuid>
    <ao:suffix>is predominantly metabolized by Cytochrome P450 (CYP) isoenzyme 2C8, with CYP2C9 contributing as a minor pathway.</ao:suffix>
    <ao:prefix>In vitro data demonstrate that </ao:prefix>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F61456F1-3C46-41AF-8738-36A6475ABE3C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:14:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFED0A33-952C-44BC-A113-497C82AC3B6E">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 16:05:57 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N12a097a842fd4cf08bb4dfd388c55376"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7A4B7074-A905-47FF-B120-779E470477B9</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F94E16A-024F-416B-9422-E821C3961017"/>
    <pav:lastSavedOn>2014-07-14 16:05:57 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6412A35D-228A-46FC-B733-4EB7F3051BD8">
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D8FF93B7-DDE6-4254-BCF4-3E197FCFBF40">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C3D2B9B7-F4E4-493F-8CAD-A21CD146CFF3"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BAACDE98-5CB9-45DD-AED0-2BEBE40AFBDF">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BAACDE98-5CB9-45DD-AED0-2BEBE40AFBDF"/>
    <ao:exact>N-desmethyl metabolite</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BAACDE98-5CB9-45DD-AED0-2BEBE40AFBDF</domeo:uuid>
    <pav:createdOn>2014-07-07 09:49:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:229D895E-8280-4B79-B558-71ED416F58DD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 23:54:56 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D2BB64D-347B-4107-A2D7-337FA4A2FEA6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19A220B4-9579-4FC7-B16C-BE7A6723CC83">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF0C661E-C375-447A-8975-4589DBCCFA39"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7120AB7A-7867-43E7-8DC3-5404D7106D51</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:12:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:12:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6318D475-571D-4887-9A96-F15289C06308">
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6318D475-571D-4887-9A96-F15289C06308"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>6318D475-571D-4887-9A96-F15289C06308</domeo:uuid>
    <ao:exact>The pharmacokinetics of propafenone was not affected by the coadministration of either propranolol or metoprolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:43:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8739B89-379B-40B4-A540-C9AF6C5A1304">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8739B89-379B-40B4-A540-C9AF6C5A1304"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>B8739B89-379B-40B4-A540-C9AF6C5A1304</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatm</ao:suffix>
    <pav:createdOn>2014-07-13 14:50:17 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2D3876F-AC33-4A2B-B3DB-97296D114AE7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:13:09 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Nd8b9a7b349fe4834beade99986389b04"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 22:13:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA1D1A5E-57ED-4A20-AC6A-C7662E37F0ED"/>
    <pav:previousVersion>urn:domeoserver:annotationset:EF444ECC-4F07-47A1-B3B6-C718307457E2</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7972E3FF-C889-40D0-BA5B-B52CA2B34BBB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:33:00 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:1A6DBAC5-C2B5-4C94-9C48-C015DF1BA576</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5800632F-7E08-4E2B-834F-32BE7A537D21"/>
    <pav:lastSavedOn>2014-07-14 14:33:16 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FFC4712-D696-40A1-914B-B1BBE98E3CA3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB974B54-2A54-46AB-9758-4C69979EDADB"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C3F0A74B-8BF7-4192-BD02-50E6C63EE46C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <ao:body rdf:nodeID="N87d7efd1dcee430e8b57f09b04b7753e"/>
    <pav:createdOn>2014-07-20 22:10:29 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:10:31 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D3713BE0-3453-4C7B-8754-7AAB6051231F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0509C8AA-EF81-4DE6-BE6D-A72681D9B74F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F4392DBE-9713-4D50-A3FB-39E2B4EB12A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B">
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:EEC8FD7A-992F-4E5F-B227-7FA41DD74071"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F37052E8-4866-4310-83E4-2A54C40DD77C"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4452DAE2-DD46-4916-9432-8B794E524A8C"/>
    <pav:lastSavedOn>2014-07-20 21:52:37 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/41e998a2-2e13-4a72-8328-16f5f342d014"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:484f7a0f-bd5e-4f5c-ba77-bd900650692d</pav:lineageUri>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4B99BA0-98BC-49A6-B72D-93863912B445"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:66D886AA-95C6-4AFC-B94C-687C19B04A6C"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <permissions:permissions rdf:nodeID="N8cf75bc8ad824626a320ae8d8f450db0"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:10DCD1C7-D074-4E4A-9AD3-8711E6FD6C3C</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:8AAE83FD-A3FA-4118-A8CE-F534CC555020"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8619FBA0-A893-4E40-9357-D4E615C15884">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and midazolam, respectively.</ao:suffix>
    <ao:prefix>(intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for </ao:prefix>
    <domeo:uuid>8619FBA0-A893-4E40-9357-D4E615C15884</domeo:uuid>
    <ao:exact>nifedipine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 13:42:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8619FBA0-A893-4E40-9357-D4E615C15884"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7BD5BD1-99A2-491A-9F94-E79011F860AC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:84EC8196-4C54-4885-9F8A-B08FF5827A97</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0B5A29A-C1BE-4588-AF05-3473FCA807C1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 23:00:01 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 23:00:01 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N64e7b9aa3a0a43729b121f8efbe942bc"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB97FFC5-B995-4858-91DF-45F2675318E9">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:C173CABB-2C40-4B5D-89C2-BB9B240AAB87"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:102F29ED-1BB6-4797-BC09-88B52B6A2840"/>
    <pav:lineageUri>urn:domeoserver:annotationset:30831AEE-12AB-41BE-BDC0-1EDBEC3F29F1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:E44F8607-E886-4BD7-A4FB-E84256F75267"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N33aaf95fcebb4c95b67eacc8d5c5b8b5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BF03B48-E861-45F1-A97F-422B192D4879"/>
    <pav:lastSavedOn>2014-07-14 00:18:30 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 00:16:14 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B359FA77-047D-439E-8B4E-6AEEC553C70F">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:12:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FD6F238F-F381-4959-B940-F521E0242FF1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5209C26-98E6-4C5C-B947-5AFA24802CED">
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:03:43 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8EBDA078-21C6-4A71-B706-8B1CBCC257E6"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:277781DF-85C1-434F-8169-5C213EF16172">
    <pav:createdOn>2014-07-14 14:36:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:277781DF-85C1-434F-8169-5C213EF16172"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. No clinically significant reductions in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>glimepiride </ao:exact>
    <domeo:uuid>277781DF-85C1-434F-8169-5C213EF16172</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1742FAC2-126A-437A-AA46-05CB37AFB9CF">
    <pav:createdOn>2014-07-14 15:16:58 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D3C1D883-C5CF-4B25-88E3-79D0F5C4D585</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F82C40CD-C485-4144-ADEC-3081C7733E4E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41C35C46-D1D2-43AB-A3B5-675C4DFC616B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>41C35C46-D1D2-43AB-A3B5-675C4DFC616B</domeo:uuid>
    <pav:createdOn>2014-07-20 22:02:13 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41C35C46-D1D2-43AB-A3B5-675C4DFC616B"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0618A0D0-82A0-4A4D-A4D4-6FFE8487B428">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:08:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:55F799B3-52D6-4356-B0E9-AEE63B236D07</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:226BEBA2-B133-452C-9BB2-14457F46FE68"/>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BAA066BF-F82B-45EF-8283-780549D5ED39">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>zonisamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0483BE14-7675-4EFA-B6F1-4FC90F932480">
    <ao:prefix>decreases </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0483BE14-7675-4EFA-B6F1-4FC90F932480"/>
    <ao:suffix>gastrointestinal secretion, while erythromycin may also decrease biliary excretion.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fexofenadine </ao:exact>
    <domeo:uuid>0483BE14-7675-4EFA-B6F1-4FC90F932480</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:30:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15F2C800-276D-4AE3-BD01-15371461A222">
    <pav:createdOn>2014-07-14 15:07:12 -0400</pav:createdOn>
    <ao:prefix>at doses greater than or equal to 160 mg/day resulted in increased </ao:prefix>
    <ao:suffix>plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:15F2C800-276D-4AE3-BD01-15371461A222"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>15F2C800-276D-4AE3-BD01-15371461A222</domeo:uuid>
    <ao:exact>thioridazine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6BC95CE-8A3C-4155-B29E-23A3A869A07E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 13:59:35 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E949298-FCBB-4C0C-BD05-8F4B1CE4F72F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C55792A3-6668-49B5-AC8E-1CBF687DBA52">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CA35FE6E-C43E-4896-BC81-94DC1B97E865"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AE5102D3-EDFA-4812-A978-6A91D2DBD026"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB7FAB69-6842-4255-BB69-9C81FAA47006">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB7FAB69-6842-4255-BB69-9C81FAA47006"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <pav:createdOn>2014-07-14 15:05:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>pravastatin</ao:exact>
    <domeo:uuid>AB7FAB69-6842-4255-BB69-9C81FAA47006</domeo:uuid>
    <ao:prefix>or </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDEC0C3A-EAF5-4C8B-86B5-816C0FB5BE6A">
    <pav:createdOn>2014-07-20 21:38:18 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:89A5BDE6-1658-4E4B-BEEC-8ED3F174B45B"/>
    <pav:lastSavedOn>2014-07-20 21:38:19 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N103a1ca452f14c16ba73a1b81824450b"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:64B0AF47-31CD-4E26-8EC8-498E258CC22C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DFBECCE6-5A3B-4643-8D8E-59865ECA7C78</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1574BC9A-EE1F-4135-99B9-71A1BFEE0A19">
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:26:21 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8872CBE2-3214-4C1E-AA8B-43D4AF63F26B"/>
    <ao:body rdf:nodeID="Na5b473601ebc409ba9cc69750f815371"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76ED4D83-BD2C-4B6D-A45C-B1F016F94ADD">
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">14</pav:versionNumber>
    <pav:createdOn>2014-07-20 22:17:03 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N0af8f4a55d1a4368a7bcbec49c0a37de"/>
    <pav:lastSavedOn>2014-07-20 22:17:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD3E1667-AA33-4425-ADF2-270ACE4DA410"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:FF6FA5D6-FE6B-46FA-A2E5-E0E5667F84A5</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D51CF50F-A88D-4E00-8D9C-34A52BB5DE15">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D51CF50F-A88D-4E00-8D9C-34A52BB5DE15"/>
    <ao:exact>methadone </ao:exact>
    <ao:prefix>administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <domeo:uuid>D51CF50F-A88D-4E00-8D9C-34A52BB5DE15</domeo:uuid>
    <ao:suffix>exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <pav:createdOn>2014-07-14 15:45:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/37D76A76-2C1B-4BDC-BFD7-720461A21196">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2F34EF9-544D-4872-B221-723FBB99B1CC">
    <pav:createdOn>2014-07-14 15:30:41 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D2F34EF9-544D-4872-B221-723FBB99B1CC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D2F34EF9-544D-4872-B221-723FBB99B1CC</domeo:uuid>
    <ao:exact>ketoconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78343F36-2DB2-442B-AC16-ED47A1B8AD90">
    <ao:prefix>The absolute bioavailability of </ao:prefix>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of rosiglitazone with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). Th</ao:suffix>
    <pav:createdOn>2014-07-14 14:12:02 -0400</pav:createdOn>
    <domeo:uuid>78343F36-2DB2-442B-AC16-ED47A1B8AD90</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78343F36-2DB2-442B-AC16-ED47A1B8AD90"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08B4F0E2-7831-4C3F-872F-7908F013A5BA">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:08B4F0E2-7831-4C3F-872F-7908F013A5BA"/>
    <pav:createdOn>2014-07-14 13:54:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed fo</ao:suffix>
    <domeo:uuid>08B4F0E2-7831-4C3F-872F-7908F013A5BA</domeo:uuid>
    <ao:exact>Metronidazole </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F43F81A3-9A0E-46EA-A31F-9BBFECC33ACB">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E6FA48B7-725B-45B3-9939-A6DB77634E58"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1063CC8-8EDC-42C6-A44A-9C9EA5A38DAD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-36.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 23:20:49 -0400</pav:createdOn>
    <ao:exact>Uricosuric drugs, such as probenecid and sulfinpyrazone, can inhibit renal tubular secretion of nitrofurantoin</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1063CC8-8EDC-42C6-A44A-9C9EA5A38DAD"/>
    <domeo:uuid>C1063CC8-8EDC-42C6-A44A-9C9EA5A38DAD</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6468CCF5-0F65-4929-B5AB-F06D74A95282">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6468CCF5-0F65-4929-B5AB-F06D74A95282"/>
    <ao:prefix>dose for at least two weeks. </ao:prefix>
    <domeo:uuid>6468CCF5-0F65-4929-B5AB-F06D74A95282</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:exact>There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%)</ao:exact>
    <pav:createdOn>2014-07-13 23:56:32 -0400</pav:createdOn>
    <ao:suffix>. The metabolite,</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8">
    <ao:item rdf:resource="urn:domeoclient:uuid:34F54519-830D-46BC-B3E6-91AD60A447BE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:541AA093-0B25-4A13-A75A-755AF43911C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBED2204-2150-43DD-BA94-303ED09B9EBC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3A9FD2A-B0B5-4341-9621-BB8515123FDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C80C9FF-FE68-4414-86EC-7515CBE8C362"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:36DED415-6CB1-4E7A-B5B1-9986A117C9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8661B8B0-3D68-4D28-9DCE-DB3B508D0400"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB8BEB2A-9B3F-4964-BDE8-D0B97F7D2C3A"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:821E7BF5-ADFE-4F2C-BC58-27F2B4082E9C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC53ABB3-D58B-42A4-9A28-0CA93DF4F460"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DABDBDEB-926C-4903-8855-23E82662F9B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:88998899-DEBD-4168-A53F-878575C09DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D87371FE-EEF3-4059-9416-BEAD2E444272"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:184804F1-B516-4468-8703-9B4D153EEC3D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A74600-0E76-4D41-AF58-7F4E323A1F24"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4995119-D6E2-4FDC-AB29-6DB9B00EC5A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D7ACB235-8D9B-4E52-8541-DFCEC757F344"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55EEB992-867A-4139-80A1-95B1E3282C3A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:26091D80-4371-4E7C-B05E-E00DE9B74DF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8089CFAC-1281-4F58-A0F9-C39DB631F17F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB409338-703B-4C6B-A32D-933D72D9FF08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CABDB1CD-E0B8-4835-A612-75FB6F36823D"/>
    <pav:createdOn>2014-07-14 15:48:47 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:85F697CB-EB7F-4291-A7DA-6DBF1AEE52AF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0B558C53-5A17-4213-A237-CE3FF4209736"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40CC5EFF-E25A-4261-B9ED-D4A4846C4701"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:50B4C61F-99FA-48C1-95C6-A8C257EFA76C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB1D2C56-B391-413A-A970-372953DCE4C1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78032DB5-9E69-4584-A595-72EB0760CCB3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABCADE51-836E-43BA-BD8F-3297CA616FA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15129A73-23CF-455C-AFF8-E6DA6AE86FD9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C11DA735-89DB-4504-8691-44020EFABE01"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3E2E401-6FC0-4931-B402-95E39E8B1F3B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:11F5743A-7576-46DC-8368-4F0183E1CD32"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EBDE3DE-4364-4AE3-8C04-B162F8F0D527"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34716919-5607-440F-9914-55F00D11E133"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C607CD4B-89A0-4CB9-A1B8-06AB1AD3BF17"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3268C318-9E0E-42A3-837E-A29259EE9C34"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDBCBC8C-EA8A-45FE-9E61-B9BF9DF720D0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F5AB0C8-ED87-493D-9E3F-61FF2F48B317"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92A4787E-9923-49B7-80F4-F4C6B8613CD7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:78260399-4B48-4D6A-BB23-1F5C1DB11C63"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">12</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:2033976B-F874-4E7B-956B-40B658CA469D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A245DCDD-E95F-4384-B2F2-DEB4EAE21633"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:205CFCBC-A919-4EA5-BC16-4725E5D0CA62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C0455A7F-96B6-4209-AABD-FA22BB6B5907"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C5209C26-98E6-4C5C-B947-5AFA24802CED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C82C599E-BAF1-47F2-B8FE-4366444E53F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04AF22FB-0B37-4C7B-9E2C-FD00FDD2A0AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55065BCB-C09B-414C-8265-57F9C477B91E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D8C95AA-2AAC-46E2-81D6-932A6B995F67"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44E979F8-20F5-4AF4-8695-07429A3644DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:056D4261-BB10-4D09-934B-CB16DA6CDEDF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4FEFDBFE-05DB-4446-A587-323C26F91BBD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D358E409-61E7-457C-A5D9-5ACD5DED0A00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:28532EB6-2049-433D-A3BE-E723EF7A10A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BC63BED-1F6A-4D4E-83B9-87707421129A"/>
    <permissions:permissions rdf:nodeID="N6eb0bceb25e744819a908c2a8130986a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0618A0D0-82A0-4A4D-A4D4-6FFE8487B428"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE21E93E-223E-4EDB-BDBE-2A17DCAA138C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91EA5CE1-31BF-442E-8829-C1BAF58B3517"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F702CD55-D36B-4937-B3A4-9A0D5F8D1E62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:13FE2CC3-3AE5-4618-9800-E7722E7FDCA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:53880A79-12CC-4CDE-9A8C-D7DBD019382D"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:98319744-95C1-4B4B-84B4-4706ADF1D085"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F77E3693-4D30-47E9-AEFB-8D6F448334F7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFF4B2C0-796E-4C98-B71D-F333EE2A91B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:508553F6-27A3-42CB-B39B-593992C39C25"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86866714-B907-49D3-B3E9-0F83CD0BFE46"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A978E284-2C0C-4CBD-BAA7-31EB877998F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D7E62662-063A-402F-A0A0-B5876A3D37C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4294722-E6EA-4B43-BE16-12C1938ECEB6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C75AF6B7-A8C3-447E-8C18-98595A566BBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9752B97-948E-491E-816E-99A901AB1153"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:80FE2422-436F-4EC5-B820-9ABD428FF42A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3359A31B-60B9-49E7-97EE-F55483A9891C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2CEA7D67-F9F8-4FE7-8D95-EBB184D52C09"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AFED0A33-952C-44BC-A113-497C82AC3B6E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E87D76B-1566-4252-B7F3-81706DAAB825"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:667D8415-762A-406F-97E4-8900ACD6EB7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2A5A5496-7D04-4675-AD68-7DC013E096D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D64A5B7-56D4-4FC2-B0AD-C9C46D60E35D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5FAB5D90-9436-4813-986F-0D1433339D6A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FC2251EF-FBAC-4CED-BF3D-AFA15C4D0C83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6260603-DCBF-4AB1-AE3A-3B928363379D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F1EF859-21C9-4ACB-A0EC-ACB39F9ED589"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C64E0D3D-B80A-4982-B8EC-C0ED615FE918"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A42A7E98-DFAE-45C5-94AA-6C0CC759F34F"/>
    <pav:previousVersion>urn:domeoserver:annotationset:B08F49F1-15AF-468B-940F-2EB478A75BDD</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:1BD2C839-F167-465D-A898-1429ECDD43B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A490ECC-0CF7-4BB4-9195-08FC09D9D48C"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:25BE976C-D191-4841-A63E-EAC8770A3C88"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A63DD496-7D43-4980-8684-306F2263FD13"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BF05A6E-C3A4-4378-9E7C-D7DCE60F8E50"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:784AC4F0-ED08-44DF-929B-24E7F5628FA2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3B315E5-7A3D-41B5-81DB-2795EB8FC454"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B374D320-B072-4709-B310-4445E70524F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DCD69664-0D59-4A3B-A42A-F487BC79D263"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1F27D930-7AB6-45D4-A664-0F78688A973B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:22C86EF1-01BF-4703-B1EA-9C65647D5BC2"/>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F65794E-6F82-4339-8ACA-530B5350C8E8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/f16f4148-1c48-4f6f-9232-594b605319a6">
    <pav:createdOn>2014-07-07 08:09:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:43094D9A-060D-4712-A34E-09F917644BF8</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:810d4247-b95c-46b5-a207-7b6e880ba4b3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:c4cc0b55-16cf-45eb-a692-55166c0ff571</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:09:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:320A8D35-F4C0-4984-8AEF-324E2492E35F">
    <pav:createdOn>2014-07-20 21:24:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:320A8D35-F4C0-4984-8AEF-324E2492E35F"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:hasSource>
    <domeo:uuid>320A8D35-F4C0-4984-8AEF-324E2492E35F</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>SEPTRA may inhibit the hepatic metabolism of phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:175A41D6-7C03-45D4-9BC1-0B116037B32C">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:8FF01BD0-F6ED-4164-B591-5BB7FEEEC86E"/>
    <permissions:permissions rdf:nodeID="Nc921957da7e84b72841088fba02f0ccc"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE8345E7-F989-4625-858B-441DB7D63965"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-14 00:30:37 -0400</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:9ADA86EB-925D-461C-9857-C255E0554F1F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:525E6533-B207-4AA7-BB35-30207AEE4191</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-14 00:31:13 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B69BFA0-BE22-4A91-823D-BD12B525B6D9">
    <domeo:uuid>1B69BFA0-BE22-4A91-823D-BD12B525B6D9</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B69BFA0-BE22-4A91-823D-BD12B525B6D9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Maalox</ao:exact>
    <pav:createdOn>2014-07-14 15:21:40 -0400</pav:createdOn>
    <ao:suffix>®1) decreased fexofenadine AUC by 41% and Cmax by 43%.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/32854C22-67DF-4D38-8D09-17CDBFBB691E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>azithromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/18631</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FB4E2C1-35BD-4DB3-B908-3851B4DE21AE">
    <pav:lineageUri>urn:domeoserver:annotation:8D75B505-5333-4795-A9AD-64E3B1877F37</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 23:13:27 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:72896ED1-53B7-4FF8-98B1-ACE47FAF1282</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N8ee4e9a395524d0e8ecb58e461c2139a"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 23:13:26 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D9BF9335-168A-48CA-BF74-27163A0299F6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E08FCB04-9F93-498A-9CFA-8C5A02C92F37">
    <ao:context rdf:resource="urn:domeoclient:uuid:794B5A25-B381-400D-B87D-93B9650232CA"/>
    <pav:lastSavedOn>2014-07-14 00:15:21 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:EC7605DE-8042-41B3-BF46-3537BA733AED</pav:lineageUri>
    <pav:createdOn>2014-07-14 00:14:54 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:0DDC59BD-AAC3-4EED-BE5B-6543DF99A54C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6381CCF-2191-468D-8649-C27E419DFB61">
    <pav:createdOn>2014-07-14 15:33:32 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:93D62306-7D47-4D71-AFE2-D02DC6324DB6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:286E33BA-D934-4A56-8459-3F4028F7033A"/>
    <pav:lastSavedOn>2014-07-14 15:33:30 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CCB6474C-E1D3-4268-BF2A-E1AFDA289F56</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A1C121E-A46B-4DD7-B058-0437DE8B3665">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BC1B284C-A4F7-4895-B220-F120536CCEE8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:DF4404FF-B26A-490C-9105-3A6BCA5B2B5B</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:01:21 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:01:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N4a6b189e9c4e44ea98c1784cf19afa14"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4EB5CCA0-E7A8-44DB-9A3D-A4FC0CCFCB59">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:01:33 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">12</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:01:31 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:057E0FF7-67D7-4D0E-BA0F-3B21830FA757</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D876D927-32CF-4C3A-98BB-86C758433B46"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N1e623b7fed294cdd8faaf7fdd37d1350"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/166A3DA7-CAA5-4844-B69D-3ADC07E94AF9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>donepezil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8C545DA-9FDD-4C41-B839-2F0031E766AA">
    <ao:body rdf:nodeID="N3a4e8501d10344c0813d7829b17fa944"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:23:09 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:23:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:63CF2643-0DB0-42D9-95B4-7EB7F105B216"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:DD34F264-2706-4121-AFB1-5F59001C3BC9</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7239942A-3971-4A3D-A133-94C5843F811E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">12</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-14 14:27:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B9F6D9B1-8A06-4831-AE18-EC7D0814A286"/>
    <ao:body rdf:nodeID="Nd59af527dda84308958dc429442670e1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:27:52 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:10A82C01-9937-497B-827B-52A1DFDA2A03</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8A97BED-E65E-434A-92E5-9B9E3B8B801D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:10:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F81042B-493D-4D78-BBB6-E6540791B04A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:217F4CF8-C040-4AAC-9367-95C3CCB92CF6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:217F4CF8-C040-4AAC-9367-95C3CCB92CF6"/>
    <domeo:uuid>217F4CF8-C040-4AAC-9367-95C3CCB92CF6</domeo:uuid>
    <ao:exact>Cytochrome P450</ao:exact>
    <pav:createdOn>2014-07-14 14:23:16 -0400</pav:createdOn>
    <ao:prefix>Drugs That Inhibit, Induce, or are Metabolized by </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:557B5FC1-535D-46F4-B99D-C73CC84690A0">
    <ao:exact>cyclosporine </ao:exact>
    <ao:suffix>AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 23:50:23 -0400</pav:createdOn>
    <domeo:uuid>557B5FC1-535D-46F4-B99D-C73CC84690A0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:557B5FC1-535D-46F4-B99D-C73CC84690A0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>dose for at least 6 weeks. There was a significant increase in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7CA665B-3294-4A89-900F-79EBB2C31E88">
    <pav:createdOn>2014-07-14 13:52:17 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C2E400F-C65F-418B-B1CC-8A67F1884B6A"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:175DE992-5EA0-40AF-8BC8-6F899E0B93D0</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 13:53:55 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:93309B9B-407D-4079-9FD3-A2F470686E90</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E861E0FF-0822-455F-A4AF-37F3B6D32715">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9069</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine sulfate</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8C52EF1-5A65-4253-A293-005A68BF9C4E">
    <ao:exact>Fexofenadine hydrochloride</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8C52EF1-5A65-4253-A293-005A68BF9C4E"/>
    <domeo:uuid>E8C52EF1-5A65-4253-A293-005A68BF9C4E</domeo:uuid>
    <ao:suffix> should not be taken closely in time with aluminum and magnesium containing antacids. In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:20:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:32695D30-116C-4B63-ABF4-77566437369D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B3C38113-5A83-4DA6-A0CD-5D747E31779E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BFD9E549-C79A-46ED-A639-5BC6971D2257"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04D5BE4C-3158-45A9-B8BC-540CC74E85B6">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E319773F-0E12-4A32-B595-AADAC90B0D6D</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nd0feec6f25de4d2693502401ddf4cf55"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:687F59AF-4F7F-4733-B844-220CD26B0990"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:createdOn>2014-07-20 21:59:22 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 21:59:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5683C35-E3C0-4011-8950-F1D1EF689BC2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:C9BB62A2-18A0-4EE8-9B5E-3CDDE54470C5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:24:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-14 00:05:32 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-13 23:59:10 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8FB9935-F34A-4ABB-BA0F-6671CE5EABC1"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D09D111-4D78-40FE-AF86-76A63E4BC020"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FC383F43-6551-4557-905F-11DDD907115D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C21388FA-DEA8-4B20-9CBE-23E53F00CA45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5FDE992E-5DDB-464A-89E3-9C06D0B1EBE1"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:41DFFC41-28E3-4FB3-856D-5A7AE09D79C1"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:822F77AE-2E7D-4534-B4E7-F8C6C5D1D1B2"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:72B3FB4B-4342-450C-ADD0-DC229F74687D"/>
    <pav:previousVersion>urn:domeoclient:uuid:A0C54DC3-0679-479B-AB51-38ED91C6FA91</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N922d2df3bcc34a7a80cab4ad3c644365"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N274476169c924a218e109782ddf6e3cb">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40EBA023-1798-45FC-888F-3A87913C74E4">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N8739c95421b74ebda5dbd24a900a36fa"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1ADBB4BB-0B79-4B5A-AB3E-6B67CE15EA39"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-13 23:58:22 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 23:58:24 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:7EF2DD21-C72E-4F72-85D9-729871FF325A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EABA63DF-BDDB-4F00-AA39-2B82E5E22B7A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/183ECA96-0948-49B8-8B33-F80FDF74521E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C650BAE-FB6A-404E-AE82-B7B7DEC33989"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1CEAFA26-3EE3-48A5-9562-268F8876D4CB">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/30CDE530-1807-42E6-80C9-9513AC295DFD">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>quinupristin/dalfopristin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55EEB992-867A-4139-80A1-95B1E3282C3A">
    <pav:lineageUri>urn:domeoserver:annotation:E4057817-11A0-457A-B8B5-5174AE9D09BC</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:45DE64F7-4E3C-4891-BFC6-E966DB8631ED"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:07:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4972CD43-FEF3-4B35-9E87-053F8552F104">
    <ao:exact>zidovudine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4972CD43-FEF3-4B35-9E87-053F8552F104</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:prefix>Plasma </ao:prefix>
    <pav:createdOn>2014-07-13 23:54:43 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4972CD43-FEF3-4B35-9E87-053F8552F104"/>
    <ao:suffix> concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D302BD2E-5DF3-4ABA-B01E-088D03DE29D3">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D302BD2E-5DF3-4ABA-B01E-088D03DE29D3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <domeo:uuid>D302BD2E-5DF3-4ABA-B01E-088D03DE29D3</domeo:uuid>
    <pav:createdOn>2014-07-20 22:02:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A1B37F80-6B12-460D-B31A-F72AB1A3C675">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zidovudine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:038C6A1D-4D73-4F19-B0BD-CE47A58936A2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>administration (600 mg once a day), an inducer of </ao:prefix>
    <domeo:uuid>038C6A1D-4D73-4F19-B0BD-CE47A58936A2</domeo:uuid>
    <ao:suffix>, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <ao:exact>CYP2C8</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:31:16 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:038C6A1D-4D73-4F19-B0BD-CE47A58936A2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD3E1667-AA33-4425-ADF2-270ACE4DA410">
    <domeo:uuid>AD3E1667-AA33-4425-ADF2-270ACE4DA410</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD3E1667-AA33-4425-ADF2-270ACE4DA410"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:17:03 -0400</pav:createdOn>
    <ao:suffix>. When either concomitant</ao:suffix>
    <ao:exact>Paroxetine lowered the concentration of 9-hydroxyrisperidone by about 10%</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F711382-433B-491F-BB41-FEA554DAAE64">
    <pav:createdOn>2014-07-20 23:21:54 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 23:21:56 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CFC858C1-4357-4A7E-B3F6-AEC0208DCC3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nca1709bb50264c228443737e485a9d77"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DF4FA47B-9EEB-41E0-9099-762E81A9C0CF"/>
    <pav:lineageUri>urn:domeoserver:annotation:075F5719-C15D-4F9E-832B-E3F2FE0CA0BD</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7e6ff7cd-fb12-4ab8-977e-e796227c1866">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:bc5ada19-3d47-4d7f-8835-bbbf681e80b6"/>
    <pav:lastSavedOn>2014-07-07 08:09:11 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:09:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E294FA4-87CC-456B-8D0D-7E0234FDF6B6">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2356EE0-FA67-482D-A3CA-AE99BFF1A189"/>
    <pav:createdOn>2014-07-14 14:18:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCED36C6-B2BC-46B8-B71D-F0ADBB7CC685">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:46:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:D460FE66-43F6-459C-9975-01A48F6E3565</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:11D22EAE-170D-4047-A6B6-AC5C21C9E4CC"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CABE46C4-C26E-435D-88C2-CBF429E23816">
    <ao:prefix>at steady-state with a single oral dose of </ao:prefix>
    <domeo:uuid>CABE46C4-C26E-435D-88C2-CBF429E23816</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:34:11 -0400</pav:createdOn>
    <ao:suffix>resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnorma</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:exact>azithromycin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CABE46C4-C26E-435D-88C2-CBF429E23816"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9945954-4A2B-436D-996C-B843A85C8833">
    <pav:lastSavedOn>2014-07-20 21:18:41 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N9c1c644fe35146ef82890f07aecf9f06"/>
    <pav:createdOn>2014-07-20 21:18:39 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C53015C-AAF6-411C-AD20-6B65BA28B515"/>
    <pav:lineageUri>urn:domeoserver:annotation:404C586C-8A06-4168-8798-399013F41E8B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9A464B6-AC1C-48E7-810F-2497DEB9ACC4</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5586FE3A-D0FD-4448-A4D4-669F6071F77E">
    <ao:suffix>values.</ao:suffix>
    <pav:createdOn>2014-07-14 15:17:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5586FE3A-D0FD-4448-A4D4-669F6071F77E</domeo:uuid>
    <ao:exact>carbamazepine </ao:exact>
    <ao:prefix>) by 76 and 60%, respectively, compared to pre-</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5586FE3A-D0FD-4448-A4D4-669F6071F77E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E032555E-3004-4710-AB25-B8EEB5368379">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B3EF6E27-3DE7-43FA-9061-1D49CFD57FE0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5DDAA4B3-F4A1-4EEE-A916-6B0FAF8FA35B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D7E14EC-7E04-46C4-8A4F-7C62FA7F3F21">
    <pav:createdOn>2014-07-14 15:00:03 -0400</pav:createdOn>
    <ao:prefix>AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in </ao:prefix>
    <ao:exact>propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:suffix>concentrations.</ao:suffix>
    <domeo:uuid>5D7E14EC-7E04-46C4-8A4F-7C62FA7F3F21</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5D7E14EC-7E04-46C4-8A4F-7C62FA7F3F21"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63B80A52-CC3A-4B8F-9431-862133269C24">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:63B80A52-CC3A-4B8F-9431-862133269C24"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>63B80A52-CC3A-4B8F-9431-862133269C24</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 11:14:00 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concomitant administration of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg) did not affect the pharmacokinetics of sildenafil</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B321CD6F-2C57-4243-9343-115D92773E59">
    <pav:previousVersion>urn:domeoserver:annotationset:7120AB7A-7867-43E7-8DC3-5404D7106D51</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:12:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:12:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:78343F36-2DB2-442B-AC16-ED47A1B8AD90"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:471BA62B-8C73-4467-A4CB-476ADB01B676">
    <pav:createdOn>2014-07-14 14:37:20 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:471BA62B-8C73-4467-A4CB-476ADB01B676"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>471BA62B-8C73-4467-A4CB-476ADB01B676</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Single oral doses of glimepiride in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of AVANDIA</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59A35842-09FF-485C-B13A-8ABBA487A4B7">
    <pav:createdOn>2014-07-07 09:39:47 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59A35842-09FF-485C-B13A-8ABBA487A4B7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>REVATIO </ao:exact>
    <domeo:uuid>59A35842-09FF-485C-B13A-8ABBA487A4B7</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Effects of </ao:prefix>
    <ao:suffix>on Blood Pressure</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DBA559A-FC52-400A-AC4C-7F559D51382E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>is contraindicated in patients with renal impairment, coadministration of </ao:prefix>
    <pav:createdOn>2014-07-14 14:21:18 -0400</pav:createdOn>
    <ao:exact>metformin </ao:exact>
    <domeo:uuid>5DBA559A-FC52-400A-AC4C-7F559D51382E</domeo:uuid>
    <ao:suffix>with</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DBA559A-FC52-400A-AC4C-7F559D51382E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/85207E6C-0847-422E-9BED-B5040130A4EC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDE9697B-4596-4560-B3CC-D852CBB6AF20">
    <ao:item rdf:resource="urn:domeoclient:uuid:004698D0-124C-41AE-8A7F-D640A8C3CD3F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8145F723-C130-46D4-81F4-21A84E679258"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-14 00:23:20 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:948E199A-77E3-4355-86B7-EFEAAA45D5E3</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N5fcb805256024b6f84e541b3996a9dfd"/>
    <pav:createdOn>2014-07-14 00:22:05 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3A9FD2A-B0B5-4341-9621-BB8515123FDB">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6A4E3BF0-E555-4B66-960D-DFAD328E40AB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:53:06 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D0616EF-BE18-4B8B-879A-2CB0C293929C">
    <rdfs:label>verapamil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11170</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5CC5FB4-810F-46EE-9C08-31F9EEED4452">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:9EC4F693-044A-46D0-84B1-F58E4BF4DD2A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:28:24 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6FAB58C-924E-4B34-86A6-41311AD57722">
    <ao:exact>Propranolol </ao:exact>
    <domeo:uuid>D6FAB58C-924E-4B34-86A6-41311AD57722</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:05:20 -0400</pav:createdOn>
    <ao:prefix>, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6FAB58C-924E-4B34-86A6-41311AD57722"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C0BD5DF6-AB55-41AD-B946-7F6C6BEB7A4E">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D809732C-2ED6-481E-87C3-CD8484597163"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/550AF52B-3C3C-43EC-9A82-220470A00179">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:050AE3EA-FA24-4A46-84DE-D6F7D32DCEF2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:050AE3EA-FA24-4A46-84DE-D6F7D32DCEF2"/>
    <pav:createdOn>2014-07-07 09:43:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>REVATIO </ao:exact>
    <domeo:uuid>050AE3EA-FA24-4A46-84DE-D6F7D32DCEF2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When REVATIO is taken</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11C7E2AE-F02A-46F0-8F5F-C0E3A60F43EE">
    <pav:createdOn>2014-07-14 14:23:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>11C7E2AE-F02A-46F0-8F5F-C0E3A60F43EE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:11C7E2AE-F02A-46F0-8F5F-C0E3A60F43EE"/>
    <ao:prefix>enzymes at clinically relevant concentrations. In vitro data demonstrate that </ao:prefix>
    <ao:suffix> is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which ar</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:745C89A1-1AF7-4B52-ADC7-BBB0B4D97B56">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:745C89A1-1AF7-4B52-ADC7-BBB0B4D97B56"/>
    <domeo:uuid>745C89A1-1AF7-4B52-ADC7-BBB0B4D97B56</domeo:uuid>
    <pav:createdOn>2014-07-14 00:30:59 -0400</pav:createdOn>
    <ao:exact>zonisamide </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <ao:suffix>who experienced an event on at least one occasion. All events are included except those already listed in the previous table or discussed in WARNINGS or PRECAUTIONS, trivial events, those too general to be informative, and those not reasonably associated</ao:suffix>
    <ao:prefix>e of the proportion of individuals having adverse events, similar events have been grouped into a smaller number of standardized categories using a modified COSTART dictionary. The frequencies represent the proportion of the 1,598 individuals exposed to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BBB08782-7AD9-431A-A87A-D5268FE02E4A">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC2251EF-FBAC-4CED-BF3D-AFA15C4D0C83">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:52:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8B85EE2-490D-4FA9-BE2B-8697019FB457"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFF4B2C0-796E-4C98-B71D-F333EE2A91B0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:7E411EE4-F02D-4985-9505-75342E845FE0</pav:previousVersion>
    <ao:body rdf:nodeID="Nca28e3d878bd4fe1a23609a00d14a2da"/>
    <pav:createdOn>2014-07-14 16:06:18 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7925A81E-6575-4442-A711-93EDD25090C1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 16:06:24 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC3BDF29-3596-4AC6-90E9-9C0A5E672FA9">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:56:54 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CC3BDF29-3596-4AC6-90E9-9C0A5E672FA9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC3BDF29-3596-4AC6-90E9-9C0A5E672FA9"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>In vitro data indicate ribavirin reduces phosphorylation of lamivudine, stavudine, and zidovudine. However, no pharmacokinetic (e.g., plasma concentrations or intracellular triphosphorylated active metabolite concentrations) or pharmacodynamic (e.g., loss of HIV-1/HCV virologic suppression) interaction was observed when ribavirin and lamivudine (n = 18), stavudine (n = 10), or zidovudine (n = 6) were coadministered as part of a multi-drug regimen to HIV-1/HCV co-infected patients</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D99FDDDB-F0E0-44E5-BFF6-F7E22260E78C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F31802E-7861-4C87-82FB-71DD824528F0"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:20:29 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6484A9BF-2A66-459D-9606-6D96B7FA2AC8">
    <pav:createdOn>2014-07-14 15:43:44 -0400</pav:createdOn>
    <ao:suffix>therapy should be closely monitored so that toxic effects are detected promptly. Baseline assessment should include a complete blood count with differential and platelet counts, hepatic enzymes, renal function tests, and a chest X-ray. During therapy of </ao:suffix>
    <ao:prefix>Patients undergoing </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6484A9BF-2A66-459D-9606-6D96B7FA2AC8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-167.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6484A9BF-2A66-459D-9606-6D96B7FA2AC8</domeo:uuid>
    <ao:exact>methotrexate </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7B62A88-F614-4DCF-9749-882CA702B315">
    <ao:body rdf:nodeID="Nbdd04983f3704d969714245a3ae87fb3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">21</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:FA63CD83-11BF-442A-93B0-66CABBAA9469</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3377FF83-DAA0-46E0-8AF0-43B2164B4E45"/>
    <pav:lastSavedOn>2014-07-20 20:42:29 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 20:42:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4D5A996C-EB58-4FA9-952C-72983F2BD075">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D14EBB20-3195-44D9-B4BE-A56ADA56563C">
    <rdfs:label>ranitidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA6B64F9-AA81-4128-8323-1437004E8AC8">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 22:09:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA6B64F9-AA81-4128-8323-1437004E8AC8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BA6B64F9-AA81-4128-8323-1437004E8AC8</domeo:uuid>
    <ao:exact>Amitriptyline did not affect the pharmacokinetics of risperidone or risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA548A1D-68C2-4599-89EF-8C0B45EAA27B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 09:42:42 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C2523401-1969-467B-8B7E-F02CD5439FD6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6C4FF91-954A-4AE0-9C7A-B4B73091AE14">
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:26:10 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:ACFCFD73-0B90-4146-91B5-FC8207FB5730"/>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48820B68-CAF4-4D1A-8572-BF79D1A8D37E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na17fcb831e564d9a84eb29add4bac397"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:55E86D0B-B096-4EE2-AE98-DE2DF348C9EC</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE0BA818-EB34-49AB-8619-92F93C8EF114"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">24</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:45:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-14 14:45:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N846a128fdf8744b1817cd0e24f39bdc0">
    <domeo:sets rdf:resource="urn:pddi:uuid:83AA1C5E-9627-4620-9711-9C213B09ACAE"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1E398B61-DE44-430D-87A7-BB7089E845A0">
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58117380-1B98-4B60-B393-8941A7283E84">
    <domeo:uuid>58117380-1B98-4B60-B393-8941A7283E84</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58117380-1B98-4B60-B393-8941A7283E84"/>
    <ao:exact>However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 15:56:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/35AB51EE-DA9E-438C-824A-1AB8780D6566">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3ffa64939e9e471baabbe47f8919f0c9">
    <domeo:sets rdf:resource="urn:pddi:uuid:B342234D-85FE-4DF4-A172-94D9DAD30AED"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A13AE44B-49B5-4021-B2A3-47BF6869E397">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>itraconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/28031</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A57C429-7B2E-4810-8892-3F6F01669541">
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA4D6F29-F235-4592-88ED-21FD2B7D3E1E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 22:44:12 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N7b245890fda94fe388a2cc71a0a98aee"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF491442-6BC1-4F1D-B36A-0955B91CDFDD"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 22:44:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B21C38DC-C3A7-4A9D-9F3B-90FD2E07D804</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8FB0779-067F-4328-BD85-6BD79616D728">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-13 23:56:32 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nf75db4eb159c4678a094e624986ada8a"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6468CCF5-0F65-4929-B5AB-F06D74A95282"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F57F8DB9-3784-491E-9D27-DE3A3D01FF83">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E7028888-FEE6-4400-84A4-EB9054028F7F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39AB4B6D-18E5-435D-8BE4-19DD2E0F6323">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:39AB4B6D-18E5-435D-8BE4-19DD2E0F6323"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>39AB4B6D-18E5-435D-8BE4-19DD2E0F6323</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:21:20 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of other known enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D32701E-1F86-4999-B744-F0E3FCED3EF0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4D32701E-1F86-4999-B744-F0E3FCED3EF0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D32701E-1F86-4999-B744-F0E3FCED3EF0"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 15:25:36 -0400</pav:createdOn>
    <ao:prefix>. </ao:prefix>
    <ao:exact>Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76CBD0E6-5C5B-47A4-821F-CDA8BC7E8158">
    <pav:createdOn>2014-07-14 16:03:35 -0400</pav:createdOn>
    <ao:suffix>, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs meta</ao:suffix>
    <domeo:uuid>76CBD0E6-5C5B-47A4-821F-CDA8BC7E8158</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rifampin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76CBD0E6-5C5B-47A4-821F-CDA8BC7E8158"/>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74B96093-C3F9-4CA0-957A-C0D40AED273C">
    <ao:suffix>in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of risperidone in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone do</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <ao:prefix>Hepatic Impairment: While the pharmacokinetics of </ao:prefix>
    <domeo:uuid>74B96093-C3F9-4CA0-957A-C0D40AED273C</domeo:uuid>
    <pav:createdOn>2014-07-14 16:07:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74B96093-C3F9-4CA0-957A-C0D40AED273C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89A5BDE6-1658-4E4B-BEEC-8ED3F174B45B">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 21:38:18 -0400</pav:createdOn>
    <ao:exact>Combined administration of citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89A5BDE6-1658-4E4B-BEEC-8ED3F174B45B"/>
    <domeo:uuid>89A5BDE6-1658-4E4B-BEEC-8ED3F174B45B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB78BFA3-26C0-48E6-A00B-71C81CA3CB84">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N04838ef6ea24468f847fbbc01c5777dd"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:5F683E6F-3ADB-4D66-B5A0-D258D4A4211C</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:49:33 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 22:49:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C95081B-328F-4E21-817A-D42CE8FEDE58"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB8BEB2A-9B3F-4964-BDE8-D0B97F7D2C3A">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:53:57 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7169193-484E-459B-9085-BFA94E61FF1B"/>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5840ED50-9DC2-4896-9799-FF7D2B94281E">
    <ao:prefix>Unbound oral clearance of </ao:prefix>
    <pav:createdOn>2014-07-14 14:18:20 -0400</pav:createdOn>
    <domeo:uuid>5840ED50-9DC2-4896-9799-FF7D2B94281E</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>was significantly lower in patients with moderate to severe liver disease (Child-Pugh Class B/C) compared to healthy subjects. As a result, unbound Cmax and AUC0-inf were increased 2- and 3-fold, respectively. Elimination half-life for rosiglitazone was </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5840ED50-9DC2-4896-9799-FF7D2B94281E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51E1B74C-9C01-4628-830F-AC07648ED9CC">
    <pav:createdOn>2014-07-14 16:03:34 -0400</pav:createdOn>
    <domeo:uuid>51E1B74C-9C01-4628-830F-AC07648ED9CC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., </ao:prefix>
    <ao:exact>carbamazepine</ao:exact>
    <ao:suffix>, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolis</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:51E1B74C-9C01-4628-830F-AC07648ED9CC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/30D4FCAA-5252-4450-8869-F5567F8A8C35">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:521F4DE2-CCEF-4D75-B5D8-2331E2C11BC6">
    <ao:context rdf:resource="urn:domeoclient:uuid:8E931211-85E6-4C25-BEBC-A70D9937ED46"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 22:01:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:00:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:338D89FA-A2F3-4A78-82F4-B1B7A34C002A</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nf72b41c5d78f43c6aabc0824f7839560"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5772FFB-759F-46D8-8CA7-C4825EDB14E1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1F0575F-0EA8-4601-9DA4-60E50A820833">
    <ao:prefix>(30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1F0575F-0EA8-4601-9DA4-60E50A820833"/>
    <ao:exact>procyclidine </ao:exact>
    <ao:suffix>(5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:08:45 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D1F0575F-0EA8-4601-9DA4-60E50A820833</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F150AB38-F506-40B5-9C7C-56FFD632EB91">
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BAEA7B48-2542-4BC2-8109-715A58FA3676">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9A56C127-05E1-4C70-A61C-29A6D86550D9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:42:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:51A456EA-41D7-4564-92A5-24D17C879A5D"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F383AF3-3F5A-44FF-AFC4-A40A7B9FF05C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F383AF3-3F5A-44FF-AFC4-A40A7B9FF05C"/>
    <pav:createdOn>2014-07-14 14:54:41 -0400</pav:createdOn>
    <domeo:uuid>4F383AF3-3F5A-44FF-AFC4-A40A7B9FF05C</domeo:uuid>
    <ao:exact>Propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:suffix>does not affect the pharmacokinetics of verapamil and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80946A21-D6CC-4F00-BE40-C81A4D5974E3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:80946A21-D6CC-4F00-BE40-C81A4D5974E3"/>
    <ao:suffix> compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in t</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2014-07-13 14:49:26 -0400</pav:createdOn>
    <domeo:uuid>80946A21-D6CC-4F00-BE40-C81A4D5974E3</domeo:uuid>
    <ao:exact>norethindrone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:910E78BB-89E3-4CEE-908C-1B6B4C8C7A76">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:24975FF3-586B-43C2-89BF-1FEC9CAF4D07"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:850AED04-DBFD-4D40-A1CB-02366C5EF7F2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:42:20 -0400</pav:createdOn>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>850AED04-DBFD-4D40-A1CB-02366C5EF7F2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>to healthy volunteers, the largest mean change from baseline in supine systolic and supine diastolic blood pressures was a decrease of 9.0 mmHg and 8.4 mmHg, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:850AED04-DBFD-4D40-A1CB-02366C5EF7F2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D96E7FD7-4D7D-4302-AB4F-1812AB468632">
    <pav:createdOn>2014-07-20 21:08:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D96E7FD7-4D7D-4302-AB4F-1812AB468632"/>
    <domeo:uuid>D96E7FD7-4D7D-4302-AB4F-1812AB468632</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> metabolism, although CYP2D6 also contributes to the formation of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>M–2</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:105DA8CC-4801-42A7-B880-1FF45DF02C0F">
    <ao:suffix>and glyburide at week 52 were statistically significant.</ao:suffix>
    <ao:prefix>were 3.2, 3.1, and 2.9. The differences in change from baseline between </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:11:13 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <domeo:uuid>105DA8CC-4801-42A7-B880-1FF45DF02C0F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:105DA8CC-4801-42A7-B880-1FF45DF02C0F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24891D4D-D3AB-40C2-B5FC-2FDB82D4C4EA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>24891D4D-D3AB-40C2-B5FC-2FDB82D4C4EA</domeo:uuid>
    <pav:createdOn>2014-07-07 11:09:15 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>did not alter the pharmacokinetics of either sildenafil or atorvastatin.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>atorvastatin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:24891D4D-D3AB-40C2-B5FC-2FDB82D4C4EA"/>
    <ao:prefix>with 10 mg of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5E18221F-5E96-4E3E-881C-6DA9000AC86A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AF9A31FA-04E9-4956-AFDA-28A7EFE05FB3"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8A05847-D879-446C-9D40-4C89810755CC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8A05847-D879-446C-9D40-4C89810755CC"/>
    <pav:createdOn>2014-07-13 23:59:21 -0400</pav:createdOn>
    <ao:prefix>200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>theophylline </ao:exact>
    <ao:suffix>AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). </ao:suffix>
    <domeo:uuid>B8A05847-D879-446C-9D40-4C89810755CC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F034B5E-984A-4C69-A6C9-CF72CF9D5AF9">
    <ao:exact>levonorgestrel </ao:exact>
    <pav:createdOn>2014-07-13 14:38:43 -0400</pav:createdOn>
    <domeo:uuid>6F034B5E-984A-4C69-A6C9-CF72CF9D5AF9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F034B5E-984A-4C69-A6C9-CF72CF9D5AF9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:prefix> AUC was 6% (range: -47 to 108%) and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2D769D8C-6934-4E1C-B062-55583CBF6A6B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:85D627ED-5BBE-47B6-83B2-9E4657A52CC5"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B71211C5-72A2-434C-9E59-DF72849DAADA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>acarbose </ao:exact>
    <pav:createdOn>2014-07-14 14:44:28 -0400</pav:createdOn>
    <domeo:uuid>B71211C5-72A2-434C-9E59-DF72849DAADA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>(100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of AVANDIA.</ao:suffix>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B71211C5-72A2-434C-9E59-DF72849DAADA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76633D97-248B-4FB2-965F-C93E63D6F1C0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Ne413ff69319a4499bf0dfe4527d75ef9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:21:15 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 00:21:13 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:53E9B850-3012-4F0A-B778-2430188B3CB9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:647A94EA-76ED-4DF0-8B1C-870E35E712AF"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9F86329-963B-49B5-97BC-DB59DCB9FBE8">
    <domeo:uuid>F9F86329-963B-49B5-97BC-DB59DCB9FBE8</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Acyclovir</ao:exact>
    <pav:createdOn>2014-07-14 15:36:15 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F9F86329-963B-49B5-97BC-DB59DCB9FBE8"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEE4B475-DEAF-45A4-8AE5-5C3497B0BA86">
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4AD4F461-D05B-491D-9FDF-1C39784C1963"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:22:46 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA638B1B-85C2-4801-9004-5DAE5B879088">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:1A6DBAC5-C2B5-4C94-9C48-C015DF1BA576</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:33:15 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:33:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A1B8A19A-60AF-40EE-9D04-50544D59019F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD47852A-FBF5-4E76-B498-B105F27CF209">
    <ao:context rdf:resource="urn:domeoclient:uuid:E25023F1-C40D-45D7-857F-C13422A84252"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 11:10:03 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D49C0874-F0CE-46ED-990B-86226E4F2C32">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>single dose pharmacokinetic parameters were not affected by cimetidine (300 mg four times a day for 12 days).</ao:suffix>
    <pav:createdOn>2014-07-14 00:29:04 -0400</pav:createdOn>
    <domeo:uuid>D49C0874-F0CE-46ED-990B-86226E4F2C32</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <ao:exact>Zonisamide </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D49C0874-F0CE-46ED-990B-86226E4F2C32"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B7080B4-5D9A-455A-BD5A-4F61B472C0C3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG. After chronic dosing of 80 mg TID to patients with pulmonary arterial hypertension, no clinically relevant effects on ECG were reported.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>Single oral doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3B7080B4-5D9A-455A-BD5A-4F61B472C0C3"/>
    <domeo:uuid>3B7080B4-5D9A-455A-BD5A-4F61B472C0C3</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:41:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A72BAEFC-1EC6-4248-889B-1624DD187092">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C55DC5E6-47B5-44DB-9A36-ED918A3B1E40</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:16:05 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:15:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F032814-6089-46B4-A871-06E53268C5B4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F8ACDA4D-F030-445D-BCFB-D87D7EC9400F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E57FC17E-1CF0-465F-84C3-5053D76E01B5"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7B5D92B-3E31-426E-A1D1-F5290C6499FD">
    <pav:createdOn>2014-07-14 00:23:11 -0400</pav:createdOn>
    <domeo:uuid>B7B5D92B-3E31-426E-A1D1-F5290C6499FD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7B5D92B-3E31-426E-A1D1-F5290C6499FD"/>
    <ao:exact>quinidine sulfate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:hasSource>
    <ao:prefix> Extended-release Tablet contains 300 mg of </ao:prefix>
    <ao:suffix> (249 mg of quinidine base) in a formulation to provide extended release; the inactive ingredients are: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, polydextrose, polyethylene glycol, povidone, triacetin and titanium dioxide</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC96EA06-C785-4B23-953D-688275008825">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D2B16DF1-164C-41AC-B93E-660A361A173A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:937BDF87-2BCF-4A99-B843-DF893A173164"/>
    <pav:createdOn>2014-07-14 15:31:24 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1ECBDB41-455D-43EA-BA16-FA5E3905DEBD">
    <pav:createdOn>2014-07-14 15:12:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In vitro drug metabolism studies reveal that </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1ECBDB41-455D-43EA-BA16-FA5E3905DEBD"/>
    <domeo:uuid>1ECBDB41-455D-43EA-BA16-FA5E3905DEBD</domeo:uuid>
    <ao:suffix>is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4072B5D8-2FFC-4AAD-8EEB-C43C8CA94210">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N0eda3c4e94c544909c8814dc2787b5b9"/>
    <pav:createdOn>2014-07-20 22:19:19 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:30E34732-A773-4F36-A134-455AA339C4E2</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 22:19:21 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A6C41C38-4F67-48C7-8D2C-58EDEC2DD7F3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0548AE30-FC3F-4664-9E05-3EF1B2774D5F">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABCADE51-836E-43BA-BD8F-3297CA616FA4">
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:02:49 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD8D5681-0F0C-4BD5-B8D9-00EE03F4A437"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3E76C645-2B57-448B-87FB-30CD72D35828">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A22768E3-A426-444E-876F-EFC695201FAE">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ne6879680ef9d4b0fa5c02e37d538bed9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8D3B1F08-0157-4BB7-952C-27C84BE1CAEA"/>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:03:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCC6FFC8-D9C8-4E16-80A0-15EBAFCF5797">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:03:09 -0400</pav:createdOn>
    <ao:prefix>Co-administration of </ao:prefix>
    <domeo:uuid>CCC6FFC8-D9C8-4E16-80A0-15EBAFCF5797</domeo:uuid>
    <ao:exact>cholestyramine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CCC6FFC8-D9C8-4E16-80A0-15EBAFCF5797"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64D3106E-1308-4AAC-A7F0-911A2DACDF00">
    <pav:lineageUri>urn:domeoserver:annotationset:17778f09-3c5c-4c6f-9513-62d64b4008bc</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C7E1A06-29C8-4D5B-A8CD-5F7FBC4B65E6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACFBFD00-EB6E-4721-9C8E-346CECC1A79E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:48:27 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 21:48:25 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:F2B215E2-3D81-464F-8778-C324A23F5F71</pav:previousVersion>
    <ao:body rdf:nodeID="N17aadf86ec0b4905b3bf0d5baabc7523"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BB45444-BC21-4F91-AD74-52A83BF2D105">
    <ao:body rdf:nodeID="Nebdfd63411164caa9296499716f73823"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:19:21 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:19:05 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:78EDBD99-45E4-4D47-A087-446C0E1BD184"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:30E34732-A773-4F36-A134-455AA339C4E2</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D19D43BA-73EE-4262-B97A-E3ED181E7553">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:exact>CYP3A4</ao:exact>
    <ao:prefix>induces </ao:prefix>
    <domeo:uuid>D19D43BA-73EE-4262-B97A-E3ED181E7553</domeo:uuid>
    <ao:suffix>. Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:16:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D19D43BA-73EE-4262-B97A-E3ED181E7553"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC383F43-6551-4557-905F-11DDD907115D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:364FB984-763A-42BB-BC13-2835BDC26EEA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 23:59:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4ABE7DE-E61C-4D46-A3FE-379D9EA353C6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A986932-6EA8-4E58-90EA-CB9D6260185F"/>
    <pav:lastSavedOn>2014-07-14 14:06:35 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:05:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB42C0C7-E2EA-4FB1-9566-1CB2FBBEE7F0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>The mean Cmax and AUC of nifedipine are increased by 64% and 79%, respectively, by co-administration of propranolol</ao:exact>
    <pav:createdOn>2014-07-14 14:53:57 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB42C0C7-E2EA-4FB1-9566-1CB2FBBEE7F0"/>
    <domeo:uuid>BB42C0C7-E2EA-4FB1-9566-1CB2FBBEE7F0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E30EFC94-7D10-4338-8630-3BBAB8B93765">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 20:52:10 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:42A20FCF-5038-40E2-82E8-F347E1618A10"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:1872E227-F7E4-4791-BBBD-81E3DED1B6E8</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <ao:body rdf:nodeID="Nb5fd903ed1e94c0a81b1d84dd01c76c2"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 20:52:11 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D53D99C-6AEB-4A16-A8E3-BF35F707CA3A">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0D53D99C-6AEB-4A16-A8E3-BF35F707CA3A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <ao:exact>Co-administration of long-acting propranolol at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%</ao:exact>
    <domeo:uuid>0D53D99C-6AEB-4A16-A8E3-BF35F707CA3A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:08:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:10EE7EF0-C3E0-479A-9CEF-39DF8F8D9561">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>NER Sets</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoclient:uuid:505e7e21-5013-4387-a5ca-3a2fc425e20c</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 21:44:10 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFE3AE13-0463-40CC-919F-3A2FF52C336D"/>
    <pav:createdOn>2014-07-07 08:09:16 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-85.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="Nd2b1a67c3e9c4913b8c021ae94191d9e"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/fac7cd0f-f768-4a65-a46f-d3a894c2b450"/>
    <pav:lineageUri>urn:domeoserver:annotationset:b4c805e1-364e-451f-8f52-6f4ddeafb749</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE9A03FE-FD6B-4A90-BC32-A568886CF7F2">
    <ao:prefix>as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different from placebo or glyb</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:10:29 -0400</pav:createdOn>
    <ao:exact>u</ao:exact>
    <ao:suffix>ride controls (Table 7).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>EE9A03FE-FD6B-4A90-BC32-A568886CF7F2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE9A03FE-FD6B-4A90-BC32-A568886CF7F2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C15C9A48-1F20-4DF1-9116-F2DA550013E6">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C15C9A48-1F20-4DF1-9116-F2DA550013E6"/>
    <pav:createdOn>2014-07-14 14:52:33 -0400</pav:createdOn>
    <ao:exact>The metabolism of propranolol is reduced by co-administration of quinidine, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C15C9A48-1F20-4DF1-9116-F2DA550013E6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26091D80-4371-4E7C-B05E-E00DE9B74DF5">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 16:03:26 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0BE7D582-CC4A-4D99-9DC7-5231BCE61355"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/20790BCD-4E13-419C-BA5C-F8EBBD722E56">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>acarbose</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/16681</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9B292E1-8CFA-4E72-8F49-3149861E1CF6">
    <ao:prefix> with either </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine h</ao:suffix>
    <domeo:uuid>C9B292E1-8CFA-4E72-8F49-3149861E1CF6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C9B292E1-8CFA-4E72-8F49-3149861E1CF6"/>
    <ao:exact>ketoconazole </ao:exact>
    <pav:createdOn>2014-07-14 15:23:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F9FD200-00A1-4CDD-9B85-ADB47441530D">
    <pav:createdOn>2014-07-14 14:53:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D67E4EBA-2902-4F1F-B709-6F53A4DE73E0</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC296F6D-5DB5-4763-AAD4-16B8322506D4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:75BABCCE-F7F6-4E49-ABD5-0B81E82F6275</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:53:55 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5685601-EB22-482B-8CE4-373F2704CCD3">
    <pav:lineageUri>urn:domeoserver:annotation:4F1D0017-8C48-4582-958F-1D447324DC89</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:D328F557-C8F8-4D5F-90D2-8348B1E2763C</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-14 00:11:20 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-14 00:11:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:494E21FB-CA45-4C90-99C7-C526B71F1C26"/>
    <ao:body rdf:nodeID="Nb3696d05db4b43a39754c07c59cf4170"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F6B5F1D-46CF-49E7-B31C-2D2D38DB56F6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 15:54:38 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:112550DE-F811-433C-9B7A-F824D4140201"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E1A0CBEE-CB7F-4544-BCCF-2ADE431F7120">
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB5B2D9E-4DF7-4736-87A4-E3DFD672B769">
    <ao:suffix>. Upon discontinuation of</ao:suffix>
    <pav:createdOn>2014-07-14 15:47:30 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB5B2D9E-4DF7-4736-87A4-E3DFD672B769"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:exact>In a pharmacokinetic study with patients on methadone maintenance therapy, phenytoin administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently</ao:exact>
    <domeo:uuid>DB5B2D9E-4DF7-4736-87A4-E3DFD672B769</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19B15449-8704-44E3-8F67-69BE4EF69C7F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:19B15449-8704-44E3-8F67-69BE4EF69C7F"/>
    <ao:exact>nefazodone </ao:exact>
    <pav:createdOn>2014-07-14 13:48:46 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>results in insufficient plasma concentrations of </ao:prefix>
    <ao:suffix>and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <domeo:uuid>19B15449-8704-44E3-8F67-69BE4EF69C7F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEA4FAB9-BDD3-4A2F-B84F-C7727D1822D6">
    <domeo:uuid>EEA4FAB9-BDD3-4A2F-B84F-C7727D1822D6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEA4FAB9-BDD3-4A2F-B84F-C7727D1822D6"/>
    <pav:createdOn>2014-07-14 14:31:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Rifampin </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6652B5E8-DB94-44BC-AFD3-56D7E9801B35">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:prefix>with </ao:prefix>
    <pav:createdOn>2014-07-14 14:21:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6652B5E8-DB94-44BC-AFD3-56D7E9801B35"/>
    <ao:suffix>is contraindicated in these patients</ao:suffix>
    <domeo:uuid>6652B5E8-DB94-44BC-AFD3-56D7E9801B35</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C217E92D-6350-4E95-9C85-F1BB7DDCE810">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5C9684F0-23C4-4F1E-B84C-9B4999A51318">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>gemfibrozil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1E018521-5500-4F78-B83E-587AE0D5B47B">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDEBBB06-8BD4-4F89-A187-A2C9DCE011D5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:07:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B17EF3F-E28E-4C4D-9190-BC69DD8A215C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4477B066-614B-4766-BF4D-5EE07E18E1DB">
    <ao:item rdf:resource="urn:domeoclient:uuid:FFED4092-B970-4B17-922C-528A90463EBE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-14 00:08:06 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="Nfa550ad3d80f4e1d804dc28ca2e4599e"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:62C9AD15-C2E2-40FD-BDF9-997FB03D5443"/>
    <pav:createdOn>2014-07-14 00:06:46 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:06F62C9C-E537-4C34-9FE3-30C21F5E19C9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D6B401A-1A0D-49F0-8921-B49A25D3A271"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B2982374-B594-4E7D-B76D-DD0AF24A12B2</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4939BE5-4896-48A2-81CD-F3766D80D088"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E325F55-DDB4-4E92-ACA2-3E12A96F014F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C165BA14-BA54-484E-9E3F-F42114C1202A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5896BA13-194C-4FE4-B3C7-9D01720C79B1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:790D2F5D-2789-4322-93FD-667041115FA7">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E840C550-A3FA-4315-9644-0E54F7F3EA8F"/>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:35C2AA50-A88C-4A5F-9324-D39FA6EDBB02</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 14:38:36 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFD2B5C9-7227-43DE-97BC-F2B1BC29D00C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:77BB8A02-6EBB-4C81-B877-FDAB4DCC276A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:12B960AF-D929-4A05-8764-0039F3516901</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 13:51:27 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N9b38b55a6b0d4693a2814b53a43432d1"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-14 13:51:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/25CE3B83-6EBB-4832-B95E-A8BFCA13EF20">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/13BFF386-01D9-401E-9EF8-399F8B314789">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>zonisamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14AC6BA0-DAE6-4647-8E16-2C610521F939">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>14AC6BA0-DAE6-4647-8E16-2C610521F939</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of other known enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14AC6BA0-DAE6-4647-8E16-2C610521F939"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:21:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:124B7EBA-78D6-4D17-A8C3-0E0EB5858BEB">
    <domeo:uuid>124B7EBA-78D6-4D17-A8C3-0E0EB5858BEB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>with lovastatin or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <pav:createdOn>2014-07-14 15:05:05 -0400</pav:createdOn>
    <ao:exact>propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:124B7EBA-78D6-4D17-A8C3-0E0EB5858BEB"/>
    <ao:prefix>Co-administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59FBA095-B3A8-4E16-B0CC-BCE685195A78">
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59FBA095-B3A8-4E16-B0CC-BCE685195A78"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>59FBA095-B3A8-4E16-B0CC-BCE685195A78</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:hasSource>
    <ao:exact>Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:07:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C1A437A-FA92-4589-9BD2-268CDFAC3A67">
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:538EFDB0-08D4-4D6E-BFB3-DCDBAE9C60D2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 16:03:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 16:03:46 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D8E4BE9A-8C99-4EB9-85AA-F2B14158E2AB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/55A7764D-FFA7-46CB-86D7-34D93356BF36">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E2CDB4C5-918E-4F6E-AFA2-A00065A974E5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1943E1F8-418E-4408-A233-6464D5AAFC42"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24A0AFEC-D04E-4A9E-8F17-8C7F1A891B98">
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:45:53 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:63A02BC2-3B9D-4BDD-840E-F3B581B19B43</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D51CF50F-A88D-4E00-8D9C-34A52BB5DE15"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4703F4F8-4BAE-4BD3-B47F-AB840CA05806">
    <pav:createdOn>2014-07-14 16:06:53 -0400</pav:createdOn>
    <ao:prefix>and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-</ao:prefix>
    <domeo:uuid>4703F4F8-4BAE-4BD3-B47F-AB840CA05806</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>administered as solution to three healthy male volunteers, total recovery of radioactivity at 1 week was 84%, including 70% in the urine and 14% in the feces.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4703F4F8-4BAE-4BD3-B47F-AB840CA05806"/>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/fac7cd0f-f768-4a65-a46f-d3a894c2b450">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:10EE7EF0-C3E0-479A-9CEF-39DF8F8D9561</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 08:09:16 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:b4c805e1-364e-451f-8f52-6f4ddeafb749</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:09:16 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1ea69e04-7e08-4809-bf85-09236c8dda10"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5482918E-25A3-416A-9A0F-2447BC00CD12">
    <ao:body rdf:nodeID="N34d4882dc1cb41288ccf022360c0bd83"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 21:56:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 21:56:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:255EA68B-F450-41F7-87DE-639FBD806F13"/>
    <pav:previousVersion>urn:domeoserver:annotationset:058292D1-F68D-4213-BC3B-8D89F9C0500A</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD50B5C1-AAF3-4843-AA32-25D3162C15A5">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2020F44B-D763-4D61-8706-6F3FF2DBCBEE"/>
    <pav:lastSavedOn>2014-07-20 23:15:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACB34A20-F0B5-4EE4-ACC8-901687DDB0F2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N941c92b113e24a84918408aa70bfbc4a"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:3CEE0C16-04DD-4794-A80A-32848EDC8084</pav:lineageUri>
    <pav:createdOn>2014-07-20 23:15:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:671E5E2E-B23D-4158-81A3-86E7751046B8">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>671E5E2E-B23D-4158-81A3-86E7751046B8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:671E5E2E-B23D-4158-81A3-86E7751046B8"/>
    <ao:exact>Digoxin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 14:44:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CF95123-8C3E-4AC8-8FE8-F0045B6D7338">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 09:44:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7BC52D02-7640-4D42-95BE-5D90FF4F971A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:451E44A3-B8EF-41F7-8969-E3AF5BD59221">
    <ao:prefix> levels should be determined prior to concurrent administration with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:451E44A3-B8EF-41F7-8969-E3AF5BD59221"/>
    <domeo:uuid>451E44A3-B8EF-41F7-8969-E3AF5BD59221</domeo:uuid>
    <ao:exact>isonia-\n\nzid</ao:exact>
    <pav:createdOn>2014-07-20 20:05:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, signs and symptoms of</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50914E70-C6F2-4529-A744-2FD5C6E72827">
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50914E70-C6F2-4529-A744-2FD5C6E72827"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. Relatively weak binding of </ao:prefix>
    <pav:createdOn>2014-07-14 16:06:42 -0400</pav:createdOn>
    <domeo:uuid>50914E70-C6F2-4529-A744-2FD5C6E72827</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C607CD4B-89A0-4CB9-A1B8-06AB1AD3BF17">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 16:03:46 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7078FC9-80E4-46FF-A5E8-CF4E4C84DB04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58B8F7BA-C39C-42D5-A483-C5E72801402C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB55CED7-33C4-4E9D-8CED-1E430C3CB00F"/>
    <pav:createdOn>2014-07-14 14:55:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:55:22 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nb26c5b0d06e84ea2a441b4200f4adba1"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7F37B01-1324-449A-A8F7-9C96CE99B5ED"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D6F381AA-E6C9-4951-87E7-D9872FF197F0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-14 15:40:10 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N77616acbbb264bf1859fb2fcd89ec43a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9EDF4371-2A0F-4873-BFD4-754892583990"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BAEA7B48-2542-4BC2-8109-715A58FA3676"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5C50FF8-852E-4393-A357-96F2F8F12C68"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:67EC4DE2-C1C6-463E-B7A6-1812ECDCBDED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C4D4AD1-7E71-4290-B0D5-CDDB01D0EB7F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:211DE4D6-1280-4905-B502-EB4B87C6FE28"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:01AC8AFF-3347-4FBB-9ABB-BB103A58CA24">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7114F5CD-3259-4ED6-B9FE-B03F8D23A618"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FC6211D-711C-444F-8347-D36CBB26F443">
    <ao:exact>Cimetidine increased the Cmax and AUC of tacrine by approximately 54% and 64%, respectively</ao:exact>
    <domeo:uuid>8FC6211D-711C-444F-8347-D36CBB26F443</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-84.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8FC6211D-711C-444F-8347-D36CBB26F443"/>
    <pav:createdOn>2014-07-20 21:43:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5E9EC647-C1F0-425B-802C-E52C7B889D3E">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:378EB634-E0EE-4103-9EFA-D05FA194855C">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8842B8AA-F18A-4534-BB18-6BC1A9090677"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7D65E14-F652-4B4E-9675-7F1CD8CF3003">
    <pav:lastSavedOn>2014-07-14 13:51:02 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:3C90379C-A4B8-4DFB-954A-60B0D121F2BF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 13:48:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-13 14:36:43 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B97D060-A92E-4DE6-9631-D9431C40495A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:790D2F5D-2789-4322-93FD-667041115FA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F58EE2F4-90DB-432C-919A-90C0F28B1531"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <permissions:permissions rdf:nodeID="N9f130eaba7e640d18ac73156f1aec38e"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:038A8C9B-DBAD-4ED4-8716-F8B60581CC86"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:7B84852A-E278-4DA9-9E64-518338AC55DE</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FC511C-51CF-4E60-8BE9-5C437CB14B89"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AEECEADA-4021-4297-A6AF-E35D84498734"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:774A40A6-D325-4431-8107-3273A2B52E71"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C26FC4D-EFE8-4072-AFA4-B47B9997E371"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60A4D5FB-7A8D-40DF-B1FF-0D6B7599C889">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>carbamazepine</ao:exact>
    <ao:prefix>, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60A4D5FB-7A8D-40DF-B1FF-0D6B7599C889"/>
    <ao:suffix>, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other d</ao:suffix>
    <domeo:uuid>60A4D5FB-7A8D-40DF-B1FF-0D6B7599C889</domeo:uuid>
    <pav:createdOn>2014-07-14 00:24:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.1alpha-050">
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
    <foafx:build>050</foafx:build>
    <foafx:version>2.1alpha</foafx:version>
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
    <foafx:homepage></foafx:homepage>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E23C3B0-0942-4F1B-A258-005D1C03A60D">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5FC2678A-27CB-404F-B580-EF24CFBD2537"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D5F4E3E-4FC7-482C-A927-B1A9285BEA91">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D5F4E3E-4FC7-482C-A927-B1A9285BEA91"/>
    <ao:prefix> is predominantly metabolized by </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:exact>CYP2C8</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>3D5F4E3E-4FC7-482C-A927-B1A9285BEA91</domeo:uuid>
    <pav:createdOn>2014-07-14 14:23:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACC34EC8-444B-425C-A010-DE6064EE2495">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N69d5426d2cbc44a78e5726d3ba0b2620"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8204760A-0B03-4608-B1B3-EA9D65C0052D"/>
    <pav:lineageUri>urn:domeoserver:annotation:C0424317-6C9D-4401-AD86-59666D36E47D</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:56:23 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:56:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EC80DFF-71D4-4B0F-88B9-A3BA543576EC">
    <ao:context rdf:resource="urn:domeoclient:uuid:68D6BA0D-201C-474B-B27F-81160B60D4D6"/>
    <pav:createdOn>2014-07-14 15:45:52 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:FC32B90B-8888-4F91-A600-16280708BABD</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40D93E65-EFFA-4110-BB95-3F6525050777">
    <pav:createdOn>2014-07-14 14:23:16 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:217F4CF8-C040-4AAC-9367-95C3CCB92CF6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7842F04E-DAC6-4560-9470-E882DD2419F5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:10:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9A1179DB-EC75-4FF4-AD92-D72E498ADEFD"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FAB5D90-9436-4813-986F-0D1433339D6A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:52:43 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4E0B13B-9379-408D-9C23-627A7E4A5E95"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DE981F4-541F-4902-AC82-FCE6D2B02FA1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">14</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:76AAE184-615C-4489-B09E-1015897F9E1C</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B0B8A783-7E49-4CC6-AB35-1B52E96A9092"/>
    <pav:lastSavedOn>2014-07-14 14:30:46 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Nffd7b94d2f834ff59c9013d306f9f454"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:29:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ff6014c3-a89b-44e5-af62-f0623f958a50">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:47b96dd3-a21e-47cc-b7ee-3de367a95ec8</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:09:20 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:e3357242-f7ef-45e3-a5a7-f730d1d97a22"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8174B810-E408-49FB-BA8C-C21B362AF392</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE064B1E-6EB0-44B4-B8F3-6D8DD94F363E">
    <pav:lastSavedOn>2014-07-20 20:20:18 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:19:53 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:11750F37-DAB4-4675-B253-7F67E608D51F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:6e22c92c-7297-4e91-ba82-ac1dc0a550ab</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D8C95AA-2AAC-46E2-81D6-932A6B995F67">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 16:01:59 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B0B27292-E9F9-4475-AE1C-7EB529AC35EA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5340CC8B-23A9-4D27-BC47-DDBC410BF494">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E462ECE-8A32-48E6-9BC8-1DB650956237">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:68B5D673-3DEA-4E97-834D-35CCF1011A9F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCD69664-0D59-4A3B-A42A-F487BC79D263">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2014-07-14 16:02:08 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:262FFA97-091E-41E6-B55A-C7A7E163D935"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F6C54C0-A4DC-4A76-9591-12C85826E330">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:18:02 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. Plasma concentrations of</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%</ao:exact>
    <domeo:uuid>3F6C54C0-A4DC-4A76-9591-12C85826E330</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F6C54C0-A4DC-4A76-9591-12C85826E330"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F931F147-885D-41D0-852B-E34B0168B75C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F16EAEA7-6C82-4EB8-9CB4-39F6CC348F55</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:45:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:17241D6B-945E-4F06-B117-C3A572F5FD80"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70A02B0A-E2D3-4C76-A00D-07A21B7A4FA3">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:37:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:471BA62B-8C73-4467-A4CB-476ADB01B676"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N817023e10c454a1490767ef35bfe38db"/>
    <pav:lastSavedOn>2014-07-14 14:37:20 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:1B2D1CB1-AF4A-4392-B9F9-E4972994FD93</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB06DF4D-0830-462A-9590-A7DAF82A62D4">
    <pav:createdOn>2014-07-14 13:48:40 -0400</pav:createdOn>
    <domeo:uuid>AB06DF4D-0830-462A-9590-A7DAF82A62D4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB06DF4D-0830-462A-9590-A7DAF82A62D4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <ao:suffix>with nefazodone results in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:exact>carbamazepine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Coadministration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:924CB816-82B2-4133-BB74-66D1A3E04605">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:84EC8196-4C54-4885-9F8A-B08FF5827A97</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 23:00:01 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5EC9986C-FF4A-44D3-983F-404983FDCCB7"/>
    <ao:body rdf:nodeID="N23787a0bd9f24765a285ee853d2be17d"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:59:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9642BA7C-B767-4A07-A0CF-4DFFB1E0F3F5">
    <pav:createdOn>2014-07-20 20:33:31 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:EC97C654-DB7C-4BE4-A756-0AD8D9C9CE9B</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:33:32 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ne91dadaeffc442c6a034790e0f269cd5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4CA48B6D-44B8-43E5-9406-172F17271580"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4ad4f9b8-25d8-4206-ba7d-b95d7573abef">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:08:55 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:017f0cd2-2813-4160-8b5c-a97457d091b4</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:66793693-4af2-4f8f-ae38-b2b894d8b298"/>
    <pav:createdOn>2014-07-07 08:08:55 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:77F8EC3D-E8BD-4D6A-A6D7-2C534926E795</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8594AEA3-40C7-4EFE-A73C-718308321858">
    <ao:prefix>specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of </ao:prefix>
    <pav:createdOn>2014-07-07 09:37:23 -0400</pav:createdOn>
    <domeo:uuid>8594AEA3-40C7-4EFE-A73C-718308321858</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>cGMP</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8594AEA3-40C7-4EFE-A73C-718308321858"/>
    <ao:suffix>. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:588738AA-7EC6-43C4-B157-BE36F827A71B">
    <ao:context rdf:resource="urn:domeoclient:uuid:CD8911DB-833A-40A4-BCEC-B0B40B660AE7"/>
    <pav:lastSavedOn>2014-07-20 20:39:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N0fcb0f2a1363483889f78397f6a7d570"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:1794100C-4C38-4154-9980-B12DD6F615EB</pav:previousVersion>
    <pav:createdOn>2014-07-20 20:37:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:891CAAA4-5905-457B-AE2E-CBE044222C89">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N0b30b981e3ec4dab8ee449dd213e0981"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B9947827-FEA3-40ED-803D-77F791CE87D5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:663FA7F9-D3FD-4437-A28A-EA822FBC208F"/>
    <pav:createdOn>2014-07-14 13:46:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAAD3F51-F985-4954-8B78-ED5FFC54D881">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CAAD3F51-F985-4954-8B78-ED5FFC54D881</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAAD3F51-F985-4954-8B78-ED5FFC54D881"/>
    <ao:suffix>), has been identified in the plasma following single-dose intravenous (IV) administration of </ao:suffix>
    <ao:prefix>(</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>AMT</ao:exact>
    <pav:createdOn>2014-07-20 20:46:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB974B54-2A54-46AB-9758-4C69979EDADB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB974B54-2A54-46AB-9758-4C69979EDADB"/>
    <domeo:uuid>AB974B54-2A54-46AB-9758-4C69979EDADB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Cimetidine and ranitidine increased the bioavailability of risperidone by 64% and 26%, respectively</ao:exact>
    <pav:createdOn>2014-07-20 22:10:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd1563ee10a484a7e8d32a96a00c063f9">
    <domeo:sets rdf:resource="urn:pddi:uuid:0AAD930F-D24D-431A-9644-CBA937E6B04F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A9A544F-592E-407F-BACD-ECCDD495C48A">
    <pav:createdOn>2014-07-20 21:33:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0CBA1D0E-EE21-43A4-A435-C10B50636A5C</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D0C75F6-6E68-4F8D-B2B1-A755E8E3425B"/>
    <ao:body rdf:nodeID="Necf1faa724754326bdbbfdfaabc842dc"/>
    <pav:lineageUri>urn:domeoserver:annotation:36F38B43-D4DB-4067-96A8-1ABC8CD04446</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 21:33:07 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D328F557-C8F8-4D5F-90D2-8348B1E2763C">
    <ao:item rdf:resource="urn:domeoclient:uuid:D08D9252-FCA0-4CEC-89A8-86C09C07165C"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 00:11:19 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5685601-EB22-482B-8CE4-373F2704CCD3"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:65A558A9-12F4-4D81-A91F-21B650B4DA1C</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N13260a3323d140649e6eb0540cb689d4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8690C5F-D60D-43A3-84B0-AA8DFD3C1522"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 00:08:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:110ED8F7-1F26-4899-9D11-3EE5C6B346E8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7CE9219D-9E90-40F6-9706-415483FC7A28">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:59974561-254A-4048-89B1-CE33383CA99F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:595D178B-3D2E-43EC-B368-0DFEA77B3E38">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F35EA7C7-C6F4-43EC-8A92-8945497CF80F"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae44827563c94e83a6640cc7f48d59be">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:636E1844-D80E-4DAF-A97C-25ED9D6C639F">
    <ao:suffix>/aluminum hydroxide) did not affect the bioavailability of sildenafil.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 11:09:33 -0400</pav:createdOn>
    <ao:prefix>Single doses of antacid (</ao:prefix>
    <domeo:uuid>636E1844-D80E-4DAF-A97C-25ED9D6C639F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:636E1844-D80E-4DAF-A97C-25ED9D6C639F"/>
    <ao:exact>magnesium hydroxide</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncc1eb7224e7141969ea248097132cd57">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E299A69-7012-4228-8CC3-DC2F6A333380">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E299A69-7012-4228-8CC3-DC2F6A333380"/>
    <ao:suffix>) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes tre</ao:suffix>
    <ao:prefix> (e.g., </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>gemfibrozil</ao:exact>
    <domeo:uuid>6E299A69-7012-4228-8CC3-DC2F6A333380</domeo:uuid>
    <pav:createdOn>2014-07-14 13:59:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C2E400F-C65F-418B-B1CC-8A67F1884B6A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C2E400F-C65F-418B-B1CC-8A67F1884B6A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2C2E400F-C65F-418B-B1CC-8A67F1884B6A</domeo:uuid>
    <ao:exact>oxacillin </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 13:52:17 -0400</pav:createdOn>
    <ao:prefix>(7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed meth</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BAB5BBB4-B6BC-42B8-8632-63348C417059">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5BE227F-7164-4DAD-89D8-684BD64D96EF">
    <rdfs:label>hydralazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31EE5963-852E-4178-904F-C17B5990CE12">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>in combination with other hypoglycemic agents were generally similar to those seen with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:31EE5963-852E-4178-904F-C17B5990CE12"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:11:26 -0400</pav:createdOn>
    <domeo:uuid>31EE5963-852E-4178-904F-C17B5990CE12</domeo:uuid>
    <ao:suffix>in monotherapy.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N871c35198bc94f4d8af24ad7242297b7">
    <domeo:sets rdf:resource="urn:pddi:uuid:3E155A1B-B3FE-4145-98DB-88EF9FA7F85C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E30DB90-3C1D-446F-A8AE-B84FAE8A061B">
    <ao:exact>aluminum hydroxide</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E30DB90-3C1D-446F-A8AE-B84FAE8A061B"/>
    <ao:prefix>/</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>) did not affect the bioavailability of sildenafil.</ao:suffix>
    <pav:createdOn>2014-07-07 11:09:35 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>3E30DB90-3C1D-446F-A8AE-B84FAE8A061B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0481a643-a919-4938-bfcb-05565f3a094d">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:08:58 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:e6712706-f454-49c6-89a1-48570d61642c"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:08:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1CE97FA-1E37-43BD-B37F-9C89C869ECF4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDDC451D-DB10-45C3-916F-DE83B5FA894A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7AC88968-5799-4BEB-A9BC-D20C067E2451"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 23:54:43 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB3671FF-0F24-45EE-AB36-F7D339EF8FEF"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:1659FBB8-F690-4BB3-8312-06E2B7EE26F6"/>
    <pav:previousVersion>urn:domeoclient:uuid:6F9E9067-897D-4374-8A33-DDAD93291643</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:40EBA023-1798-45FC-888F-3A87913C74E4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37EFD623-A7A1-49CD-9469-F5C8F3A5CE0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8FB0779-067F-4328-BD85-6BD79616D728"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:229D895E-8280-4B79-B558-71ED416F58DD"/>
    <permissions:permissions rdf:nodeID="Nd2a4329a3ed14afc88ff582778865a7c"/>
    <pav:lastSavedOn>2014-07-13 23:58:24 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DB34EDF1-26C6-49DE-AE5A-91AB2D9BE8DD"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:28:14 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4B7B734-D16E-4939-BE06-A0EBD20656D2"/>
    <pav:previousVersion>urn:domeoserver:annotationset:BBD0DE1B-6787-46CB-A3A0-D8BD33B4700A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB1485F2-066E-4648-9278-72F56EA2D34B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A9436CD-961A-429A-9900-991E3858E7AB"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:0CFFC5D6-2D2A-4C1B-8A07-494C53091242"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:26ECEC8C-6E12-4D2E-B551-405BFF824207"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:18FAEB01-EF5E-49F1-AFFD-BBDD9ACA5FC6"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N21b1c32ea9ee46a1a14f30025709408b"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:createdOn>2014-07-14 00:24:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:398AD193-EFD5-4789-ACAD-65E9E3D92EB1"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3DB0398-D4A3-4A23-BE1A-E9C2AE2D2167"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A14E08F0-BF86-4EB3-9B2B-1B46D3BF71FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:791108D1-BF81-414D-87F1-B5D4A0A7D91E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A42A7E98-DFAE-45C5-94AA-6C0CC759F34F">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:58DFC95D-E8F9-481A-B665-6DB6C142031D"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 16:03:38 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DAE71506-BABB-434A-83B9-CFB40FF24261">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DAE71506-BABB-434A-83B9-CFB40FF24261"/>
    <ao:exact>peroxisome proliferator-activated receptor-gamma</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:06:24 -0400</pav:createdOn>
    <ao:prefix>is a highly selective and potent agonist for the </ao:prefix>
    <ao:suffix> (PPARγ). In humans, PPAR receptors are found in key target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPARγ nuclear receptors regulates the transcription of insulin-responsive genes involved in the contr</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DAE71506-BABB-434A-83B9-CFB40FF24261</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4B99BA0-98BC-49A6-B72D-93863912B445">
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:52:06 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:DC19A65A-DDCD-459F-A222-A795B6489940</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 21:52:37 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:17F34F7F-E25E-44F5-93C8-01A2B1B1BDD6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33C973CD-EFB1-42B4-B1D8-5406520B9A3C">
    <ao:body rdf:nodeID="Nbf442b26c2af4b988fdb06eaf8306b39"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA3AD80C-88A6-482F-9FC4-6DE41DEB8ECF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:D8133263-824A-4884-8AA1-BAE4F08600A0</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:14:55 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:14:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A5C0B7D-E4B9-44CB-9047-E9015462CC2F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 15:54:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8046D798-CE5E-424C-A505-4DCEF2C7A1B1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B530E20-E9BD-4FE9-9DB6-C2F0CC95B9BF">
    <pav:createdOn>2014-07-13 23:53:01 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:543886EE-4023-4CAE-97A8-EFD8E0A60084</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 23:53:02 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na8937d0bd8b8474696e7ef176fe03d72"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:57DB318A-AA7B-4257-A972-9810A2CB86D6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0AC45CA0-F2B5-408C-9905-4A9CFE6B7ECF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluvoxamine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96D666C3-78BD-47F1-BF8E-5E87B88B41EC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:96D666C3-78BD-47F1-BF8E-5E87B88B41EC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>96D666C3-78BD-47F1-BF8E-5E87B88B41EC</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 14:56:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Propranolol does not affect the pharmacokinetics of verapamil and norverapamil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E234B393-5FE6-4CFD-9138-E244B2D96757">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F6C54C0-A4DC-4A76-9591-12C85826E330"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N5dbcdebcfb5241e19dc715f17492bc77"/>
    <pav:previousVersion>urn:domeoserver:annotationset:5002655C-D5AA-4303-86AC-B3CF931BC345</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:18:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:18:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C060DD22-64A7-45A3-924E-F9892256E2B0">
    <pav:createdOn>2014-07-14 15:17:05 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:CDAFEAC2-1BAB-47A6-8C7B-51E192EC83D5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:82DA41F1-F125-4E08-AD5D-0AA52A705421"/>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B32451E8-0A5F-4AB6-ACC3-9321720FC94C">
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC53ABB3-D58B-42A4-9A28-0CA93DF4F460">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 16:01:36 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C61B6F1-9109-41B3-87A4-E24912A9568C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9815E44-1531-43E6-8C71-52B358B999C2">
    <ao:suffix> [see Warnings and Precautions (5.4)]</ao:suffix>
    <domeo:uuid>F9815E44-1531-43E6-8C71-52B358B999C2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F9815E44-1531-43E6-8C71-52B358B999C2"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 20:56:37 -0400</pav:createdOn>
    <ao:exact>In vitro data indicate ribavirin reduces phosphorylation of lamivudine, stavudine, and zidovudine. However, no pharmacokinetic (e.g., plasma concentrations or intracellular triphosphorylated active metabolite concentrations) or pharmacodynamic (e.g., loss of HIV-1/HCV virologic suppression) interaction was observed when ribavirin and lamivudine (n = 18), stavudine (n = 10), or zidovudine (n = 6) were coadministered as part of a multi-drug regimen to HIV-1/HCV co-infected patients</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB3A01BA-4FB4-43BD-A2A8-5F83114CC427">
    <ao:suffix> dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to </ao:suffix>
    <ao:prefix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB3A01BA-4FB4-43BD-A2A8-5F83114CC427"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EB3A01BA-4FB4-43BD-A2A8-5F83114CC427</domeo:uuid>
    <pav:createdOn>2014-07-13 14:49:15 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F2270508-35DB-4484-A584-328762624BF8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5D35D32E-5B0C-47ED-8F3E-49720874CD62"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:826569BE-2214-48AC-B6FE-A4A3C8124CF1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>826569BE-2214-48AC-B6FE-A4A3C8124CF1</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:826569BE-2214-48AC-B6FE-A4A3C8124CF1"/>
    <pav:createdOn>2014-07-14 15:48:47 -0400</pav:createdOn>
    <ao:prefix>The mechanism of action of </ao:prefix>
    <ao:suffix>, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E37BF728-310F-493F-B5BF-0546D1344119">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CDE13C93-F325-4362-9DB4-C25339BA56D6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EF11FADD-9234-456D-8F3B-BF599386DACE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C760DC9E-6990-45D9-8826-92A327DA84A2">
    <ao:exact>azithromycin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C760DC9E-6990-45D9-8826-92A327DA84A2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C760DC9E-6990-45D9-8826-92A327DA84A2</domeo:uuid>
    <ao:prefix>resulted in increased </ao:prefix>
    <ao:suffix>serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is w</ao:suffix>
    <pav:createdOn>2014-07-14 15:34:12 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E123EA8-4CB0-41ED-A5BC-BDAAECF21AB6">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A9ED8E10-DD66-4041-B97A-29FC4BD8C2B2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:07:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D90AC6D7-DC03-417E-9804-9B5BDBB189B6">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0AD41BC2-2669-49F8-A3B8-7D1FC6F2C930"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5617F774-D0B5-4B59-A464-6F71FBBCCE61">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:51:51 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:A4CAF33B-7EDE-454B-A091-25FEDF0ECA63</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:52:31 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:873CF841-5851-4934-AF20-5A7BBF703196"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DC39656D-4BC2-495B-AE16-381F4232691E</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BD2C839-F167-465D-A898-1429ECDD43B6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2630D418-D55B-4389-8913-65E1C14B5B03"/>
    <pav:createdOn>2014-07-14 15:59:25 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:EAEFDF96-7A62-4DA2-9546-8FD1F72EB7CB</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:59:23 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N06b620e998ca4dd58f6c029171911bb8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F33B91B1-7A0C-42CF-930F-7D354B2E7667">
    <pav:createdOn>2014-07-07 11:09:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F33B91B1-7A0C-42CF-930F-7D354B2E7667</domeo:uuid>
    <ao:prefix>Concomitant administration of a single 100 mg dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F33B91B1-7A0C-42CF-930F-7D354B2E7667"/>
    <ao:suffix>with 10 mg of atorvastatin did not alter the pharmacokinetics of either sildenafil or atorvastatin.</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9BB62A2-18A0-4EE8-9B5E-3CDDE54470C5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and oral contraceptives (</ao:prefix>
    <ao:exact>ethinyl estradiol</ao:exact>
    <domeo:uuid>C9BB62A2-18A0-4EE8-9B5E-3CDDE54470C5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix> and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C9BB62A2-18A0-4EE8-9B5E-3CDDE54470C5"/>
    <pav:createdOn>2014-07-14 14:24:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A22A7401-D44F-4B96-825C-D6B7A0326C39">
    <ao:exact>fluvastatin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A22A7401-D44F-4B96-825C-D6B7A0326C39"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>.</ao:suffix>
    <ao:prefix>did not have an effect on the pharmacokinetics of </ao:prefix>
    <pav:createdOn>2014-07-14 15:05:22 -0400</pav:createdOn>
    <domeo:uuid>A22A7401-D44F-4B96-825C-D6B7A0326C39</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34405F1F-C97A-42B2-8733-48B762481C13">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ncb05e923bcb843b281c1088cf60bebe1"/>
    <pav:lineageUri>urn:domeoserver:annotation:B4339A67-D4F2-47B5-866D-E8BD3934E143</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:C35B4EB4-FABA-4308-A858-D024FD0CD40F"/>
    <pav:createdOn>2014-07-20 21:39:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 21:39:28 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DCA01201-900A-484E-A265-59DB0E1CD1C5</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0341915A-FEB3-47F5-834B-95B81FE9E127">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:702C8EF4-BCF2-415D-A4F0-5F8414627041"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9d8f35a8-4978-4d7e-a9b3-ecacfc22eab5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:93449bac-6ffe-4b83-b57d-eac1853867c0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:08:48 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78cb3beb-2fce-4a58-bb25-b7abe617cb72">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> by 21% and 10%, respectively,</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:hasSource>
    <ao:prefix>ecreased the Cmax and AUC of </ao:prefix>
    <ao:exact>ketoconazole</ao:exact>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78cb3beb-2fce-4a58-bb25-b7abe617cb72"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C66DD857-DBA8-47C6-949E-883D629C3B3F">
    <ao:exact>The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C66DD857-DBA8-47C6-949E-883D629C3B3F"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>C66DD857-DBA8-47C6-949E-883D629C3B3F</domeo:uuid>
    <ao:prefix>. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 14:58:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7337B1D-4B6D-4960-BF16-21FDA2383475">
    <domeo:uuid>D7337B1D-4B6D-4960-BF16-21FDA2383475</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. However,</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7337B1D-4B6D-4960-BF16-21FDA2383475"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:10:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Cimetidine and ranitidine increased the bioavailability of risperidone by 64% and 26%, respectively</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAA5A7A6-84FE-4ABF-A7FB-47F245D8854F">
    <ao:prefix> immediate release 150 mg three times daily regimen. Mean exposure to</ao:prefix>
    <domeo:uuid>FAA5A7A6-84FE-4ABF-A7FB-47F245D8854F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAA5A7A6-84FE-4ABF-A7FB-47F245D8854F"/>
    <ao:suffix> was about 20-25% higher after SR capsule administration than after immediate release tablet administration.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:19:01 -0400</pav:createdOn>
    <ao:exact> 5-hydroxypropafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3359A31B-60B9-49E7-97EE-F55483A9891C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:686F818D-4CF5-4BBA-9F7B-79FEC0C034F3</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F30CD26-B53E-4DF3-978F-C9EBD8AD2A78"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 16:07:19 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FC27BC2-08A8-4F93-B114-7BBC12BB7BB0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FC27BC2-08A8-4F93-B114-7BBC12BB7BB0"/>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>5FC27BC2-08A8-4F93-B114-7BBC12BB7BB0</domeo:uuid>
    <pav:createdOn>2014-07-14 14:58:06 -0400</pav:createdOn>
    <ao:exact>Propranolol can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEA85DD8-2324-4212-A280-5F3A64C27AE5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2940F792-08F6-422F-98F1-8DF507C61EE2"/>
    <pav:createdOn>2014-07-20 23:00:26 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:3E51DAFF-CCF7-4797-8B85-53716EDFE80C</pav:previousVersion>
    <ao:body rdf:nodeID="Nb2729cf9cb4e4e079b4181d2ab55c1ab"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 23:00:28 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A59E408F-78B0-4BBF-9F91-E726F20C150D">
    <pav:createdOn>2014-07-14 15:29:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0C56EA4-8A53-4E06-B285-6507BED225BB"/>
    <pav:lastSavedOn>2014-07-14 15:29:52 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:F639B167-2183-4B47-BB47-F126C38CD529</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N7b7c0e745c9242c3aee312a1b920bca5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7498C777-B69C-4843-AAA6-0C05B68090AC">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D8D6598-02B5-4252-8B43-E1E2CE625D70">
    <domeo:uuid>2D8D6598-02B5-4252-8B43-E1E2CE625D70</domeo:uuid>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D8D6598-02B5-4252-8B43-E1E2CE625D70"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:58:08 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DCBC5F5-3A41-4266-BB5A-B26163D5E0DC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:01:51 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:48E7C71B-AF8F-43A2-8425-6DEAE82F7EAE"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:1F4DB871-B0E2-4CBE-B57A-8CC4639877CD</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:02:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:63FE9723-86C9-4238-9E11-9C4879AC39DA</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C172398-DC8A-4607-B1F6-6B8C6EACF2C5">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 13:59:54 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DA0108CB-7F76-4EFE-87DC-8F7E6E214712"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:475E3B29-A953-4362-9AFB-734B47790E99">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:39:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:39:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DF0B4A2-95DB-440C-80BB-6951AC703786"/>
    <pav:lineageUri>urn:domeoserver:annotation:84D507B5-62A1-44E9-B1D6-522E0ECCFA62</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N2df8e6142fe84b1985266b177dd3859f"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EAEE64A7-CF36-45A6-A47C-DC3395498A7F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DA5E3840-738A-4E89-BF0C-B8F2A22C8378"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F5C8BE47-13CA-4CE1-A05F-B1A4280B8693"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACF80F3F-F2DA-4EF5-9569-3CFF202441BE">
    <ao:prefix>is extensively metabolized with most metabolites appearing in the urine. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACF80F3F-F2DA-4EF5-9569-3CFF202441BE"/>
    <ao:exact>Propranolol </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>ACF80F3F-F2DA-4EF5-9569-3CFF202441BE</domeo:uuid>
    <ao:suffix>is metabolized through three primary routes: aromatic hydroxylation (mainly 4-hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucuronidation. It has been estimated that the percentage contributions of these routes to </ao:suffix>
    <pav:createdOn>2014-07-14 15:10:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6AB17E9-F7F0-4949-B4EB-FE4BD6E7C995">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C6AB17E9-F7F0-4949-B4EB-FE4BD6E7C995"/>
    <ao:suffix>/ritonavir with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:prefix>Co-administration of </ao:prefix>
    <domeo:uuid>C6AB17E9-F7F0-4949-B4EB-FE4BD6E7C995</domeo:uuid>
    <pav:createdOn>2014-07-14 00:12:01 -0400</pav:createdOn>
    <ao:exact>fosamprenavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9372314C-A230-4A4C-8D91-E38EB06994EB">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:createdOn>2014-07-20 22:00:12 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 22:00:16 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:08183A85-C165-41A8-BB91-6C70CFA02F7D</pav:previousVersion>
    <ao:body rdf:nodeID="Nf40065dd36694b7ca04ebb73584ccdec"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:05A624D1-7D8F-4A66-8316-E5E33B610293"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB34EDF1-26C6-49DE-AE5A-91AB2D9BE8DD">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F0CE3644-9936-4C5C-AC71-4A14260D0FD3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:28:14 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:28120C08-9093-4E03-AEE4-E77A8FCA5C7F"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-14 00:28:13 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N3fb93498788c44cb983297e497c80e4d"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:08B210AA-3CC1-46FB-A287-17294AF1A1DC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/605EB540-8417-4004-AB2E-AF61974DA39A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/76ACE6B5-3D00-4147-905B-481C54B994FB"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E1923CB2-0FF7-4945-8F06-DC30AD67F99D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>hydralazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A096CC4B-894E-41A0-AF6D-BD5FA00A75FE">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:15376922-DE98-4B35-89FC-15A1DDE1A8D0"/>
    <ao:body rdf:nodeID="Neb21cd35a2b542efbeafde327dfb45bb"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:25:51 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:4DCD0B8C-5C05-41E7-A6A0-8DBC57540B33</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:25:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:41FADBF6-DB61-48C1-8758-89F516D57C5A">
    <permissions:permissions rdf:nodeID="Nd60261bfca1a42a9b60300e8876ddc76"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lastSavedOn>2014-07-20 21:36:24 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/17b187f9-7c97-4316-ab80-f59bd34b0311"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-83.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:1E20EDE8-9BAA-4231-99E9-030B2330A94E"/>
    <pav:createdOn>2014-07-07 08:08:47 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:previousVersion>urn:domeoclient:uuid:20f83003-e2f3-4e81-a859-783bc775f109</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:ebe61c71-4bd3-4aa1-9a6a-e9cb12d5e1ce</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9752B97-948E-491E-816E-99A901AB1153">
    <ao:context rdf:resource="urn:domeoclient:uuid:4F4AAD83-4F30-4757-8C51-DF22D331E0F8"/>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:55:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E69164F-0CFB-4629-B36A-A64D4F4BA25A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E69164F-0CFB-4629-B36A-A64D4F4BA25A"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 14:45:41 -0400</pav:createdOn>
    <ao:exact>There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%)</ao:exact>
    <domeo:uuid>4E69164F-0CFB-4629-B36A-A64D4F4BA25A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D70AF55E-8385-4447-8A13-50FB670CC3D9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <domeo:uuid>D70AF55E-8385-4447-8A13-50FB670CC3D9</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>In 13 normal male volunteers, there was significant increase in tolbutamide (500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%)</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 00:08:06 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D70AF55E-8385-4447-8A13-50FB670CC3D9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1B71F769-A5DC-48DD-8815-91370C23B2F4">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7FB518E0-065F-4883-8772-40243E88D540"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74DEB7D4-9543-4829-B272-BF59AA13AC97">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DF82AD9B-B554-429C-BECD-208870577B01"/>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:43:58 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7e0b557d-0dcc-4047-bd64-ba377642295c">
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7e0b557d-0dcc-4047-bd64-ba377642295c"/>
    <ao:suffix> will hasten the movement of f</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>metoclopramide</ao:exact>
    <ao:prefix>sulin Because the action of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F482EC3-1EC0-4591-9CE4-4E8266FEEA69">
    <pav:lineageUri>urn:domeoserver:annotationset:CA1C3EDB-B522-4D4F-8B67-C10290D5EE9A</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:08:44 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1DAF89A-7686-4858-BC0D-575EE8454B85"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E87D07CB-7EA1-44C2-B67C-79CB3E3A3EF9"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:CE40501B-5515-449B-BF8B-E14157E3591E"/>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F302C840-2655-4D95-A4D4-C15C333402B9"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-14 15:07:06 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:1E62563B-DD9B-423D-B300-7267DA7DFBD5"/>
    <permissions:permissions rdf:nodeID="Ne47ee4ad591c4334923442310380e95b"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41DD6E21-FEC9-48EA-8EF8-3CDB1DC0A66E">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41DD6E21-FEC9-48EA-8EF8-3CDB1DC0A66E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:06:15 -0400</pav:createdOn>
    <domeo:uuid>41DD6E21-FEC9-48EA-8EF8-3CDB1DC0A66E</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8ee4e9a395524d0e8ecb58e461c2139a">
    <domeo:sets rdf:resource="urn:pddi:uuid:70199B63-618E-4F0B-B2BF-F39B1B449269"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB790708-0E38-42AE-BEAA-E69185046E54">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB790708-0E38-42AE-BEAA-E69185046E54"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>BB790708-0E38-42AE-BEAA-E69185046E54</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:38:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/58B9A07A-8BF3-4F39-9D31-B08A28A103B4">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2413F09F-9AD6-4337-8C6A-F897CF9C9EE3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>2413F09F-9AD6-4337-8C6A-F897CF9C9EE3</domeo:uuid>
    <pav:createdOn>2014-07-14 15:55:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2413F09F-9AD6-4337-8C6A-F897CF9C9EE3"/>
    <ao:suffix>(100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of </ao:prefix>
    <ao:exact>sulfamethazine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F35FBAAE-14A5-4DAF-A539-404D646A58D9">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B6255E2A-6F5B-4EF8-94C7-E0ECE9F9449D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:169A20D5-E605-435F-A9BA-17F7C8E8CA24">
    <ao:exact>High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:169A20D5-E605-435F-A9BA-17F7C8E8CA24"/>
    <pav:createdOn>2014-07-14 15:58:53 -0400</pav:createdOn>
    <domeo:uuid>169A20D5-E605-435F-A9BA-17F7C8E8CA24</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AC2A4C59-3807-4E20-A0C1-1E6705DD1852">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>acyclovir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/281</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EF0D417-70EE-4247-ADF5-6E19AA1B61AA">
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:11C7E2AE-F02A-46F0-8F5F-C0E3A60F43EE"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:23:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:508553F6-27A3-42CB-B39B-593992C39C25">
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E236BA8C-C033-4DC5-BC67-703822FB0BAA"/>
    <pav:createdOn>2014-07-14 16:02:39 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE35E9E9-3163-4055-A3AF-F0F2DB4FEF84">
    <ao:body rdf:nodeID="N17d9c595ef704daf9c76418c50ad5846"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E5D50B11-E540-43F7-AD00-01F9109C8870"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:createdOn>2014-07-20 21:59:02 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 21:59:03 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:B208DB61-8DCE-4EF6-8A5D-F8F8F5BDB70A</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F5518D9-E5B3-446E-97D7-47FD4A6369F0">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 21:24:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8174B810-E408-49FB-BA8C-C21B362AF392</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:47b96dd3-a21e-47cc-b7ee-3de367a95ec8</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:fc10c513-bb42-4275-ab45-ceee376030b8</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:24:06 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N45709e34b0824899b2e764877caf7505"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:320A8D35-F4C0-4984-8AEF-324E2492E35F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:943B3C2F-578A-415C-B0AC-A08AFFAD1F8C">
    <domeo:uuid>943B3C2F-578A-415C-B0AC-A08AFFAD1F8C</domeo:uuid>
    <ao:suffix>200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour conce</ao:suffix>
    <ao:prefix>AUC and Cmax were determined before and after the administration of </ao:prefix>
    <ao:exact>fluconazole </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:943B3C2F-578A-415C-B0AC-A08AFFAD1F8C"/>
    <pav:createdOn>2014-07-13 23:50:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72B3FB4B-4342-450C-ADD0-DC229F74687D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 23:59:17 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:63AA3B2B-C74B-423C-A470-42D9557E1562"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F29A5602-9739-4278-BA8A-DBBF58A6459C">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:A7CF76A0-A5C2-4C16-A32F-635827C3D643</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:44:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:42:24 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F850764-41D1-4729-91C3-3EF7C8510B13"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8872CBE2-3214-4C1E-AA8B-43D4AF63F26B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:26:21 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8872CBE2-3214-4C1E-AA8B-43D4AF63F26B"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>8872CBE2-3214-4C1E-AA8B-43D4AF63F26B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:589CB32E-D12B-4981-B9E7-9A24B0A920F2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:12:52 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DB3DD08-D458-41F9-AAE1-4DFA655290B9"/>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7607CDA-5717-4160-8134-A93E0AAD226D">
    <ao:prefix>(1g q8h iv) in the second study (JRV 305); however, in both studies </ao:prefix>
    <ao:suffix>(1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled </ao:suffix>
    <pav:createdOn>2014-07-14 13:52:54 -0400</pav:createdOn>
    <ao:exact>vancomycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E7607CDA-5717-4160-8134-A93E0AAD226D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7607CDA-5717-4160-8134-A93E0AAD226D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25BE976C-D191-4841-A63E-EAC8770A3C88">
    <ao:context rdf:resource="urn:domeoclient:uuid:C19CA7A9-286D-4067-8225-C269F833476C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:01:22 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19363756-DA7D-42DD-BC1A-7C23AB39120E">
    <ao:prefix>is not recommended when administered in combination with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>19363756-DA7D-42DD-BC1A-7C23AB39120E</domeo:uuid>
    <pav:createdOn>2014-07-14 15:35:34 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:19363756-DA7D-42DD-BC1A-7C23AB39120E"/>
    <ao:exact>nelfinavir</ao:exact>
    <ao:suffix>, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28A340DD-B098-45BA-8CDE-2776C36F13B5">
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:20:51 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:400C4FAD-156D-4E7E-AA74-8D202CCF017A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D09D111-4D78-40FE-AF86-76A63E4BC020">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 23:59:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AE2E24E-6D34-420A-9262-8D5876FBCA0F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A4F61E62-1D94-4511-B7A3-D2C56C6931BB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BCD0B743-9B84-46D4-AF44-FC27ECC0AA54"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2F4CF0DE-41F6-4BE0-9A8F-2FB4F52CE344"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb2614eda862c44c5b4f5f50dcf838f6d">
    <domeo:sets rdf:resource="urn:pddi:uuid:54028D9B-7715-44BC-A4EA-B8F5F304325B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E7B7E36-55A8-4E47-B362-10871D883352">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 23:14:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N71b2e7ae525840e3a4bc660f5fac41e6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACB34A20-F0B5-4EE4-ACC8-901687DDB0F2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:52B8F103-AF5D-4436-9A5A-E301AFAA07AB"/>
    <pav:lastSavedOn>2014-07-20 23:15:46 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:7ECF0F68-0AB7-4B4B-946E-C6CA40F33806</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:329635CE-386E-4F46-8480-7264A536E492">
    <domeo:uuid>329635CE-386E-4F46-8480-7264A536E492</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:329635CE-386E-4F46-8480-7264A536E492"/>
    <ao:prefix>with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:59:02 -0400</pav:createdOn>
    <ao:suffix>, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B2EB96C-F4AD-441F-9F44-0D0160AB092A">
    <ao:prefix>, also called </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8B2EB96C-F4AD-441F-9F44-0D0160AB092A"/>
    <domeo:uuid>8B2EB96C-F4AD-441F-9F44-0D0160AB092A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:02:02 -0400</pav:createdOn>
    <ao:exact>debrisoquin hydroxylase</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>, is the enzyme responsible for metabolism of many neuroleptics, antidepressants, antiarrhythmics, and other drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95FD6F44-4A5A-4BB7-AE18-9BBEAC51F31A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:95FD6F44-4A5A-4BB7-AE18-9BBEAC51F31A"/>
    <ao:suffix> alone or in combination with either erythromycin or ketoconazole. The findings of these studies are summarized in the following table</ao:suffix>
    <domeo:uuid>95FD6F44-4A5A-4BB7-AE18-9BBEAC51F31A</domeo:uuid>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:26:34 -0400</pav:createdOn>
    <ao:prefix>400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:5E26D8B8-3109-4C14-B9D9-36AE9589E7A8">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BFB4A22-7E1E-4883-89B5-129E3B3002B5"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:96BB1DE8-8C2D-40DC-A374-69AEA92E3A57</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-109.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Naadcbe8417e94f6a8391434b13d10206"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/2c98e6b6-7366-42e4-b2e6-0c90498bf53f"/>
    <pav:lastSavedOn>2014-07-20 22:29:24 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:b1f5c441-748a-4cd0-a1a5-0253e14e1bf0</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdOn>2014-07-07 08:09:19 -0400</pav:createdOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EBDE3DE-4364-4AE3-8C04-B162F8F0D527">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:55:17 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D96EE18C-074F-4BB7-9249-3A40A7487919"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7411787E-8861-4924-A5B0-9D47943208C0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:86B62478-6CF0-4E31-A87E-4D5FED28239F</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:38166EF0-AD62-493D-84F0-1247DF9E2732"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:01:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:01:04 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0645BCBF-7588-44D9-9F0F-259C54E9DB46">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>quinidine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0645BCBF-7588-44D9-9F0F-259C54E9DB46"/>
    <domeo:uuid>0645BCBF-7588-44D9-9F0F-259C54E9DB46</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:03:17 -0400</pav:createdOn>
    <ao:suffix>have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazepi</ao:suffix>
    <ao:prefix>in patients receiving </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BD1E204-38A7-49B9-ACA0-4DC13B347F61">
    <ao:context rdf:resource="urn:domeoclient:uuid:77A78F8D-150E-4242-A11B-185D813450A6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:F639B167-2183-4B47-BB47-F126C38CD529</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:29:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:29:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A6723E3-B569-4896-8C19-1562EB2F69AB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>On the first day of dosing, fluconazole increased the midazolam AUC and Cmax by 259% and 150%, respectively</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. </ao:prefix>
    <domeo:uuid>7A6723E3-B569-4896-8C19-1562EB2F69AB</domeo:uuid>
    <pav:createdOn>2014-07-20 23:15:19 -0400</pav:createdOn>
    <ao:suffix>. On the sixth day of dosing,</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A6723E3-B569-4896-8C19-1562EB2F69AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A56F00CB-AF7C-453F-98C0-4F13056D3FFD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:59:18 -0400</pav:createdOn>
    <ao:exact>VAPRISOL 40 mg/day increased the mean AUC values by approximately 2- and 3-fold for 1 mg intravenous or 2 mg oral doses of midazolam, respectively</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A56F00CB-AF7C-453F-98C0-4F13056D3FFD"/>
    <domeo:uuid>A56F00CB-AF7C-453F-98C0-4F13056D3FFD</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0DBAE87C-A5F2-4BEB-A373-2EB8F9249D53">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A121296A-BFE9-431D-B5F0-5FBD4D494F16"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B17EF3F-E28E-4C4D-9190-BC69DD8A215C">
    <pav:createdOn>2014-07-14 14:07:23 -0400</pav:createdOn>
    <domeo:uuid>1B17EF3F-E28E-4C4D-9190-BC69DD8A215C</domeo:uuid>
    <ao:exact>Rosiglitazone </ao:exact>
    <ao:suffix>reduces blood glucose concentrations and reduces hyperinsulinemia in the ob/ob obese mouse, db/db diabetic mouse, and fa/fa fatty Zucker rat.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B17EF3F-E28E-4C4D-9190-BC69DD8A215C"/>
    <ao:prefix>has been demonstrated in animal models of type 2 diabetes in which hyperglycemia and/or impaired glucose tolerance is a consequence of insulin resistance in target tissues. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43C62C1D-C7E6-4C37-A40A-42AC965306C4">
    <pav:lineageUri>urn:domeoserver:annotation:91B9EAB5-D951-4C4F-87F2-754EB38E4326</pav:lineageUri>
    <pav:createdOn>2014-07-20 22:06:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:06:38 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Ne0d716ccdf6448878a60c9bdd7135ae7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A2C1A11E-24E0-405D-A5ED-B54DA23BE3A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEECEADA-4021-4297-A6AF-E35D84498734">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A53ED7CE-0B72-413D-9DCE-5CE1F14AF03A"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F0F1013A-BAEB-4CDA-A293-01BE7B4DD5D8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 14:36:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DFB4CAFA-452A-4113-88AD-9E9CF21546C1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>VAPRISOL</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7474E3EA-79D8-4C3B-9FCC-4EFAD31CFA68">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D68EB7E6-A0B4-4DA3-993E-C98A47021177"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:355E97C3-7B62-4B90-9BD2-37DBA2F13617">
    <domeo:uuid>355E97C3-7B62-4B90-9BD2-37DBA2F13617</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is extensively metabolized with most metabolites appearing in the urine. Propranolol is metabolized through three primary routes: aromatic hydroxylation (mainly 4-hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucuro</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:355E97C3-7B62-4B90-9BD2-37DBA2F13617"/>
    <ao:exact>Propranolol </ao:exact>
    <pav:createdOn>2014-07-14 15:10:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2722CAF7-81B6-4BC0-A47B-F2C238A177B9">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:618B6E0E-D9D7-430F-BA8F-13E2F205027D"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E94D5B8-B48B-42EC-8C5F-24ABCB171116">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>haloperidol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E94D5B8-B48B-42EC-8C5F-24ABCB171116"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) for cholinergic muscarinic or β1 and β2 adrenergic receptors.</ao:suffix>
    <ao:prefix>has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and </ao:prefix>
    <pav:createdOn>2014-07-14 15:51:21 -0400</pav:createdOn>
    <domeo:uuid>9E94D5B8-B48B-42EC-8C5F-24ABCB171116</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:040F2562-F192-48FD-A7AE-B14DD73235FD">
    <ao:exact>colestipol </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:040F2562-F192-48FD-A7AE-B14DD73235FD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>with propranolol resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <domeo:uuid>040F2562-F192-48FD-A7AE-B14DD73235FD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>or </ao:prefix>
    <pav:createdOn>2014-07-14 15:03:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E8A6ADD4-6ACC-41F6-96BE-B9C1D83EBEE8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B6CDF27C-DC05-493D-9C83-D1BA7D50260F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/39A94FF0-9FCB-46BD-B664-CA5916E92D1F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F74156F-F9E3-4353-8CFB-EEF85D9F7A4D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F74156F-F9E3-4353-8CFB-EEF85D9F7A4D"/>
    <ao:suffix>, has similar sodium and calcium channel activity, but about 10 times less beta-blocking activity (N-depropylpropafenone has weaker sodium channel activity but equivalent affinity for beta-receptors).</ao:suffix>
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <pav:createdOn>2014-07-20 20:15:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8F74156F-F9E3-4353-8CFB-EEF85D9F7A4D</domeo:uuid>
    <ao:prefix>, the main metabolite, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A63DD496-7D43-4980-8684-306F2263FD13">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-14 15:58:53 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:169A20D5-E605-435F-A9BA-17F7C8E8CA24"/>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:body rdf:nodeID="N344d760faf3342c48fe43f1d4b625ff1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE4A6BB6-A85B-432C-AD77-407E7DE313E2">
    <domeo:uuid>CE4A6BB6-A85B-432C-AD77-407E7DE313E2</domeo:uuid>
    <ao:suffix>results in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. Coadministration of carbamazepine with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CE4A6BB6-A85B-432C-AD77-407E7DE313E2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <ao:exact>nefazodone </ao:exact>
    <ao:prefix>with </ao:prefix>
    <pav:createdOn>2014-07-14 13:48:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DB35158-84F0-451C-81BE-632308DA163D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DB35158-84F0-451C-81BE-632308DA163D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-07 11:09:40 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid>6DB35158-84F0-451C-81BE-632308DA163D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>) did not affect the bioavailability of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C44E4401-663D-4E26-816A-96BDE160CC13">
    <pav:createdOn>2014-07-14 16:03:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C44E4401-663D-4E26-816A-96BDE160CC13"/>
    <ao:suffix>pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone d</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C44E4401-663D-4E26-816A-96BDE160CC13</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>, giving essentially all recipients a </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C6BE226D-4378-4938-AFFA-82B2DACBBBED">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EC249FC3-5491-4D3D-BE87-557730ECBC72"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C">
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-14 15:34:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:96288495-67AC-401A-B876-1DE6A3A49BA5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93D95988-FA8C-4C03-BBC8-E4B77EB9071B"/>
    <permissions:permissions rdf:nodeID="N1d4d8f0f004e4a309f4aed1e1f581492"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:16AE6D16-D2D3-4D3D-96E9-107AB8AAA5D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BB64CBF-BDBF-477A-9E52-1B0AD00A4236"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:6B4B5D34-7604-4F0A-94CD-18210AE0F222</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:24E3D83E-9C5E-49DF-AB2D-C19982646DF4"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:39E42543-B843-4862-B3F0-967AEEAE113B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7ADD8893-9F56-44EC-840E-87F53C402E8C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C695803C-F876-4316-8563-FFD22F9C8D2E</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-14 15:35:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A986932-6EA8-4E58-90EA-CB9D6260185F">
    <pav:createdOn>2014-07-14 14:05:34 -0400</pav:createdOn>
    <domeo:uuid>0A986932-6EA8-4E58-90EA-CB9D6260185F</domeo:uuid>
    <ao:exact>Rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, a member of the thiazolidinedione class of antidiabetic agents, improves glycemic control by improving insulin sensitivity. </ao:prefix>
    <ao:suffix>is a highly selective and potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARγ). In humans, PPAR receptors are found in key target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A986932-6EA8-4E58-90EA-CB9D6260185F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3E8F00A1-B0E0-4F93-958E-1FE581EA19EE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10502</dailymed:activeMoietyRxCUI>
    <rdfs:label>thioridazine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DF80D84-8381-4449-9F22-4ABD6660C6AD">
    <ao:body rdf:nodeID="Nfac35edb7ead4b5a9ded98d0451bb327"/>
    <pav:lineageUri>urn:domeoserver:annotation:1BBED225-3569-4943-833E-2305DAE19810</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:04:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:13205CB9-236A-4BA9-8CF4-CDD945EDDE07"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:04:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7d1fcdc71a664ad3b41d0805f9a0d59f">
    <domeo:sets rdf:resource="urn:pddi:uuid:5EBAC55A-C458-45FE-9A01-FE230027AFB2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ad23b8b6-7ff4-4fb5-a832-18bcb6092635">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:08:55 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1975d26e-9996-4882-93ad-95beba0bcca0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:08:55 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D450F3A9-C16A-4A8D-B153-31D8AAB3C25A">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:45FDC95A-BBBE-4730-987D-65034C77F623"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C3876BC-3973-4F99-BFFC-1B257D08A7C3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 13:51:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:CE4A6BB6-A85B-432C-AD77-407E7DE313E2"/>
    <pav:createdOn>2014-07-14 13:48:43 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E87E36F-1E46-4449-B5E6-24C6748D28B7">
    <pav:createdOn>2014-07-20 20:58:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2E87E36F-1E46-4449-B5E6-24C6748D28B7"/>
    <ao:suffix> is a weak inhibitor of the cellular DNA polymerases α and γ and has been reported to be incorporated into the DNA of cells in culture.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>ZDV-TP</ao:exact>
    <domeo:uuid>2E87E36F-1E46-4449-B5E6-24C6748D28B7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03F0D3A3-146C-4F88-8409-2B6C80859477">
    <ao:prefix> ER b.i.d. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:hasSource>
    <ao:exact>Coadministration of nifedipine resulted in a decrease in AUC and Cmax of doxazosin to 83% and 86% of the values in the absence of nifedipine, respectively</ao:exact>
    <ao:suffix>. In the presence of</ao:suffix>
    <domeo:uuid>03F0D3A3-146C-4F88-8409-2B6C80859477</domeo:uuid>
    <pav:createdOn>2014-07-20 21:27:40 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03F0D3A3-146C-4F88-8409-2B6C80859477"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87C87B25-2788-4E6F-A04F-27F5AF9D1A53">
    <ao:item rdf:resource="urn:domeoclient:uuid:DB712A50-FDAC-4F84-B611-70452F26DD55"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:168928F7-95DE-44CA-A25E-A8A52D80A2FF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:F069D13E-F4B1-4623-8B81-411C6E9A0C3A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <permissions:permissions rdf:nodeID="Nc11d8358a4d54d248d35c7dad963c5cf"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-14 15:09:14 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97E9BE77-131E-49FA-B836-5E6BD12DA8E8"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:D3271866-728B-476C-ADE5-187F6BD98584</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:09:57 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1">
    <pav:lastSavedOn>2014-07-20 21:23:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-07 08:09:16 -0400</pav:createdOn>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/4ad7ea20-a6d6-4758-8719-7d6e4ddfae7a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF145074-B0D2-4898-914E-DE96D5E2F3B3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4490C5F6-212F-4CBC-8F6A-AD57B556EBC2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7BE34F8-2F1F-483B-A232-B5D09B02D59B"/>
    <pav:previousVersion>urn:domeoserver:annotationset:55A79F67-B2CD-402C-A74C-0B1780814093</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB295A84-CC6E-42F0-AF6A-6072389AE082"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE726D8C-7F7E-43C2-BEA5-31259689A4A0"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="Ned54f3fd89ca4567b2feebb8788c3e81"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:894D73EE-A600-4C47-AEBD-E8B459A41991"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACE16AEE-94A1-44D3-8155-5F29E6571424">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>ACE16AEE-94A1-44D3-8155-5F29E6571424</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Sildenafil had no impact on the plasma levels of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg)</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACE16AEE-94A1-44D3-8155-5F29E6571424"/>
    <pav:createdOn>2014-07-07 11:14:46 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D081B5F5-9045-4A1B-AD73-C9FCB9CD6FD8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:59:50 -0400</pav:createdOn>
    <domeo:uuid>D081B5F5-9045-4A1B-AD73-C9FCB9CD6FD8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D081B5F5-9045-4A1B-AD73-C9FCB9CD6FD8"/>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24DB52AD-E793-4A6E-B4CF-F0BAA1421330">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:02:35 -0400</pav:createdOn>
    <domeo:uuid>24DB52AD-E793-4A6E-B4CF-F0BAA1421330</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:24DB52AD-E793-4A6E-B4CF-F0BAA1421330"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EDD1CE4-01B2-4266-8872-6FFCBDEC546E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>9EDD1CE4-01B2-4266-8872-6FFCBDEC546E</domeo:uuid>
    <ao:prefix>. </ao:prefix>
    <ao:exact>Avoid concomitant use of propafenone and quinidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EDD1CE4-01B2-4266-8872-6FFCBDEC546E"/>
    <pav:createdOn>2014-07-20 20:39:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F40FD644-8BD9-4A38-AB84-DDB7EDF84363">
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:03:13 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C6C13FE5-66B6-4E94-9AE2-29A6538BF6E0"/>
    <pav:lastSavedOn>2014-07-20 22:03:25 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:7AF5C47F-9B5F-4E72-B146-F4CEA1051891</pav:previousVersion>
    <ao:body rdf:nodeID="N29d3ffe3ecec44a882abce7db3471bbd"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB0F1F1A-5D16-4DB0-BA65-41402D7709D6">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 00:12:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EB0F1F1A-5D16-4DB0-BA65-41402D7709D6</domeo:uuid>
    <ao:exact>paroxetine</ao:exact>
    <ao:suffix>. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB0F1F1A-5D16-4DB0-BA65-41402D7709D6"/>
    <ao:prefix>significantly decreased plasma levels of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E8EC5FE2-5508-43D1-806A-88788DEA96D3">
    <rdfs:label>Carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9603BE1B-7FD7-4631-804C-D6FB0F060B00">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:suffix>and norverapamil. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <ao:exact>verapamil </ao:exact>
    <domeo:uuid>9603BE1B-7FD7-4631-804C-D6FB0F060B00</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>does not affect the pharmacokinetics of </ao:prefix>
    <pav:createdOn>2014-07-14 14:54:43 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9603BE1B-7FD7-4631-804C-D6FB0F060B00"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93D95988-FA8C-4C03-BBC8-E4B77EB9071B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:35:34 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:33B5A3D9-8CC4-4D7D-AE7D-5A55C27D4FB7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:35:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:19363756-DA7D-42DD-BC1A-7C23AB39120E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFED4092-B970-4B17-922C-528A90463EBE">
    <pav:createdOn>2014-07-14 00:07:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4477B066-614B-4766-BF4D-5EE07E18E1DB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7DAEE4FE-35D0-4C93-AEB4-94946EA5B25A</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:08:06 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AF466FE-03C5-4186-B5C7-A3A03F49AC7B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5859887-8D70-4483-B3AB-D761286AB512">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:522B2F1E-129E-41C7-B7BF-FA750F75C38B</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:body rdf:nodeID="Nf4dbd9070fca4064824f0446d137b969"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:03:01 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D302BD2E-5DF3-4ABA-B01E-088D03DE29D3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 22:02:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/c7ab95ab-10d2-4e51-bc1b-07d77f1bd0b0">
    <domeo:belongsToSet>urn:domeoserver:annotationset:DF431C5E-B3FD-41E4-8BBD-0C3B0F8AC4DB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:9770f851-f52b-436d-b496-4d66f0e28d00</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2b815744-9c87-490d-8776-c23d89fb931c"/>
    <pav:lastSavedOn>2014-07-07 08:09:12 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B9688098-0E77-4F0B-9B9B-C40FA96AE9BF">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:89624854-C052-41C5-872A-DDF2A9B14308"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5EDBE7EC-DFAA-426E-BB67-42D78AED75C7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:47:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>5EDBE7EC-DFAA-426E-BB67-42D78AED75C7</domeo:uuid>
    <ao:exact>Ranitidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5EDBE7EC-DFAA-426E-BB67-42D78AED75C7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D6B401A-1A0D-49F0-8921-B49A25D3A271">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FDC90F44-144D-4B75-A9A7-977445775B68"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B9F06C42-0941-4041-9966-AE6FADA90AB5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4477B066-614B-4766-BF4D-5EE07E18E1DB</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 00:08:06 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 00:06:52 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBF8E447-EC05-4028-8E62-2FC413F3DD46">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 22:47:46 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <pav:createdOn>2014-07-20 22:47:45 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:9b9adb60-a447-4aa7-82fc-e4bcf10dd788</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N45d1f7deac3a4cebab4d7e707fbda7b2"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:177A684C-EA21-44B3-AF53-9CAF9DBF3FD3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C173CABB-2C40-4B5D-89C2-BB9B240AAB87">
    <pav:lastSavedOn>2014-07-14 00:18:31 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9FBE73AE-3CD5-4285-AA45-E52AA807CB58</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2C968C2-BA32-4B38-830C-0A6320289FAE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB97FFC5-B995-4858-91DF-45F2675318E9</domeo:belongsToSet>
    <ao:body rdf:nodeID="N84d77bbf063246fbae0da3db3228ec8e"/>
    <pav:createdOn>2014-07-14 00:18:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98319744-95C1-4B4B-84B4-4706ADF1D085">
    <ao:body rdf:nodeID="N1e478010733740ff948b7ffc4db618ac"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAE4045A-8AD6-4D51-B729-51AF773DA421"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:00:42 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:065B9700-50B9-499A-B366-681E6000407C</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:00:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5625800-8A35-40BE-870E-CD2162CBB36C">
    <ao:context rdf:resource="urn:domeoclient:uuid:301B376B-CCC4-46DE-9B3B-27F8BD78F414"/>
    <pav:lineageUri>urn:domeoserver:annotation:E547DAA4-466D-43B6-BD75-F4D202E04F28</pav:lineageUri>
    <ao:body rdf:nodeID="N69ada55a66c942b2852a0e1a7e3bbb54"/>
    <pav:createdOn>2014-07-20 23:17:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 23:17:25 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:77F8EC3D-E8BD-4D6A-A6D7-2C534926E795</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30AAE68F-C689-411E-BFF1-7C8B847A39AB">
    <ao:prefix>(100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30AAE68F-C689-411E-BFF1-7C8B847A39AB"/>
    <pav:createdOn>2014-07-14 14:44:34 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>30AAE68F-C689-411E-BFF1-7C8B847A39AB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0AA4C48-41A9-43BD-8EE8-F31A4DCC7D18">
    <pav:createdOn>2014-07-14 00:14:01 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N94961683976e440d831a45ca517d1eec"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:83F1E844-4921-4B01-8921-B8B220CE103D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7BE1E166-79EF-4EA3-91A4-E33A8867A502"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7F70F54E-417D-4B2A-9C97-D851FE0D7CD0">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9455A366-6768-4BC4-8C0C-BAD815D80B32"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF0B7B1E-EA73-4BD2-9FE7-D1E402400807">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 00:19:06 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A870C365-8C19-4306-AC88-4894594AFEC6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:8D0FD1FB-C6C8-4BDE-B4CD-D6904C8E9AA2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 00:20:21 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54625714-C1D4-44A4-B970-A16C630AB9F3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:23:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:685C5022-D3B6-4E6E-BBE0-FCDDC2C0B199"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EDF4371-2A0F-4873-BFD4-754892583990">
    <ao:context rdf:resource="urn:domeoclient:uuid:3D1AFC77-0930-41BE-8564-87038FCC0C62"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:40:10 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:4231E994-FCFD-4595-AD8B-BC554CBD7A85</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02C2312F-ABBC-4D65-A43F-172B57B75726">
    <pav:lastSavedOn>2014-07-20 23:20:51 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:585C6B99-D509-47B5-B76E-7814527DCE3C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 23:20:49 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1063CC8-8EDC-42C6-A44A-9C9EA5A38DAD"/>
    <pav:lineageUri>urn:domeoserver:annotation:A8D70334-B7C9-4DB1-94BC-D6F4D42DB8C2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N03b37d502772494b81b1e7d527ed35e2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686">
    <ao:item rdf:resource="urn:domeoclient:uuid:65E13557-2211-4E38-9F17-B33E6FF2D2A8"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE064B1E-6EB0-44B4-B8F3-6D8DD94F363E"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:previousVersion>urn:domeoserver:annotationset:3098FE7B-407A-4FDA-AB2B-F1212082175A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32B2F675-54DA-43C7-9F4E-34FC3B29654D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3630F892-8B97-4E54-83B6-89A8ABA5C1BB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F2E0992-1D21-43B2-8240-EA6485BD1358"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7446410-AFD6-4534-8BD2-37101F8219A5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:40661BFA-363F-4758-AC1A-42AFFA1647A6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DC8E87C-050D-4499-84A3-7FCA33EAD340"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:89F7D02C-486F-47FE-B0D9-AF05F4BA971A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:583A1C18-899D-488C-94D8-45B640605797"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdOn>2014-07-07 08:09:14 -0400</pav:createdOn>
    <permissions:permissions rdf:nodeID="N27efbfd403474225b45cac3f0e298393"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90B9CB8D-53E1-4660-BF50-C1D7A05E574C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:43331416-04A5-4D68-9A8A-4010B568E1C2"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/d40888ba-5671-405a-b36f-800052b7cd47"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F754437E-B6ED-42FE-916D-C298DFEF0B1E"/>
    <pav:lastSavedOn>2014-07-20 20:24:55 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:91EE9E77-FE27-4232-946E-7304DDE28BD4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3435341E-7364-4F7A-8B30-06C2BF5C3AC2">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>In vitro drug metabolism studies reveal that trazodone is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir</ao:exact>
    <ao:suffix>. The effect of short-term administration of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3435341E-7364-4F7A-8B30-06C2BF5C3AC2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3435341E-7364-4F7A-8B30-06C2BF5C3AC2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:14:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35B872AD-CE76-475F-A13E-387450CA96D9">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:772407C0-472A-4EF2-9082-C74D76A5884F"/>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:09:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A490ECC-0CF7-4BB4-9195-08FC09D9D48C">
    <ao:context rdf:resource="urn:domeoclient:uuid:46BDC2C5-99E2-4E4A-BE6B-3805D0C8BFC1"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:02:42 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:758EFBB3-A920-4A75-9612-C86DEB749233">
    <pav:previousVersion>urn:domeoserver:annotationset:2C67D50E-A6FC-4FF0-A510-94E1364C23E1</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 21:48:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:FACFFF9F-2F17-41D2-B71B-C4596CEA8966"/>
    <pav:lineageUri>urn:domeoserver:annotationset:17778f09-3c5c-4c6f-9513-62d64b4008bc</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nc082c6fb089048488fb7f0aae5d72642"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:48:06 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACFBFD00-EB6E-4721-9C8E-346CECC1A79E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AC6C502B-E088-4AB7-93D3-80FE49A5CA62">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0A8EB37F-7C12-4832-A5C2-B5333A576E93"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA4D18FA-C7EE-4EDE-8F9D-15957DECEF78">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA4D18FA-C7EE-4EDE-8F9D-15957DECEF78"/>
    <pav:createdOn>2014-07-20 23:11:23 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <ao:exact>Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>FA4D18FA-C7EE-4EDE-8F9D-15957DECEF78</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0da1145c2a324636886c22fe24ba02e0">
    <domeo:sets rdf:resource="urn:pddi:uuid:21AA3530-DA83-4682-9BA6-2C42908752D7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18FAEB01-EF5E-49F1-AFFD-BBDD9ACA5FC6">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6BEF65DF-682B-4643-B62F-8F5B56031590"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 00:25:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2E7917BC-D9D5-4BE7-B445-15953D34CCA2">
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:102F29ED-1BB6-4797-BC09-88B52B6A2840">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:56AED5B7-A8E4-4C4D-B335-BE7C6BD2440E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB97FFC5-B995-4858-91DF-45F2675318E9</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8E0087F1-0046-4AFF-AAD2-03768117AF07</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 00:18:31 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 00:16:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D87371FE-EEF3-4059-9416-BEAD2E444272">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 16:01:45 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:56F44DD3-0A66-4A1F-9EA5-32F07BA718E5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B119365E-FA3A-4C81-A0DD-4035AD4A41BC">
    <pav:lastSavedOn>2014-07-14 14:33:16 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:33:09 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E914FB8C-7421-4EC6-96A3-46D1BE508620"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:1A6DBAC5-C2B5-4C94-9C48-C015DF1BA576</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E54D9CBB-F98A-4963-89F4-04EE51245BA0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:468A1229-A665-4082-AB69-A7A95E79DC1F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>metformin</ao:exact>
    <pav:createdOn>2014-07-14 14:17:31 -0400</pav:createdOn>
    <ao:suffix>, AVANDIA improved glycemic control in both males and females. In metformin combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <domeo:uuid>468A1229-A665-4082-AB69-A7A95E79DC1F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>As monotherapy and in combination with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:468A1229-A665-4082-AB69-A7A95E79DC1F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE">
    <ao:item rdf:resource="urn:domeoclient:uuid:28737438-E6F7-4010-A0FB-C1DDF98AB0D9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:45C36CE1-788C-4B0E-89C7-BF221CF9D14A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6C4FF91-954A-4AE0-9C7A-B4B73091AE14"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1E5483B-7558-449D-9B6F-F67BB8FA95E3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E959E9B3-A8CD-41A2-A5D4-8B0796B45BD6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A096CC4B-894E-41A0-AF6D-BD5FA00A75FE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D01B81CE-09EA-4696-9C80-161065BB8C80"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:D5D61D37-A1DA-4DB6-BA3C-CB2FBD947A29</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7D034A9-5BE6-4FEE-9A96-82705DBAC918"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54333B22-518F-4D3F-B869-CFF454FC8BBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F46E6D59-7A1E-4B67-9077-24555C7124B8"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5279783C-4656-44AD-9D33-3295D5E3CF29"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B172284-1159-409B-8B5C-BF683FC8ED29"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43A63EF4-DDA2-41F8-A24F-8B3A51C5D580"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:19A7644F-0F40-49F8-B449-4B9D169980AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FC96EA06-C785-4B23-953D-688275008825"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8214E12-1EB1-4754-9F28-E3075529460F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D028659-C4A2-45FC-84D5-9CF0E9391856"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:548FEE08-2C12-4A6D-807D-15917CC4A9A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1F5EB7B-46D3-4D13-8E55-70EFABCCA7F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BD1E204-38A7-49B9-ACA0-4DC13B347F61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:423EEF41-6A78-441A-951D-9E623D5E38B9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:326EA6F9-E479-46B9-9608-83693CF9C34F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1AEEBD12-7FCB-492B-8DC4-97EADE4AF772"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A36EEE57-DE0D-4DD8-841A-156CD3EEE12E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:47763CE8-530A-473D-849D-AA25F7CB8111"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:38CB4DE2-2AAB-4EEA-B57F-C6E19E8E570F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CEA0A94C-F5E5-483D-9C00-D034DFD1650B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69F69FA8-3DE1-4421-91B8-02129972291A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:087EAC3A-6E83-4C04-B907-68432A0029EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1923A71C-0141-44B5-B172-80119AF25734"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BA0AB33-8E5A-4A5A-826E-79EC3567BF12"/>
    <permissions:permissions rdf:nodeID="N3a448a210dbe4cfdbe148633662dd636"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:B92D7895-B2DA-40B9-957A-6EC78F73694B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D080FA0-1886-4F9D-B9FD-CD7D771BC129"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A59E408F-78B0-4BBF-9F91-E726F20C150D"/>
    <pav:createdOn>2014-07-14 15:20:48 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:42647566-E62B-4C24-8042-AC83B5451B02"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:002204EA-D76A-4067-B3E6-CE9CAB5ADB69"/>
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B8139538-CBBA-4CC7-BE1E-8A2ABF951A1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A16A851-1CC1-4290-93A4-E3DBFF45BD03"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E4F714AD-C2ED-442A-8F74-0D13572896E3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92A7CB6D-D7B8-48DB-AFD9-D1DCED3C48BF"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BEE4B475-DEAF-45A4-8AE5-5C3497B0BA86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E5848B3-AC12-4006-9D5A-3AFEFEF9B66E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFCC95EE-237F-4ED7-919A-A92520CE7BA9"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4E0B13B-9379-408D-9C23-627A7E4A5E95">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and its major metabolite, </ao:prefix>
    <ao:suffix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <pav:createdOn>2014-07-14 15:52:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C4E0B13B-9379-408D-9C23-627A7E4A5E95</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4E0B13B-9379-408D-9C23-627A7E4A5E95"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C161CDA1-9B5D-42D6-81A6-A9E3FF049191">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB069CFF-7092-43EF-95CE-DCF8A6033A3B"/>
    <pav:lineageUri>urn:domeoserver:annotation:1E700F50-E5C4-43A1-BA2E-546105FA33FA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:45:35 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C60CF2F-8840-4590-A2BC-C7FCAFC6225B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine</ao:exact>
    <pav:createdOn>2014-07-20 22:33:12 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <domeo:uuid>1C60CF2F-8840-4590-A2BC-C7FCAFC6225B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C60CF2F-8840-4590-A2BC-C7FCAFC6225B"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/71189083-1F17-49A3-8613-19DD6DEAC398">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>tetracycline</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7D034A9-5BE6-4FEE-9A96-82705DBAC918">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:382C65D8-90C4-4FC9-AECE-C467CC36503D"/>
    <pav:lineageUri>urn:domeoserver:annotation:409C3FD4-6984-4C38-853F-0EB7A153EBC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:31:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F5C8AD9-ABDB-49B1-862B-C5AF02B55368">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5F5C8AD9-ABDB-49B1-862B-C5AF02B55368"/>
    <ao:suffix> by 74 and 20%, respectively. Urinary excretion of </ao:suffix>
    <domeo:uuid>5F5C8AD9-ABDB-49B1-862B-C5AF02B55368</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:prefix> plasma concentrations and increased the AUC and Cmax of </ao:prefix>
    <ao:exact>norpropafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:35:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:205CFCBC-A919-4EA5-BC16-4725E5D0CA62">
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:90B4DA79-4F01-467E-93D3-94852D9347E6"/>
    <pav:createdOn>2014-07-14 16:02:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2CA8D60-E691-4A31-BA4D-BE52E838AF6A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2CA8D60-E691-4A31-BA4D-BE52E838AF6A"/>
    <ao:prefix>:</ao:prefix>
    <pav:createdOn>2014-07-20 21:21:41 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F2CA8D60-E691-4A31-BA4D-BE52E838AF6A</domeo:uuid>
    <ao:exact>In vitro drug interaction studies have demonstrated that quinupristin/dalfopristin significantly inhibits the CYP3A metabolism of nifedipine</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1E29A9F-A024-4F8B-BE96-7C827681A402">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:23:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3D5F4E3E-4FC7-482C-A927-B1A9285BEA91"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5B3E6D1-A159-4297-A53B-43BD0352DB0F">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:23:22 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:42526B14-2925-4E0A-B27E-F7AB349EFB23"/>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74D65DF9-9F25-4D02-A82C-4401E6E04533">
    <pav:createdOn>2014-07-14 15:30:28 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74D65DF9-9F25-4D02-A82C-4401E6E04533"/>
    <ao:suffix>may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary ex</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>fexofenadine </ao:exact>
    <ao:prefix>. This observed increase in the bioavailability of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>74D65DF9-9F25-4D02-A82C-4401E6E04533</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:483B5894-871E-41EE-920E-148635088DD9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:22:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:22:42 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F568CD0E-0FFA-473E-A6DE-647C158772D1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:body rdf:nodeID="Ncec5cb4072724aedb8cd8aae5642b089"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:AE68E7B6-F348-4585-BD92-7A33F1F069D9</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4F57AE27-30FC-483E-8AB1-CAA90A44FAD4">
    <rdfs:label>tolbutamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1DAF89A-7686-4858-BC0D-575EE8454B85">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:0F5822B6-A547-4AA8-BD60-56A55F5B662B</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:15F2C800-276D-4AE3-BD01-15371461A222"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:08:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3F482EC3-1EC0-4591-9CE4-4E8266FEEA69</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:07:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18A5BB82-A18E-4282-AD00-A5E5846C0059">
    <domeo:uuid>18A5BB82-A18E-4282-AD00-A5E5846C0059</domeo:uuid>
    <ao:prefix>plasma concentrations ranging from 55% to 369% and increased </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:18A5BB82-A18E-4282-AD00-A5E5846C0059"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:07:23 -0400</pav:createdOn>
    <ao:suffix>metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>thioridazine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:286E33BA-D934-4A56-8459-3F4028F7033A">
    <ao:suffix>treatment.</ao:suffix>
    <pav:createdOn>2014-07-14 15:33:32 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:286E33BA-D934-4A56-8459-3F4028F7033A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
    <ao:exact>mexiletine </ao:exact>
    <ao:prefix>ted reports of drowsiness, nystagmus, ataxia, dyspepsia, hypersensitivity reaction, and exacerbation of congestive heart failure in patients with pre-existing compromised ventricular function. There have been rare reports of pancreatitis associated with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>286E33BA-D934-4A56-8459-3F4028F7033A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0C69412C-08BB-489E-9EF7-E2E732E0249D">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:77106F8D-325E-4CD7-8C24-445EA5935113"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F79B0B0D-272A-42BC-A10E-2C99CEB64A33">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8A9C5576-9FBA-4761-BDC3-D7E95513FE14"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D7B37B7F-DC3C-4767-B041-7F3082A40CA9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/697C8178-1E90-4FC2-B563-31C879E3182D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4C62F38B-DB19-420D-9503-7EF687C9BB80"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E5848B3-AC12-4006-9D5A-3AFEFEF9B66E">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:29:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:F639B167-2183-4B47-BB47-F126C38CD529</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8BC6124C-5A53-4CFA-9D7E-494AD457221B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:29:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7BE34F8-2F1F-483B-A232-B5D09B02D59B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:48E0846A-ADE4-47F5-B6CC-0E356860C874</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 21:22:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A0665E2A-EBBB-4400-A27A-04D9C66A1F84"/>
    <pav:lastSavedOn>2014-07-20 21:23:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50322999-A991-4F23-9FD7-0F077D595963">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Compared to</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50322999-A991-4F23-9FD7-0F077D595963"/>
    <ao:prefix>. I</ao:prefix>
    <domeo:uuid>50322999-A991-4F23-9FD7-0F077D595963</domeo:uuid>
    <pav:createdOn>2014-07-20 21:28:00 -0400</pav:createdOn>
    <ao:exact>n the presence of doxazosin, AUC and Cmax of nifedipine were increased by factors of 1.13 and 1.23, respectively</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C3023C0-3E95-4AE2-9020-E88729805E3C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C3023C0-3E95-4AE2-9020-E88729805E3C"/>
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>5C3023C0-3E95-4AE2-9020-E88729805E3C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively.</ao:suffix>
    <pav:createdOn>2014-07-07 09:42:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1500E4D9-0C81-43EF-B2FB-A27B523CC477">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1500E4D9-0C81-43EF-B2FB-A27B523CC477"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> interfere with conversion of risperidone to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and ad</ao:suffix>
    <domeo:uuid>1500E4D9-0C81-43EF-B2FB-A27B523CC477</domeo:uuid>
    <ao:prefix>could be subject to two kinds of drug-drug interactions. First, inhibitors of </ao:prefix>
    <ao:exact>CYP 2D6</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:02:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2C4B106-E756-47B2-84EF-9A6E459BC308">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:821E7BF5-ADFE-4F2C-BC58-27F2B4082E9C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3D1CCD2-BB57-4A12-931D-47E61BCC9D1E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:53:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFCC95EE-237F-4ED7-919A-A92520CE7BA9">
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:21:46 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C217FC2F-B5B6-45CC-8596-DD4F565DB7A0"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:22:36 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F95FCDA-7386-40AD-8F48-8C08EDD4B0C3">
    <pav:createdOn>2014-07-14 15:59:56 -0400</pav:createdOn>
    <domeo:uuid>4F95FCDA-7386-40AD-8F48-8C08EDD4B0C3</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F95FCDA-7386-40AD-8F48-8C08EDD4B0C3"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79513C56-303B-424C-B5F7-27F9ED45305C">
    <ao:suffix>may also decrease biliary excretion.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:30:45 -0400</pav:createdOn>
    <ao:prefix>gastrointestinal secretion, while </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79513C56-303B-424C-B5F7-27F9ED45305C"/>
    <ao:exact>erythromycin </ao:exact>
    <domeo:uuid>79513C56-303B-424C-B5F7-27F9ED45305C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41DFFC41-28E3-4FB3-856D-5A7AE09D79C1">
    <ao:context rdf:resource="urn:domeoclient:uuid:B8A05847-D879-446C-9D40-4C89810755CC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 23:59:21 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2C968C2-BA32-4B38-830C-0A6320289FAE">
    <ao:exact>Perhaps because of competition for the P450 3A4metabolic pathway, quinidine levels rise when ketoconazole is coadministered</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>E2C968C2-BA32-4B38-830C-0A6320289FAE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 00:18:30 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2C968C2-BA32-4B38-830C-0A6320289FAE"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5C965236-9F90-4E18-80C2-DE3F153B1810">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zidovudine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DD5735BA-36E3-4565-8CF0-8243BF5BD861">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C0FF29B5-3436-4FB1-937A-B10528573293"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CCB57B2F-E3A7-4069-B4C7-0471744F8DB2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9ae2f5b8a8b04e63a417930d1ca19b13">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C7473C1-3AD7-48FC-ACAF-AF71E873A853">
    <pav:createdOn>2014-07-14 14:00:01 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:1871A1A9-1F13-4238-A1E3-D13A2366CD43"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7F65C12-3365-45AB-AEA5-66B70722A017">
    <ao:prefix>The usual initial dosage of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>acebutolol</ao:exact>
    <domeo:uuid>A7F65C12-3365-45AB-AEA5-66B70722A017</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7F65C12-3365-45AB-AEA5-66B70722A017"/>
    <ao:suffix> is 400 mg daily given as 200 mg b.i.d. Dosage should be increased gradually until an optimal clinical response is obtained, generally at 600 to 1200 mg per day. If treatment is to be discontinued, the dosage should be reduced gradually over a period of </ao:suffix>
    <pav:createdOn>2014-07-11 23:26:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E">
    <ao:item rdf:resource="urn:domeoclient:uuid:79960439-A3DB-4FCF-A8A3-20CEC06482C1"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:870D6BED-1AF2-4FA5-A519-4BFAB3E132E1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 23:02:32 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:EEA85DD8-2324-4212-A280-5F3A64C27AE5"/>
    <permissions:permissions rdf:nodeID="Naff6134a114a4f2ab2a2e1c3755fbb12"/>
    <pav:createdOn>2014-07-07 08:08:58 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:924CB816-82B2-4133-BB74-66D1A3E04605"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/0481a643-a919-4938-bfcb-05565f3a094d"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:D987AA7A-4C03-4BD0-8B25-E23982DBEEAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7BD5BD1-99A2-491A-9F94-E79011F860AC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EBA0136A-E3AC-425E-AA53-0A9D099D4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21BFCA0F-FA05-477F-A9DB-3C9BCD7A8649"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F947B7D0-C735-4D70-ADE5-C0152DA0CF7D"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7F697A47-B23E-4ED6-B388-4B245A38A61B</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0B3F136-A2DA-402C-966A-F651CF933AB6">
    <ao:prefix>inhibitors </ao:prefix>
    <ao:exact>ketoconazole</ao:exact>
    <domeo:uuid>C0B3F136-A2DA-402C-966A-F651CF933AB6</domeo:uuid>
    <pav:createdOn>2014-07-14 15:12:51 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0B3F136-A2DA-402C-966A-F651CF933AB6"/>
    <ao:suffix>, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C44D15C-34C7-4C2C-9997-221A4390017A">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7337B1D-4B6D-4960-BF16-21FDA2383475"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:C3F0A74B-8BF7-4192-BD02-50E6C63EE46C</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:10:18 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N6066da43d1de4b55811429701da0e26d"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:10:31 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5AB19256-B710-4B62-98E0-3D0706EA1FE1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D19D43BA-73EE-4262-B97A-E3ED181E7553"/>
    <pav:createdOn>2014-07-14 15:16:59 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:5682B151-BEE7-418B-9DB1-7CE155BD7A4B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DE3F8F31-9BEC-4927-8C65-5F24C55EEA57">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:54F32B69-C007-4252-9B92-878BB3D2EF90"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDDB7D24-DB36-4290-8D46-E3A008DAB715">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 21:30:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N877238f8f2dd4822bb05da4c8b21e6f5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5BD6AA8F-46DC-4A84-891D-E3CE8ADADC9D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9FE19E91-A4BB-46E3-873A-BC789A127031</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3E337AF-8833-443E-8D8E-B84EA8922DC6"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 21:30:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7E62662-063A-402F-A0A0-B5876A3D37C4">
    <ao:body rdf:nodeID="N569394208d78439980c576780ff80238"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F95FCDA-7386-40AD-8F48-8C08EDD4B0C3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:59:56 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:8240946D-0B34-4B55-B255-B783851DFD15</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:59:54 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6DB0627-5E34-43BF-869B-6EB865E16C2C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F9704DE-3FF8-4450-98C0-00F719F45601"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:11:24 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:14AB1D39-B655-4475-9217-3D44297E170A</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4482B909-BE5F-4FEC-A0D4-751B610A123A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4482B909-BE5F-4FEC-A0D4-751B610A123A"/>
    <pav:createdOn>2014-07-20 20:41:21 -0400</pav:createdOn>
    <ao:exact>The concomitant administration of propafenone and warfarin increased warfarin plasma concentrations at steady state by 39% in healthy volunteers and prolonged the prothrombin time (PT) in patients taking warfarin</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>4482B909-BE5F-4FEC-A0D4-751B610A123A</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BC52D02-7640-4D42-95BE-5D90FF4F971A">
    <ao:exact>N-desmethyl</ao:exact>
    <ao:suffix> metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7BC52D02-7640-4D42-95BE-5D90FF4F971A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BC52D02-7640-4D42-95BE-5D90FF4F971A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>and its major circulating </ao:prefix>
    <pav:createdOn>2014-07-07 09:44:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BC463965-35ED-4517-B542-3922995BCA4F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:16E3723C-08FA-4B14-9694-FA8EECC549F3"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12A214CB-57E6-4F1E-B26D-0BFA14AFAB94">
    <ao:suffix>. In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of</ao:suffix>
    <pav:createdOn>2014-07-20 22:47:18 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:12A214CB-57E6-4F1E-B26D-0BFA14AFAB94"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration</ao:exact>
    <domeo:uuid>12A214CB-57E6-4F1E-B26D-0BFA14AFAB94</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2c704c4e-ea9a-4183-831f-c1fef008c8ae">
    <ao:context rdf:resource="urn:domeoclient:uuid:221b47ac-9621-4db5-afb0-9d3d98babebe"/>
    <pav:lineageUri>urn:domeoserver:annotationset:112111a6-38c8-4ac2-ac18-c0a6e17f87e6</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:09:02 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9A464B6-AC1C-48E7-810F-2497DEB9ACC4</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DAF50EB-2D45-4210-9A7A-540211CE77CA">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 20:30:00 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:3259727D-80E8-48AE-9391-3BA364F092A5</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N2e161b402a834c6e909ac00985455c16"/>
    <pav:lastSavedOn>2014-07-20 20:38:24 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:027918B1-469E-419C-82BD-87C275C47917"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D08D9252-FCA0-4CEC-89A8-86C09C07165C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:877F2652-A406-4678-9B9C-7CB17872B370</pav:lineageUri>
    <pav:createdOn>2014-07-14 00:08:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:D328F557-C8F8-4D5F-90D2-8348B1E2763C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9D31ADB0-89B2-4CC9-B818-E1337FACE0E9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 00:11:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6260603-DCBF-4AB1-AE3A-3B928363379D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5CE5412A-076B-48A3-AD53-8E38525CF9CD"/>
    <pav:createdOn>2014-07-14 15:55:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17C547A4-5ED4-49FA-857A-120F65333FFF">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:17C547A4-5ED4-49FA-857A-120F65333FFF"/>
    <ao:exact>Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>17C547A4-5ED4-49FA-857A-120F65333FFF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:47:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E4C8974F-CE04-47B7-8F68-65219E597449">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2C6267E-AE2D-49A6-9562-7DC8679EB032"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/23AF8418-C91F-4F60-859B-9F403F627A8D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E54859A-7A40-4A60-B485-110537DF2A74">
    <ao:context rdf:resource="urn:domeoclient:uuid:C603902B-543F-4C61-8861-8BB8862F1CEE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:14:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AC88968-5799-4BEB-A9BC-D20C067E2451">
    <pav:createdOn>2014-07-13 23:55:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F32B7046-21D2-4BEC-97EF-224627866A71"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BF32B3FE-4A0D-4A12-ABEB-F292B848616D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE5758E3-D998-40B9-AC08-851C30EF4865"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E540506D-410E-41F8-A76C-03C37390521E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43331416-04A5-4D68-9A8A-4010B568E1C2">
    <pav:createdOn>2014-07-20 20:15:25 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F74156F-F9E3-4353-8CFB-EEF85D9F7A4D"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:6e22c92c-7297-4e91-ba82-ac1dc0a550ab</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 20:20:18 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:519206D3-C89E-46D3-B9DD-DCBA22D3A157">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:AFBD4DF3-2F53-4791-8488-6668A4EB10FD</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 13:57:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N0abd9f58fa9c429985dc171744dc9aab"/>
    <pav:lastSavedOn>2014-07-14 13:57:24 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2C001985-B459-471C-BD59-D32183CE4763</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:66014D4C-8DCF-428C-A4FB-10DC8A3E36BB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7376813C-18F5-4DFB-9351-3C431415603A">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8DF46239-225C-4774-B0A1-D86F73818C99"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBCC441D-CC6D-43EF-9768-612425898015">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:37:53 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:42F5C75D-314E-47EE-82D1-B11BDC6E1AF0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F4DB871-B0E2-4CBE-B57A-8CC4639877CD">
    <ao:item rdf:resource="urn:domeoclient:uuid:776E86C1-F47A-4F23-8688-6170E6F36145"/>
    <pav:lineageUri>urn:domeoserver:annotationset:17C3B71B-4D17-476C-A0A4-C17909917C64</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDCFEC33-7FC2-43C8-A53F-23F8FE6760DF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F8D66D2-A142-4BFF-9BA1-117E181DBCE2"/>
    <pav:lastSavedOn>2014-07-14 15:02:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:01:51 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DCBC5F5-3A41-4266-BB5A-B26163D5E0DC"/>
    <permissions:permissions rdf:nodeID="Ne87c20edd8414a3398cca6b9191a7c1f"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B342234D-85FE-4DF4-A172-94D9DAD30AED">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:15A786B1-82C5-4059-A056-195138C3131F"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7D64D1F-8DA7-4472-941E-8F193465EBC8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:F743ABC6-D666-4FC3-A24D-5FCA56BC32ED</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:18:08 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:17:55 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE0B8B26-849E-41D5-A290-DC147AFC1489"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/05AA0649-FFEE-4563-9292-318B3DFD94BB">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6BEF65DF-682B-4643-B62F-8F5B56031590">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:exact>cytochrome P450</ao:exact>
    <domeo:uuid>6BEF65DF-682B-4643-B62F-8F5B56031590</domeo:uuid>
    <ao:suffix>), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:suffix>
    <ao:prefix>did not inhibit mixed-function liver oxidase enzymes (</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6BEF65DF-682B-4643-B62F-8F5B56031590"/>
    <pav:createdOn>2014-07-14 00:25:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2FA1215F-246E-4F45-B34F-9369A6E2AA08">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F3AE4048-D8E7-4389-AA51-357C8C5B6A87"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121">
    <ao:item rdf:resource="urn:domeoclient:uuid:C060DD22-64A7-45A3-924E-F9892256E2B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93F06F85-9901-4CFD-A872-94ACD592FF32"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1742FAC2-126A-437A-AA46-05CB37AFB9CF"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A8A5BE3-9A8B-4E32-B698-3A155F1E8736"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5AB19256-B710-4B62-98E0-3D0706EA1FE1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:897EA484-D7E4-4C5E-928A-9C6E63C63BEF</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:9272E4C5-F69B-4DAE-8C2F-3915DC3328FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E23049C4-5655-4DDA-A22E-87B5E2B63F9E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8137EA2C-6AB4-4C03-909F-0CC70E86AE37"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35BF2F03-05AF-4832-A0A2-B1A6EEE52304"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdOn>2014-07-14 15:16:58 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N0f71287e8a964e1ab0f0d426af0dbc6d"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8B869658-C315-4932-8DF4-C5287264BC7B">
    <rdfs:label>nifedipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A578511B-AD5F-4453-BCF7-B667E5B06A96">
    <pav:lineageUri>urn:domeoserver:annotation:54BD92B2-C22C-4C8F-B456-1CC17566CA27</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8266861F-2C84-490C-8CF3-4B2AD8E9E61F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:47:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:48:59 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BA3C8777-2A2E-476C-8511-99CBFFF4DF20">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cyclosporine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3008</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6FF0331F-E778-4CA2-B1B4-5B09969CFE9F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F1C62938-6219-4B76-B5EF-ED73F7A5E5F5"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39E42543-B843-4862-B3F0-967AEEAE113B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C695803C-F876-4316-8563-FFD22F9C8D2E</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:35:21 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C760DC9E-6990-45D9-8826-92A327DA84A2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:34:12 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92D4CCDA-CBDA-4CC3-835E-AB36D79BCBFD">
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8209DD89-3405-4E3B-9DE0-854D524E41B8"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:32:03 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:1794100C-4C38-4154-9980-B12DD6F615EB</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:39:57 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N6c8ca5a8f7634e68974d0e35a3958b60"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8E146A6D-284E-4C0F-B6FD-F6D2577C74A8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>alprazolam</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/596</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:400C4FAD-156D-4E7E-AA74-8D202CCF017A">
    <pav:createdOn>2014-07-14 14:20:51 -0400</pav:createdOn>
    <ao:prefix>. Since </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>400C4FAD-156D-4E7E-AA74-8D202CCF017A</domeo:uuid>
    <ao:exact>metformin </ao:exact>
    <ao:suffix>is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:400C4FAD-156D-4E7E-AA74-8D202CCF017A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0341E67A-5AAE-4E27-A5C0-2D99A42E6AEA">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFAB68BD-49C7-439D-A842-617C4AE3D9EB">
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:10:29 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE9A03FE-FD6B-4A90-BC32-A568886CF7F2"/>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97BCF13B-E472-4968-B77F-E299F71BB9B8">
    <pav:createdOn>2014-07-14 15:15:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:15:14 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N512bb9424f4d4e96b05aad50e8a9ac3a"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:6DD5814B-3FBA-4541-A555-989527FB4AE4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:106C15A5-3A73-4B7F-B2F9-96E7C834B7AF"/>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D304B1FC-62B9-42D4-8705-B7235C5D2862">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nf34b03160e074b2c97d38c6227503156"/>
    <pav:lastSavedOn>2014-07-13 14:58:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BBFA9270-6F9B-4389-96DA-CCFBCD34611C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DC51EFFF-046C-4BAE-A26F-8209178C5832</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 14:56:48 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A9436CD-961A-429A-9900-991E3858E7AB">
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:FD1A00D3-83B1-4C65-B898-BABCA38F2FD7"/>
    <pav:createdOn>2014-07-14 00:24:13 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6C67093-B83F-46A1-A581-1D36BE3D85E9">
    <domeo:uuid>F6C67093-B83F-46A1-A581-1D36BE3D85E9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 20:46:21 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6C67093-B83F-46A1-A581-1D36BE3D85E9"/>
    <ao:prefix>. </ao:prefix>
    <ao:exact>GZDV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix> AUC is about 3-fold greater than the </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD8911DB-833A-40A4-BCEC-B0B40B660AE7">
    <ao:suffix>. Monitor plasma</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD8911DB-833A-40A4-BCEC-B0B40B660AE7"/>
    <ao:exact>Concomitant use of propafenone and digoxin increased steady-state serum digoxin exposure (AUC) in patients by 60 to 270%, and decreased the clearance of digoxin by 31 to 67%</ao:exact>
    <domeo:uuid>CD8911DB-833A-40A4-BCEC-B0B40B660AE7</domeo:uuid>
    <pav:createdOn>2014-07-20 20:39:55 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:72896ED1-53B7-4FF8-98B1-ACE47FAF1282">
    <pav:previousVersion>urn:domeoclient:uuid:45e601eb-8158-4a04-88b9-89a945bca0c7</pav:previousVersion>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/1bcf27e5-2e7e-4306-a122-b1fd4e34764c"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:13109ea8-1007-4b31-81f8-43d48ede873c</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nce6a27d48e274e5fbd4561f56d487c23"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-07 08:09:00 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA708CC1-40BC-4D59-AB45-DAD9F78EDB2D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 23:13:27 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FB4E2C1-35BD-4DB3-B908-3851B4DE21AE"/>
    <rdfs:label>NER Sets</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10EEA40E-566D-4742-B7DB-CB394F8DD2CD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:36:22 -0400</pav:createdOn>
    <ao:prefix>. </ao:prefix>
    <ao:exact>In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:10EEA40E-566D-4742-B7DB-CB394F8DD2CD"/>
    <domeo:uuid>10EEA40E-566D-4742-B7DB-CB394F8DD2CD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E9ED0D8-2D96-486C-A6BA-5600DBDFB0E8">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0F27516C-2C2A-4BAA-AA26-AED2747AF3C2</pav:lineageUri>
    <ao:body rdf:nodeID="Nb5fb298ab1714da69f6ab2464a84c775"/>
    <pav:lastSavedOn>2014-07-14 15:38:27 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:38:30 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AA398AA3-ABF6-4755-B6EF-DBD36D20832C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5C50FF8-852E-4393-A357-96F2F8F12C68">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE991691-BDFF-4ADF-9C96-0A0635EB225A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:89619CF7-50CE-4901-808D-E97DFA47BE47</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:42:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C11DA735-89DB-4504-8691-44020EFABE01">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:53:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B5BA909-C73E-46FA-9624-82C1B8CDA3B2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4FF1273-AA82-4906-919B-425ECBAD5DF2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4FF1273-AA82-4906-919B-425ECBAD5DF2"/>
    <pav:createdOn>2014-07-20 21:22:28 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of quinupristin/dalfopristin and nifedipine (repeated oral dose) in healthy volunteers increased AUC and Cmax for nifedipine by factors of 1.44 and 1.18, respectively, compared to nifedipine monotherapy</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A4FF1273-AA82-4906-919B-425ECBAD5DF2</domeo:uuid>
    <ao:prefix>. </ao:prefix>
    <ao:suffix>. Upon coadministration of</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA7E7331-6C3B-4BA7-9444-303E55440FF5">
    <ao:exact>Synercid </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA7E7331-6C3B-4BA7-9444-303E55440FF5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(7.5 mg/kg q12h intravenously [iv]) in the treatment of complicated skin and skin structure infections were performed. The comparator drug was oxacillin (2g q6h iv) in the first study (JRV 304) and cefazolin (1g q8h iv) in the second study (JRV 305); how</ao:suffix>
    <ao:prefix>Two randomized, open-label, controlled clinical trials of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>BA7E7331-6C3B-4BA7-9444-303E55440FF5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 13:52:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:475EFF62-7E37-4C7A-A1A3-56FCD2668FE3">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:34:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:475EFF62-7E37-4C7A-A1A3-56FCD2668FE3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>475EFF62-7E37-4C7A-A1A3-56FCD2668FE3</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CCA8839-937C-41A8-A4EB-A0C5BCB1F668">
    <domeo:uuid>1CCA8839-937C-41A8-A4EB-A0C5BCB1F668</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>An open-label, randomized, three-way crossover study in 18 healthy subjects assessed the effect of a single 800 mg oral dose of fluconazole on the pharmacokinetics of a single 1200 mg oral dose of azithromycin as well as the effects of azithromycin on the pharmacokinetics of fluconazole. There was no significant pharmacokinetic interaction between fluconazole and azithromycin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1CCA8839-937C-41A8-A4EB-A0C5BCB1F668"/>
    <pav:createdOn>2014-07-20 23:13:14 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C789F60-840A-4189-AB01-0464184BB388">
    <pav:createdOn>2014-07-14 14:45:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">24</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:55E86D0B-B096-4EE2-AE98-DE2DF348C9EC</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:45:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F89D4DA-B6B3-4AB3-AD05-08DA94D021FF"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79960439-A3DB-4FCF-A8A3-20CEC06482C1">
    <pav:lineageUri>urn:domeoserver:annotation:AAF68E7A-9F7D-47CE-99B8-32899829B756</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DCC874F-D846-45E7-9105-996551F6946D"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nb927984741b84931a331a7a4796ac53a"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 23:02:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 23:02:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47763CE8-530A-473D-849D-AA25F7CB8111">
    <pav:createdOn>2014-07-14 15:26:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF87ED59-91D1-477C-BB84-45ED85DC70A8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0acaf3df-3f9c-4010-969e-4d473d6e8621">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACB34A20-F0B5-4EE4-ACC8-901687DDB0F2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:f1865be7-6e65-4979-bd22-e0723730e86b</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 08:09:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:456e383f-5eb5-4c7d-8fd7-3c93dadcc92a"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:332482F4-0A00-4F5A-95ED-AC415A589F11">
    <pav:createdOn>2014-07-14 14:28:28 -0400</pav:createdOn>
    <domeo:uuid>332482F4-0A00-4F5A-95ED-AC415A589F11</domeo:uuid>
    <ao:prefix>(4 mg once daily) for 7 days increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:332482F4-0A00-4F5A-95ED-AC415A589F11"/>
    <ao:suffix>AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug I</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F75A828E-CBAD-47C8-BBC3-45B5E8A39C6C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7120AB7A-7867-43E7-8DC3-5404D7106D51</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:12:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:11:49 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:72AA2676-2CD7-4866-982E-C23740797310"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E050D2E-48AF-46B6-B2D3-9D1C161CC871">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-13 14:58:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E050D2E-48AF-46B6-B2D3-9D1C161CC871"/>
    <domeo:uuid>8E050D2E-48AF-46B6-B2D3-9D1C161CC871</domeo:uuid>
    <ao:suffix>. The individual AUC values of</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8DE0546-D425-4DD3-9B20-F4CBFE8AA67A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8DE0546-D425-4DD3-9B20-F4CBFE8AA67A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:prefix>can inhibit the metabolism of </ao:prefix>
    <domeo:uuid>A8DE0546-D425-4DD3-9B20-F4CBFE8AA67A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>diazepam</ao:exact>
    <pav:createdOn>2014-07-14 14:57:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FD6763FE-BDA1-4A8F-BBC8-FBC3AD2F37CD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8134</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenobarbital</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1CE7E20-02F5-410E-839C-E99EA883E19D">
    <ao:context rdf:resource="urn:domeoclient:uuid:74525FB0-10E0-42F9-806E-5D10CBC2E4E2"/>
    <pav:previousVersion>urn:domeoclient:uuid:96d6147f-d0f2-48d7-b636-5b3a4ca034f6</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:EEC5A3A2-87BE-42FE-BBEB-F8F93FAEACE9</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:b344dc7c-6e63-4256-a61e-8d0aa7e1c056</pav:lineageUri>
    <pav:createdOn>2014-07-20 23:11:07 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N74bb4a2994994db6aa305ae769890711"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 23:11:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F46B4D8-4631-4D18-8A0D-F3926DB466AB">
    <ao:context rdf:resource="urn:domeoclient:uuid:6FB3340D-F382-46CF-B042-DBEB5BDD4CC7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 13:41:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A9E01583-5D99-40CD-80E2-04991950CBCC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8C8DEDE-5F80-4E2C-B97C-A73C6535CC99">
    <pav:lineageUri>urn:domeoserver:annotation:3D1A1AD1-6EFF-4263-A9C1-F4685AAF2E26</pav:lineageUri>
    <pav:createdOn>2014-07-14 13:47:12 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nc1ece97173d74c82ac0f5e97209f9666"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:52DC89CB-DD6F-4216-A7CA-3413F940ED3A"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:263ACF7F-CFA7-4427-8A35-2A3BDEAD47FD">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin)</ao:exact>
    <ao:suffix>, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g.,</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:32:19 -0400</pav:createdOn>
    <domeo:uuid>263ACF7F-CFA7-4427-8A35-2A3BDEAD47FD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:263ACF7F-CFA7-4427-8A35-2A3BDEAD47FD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92A7CB6D-D7B8-48DB-AFD9-D1DCED3C48BF">
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E103D65B-D651-41B3-A813-4810CD52C7ED"/>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:23:27 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:664D6307-208B-425F-93A8-7363152E7FFA">
    <ao:exact>carbamazepine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:664D6307-208B-425F-93A8-7363152E7FFA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:55:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>(10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <domeo:uuid>664D6307-208B-425F-93A8-7363152E7FFA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(10 mcg/mL), and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E155A1B-B3FE-4145-98DB-88EF9FA7F85C">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9087967D-2C33-4197-9230-286BCFCC6471"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:865FF816-F198-4824-B5ED-629F2B0C7EEC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:865FF816-F198-4824-B5ED-629F2B0C7EEC"/>
    <ao:prefix>, or </ao:prefix>
    <ao:exact>valproate </ao:exact>
    <pav:createdOn>2014-07-14 00:24:10 -0400</pav:createdOn>
    <ao:suffix>during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are m</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>865FF816-F198-4824-B5ED-629F2B0C7EEC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80D806E1-7D43-4654-B166-F2716BEAE049">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FC056A21-615F-44B8-8E1B-A2A2E8DCB977</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:38:59 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB60D2F5-F01F-4FED-9269-88A5958AF552"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:39:28 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3748F22-F64D-4F58-A221-A10B5E5782EC">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:15:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3748F22-F64D-4F58-A221-A10B5E5782EC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>E3748F22-F64D-4F58-A221-A10B5E5782EC</domeo:uuid>
    <ao:exact>Cytochrome P450 (CYP) isoenzyme 2C8</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:617CFBFD-33F7-4D4A-873E-9FADBE8098CB">
    <pav:lastSavedOn>2014-07-14 15:38:08 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FBA50C9E-51D5-4418-9757-8D5148B012E1"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:261FBCCB-D709-4392-82BC-685600FA5428</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:38:10 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nc1e43c48a40f4d1b85d2b6d133c95ab1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB3671FF-0F24-45EE-AB36-F7D339EF8FEF">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 23:54:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4972CD43-FEF3-4B35-9E87-053F8552F104"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0F5BEC69-11F5-4641-A571-CFBB9DDA6CC2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0988428D-F548-48AE-A856-82357493909C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/550AF52B-3C3C-43EC-9A82-220470A00179"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBBC3BF4-D014-4529-ACAF-B10B20BF3167">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:46:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:46:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">25</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:544569B7-B04B-4D08-8480-81069D93C09C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:B007B37B-2A74-4AFA-BE1E-EDA76A331AAE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:45FDC95A-BBBE-4730-987D-65034C77F623">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/77924DDB-A826-427D-89C1-60F26E350FB5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/49F53E2D-1FA8-470A-8C7C-B9F35EFF552A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FE1D9CF-5460-48BB-BAA6-538EAE7BE3AA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-07 11:18:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7FE1D9CF-5460-48BB-BAA6-538EAE7BE3AA"/>
    <domeo:uuid>7FE1D9CF-5460-48BB-BAA6-538EAE7BE3AA</domeo:uuid>
    <ao:exact>Single doses of antacid (magnesium hydroxide/aluminum hydroxide) did not affect the bioavailability of sildenafil</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0EFC0480-98C5-44E3-8C41-3925C3D9A089">
    <ao:body rdf:nodeID="N3931debc13d94ba2b6e34489f0f2274b"/>
    <pav:createdOn>2014-07-14 14:45:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E1E07746-0BDA-452C-A969-C53F879C9E52"/>
    <pav:previousVersion>urn:domeoserver:annotationset:8A66A3C5-1E5E-4EBF-8342-14A271B60E81</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">23</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:45:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:002204EA-D76A-4067-B3E6-CE9CAB5ADB69">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:23:22 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:962F8CCC-F233-4452-8472-02DFBE2B857C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23827F66-35D1-4DDB-8B41-2992CD55BA1D">
    <pav:createdOn>2014-07-13 14:49:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:615B32D2-20A2-4C4F-BA0C-590A35006E47"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1C1D291-5405-44E0-9345-DCA9FC19CC46">
    <pav:lastSavedOn>2014-07-14 13:51:02 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 13:48:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:19B15449-8704-44E3-8F67-69BE4EF69C7F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D987AA7A-4C03-4BD0-8B25-E23982DBEEAA">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nd13194d78f384ed184ffa762c1bb5222"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:6A8C5F4D-316F-4ED6-80F3-1355375FE51E</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8D53476D-5323-4EF0-A072-E479B6EA2D79"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 23:01:08 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 23:01:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2523401-1969-467B-8B7E-F02CD5439FD6">
    <ao:prefix>After chronic dosing of 80 mg TID </ao:prefix>
    <pav:createdOn>2014-07-07 09:42:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2523401-1969-467B-8B7E-F02CD5439FD6"/>
    <ao:exact>sildenafil </ao:exact>
    <ao:suffix>to patients with pulmonary arterial hypertension, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg).</ao:suffix>
    <domeo:uuid>C2523401-1969-467B-8B7E-F02CD5439FD6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:DCA01201-900A-484E-A265-59DB0E1CD1C5">
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/ae21e08a-7338-428a-9d9b-ba327d8add63"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-81.txt.html</ao:annotatesResource>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:8f132d8b-8ec4-4488-bf78-60475ab3d167</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:66c79945-6b7d-4d5a-81a5-09c5f4172fa8</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N3e8ffe80b8b24c299836da8dd1c622e6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34405F1F-C97A-42B2-8733-48B762481C13"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:39:26 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E21D1443-5FF2-44C6-981C-9FCFB1DA42A3">
    <domeo:uuid>E21D1443-5FF2-44C6-981C-9FCFB1DA42A3</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-13 14:57:13 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E21D1443-5FF2-44C6-981C-9FCFB1DA42A3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78F4A53A-48DF-47FD-B430-96D6F6DA5FAF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FEC3F002-6EA8-4C3C-A1D3-F7323E6E2CBC"/>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 11:09:46 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C1A7E2A-125A-4FE9-B7D5-EAC3E7B561F0">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3C1A7E2A-125A-4FE9-B7D5-EAC3E7B561F0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:00:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>3C1A7E2A-125A-4FE9-B7D5-EAC3E7B561F0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F89D4DA-B6B3-4AB3-AD05-08DA94D021FF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F89D4DA-B6B3-4AB3-AD05-08DA94D021FF"/>
    <ao:suffix>(0.375 mg once daily) in healthy volunteers.</ao:suffix>
    <domeo:uuid>9F89D4DA-B6B3-4AB3-AD05-08DA94D021FF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:45:25 -0400</pav:createdOn>
    <ao:exact>digoxin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F58EE2F4-90DB-432C-919A-90C0F28B1531">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 14:44:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A9FFE004-DD07-481F-94A3-33FF9982C6A6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9D1DA224-0F33-42EE-BBB2-3AC605173F87</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N37f2b3eadb4b4054bbe380f25a2c7aa0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/75FD13B5-0EEA-4E75-B21F-BA39BBFFF746">
    <rdfs:label>glyburide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDE41278-0B38-42E0-B1A1-FCA02A6FF966">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>PDE5 </ao:exact>
    <ao:prefix>. Its effect is more potent on </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CDE41278-0B38-42E0-B1A1-FCA02A6FF966"/>
    <domeo:uuid>CDE41278-0B38-42E0-B1A1-FCA02A6FF966</domeo:uuid>
    <pav:createdOn>2014-07-07 09:37:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>than on other known phosphodiesterases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in con</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:986AC187-5D34-4867-AFBA-C8433F2C989A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 00:12:02 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9C0F9B59-0BA9-451F-A2FF-1319F18ECF53</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:677CCD05-B1FC-494E-9BAB-C4F5AB8C4F35"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D2F36F05-9358-4277-AC9A-6BD395B4B1CB">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1975d26e-9996-4882-93ad-95beba0bcca0">
    <ao:exact>ritonavir</ao:exact>
    <ao:suffix> pharmacokinetics in healthy m</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1975d26e-9996-4882-93ad-95beba0bcca0"/>
    <pav:createdOn>2014-07-07 08:08:55 -0400</pav:createdOn>
    <ao:prefix> older patients. A study of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C35B4EB4-FABA-4308-A858-D024FD0CD40F">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Administration of 40 mg/day citalopram for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C35B4EB4-FABA-4308-A858-D024FD0CD40F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>C35B4EB4-FABA-4308-A858-D024FD0CD40F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-81.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:39:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E384BCF-D1F1-4D7E-84ED-828D7761EBAD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:51:06 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DDA49FDD-8FCD-4E9A-8319-0BA3F2353C0E</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 22:50:40 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:BEC79822-394E-4C36-B6DF-4C2632AFB381"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd101d7528ec7402e8f4b3642aa022d73">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11750F37-DAB4-4675-B253-7F67E608D51F">
    <domeo:uuid>11750F37-DAB4-4675-B253-7F67E608D51F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>N-depropylpropafenone</ao:exact>
    <ao:prefix> which is formed by CYP2D6 and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:suffix> (norpropafenone) which is formed by both CYP3A4 and CYP1A2. In less than 10% of patients, metabolism of </ao:suffix>
    <pav:createdOn>2014-07-20 20:19:53 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:11750F37-DAB4-4675-B253-7F67E608D51F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65171858-7BDA-4D2C-8CBF-607CAC4FBCC0">
    <pav:lastSavedOn>2014-07-14 14:44:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:71EE833C-D364-46D8-93C8-22F3A8890CD8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-14 14:44:15 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N3b074ea632b640ec948fde4718e6b7c6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:A7CF76A0-A5C2-4C16-A32F-635827C3D643</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C44B1D22-7C27-4777-B5F4-0311E02D7AC9">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3FABE034-92E5-4B4C-95BC-8F8BD117B066"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7120E47E-4F61-491A-B71C-522A35540598">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:16:15 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:1F706A03-A24F-4C5B-B78E-4C3F58FD1BDA</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F95B7E2-37E2-404A-83FE-172E0A5C760A"/>
    <pav:lastSavedOn>2014-07-14 14:17:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0CF5D433-1574-4FBC-B8DD-9393ED93FBEB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/40254</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>valproate</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:AF93E7BB-716E-4E64-BCE0-B1DA8CE4D2F9">
    <pav:lineageUri>urn:domeoserver:annotationset:6786357b-e997-4536-ac15-089f11895856</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:d7033b26-8982-4061-909f-98ac85346b59</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:90535690-FF72-467C-BFC9-66E4C3B86FC3"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-86.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="N314ddd94861743eb844bca84080dbceb"/>
    <pav:lastSavedOn>2014-07-20 21:40:59 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFBD4DF3-2F53-4791-8488-6668A4EB10FD">
    <ao:item rdf:resource="urn:domeoclient:uuid:519206D3-C89E-46D3-B9DD-DCBA22D3A157"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0D1B0F4-93D2-4F43-9CFA-E9DCB99FE550"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B6F0AC6-2C59-43FE-8098-6CAFDC55E355"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:51429A7F-A009-4AB3-9EA7-6F6DC2EA9519"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N70f67ef332bf4516ad8d98de856ef63d"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:D9FB5C61-5F45-4BA6-9B5B-1C81586E2235</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:1C8C09E9-486C-451A-91CC-01423F65BFD6"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-14 13:54:28 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 13:57:24 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58344963-021B-4687-9C11-13F2008A11CE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:DB0D1FEC-3C7D-4868-99F4-560643644FD4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 13:58:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:1B5054EB-3026-421C-9AF8-C13A7D278AA8</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B6837FB6-9E20-4C81-9D1C-5DE7964FACB9"/>
    <pav:createdOn>2014-07-14 13:58:22 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:45B9EFF8-EFE2-45F1-97EE-0C8D41035AE6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0FFA60EB-5522-42FD-9E90-074DB5BB439F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D33C77EA-D41A-4970-8A53-217A26462C9B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5DDAA4B3-F4A1-4EEE-A916-6B0FAF8FA35B">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <rdfs:label>conivaptan</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N27b514ff7304434d98ead3edc00a9c66">
    <domeo:sets rdf:resource="urn:pddi:uuid:C5FDF9F2-CDBD-44DE-A6BB-F9BB67F0B776"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B26D279-9E2C-408C-BCE6-0F2C1BDD11BE">
    <pav:lastSavedOn>2014-07-20 21:14:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:c617ed29-a536-4a51-95a3-3f1cbb9e8b61</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 21:07:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1CFD1411-ACED-46D4-87C2-0F32F599E1A7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1836881-F5BA-4408-90EB-3CA93988F140">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B1836881-F5BA-4408-90EB-3CA93988F140"/>
    <pav:createdOn>2014-07-13 23:54:47 -0400</pav:createdOn>
    <ao:suffix>200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20%</ao:suffix>
    <ao:prefix> concentrations were determined on two occasions (before and following </ao:prefix>
    <domeo:uuid>B1836881-F5BA-4408-90EB-3CA93988F140</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD1A00D3-83B1-4C65-B898-BABCA38F2FD7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FD1A00D3-83B1-4C65-B898-BABCA38F2FD7"/>
    <ao:exact>Zonisamide </ao:exact>
    <pav:createdOn>2014-07-14 00:24:13 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>during clinical trials. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>FD1A00D3-83B1-4C65-B898-BABCA38F2FD7</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:suffix>did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro. Zonisamide is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozy</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DAE6E63-AB8A-4646-AF5D-118E6D05F6CC">
    <pav:createdOn>2014-07-20 21:27:40 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 21:27:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7ad52825-94f0-471d-9071-5f85d8c8df4e</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5306453341b64d85a92dbf42dd3fa56b"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:03F0D3A3-146C-4F88-8409-2B6C80859477"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:d6bb10c8-408c-4332-92d2-ec2babcc5720</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4F4757D4-A915-4B00-A8C6-82EA8D7F5519</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63CF2643-0DB0-42D9-95B4-7EB7F105B216">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:23:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:63CF2643-0DB0-42D9-95B4-7EB7F105B216"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>In drug interaction studies, risperidone did not significantly affect the pharmacokinetics of donepezil and galantamine, which are metabolized by CYP 2D6</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <domeo:uuid>63CF2643-0DB0-42D9-95B4-7EB7F105B216</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25F0D12B-D8EC-447B-B1E9-2252F9B8001A">
    <pav:createdOn>2014-07-14 00:17:15 -0400</pav:createdOn>
    <domeo:uuid>25F0D12B-D8EC-447B-B1E9-2252F9B8001A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>metabolic pathway, </ao:suffix>
    <ao:exact>P450 3A4</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25F0D12B-D8EC-447B-B1E9-2252F9B8001A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <ao:prefix>Perhaps because of competition for the </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06F62C9C-E537-4C34-9FE3-30C21F5E19C9">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:905924BD-5607-4D93-8AE7-2DA7DA0FF26B</pav:lineageUri>
    <ao:body rdf:nodeID="Nf2b2f85e673540c3830d908a4cac008c"/>
    <pav:createdOn>2014-07-14 00:08:06 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D70AF55E-8385-4447-8A13-50FB670CC3D9"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:08:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4477B066-614B-4766-BF4D-5EE07E18E1DB</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:258150E5-0E95-4DFF-8AE4-CDD71E9734C9">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:261FBCCB-D709-4392-82BC-685600FA5428</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:36:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F9F86329-963B-49B5-97BC-DB59DCB9FBE8"/>
    <pav:lastSavedOn>2014-07-14 15:38:08 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:544569B7-B04B-4D08-8480-81069D93C09C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:544569B7-B04B-4D08-8480-81069D93C09C"/>
    <pav:createdOn>2014-07-14 14:46:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>warfarin </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>544569B7-B04B-4D08-8480-81069D93C09C</domeo:uuid>
    <ao:prefix>had no clinically relevant effect on the steady-state pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>enantiomers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6B4FFAB2-8E33-4C8E-8C18-152C4A363FCD">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdfs:label>methadone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/94475638-AF19-4A8F-A6B0-2AAABF65AC60">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/29170</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>magnesium trisilicate</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58C9619F-518B-44E5-A36D-530B8A48B4C7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:49:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:BAACDE98-5CB9-45DD-AED0-2BEBE40AFBDF"/>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD22DF06-EA15-4549-85B5-842A0F4D11C6">
    <pav:createdOn>2014-07-20 22:02:51 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:57089BDA-24A6-4128-85C0-8AB8591105EB"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:522B2F1E-129E-41C7-B7BF-FA750F75C38B</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:03:01 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:body rdf:nodeID="Nb14a7acab571481ba2d9f96e5a901269"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0DB30838-4830-49C5-968E-53C2911121DC">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2E88C8E6-71AE-4A0B-8DF1-6C12E874CE1A"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27686EA6-093D-4F11-BCF2-8C755CF6E4F7">
    <ao:context rdf:resource="urn:domeoclient:uuid:FEBC010D-01EB-4618-91A9-64C6C13EDFA0"/>
    <ao:body rdf:nodeID="N11429616c61f4661b462078e550e606d"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:FF36675E-FE40-4215-AC06-372FF3F86300</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:20:51 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">19</pav:versionNumber>
    <pav:createdOn>2014-07-20 22:20:49 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FAB530E-2E79-4327-93D1-F62EDC7FD648">
    <ao:suffix>blood levels (eg, dehydration), more frequent monitoring may also be indicated.</ao:suffix>
    <ao:prefix>commended: hematology at least monthly, renal function and liver function every 1 to 2 months. More frequent monitoring is usually indicated during antineoplastic therapy. During initial or changing doses, or during periods of increased risk of elevated </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>methotrexate </ao:exact>
    <domeo:uuid>9FAB530E-2E79-4327-93D1-F62EDC7FD648</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-167.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9FAB530E-2E79-4327-93D1-F62EDC7FD648"/>
    <pav:createdOn>2014-07-14 15:44:08 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C4F4974-1D16-456F-8957-6B4A1BA678C2">
    <pav:lastSavedOn>2014-07-11 23:30:05 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N221ebde0b77546dc93d797b23fa32d8b"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:87B2254C-9EDA-4A13-8A44-5E216F7A452D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:507903E6-DE7C-47BB-8279-84234908AD7B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2A7B770A-84A8-41E0-BA99-F4C20EC7A3BA</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:4800F891-C244-4234-A891-55160E585E64"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-11 23:29:10 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F55429F-3B64-4FF6-9A95-6B45519907E4">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:47:46 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:17C547A4-5ED4-49FA-857A-120F65333FFF"/>
    <ao:body rdf:nodeID="N5ef045aae102479dba0ffe9ac6f8aa06"/>
    <pav:previousVersion>urn:domeoclient:uuid:9b9adb60-a447-4aa7-82fc-e4bcf10dd788</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:47:35 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A69FCE6F-B369-4F8B-A1D6-3F2BDD659606">
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:b92686cf-78e8-47e8-a8d4-767477cf1b9c</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAAD3F51-F985-4954-8B78-ED5FFC54D881"/>
    <pav:lastSavedOn>2014-07-20 20:47:11 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-20 20:46:40 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCBFA5E1-EFEF-4C8E-BF6A-BE338D0CAB9F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdOn>2014-07-20 20:35:03 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:2F469CFC-07B6-45D2-A099-85C1219DCE19</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:39B734C2-006D-4C33-9B54-03E563108307"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:35:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0D472E1-4467-4227-8199-B6A0B3CA5859">
    <pav:lastSavedOn>2014-07-20 20:48:09 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB901F0D-0D81-48D5-9F32-5A7B3784E342"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D4AF08F6-86FC-4B37-8629-C8D6EDCE95E4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-20 20:47:17 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2F7EEDA-1E3B-4EDB-9900-BF1CB6A77ACF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rifampin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4871EF5-CA78-4A31-B579-2BBD09C2EB35">
    <pav:previousVersion>urn:domeoserver:annotationset:7120AB7A-7867-43E7-8DC3-5404D7106D51</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E316C0F-2E10-4726-8DAA-88A51D60223D"/>
    <pav:createdOn>2014-07-14 14:12:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:12:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768">
    <ao:item rdf:resource="urn:domeoclient:uuid:7E705EC7-0CB6-4526-8E88-A6FB134082D6"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:472F53B3-2FCC-4314-A8D4-EB80BB179B88"/>
    <pav:createdOn>2014-07-07 08:09:09 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED0E8432-9B43-4984-97EA-10003B00C871"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DAF50EB-2D45-4210-9A7A-540211CE77CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6AC6A3C8-B628-4D4D-A13C-2B5D3F83EF1E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCBFA5E1-EFEF-4C8E-BF6A-BE338D0CAB9F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:87EF6045-0E89-402E-8935-1D573FC4CA1C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A6C74EE-C39E-4081-8AFC-14C5523620DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9642BA7C-B767-4A07-A0CF-4DFFB1E0F3F5"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoserver:annotationset:86876A35-5320-4C53-8994-D3F083508783</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N274476169c924a218e109782ddf6e3cb"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA129433-8D22-4EE5-B5AB-8639F127E397"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4B089881-295F-41FF-9641-1820771D71BB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:139049AE-7811-4FDD-8348-ED6F1B6F34CD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F29511BE-AFB8-43BB-AD8D-C5E14FB83F1B"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:47A6BC6B-5B07-409B-A868-99A2F0862BC2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92D4CCDA-CBDA-4CC3-835E-AB36D79BCBFD"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-20 20:44:54 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/b1964cb5-59bc-4759-b4d5-8008fbeecbb8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59F792DD-27B7-4ADC-8812-83EBB783AAEC"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADCC54B3-8D38-4CF2-83B8-A67981B7DBE0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">25</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:E05A9B62-0A33-418F-B36D-FC4762F8D912"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:588738AA-7EC6-43C4-B157-BE36F827A71B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6106BAF6-6556-420F-8793-84970B7F446A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FFA5AD69-5770-4C97-B73E-8AA721042363"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE666A09-D3D2-40C5-8258-A66C8CB88000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7B62A88-F614-4DCF-9749-882CA702B315"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F95B7E2-37E2-404A-83FE-172E0A5C760A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:16:15 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F95B7E2-37E2-404A-83FE-172E0A5C760A"/>
    <ao:suffix>in female patients (n = 405) was approximately 6% lower compared to male patients of the same body weight (n = 642).</ao:suffix>
    <domeo:uuid>8F95B7E2-37E2-404A-83FE-172E0A5C760A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Results of the population pharmacokinetics analysis showed that the mean oral clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E309DB08-9A92-4488-B8ED-46C4A893633C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E309DB08-9A92-4488-B8ED-46C4A893633C"/>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:05:48 -0400</pav:createdOn>
    <domeo:uuid>E309DB08-9A92-4488-B8ED-46C4A893633C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CD686BD4-A9E6-46B2-9464-CEDAD3442C08">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:96CF9CA3-B56C-4FFE-8C46-58FA48BE1F98"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F37052E8-4866-4310-83E4-2A54C40DD77C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-20 21:52:37 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:52:18 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A37E1EC5-6D5E-4F60-8C30-EB9B7AB8FB22</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E28C9449-DDBE-45EB-B94F-C720A3460BEC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F019B52A-2B3C-4F08-B43A-567107C07EB8">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EB42C18-3953-48EA-8026-7A33FFBC87D1">
    <ao:suffix> AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole hal</ao:suffix>
    <ao:exact>fluconazole </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <domeo:uuid>2EB42C18-3953-48EA-8026-7A33FFBC87D1</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2EB42C18-3953-48EA-8026-7A33FFBC87D1"/>
    <pav:createdOn>2014-07-13 15:57:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6AC6A3C8-B628-4D4D-A13C-2B5D3F83EF1E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nae657714f3b44524889270fa66f8306f"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3F767F3-B0B3-4391-BCE6-8ED28C0AE0BA"/>
    <pav:createdOn>2014-07-20 20:33:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:1794100C-4C38-4154-9980-B12DD6F615EB</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 20:39:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50A55843-DBDC-4F66-9F65-1DD94DBEFD6B">
    <ao:suffix>) concentrations ranging from 33% to 209%.</ao:suffix>
    <ao:exact>mesoridazine</ao:exact>
    <pav:createdOn>2014-07-14 15:07:24 -0400</pav:createdOn>
    <ao:prefix>metabolite (</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50A55843-DBDC-4F66-9F65-1DD94DBEFD6B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>50A55843-DBDC-4F66-9F65-1DD94DBEFD6B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6077C77-F288-423E-95CF-9688004B9EA3">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B02C8B01-78CE-464C-9942-8C24AA78717A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FE0073A-9CEB-432B-BA69-8C35C7CF3119"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:48:58 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5dd91f1e49ea4c199578fbc2c55b3a03"/>
    <pav:lastSavedOn>2014-07-14 14:48:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B175DCD-D292-4747-9C4E-526DBDA5291D">
    <ao:suffix>(3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>glyburide </ao:exact>
    <pav:createdOn>2014-07-14 14:33:35 -0400</pav:createdOn>
    <domeo:uuid>7B175DCD-D292-4747-9C4E-526DBDA5291D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B175DCD-D292-4747-9C4E-526DBDA5291D"/>
    <ao:prefix>(2 mg twice daily) taken concomitantly with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A4E36D6-6A02-481C-AF4A-464C53F2BD1E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A4E36D6-6A02-481C-AF4A-464C53F2BD1E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>0A4E36D6-6A02-481C-AF4A-464C53F2BD1E</domeo:uuid>
    <pav:createdOn>2014-07-13 16:03:21 -0400</pav:createdOn>
    <ao:suffix> (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E253EFE5-32BE-4DA0-9296-CDE33C3C83F6">
    <pav:createdOn>2014-07-14 13:41:26 -0400</pav:createdOn>
    <domeo:uuid>E253EFE5-32BE-4DA0-9296-CDE33C3C83F6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E253EFE5-32BE-4DA0-9296-CDE33C3C83F6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, </ao:suffix>
    <ao:exact>nifedipine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:prefix>and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/07155DEC-567B-4837-8BAA-FD75C9F0234F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tolbutamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8241C483-1F0F-4F1E-AFEB-B67E9CA5E1FE">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EC29843-C5A8-40A5-93EE-2640705D81EB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:11:15 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:C990C802-3E03-4941-BF27-D0ABB28068F3"/>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/41C827FD-34CA-4622-8D55-F71BEBBFC260">
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2377A11E-B1BA-42FE-AE0B-FE66AB102192">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3DA943FA-B4B7-4998-B325-3B3F66882436">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:66CE9C76-A8AD-4556-87A8-949FEF25AEA3"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88666D2A-5D3B-46F7-9326-9197168C6938">
    <ao:prefix>Excretion: </ao:prefix>
    <ao:exact>Risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:06:47 -0400</pav:createdOn>
    <ao:suffix>and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-risperidone administered as solution to three healthy male volunteers, total recovery o</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88666D2A-5D3B-46F7-9326-9197168C6938"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>88666D2A-5D3B-46F7-9326-9197168C6938</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9038129F-73A3-48E1-ADAB-876E955F297E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/002AA166-DDBC-4D77-9AD1-BA0DBC4F104D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5BE227F-7164-4DAD-89D8-684BD64D96EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3079DA6A-B893-4381-B554-F583232CB187">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8401DCE8-4998-4888-BF09-06B17C2FF790"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:34:03 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8FB9935-F34A-4ABB-BA0F-6671CE5EABC1">
    <ao:body rdf:nodeID="Nd04459bbb6e747fbb916090949b8ce48"/>
    <pav:lineageUri>urn:domeoserver:annotation:8DB457D2-932A-4CA7-A094-5F9D108DCC7F</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 00:05:31 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6294BE6-FDE8-4823-A9D1-0BCD1DEE4E9F"/>
    <pav:lastSavedOn>2014-07-14 00:05:32 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5EBAC55A-C458-45FE-9A01-FE230027AFB2">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D1127A23-F2D5-4DCB-BA73-F678B5ECDAAB"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/206D43F2-9AC9-4A1A-81B5-B254E7F11CB2">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9B5A79C-FB84-4D6A-9080-E86C010F4D0B">
    <domeo:uuid>D9B5A79C-FB84-4D6A-9080-E86C010F4D0B</domeo:uuid>
    <ao:suffix>are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of 9-hydroxyrisperidone are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:53:28 -0400</pav:createdOn>
    <ao:prefix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D9B5A79C-FB84-4D6A-9080-E86C010F4D0B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA81DB93-7F03-40B8-AD19-BFEE26897B7C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Repeat dosing with AVANDIA had no clinically relevant effect on the steady-state pharmacokinetics of warfarin enantiomers</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>EA81DB93-7F03-40B8-AD19-BFEE26897B7C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EA81DB93-7F03-40B8-AD19-BFEE26897B7C"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 14:46:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36DED415-6CB1-4E7A-B5B1-9986A117C9F0">
    <pav:createdOn>2014-07-14 16:03:09 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7B0466C-240A-49CD-AE9D-082313F61373"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83C4E132-8D8D-4BDD-A355-625A6131A8CB">
    <ao:prefix>with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83C4E132-8D8D-4BDD-A355-625A6131A8CB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:03:11 -0400</pav:createdOn>
    <domeo:uuid>83C4E132-8D8D-4BDD-A355-625A6131A8CB</domeo:uuid>
    <ao:suffix>resulted in up to 50% decrease in propranolol concentrations.</ao:suffix>
    <ao:exact>propranolol </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3FEDA41F-3483-4B12-A922-A899BF63231C">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E98D39A-743C-4581-B214-D365FB040563">
    <pav:createdOn>2014-07-14 00:20:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N886fcd5a02a34130b22fd7556ffbe05b"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C11E308-F44D-4CE2-A61C-6C5825C4A343"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:4386E35B-DB66-44F5-A199-09C12280A673</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 00:20:21 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C961A91-7FF4-46F4-852E-CB250589B873">
    <pav:lastSavedOn>2014-07-14 14:17:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:17:37 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:1F706A03-A24F-4C5B-B78E-4C3F58FD1BDA</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2FB2355B-FC49-41F0-B1BB-B89F682207E9"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:147F3C87-DF3E-4617-812D-E628655927FA">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:053950FB-A8F0-4086-BB28-FB762D2C6677"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3821D7D9-A384-4657-A442-EC5C01D153FA">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3CD46515-2729-43FE-B968-BF2E3ADAD48F"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97E9BE77-131E-49FA-B836-5E6BD12DA8E8">
    <pav:lineageUri>urn:domeoserver:annotation:BAF7A90C-2FF4-4366-AB08-E1BFE341B7A5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF81CE81-E3E7-47BA-ADFC-81174E136A35"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:09:57 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:09:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:87C87B25-2788-4E6F-A04F-27F5AF9D1A53</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:677CCD05-B1FC-494E-9BAB-C4F5AB8C4F35">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <domeo:uuid>677CCD05-B1FC-494E-9BAB-C4F5AB8C4F35</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:677CCD05-B1FC-494E-9BAB-C4F5AB8C4F35"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:12:02 -0400</pav:createdOn>
    <ao:exact>ritonavir </ao:exact>
    <ao:suffix>with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <ao:prefix>/</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:82554599-69C0-4F4F-B23D-1FCD1062BE90">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A9706F29-D8F1-4B81-9647-EFDA6810F208"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6C41C38-4F67-48C7-8D2C-58EDEC2DD7F3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A6C41C38-4F67-48C7-8D2C-58EDEC2DD7F3"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%. Plasma concentrations of carbamazepine did not appear to be affected</ao:exact>
    <pav:createdOn>2014-07-20 22:19:19 -0400</pav:createdOn>
    <domeo:uuid>A6C41C38-4F67-48C7-8D2C-58EDEC2DD7F3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N93d1d9575675424c98d2a470c2d688d9">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:502FA972-3333-4B87-BBCC-290F611104F3">
    <ao:suffix> metabolite occurs in quantities comparable to the levels occurring in extensive metabolizers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> whose metabolism is mediated by the CYP2D6 isozyme. In these patients, the </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:502FA972-3333-4B87-BBCC-290F611104F3"/>
    <domeo:uuid>502FA972-3333-4B87-BBCC-290F611104F3</domeo:uuid>
    <ao:exact>N-depropylpropafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:21:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:716FE94B-EF89-4FA5-BDB5-34D9D634F049">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:44F9CB2D-A1DE-4461-8533-C94770D13017"/>
    <pav:createdOn>2014-07-14 14:20:18 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/439E7E9D-3CE5-48F4-A17C-0ECECF0D7CFB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluvoxamine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7998E9DB-B8C4-467F-8FF0-00F310A2DDBC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:31EE5963-852E-4178-904F-C17B5990CE12"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:11:29 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:11:26 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:112B1B73-DB37-4023-B62F-FF624A1BA519</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:936E07F0-EB98-40E1-A094-0BC98472D52C">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:36:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>936E07F0-EB98-40E1-A094-0BC98472D52C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:936E07F0-EB98-40E1-A094-0BC98472D52C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Glimepiride</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N221ebde0b77546dc93d797b23fa32d8b">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:033A02C1-428B-407E-AF6F-A0214E996ADB">
    <ao:suffix>(2 mg twice daily) taken concomitantly with glyburide (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy. Repeat doses of AVANDIA (8 mg once daily)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:033A02C1-428B-407E-AF6F-A0214E996ADB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:33:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>033A02C1-428B-407E-AF6F-A0214E996ADB</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1E07746-0BDA-452C-A969-C53F879C9E52">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>E1E07746-0BDA-452C-A969-C53F879C9E52</domeo:uuid>
    <ao:exact>Coadministration of acarbose (100 mg three times daily) for 7 days in healthy volunteers had no clinically relevant effect on the pharmacokinetics of a single oral dose of AVANDIA</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:45:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E1E07746-0BDA-452C-A969-C53F879C9E52"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F11C456-0E5E-4949-BC6F-F51743F45391">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9C823F0D-8D67-45C5-A37F-7BE8ED2E3352"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52B8F103-AF5D-4436-9A5A-E301AFAA07AB">
    <ao:exact>The effect of fluconazole on the pharmacokinetics and pharmacodynamics of midazolam was examined in a randomized, cross-over study in 12 volunteers. In the study, subjects ingested placebo or 400 mg fluconazole on Day 1 followed by 200 mg daily from Day 2 to Day 6. In addition, a 7.5 mg dose of midazolam was orally ingested on the first day, 0.05 mg/kg was administered intravenously on the fourth day, and 7.5 mg orally on the sixth day. Fluconazole reduced the clearance of IV midazolam by 51%</ao:exact>
    <pav:createdOn>2014-07-20 23:14:59 -0400</pav:createdOn>
    <domeo:uuid>52B8F103-AF5D-4436-9A5A-E301AFAA07AB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52B8F103-AF5D-4436-9A5A-E301AFAA07AB"/>
    <ao:suffix>. On the first day of dosing,</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DCD6F21-199D-49F7-9E03-1C71E495E7C7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1DCD6F21-199D-49F7-9E03-1C71E495E7C7"/>
    <pav:createdOn>2014-07-14 14:47:02 -0400</pav:createdOn>
    <ao:prefix>A single administration of a moderate amount of alcohol did not increase the risk of acute hypoglycemia in type 2 diabetes mellitus patients treated with </ao:prefix>
    <domeo:uuid>1DCD6F21-199D-49F7-9E03-1C71E495E7C7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E434D2F-EB71-47C1-AEE3-9486EF9EA0CB">
    <ao:suffix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 </ao:suffix>
    <ao:prefix>. There was a mean ± SD reduction in </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 15:58:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E434D2F-EB71-47C1-AEE3-9486EF9EA0CB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1E434D2F-EB71-47C1-AEE3-9486EF9EA0CB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B9259B0-DBD5-41CD-88C4-21C8AD25C2E3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B9259B0-DBD5-41CD-88C4-21C8AD25C2E3"/>
    <ao:suffix>. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%). The Cmin increased 157% ± 96% (range: 33 to 360%). The apparent oral clearance decreased 45% ± 15% (range: -15 to -60%). (See PRECAUTIONS</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 23:50:29 -0400</pav:createdOn>
    <domeo:uuid>5B9259B0-DBD5-41CD-88C4-21C8AD25C2E3</domeo:uuid>
    <ao:prefix>AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:175DE992-5EA0-40AF-8BC8-6F899E0B93D0">
    <ao:item rdf:resource="urn:domeoclient:uuid:D99DDD3F-7390-4001-A123-40B454B4F0C9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5262EE64-9963-44C3-9E5E-21E6A58C8C1E"/>
    <permissions:permissions rdf:nodeID="N6af2bf564e2e4ddcbad31de288c88ba5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7CA665B-3294-4A89-900F-79EBB2C31E88"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-14 13:52:07 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:659CD84D-DB19-4A46-914D-AA4540395D31"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:annotatesResource>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E3B65C6-5BB3-4446-9E9F-3B0C7A7A1280"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:613A0835-EE8C-4537-A573-DC355C3ACC38</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-14 13:53:55 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N06b620e998ca4dd58f6c029171911bb8">
    <domeo:sets rdf:resource="urn:pddi:uuid:605C3C8F-6ED3-4242-9772-981FED64FB93"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D38C181D-9E35-4C4F-99E8-EF1646AEE376">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:D5F24F1F-C8C7-407E-A957-9FABB9323E50</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:19:48 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0A7E040-C2A3-466D-A330-8114D95E734B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A58CFEE-CB47-4FAF-B2C3-F078F9107715"/>
    <pav:lastSavedOn>2014-07-14 15:19:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbb1c578995e946de92d178f16848c392">
    <domeo:sets rdf:resource="urn:pddi:uuid:3B23570A-CB5D-4241-8BA5-8AEA1A000F41"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/b89db52a-3657-44e3-913d-750857246bcc">
    <pav:lastSavedOn>2014-07-07 08:09:20 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:dbc1a5f3-076e-454b-afe3-a6fd24542dd5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACFBFD00-EB6E-4721-9C8E-346CECC1A79E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:17778f09-3c5c-4c6f-9513-62d64b4008bc</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52590A14-5FB3-4D4F-96A8-303FF0B2DAF2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:22:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52590A14-5FB3-4D4F-96A8-303FF0B2DAF2"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Ketoconazole</ao:exact>
    <domeo:uuid>52590A14-5FB3-4D4F-96A8-303FF0B2DAF2</domeo:uuid>
    <ao:prefix>and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0AE89A88-9434-4013-91F8-9E041E2BDF3C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BF310945-7984-47E6-BEFD-E10A37493532"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A421213-E3B1-4CA4-9505-3A6E4AC99E2C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF843CCA-9BE0-4A0E-AA53-9AA6CB32F36C">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:31:16 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:038C6A1D-4D73-4F19-B0BD-CE47A58936A2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:32:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C174BCA4-061F-41B5-90F6-36B15766499B</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C603902B-543F-4C61-8861-8BB8862F1CEE">
    <ao:prefix>and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C603902B-543F-4C61-8861-8BB8862F1CEE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <domeo:uuid>C603902B-543F-4C61-8861-8BB8862F1CEE</domeo:uuid>
    <ao:suffix>were coadministered.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:14:20 -0400</pav:createdOn>
    <ao:exact>trazodone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09DFFBB4-F660-4D6E-AB1D-CC0E54A371C7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9364296A-3008-4436-B18B-9519EB15C638"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 15:58:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A5A5496-7D04-4675-AD68-7DC013E096D4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2D168BC-003D-4DD7-A72D-9CDBBA1B5D0F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:53:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:784AC4F0-ED08-44DF-929B-24E7F5628FA2">
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:53:12 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:88E50021-C9C3-43EB-86E1-D81D2F4ACAD0"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB9F17B9-B721-4894-8783-C28EDBC57A75">
    <domeo:uuid>BB9F17B9-B721-4894-8783-C28EDBC57A75</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of </ao:prefix>
    <ao:exact>phenytoin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB9F17B9-B721-4894-8783-C28EDBC57A75"/>
    <pav:createdOn>2014-07-14 15:46:17 -0400</pav:createdOn>
    <ao:suffix>, the incidence of withdrawal symptoms decreased and methadone exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AECFDB06-4994-495B-B646-93000B6E5876">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AECFDB06-4994-495B-B646-93000B6E5876"/>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>AECFDB06-4994-495B-B646-93000B6E5876</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:52:36 -0400</pav:createdOn>
    <ao:prefix>The clinical effect from </ao:prefix>
    <ao:suffix>results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84B677A9-F69E-40FC-BB74-CEA3742E0ACC">
    <domeo:uuid>84B677A9-F69E-40FC-BB74-CEA3742E0ACC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84B677A9-F69E-40FC-BB74-CEA3742E0ACC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma conce</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:53:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F89683C5-7B89-4FE1-ADF5-92657120E8C0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F89683C5-7B89-4FE1-ADF5-92657120E8C0</domeo:uuid>
    <ao:prefix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F89683C5-7B89-4FE1-ADF5-92657120E8C0"/>
    <pav:createdOn>2014-07-13 15:54:57 -0400</pav:createdOn>
    <ao:exact>fluconazole </ao:exact>
    <ao:suffix> 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2F7706D-1BF4-41FA-8BEC-1597D569BEA0"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:778137C2-B992-489F-9C34-3E57FAD9B734"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43177377-6759-44F6-ADFE-4B2D8D998013"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:158806C8-EDEF-4315-8072-AB9961CEBF65"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N6df5a60e205f4db6988b80428171e288"/>
    <pav:lastSavedOn>2014-07-13 16:05:40 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6A56289-EABC-41BE-B177-D474556420A8"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C1A437A-FA92-4589-9BD2-268CDFAC3A67"/>
    <pav:previousVersion>urn:domeoclient:uuid:6C2EC6F8-7C73-4E45-85A8-8AFE7C5E071E</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:73078006-A158-460B-ACBB-D093DA6DAC5F"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <pav:createdOn>2014-07-13 16:03:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:ACFBFD00-EB6E-4721-9C8E-346CECC1A79E">
    <pav:lastSavedOn>2014-07-20 21:49:13 -0400</pav:lastSavedOn>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:AEA45FA3-06B3-42DB-BA7C-46C3304DC041</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N8be9ff0857324fe3b692ff141d84d830"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:64D3106E-1308-4AAC-A7F0-911A2DACDF00"/>
    <pav:lineageUri>urn:domeoserver:annotationset:17778f09-3c5c-4c6f-9513-62d64b4008bc</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/b89db52a-3657-44e3-913d-750857246bcc"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:758EFBB3-A920-4A75-9612-C86DEB749233"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:E9876049-7559-42C7-9213-89E83E9A64C5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3DB39160-09B3-4E2A-B3D8-3444B85025A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3EAF9A6-FFDF-4068-A8D8-950A69516F6D">
    <ao:prefix>have been used to treat severe reactions, with the addition of intravenous </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3EAF9A6-FFDF-4068-A8D8-950A69516F6D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>chlorpromazine </ao:exact>
    <ao:suffix>in those cases exhibiting hypertension and hyperpyrexia. The usefulness and safety of narcotic antagonists in the treatment of these reactions is unknown.)</ao:suffix>
    <domeo:uuid>F3EAF9A6-FFDF-4068-A8D8-950A69516F6D</domeo:uuid>
    <pav:createdOn>2014-07-14 15:42:21 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58DFC95D-E8F9-481A-B665-6DB6C142031D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58DFC95D-E8F9-481A-B665-6DB6C142031D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak b</ao:suffix>
    <ao:prefix>) with </ao:prefix>
    <pav:createdOn>2014-07-14 16:03:38 -0400</pav:createdOn>
    <domeo:uuid>58DFC95D-E8F9-481A-B665-6DB6C142031D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B06ECAA-52F8-419F-A47B-2B99C705DFAF">
    <pav:lastSavedOn>2014-07-14 00:30:03 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED4BC8F1-515A-4681-8194-802B920EB45A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N00362320461844a3a4d92972d54e9210"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE993110-C132-4AEB-BCA5-4D904C479F52"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-14 00:29:04 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:1FCCCCCA-5520-404A-99A5-8160FCE712C3</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:FD2B3E06-3780-4FA7-A32D-61CDBB5F7368"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/190B7F86-3784-4EB5-80FD-4CC4C7F36CD5">
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD8CE684-D437-4E97-A17B-32DDE469E97C">
    <pav:createdOn>2014-07-14 14:09:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F69FF573-B8E4-4EA9-8CCB-D2780F7E0179"/>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C553B9B3-1DAD-45FD-BA67-C43B6EB873F2">
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:56:58 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE675E22-D94C-45D9-9698-178FAE508C83"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:58:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C09E880F-9356-4266-BB07-F075BDDEA9AE">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <rdfs:label>conivaptan</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73AD999B-6A8A-4004-A4C3-875F3588E8B7">
    <ao:context rdf:resource="urn:domeoclient:uuid:676D2C9A-DA84-49E3-9398-72BAE4D0F643"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:12:31 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2B3667B-3201-40EE-BDFC-327B76EBC35B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B2B3667B-3201-40EE-BDFC-327B76EBC35B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <ao:prefix>Perhaps because of competition for the P450 3A4metabolic pathway, </ao:prefix>
    <domeo:uuid>B2B3667B-3201-40EE-BDFC-327B76EBC35B</domeo:uuid>
    <ao:exact>quinidine </ao:exact>
    <ao:suffix>levels rise when ketoconazole is coadministered.</ao:suffix>
    <pav:createdOn>2014-07-14 00:16:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7EEC6BC-124A-48D0-8A0B-89DC26C3A2AC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E7EEC6BC-124A-48D0-8A0B-89DC26C3A2AC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7EEC6BC-124A-48D0-8A0B-89DC26C3A2AC"/>
    <ao:suffix>is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina and involved in the phototransduction pathway of the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed wit</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:38:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>terases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility. </ao:prefix>
    <ao:exact>Sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C237145-BE09-4FE5-A114-C4FBF59F00B1">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>4C237145-BE09-4FE5-A114-C4FBF59F00B1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Diazepam does not alter the pharmacokinetics of propranolol</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C237145-BE09-4FE5-A114-C4FBF59F00B1"/>
    <pav:createdOn>2014-07-14 14:58:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/69FC2C6F-38BF-4D16-904F-3726979881CF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diazepam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF3DC084-925C-44BB-A4C0-3BBC2F3488AB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF3DC084-925C-44BB-A4C0-3BBC2F3488AB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:06:35 -0400</pav:createdOn>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. It would also be possible for </ao:prefix>
    <ao:suffix>to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AF3DC084-925C-44BB-A4C0-3BBC2F3488AB</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E87D76B-1566-4252-B7F3-81706DAAB825">
    <ao:context rdf:resource="urn:domeoclient:uuid:7CD71919-DE30-49A3-8A5C-FA0B4875C22B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:61F341E7-A0E6-4108-9CBB-95301708FF0A</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 16:07:17 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA75BC42-49F0-47ED-B401-D7BF593B7EDE">
    <rdfs:label>digoxin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:85659FB4-58AC-4A68-9866-A7B71CD8E342">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A143B9D3-083E-40DC-BB2A-069C9BC44AA1"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1284E9CF-B8EE-488B-8CD1-506043FF5504">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F251274-63AC-4938-AFF6-DE7C31B47267"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:19:53 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEC8FD7A-992F-4E5F-B227-7FA41DD74071">
    <pav:lastSavedOn>2014-07-20 21:52:37 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 21:52:25 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7B51A7A-B3D1-4922-908B-0D816DD32A36"/>
    <pav:lineageUri>urn:domeoserver:annotation:40D45B51-3305-4DA4-B8F3-1666F95B626B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E721348C-C086-4DAE-AF5C-FEAE96FEADCC">
    <pav:lastSavedOn>2014-07-20 20:58:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:188066D2-D8DF-41BA-8D27-20EBE6CC91EC</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F8D54F9-05F8-484D-AC39-B03ED5375925"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 20:57:50 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:652C7468-30D0-4D63-B4BF-90221B6ADECD">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:60A44009-2A71-44FD-B5F4-665D620FC14A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6EE65F7-6FA6-4781-8E7C-4CE575F0DF11">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:body rdf:nodeID="N8c017f596b2c417085e055b761f9833a"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:createdOn>2014-07-20 21:55:59 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:d490020d-fbdb-4f4a-8dbb-541406b4038c</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 21:56:13 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D8479230-F9DA-4188-A1A4-602E8388DCF9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5d3464d841024ea7a81fd5414a1a99d8">
    <domeo:sets rdf:resource="urn:pddi:uuid:D8FF93B7-DDE6-4254-BCF4-3E197FCFBF40"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C823F0D-8D67-45C5-A37F-7BE8ED2E3352">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D14EBB20-3195-44D9-B4BE-A56ADA56563C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4D5A996C-EB58-4FA9-952C-72983F2BD075"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EC9C19E7-72B3-413C-B01C-D35DCBED1545">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>glipizide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4821</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/23AF8418-C91F-4F60-859B-9F403F627A8D">
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:262F14F9-4189-4E89-83B6-24A1E72416A6">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F383AF3-3F5A-44FF-AFC4-A40A7B9FF05C"/>
    <pav:createdOn>2014-07-14 14:54:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:55:22 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80C1776E-DF0D-41B9-94D8-3CC44EA820F9">
    <ao:suffix>. Thus, risperidone can be given with or without meals.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:80C1776E-DF0D-41B9-94D8-3CC44EA820F9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Food Effect: Food does not affect either the rate or extent of absorption of </ao:prefix>
    <pav:createdOn>2014-07-14 15:53:42 -0400</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>80C1776E-DF0D-41B9-94D8-3CC44EA820F9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE5ED7B4-D954-413C-966C-E8ACD7BE1B30">
    <pav:previousVersion>urn:domeoclient:uuid:b92686cf-78e8-47e8-a8d4-767477cf1b9c</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-20 20:46:38 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 20:47:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C7BBB7AA-7E29-4784-B124-0C1FF7BE4435"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1CE97FA-1E37-43BD-B37F-9C89C869ECF4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B1836881-F5BA-4408-90EB-3CA93988F140"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 23:54:47 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EE71BC7A-5DA3-48ED-BAA9-99D54ADB141E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>paroxetine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38E1F199-7B1C-40D5-8766-2CEADB62D668">
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:createdOn>2014-07-07 11:07:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FFD4D56D-7032-40B5-8E9A-3FEC6523482B"/>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9876049-7559-42C7-9213-89E83E9A64C5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:17778f09-3c5c-4c6f-9513-62d64b4008bc</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 21:48:38 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N37e25a0dde23408aaf1e4808d1bf51a2"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:72A6487A-7B3C-4EA8-81EC-4050E2715191"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:B72BE56B-725E-4F9B-8C7E-82D35E363610</pav:previousVersion>
    <pav:createdOn>2014-07-20 21:47:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACFBFD00-EB6E-4721-9C8E-346CECC1A79E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB84529D-6E38-4ED9-A05C-BE5515EA7F80">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4CF0705-EC2A-4E95-95FD-59BF5CA9A244"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:28:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38464E2F-D76E-485E-92D2-493EA6207953">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:36:43 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:1B2D1CB1-AF4A-4392-B9F9-E4972994FD93</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E543D5CA-F914-4E78-8EBA-9FD0D5A221A9"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:37:20 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C442770-348C-4AAB-8CE7-5AE43CBBEEEB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C442770-348C-4AAB-8CE7-5AE43CBBEEEB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-st</ao:suffix>
    <pav:createdOn>2014-07-14 15:25:20 -0400</pav:createdOn>
    <ao:prefix>had no effect on the pharmacokinetics of either </ao:prefix>
    <ao:exact>erythromycin </ao:exact>
    <domeo:uuid>0C442770-348C-4AAB-8CE7-5AE43CBBEEEB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74525FB0-10E0-42F9-806E-5D10CBC2E4E2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74525FB0-10E0-42F9-806E-5D10CBC2E4E2"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>74525FB0-10E0-42F9-806E-5D10CBC2E4E2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <ao:exact>Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> steady-state concentration was evaluated in ten male inpatients with schizophrenia. </ao:prefix>
    <pav:createdOn>2014-07-20 23:11:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7027B12A-8A29-492D-AB5A-86895E4B5450">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB87A9EF-7D85-4C94-B4C9-B9DDB2353518"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:55:22 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:54:48 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3A14F94-1A6C-4022-A4A0-EF79650D3C92">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na027d14f26744d2194672cd4865c14b2"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:34:40 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 22:33:12 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:2162DF76-B757-40AF-BA38-AFBC392D484D</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C60CF2F-8840-4590-A2BC-C7FCAFC6225B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9F6D9B1-8A06-4831-AE18-EC7D0814A286">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:27:53 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4</ao:exact>
    <domeo:uuid>B9F6D9B1-8A06-4831-AE18-EC7D0814A286</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B9F6D9B1-8A06-4831-AE18-EC7D0814A286"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:634D2AAB-74D7-4264-B8F7-545FA873F964">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. </ao:prefix>
    <domeo:uuid>634D2AAB-74D7-4264-B8F7-545FA873F964</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>In normotensive subjects receiving single doses of 10 mg or multiple doses of up to 20 mg nifedipine t.i.d. alone or together with cimetidine up to 1000 mg/day, the AUC values of nifedipine in the presence of cimetidine were between 1.52 and 2.01 times those in the absence of cimetidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:634D2AAB-74D7-4264-B8F7-545FA873F964"/>
    <pav:createdOn>2014-07-20 21:32:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE630A5E-671E-4A0A-8743-2982127399A0">
    <ao:prefix> (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>phenytoin</ao:exact>
    <pav:createdOn>2014-07-13 16:03:27 -0400</pav:createdOn>
    <domeo:uuid>FE630A5E-671E-4A0A-8743-2982127399A0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE630A5E-671E-4A0A-8743-2982127399A0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6">
    <pav:previousVersion>urn:domeoserver:annotationset:1B083018-46F5-4065-8214-392ECCA85143</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:771E05FA-9239-4B01-8A30-D927BC6F98C3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3A14F94-1A6C-4022-A4A0-EF79650D3C92"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:38348B3E-8881-4ABD-AD4D-18AF0C140E4C"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/a440efa4-9b30-400b-a47f-ef46ebc32fed"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DD889F5-7805-42CF-A30C-5024DA3783AE"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 22:34:40 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="Neab8265742c74e1191c19a32a4d0a911"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C1D7D94-E8DC-4AD9-A34B-AB98CFC25DD2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:541CC392-EE3B-4E29-85AF-7380F847B755"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a44e2c8f-4b9e-4967-b8db-c857796f8ffa</pav:lineageUri>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAE4045A-8AD6-4D51-B729-51AF773DA421">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAE4045A-8AD6-4D51-B729-51AF773DA421"/>
    <domeo:uuid>CAE4045A-8AD6-4D51-B729-51AF773DA421</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 16:00:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:659CD84D-DB19-4A46-914D-AA4540395D31">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:672A2872-52FC-441F-92CF-C033551120BA</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA7E7331-6C3B-4BA7-9444-303E55440FF5"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:175DE992-5EA0-40AF-8BC8-6F899E0B93D0</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 13:52:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 13:53:55 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AD3DA61-6FAA-4BFF-B81D-32F29A568B10">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D59A49D7-1642-4596-BA9C-BE01E1851529"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:42:57 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:E49A2FF1-3433-401B-BC4C-02CCC11D74A4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1C004977-FCD8-451C-81F2-8F24A2FD06FB</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:43:08 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF4ACE24-4288-486D-A52C-EF3CE988E132">
    <domeo:uuid>AF4ACE24-4288-486D-A52C-EF3CE988E132</domeo:uuid>
    <ao:prefix>clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>theophylline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
    <pav:createdOn>2014-07-13 23:59:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF4ACE24-4288-486D-A52C-EF3CE988E132"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/697C8178-1E90-4FC2-B563-31C879E3182D">
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBE3231F-0615-427F-83B8-D983B42AB82D">
    <pav:createdOn>2014-07-14 15:53:04 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BBE3231F-0615-427F-83B8-D983B42AB82D"/>
    <domeo:uuid>BBE3231F-0615-427F-83B8-D983B42AB82D</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Pharmacokinetic studies showed that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>oral solution is bioequivalent to risperidone tablets.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:15FF2225-61E8-4C64-ACEE-16EFAE88DFBB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A166D9DF-7636-4C9B-BEB4-D328C9DDD969"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2F5F9699-3D40-44BA-887D-A3C62277F73F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:870D6BED-1AF2-4FA5-A519-4BFAB3E132E1">
    <pav:previousVersion>urn:domeoclient:uuid:662ac9a4-9184-4f50-aeb5-c3c64969fa45</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <ao:body rdf:nodeID="N3ca2645798234ff6a41894a258dbe992"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:58:10 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:57:36 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A1494F6-227B-4B1A-B07C-55A33FBB1BA8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29E3CA46-5750-4CD6-B1F0-F9B55F72F92C">
    <domeo:uuid>29E3CA46-5750-4CD6-B1F0-F9B55F72F92C</domeo:uuid>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:29E3CA46-5750-4CD6-B1F0-F9B55F72F92C"/>
    <ao:prefix>to</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 16:03:01 -0400</pav:createdOn>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A9A464B6-AC1C-48E7-810F-2497DEB9ACC4">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9945954-4A2B-436D-996C-B843A85C8833"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N294956d67c71431ab563e7c1f7fd19bc"/>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-20 21:18:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:b3fb5818-2193-44bb-81fe-81e888d45719</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/2c704c4e-ea9a-4183-831f-c1fef008c8ae"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:112111a6-38c8-4ac2-ac18-c0a6e17f87e6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-115.txt.html</ao:annotatesResource>
    <rdfs:label>NER Sets</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBEB6B33-EFE4-489D-801E-A793994E27BD">
    <ao:exact>Next Choice</ao:exact>
    <ao:suffix>TM is believed to act as an emergency contraceptive principally by preventing ovulation or fertilization (by altering tubal transport of sperm and/or ova). In addition, they may inhibit implantation (by altering the endometrium). It is not effective once</ao:suffix>
    <ao:prefix>Emergency contraceptive pills are not effective if a woman is already pregnant. </ao:prefix>
    <domeo:uuid>BBEB6B33-EFE4-489D-801E-A793994E27BD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BBEB6B33-EFE4-489D-801E-A793994E27BD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:50:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3738E94-1946-433B-A314-952659477146">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C160940E-1FC7-4D9E-B418-5292AC237BA4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FDDEB300-E784-422D-A16F-6A161F5BD43F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:295337EC-3B4E-4FE5-BE12-8F076F7CBEF3">
    <ao:exact>zonisamide</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:295337EC-3B4E-4FE5-BE12-8F076F7CBEF3"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <ao:prefix>perienced an event on at least one occasion. All events are included except those already listed in the previous table or discussed in WARNINGS or PRECAUTIONS, trivial events, those too general to be informative, and those not reasonably associated with </ao:prefix>
    <domeo:uuid>295337EC-3B4E-4FE5-BE12-8F076F7CBEF3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:31:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C82C599E-BAF1-47F2-B8FE-4366444E53F0">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4AA712FF-F266-46CE-8830-A90C4AE19B77"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 16:01:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AFE28430-95D3-4E46-A0DF-E9B20DC549E1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61112620-1A34-41CB-9D48-2B9A70FEA7EC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F63BB256-FFD8-4275-A145-4E26D6C75211"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37DCDAA3-8F09-43C1-830B-07F0B282AB03">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A57DF30-9529-479A-9A9B-A5D7BF6A7BD0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 13:41:29 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:17E8E09D-EC16-4D02-B709-2AF4F034303E</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52DC89CB-DD6F-4216-A7CA-3413F940ED3A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively</ao:exact>
    <domeo:uuid>52DC89CB-DD6F-4216-A7CA-3413F940ED3A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52DC89CB-DD6F-4216-A7CA-3413F940ED3A"/>
    <pav:createdOn>2014-07-14 13:47:12 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:244F3A12-D743-4F47-87C7-CFA1C1A7E87D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7972C0E9-AD08-4562-BB70-4D6882398B5D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0ED2CF13-8DE7-42A5-BF96-CFEBD9F406CB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B18EE4D7-99CC-41CB-817D-AE74A036FC32">
    <pav:createdOn>2014-07-14 14:36:22 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:10EEA40E-566D-4742-B7DB-CB394F8DD2CD"/>
    <pav:previousVersion>urn:domeoserver:annotationset:ED910C40-DEE1-491D-A571-197762509711</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:36:21 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">19</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N92e452c023c248f4ad47e76fb56e25b3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B5ABA6C4-0D4C-40DD-A027-0B1E773C4B9B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E54D9CBB-F98A-4963-89F4-04EE51245BA0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BAA066BF-F82B-45EF-8283-780549D5ED39"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93F18B89-6C7E-4D12-AE68-BBE16A8D0629">
    <pav:createdOn>2014-07-14 00:23:03 -0400</pav:createdOn>
    <ao:exact>Quinidine Sulfate</ao:exact>
    <ao:suffix> Extended-release Tablet contains 300 mg of</ao:suffix>
    <domeo:uuid>93F18B89-6C7E-4D12-AE68-BBE16A8D0629</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93F18B89-6C7E-4D12-AE68-BBE16A8D0629"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-55.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8ED67CAA-C06A-47A2-BAA9-A3A8E79802A9">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2447</dailymed:activeMoietyRxCUI>
    <rdfs:label>cholestyramine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C6C01F5-90FE-4383-8FBD-7C4886430C84">
    <pav:createdOn>2014-07-14 13:58:34 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7574F414-D77A-4682-A163-7AD087FFF9A6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:DB0D1FEC-3C7D-4868-99F4-560643644FD4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 13:58:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8FE0C4BF-1A6F-4266-BF6B-E543E8955876"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59F792DD-27B7-4ADC-8812-83EBB783AAEC">
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <ao:body rdf:nodeID="N3466f19ff4bd4095a99b7c2ef3295718"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:BEA07018-7826-4E16-906F-E9BC5F67F0B7"/>
    <pav:previousVersion>urn:domeoserver:annotationset:3259727D-80E8-48AE-9391-3BA364F092A5</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:38:24 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:30:31 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2D5FD229-D29F-4031-8F09-640B6C138477">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2685</dailymed:activeMoietyRxCUI>
    <rdfs:label>colestipol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BF310945-7984-47E6-BEFD-E10A37493532">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>zonisamide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6F023E3E-91F6-4410-BE18-54AC3343B43B">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5769AD63-ABC9-4E79-BAF4-A40D4D6698C0"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:472F53B3-2FCC-4314-A8D4-EB80BB179B88">
    <pav:createdOn>2014-07-20 20:41:21 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Ncbeffbe0b8d2406aa37f8b75e2695939"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">19</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:8EA59317-FF1D-4DC3-A0C8-28E4BD980B9B</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4482B909-BE5F-4FEC-A0D4-751B610A123A"/>
    <pav:lastSavedOn>2014-07-20 20:41:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3E2E401-6FC0-4931-B402-95E39E8B1F3B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AECFDB06-4994-495B-B646-93000B6E5876"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:52:36 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD27ECE3-5334-49C3-8D2C-48542FE87542">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D6131B93-FE3F-4D5C-B0AD-F423E8B0B768"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:585C6B99-D509-47B5-B76E-7814527DCE3C">
    <rdfs:label>NER Sets</rdfs:label>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-07 08:09:04 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:02C2312F-ABBC-4D65-A43F-172B57B75726"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 23:20:50 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-36.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:9f31e32a-f9ae-4dd7-b759-7157d72841b5</pav:previousVersion>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/d92d8b52-5bc0-4fee-b53e-99da7e496003"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N996de8fe22cb4259af28e3f72f596cd9"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:91f910d1-bfe7-4646-b378-0be2e2e1db84</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:69969A71-4C2D-4D6A-8BC7-C074029459E8"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3B315E5-7A3D-41B5-81DB-2795EB8FC454">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:6B051EEA-882B-4D78-87FB-42AAA3907F4A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:07:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E17E273-E5CB-4715-8F28-63527DD43E33"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87B2254C-9EDA-4A13-8A44-5E216F7A452D">
    <domeo:belongsToSet>urn:domeoclient:uuid:3C4F4974-1D16-456F-8957-6B4A1BA678C2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:626D1AC1-69C1-41BF-AD16-FCD0D23AC685</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-11 23:29:39 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-11 23:30:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E164B984-DE06-43B6-A297-7FFE20CB56B7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <permissions:permissions rdf:nodeID="Nc0c6984492084f55a8a942b9c2af9f80"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2C3407C-A606-4F0E-BD2A-3D965CC96B06"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58B8F7BA-C39C-42D5-A483-C5E72801402C"/>
    <pav:previousVersion>urn:domeoserver:annotationset:32012947-2A00-4C1B-8E5C-44BD8A55BE8C</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0519F930-889D-4B19-96E0-3795C5DAF399"/>
    <pav:createdOn>2014-07-14 14:54:41 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:8793105D-39F7-4693-A826-2A652E7E4617"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:ACC34EC8-444B-425C-A010-DE6064EE2495"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:7027B12A-8A29-492D-AB5A-86895E4B5450"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4ECCFA2E-96CF-4E39-8D93-07103CEE402B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:262F14F9-4189-4E89-83B6-24A1E72416A6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:56:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E20EDE8-9BAA-4231-99E9-030B2330A94E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 21:36:25 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41FADBF6-DB61-48C1-8758-89F516D57C5A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAB0A6E4-9768-4646-9FC4-94B022BB60A1"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Nba2d6a7b7bdd4f3e8fe279af519bb2da"/>
    <pav:createdOn>2014-07-20 21:36:24 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F15E3B9E-F06E-440B-A7A4-83F334ACF4EC</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/751AEBCC-3E27-4D39-A41B-553472BD7EBB">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C124B6AE-EBE9-4FA6-BAB5-C51F48134049">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluvoxamine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:139049AE-7811-4FDD-8348-ED6F1B6F34CD">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <pav:createdOn>2014-07-20 20:35:18 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:35:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2F469CFC-07B6-45D2-A099-85C1219DCE19</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5F5C8AD9-ABDB-49B1-862B-C5AF02B55368"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E57FC17E-1CF0-465F-84C3-5053D76E01B5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/72635375-D69A-49A5-87A1-CAC337245FF6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/50254AB7-1254-43B8-96CB-C345B4C5D3DC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5AD781D5-79C0-4997-A8FE-2DA3F3BB2502">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE65945C-A3A8-4FE9-9507-1BD45BE40703"/>
    <pav:lastSavedOn>2014-07-07 11:17:03 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 11:17:07 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <ao:body rdf:nodeID="N7dc0c91299cb42c891cb12fc1156f072"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:0E282EF2-9AD2-409C-BBB2-47685BCC3402</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3DB0398-D4A3-4A23-BE1A-E9C2AE2D2167">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:D0840A76-AA39-48E3-BAF5-5F81D12F4275</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3AE68A18-97D3-4D92-A348-4A4E6CC91EB7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <ao:body rdf:nodeID="N9711f470db104ea5a9984fcab9f0d00c"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:27:32 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:27:32 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:242AFE5F-099E-4E09-913F-71C48733F9EC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/22A5F38C-DB67-475E-9072-E66FB5AD4C11"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/337C79E0-4E29-4C81-BED4-C97B5A8A4C7D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E949298-FCBB-4C0C-BD05-8F4B1CE4F72F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E949298-FCBB-4C0C-BD05-8F4B1CE4F72F"/>
    <domeo:uuid>3E949298-FCBB-4C0C-BD05-8F4B1CE4F72F</domeo:uuid>
    <pav:createdOn>2014-07-14 13:59:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>CYP2C8</ao:exact>
    <ao:prefix>An inhibitor of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:suffix> (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, chan</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53880A79-12CC-4CDE-9A8C-D7DBD019382D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:C9BFBE1A-1B72-4403-A672-D0101E2D3EE6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:08:38 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B2D997D5-9E92-45B0-8090-9A0A4C716200"/>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B86BDB91-30BA-4D92-AD89-8E468545F774">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECFE4B83-555A-4391-AF28-97683C79D6E9"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:34:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2C0175E-5534-499F-941C-68D048DA812C">
    <ao:exact>norverapamil</ao:exact>
    <ao:prefix>and </ao:prefix>
    <ao:suffix>. Verapamil does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2C0175E-5534-499F-941C-68D048DA812C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <domeo:uuid>A2C0175E-5534-499F-941C-68D048DA812C</domeo:uuid>
    <pav:createdOn>2014-07-14 14:54:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3E337AF-8833-443E-8D8E-B84EA8922DC6">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-110.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3E337AF-8833-443E-8D8E-B84EA8922DC6"/>
    <domeo:uuid>A3E337AF-8833-443E-8D8E-B84EA8922DC6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites by nifedipine. However, in clinical studies, concomitant nifedipine had no effect on irbesartan pharmacokinetics</ao:exact>
    <ao:prefix>: </ao:prefix>
    <pav:createdOn>2014-07-20 21:30:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8137EA2C-6AB4-4C03-909F-0CC70E86AE37">
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N7d29e7d10ee84522ae08da83f3722ff2"/>
    <pav:createdOn>2014-07-14 15:18:48 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0E77AEA-B837-4C8E-9F0F-573151C5CB69"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:181AA486-8F6E-435E-B0B3-149B54C1C8BB</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A530B793-9D12-4AA6-BE63-2960BB5CAAD5">
    <pav:createdOn>2014-07-14 14:46:45 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nb412c1a555734327ad6d10a03b0dd895"/>
    <pav:previousVersion>urn:domeoserver:annotationset:B007B37B-2A74-4AFA-BE1E-EDA76A331AAE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:46:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">25</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EA81DB93-7F03-40B8-AD19-BFEE26897B7C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:776E86C1-F47A-4F23-8688-6170E6F36145">
    <pav:lineageUri>urn:domeoserver:annotation:D05C5AA8-EAAC-497A-BCC1-952BDAEA71E9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:02:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:02:41 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B0890C2-9185-4AEA-9C8C-872077911D09"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N4028725cae12467a983c4ff5e38c8e9b"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:1F4DB871-B0E2-4CBE-B57A-8CC4639877CD</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2020F44B-D763-4D61-8706-6F3FF2DBCBEE">
    <ao:prefix>. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2020F44B-D763-4D61-8706-6F3FF2DBCBEE</domeo:uuid>
    <ao:exact>On the sixth day of dosing, fluconazole increased the midazolam AUC and Cmax by 259% and 74%, respectively</ao:exact>
    <ao:suffix>. The psychomotor effects of</ao:suffix>
    <pav:createdOn>2014-07-20 23:15:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2020F44B-D763-4D61-8706-6F3FF2DBCBEE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298">
    <ao:item rdf:resource="urn:domeoclient:uuid:7C3876BC-3973-4F99-BFFC-1B257D08A7C3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F92D55A-2A47-4519-BDB4-DAD8E8BD588E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1C1D291-5405-44E0-9345-DCA9FC19CC46"/>
    <pav:previousVersion>urn:domeoclient:uuid:F3335D55-F2EC-4378-8F56-38A4CAF1D7C9</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-14 13:51:27 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 13:48:40 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1A7C521-2B72-4026-944B-55F50A8D98EA"/>
    <permissions:permissions rdf:nodeID="Nc93e61e8a7a4401a95d07294264dc54b"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7D65E14-F652-4B4E-9675-7F1CD8CF3003"/>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C5458A17-9E39-47F0-81AD-6F96B19F34F3"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFD2B5C9-7227-43DE-97BC-F2B1BC29D00C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D64A5B7-56D4-4FC2-B0AD-C9C46D60E35D">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:975886EB-57DD-4967-8136-0DA53B4B6335"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:52:49 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:50D2384C-A6CF-4368-A352-CA03FF3C56CA">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3E8A15DD-0969-4FEE-B0C5-095BF99262D7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4B2D19E1-EB91-4410-9409-BE80B2C22924">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BFC20C25-3D1C-4C10-A1F3-06D7CEDB5BFF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CB6247B4-061D-4F49-B45E-0DBC3F8505C8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N69ada55a66c942b2852a0e1a7e3bbb54">
    <domeo:sets rdf:resource="urn:pddi:uuid:652C7468-30D0-4D63-B4BF-90221B6ADECD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67E793B4-B7C1-4873-81F6-CDDC4A13B720">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8D8B56A2-F0C4-40E5-8EBE-20A7103FC3D8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:40:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7203243A-1F22-4097-B0B6-2E6B9FD1DD0A">
    <ao:body rdf:nodeID="Ncad08869c6244338a78ed30ed4b2a952"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 22:00:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7B9D671-D81E-4459-B19A-4498ED40C220"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 22:00:02 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:08183A85-C165-41A8-BB91-6C70CFA02F7D</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:98106A81-8770-4585-BCB1-F0C9D05DC91F">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9CA222E0-A4FD-47D2-BD23-B1A90DC85E25"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AD5962F-9377-44EA-9537-7FD6E957079C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 13:59:42 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F83EE871-5DC8-460E-BAAD-6DB098973963"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9087967D-2C33-4197-9230-286BCFCC6471">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/88A3C850-58F9-4E63-8C78-7F560C63E678"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C6F9E537-6324-4E47-9C8C-2390455D5297"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA1D1A5E-57ED-4A20-AC6A-C7662E37F0ED">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Repeated oral doses of risperidone (3 mg twice daily) did not affect the exposure (AUC) or peak plasma concentrations (Cmax) of lithium (N=13)</ao:exact>
    <domeo:uuid>CA1D1A5E-57ED-4A20-AC6A-C7662E37F0ED</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:13:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA1D1A5E-57ED-4A20-AC6A-C7662E37F0ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF4FA47B-9EEB-41E0-9099-762E81A9C0CF">
    <pav:createdOn>2014-07-20 23:21:54 -0400</pav:createdOn>
    <ao:exact>Antacids containing magnesium trisilicate, when administered concomitantly with nitrofurantoin, reduce both the rate and extent of absorption</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-35.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DF4FA47B-9EEB-41E0-9099-762E81A9C0CF"/>
    <ao:suffix>. The mechanism for this interaction probably is adsorption of</ao:suffix>
    <domeo:uuid>DF4FA47B-9EEB-41E0-9099-762E81A9C0CF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16145B2E-A4C7-4736-B95B-95CABCAC8A65">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8BAEF029-45AB-4A6B-84A1-58ABEFA52BA0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidon</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB3BE992-5262-45BF-BB27-58180B0F46B0">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:20E9BBCF-0B8E-4E32-A17B-036CC033AC70"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 15:57:39 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2AFC481A-FB29-476F-AAE6-47C17237FE11">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC500AD3-21EB-412A-9942-E54A1FA042B4"/>
    <pav:previousVersion>urn:domeoserver:annotationset:EF444ECC-4F07-47A1-B3B6-C718307457E2</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:13:09 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:12:43 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91E4A62D-D081-48ED-B0E9-BF74542B5243">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:18:44 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2334F3FF-B599-4CCC-A4C5-7EBEA16B8EFE"/>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2940F792-08F6-422F-98F1-8DF507C61EE2">
    <ao:suffix> [see Warnings and Precautions (5.4)]</ao:suffix>
    <pav:createdOn>2014-07-20 23:00:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2940F792-08F6-422F-98F1-8DF507C61EE2</domeo:uuid>
    <ao:exact>Coadministration of a 0.5 mg dose of digoxin, a P-glycoprotein substrate, with oral conivaptan hydrochloride 40 mg twice daily resulted in a 30% reduction in clearance and 79% and 43% increases in digoxin Cmax and AUC values, respectively</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2940F792-08F6-422F-98F1-8DF507C61EE2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7003EE0A-5F81-4965-8103-157235E59988">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7003EE0A-5F81-4965-8103-157235E59988"/>
    <domeo:uuid>7003EE0A-5F81-4965-8103-157235E59988</domeo:uuid>
    <ao:suffix> AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 15:54:41 -0400</pav:createdOn>
    <ao:prefix>, there was a significant decrease in </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N3347a17f44024c9db387a170ca0a4959"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37DCDAA3-8F09-43C1-830B-07F0B282AB03"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:891CAAA4-5905-457B-AE2E-CBE044222C89"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2789A923-085E-4F37-8C95-21C808E3EA3F</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8DCF8DAE-FCDB-4B1F-B2DF-E09F36479DCC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8C8DEDE-5F80-4E2C-B97C-A73C6535CC99"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F50D9621-2894-4BB2-83B2-3A401583118B"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F46B4D8-4631-4D18-8A0D-F3926DB466AB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 13:41:25 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:647CE46D-76F3-4F61-B086-0748D7779113"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5A4A433-7D87-4503-98A3-545B5B12BF1D">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>, but </ao:prefix>
    <ao:suffix>does not alter the kinetics of diltiazem.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5A4A433-7D87-4503-98A3-545B5B12BF1D"/>
    <ao:exact>quinidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 00:19:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B1916EB5-0C06-4808-A0BF-13955B6AAFB9">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9D71D4C6-B25C-42A8-8F7F-9B0E2A650305"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4ea384c1-110a-4f6a-8040-ac8b2e9d26e7">
    <pav:lastSavedOn>2014-07-07 08:09:08 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:09:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:831af861-283a-4830-a91e-c36b0a7b18d4</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:cff4f855-553a-4ab7-b3dd-40ee90a09bd2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0CBA1D0E-EE21-43A4-A435-C10B50636A5C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64504D98-005B-4ECB-AFA2-A4D9BB1CFCC3">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:636E1844-D80E-4DAF-A97C-25ED9D6C639F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 11:09:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C1D4E424-6FF6-499D-9316-26826869645E">
    <rdfs:label>quinidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:859ABA2E-7C8E-4051-8D7F-DF2DF5EE8EDC">
    <ao:exact>Coadministration of oral conivaptan hydrochloride 10 mg with ketoconazole 200 mg resulted in 4- and 11-fold increases in Cmax and AUC of conivaptan, respectively</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:859ABA2E-7C8E-4051-8D7F-DF2DF5EE8EDC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>859ABA2E-7C8E-4051-8D7F-DF2DF5EE8EDC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:58:10 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4ac59cdab361414a8c244436cca93ea4">
    <domeo:sets rdf:resource="urn:pddi:uuid:99EC88BD-F1AE-450A-9DF4-E909D77DB021"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:83AA1C5E-9627-4620-9711-9C213B09ACAE">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BD7F19AE-1C7D-4B30-8B3E-92E2A06E2AAB"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42035FD4-F504-4E31-BE05-66C9A2B24E0C">
    <ao:prefix>(2g q6h iv) in the first study (JRV 304) and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(1g q8h iv) in the second study (JRV 305); however, in both studies vancomycin (1g q12h iv) could be substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42035FD4-F504-4E31-BE05-66C9A2B24E0C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <domeo:uuid>42035FD4-F504-4E31-BE05-66C9A2B24E0C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>cefazolin </ao:exact>
    <pav:createdOn>2014-07-14 13:52:32 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A3F493D-D5D9-42DA-93A9-044EECCA06FE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CBE82BD6-3D80-4EA4-A8C0-F9D242A9DC3D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DB9D9E00-DFD4-4A75-B2EA-B98E8D4E08C1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F997B91A-ADF6-4AD0-BC5A-6BB52A35147D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F997B91A-ADF6-4AD0-BC5A-6BB52A35147D"/>
    <pav:createdOn>2014-07-14 15:19:38 -0400</pav:createdOn>
    <ao:suffix> tablets should be taken shortly after a meal or light snack. Symptomatic relief may be seen during the first week, with optimal antidepressant effects typically evident within two weeks. Twenty-five percent of those who respond to trazodone require more</ao:suffix>
    <ao:prefix>e should be initiated at a low level and increased gradually, noting the clinical response and any evidence of intolerance. Occurrence of drowsiness may require the administration of a major portion of the daily dose at bedtime or a reduction of dosage. </ao:prefix>
    <domeo:uuid>F997B91A-ADF6-4AD0-BC5A-6BB52A35147D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Trazodone hydrochloride</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A34FB7D9-5215-46FC-9058-F443376565D1">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:41939ED2-CEA5-43F8-9BBA-2834749FC3FD"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7E7C29E-500F-4496-B978-B8D495F0825D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 21:05:08 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:hasSource>
    <domeo:uuid>D7E7C29E-500F-4496-B978-B8D495F0825D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7E7C29E-500F-4496-B978-B8D495F0825D"/>
    <ao:exact>Concomitant administration of fluvastatin (40 mg) and itraconazole (100 mg daily x 4 days) does not affect plasma itraconazole or fluvastatin levels</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A245DCDD-E95F-4384-B2F2-DEB4EAE21633">
    <pav:previousVersion>urn:domeoserver:annotationset:FEB3E9B5-ED30-4613-B974-43E5FEDE6BD0</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 16:01:07 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdOn>2014-07-14 16:01:09 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C36F1196-8714-4AB2-9ECF-693909AC4882"/>
    <ao:body rdf:nodeID="Nacddcbea03f6463ebdb5e7d6d130191b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:526026F3-4929-4F0D-B47C-30290D932427">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6FF24A2B-6FD8-4229-A576-9E9C82C2CC47"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E6EA8111-0DC2-4CA6-A00A-591BB946CDB3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD646070-415D-4D07-BF43-60EE661A0C33">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2F7EEDA-1E3B-4EDB-9900-BF1CB6A77ACF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8082DF4D-66CB-496A-A4D4-4AD47A172468"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B172284-1159-409B-8B5C-BF683FC8ED29">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:66989149-6046-43D5-B767-424E2541CB6E"/>
    <ao:body rdf:nodeID="Nea15e5b3f76c476ab2d07f31f4f99e14"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:28:04 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEA07018-7826-4E16-906F-E9BC5F67F0B7">
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BEA07018-7826-4E16-906F-E9BC5F67F0B7"/>
    <domeo:uuid>BEA07018-7826-4E16-906F-E9BC5F67F0B7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 20:37:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38CB4DE2-2AAB-4EEA-B57F-C6E19E8E570F">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:475DA2FE-928A-4FC5-8BF1-461E941EB8A4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:26:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA708CC1-40BC-4D59-AB45-DAD9F78EDB2D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N23839800323844e08b03916856119ea0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:72896ED1-53B7-4FF8-98B1-ACE47FAF1282</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:50448212-D6D7-4F1B-B1CC-FAB32C6E6056</pav:lineageUri>
    <pav:createdOn>2014-07-20 23:13:14 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1CCA8839-937C-41A8-A4EB-A0C5BCB1F668"/>
    <pav:lastSavedOn>2014-07-20 23:13:27 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:113E0FF8-269E-46B2-88C3-27D56B7CB970">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:16AF6B78-9915-4978-BA10-0534B7220A56</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:51:13 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C38D46E9-3AB5-4FA0-B3D5-841EE205AD28</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:50:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5E2469D-E6D0-484F-8BD4-5D020C870923"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:255EA68B-F450-41F7-87DE-639FBD806F13">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:255EA68B-F450-41F7-87DE-639FBD806F13"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 21:56:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>255EA68B-F450-41F7-87DE-639FBD806F13</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F610AB14-FAD2-4F3A-862C-0B9DA946ED85">
    <ao:context rdf:resource="urn:domeoclient:uuid:ACF80F3F-F2DA-4EF5-9569-3CFF202441BE"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:10:41 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:6AB37813-01F0-4BA3-B451-66A285E088B8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3E6782C-4CBB-4B80-BC69-BEFADA6301A7">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EA113A4C-9E62-4E18-A11E-423B3714DFB2"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77B38702-1D76-480C-B0B1-B21475D8164C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:05:48 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E309DB08-9A92-4488-B8ED-46C4A893633C"/>
    <ao:body rdf:nodeID="N2e1d01f6cbaf4eec8c3d6094c69f9238"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:315CD54F-838F-4C83-A20D-2F4DA62C2F37</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:06:38 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:1353EFCE-C5CB-4CE7-9955-93F35EC83D57">
    <pav:lineageUri>urn:domeoserver:annotationset:910d81dd-ca06-45c6-b40e-2d1d4638a212</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <permissions:permissions rdf:nodeID="N765f970e9eb24c1fb852d0c19141c370"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-199.txt.html</ao:annotatesResource>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:04:30 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:2877917d-6e6b-4ef6-948a-2664257f611d</pav:previousVersion>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C0BEB2E3-B860-4F17-9C62-F823B89F9948"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/4b726c55-6b2f-4746-a732-02879c92a7bf"/>
    <pav:createdOn>2014-07-07 08:09:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8CF5EBE9-69EE-4D30-BD8E-0DB53AA98915">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:63E79435-4988-4364-8897-B91CCDEDCA6A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8C5B6F2A-C8EE-4A82-B56B-000EE8CC013E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2C4B106-E756-47B2-84EF-9A6E459BC308"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89A88D98-1294-4F80-A248-88FC6CE69FC2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:36:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:277781DF-85C1-434F-8169-5C213EF16172"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:37:20 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:1B2D1CB1-AF4A-4392-B9F9-E4972994FD93</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B6CDF27C-DC05-493D-9C83-D1BA7D50260F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C64610CC-A0C0-45CA-A872-B67AC5497E43">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:79659A32-2EE7-403B-8B6C-54B98F28E027</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:14AC6BA0-DAE6-4647-8E16-2C610521F939"/>
    <ao:body rdf:nodeID="N542ef07d8520468aba7e305e324b03ea"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:21:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">21</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:21:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF145074-B0D2-4898-914E-DE96D5E2F3B3">
    <ao:body rdf:nodeID="N5367d44d73484a3898375bc988991f41"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:22:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:34B0CD03-6104-466C-8733-06115032AD32</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 21:22:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4FF1273-AA82-4906-919B-425ECBAD5DF2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABDD3FF1-CCBC-447B-AB65-DB9167759343">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N66e088b537f54c719a5e08f7a6a43d02"/>
    <pav:createdOn>2014-07-20 21:25:05 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 21:25:23 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:47b96dd3-a21e-47cc-b7ee-3de367a95ec8</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8174B810-E408-49FB-BA8C-C21B362AF392</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:102CC1DC-7EAC-4823-A679-CA0023AEB5B7"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E4913095-2654-4B02-A3A9-5C6C91A87EBF</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26ECEC8C-6E12-4D2E-B551-405BFF824207">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 00:24:10 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:865FF816-F198-4824-B5ED-629F2B0C7EEC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99E269C8-B4FC-4C25-9656-24B8639B4E3D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>99E269C8-B4FC-4C25-9656-24B8639B4E3D</domeo:uuid>
    <pav:createdOn>2014-07-14 15:43:07 -0400</pav:createdOn>
    <ao:prefix>with concomitant hematologic and gastrointestinal toxicity have been observed with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>methotrexate</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:99E269C8-B4FC-4C25-9656-24B8639B4E3D"/>
    <ao:suffix>. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82163860-C957-475F-86C9-1232D0DE8CFF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclid</ao:suffix>
    <domeo:uuid>82163860-C957-475F-86C9-1232D0DE8CFF</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82163860-C957-475F-86C9-1232D0DE8CFF"/>
    <pav:createdOn>2014-07-14 00:08:38 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:exact>paroxetine </ao:exact>
    <ao:prefix>Daily oral dosing of immediate-release </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8502D74D-66FB-43A8-ADAB-4275537B2C81">
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09B8A373-C6AA-4951-A8D2-F7AE5D696B36">
    <pav:lineageUri>urn:domeoserver:annotationset:FC056A21-615F-44B8-8E1B-A2A2E8DCB977</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:39:30 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:39:28 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N4da253f9c6f34350bf0283171afd03f8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3B0FF3DD-F960-4681-B093-071C65493026"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B972E3FA-7CD1-4B9E-855F-A6D78A080560">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/40DA3D3F-0BF9-4A34-85C9-CB703565E2F2">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:161CCA94-9344-419F-88FE-0FFF2CBB66A0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:161CCA94-9344-419F-88FE-0FFF2CBB66A0"/>
    <ao:prefix>is 90%, and that of its major metabolite, </ao:prefix>
    <pav:createdOn>2014-07-14 15:55:12 -0400</pav:createdOn>
    <domeo:uuid>161CCA94-9344-419F-88FE-0FFF2CBB66A0</domeo:uuid>
    <ao:exact>9-hydroxyrisperidon</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>e, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in t</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne0d716ccdf6448878a60c9bdd7135ae7">
    <domeo:sets rdf:resource="urn:pddi:uuid:AD5BDFD5-73D5-441E-AC12-865C5D80E7A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB901F0D-0D81-48D5-9F32-5A7B3784E342">
    <ao:prefix> and </ao:prefix>
    <ao:suffix> half-life and AUC in patients with impaired renal function (n = 14) following a single 200 mg oral dose (Table 7). Plasma concentrations of AMT were not determined. A dose adjustment should not be necessary for patients with </ao:suffix>
    <domeo:uuid>BB901F0D-0D81-48D5-9F32-5A7B3784E342</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:47:17 -0400</pav:createdOn>
    <ao:exact>GZDV</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB901F0D-0D81-48D5-9F32-5A7B3784E342"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1871BB3-1B3F-4173-A606-3843483F8AAE">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N2933d702d6a642c4a474fdd2c7970ef6"/>
    <pav:createdOn>2014-07-20 22:06:36 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D91A70B2-C642-47C9-8D81-05052F37F9E3</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FF2581E-3442-43CB-AE3F-F76A262F8BDD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:06:38 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A087E78-389B-4C1E-BE4A-2FEFCD234583">
    <ao:body rdf:nodeID="Nd1751ec5c8694828a93bb4edd0da13b2"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A04A4921-2A3C-45F3-AC1B-B3AC14630075"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:05:59 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:06:00 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/03687b20-0313-4307-8a9e-7154e2367b29">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC4BE7C9-BF81-424F-84EF-295509BA81F3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d5975122-3a09-47fd-8229-08ca67318591</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3e5ad90c-37fb-4eae-983e-46f0fa9638b2"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:08:53 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38067FFD-3631-467F-B88A-13472691F76E">
    <pav:createdOn>2014-07-20 20:04:29 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Experimental evidence demonstrated that methadone increased the area under the concentration-time curve (AUC) of zidovudine which could result in toxic effects</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-199.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>38067FFD-3631-467F-B88A-13472691F76E</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38067FFD-3631-467F-B88A-13472691F76E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:625339B0-E33C-4275-B545-10EB2041FE72">
    <ao:prefix>ted above baseline throughout the trials. In contrast, HDL continued to rise over time. As a result, the LDL/HDL ratio peaked after 2 months of therapy and then appeared to decrease over time. Because of the temporal nature of lipid changes, the 52-week </ao:prefix>
    <pav:createdOn>2014-07-14 14:11:02 -0400</pav:createdOn>
    <ao:suffix>-controlled study is most pertinent to assess long-term effects on lipids. At baseline, week 26, and week 52, mean LDL/HDL ratios were 3.1, 3.2, and 3.0, respectively, for AVANDIA 4 mg twice daily. The corresponding values for glyburide were 3.2, 3.1, an</ao:suffix>
    <domeo:uuid>625339B0-E33C-4275-B545-10EB2041FE72</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:625339B0-E33C-4275-B545-10EB2041FE72"/>
    <ao:exact>glyburide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CCDB9DFF-54C5-4FDD-AA1D-77E1E4826197">
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E071D1FC-20CD-4D09-B79E-A18C918F0469">
    <ao:suffix> and norpropafenone metabolites have electrophysiologic properties similar to </ao:suffix>
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:prefix>The </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E071D1FC-20CD-4D09-B79E-A18C918F0469"/>
    <pav:createdOn>2014-07-20 20:22:37 -0400</pav:createdOn>
    <domeo:uuid>E071D1FC-20CD-4D09-B79E-A18C918F0469</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9A3C7EA5-81A2-4747-9EC7-7790912C3041">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <rdfs:label>metoclopramide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:707031EA-7C19-401C-BBCC-48A2AB5E98C0">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:1F706A03-A24F-4C5B-B78E-4C3F58FD1BDA</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:468A1229-A665-4082-AB69-A7A95E79DC1F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:17:31 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:17:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2BBFE57-E0B3-43DA-81C2-3092EBC29667">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7B10A6D9-A218-4814-932F-F9FDB15DE4A0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEC64962-88E1-47B5-B8E1-47C8ED38FB33">
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of </ao:prefix>
    <domeo:uuid>EEC64962-88E1-47B5-B8E1-47C8ED38FB33</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEC64962-88E1-47B5-B8E1-47C8ED38FB33"/>
    <ao:suffix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <pav:createdOn>2014-07-13 15:54:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E87D07CB-7EA1-44C2-B67C-79CB3E3A3EF9">
    <pav:lastSavedOn>2014-07-14 15:08:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:3F482EC3-1EC0-4591-9CE4-4E8266FEEA69</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4D292309-71E0-4BA8-8148-F090CE174BF1</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:07:06 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BC7FA80F-0DC3-497A-96E9-C184DEC52643"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB793394-CF03-4F57-852F-2CE4B147A90B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:64B0AF47-31CD-4E26-8EC8-498E258CC22C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:7dc69d20-4aed-4c9f-9940-a84a04c16b52</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nd849945786f34cd6ab4fc70f7b44326b"/>
    <pav:createdOn>2014-07-20 21:37:58 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:8956d2da-97db-4647-82f8-34399e891814</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 21:38:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4721B9D4-2D04-4C39-9021-EAACA3631195"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1BEE739F-C465-4D59-950F-BBD38CD4D344">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/55A7764D-FFA7-46CB-86D7-34D93356BF36"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/42D79F9E-1F0E-423B-B507-620DF8808840"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E49A2FF1-3433-401B-BC4C-02CCC11D74A4">
    <pav:lineageUri>urn:domeoserver:annotationset:2D777024-2DDB-4A9A-82E1-35FC9F145C19</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A9F3111-7009-4BED-AB9C-093B5D4772BC"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:42:57 -0400</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-14 15:43:08 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:64ED2B68-620C-43AB-8558-FA289B16069E"/>
    <permissions:permissions rdf:nodeID="N863a31e9e7ba440183166d1f240f501e"/>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AD3DA61-6FAA-4BFF-B81D-32F29A568B10"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F42DB7E3-2384-440A-A103-1C9D3D952062"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6F38620-50D4-4687-B3AE-CCED6536A591">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-20 20:48:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C09A520-E13B-4BDC-91AE-DCD8B50E4EBA"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D4AF08F6-86FC-4B37-8629-C8D6EDCE95E4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:48:09 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC64C9D4-D56B-452A-813C-E1D9FAE070C1">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC64C9D4-D56B-452A-813C-E1D9FAE070C1"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>has been demonstrated in animal models of type 2 diabetes in which hyperglycemia and/or impaired glucose tolerance is a consequence of insulin resistance in target tissues. Rosiglitazone reduces blood glucose concentrations and reduces hyperinsulinemia i</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Insulin resistance is a common feature characterizing the pathogenesis of type 2 diabetes. The antidiabetic activity of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>CC64C9D4-D56B-452A-813C-E1D9FAE070C1</domeo:uuid>
    <pav:createdOn>2014-07-14 14:07:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/b7910d8b-c30e-4bcc-9b91-04acc5f01d22">
    <pav:lastSavedOn>2014-07-07 08:08:48 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7dcd014b-3d57-48c7-9d18-a2b902f5087b"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:56608c00-757d-4238-aeae-e22c3322344b</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA4D6F29-F235-4592-88ED-21FD2B7D3E1E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD0BF603-5ECF-4DED-BCDD-8E6064A9FB9C">
    <ao:prefix>in healthy volunteers. These results suggest that the absorption of oral </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD0BF603-5ECF-4DED-BCDD-8E6064A9FB9C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DD0BF603-5ECF-4DED-BCDD-8E6064A9FB9C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>is not altered in conditions accompanied by increases in gastrointestinal pH.</ao:suffix>
    <ao:exact>rosiglitazone </ao:exact>
    <pav:createdOn>2014-07-14 14:47:46 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C3C2FC6-9B5D-4540-A8AC-95984897F9F7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:86DFD58D-9AC9-48B9-A8FF-24D88A8C1436</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:09:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BF64C85-A3D3-447B-B78D-B19FFFF57D80"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 20:09:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E1986ECE-7BE0-47FD-AD80-436D88618757</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N3b49022c53ec42b4adbc277585506e60"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56F44DD3-0A66-4A1F-9EA5-32F07BA718E5">
    <domeo:uuid>56F44DD3-0A66-4A1F-9EA5-32F07BA718E5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56F44DD3-0A66-4A1F-9EA5-32F07BA718E5"/>
    <pav:createdOn>2014-07-14 16:01:45 -0400</pav:createdOn>
    <ao:prefix>plus </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:cff4f855-553a-4ab7-b3dd-40ee90a09bd2">
    <ao:exact>nifedipine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 08:09:08 -0400</pav:createdOn>
    <ao:suffix> in the presence of cimetidine</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:cff4f855-553a-4ab7-b3dd-40ee90a09bd2"/>
    <ao:prefix>metidine. The Cmax values of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3740B38-EEB8-4BED-96FC-65982B563AFC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3740B38-EEB8-4BED-96FC-65982B563AFC"/>
    <domeo:uuid>D3740B38-EEB8-4BED-96FC-65982B563AFC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:42:17 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:prefix>or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>have been used to treat severe reactions, with the addition of intravenous chlorpromazine in those cases exhibiting hypertension and hyperpyrexia. The usefulness and safety of narcotic antagonists in the treatment of these reactions is unknown.)</ao:suffix>
    <ao:exact>prednisolone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3012FD39-24D7-49F8-95F1-4D55E546E46D">
    <pav:lastSavedOn>2014-07-20 20:58:11 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdOn>2014-07-20 20:58:02 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:188066D2-D8DF-41BA-8D27-20EBE6CC91EC</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2E87E36F-1E46-4449-B5E6-24C6748D28B7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FA21F32-D373-4CF9-ADFC-31F76BED0A67">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>4FA21F32-D373-4CF9-ADFC-31F76BED0A67</domeo:uuid>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:01:48 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FA21F32-D373-4CF9-ADFC-31F76BED0A67"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1bcf27e5-2e7e-4306-a122-b1fd4e34764c">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:72896ED1-53B7-4FF8-98B1-ACE47FAF1282</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:09:00 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:09:00 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:04ccfbeb-b000-4a55-a4fa-a9d92008534b"/>
    <pav:lineageUri>urn:domeoserver:annotationset:13109ea8-1007-4b31-81f8-43d48ede873c</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C02DFCCC-9726-44BD-8697-1228625232F8">
    <ao:suffix>. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>C02DFCCC-9726-44BD-8697-1228625232F8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C02DFCCC-9726-44BD-8697-1228625232F8"/>
    <ao:exact>indinavir</ao:exact>
    <pav:createdOn>2014-07-14 15:12:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E77167B9-73C0-4DD8-967D-A44399BB9F06">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/100A9E92-F267-47F8-8748-743E8EE01276"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6D09FECA-282C-4811-95D2-78A4C3D2CEA8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/545051f6-2efe-4d5a-bac3-a97ee5d29585">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4F4757D4-A915-4B00-A8C6-82EA8D7F5519</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9c28ff79-d540-4c8b-8c3d-158f705a60b2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7ad52825-94f0-471d-9071-5f85d8c8df4e</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 08:09:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ACB7E01C-061A-4238-9522-CEDC267166F6">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1C793FA1-2DFF-4B22-845B-6425AF123C01"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:615B32D2-20A2-4C4F-BA0C-590A35006E47">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:615B32D2-20A2-4C4F-BA0C-590A35006E47"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compar</ao:suffix>
    <pav:createdOn>2014-07-13 14:49:33 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>615B32D2-20A2-4C4F-BA0C-590A35006E47</domeo:uuid>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:prefix> compared to similar placebo dosing. The mean AUCs of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5405B241-3FC8-4552-99D5-456F4EEE2F8B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4BFA045F-3B46-4F1E-879D-D490C5E15214"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5AB35BA-4B97-4F14-97F9-6E876D419EE4">
    <rdfs:label>lovastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6472</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ECCCCFB0-A5B6-4713-808D-F519ABC2ED7F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>nitrofurantoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7454</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A870C365-8C19-4306-AC88-4894594AFEC6">
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-14 00:19:06 -0400</pav:createdOn>
    <ao:suffix>, but quinidine does not alter the kinetics of diltiazem.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>significantly decreases the clearance and increases the t1/2 of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A870C365-8C19-4306-AC88-4894594AFEC6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:exact>quinidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CAF6513-973A-4443-A0D0-3B06DC7D7034">
    <domeo:uuid>0CAF6513-973A-4443-A0D0-3B06DC7D7034</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0CAF6513-973A-4443-A0D0-3B06DC7D7034"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:36:20 -0400</pav:createdOn>
    <ao:prefix>and its metabolite, </ao:prefix>
    <ao:exact>normeperidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <ao:suffix>, may be increased by acyclovir, thus caution should be used with concomitant administration.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:594745C0-2398-42CD-9D5F-73771B352E35">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C7655B01-FEB6-4246-B058-700294CFE31B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:43:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7E95BDA-456E-448B-90CA-98BC7E00471A">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:0AAA96B2-F8F3-42CA-9919-D8791FDD3499"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdOn>2014-07-20 20:57:09 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Ncad9e603157743999aec11e9f0afb176"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:4AB9EFB2-30A6-44BD-90C3-6951D971D64F</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:57:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BB71E2C-9151-4B2C-AFD1-E9B1B54CA1E1">
    <ao:exact>In 4 patients, administration of metoprolol with propafenone increased the metoprolol plasma concentrations at steady state by 100-400%</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4BB71E2C-9151-4B2C-AFD1-E9B1B54CA1E1"/>
    <ao:suffix>. The pharmacokinetics of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:42:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>4BB71E2C-9151-4B2C-AFD1-E9B1B54CA1E1</domeo:uuid>
    <ao:prefix>. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FEF31AFC-1AB3-45EC-A79F-0519A5C004AC">
    <pav:createdOn>2014-07-20 22:01:19 -0400</pav:createdOn>
    <domeo:uuid>FEF31AFC-1AB3-45EC-A79F-0519A5C004AC</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FEF31AFC-1AB3-45EC-A79F-0519A5C004AC"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71AAB634-BDBC-40EC-A82C-C08EED1A2122">
    <pav:createdOn>2014-07-14 16:07:09 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, wi</ao:suffix>
    <domeo:uuid>71AAB634-BDBC-40EC-A82C-C08EED1A2122</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71AAB634-BDBC-40EC-A82C-C08EED1A2122"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix>was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E10C4B4-CF29-40DD-A054-507F791D2E26">
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2E10C4B4-CF29-40DD-A054-507F791D2E26"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:58:36 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <domeo:uuid>2E10C4B4-CF29-40DD-A054-507F791D2E26</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70199B63-618E-4F0B-B2BF-F39B1B449269">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B164D2E1-3E27-4390-9268-95C1A89A328A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D33C77EA-D41A-4970-8A53-217A26462C9B">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBA6A223-96BD-43E6-8FA8-1E6B9A988244">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EBA6A223-96BD-43E6-8FA8-1E6B9A988244"/>
    <domeo:uuid>EBA6A223-96BD-43E6-8FA8-1E6B9A988244</domeo:uuid>
    <pav:createdOn>2014-07-14 14:11:10 -0400</pav:createdOn>
    <ao:prefix>-controlled study is most pertinent to assess long-term effects on lipids. At baseline, week 26, and week 52, mean LDL/HDL ratios were 3.1, 3.2, and 3.0, respectively, for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>4 mg twice daily. The corresponding values for glyburide were 3.2, 3.1, and 2.9. The differences in change from baseline between AVANDIA and glyburide at week 52 were statistically significant.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5D50B11-E540-43F7-AD00-01F9109C8870">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E5D50B11-E540-43F7-AD00-01F9109C8870"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 21:59:02 -0400</pav:createdOn>
    <domeo:uuid>E5D50B11-E540-43F7-AD00-01F9109C8870</domeo:uuid>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/72635375-D69A-49A5-87A1-CAC337245FF6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F90242F8-094E-45F6-97EF-A95FD7C31B2B">
    <ao:exact>AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F90242F8-094E-45F6-97EF-A95FD7C31B2B"/>
    <domeo:uuid>F90242F8-094E-45F6-97EF-A95FD7C31B2B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 14:26:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08FF2C42-9920-45DA-A215-F6C143AE525D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:08FF2C42-9920-45DA-A215-F6C143AE525D"/>
    <ao:exact>trazodone </ao:exact>
    <ao:prefix>reduced plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-07-14 15:17:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>08FF2C42-9920-45DA-A215-F6C143AE525D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:740BE9BF-079B-434B-A7CE-DB1241AC5C51">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A87CD883-8C2E-456D-9F84-A2BE8C243FA4"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 11:07:44 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ED43869C-D208-4E1F-8C4C-F89CEBB3137C">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0455A7F-96B6-4209-AABD-FA22BB6B5907">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8B2EB96C-F4AD-441F-9F44-0D0160AB092A"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:02:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3B4CE15B-D026-4910-88C7-4C6897125F6B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rifampin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44AC7B14-15B3-4219-8906-379A35F61CEF">
    <domeo:uuid>44AC7B14-15B3-4219-8906-379A35F61CEF</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:44AC7B14-15B3-4219-8906-379A35F61CEF"/>
    <pav:createdOn>2014-07-20 21:57:17 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D13EEBF-6744-4949-89CE-47AD2806435E">
    <ao:exact>Phenytoin AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8D13EEBF-6744-4949-89CE-47AD2806435E"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:suffix>. The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of</ao:suffix>
    <pav:createdOn>2014-07-13 16:05:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8D13EEBF-6744-4949-89CE-47AD2806435E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E743095-492B-413E-ACD5-5890ED7190FF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 21:58:20 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:body rdf:nodeID="Ndef4eba659bf468abf6cb171ba970895"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED1D9799-1C19-467A-AB21-070D2CD81BCC"/>
    <pav:lastSavedOn>2014-07-20 21:58:22 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:0D9DD421-A8FE-400F-8177-B36F3FFB880C</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A13E9935-F0E6-4CA1-8840-A95120AD10BF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>VAPRISOL</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A14E08F0-BF86-4EB3-9B2B-1B46D3BF71FF">
    <ao:context rdf:resource="urn:domeoclient:uuid:423A0B64-88FB-4E01-A630-2DAE02100296"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N64a80a0cff084384905dd430462a15b8"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:27:46 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 00:27:49 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:9C400943-E000-46E8-B34F-E49C63D87F11</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5EC9986C-FF4A-44D3-983F-404983FDCCB7">
    <ao:exact>VAPRISOL 30 mg/day resulted in a 3-fold increase in the AUC of simvastatin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5EC9986C-FF4A-44D3-983F-404983FDCCB7"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 22:59:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>5EC9986C-FF4A-44D3-983F-404983FDCCB7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:885098EE-12EB-405C-B70A-661E8D02785F">
    <ao:exact>fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:885098EE-12EB-405C-B70A-661E8D02785F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:23:59 -0400</pav:createdOn>
    <ao:prefix>has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of </ao:prefix>
    <domeo:uuid>885098EE-12EB-405C-B70A-661E8D02785F</domeo:uuid>
    <ao:suffix>. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythro</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:685C5022-D3B6-4E6E-BBE0-FCDDC2C0B199">
    <ao:suffix>(4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <pav:createdOn>2014-07-14 14:23:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>685C5022-D3B6-4E6E-BBE0-FCDDC2C0B199</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:685C5022-D3B6-4E6E-BBE0-FCDDC2C0B199"/>
    <ao:prefix>. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>AVANDIA </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DEE22A2-CE94-48E7-8F18-7E31D556F66B">
    <ao:exact>GZDV</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1DEE22A2-CE94-48E7-8F18-7E31D556F66B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:46:26 -0400</pav:createdOn>
    <domeo:uuid>1DEE22A2-CE94-48E7-8F18-7E31D556F66B</domeo:uuid>
    <ao:suffix> accounts for 14% and 74%, respectively, of the dose following oral administration. A second metabolite, 3'-amino-3'-deoxythymidine (AMT), has been identified in the plasma following single-dose intravenous (IV) administration of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/190988b9-4287-4093-8df5-f94d8b89cd26">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:e17d8d63-b009-4463-827b-f6bbf67ddbfd</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4febcca7-67fe-4408-9515-214a0dcf92b5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 08:09:12 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ADA754D7-8F98-4A1B-A03A-7494BA24B16A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:316C1128-C3FD-4C92-B42D-A1C6EFB607A3">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:421A6913-51A7-43BE-B7F8-F95085E33887"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:314A9916-550D-4E1C-8B93-378A6818577A">
    <ao:body rdf:nodeID="N212e354c6ff64cdbba1a13a8b78e0261"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">16</pav:versionNumber>
    <pav:createdOn>2014-07-20 22:03:23 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:03:25 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7AF5C47F-9B5F-4E72-B146-F4CEA1051891</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:6ABEE6C3-D942-4DE8-92B1-88B439CECB7A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:4F4757D4-A915-4B00-A8C6-82EA8D7F5519">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E61F10B7-ECE5-478C-820C-2B2BE650E32D</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:4AB0B7AA-F6AE-4D4B-9D5B-567017B8A381"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4DAE6E63-AB8A-4646-AF5D-118E6D05F6CC"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:28:01 -0400</pav:lastSavedOn>
    <rdfs:label>NER Sets</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/545051f6-2efe-4d5a-bac3-a97ee5d29585"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7ad52825-94f0-471d-9071-5f85d8c8df4e</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <permissions:permissions rdf:nodeID="N0a997d57c8be4b85b4411b91651195c3"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A169EB2C-6279-470C-AE93-A636E8E48071">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:47:18 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:47:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:9b9adb60-a447-4aa7-82fc-e4bcf10dd788</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:12A214CB-57E6-4F1E-B26D-0BFA14AFAB94"/>
    <ao:body rdf:nodeID="N81de8813ea65411b930986a3392d12d9"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0E399497-ABC6-4278-8F3B-E80169F841A2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6F67B5E-C430-4E32-B343-5355CD86E7C6">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:67283516-D3C3-4CFB-9AE2-4A7ED9A0D37A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E4BBBE3C-98BA-4ED1-AABA-93616B3981E9">
    <rdfs:label>levonorgestrel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:317005E2-B178-4EE5-8B87-E087CA90B237">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 00:19:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 00:20:21 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E5124CEA-C04A-4D9B-9B25-05C1B044A10F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7082442F-ABFA-4F7D-BB51-7C8C3462D2DF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:933191E0-98FC-4AED-BE77-500BD2A1480E">
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 13:59:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:60D77858-A611-4115-8BB1-AF0CC9253AEE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:78166130-A78D-421F-9B32-479B0E71245F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1E018521-5500-4F78-B83E-587AE0D5B47B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/751AEBCC-3E27-4D39-A41B-553472BD7EBB"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DE9B7D01-343C-488A-8C0D-DB8926A4CC9F">
    <rdfs:label>fexofenadine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1923A71C-0141-44B5-B172-80119AF25734">
    <ao:context rdf:resource="urn:domeoclient:uuid:C9B292E1-8CFA-4E72-8F49-3149861E1CF6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:23:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C6D52A0-BA79-4D38-87DE-8E3E185A35CC">
    <pav:createdOn>2014-07-20 20:22:51 -0400</pav:createdOn>
    <ao:suffix> metabolite is usually present in concentrations less than 10% of </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C6D52A0-BA79-4D38-87DE-8E3E185A35CC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:exact>norpropafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1C6D52A0-BA79-4D38-87DE-8E3E185A35CC</domeo:uuid>
    <ao:prefix>. The </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:ACB34A20-F0B5-4EE4-ACC8-901687DDB0F2">
    <ao:item rdf:resource="urn:domeoclient:uuid:DD50B5C1-AAF3-4843-AA32-25D3162C15A5"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="Ncbaee63d72044c6b905027dcff2a8768"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1735D1B7-6087-457F-AB69-9E05760B11B3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:48f947b7-d42e-47e6-8189-3427ef2218dd</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 23:15:45 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/0acaf3df-3f9c-4010-969e-4d473d6e8621"/>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:f1865be7-6e65-4979-bd22-e0723730e86b</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8E7B7E36-55A8-4E47-B362-10871D883352"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/84DACE90-8C33-4696-B741-A48617B193E5">
    <rdfs:label>metoclopramide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/06B487BC-9C29-4A3A-93F9-5E9E2415AC2C">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>irbesartan</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/965D23DD-3DF3-4804-9EF4-8AC641751517">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD220006-465B-4E36-A6AA-489C88FBF033">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:48:25 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD220006-465B-4E36-A6AA-489C88FBF033"/>
    <domeo:uuid>CD220006-465B-4E36-A6AA-489C88FBF033</domeo:uuid>
    <ao:suffix> plasma concentrations. Apparent </ao:suffix>
    <ao:prefix>uated in a multiple-dose study in patients undergoing hemodialysis (n = 5) or peritoneal dialysis (n = 6) receiving escalating doses up to 200 mg 5 times daily for 8 weeks. Daily doses of 500 mg or less were well tolerated despite significantly elevated </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:669E920E-396B-462B-AC4D-481E8F50D445">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6287B469-D287-4523-8F3E-755BBDB6258A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FC056A21-615F-44B8-8E1B-A2A2E8DCB977</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:39:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:39:28 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:15A786B1-82C5-4059-A056-195138C3131F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1A864AE3-EA88-4E3D-BAD5-2178849B6589"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A745D949-FBDE-4D07-B202-0EAFED08A320"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:029E52B0-072A-4657-8D5C-91219EA7DAF1">
    <ao:exact>Zonisamide single dose pharmacokinetic parameters were not affected by cimetidine (300 mg four times a day for 12 days)</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 00:30:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:029E52B0-072A-4657-8D5C-91219EA7DAF1"/>
    <domeo:uuid>029E52B0-072A-4657-8D5C-91219EA7DAF1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BE7D582-CC4A-4D99-9DC7-5231BCE61355">
    <ao:prefix>have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given </ao:prefix>
    <domeo:uuid>0BE7D582-CC4A-4D99-9DC7-5231BCE61355</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0BE7D582-CC4A-4D99-9DC7-5231BCE61355"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma co</ao:suffix>
    <pav:createdOn>2014-07-14 16:03:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1C793FA1-2DFF-4B22-845B-6425AF123C01">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/91761C29-F59A-4EA4-AD3F-2E1447428677"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A94D80E8-FAFB-4F33-AAF3-DB15A4A94CD0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:474EA34E-2BB6-454D-AE7E-19E51623CA66">
    <pav:createdOn>2014-07-11 23:26:36 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:CAC67052-E9E2-4074-95C0-FE71AAB4C7EA</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N034a6bda9f8d43aaa246672ca7a5c778"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E400BFA4-1477-48B4-ADCF-6FB840BC64F4"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-11 23:26:37 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7B148F16-776F-4635-93A8-884E889701FD">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:29DA5432-AB0B-44DE-908F-9EE60E838A70"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3F4A0740-FAA6-4358-AD68-77F5941EBBC0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC1B284C-A4F7-4895-B220-F120536CCEE8">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BC1B284C-A4F7-4895-B220-F120536CCEE8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BC1B284C-A4F7-4895-B220-F120536CCEE8</domeo:uuid>
    <ao:prefix>. </ao:prefix>
    <pav:createdOn>2014-07-14 15:01:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AF466FE-03C5-4186-B5C7-A3A03F49AC7B">
    <ao:suffix>Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>8AF466FE-03C5-4186-B5C7-A3A03F49AC7B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AF466FE-03C5-4186-B5C7-A3A03F49AC7B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>AUC of 26% ± 9% (range: 12 to 39%). </ao:prefix>
    <ao:exact>Tolbutamide </ao:exact>
    <pav:createdOn>2014-07-14 00:07:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3DF3CE3-951D-40C8-8219-1C8563023350">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 20:52:41 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 20:52:42 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F07FEB25-225A-4C9A-A90C-03DF5A77406A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:15F4920F-9601-4833-A66A-C1EB497DFB21</pav:previousVersion>
    <ao:body rdf:nodeID="Nd5c8cf74585b465f9873bffa7049709e"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/41e998a2-2e13-4a72-8328-16f5f342d014">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:09:15 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6f528b43-e953-4f77-a06d-c893ede78645"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:484f7a0f-bd5e-4f5c-ba77-bd900650692d</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D2367BD-3A38-43EB-A3B0-C110E67D40FD">
    <pav:createdOn>2014-07-14 14:44:28 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:45:11 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">23</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:8A66A3C5-1E5E-4EBF-8342-14A271B60E81</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B71211C5-72A2-434C-9E59-DF72849DAADA"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5501a375535f4b8d90986e0b04d2d37f">
    <domeo:sets rdf:resource="urn:pddi:uuid:F35FBAAE-14A5-4DAF-A539-404D646A58D9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B374D320-B072-4709-B310-4445E70524F8">
    <ao:context rdf:resource="urn:domeoclient:uuid:17BA47FB-892D-4094-B47A-EA05DF25E13B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:02:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD8D5681-0F0C-4BD5-B8D9-00EE03F4A437">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD8D5681-0F0C-4BD5-B8D9-00EE03F4A437"/>
    <ao:suffix>could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone </ao:suffix>
    <ao:exact>Risperidone </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>CD8D5681-0F0C-4BD5-B8D9-00EE03F4A437</domeo:uuid>
    <pav:createdOn>2014-07-14 16:02:49 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4977430A-75B0-4EB8-B005-F04BD520C42B">
    <pav:createdOn>2014-07-14 14:11:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:30CF1F0C-3A8D-4951-8D5B-CA8DCC86029F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:112B1B73-DB37-4023-B62F-FF624A1BA519</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:11:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7B9D671-D81E-4459-B19A-4498ED40C220">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D7B9D671-D81E-4459-B19A-4498ED40C220</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:00:02 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7B9D671-D81E-4459-B19A-4498ED40C220"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EBF6B9D-30C7-425A-8E9E-B990CBABD166">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:FEC02606-5833-48BA-BFC1-C05F256F196C</pav:lineageUri>
    <pav:createdOn>2014-07-20 21:34:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:67EF6373-65E8-44B4-BC03-21748A973E3E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3ECBCEF7-04B5-404B-8B20-CB0BDF2CBAA8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-20 21:34:22 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F996471B-0832-4AFA-9958-6D0983523181">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D1D6680D-FD65-439F-BA94-5952BEE9EBB7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51255C4A-016D-4EC5-8FDD-638FE9C2A7E7">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DB35158-84F0-451C-81BE-632308DA163D"/>
    <pav:createdOn>2014-07-07 11:09:40 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02DCE132-9725-4F90-89A3-DB8B43187944">
    <pav:createdOn>2014-07-14 14:06:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:DAE71506-BABB-434A-83B9-CFB40FF24261"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:06:35 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3DC3A969-67F2-4B4B-B465-572111454443">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B82DA1FB-FA13-46A0-9259-E6B630A4F4E9"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7078FC9-80E4-46FF-A5E8-CF4E4C84DB04">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7078FC9-80E4-46FF-A5E8-CF4E4C84DB04"/>
    <domeo:uuid>B7078FC9-80E4-46FF-A5E8-CF4E4C84DB04</domeo:uuid>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <pav:createdOn>2014-07-14 16:03:46 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>and</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F21B02F9-EA1F-4306-BAA9-5C36738F8E06">
    <domeo:uuid>F21B02F9-EA1F-4306-BAA9-5C36738F8E06</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F21B02F9-EA1F-4306-BAA9-5C36738F8E06"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <pav:createdOn>2014-07-20 22:03:35 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BACEEB50-96DF-4265-8FFA-3D5717A1CD80">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>hydralazine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/49B90764-F0CD-4515-A756-3494FEF2D288">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>trazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N90ad41a4079e461bb1d5b1526e63fe56">
    <domeo:sets rdf:resource="urn:pddi:uuid:226D4AE3-0F57-4B88-82B5-27F44F535A40"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F702CD55-D36B-4937-B3A4-9A0D5F8D1E62">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 16:06:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:39ED9801-C6D0-4247-B111-2113B050FC35</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF3DC084-925C-44BB-A4C0-3BBC2F3488AB"/>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:269A1BD5-E6E1-445D-90A6-20780500924A">
    <pav:createdOn>2014-07-07 09:37:33 -0400</pav:createdOn>
    <ao:exact>Sildenafil</ao:exact>
    <ao:suffix>, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemi</ao:suffix>
    <ao:prefix>. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>269A1BD5-E6E1-445D-90A6-20780500924A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:269A1BD5-E6E1-445D-90A6-20780500924A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C51C6F7B-7A2F-4F4B-9664-90D777CC7343">
    <ao:exact>metronidazole</ao:exact>
    <pav:createdOn>2014-07-14 13:55:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(</ao:prefix>
    <ao:suffix>) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
    <domeo:uuid>C51C6F7B-7A2F-4F4B-9664-90D777CC7343</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C51C6F7B-7A2F-4F4B-9664-90D777CC7343"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA0108CB-7F76-4EFE-87DC-8F7E6E214712">
    <ao:exact>rosiglitazone</ao:exact>
    <domeo:uuid>DA0108CB-7F76-4EFE-87DC-8F7E6E214712</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 13:59:54 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DA0108CB-7F76-4EFE-87DC-8F7E6E214712"/>
    <ao:suffix>. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
    <ao:prefix>) may decrease the AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C21388FA-DEA8-4B20-9CBE-23E53F00CA45">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A39193A8-6C6E-4F3E-957F-A9D6F24E732E"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 23:59:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F40EE419-3A0B-40B1-A302-921CD072A58A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F40EE419-3A0B-40B1-A302-921CD072A58A</domeo:uuid>
    <pav:createdOn>2014-07-14 14:06:27 -0400</pav:createdOn>
    <ao:prefix> (</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>PPARγ</ao:exact>
    <ao:suffix>). In humans, PPAR receptors are found in key target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPARγ nuclear receptors regulates the transcription of insulin-responsive genes involved in the control of g</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F40EE419-3A0B-40B1-A302-921CD072A58A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEC79822-394E-4C36-B6DF-4C2632AFB381">
    <ao:suffix>, </ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BEC79822-394E-4C36-B6DF-4C2632AFB381"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:50:40 -0400</pav:createdOn>
    <ao:exact>Digitalis glycosides</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <domeo:uuid>BEC79822-394E-4C36-B6DF-4C2632AFB381</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D3B1F08-0157-4BB7-952C-27C84BE1CAEA">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8D3B1F08-0157-4BB7-952C-27C84BE1CAEA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:03:20 -0400</pav:createdOn>
    <domeo:uuid>8D3B1F08-0157-4BB7-952C-27C84BE1CAEA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCCFF116-9AF0-48F4-8DC7-635E3824156A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fluconazole</ao:exact>
    <domeo:uuid>DCCFF116-9AF0-48F4-8DC7-635E3824156A</domeo:uuid>
    <ao:suffix> half-life decreased from 33.4 ± 4.4 hours to 26.8 </ao:suffix>
    <pav:createdOn>2014-07-13 15:58:22 -0400</pav:createdOn>
    <ao:prefix> increased 32% ± 17% (range: 16 to 72%). </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DCCFF116-9AF0-48F4-8DC7-635E3824156A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E400BFA4-1477-48B4-ADCF-6FB840BC64F4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7F65C12-3365-45AB-AEA5-66B70722A017"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:474EA34E-2BB6-454D-AE7E-19E51623CA66</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-11 23:26:37 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-11 23:26:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D0F20321-6CD4-4621-89C0-0B272FD7DED7</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49059DD3-063E-440E-A478-00A3FD35C784">
    <pav:lastSavedOn>2014-07-14 14:16:05 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F661C953-C092-4CF9-A834-4064239448F2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C55DC5E6-47B5-44DB-9A36-ED918A3B1E40</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:15:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96288495-67AC-401A-B876-1DE6A3A49BA5">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:35:30 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:AF05284A-C6B1-44A2-A643-2F4CF94AC64C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:35:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:88352EB3-5DB8-47ED-8B33-617597299006"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37EFD623-A7A1-49CD-9469-F5C8F3A5CE0A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 23:54:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C5F7E373-46D9-4E9A-8DFB-7F22F3F61F19"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A441F1E-2DC6-402E-97CA-DE8DA2F93DE6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:11:11 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A441F1E-2DC6-402E-97CA-DE8DA2F93DE6"/>
    <ao:suffix>were 3.2, 3.1, and 2.9. The differences in change from baseline between AVANDIA and glyburide at week 52 were statistically significant.</ao:suffix>
    <ao:exact>glyburide </ao:exact>
    <ao:prefix>4 mg twice daily. The corresponding values for </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>4A441F1E-2DC6-402E-97CA-DE8DA2F93DE6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13205CB9-236A-4BA9-8CF4-CDD945EDDE07">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:13205CB9-236A-4BA9-8CF4-CDD945EDDE07"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>13205CB9-236A-4BA9-8CF4-CDD945EDDE07</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-131.txt.html</ao:hasSource>
    <ao:exact>Co-administration of cholestyramine or colestipol with propranolol resulted in up to 50% decrease in propranolol concentrations</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:04:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC9296A5-C566-49AE-BC1C-8A52E61ED7B2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC9296A5-C566-49AE-BC1C-8A52E61ED7B2"/>
    <ao:prefix>. The heart rate in the initial interval after drug administration was increased by up to 17.9 beats/minute. </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>The exposure to quinidine was not importantly changed in the presence of nifedipine</ao:exact>
    <pav:createdOn>2014-07-20 22:26:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:hasSource>
    <domeo:uuid>DC9296A5-C566-49AE-BC1C-8A52E61ED7B2</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/619CE452-7F19-4801-A2D1-9376A3FA2F9C">
    <rdfs:label>Cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E17E273-E5CB-4715-8F28-63527DD43E33">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E17E273-E5CB-4715-8F28-63527DD43E33"/>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The apparent half-life of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of 9-hydroxyrisperidone was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokineti</ao:suffix>
    <pav:createdOn>2014-07-14 16:07:02 -0400</pav:createdOn>
    <domeo:uuid>7E17E273-E5CB-4715-8F28-63527DD43E33</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB1485F2-066E-4648-9278-72F56EA2D34B">
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:25:08 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB625DCA-C79A-45A3-8935-EB4041F9E9C4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54B90F5C-1D92-4337-8EC1-596F87DA0671">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6652B5E8-DB94-44BC-AFD3-56D7E9801B35"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:21:19 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5C63E6B4-57F3-4DD0-B058-6040036328ED">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59E0E704-7AEB-447D-9026-0EF674096051">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 15:58:15 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E434D2F-EB71-47C1-AEE3-9486EF9EA0CB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26357DD6-B902-4E86-BFA6-ECE08DFF6F2C">
    <pav:lineageUri>urn:domeoserver:annotation:59216B6A-EBEE-47F6-AFC3-305CFE77B9E1</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6010B101-D502-4923-8C84-9A4A6BEE20D5</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8FC6211D-711C-444F-8347-D36CBB26F443"/>
    <pav:createdOn>2014-07-20 21:43:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 21:43:13 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Nf776f5ea6f6e47b782d386e888d22445"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6ED1B51A-5BBC-45C8-97C4-2CED36FE7F72">
    <pav:createdOn>2014-07-14 14:37:53 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nb9c2eba4a4f84605b7c88dd5db8aa8ba"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">21</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B071B771-088E-470A-8A36-C857D4744FE3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:37:56 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:8D9EE17A-6F8A-496A-B116-84BBA0F811AE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7655B01-FEB6-4246-B058-700294CFE31B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>on visual acuity, intraocular pressure, or pupillometry.</ao:suffix>
    <ao:prefix>-hue test, with peak effects near the time of peak plasma levels. This finding is consistent with the inhibition of PDE6, which is involved in phototransduction in the retina. An evaluation of visual function at doses up to 200 mg revealed no effects of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>REVATIO </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C7655B01-FEB6-4246-B058-700294CFE31B"/>
    <pav:createdOn>2014-07-07 09:43:15 -0400</pav:createdOn>
    <domeo:uuid>C7655B01-FEB6-4246-B058-700294CFE31B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1C07DDC3-EE07-4A3F-8C17-E728721FB56A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7ADD8893-9F56-44EC-840E-87F53C402E8C">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:34A7931A-D4A8-4215-B1E6-8B27A302ED43</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:C917B771-FB95-4A3D-B8B5-183FE4B30FF1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:35:38 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:35:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:18030AAA-03FC-4472-BF74-3E3DBAEA79D7">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B5ABA6C4-0D4C-40DD-A027-0B1E773C4B9B"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D59A49D7-1642-4596-BA9C-BE01E1851529">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D59A49D7-1642-4596-BA9C-BE01E1851529"/>
    <ao:exact>methotrexate</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Penicillins may reduce the renal clearance of </ao:prefix>
    <pav:createdOn>2014-07-14 15:42:57 -0400</pav:createdOn>
    <domeo:uuid>D59A49D7-1642-4596-BA9C-BE01E1851529</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FE0073A-9CEB-432B-BA69-8C35C7CF3119">
    <pav:createdOn>2014-07-14 14:48:58 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FE0073A-9CEB-432B-BA69-8C35C7CF3119"/>
    <ao:suffix>. These results suggest that the absorption of oral</ao:suffix>
    <ao:exact>Pretreatment with ranitidine (150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of rosiglitazone in healthy volunteers</ao:exact>
    <domeo:uuid>4FE0073A-9CEB-432B-BA69-8C35C7CF3119</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8228F109-6A70-4C8B-BCAB-741F4BD594E9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:36:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F4A56748-F5DC-4077-A548-565DC9DE900B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:37:20 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:1B2D1CB1-AF4A-4392-B9F9-E4972994FD93</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:106C15A5-3A73-4B7F-B2F9-96E7C834B7AF">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>In vitro drug metabolism studies reveal that trazodone is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir</ao:exact>
    <domeo:uuid>106C15A5-3A73-4B7F-B2F9-96E7C834B7AF</domeo:uuid>
    <pav:createdOn>2014-07-14 15:15:16 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:106C15A5-3A73-4B7F-B2F9-96E7C834B7AF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DAD668E7-4FE9-4E53-87DA-A40162094D4D">
    <ao:body rdf:nodeID="N4209c4790ff0455b9e16bc53bd59853e"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 15:55:44 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:19ED5691-8834-4E22-B743-CC7AE08C5F3B</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA1F5AD4-3F7F-4E4F-B64D-3D22AA1AAA18"/>
    <pav:lastSavedOn>2014-07-13 15:55:44 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2b815744-9c87-490d-8776-c23d89fb931c">
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2b815744-9c87-490d-8776-c23d89fb931c"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-39.txt.html</ao:hasSource>
    <ao:prefix>d when a patient was given a </ao:prefix>
    <ao:exact>phenothiazine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and a concomitant high dose o</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE993110-C132-4AEB-BCA5-4D904C479F52">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:39474525-6DD4-4D4B-B896-FF7EB694C667</pav:lineageUri>
    <ao:body rdf:nodeID="N301aca5e8c2e4aa18ec165f51285bf38"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B06ECAA-52F8-419F-A47B-2B99C705DFAF</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:30:03 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:029E52B0-072A-4657-8D5C-91219EA7DAF1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:30:03 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:96CF9CA3-B56C-4FFE-8C46-58FA48BE1F98">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BAB5BBB4-B6BC-42B8-8632-63348C417059"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5C9684F0-23C4-4F1E-B84C-9B4999A51318"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/97151C04-AE20-4C55-B504-7F805BCE8620">
    <rdfs:label>methadone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:806E7BF4-2821-4AD1-A0EA-EC4A8AC9EE3F">
    <pav:createdOn>2014-07-14 16:03:35 -0400</pav:createdOn>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>phenytoin</ao:exact>
    <ao:suffix>, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other </ao:suffix>
    <domeo:uuid>806E7BF4-2821-4AD1-A0EA-EC4A8AC9EE3F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:806E7BF4-2821-4AD1-A0EA-EC4A8AC9EE3F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:301B376B-CCC4-46DE-9B3B-27F8BD78F414">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:301B376B-CCC4-46DE-9B3B-27F8BD78F414"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Five subjects required oral glucose following the ingestion of</ao:suffix>
    <ao:exact>The AUC and Cmax of glyburide (5 mg single dose) were significantly increased following the administration of fluconazole in 20 normal male volunteers. There was a mean ± SD increase in AUC of 44% ± 29% (range: -13 to 115%) and Cmax increased 19% ± 19% (range: -23 to 62%)</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 23:17:19 -0400</pav:createdOn>
    <domeo:uuid>301B376B-CCC4-46DE-9B3B-27F8BD78F414</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BFEB82CF-CDE5-4E85-9B81-DC9BDD2A5563">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/42D5AEA7-A8A3-481F-BFBD-34546E0CA5FC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6904FF0B-3309-43D8-BDD0-7346C4FC4B5A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3956C85C-5ADE-4B49-853F-74AC124377EC">
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-07 11:16:41 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:495B7035-DC16-4E0D-930A-FD87EC2B6B87</pav:previousVersion>
    <ao:body rdf:nodeID="Nd86d468b84ec4eb5b5b18e7ba7658e46"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 11:16:37 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:706C81F6-D61C-4419-A495-0BDFE8E2F22B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEE1968C-30D8-4376-A0D9-107831DABF5A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CEE1968C-30D8-4376-A0D9-107831DABF5A"/>
    <ao:exact>The AUC of propafenone is increased by more than 200% by co-administration of propranolol</ao:exact>
    <pav:createdOn>2014-07-14 14:51:15 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CEE1968C-30D8-4376-A0D9-107831DABF5A</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:73B3FB5F-25C5-439F-BCD2-31E69052EA41">
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-20 21:05:28 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoclient:uuid:39d3a40c-8f2d-4bcc-bec4-d1f10e7f08af</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:84abe5ef-54b1-42df-9d7c-d832206dd6df</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:139B287C-D55A-466E-A2B3-446B35FF8A98"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/237818a2-f844-4ad9-9e0e-0168ac7bdfdd"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0CF6529-B457-4866-8946-0E9C63BFB4EA"/>
    <permissions:permissions rdf:nodeID="N782c06a6a69a49c9a8979e06ad465e56"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdOn>2014-07-07 08:09:04 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6C2CD101-32D2-45E8-8F3A-D793AD011D39">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E77167B9-73C0-4DD8-967D-A44399BB9F06"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDC90F44-144D-4B75-A9A7-977445775B68">
    <ao:suffix>. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:prefix>(500 mg single dose) AUC and Cmax following the administration of </ao:prefix>
    <pav:createdOn>2014-07-14 00:06:52 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FDC90F44-144D-4B75-A9A7-977445775B68"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FDC90F44-144D-4B75-A9A7-977445775B68</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82">
    <ao:item rdf:resource="urn:domeoclient:uuid:C2D86325-FD14-48B2-8242-A7EF820BB81D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE8C0E9F-FC4E-49FB-B707-2F0CB03FB060"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0F7756A-4E44-46AB-994A-694CB790B5E5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7C51B56B-3ED5-4D07-96A6-1858FE942795"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:88924AE7-7FDD-4FE3-B89A-5414BFA6907E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:909923E3-7362-4E33-B8B6-C455FD83097A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-13 14:58:45 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:90638CFD-3676-442F-A5C4-0C0D91A67C0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E90C922-200C-441C-B682-73453015A7E3"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:49FB6983-E51C-4611-BCBF-B8EE2F771B88"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3532DFFB-3D9C-4C29-8E95-67559D564F54"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <pav:previousVersion>urn:domeoserver:annotationset:AE71B236-7D11-4279-BB20-D56DE1B41E5E</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7657BFC0-26B2-4FF7-96A4-A1862BDF0E64"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23827F66-35D1-4DDB-8B41-2992CD55BA1D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B207B1E0-73C7-436A-A97E-15D9A6DF068D"/>
    <pav:createdOn>2014-07-13 14:48:52 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:D304B1FC-62B9-42D4-8705-B7235C5D2862"/>
    <permissions:permissions rdf:nodeID="Ndf2d1b8a02d64c33bec77e9ebbb42e63"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:4312A4DE-E052-44DE-B2A6-3786835D567F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DD0A32F-ECBB-4255-88EE-2AFF24578DA2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DF16459-E6DB-498D-9BF2-44EC35A17409">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:13:42 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3DF16459-E6DB-498D-9BF2-44EC35A17409"/>
    <ao:exact>Rosiglitazone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is extensively metabolized with no unchanged drug excreted in the urine. The major routes of metabolism were N-demethylation and hydroxylation, followed by conjugation with sulfate and glucuronic acid. All the circulating metabolites are considerably les</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>3DF16459-E6DB-498D-9BF2-44EC35A17409</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73892C75-68B3-40A7-B894-3766EFD48411">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:73892C75-68B3-40A7-B894-3766EFD48411"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 16:05:39 -0400</pav:createdOn>
    <domeo:uuid>73892C75-68B3-40A7-B894-3766EFD48411</domeo:uuid>
    <ao:exact>Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D23FE156-8323-4595-8D98-94FCE429BA33">
    <ao:body rdf:nodeID="Na4984cfbb11148429771595086e47c95"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:56:37 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F9815E44-1531-43E6-8C71-52B358B999C2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:4AB9EFB2-30A6-44BD-90C3-6951D971D64F</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 20:57:10 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FF65FC1-23D5-4F70-A676-40AACF45649D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C6AB17E9-F7F0-4949-B4EB-FE4BD6E7C995"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:616D08A3-417F-4D2C-A9D3-3DB98DED1F08</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:12:01 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:823AAEA7-7520-4C13-9619-19020FB47FCD">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:14:00 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:939183D2-85B4-42C3-B5A5-604CACF45D5D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CE009CE-9A28-417B-B003-33CDFDB4E8FF">
    <pav:lastSavedOn>2014-07-14 15:44:08 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-167.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:586A1A5A-2F81-4CCD-892E-FCD763AA2787"/>
    <pav:createdOn>2014-07-14 15:43:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:25311D1B-E6E5-4536-A718-44543B7E8CAC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N4b79c62cfa034843b7859f4ca63e26b8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:74EBC91E-D2D0-4BAF-B874-B14471DFFFF7</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A46CDB1D-9E27-4DEF-AEAA-DBA556467619">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9CBB97FE-955F-436E-A6E1-66ED994C5AB8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:05223ED7-E009-478C-9BB2-6EACF796798A">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:526026F3-4929-4F0D-B47C-30290D932427"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE7F178F-D344-411B-BAF8-9075ACE496DB">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEA4FAB9-BDD3-4A2F-B84F-C7727D1822D6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:32:14 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C174BCA4-061F-41B5-90F6-36B15766499B</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:31:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB712A50-FDAC-4F84-B611-70452F26DD55">
    <pav:lineageUri>urn:domeoserver:annotation:D6F921A5-81BC-4DEF-ABA0-615B5288972E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:09:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:68CEE9BB-A652-4D96-B365-474F2E117D8B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:09:17 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:87C87B25-2788-4E6F-A04F-27F5AF9D1A53</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FB1D2C56-B391-413A-A970-372953DCE4C1">
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:51:21 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E94D5B8-B48B-42EC-8C5F-24ABCB171116"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7532FA2-5D93-4CFB-98F8-38F38867DC13">
    <ao:suffix> or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7532FA2-5D93-4CFB-98F8-38F38867DC13"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E7532FA2-5D93-4CFB-98F8-38F38867DC13</domeo:uuid>
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl estradiol</ao:exact>
    <pav:createdOn>2014-07-13 14:37:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61726DE6-CCE8-4DFA-BA53-6657D2AE1361">
    <ao:body rdf:nodeID="N24199442850e4823a622b33a0a3ae19f"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <pav:createdOn>2014-07-20 21:59:50 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:08183A85-C165-41A8-BB91-6C70CFA02F7D</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D081B5F5-9045-4A1B-AD73-C9FCB9CD6FD8"/>
    <pav:lastSavedOn>2014-07-20 22:00:16 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nebb9de1a186b4f3e8a3f0963ecb9f7ca">
    <domeo:sets rdf:resource="urn:pddi:uuid:2E01D279-897A-4C29-BB74-37F9B70CA5FA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5FBFD379-47C3-4C8D-B6CE-90A4893F6723">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FCFAA28B-5D98-49DB-9753-32849F1AC225"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1eb27493-2522-4c5d-abb7-079b275e7f59">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:a12c625c-eafa-4490-bab9-a0b6a61b87f5</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C4E84CA0-FE12-4DA0-967D-F21854C66900</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:78e3cdd5-c0a7-467d-a0d8-fbf5bf7a9a59"/>
    <pav:lastSavedOn>2014-07-07 08:08:53 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3D23DB3-B709-4C8F-ABC8-C512BB4BBDF5">
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <ao:body rdf:nodeID="N03664362b0164e89adb2d328c325ebc3"/>
    <pav:previousVersion>urn:domeoserver:annotationset:FF36675E-FE40-4215-AC06-372FF3F86300</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8449CB7-E9F9-4DFF-8AEA-90C199A8BFED"/>
    <pav:createdOn>2014-07-20 22:20:25 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">19</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:20:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:77F8EC3D-E8BD-4D6A-A6D7-2C534926E795">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:annotatesResource>
    <rdfs:label>NER Sets</rdfs:label>
    <permissions:permissions rdf:nodeID="Ncc1eb7224e7141969ea248097132cd57"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-07 08:08:55 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5625800-8A35-40BE-870E-CD2162CBB36C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/4ad4f9b8-25d8-4206-ba7d-b95d7573abef"/>
    <pav:lastSavedOn>2014-07-20 23:17:25 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:017f0cd2-2813-4160-8b5c-a97457d091b4</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:6313da6f-9bb8-47f7-a5d8-44c6e6a53c76</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:692817DA-3EBC-4B27-8E08-0781E2438FA1">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0F5BEC69-11F5-4641-A571-CFBB9DDA6CC2"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14C82A0F-4B69-4123-8F37-CAFC568A4556">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:48:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:49:12 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:7A214A93-2426-48A1-B636-1337A2D9E56A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD220006-465B-4E36-A6AA-489C88FBF033"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19A7644F-0F40-49F8-B449-4B9D169980AC">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <ao:body rdf:nodeID="N2c0e7e8aee8647d3b03f69821bd043b0"/>
    <pav:createdOn>2014-07-14 15:24:16 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:934F1FB8-A872-4B6E-9A6D-DD0C3243B8A6"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E67B37A8-16A7-427C-AE7A-F0408136624C">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66F66C87-6ABB-422F-A3E3-5595EBB5DD0F">
    <ao:prefix>) enzyme and </ao:prefix>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66F66C87-6ABB-422F-A3E3-5595EBB5DD0F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:suffix>metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied</ao:suffix>
    <pav:createdOn>2014-07-14 15:12:34 -0400</pav:createdOn>
    <domeo:uuid>66F66C87-6ABB-422F-A3E3-5595EBB5DD0F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0eda3c4e94c544909c8814dc2787b5b9">
    <domeo:sets rdf:resource="urn:pddi:uuid:B176B227-B65D-45C6-BBB6-3653EC8509DC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:975886EB-57DD-4967-8136-0DA53B4B6335">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-14 15:52:49 -0400</pav:createdOn>
    <domeo:uuid>975886EB-57DD-4967-8136-0DA53B4B6335</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:975886EB-57DD-4967-8136-0DA53B4B6335"/>
    <ao:prefix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C26FC4D-EFE8-4072-AFA4-B47B9997E371">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:E7A007D4-E508-4D92-89D0-F683BC66E003</pav:lineageUri>
    <pav:createdOn>2014-07-13 14:37:47 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7532FA2-5D93-4CFB-98F8-38F38867DC13"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36A43FFC-CDD5-44E8-9521-7E09FE1B21F2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36A43FFC-CDD5-44E8-9521-7E09FE1B21F2"/>
    <ao:suffix>. Adverse effects including nausea, hypotension, and syncope were observed when</ao:suffix>
    <domeo:uuid>36A43FFC-CDD5-44E8-9521-7E09FE1B21F2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:16:19 -0400</pav:createdOn>
    <ao:exact>The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%</ao:exact>
    <ao:prefix>. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F4AAD83-4F30-4757-8C51-DF22D331E0F8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F4AAD83-4F30-4757-8C51-DF22D331E0F8"/>
    <pav:createdOn>2014-07-14 15:55:08 -0400</pav:createdOn>
    <ao:prefix>. The plasma protein binding of </ao:prefix>
    <domeo:uuid>4F4AAD83-4F30-4757-8C51-DF22D331E0F8</domeo:uuid>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D5E41F1-E9A0-4BB0-8282-60119CFA2048">
    <ao:context rdf:resource="urn:domeoclient:uuid:AF02596A-A8C1-43BE-8742-4816A7DC387E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:31:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C174BCA4-061F-41B5-90F6-36B15766499B</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:32:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46901420-9E20-4E05-B060-4C55DE5DF57A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Coadministration of multiple doses of quinidine sulfate, 200 mg t.i.d., and nifedipine, 20 mg t.i.d., increased Cmax and AUC of nifedipine in healthy volunteers by factors of 2.30 and 1.37, respectively</ao:exact>
    <domeo:uuid>46901420-9E20-4E05-B060-4C55DE5DF57A</domeo:uuid>
    <ao:prefix> is a substrate of CYP3A and has been shown to inhibit CYP3A in vitro. </ao:prefix>
    <pav:createdOn>2014-07-20 22:26:28 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. The heart rate in the initial interval after drug administration was increased by up to 17.9 beats/minute. The exposure to</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46901420-9E20-4E05-B060-4C55DE5DF57A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D83B6BBF-45AF-4383-A468-BAD13D03381A">
    <pav:createdOn>2014-07-14 15:55:26 -0400</pav:createdOn>
    <ao:suffix>at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D83B6BBF-45AF-4383-A468-BAD13D03381A</domeo:uuid>
    <ao:prefix>(10 mcg/mL) caused only a slight increase in the free fraction of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D83B6BBF-45AF-4383-A468-BAD13D03381A"/>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A">
    <ao:item rdf:resource="urn:domeoclient:uuid:EDC12F8F-B6FD-4140-AF07-018FA4C76974"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB3BE992-5262-45BF-BB27-58180B0F46B0"/>
    <pav:lastSavedOn>2014-07-13 16:01:59 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:59E0E704-7AEB-447D-9026-0EF674096051"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD3FEC06-8F5F-42C2-B94E-46D8D2E9A2B2"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:09DFFBB4-F660-4D6E-AB1D-CC0E54A371C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:201F90F0-CBAB-4102-8FA5-6A21E5E79DF6"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <pav:createdOn>2014-07-13 15:57:33 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9FF767E9-B3F6-41E0-83F2-C2855FB4973A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N1a6a42d398c849b080e0f4cc114e34d9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:97643795-493D-4D9D-8C5F-17F378AE22AF</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:19343D9E-0212-4E02-AC1F-6FF9B5873909"/>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0865F281-977C-4F1A-991F-9DC81C6ED426">
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 20:47:11 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 20:46:20 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:b92686cf-78e8-47e8-a8d4-767477cf1b9c</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAFCCD75-1569-4E59-A941-DFB2068CA7A7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0274940-28B6-44EC-9939-4E6325365E22">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:850AED04-DBFD-4D40-A1CB-02366C5EF7F2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 09:42:20 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C64E0D3D-B80A-4982-B8EC-C0ED615FE918">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:03:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C44E4401-663D-4E26-816A-96BDE160CC13"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:184804F1-B516-4468-8703-9B4D153EEC3D">
    <ao:context rdf:resource="urn:domeoclient:uuid:299CDEFF-8F84-4A8F-AC8A-6E57648A52AE"/>
    <pav:createdOn>2014-07-14 16:02:27 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35BF2F03-05AF-4832-A0A2-B1A6EEE52304">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:17:21 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5586FE3A-D0FD-4448-A4D4-669F6071F77E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B9653708-3624-4DA5-A6E2-7DB80E6B55D4</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C595A0FB-B219-498E-9571-647F7989874D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ranitidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3918F53-7F45-49FF-A858-9AD333C60994">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>It has been reported that SEPTRA may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3918F53-7F45-49FF-A858-9AD333C60994"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-87.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>A3918F53-7F45-49FF-A858-9AD333C60994</domeo:uuid>
    <pav:createdOn>2014-07-20 21:42:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3672B99A-9372-400C-8697-16605C55A9F9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>Orlistat</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/37925</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9ADA86EB-925D-461C-9857-C255E0554F1F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:745C89A1-1AF7-4B52-ADC7-BBB0B4D97B56"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:30:59 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:EDFA9922-508F-4042-B2F0-DB3A9B0A2205</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 00:31:13 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:175A41D6-7C03-45D4-9BC1-0B116037B32C</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CDE13C93-F325-4362-9DB4-C25339BA56D6">
    <rdfs:label>Fluoxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd2b1a67c3e9c4913b8c021ae94191d9e">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E3238149-ACFD-459C-B1CB-26A84CFCE66C">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <rdfs:label>metoclopramide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:583A1C18-899D-488C-94D8-45B640605797">
    <ao:context rdf:resource="urn:domeoclient:uuid:1D4AF03D-DEDD-4CEA-97C4-8B14EF87650D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 20:22:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C4D4AD1-7E71-4290-B0D5-CDDB01D0EB7F">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F0D4700C-76E5-4886-BB47-F8859CE75C75</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:41:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7D053F38-6708-453F-93CB-87B91CA4DE34"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:092AE31E-B6F5-4A0D-915A-AC406DF9800E">
    <ao:suffix>, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose </ao:suffix>
    <pav:createdOn>2014-07-14 14:28:20 -0400</pav:createdOn>
    <ao:prefix>(600 mg twice daily), an inhibitor of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>092AE31E-B6F5-4A0D-915A-AC406DF9800E</domeo:uuid>
    <ao:exact>CYP2C8</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:092AE31E-B6F5-4A0D-915A-AC406DF9800E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F81042B-493D-4D78-BBB6-E6540791B04A">
    <pav:createdOn>2014-07-14 14:10:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F81042B-493D-4D78-BBB6-E6540791B04A"/>
    <ao:prefix>as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different from placebo or </ao:prefix>
    <ao:suffix>controls (Table 7)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6F81042B-493D-4D78-BBB6-E6540791B04A</domeo:uuid>
    <ao:exact>glyburide </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3EE34468-D0A2-4A18-BC8D-991824787C67">
    <pav:createdOn>2014-07-20 22:11:23 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3EE34468-D0A2-4A18-BC8D-991824787C67"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>However, cimetidine did not affect the AUC of risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <domeo:uuid>3EE34468-D0A2-4A18-BC8D-991824787C67</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EAC8256-CB08-4BDA-A39B-61D72B382F26">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:66F66C87-6ABB-422F-A3E3-5595EBB5DD0F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:12:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A48C0A37-DA7A-4F0F-A0C3-981C7FF76E06">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A48C0A37-DA7A-4F0F-A0C3-981C7FF76E06"/>
    <pav:createdOn>2014-07-14 14:33:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A48C0A37-DA7A-4F0F-A0C3-981C7FF76E06</domeo:uuid>
    <ao:exact>glyburide </ao:exact>
    <ao:prefix>(8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04416B46-CC4F-42CD-9001-3BD556AF4E3E">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:20:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B9F6E75-6F56-403A-B278-DE5594799113"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6F99DE8E-D19E-454F-9E62-4CF842716117">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7A3E0BFE-EC76-4ACA-9F6B-EE747F04F2F6"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0D091A8-A8A9-42CA-AB30-C1A370B5BF92">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:42:34 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C3023C0-3E95-4AE2-9020-E88729805E3C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F032814-6089-46B4-A871-06E53268C5B4">
    <ao:suffix>maleate, approximately 64% and 23% of the dose was eliminated in the urine and in the feces, respectively. The plasma half-life of [14C]related material ranged from 103 to 158 hours.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:15:19 -0400</pav:createdOn>
    <domeo:uuid>4F032814-6089-46B4-A871-06E53268C5B4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4F032814-6089-46B4-A871-06E53268C5B4"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:prefix>Following oral or intravenous administration of [14C]</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4AF4DAB0-56F4-4096-8D50-E9692309699A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30409CE7-08DE-493D-B7F1-09FA1E072B3D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>me of distribution (Vss/F) were shown to increase with increases in body weight. Over the weight range observed in these analyses (50 to 150 kg), the range of predicted CL/F and Vss/F values varied by &lt;1.7-fold and &lt;2.3-fold, respectively. Additionally, </ao:prefix>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>30409CE7-08DE-493D-B7F1-09FA1E072B3D</domeo:uuid>
    <ao:suffix>CL/F was shown to be influenced by both weight and gender, being lower (about 15%) in female patients.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30409CE7-08DE-493D-B7F1-09FA1E072B3D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:15:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39B734C2-006D-4C33-9B54-03E563108307">
    <ao:suffix> increased by 30%. In poor metabolizers, there was a 50% decrease in </ao:suffix>
    <pav:createdOn>2014-07-20 20:35:03 -0400</pav:createdOn>
    <ao:exact>norpropafenone</ao:exact>
    <ao:prefix>. The concentrations of </ao:prefix>
    <domeo:uuid>39B734C2-006D-4C33-9B54-03E563108307</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:39B734C2-006D-4C33-9B54-03E563108307"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:398a3d64-9f53-46f5-9f22-befa749ed504">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:398a3d64-9f53-46f5-9f22-befa749ed504"/>
    <ao:prefix>zophrenia. Concentrations of </ao:prefix>
    <pav:createdOn>2014-07-07 08:08:49 -0400</pav:createdOn>
    <ao:suffix> and its two active metabolite</ao:suffix>
    <ao:exact>thioridazine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75CE840F-35C1-4DC3-A437-252E24866FE3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F90242F8-094E-45F6-97EF-A95FD7C31B2B"/>
    <pav:createdOn>2014-07-14 14:26:52 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Na32fd67387c54cac9f14b668591c6ea2"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C7E1A06-29C8-4D5B-A8CD-5F7FBC4B65E6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C7E1A06-29C8-4D5B-A8CD-5F7FBC4B65E6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Methadone disposition was not substantially altered</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:48:25 -0400</pav:createdOn>
    <domeo:uuid>1C7E1A06-29C8-4D5B-A8CD-5F7FBC4B65E6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD23501F-AA9A-4602-941A-811BF9DA2712">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:05:20 -0400</pav:createdOn>
    <ao:exact>Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD23501F-AA9A-4602-941A-811BF9DA2712"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>CD23501F-AA9A-4602-941A-811BF9DA2712</domeo:uuid>
    <ao:prefix>do not suggest important differences between poor and extensive metabolizers. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N854d10993d994a31bad26326e26417ac">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3BCA07A-06BB-4F22-A3A4-F076C15BF4AF">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:17204A88-2ED6-4CE0-9AF8-30CE68A70B8B"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D292E9A-7301-4F30-A89D-EBB62CAFFC78">
    <domeo:uuid>3D292E9A-7301-4F30-A89D-EBB62CAFFC78</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D292E9A-7301-4F30-A89D-EBB62CAFFC78"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 20:29:10 -0400</pav:createdOn>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2A31D3B-5246-42F7-9731-B5E98AC5035F">
    <ao:prefix>or </ao:prefix>
    <domeo:uuid>C2A31D3B-5246-42F7-9731-B5E98AC5035F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>coadministration enhances fexofenadine gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enh</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:29:03 -0400</pav:createdOn>
    <ao:exact>erythromycin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C2A31D3B-5246-42F7-9731-B5E98AC5035F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85F697CB-EB7F-4291-A7DA-6DBF1AEE52AF">
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:02:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:452026D0-6F5C-4DBE-BC29-7C39FA5273F3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9BA43B7-FEEB-4BF5-ADB4-9CEC3B62EAE0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F9BA43B7-FEEB-4BF5-ADB4-9CEC3B62EAE0"/>
    <domeo:uuid>F9BA43B7-FEEB-4BF5-ADB4-9CEC3B62EAE0</domeo:uuid>
    <ao:prefix> therapy for at least 6 months and on a stable </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 23:50:19 -0400</pav:createdOn>
    <ao:suffix>dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92%</ao:suffix>
    <ao:exact>cyclosporine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BDCFB27-BF5A-4C28-8986-D566B2C6B75F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:94F076FD-DBDF-4667-BD32-D4DB832E1C33"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:14:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6904FF0B-3309-43D8-BDD0-7346C4FC4B5A">
    <rdfs:label>midazolam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF27214B-1B37-47D3-979C-AE158B7312C8">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DF27214B-1B37-47D3-979C-AE158B7312C8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concomitant administration of rifampin and propafenone in extensive metabolizers decreased the plasma concentrations of propafenone by 67% with a corresponding decrease of 5OH-propafenone by 65%</ao:exact>
    <ao:suffix>. The concentrations of norpropafenone increased by 30%. In poor metabolizers, there was a 50% decrease in</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 20:39:46 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <domeo:uuid>DF27214B-1B37-47D3-979C-AE158B7312C8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE2632C4-FA9F-4893-9121-484D938D4E67">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <ao:prefix>AUC and Cmax of approximately 30%. In Japanese subjects, </ao:prefix>
    <ao:exact>glyburide </ao:exact>
    <domeo:uuid>FE2632C4-FA9F-4893-9121-484D938D4E67</domeo:uuid>
    <pav:createdOn>2014-07-14 14:34:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE2632C4-FA9F-4893-9121-484D938D4E67"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69969A71-4C2D-4D6A-8BC7-C074029459E8">
    <pav:lineageUri>urn:domeoserver:annotation:4D70EAD2-4E9F-4455-82C9-FC1A83CDE4DF</pav:lineageUri>
    <ao:body rdf:nodeID="N3149fa67e73b4f3f8b3973b0a9bbb227"/>
    <pav:lastSavedOn>2014-07-20 23:20:51 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 23:20:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:585C6B99-D509-47B5-B76E-7814527DCE3C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:811DB7F2-5DD1-489F-B2C7-A89B8956DA8A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3E22CFD1-3023-49EC-8A81-510AC7740021">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>synercid</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8B6FBBCB-4276-419E-8958-6BD064936710">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7812AE31-F6B2-41E5-AA8F-625441C772B6"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AE2E24E-6D34-420A-9262-8D5876FBCA0F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AE2E24E-6D34-420A-9262-8D5876FBCA0F"/>
    <ao:prefix>AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD </ao:prefix>
    <pav:createdOn>2014-07-13 23:59:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTION</ao:suffix>
    <ao:exact>theophylline </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <domeo:uuid>8AE2E24E-6D34-420A-9262-8D5876FBCA0F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7865F088-4856-4644-B7F2-80FFD84F343B">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:18B1C7B3-45B4-4A32-9EAB-4ECA6CEC6AC3"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ACD4243C-A1DD-45A7-808E-9CAD9F8689C0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD7ECD61-8E14-45F2-907A-0ABA6A22D947">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:2C957DD3-C022-45FB-97ED-67A9FCFDA471</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 22:03:36 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:03:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F21B02F9-EA1F-4306-BAA9-5C36738F8E06"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nb10ef028ac604e7982ef5fd9dac74fd8"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:147E9D8C-BB67-4DAB-A0AE-3250BFC6360E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N0da1145c2a324636886c22fe24ba02e0"/>
    <pav:lastSavedOn>2014-07-20 21:17:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:43094D9A-060D-4712-A34E-09F917644BF8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8684A34A-3218-4109-9D54-0854BB1C2A26</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 21:17:03 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C6BCCE9-164B-4614-BFBD-EAD962C58711"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/90AF96F7-C319-416B-9675-C5BAE512AADA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:177A684C-EA21-44B3-AF53-9CAF9DBF3FD3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:47:45 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:177A684C-EA21-44B3-AF53-9CAF9DBF3FD3"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <ao:exact>Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration</ao:exact>
    <domeo:uuid>177A684C-EA21-44B3-AF53-9CAF9DBF3FD3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4312A4DE-E052-44DE-B2A6-3786835D567F">
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5C09A45A-A18E-40E0-B052-A23D77AAEE39"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 14:49:01 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EBB83A45-A289-45A4-86E3-D9C8DC9DA399">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0B670B09-B470-4090-B336-0A14B5F50045"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBED2204-2150-43DD-BA94-303ED09B9EBC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC6B8700-5CF9-4919-83CE-CD30B715AF09"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 16:08:06 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7E3DAD5C-3855-4797-806D-FBBC5BC83079</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9fa3636a-17b0-41cd-aa8d-1df38f7259ba">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:09:13 -0400</pav:createdOn>
    <ao:exact>tacrine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9fa3636a-17b0-41cd-aa8d-1df38f7259ba"/>
    <ao:suffix> by approximately 54% and 64%,</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>ncreased the Cmax and AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-84.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C19CA7A9-286D-4067-8225-C269F833476C">
    <domeo:uuid>C19CA7A9-286D-4067-8225-C269F833476C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C19CA7A9-286D-4067-8225-C269F833476C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <ao:suffix>to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results fro</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:01:22 -0400</pav:createdOn>
    <ao:prefix>is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0422EF3C-AE77-4564-B3F5-2957EACA0D46">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B48B2B6D-FB16-42FF-8AEB-85B7DFCF14A2"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:364FB984-763A-42BB-BC13-2835BDC26EEA">
    <domeo:uuid>364FB984-763A-42BB-BC13-2835BDC26EEA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 23:59:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:prefix>AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:364FB984-763A-42BB-BC13-2835BDC26EEA"/>
    <ao:exact>Theophylline </ao:exact>
    <ao:suffix>clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DFBF41C-F99E-4FC7-A8C8-9B7AEF3C2D4E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A541BCE2-38C1-47D7-8254-D967EDCF5416</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 23:18:21 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 23:18:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:041167D2-429F-4342-B6B6-12F1268C9179</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5076EEC9-0A3B-443B-9659-0ADEA006B499"/>
    <ao:body rdf:nodeID="Nd332c3721874471486dbb6ec7374fb1e"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF02596A-A8C1-43BE-8742-4816A7DC387E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF02596A-A8C1-43BE-8742-4816A7DC387E"/>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>, for 6 days is reported to decrease </ao:prefix>
    <domeo:uuid>AF02596A-A8C1-43BE-8742-4816A7DC387E</domeo:uuid>
    <pav:createdOn>2014-07-14 14:31:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D7D3CBB-49BB-4D03-8CAE-142B4BD512C3">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A1E62784-202B-40C3-9735-5D42D0E5DCF8"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B137523-54BF-415A-A042-5DC92B82B9E5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8B137523-54BF-415A-A042-5DC92B82B9E5"/>
    <ao:prefix>at 10 ng/mL and </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <pav:createdOn>2014-07-14 15:55:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>8B137523-54BF-415A-A042-5DC92B82B9E5</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2D86325-FD14-48B2-8242-A7EF820BB81D">
    <pav:lineageUri>urn:domeoserver:annotation:93FEDDF9-AA64-47D3-A002-012D06487721</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E050D2E-48AF-46B6-B2D3-9D1C161CC871"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 14:58:45 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N5d661e46bd5b4ed98f41ecb02694f237"/>
    <pav:createdOn>2014-07-13 14:58:02 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A41E5726-CB3A-4EB2-B011-D43D24A0CCB5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 21:59:03 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:58:49 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:555798FB-0C2E-4051-B426-FD9DAA56F7B0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:B208DB61-8DCE-4EF6-8A5D-F8F8F5BDB70A</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:body rdf:nodeID="N19d3933a912e48958707027b6db3c98e"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5F7E373-46D9-4E9A-8DFB-7F22F3F61F19">
    <ao:suffix>dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decrea</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable </ao:prefix>
    <domeo:uuid>C5F7E373-46D9-4E9A-8DFB-7F22F3F61F19</domeo:uuid>
    <ao:exact>zidovudine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C5F7E373-46D9-4E9A-8DFB-7F22F3F61F19"/>
    <pav:createdOn>2014-07-13 23:54:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C1BD8AE6-B90F-4675-B987-BB01261659D6">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>metoclopramide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C98D591-7244-4E43-B843-98E32DDD9AA0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C98D591-7244-4E43-B843-98E32DDD9AA0"/>
    <ao:suffix>, thus caution should be used with concomitant administration.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, may be increased by </ao:prefix>
    <domeo:uuid>4C98D591-7244-4E43-B843-98E32DDD9AA0</domeo:uuid>
    <ao:exact>acyclovir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:36:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB625DCA-C79A-45A3-8935-EB4041F9E9C4">
    <pav:createdOn>2014-07-14 00:25:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB625DCA-C79A-45A3-8935-EB4041F9E9C4"/>
    <ao:suffix>is not expected to interfere with the metabolism of other drugs that are metabolized by cytochrome P450 isozymes.</ao:suffix>
    <domeo:uuid>DB625DCA-C79A-45A3-8935-EB4041F9E9C4</domeo:uuid>
    <ao:prefix>), as measured in human liver microsomal preparations, in vitro. </ao:prefix>
    <ao:exact>Zonisamide </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBD0ADB5-CF5F-4CD3-9A18-248A9C9E7CD9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-13 16:01:58 -0400</pav:createdOn>
    <domeo:uuid>CBD0ADB5-CF5F-4CD3-9A18-248A9C9E7CD9</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CBD0ADB5-CF5F-4CD3-9A18-248A9C9E7CD9"/>
    <ao:exact>Administration of a single oral 200 mg dose of fluconazole after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B9F6E75-6F56-403A-B278-DE5594799113">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B9F6E75-6F56-403A-B278-DE5594799113"/>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>2B9F6E75-6F56-403A-B278-DE5594799113</domeo:uuid>
    <pav:createdOn>2014-07-14 14:20:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>in pediatric patients were established using a population pharmacokinetic analysis with sparse data from 96 pediatric patients in a single pediatric clinical trial including 33 males and 63 females with ages ranging from 10 to 17 years (weights ranging f</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Pharmacokinetic parameters of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/18899E6B-5B54-47AB-9D1C-6AA4C9C8F517">
    <rdfs:label>doxazosin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/49276</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EB795BC-BD77-43C1-8598-70A1EBB97152">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:26:06 -0400</pav:createdOn>
    <ao:exact>erythromycin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>8EB795BC-BD77-43C1-8598-70A1EBB97152</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8EB795BC-BD77-43C1-8598-70A1EBB97152"/>
    <ao:prefix> 120 mg twice daily (240 mg total daily dose) was coadministered with either </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:suffix>500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9816C3A2-2987-4FC9-AE3D-5CBD4C691E92">
    <pav:createdOn>2014-07-13 14:49:05 -0400</pav:createdOn>
    <ao:suffix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared</ao:suffix>
    <domeo:uuid>9816C3A2-2987-4FC9-AE3D-5CBD4C691E92</domeo:uuid>
    <ao:exact>norethindrone</ao:exact>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9816C3A2-2987-4FC9-AE3D-5CBD4C691E92"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91EA5CE1-31BF-442E-8829-C1BAF58B3517">
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1500E4D9-0C81-43EF-B2FB-A27B523CC477"/>
    <pav:createdOn>2014-07-14 16:02:54 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44B7FBED-89E8-4CDE-B257-5546C265C2AF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:00:03 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5D7E14EC-7E04-46C4-8A4F-7C62FA7F3F21"/>
    <pav:lastSavedOn>2014-07-14 15:00:43 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:880EA8E3-4713-4B02-A5AE-822BFEB4111E">
    <ao:prefix> is supplied for oral administration as scored tablets containing </ao:prefix>
    <ao:suffix> equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starc</ao:suffix>
    <domeo:uuid>880EA8E3-4713-4B02-A5AE-822BFEB4111E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:880EA8E3-4713-4B02-A5AE-822BFEB4111E"/>
    <ao:exact>sertraline hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-11 23:29:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DF82AD9B-B554-429C-BECD-208870577B01">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil </ao:exact>
    <domeo:uuid>DF82AD9B-B554-429C-BECD-208870577B01</domeo:uuid>
    <ao:suffix>is 105 L, indicating distribution into the tissues. Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DF82AD9B-B554-429C-BECD-208870577B01"/>
    <ao:prefix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 09:43:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7">
    <ao:item rdf:resource="urn:domeoclient:uuid:786018B0-E999-47DC-B4E3-D711FF53726E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7B4C48B-8305-4B8F-AF91-F60EC32F9052"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:617CFBFD-33F7-4D4A-873E-9FADBE8098CB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-14 15:38:27 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:261FBCCB-D709-4392-82BC-685600FA5428</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:258150E5-0E95-4DFF-8AE4-CDD71E9734C9"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE190217-F3C6-4371-AC6F-C1C99ECD2E87"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:384A69CD-B43A-46FC-9129-B901FA160550</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:8E9ED0D8-2D96-486C-A6BA-5600DBDFB0E8"/>
    <permissions:permissions rdf:nodeID="N01e02209ea594005984d9711297be9fd"/>
    <pav:createdOn>2014-07-14 15:36:15 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66997FDA-ED9B-4429-9D7D-F08F78ADD03E">
    <ao:prefix>were determined from a single intravenous dose of </ao:prefix>
    <ao:exact>aminophylline </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66997FDA-ED9B-4429-9D7D-F08F78ADD03E"/>
    <domeo:uuid>66997FDA-ED9B-4429-9D7D-F08F78ADD03E</domeo:uuid>
    <ao:suffix>(6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD t</ao:suffix>
    <pav:createdOn>2014-07-13 23:59:14 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/62ABD731-D72C-41DD-B670-76E0973C1FC5">
    <rdfs:label>glyburide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73078006-A158-460B-ACBB-D093DA6DAC5F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 16:03:36 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 16:03:46 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:7CEC7E92-F5B7-46E3-BF20-C7C846705465"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:74CA39C6-8EB5-4F9F-85D2-6ABE503CDDC8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9EADF748-CADC-4023-A087-992834D4FCDE"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C72F630F-0659-45FA-AD82-178873B7AB96">
    <ao:body rdf:nodeID="N7592b255660847f7b5b785f532133826"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 15:56:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:D6DDEC9F-7FFE-4FD0-8805-6A604F27BAA0</pav:lineageUri>
    <pav:createdOn>2014-07-13 15:56:14 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:58117380-1B98-4B60-B393-8941A7283E84"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 21:00:22 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:655AFFCF-6B1A-4B6B-A73D-AABCB594036B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:30D424F6-3E95-4F93-B5B8-5461391BEEA9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0865F281-977C-4F1A-991F-9DC81C6ED426"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A6F38620-50D4-4687-B3AE-CCED6536A591"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:13172368-8211-4AEC-B9C1-FA5063E37595"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0D472E1-4467-4227-8199-B6A0B3CA5859"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14C82A0F-4B69-4123-8F37-CAFC568A4556"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3012FD39-24D7-49F8-95F1-4D55E546E46D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:A69FCE6F-B369-4F8B-A1D6-3F2BDD659606"/>
    <pav:previousVersion>urn:domeoserver:annotationset:5AAEAB09-D3D7-46D2-A9EC-2A278308F953</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:E30EFC94-7D10-4338-8630-3BBAB8B93765"/>
    <permissions:permissions rdf:nodeID="N93d1d9575675424c98d2a470c2d688d9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F3DF3CE3-951D-40C8-8219-1C8563023350"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3535630-AEAB-4817-93D6-0BCC37D4C8A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5C5FFCB-513F-45F8-BC0B-034F17F0BE3E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:09:11 -0400</pav:createdOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/7e6ff7cd-fb12-4ab8-977e-e796227c1866"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D23FE156-8323-4595-8D98-94FCE429BA33"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:2093A3B0-20D0-46F4-B2FB-FE5C8A4793C8"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E721348C-C086-4DAE-AF5C-FEAE96FEADCC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7E95BDA-456E-448B-90CA-98BC7E00471A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70BB5879-13D2-44DC-8E3D-DEEBF333FB99"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0625A4B3-484F-482F-87A8-6C6134C2BEEA"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:13D2860A-FDF4-4C6D-A311-042031531AFB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0AB301DE-F7B3-49BC-BAD5-ADD02D903002"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE5ED7B4-D954-413C-966C-E8ACD7BE1B30"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F29511BE-AFB8-43BB-AD8D-C5E14FB83F1B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:EFB6C4B4-2C98-49E8-BC47-A5442E8DE8D1</pav:previousVersion>
    <ao:body rdf:nodeID="Nf7c1af86405a4f65bc8b78580fbf3cfc"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:29:42 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:473966E0-AC08-4E1C-86DB-0F8A619103AD"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:29:43 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1ca7dc28-841a-49ed-9e2e-7567afd000a1">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:e0906d9f-40da-4766-b22a-18cfd5648862</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:67EF6373-65E8-44B4-BC03-21748A973E3E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 08:09:02 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:e910a96a-4bbc-444e-935c-1359f6a9b81d"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1221383A-AB62-4840-A496-988B305EDC98">
    <ao:context rdf:resource="urn:domeoclient:uuid:03C51E27-B736-4A34-8C86-F7C276D4105F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9C2BF596-2C1A-41E9-BC83-F746536CED65</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 00:19:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 00:20:21 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EC4F693-044A-46D0-84B1-F58E4BF4DD2A">
    <ao:suffix>(4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone. Given the potential for dose-related adverse events with rosiglitazone, a decrease in the dose of rosiglitazone may</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EC4F693-044A-46D0-84B1-F58E4BF4DD2A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9EC4F693-044A-46D0-84B1-F58E4BF4DD2A</domeo:uuid>
    <pav:createdOn>2014-07-14 14:28:24 -0400</pav:createdOn>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:prefix>, and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11F5743A-7576-46DC-8368-4F0183E1CD32">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:58:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N2f3c2ac49c8345f0bdc7c5d62f4979fa"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:386783BA-77A0-4DE5-AF5A-F87F3B4A2466"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/49131E07-9C7D-4E6E-82BF-380178DA4CFA">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:962F8CCC-F233-4452-8472-02DFBE2B857C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:962F8CCC-F233-4452-8472-02DFBE2B857C"/>
    <pav:createdOn>2014-07-14 15:23:22 -0400</pav:createdOn>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <ao:prefix>has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adul</ao:suffix>
    <domeo:uuid>962F8CCC-F233-4452-8472-02DFBE2B857C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:64B0AF47-31CD-4E26-8EC8-498E258CC22C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:22CAB487-CE5D-4EA5-BABA-30ADCDA4B3A8</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDEC0C3A-EAF5-4C8B-86B5-816C0FB5BE6A"/>
    <permissions:permissions rdf:nodeID="N3700f30021b5479b9a9d872c9ab31496"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 21:38:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7dc69d20-4aed-4c9f-9940-a84a04c16b52</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB793394-CF03-4F57-852F-2CE4B147A90B"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/10ff23ae-618a-437e-af8b-a68b06a4d811"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2EF0A75B-A6F3-4FAA-BE4B-EC253D87AB9C">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DB39160-09B3-4E2A-B3D8-3444B85025A3">
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACFBFD00-EB6E-4721-9C8E-346CECC1A79E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 21:47:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F0022EA-9BF8-4B51-A11A-901C8CF7EA38"/>
    <pav:lastSavedOn>2014-07-20 21:49:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:17778f09-3c5c-4c6f-9513-62d64b4008bc</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:836ed51c-0487-4608-a75e-50b5a0312d98</pav:previousVersion>
    <ao:body rdf:nodeID="N83500606875c4ac49853917b26bab232"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5458A17-9E39-47F0-81AD-6F96B19F34F3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 13:48:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 13:51:02 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:36094B3F-B5BE-42CE-A62A-E38D55F5CC09"/>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:32A6B6DB-4B7D-4DCA-BC66-F25FBA3026EA">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AAA268A7-D4CA-4EA1-85EE-D6D3F5336DE7"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E959E9B3-A8CD-41A2-A5D4-8B0796B45BD6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:30:41 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D2F34EF9-544D-4872-B221-723FBB99B1CC"/>
    <pav:lastSavedOn>2014-07-14 15:31:07 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:9551BD57-E803-487A-B670-23EA129D54A7</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CA401DFE-D04E-487D-96E5-569BC123D98E">
    <rdfs:label>ketoconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8BC6124C-5A53-4CFA-9D7E-494AD457221B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:29:09 -0400</pav:createdOn>
    <ao:prefix>coadministration enhances </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8BC6124C-5A53-4CFA-9D7E-494AD457221B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine </ao:suffix>
    <domeo:uuid>8BC6124C-5A53-4CFA-9D7E-494AD457221B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine gastrointestinal</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7F16F9D5-E739-4E80-85D3-C11EC29F5D34">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5AD4974E-C3F7-456C-908E-F7D0BE872FA0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D3E30071-0826-4BC3-9DFC-799E61F90F77"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A83FFD59-1BB9-4980-90E2-2C060627CA07">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 20:06:06 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d5975122-3a09-47fd-8229-08ca67318591</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:2cef0690-4bca-4bad-9154-75f19911b7e6</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:451E44A3-B8EF-41F7-8969-E3AF5BD59221"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC4BE7C9-BF81-424F-84EF-295509BA81F3</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:05:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:038C3C1A-5603-455B-A95F-B047ED42BBD3">
    <domeo:uuid>038C3C1A-5603-455B-A95F-B047ED42BBD3</domeo:uuid>
    <pav:createdOn>2014-07-14 00:29:08 -0400</pav:createdOn>
    <ao:exact>cimetidine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-57.txt.html</ao:hasSource>
    <ao:prefix>single dose pharmacokinetic parameters were not affected by </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:038C3C1A-5603-455B-A95F-B047ED42BBD3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>(300 mg four times a day for 12 days).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AABD01B-CF0E-4F93-81A1-972D2BCC161A">
    <pav:createdOn>2014-07-20 20:46:50 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0AABD01B-CF0E-4F93-81A1-972D2BCC161A"/>
    <ao:prefix>. The </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0AABD01B-CF0E-4F93-81A1-972D2BCC161A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>AMT</ao:exact>
    <ao:suffix> AUC was one fifth of the </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:68957D9B-ACCE-414F-9A05-BFF679207D36">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:85819FE1-23CF-4717-A22F-2427ADC22667"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:ADA754D7-8F98-4A1B-A03A-7494BA24B16A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/190988b9-4287-4093-8df5-f94d8b89cd26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:22AD69A3-05C3-4F20-92A1-A29E166F01BF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-20 22:26:56 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <permissions:permissions rdf:nodeID="Nb577420e51b34dc19666c4dad89edd3d"/>
    <pav:lineageUri>urn:domeoserver:annotationset:e17d8d63-b009-4463-827b-f6bbf67ddbfd</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:EAE921BA-12A3-476F-B963-2839ED645444"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:annotatesResource>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C929DBC8-B914-403D-8C74-2DA9357CC0EC</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAB0A6E4-9768-4646-9FC4-94B022BB60A1">
    <ao:suffix>. Therefore, monitoring of plasma</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-83.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAB0A6E4-9768-4646-9FC4-94B022BB60A1"/>
    <ao:exact>Coadministration of tacrine with theophylline increased theophylline elimination half-life and average plasma theophylline concentrations by approximately 2-fold</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FAB0A6E4-9768-4646-9FC4-94B022BB60A1</domeo:uuid>
    <pav:createdOn>2014-07-20 21:36:24 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/04E00386-0669-42B9-8251-9F6C313C974B">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4A8C75E0-4929-4A79-9A23-19E6D1E3BA6F">
    <rdfs:label>midazolam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC6F400C-63D5-431C-BAB2-36C95B501228">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:12:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C8D2B81-D693-4C24-9648-AC96B3688E35"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44E979F8-20F5-4AF4-8695-07429A3644DB">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:55:30 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8B137523-54BF-415A-A042-5DC92B82B9E5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29AD0813-B2C8-4A21-A09B-04904ED8A272">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:29AD0813-B2C8-4A21-A09B-04904ED8A272"/>
    <domeo:uuid>29AD0813-B2C8-4A21-A09B-04904ED8A272</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-14 14:22:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix>Results of a population pharmacokinetic analysis including subjects of Caucasian, black, and other ethnic origins indicate that race has no influence on the pharmacokinetics of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5F414CAA-EF76-4632-85A8-1BB7C9F32B45">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/97FDB421-DF71-416B-9F87-503395671080">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADC45253-A3D7-4B7C-9820-C7A411B89173">
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:33:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:789B6118-ED30-46C2-AD27-5E0EBB7D5FE2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25F374CE-1C77-42F4-9054-82A4A5CF1633">
    <pav:createdOn>2014-07-07 09:37:33 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:269A1BD5-E6E1-445D-90A6-20780500924A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/b1964cb5-59bc-4759-b4d5-8008fbeecbb8">
    <pav:createdOn>2014-07-07 08:09:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:76d9d09c-6bdc-47f7-b01f-83ad52fb43f6"/>
    <pav:lastSavedOn>2014-07-07 08:09:09 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F27D930-7AB6-45D4-A664-0F78688A973B">
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:03:16 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A912A10-3A37-43D5-8572-60FE94EF052F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A2F08077-A14F-4CF3-B2A2-F099B1CD88F0">
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55065BCB-C09B-414C-8265-57F9C477B91E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:53:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A119350-B348-4835-AF86-FBC38BCEA446"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED6A04D4-A224-43A8-A174-A2FAD4C807EE">
    <pav:createdOn>2014-07-14 00:24:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED6A04D4-A224-43A8-A174-A2FAD4C807EE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ED6A04D4-A224-43A8-A174-A2FAD4C807EE</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:suffix>had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials. Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Zonisamide </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:e910a96a-4bbc-444e-935c-1359f6a9b81d">
    <ao:suffix>: No clinically significant ph</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>Clopidogrel</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:e910a96a-4bbc-444e-935c-1359f6a9b81d"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-112.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDB24678-2252-4E22-BEB1-2FE5D20BBEF8">
    <pav:lineageUri>urn:domeoserver:annotation:25603645-962E-4EC4-9607-E8E05682C9D2</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:58:22 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Ne2f025d1f9c046a09ac0495a9060ffaf"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C237145-BE09-4FE5-A114-C4FBF59F00B1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:58:19 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:217C265B-6D9D-4552-8330-D79644D90CAB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:217C265B-6D9D-4552-8330-D79644D90CAB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:prefix> AUC after the administration of 50 mg of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>217C265B-6D9D-4552-8330-D79644D90CAB</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 14:38:31 -0400</pav:createdOn>
    <ao:suffix>. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94F076FD-DBDF-4667-BD32-D4DB832E1C33">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:94F076FD-DBDF-4667-BD32-D4DB832E1C33"/>
    <ao:exact>ritonavir </ao:exact>
    <ao:prefix>increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and trazodone were coadministered.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:14:14 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <domeo:uuid>94F076FD-DBDF-4667-BD32-D4DB832E1C33</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39FC5D6C-2AC9-4A5A-A824-047ACF944440">
    <pav:createdOn>2014-07-20 22:12:10 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A005A1C4-8AAD-47D1-B07A-64275878D71E"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:3995DE32-0144-497C-A999-0738E4AA51CE</pav:previousVersion>
    <ao:body rdf:nodeID="Nbb1c578995e946de92d178f16848c392"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:12:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13F23DB7-73C3-47E8-BC40-8D5ADA660830">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:00:43 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Na1c030b014034a0e8a1d714daae53bbb"/>
    <pav:createdOn>2014-07-14 15:00:44 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:26E4CD1F-B881-44B8-8B69-90C83D34A0FF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C519EEC6-D4FA-4455-AB4B-A212FF7F8D09">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>hydralazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF9A07ED-2970-4904-9B8E-EC11A79F00C8">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF9A07ED-2970-4904-9B8E-EC11A79F00C8"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine</ao:exact>
    <pav:createdOn>2014-07-20 22:33:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <domeo:uuid>CF9A07ED-2970-4904-9B8E-EC11A79F00C8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:e3357242-f7ef-45e3-a5a7-f730d1d97a22">
    <ao:suffix>, given at a common clinical d</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:e3357242-f7ef-45e3-a5a7-f730d1d97a22"/>
    <ao:exact>SEPTRA</ao:exact>
    <ao:prefix>tic metabolism of phenytoin. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DDC59BD-AAC3-4EED-BE5B-6543DF99A54C">
    <pav:createdOn>2014-07-14 00:14:54 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:FF83B6CE-2CF1-4A8B-A180-53164E7B6B99</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:15:21 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Na0c2e1d3c59d4996b4ba0dd5552b23b6"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:E08FCB04-9F93-498A-9CFA-8C5A02C92F37"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0A7E040-C2A3-466D-A330-8114D95E734B">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-138.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-14 15:19:47 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F8D2749-4944-45D6-AAF0-8E0A2FC98D19"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0532F400-8779-4397-9BC9-6B73E8FF2951</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N2e5b3080510d486da0935b52aeb9f089"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D38C181D-9E35-4C4F-99E8-EF1646AEE376"/>
    <pav:createdOn>2014-07-14 15:19:38 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB466D24-CA50-430F-B8FA-5061B5E6D43C">
    <pav:createdOn>2014-07-14 15:33:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>therapy has not been established. In addition, there have been isolated reports of drowsiness, nystagmus, ataxia, dyspepsia, hypersensitivity reaction, and exacerbation of congestive heart failure in patients with pre-existing compromised ventricular fun</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BB466D24-CA50-430F-B8FA-5061B5E6D43C"/>
    <ao:prefix>therapy with or without other drugs or diseases that are known to produce pulmonary toxicity. A causal relationship to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>BB466D24-CA50-430F-B8FA-5061B5E6D43C</domeo:uuid>
    <ao:exact>mexiletine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91B8AC57-1C0B-4BD7-A12E-1E11D8BA2E15">
    <pav:previousVersion>urn:domeoserver:annotationset:7120AB7A-7867-43E7-8DC3-5404D7106D51</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:12:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC874544-B44D-467A-ADB4-9DBAC2214DF5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:12:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FEFDBFE-05DB-4446-A587-323C26F91BBD">
    <ao:context rdf:resource="urn:domeoclient:uuid:50914E70-C6F2-4529-A744-2FD5C6E72827"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:49DFFDD3-098E-4BED-A542-DC61F4FEA7EF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:06:42 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2425CE75-E5F6-4449-BA5B-7E08F3E3E468">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:28:28 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:332482F4-0A00-4F5A-95ED-AC415A589F11"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6A56289-EABC-41BE-B177-D474556420A8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 16:03:46 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 16:03:12 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:23C875B1-AA8F-47AD-8210-21D42AC08ED4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:47E6FB67-91E3-434C-9D45-3BFD345EBFB5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/202D8786-7D0E-4F67-8CAB-B7B43704CEB9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4779F991-0CD3-45E7-84DB-6DD8C19FDCE2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5E2469D-E6D0-484F-8BD4-5D020C870923">
    <domeo:uuid>A5E2469D-E6D0-484F-8BD4-5D020C870923</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5E2469D-E6D0-484F-8BD4-5D020C870923"/>
    <pav:createdOn>2014-07-14 14:50:02 -0400</pav:createdOn>
    <ao:exact>propranolol</ao:exact>
    <ao:prefix>is increased by more than 200% by co-administration of </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56CA625B-968A-4312-8B2F-922D691EDB6C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56CA625B-968A-4312-8B2F-922D691EDB6C"/>
    <ao:prefix>, </ao:prefix>
    <pav:createdOn>2014-07-14 14:17:32 -0400</pav:createdOn>
    <ao:suffix>improved glycemic control in both males and females. In metformin combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>56CA625B-968A-4312-8B2F-922D691EDB6C</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F81CA4F5-9129-4105-ADA2-F29B6192E446">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:93917F84-D890-45DF-BD44-79AF04052D3D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4800F891-C244-4234-A891-55160E585E64">
    <domeo:belongsToSet>urn:domeoclient:uuid:3C4F4974-1D16-456F-8957-6B4A1BA678C2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3B68512C-5D65-4722-9EA2-2E40F38A3A50</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-11 23:29:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-11 23:30:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:880EA8E3-4713-4B02-A5AE-822BFEB4111E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E705EC7-0CB6-4526-8E88-A6FB134082D6">
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">24</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:50A7059B-1B8B-408A-996E-9CF49601F2F8"/>
    <pav:previousVersion>urn:domeoserver:annotationset:85E2A5E4-4897-4AD7-A0E6-A22853D1FFF1</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N90ad41a4079e461bb1d5b1526e63fe56"/>
    <pav:lastSavedOn>2014-07-20 20:43:31 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:43:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/376E2B27-8F0A-4E7C-97F3-F9BCB685288E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4e5b977f-f237-4cbb-bb63-930b97e76dc9">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:624c2187-c1a7-4743-acdc-d6c8320a4c22"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:b1313b87-cdd8-4c82-a8db-8e478e7d6c5d</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CFC858C1-4357-4A7E-B3F6-AEC0208DCC3A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:08:53 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7507e0b7-e651-49fe-aa41-4d82d4654521">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Zidovudine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7507e0b7-e651-49fe-aa41-4d82d4654521"/>
    <pav:createdOn>2014-07-07 08:09:00 -0400</pav:createdOn>
    <ao:suffix> Experimental evidence demons</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-199.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44F9CB2D-A1DE-4461-8533-C94770D13017">
    <pav:createdOn>2014-07-14 14:20:18 -0400</pav:createdOn>
    <ao:prefix>tion pharmacokinetic analysis with sparse data from 96 pediatric patients in a single pediatric clinical trial including 33 males and 63 females with ages ranging from 10 to 17 years (weights ranging from 35 to 178.3 kg). Population mean CL/F and V/F of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:44F9CB2D-A1DE-4461-8533-C94770D13017"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>44F9CB2D-A1DE-4461-8533-C94770D13017</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>were 3.15 L/hr and 13.5 L, respectively. These estimates of CL/F and V/F were consistent with the typical parameter estimates from a prior adult population analysis.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:54657A16-AB6D-4506-BE2A-81079A0AF29F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F6557ED8-784C-4AB8-A6B8-8393D745216A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9976E9AB-FFB4-43A2-811D-03742C2DA427"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:056D4261-BB10-4D09-934B-CB16DA6CDEDF">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:05:20 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N4ac59cdab361414a8c244436cca93ea4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD23501F-AA9A-4602-941A-811BF9DA2712"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5a169a8bdd5b4264a5ae83990336113a">
    <domeo:sets rdf:resource="urn:pddi:uuid:8B6FBBCB-4276-419E-8958-6BD064936710"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1408AEC5-B949-4B79-8A3C-772E8B92A892">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF87ED59-91D1-477C-BB84-45ED85DC70A8">
    <ao:exact>erythromycin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF87ED59-91D1-477C-BB84-45ED85DC70A8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>BF87ED59-91D1-477C-BB84-45ED85DC70A8</domeo:uuid>
    <ao:prefix> alone or in combination with either </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>or ketoconazole. The findings of these studies are summarized in the following table:</ao:suffix>
    <pav:createdOn>2014-07-14 15:26:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6625C6B5-F306-45E9-A073-F5C64BA7B7AE">
    <pav:createdOn>2014-07-14 15:03:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:83C4E132-8D8D-4BDD-A355-625A6131A8CB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:23F36509-0614-43F9-924D-7EF7B847092B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:04:22 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7EBC5DE7-FA87-401F-9007-A48970F7C52E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>avandia</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:423EEF41-6A78-441A-951D-9E623D5E38B9">
    <pav:createdOn>2014-07-14 15:30:45 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:31:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:79513C56-303B-424C-B5F7-27F9ED45305C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:9551BD57-E803-487A-B670-23EA129D54A7</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B55C168C-D92C-4A02-8BCE-CC0FFDC09C7C">
    <ao:exact>ritonavir </ao:exact>
    <ao:prefix>. The effect of short-term administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B55C168C-D92C-4A02-8BCE-CC0FFDC09C7C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B55C168C-D92C-4A02-8BCE-CC0FFDC09C7C</domeo:uuid>
    <pav:createdOn>2014-07-14 15:13:50 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:suffix>(200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearanc</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/90F08861-0DAB-46CF-B204-46BB26CB3700">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C06802B-8803-4873-95EF-26DCB9756032">
    <ao:context rdf:resource="urn:domeoclient:uuid:127B5363-79B2-4079-8128-27356B3C4A96"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:34:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <ao:body rdf:nodeID="N8e6c6bc9e6484b71b0f9e8e0027f944d"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbb64f5dbd64145708a3f345ed964c801">
    <domeo:sets rdf:resource="urn:pddi:uuid:2D769D8C-6934-4E1C-B062-55583CBF6A6B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F">
    <ao:item rdf:resource="urn:domeoclient:uuid:AC6F400C-63D5-431C-BAB2-36C95B501228"/>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:589CB32E-D12B-4981-B9E7-9A24B0A920F2"/>
    <pav:lastSavedOn>2014-07-14 15:16:17 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FAED9F67-B764-4379-BF32-C623F2400E01"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:823AAEA7-7520-4C13-9619-19020FB47FCD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F58C78F-A896-4BA0-B9BC-4EF4857BD7DC"/>
    <permissions:permissions rdf:nodeID="Nf5c35d09001c43d5b97e8b9df171f49a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5579062F-331D-4D6D-83E6-2A7AB050CC8E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFABF2BE-C0E4-4AD2-A8A4-319D192639C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:93426740-A609-40A0-9E36-49973C8CB84B"/>
    <pav:previousVersion>urn:domeoserver:annotationset:A3645335-6A66-4111-BCBD-4E7B85C50B68</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73AD999B-6A8A-4004-A4C3-875F3588E8B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:97BCF13B-E472-4968-B77F-E299F71BB9B8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3BDCFB27-BF5A-4C28-8986-D566B2C6B75F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EAC8256-CB08-4BDA-A39B-61D72B382F26"/>
    <pav:createdOn>2014-07-14 15:12:21 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C46EE241-3381-4CEF-8D13-3BB2DF5618DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6E54859A-7A40-4A60-B485-110537DF2A74"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B359FA77-047D-439E-8B4E-6AEEC553C70F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AABDB76F-19E8-4781-9E6B-ED84810D0E54"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6D653F5-8672-4616-850F-7595FE4934A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A2A790A-7260-4CC8-B8E3-A2017774498E">
    <pav:createdOn>2014-07-14 15:22:38 -0400</pav:createdOn>
    <domeo:uuid>1A2A790A-7260-4CC8-B8E3-A2017774498E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1A2A790A-7260-4CC8-B8E3-A2017774498E"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix> should not be taken closely in time with aluminum and magnesium containing antacids. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>In healthy adult subjects, administration of 120 mg of fexofenadine hydrochloride (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3AE4048-D8E7-4389-AA51-357C8C5B6A87">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/69EA206E-14D6-42A6-9850-7107D17DFE73"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/66E45824-B2E8-422C-8F61-FEE7B9247D49"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D9BF3D5-3958-4415-B734-388AE452162D">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:244F9F35-C7EB-47DD-AA91-FDBDA904A932"/>
    <pav:lineageUri>urn:domeoserver:annotationset:FC056A21-615F-44B8-8E1B-A2A2E8DCB977</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:39:28 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:39:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F07FEB25-225A-4C9A-A90C-03DF5A77406A">
    <ao:prefix>. </ao:prefix>
    <domeo:uuid>F07FEB25-225A-4C9A-A90C-03DF5A77406A</domeo:uuid>
    <ao:exact>Although not designed to optimally assess the effect of phenytoin on zidovudine kinetics, a 30% decrease in oral zidovudine clearance was observed with phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 20:52:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F07FEB25-225A-4C9A-A90C-03DF5A77406A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F8D66D2-A142-4BFF-9BA1-117E181DBCE2">
    <domeo:belongsToSet>urn:domeoclient:uuid:1F4DB871-B0E2-4CBE-B57A-8CC4639877CD</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:02:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:01:57 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7EAB032-76D0-44E7-BD5D-E35A79A707AB"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F46D1E32-D325-418D-B769-4821BF967DAA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/22A5F38C-DB67-475E-9072-E66FB5AD4C11">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>midazolam</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70BB5879-13D2-44DC-8E3D-DEEBF333FB99">
    <pav:createdOn>2014-07-20 20:49:09 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A81B116-EAE0-4CA0-8C37-F8F5710FAAB6"/>
    <pav:previousVersion>urn:domeoserver:annotationset:7A214A93-2426-48A1-B636-1337A2D9E56A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-20 20:49:12 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EDC0F193-125D-47F1-9BF2-6FD1BA33CE0C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <rdfs:label>saquinavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6D8F646-EC4F-46FD-96F4-39786D2BF34C">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:75466C36-9AEB-49DC-8789-42264A07B198"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:864A7E17-993B-44F1-BEBF-8DA14B436612">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 23:50:41 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F9BA43B7-FEEB-4BF5-ADB4-9CEC3B62EAE0"/>
    <pav:createdOn>2014-07-13 23:50:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:d3f5505a-0bdb-483b-9bb3-a665aa8fa5b1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-109.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:09:19 -0400</pav:createdOn>
    <ao:exact>nifedipine</ao:exact>
    <ao:prefix>after a single dose of 20 mg </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:d3f5505a-0bdb-483b-9bb3-a665aa8fa5b1"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> by factors of 2.2 and 3.1, re</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2ABA45E5-17F2-4594-AFA1-0512E25679C5">
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10DAC482-B71A-46FA-8963-FB7439C208D6">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/59763</dailymed:activeMoietyRxCUI>
    <rdfs:label>stavudine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4DB3901-31B5-4984-B1A2-D06F355747BD">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>D4DB3901-31B5-4984-B1A2-D06F355747BD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 00:14:23 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4DB3901-31B5-4984-B1A2-D06F355747BD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Co-administration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1ea69e04-7e08-4809-bf85-09236c8dda10">
    <pav:createdOn>2014-07-07 08:09:16 -0400</pav:createdOn>
    <ao:exact>tacrine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> Cmax and AUC, respectively, c</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1ea69e04-7e08-4809-bf85-09236c8dda10"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-85.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and eight-fold increases in </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64c2df6e-bbb4-49b2-85f4-154ca048fba7">
    <ao:exact>conivaptan</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>ay for 3 days. Mean Cmax for </ao:prefix>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:64c2df6e-bbb4-49b2-85f4-154ca048fba7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> was 619 ng/mL and occurred at</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30D424F6-3E95-4F93-B5B8-5461391BEEA9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdOn>2014-07-20 20:46:21 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:b92686cf-78e8-47e8-a8d4-767477cf1b9c</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:47:11 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6C67093-B83F-46A1-A581-1D36BE3D85E9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66014D4C-8DCF-428C-A4FB-10DC8A3E36BB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66014D4C-8DCF-428C-A4FB-10DC8A3E36BB"/>
    <pav:createdOn>2014-07-14 13:57:23 -0400</pav:createdOn>
    <ao:suffix>. This possible drug interaction should be considered when</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:exact>Metronidazole has been reported to potentiate the anticoagulant effect of warfarin and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time</ao:exact>
    <domeo:uuid>66014D4C-8DCF-428C-A4FB-10DC8A3E36BB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9E3F4BF7-61B1-449D-AB93-F8E8EF53F25F">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4AB3F0EB-37F3-4B4B-AFCF-6C69F0314EA3"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:8174B810-E408-49FB-BA8C-C21B362AF392">
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="N2f99462895f94f928cf2800fa3a48734"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-20 21:25:23 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/ff6014c3-a89b-44e5-af62-f0623f958a50"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F5518D9-E5B3-446E-97D7-47FD4A6369F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABDD3FF1-CCBC-447B-AB65-DB9167759343"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lineageUri>urn:domeoserver:annotationset:47b96dd3-a21e-47cc-b7ee-3de367a95ec8</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:4C66B0D6-BBDE-43AE-B42D-3A3A6C041B23</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51A456EA-41D7-4564-92A5-24D17C879A5D">
    <domeo:uuid>51A456EA-41D7-4564-92A5-24D17C879A5D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:51A456EA-41D7-4564-92A5-24D17C879A5D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>are administered over the course of several hours while the patient's condition and vital signs are under careful observation. (Intravenous </ao:prefix>
    <ao:suffix>or prednisolone have been used to treat severe reactions, with the addition of intravenous chlorpromazine in those cases exhibiting hypertension and hyperpyrexia. The usefulness and safety of narcotic antagonists in the treatment of these reactions is un</ao:suffix>
    <pav:createdOn>2014-07-14 15:42:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:exact>hydrocortisone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB833643-1BB9-4375-87DE-96696F930A93">
    <domeo:belongsToSet>urn:domeoclient:uuid:CCB6474C-E1D3-4268-BF2A-E1AFDA289F56</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB466D24-CA50-430F-B8FA-5061B5E6D43C"/>
    <pav:lastSavedOn>2014-07-14 15:33:30 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:136907AA-A3B1-46B2-807D-864CE7BB7021</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:33:19 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93426740-A609-40A0-9E36-49973C8CB84B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A27C5B12-EBFF-4386-A031-3299F29ADE42"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:13:55 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7C83C8C9-0D52-4D2F-8890-E9F69B4E65C1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AEDF6EED-7EC2-4959-BE6B-8370EC949112"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/78303A4B-BD0B-46AE-9C10-5390385C9579"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76E8C4F6-1F71-435F-A40E-2A8811775877">
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:DD34E39F-1296-4ADA-BBA5-6AECFCDEF0AB</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB5B2D9E-4DF7-4736-87A4-E3DFD672B769"/>
    <pav:createdOn>2014-07-14 15:47:30 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N3ffa64939e9e471baabbe47f8919f0c9"/>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E7BB31A-CBE9-4FD7-BF48-3700BF9BBF6B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F3B8E39B-502B-4887-B0C7-B8251595AADE"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:221b47ac-9621-4db5-afb0-9d3d98babebe">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:221b47ac-9621-4db5-afb0-9d3d98babebe"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>pine 10 mg capsule and 60 mg </ao:prefix>
    <ao:suffix> coat-core tablet with phenyto</ao:suffix>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nifedipine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-115.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57DB318A-AA7B-4257-A972-9810A2CB86D6">
    <ao:prefix>dose for at least 6 weeks. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>57DB318A-AA7B-4257-A972-9810A2CB86D6</domeo:uuid>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <pav:createdOn>2014-07-13 23:53:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57DB318A-AA7B-4257-A972-9810A2CB86D6"/>
    <ao:exact>There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%). The Cmin increased 157% ± 96% (range: 33 to 360%). The apparent oral clearance decreased 45% ± 15% (range: -15 to -60%)</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBFA9270-6F9B-4389-96DA-CCFBCD34611C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BBFA9270-6F9B-4389-96DA-CCFBCD34611C"/>
    <ao:exact>In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>BBFA9270-6F9B-4389-96DA-CCFBCD34611C</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-13 14:56:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87EF6045-0E89-402E-8935-1D573FC4CA1C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:1794100C-4C38-4154-9980-B12DD6F615EB</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:464F68C8-1694-4800-B2DF-F9770157C3FE"/>
    <ao:body rdf:nodeID="N9a0d7b0b06714b92af0039486613e2fe"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:39:57 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:31:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na8937d0bd8b8474696e7ef176fe03d72">
    <domeo:sets rdf:resource="urn:pddi:uuid:3E6B5106-3F39-4E7E-A2B1-9DD87D37315C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A8E41BB9-C4B7-4A69-906F-3206A3AB67A9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/10DAC482-B71A-46FA-8963-FB7439C208D6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8B760DD1-5F03-4F94-AE5D-81FF3521C4DA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A78F5331-D727-4933-ACEB-25D18E39AA1A">
    <pav:previousVersion>urn:domeoserver:annotationset:D3FADC53-0CE2-4864-9B1E-954356539008</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:body rdf:nodeID="Na3bc410c4ca740e99355b4f1f9778492"/>
    <pav:lastSavedOn>2014-07-20 22:02:37 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">14</pav:versionNumber>
    <pav:createdOn>2014-07-20 22:02:35 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:24DB52AD-E793-4A6E-B4CF-F0BAA1421330"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66793693-4af2-4f8f-ae38-b2b894d8b298">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:08:55 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66793693-4af2-4f8f-ae38-b2b894d8b298"/>
    <ao:suffix> in 20 normal male volunteers.</ao:suffix>
    <ao:prefix>lowing the administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-31.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7BAB0BC2-81F4-4EFE-B350-702384003328">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E05590F3-5B2D-4B59-94D7-EEEE42491D85"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8BE3EAC-A77F-4A17-B4C0-BC8BE502CCD2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8BE3EAC-A77F-4A17-B4C0-BC8BE502CCD2"/>
    <ao:exact> Propranolol did not have an effect on the pharmacokinetics of fluvastatin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:06:37 -0400</pav:createdOn>
    <domeo:uuid>A8BE3EAC-A77F-4A17-B4C0-BC8BE502CCD2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, but did not alter their pharmacodynamics.</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DABDBDEB-926C-4903-8855-23E82662F9B7">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:53:36 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D43D723-6A5D-49C8-9684-291C519A0C99"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7F37B01-1324-449A-A8F7-9C96CE99B5ED">
    <pav:createdOn>2014-07-14 15:42:00 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:917227A6-6882-4EDC-9187-C16EB061E754"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:33DDC457-432C-49E2-B462-5FE55D31415E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0A8EB37F-7C12-4832-A5C2-B5333A576E93">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/13737EFC-0D15-4A99-B68E-0E6A4D9BAA39"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/36166449-43D4-4B67-9625-65F7B03F08AE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AE5102D3-EDFA-4812-A978-6A91D2DBD026">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>digoxin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:456e383f-5eb5-4c7d-8fd7-3c93dadcc92a">
    <ao:suffix> increased the midazolam AUC a</ao:suffix>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:456e383f-5eb5-4c7d-8fd7-3c93dadcc92a"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:prefix> On the sixth day of dosing, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-32.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D31ADB0-89B2-4CC9-B818-E1337FACE0E9">
    <ao:prefix>(5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9D31ADB0-89B2-4CC9-B818-E1337FACE0E9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:suffix>alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>procyclidine </ao:exact>
    <domeo:uuid>9D31ADB0-89B2-4CC9-B818-E1337FACE0E9</domeo:uuid>
    <pav:createdOn>2014-07-14 00:08:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E45AB687-4DA6-45DA-9F9D-38B84921AC27">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:665295FE-D70B-4293-8D1C-E81A5B0FF5E7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BF03B48-E861-45F1-A97F-422B192D4879">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 00:17:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:0B6C4CEC-10A4-42BF-9CA3-57FDB770ED02</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:25F0D12B-D8EC-447B-B1E9-2252F9B8001A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 00:18:31 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:CB97FFC5-B995-4858-91DF-45F2675318E9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:30F74A41-9113-481E-862D-D43B9DFD7A58">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:17D21B8A-6F46-4CC9-8B74-7302D386DA11"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:92FBAE8F-F471-41C9-9B04-B8DC58761B17">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EABA63DF-BDDB-4F00-AA39-2B82E5E22B7A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7B51A7A-B3D1-4922-908B-0D816DD32A36">
    <ao:suffix>. </ao:suffix>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7B51A7A-B3D1-4922-908B-0D816DD32A36"/>
    <pav:createdOn>2014-07-20 21:52:25 -0400</pav:createdOn>
    <domeo:uuid>B7B51A7A-B3D1-4922-908B-0D816DD32A36</domeo:uuid>
    <ao:exact>16βhydroxylevonorgestrel</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/06EE1461-B811-4FAF-8C18-CA543B3859D1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/349B2C65-9C79-4D0A-A4BB-47B56BF85AF7">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C8D2B81-D693-4C24-9648-AC96B3688E35">
    <ao:suffix>inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazo</ao:suffix>
    <ao:prefix>metabolism can be inhibited by the </ao:prefix>
    <domeo:uuid>2C8D2B81-D693-4C24-9648-AC96B3688E35</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>CYP3A4 </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C8D2B81-D693-4C24-9648-AC96B3688E35"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:12:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FAA99DF-F0F3-4209-93DD-6B3C5F1E4E36">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:11:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:625339B0-E33C-4275-B545-10EB2041FE72"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0519F930-889D-4B19-96E0-3795C5DAF399">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:96D666C3-78BD-47F1-BF8E-5E87B88B41EC"/>
    <pav:lastSavedOn>2014-07-14 14:56:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:BDABD402-9E1C-4D3B-B61B-AA43A598C142</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <ao:body rdf:nodeID="N00cafe36066f4cbe864e30bd79d95492"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-14 14:56:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAE921BA-12A3-476F-B963-2839ED645444">
    <pav:lineageUri>urn:domeoserver:annotationset:e17d8d63-b009-4463-827b-f6bbf67ddbfd</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:46901420-9E20-4E05-B060-4C55DE5DF57A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ADA754D7-8F98-4A1B-A03A-7494BA24B16A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:ded87f0b-81cc-48a9-af9e-c749ae82d145</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:26:28 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N910a0b1e33dc40b6b0bb328996c67ecd"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:26:29 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30AFA474-E4E7-4C5A-ABF1-C9EC45F21378">
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">12</pav:versionNumber>
    <ao:body rdf:nodeID="N5a169a8bdd5b4264a5ae83990336113a"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E60EAFDC-5866-46BD-B973-529C7160DA06</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:16:25 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:16:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4319A90A-4182-4E21-A4F3-8C189FF40FD0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F1D8500-6607-4DA2-A342-BE1227AE3A39">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F1D8500-6607-4DA2-A342-BE1227AE3A39"/>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>3F1D8500-6607-4DA2-A342-BE1227AE3A39</domeo:uuid>
    <pav:createdOn>2014-07-20 20:37:46 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9FFED551-DACD-47D2-B92F-8CF37055DEE6">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ED1F9738-C8E2-4846-B93B-CEFA0C5A56DF"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A44D91F-F86F-48CB-BFF5-CB7A3CDE8615">
    <ao:body rdf:nodeID="Na862c22b02134bcd9aed9f7bd816032f"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF312A94-575B-4B8B-A18C-9AACB3205407"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:23F36509-0614-43F9-924D-7EF7B847092B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:04:20 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:04:22 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:665295FE-D70B-4293-8D1C-E81A5B0FF5E7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8E02A321-E6BE-48B0-AD2C-FD1D27993FC5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1E6DC764-6D1F-4200-A5CA-249EE1992D55"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC296F6D-5DB5-4763-AAD4-16B8322506D4">
    <ao:prefix>are increased by 64% and 79%, respectively, by co-administration of </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC296F6D-5DB5-4763-AAD4-16B8322506D4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>DC296F6D-5DB5-4763-AAD4-16B8322506D4</domeo:uuid>
    <ao:exact>propranolol</ao:exact>
    <pav:createdOn>2014-07-14 14:53:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58F72512-576D-402B-A522-563246BFB1F0">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:37:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:935A3E41-35EA-4680-AFD3-93EC7AE37C97"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/87ce4dff-d0b5-41af-a8c9-c30613809c52">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:64c2df6e-bbb4-49b2-85f4-154ca048fba7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:4953480f-4108-4568-a18c-d806b07c6b57</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:09:12 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:551EB5AD-9916-4F08-A9AF-C986C18F9AA7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6A356CB5-7309-4F66-96BD-7AD69E3B869C">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DC91A43D-92CC-45A9-93A9-2419C468B150"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:939E6E39-63EA-4BDA-92CF-4473C5F8254A">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:47:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1DCD6F21-199D-49F7-9E03-1C71E495E7C7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:321AC642-D121-437D-91F7-FF9B59B85958</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:48:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5279783C-4656-44AD-9D33-3295D5E3CF29">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:9551BD57-E803-487A-B670-23EA129D54A7</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:30:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:31:07 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:74D65DF9-9F25-4D02-A82C-4401E6E04533"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E9935ADA-14AE-44E8-83F1-ED2A61242989">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>indinavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/114289</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08357EC7-543C-42F8-8ED4-776EEDC7BAC2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:21:21 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Na1d8e5c332164c2bbf4ea7724814b1b6"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2FF70D26-9D33-4871-987F-9CC7C792F8E1</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:21:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:39AB4B6D-18E5-435D-8BE4-19DD2E0F6323"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B6F5B65E-BB4E-4ED0-8C90-DCF7C40D0798">
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B9CDC9DC-84A8-452D-8D30-3281FE6EE381">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>avandia</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:398AD193-EFD5-4789-ACAD-65E9E3D92EB1">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 00:24:05 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED6A04D4-A224-43A8-A174-A2FAD4C807EE"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0B9E38A3-513E-439D-AB4A-0C99491A881F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:75CFE42C-4C0E-47B3-8935-B8E8130DE959"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21105C35-24BE-42D6-91BE-E8098A83CA63">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:58:22 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N41c92df6c10448aabda96bd0b53cf696"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:44AC7B14-15B3-4219-8906-379A35F61CEF"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:createdOn>2014-07-20 21:57:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:0D9DD421-A8FE-400F-8177-B36F3FFB880C</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4779F991-0CD3-45E7-84DB-6DD8C19FDCE2">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdfs:label>diazepam</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65E13557-2211-4E38-9F17-B33E6FF2D2A8">
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAA5A7A6-84FE-4ABF-A7FB-47F245D8854F"/>
    <pav:createdOn>2014-07-20 20:19:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:6e22c92c-7297-4e91-ba82-ac1dc0a550ab</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:20:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6BF3CF06-11E2-4144-8384-6127B6B5A3A8">
    <rdfs:label>nifedipine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F7A843C9-3689-4284-A39E-306E925D047E">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C49A99DB-6535-4834-8793-87F74FBE696B"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F02D73D6-918D-4625-8089-029A3CC832BD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F661C953-C092-4CF9-A834-4064239448F2">
    <ao:prefix>Population pharmacokinetic analyses from 3 large clinical trials including 642 men and 405 women with type 2 diabetes (aged 35 to 80 years) showed that the pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F661C953-C092-4CF9-A834-4064239448F2"/>
    <domeo:uuid>F661C953-C092-4CF9-A834-4064239448F2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>are not influenced by age, race, smoking, or alcohol consumption. Both oral clearance (CL/F) and oral steady-state volume of distribution (Vss/F) were shown to increase with increases in body weight. Over the weight range observed in these analyses (50 t</ao:suffix>
    <pav:createdOn>2014-07-14 14:15:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8046D798-CE5E-424C-A505-4DCEF2C7A1B1">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8046D798-CE5E-424C-A505-4DCEF2C7A1B1"/>
    <ao:exact>cimetidine</ao:exact>
    <pav:createdOn>2014-07-13 15:54:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14</ao:suffix>
    <ao:prefix> 100 mg was administered as a single oral dose alone and two hours after a single dose of </ao:prefix>
    <domeo:uuid>8046D798-CE5E-424C-A505-4DCEF2C7A1B1</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D8A0D55-4F25-48B4-AB24-56A28BB0519B">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A36EEE57-DE0D-4DD8-841A-156CD3EEE12E">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:109B2520-9019-4761-A1B4-DCBD1CF3730A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:22:53 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1790B3D-22E8-48F8-9BCF-5B21EF0E9EFA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentr</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E1790B3D-22E8-48F8-9BCF-5B21EF0E9EFA"/>
    <pav:createdOn>2014-07-14 16:01:26 -0400</pav:createdOn>
    <ao:prefix>to </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>E1790B3D-22E8-48F8-9BCF-5B21EF0E9EFA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/32C7ABCC-0D31-40BE-936E-A2F53238AF85">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79FE78F2-7123-4AEA-AD1B-5E5CDB703C66">
    <ao:suffix> (2 × 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox®1) decreased fexofenadine AUC by 41% and Cmax by 43%</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79FE78F2-7123-4AEA-AD1B-5E5CDB703C66"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:21:11 -0400</pav:createdOn>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <domeo:uuid>79FE78F2-7123-4AEA-AD1B-5E5CDB703C66</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0B8A783-7E49-4CC6-AB35-1B52E96A9092">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:29:58 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and rosiglitazone (4 mg once daily) for 7 days increased rosiglitazone AUC by 127%, compared to the administration of rosiglitazone (4 mg once daily) alone</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0B8A783-7E49-4CC6-AB35-1B52E96A9092"/>
    <ao:suffix>. Given the potential for dose-related adverse events with</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>B0B8A783-7E49-4CC6-AB35-1B52E96A9092</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88352EB3-5DB8-47ED-8B33-617597299006">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:35:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:suffix>is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <ao:exact>azithromycin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88352EB3-5DB8-47ED-8B33-617597299006"/>
    <ao:prefix>. Although a dose adjustment of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>88352EB3-5DB8-47ED-8B33-617597299006</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:271BB10A-D02C-45D2-B46E-982A65CD551A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F02D73D6-918D-4625-8089-029A3CC832BD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D63E7F0E-01C8-4159-9D12-DDD9188EE515"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C098CF71-98BD-4B5B-976D-9D9611326D7A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C098CF71-98BD-4B5B-976D-9D9611326D7A"/>
    <ao:suffix>does not affect the pharmacokinetics of propranolol.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:prefix>. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:54:46 -0400</pav:createdOn>
    <domeo:uuid>C098CF71-98BD-4B5B-976D-9D9611326D7A</domeo:uuid>
    <ao:exact>Verapamil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F006A75-990B-411A-8E2E-C47907768CA6">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:24602923-6C93-4FB0-829C-2483B51104AD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1ACE704-1881-4616-8238-C3E9A98146B9">
    <domeo:uuid>C1ACE704-1881-4616-8238-C3E9A98146B9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1ACE704-1881-4616-8238-C3E9A98146B9"/>
    <pav:createdOn>2014-07-14 14:24:35 -0400</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>norethindrone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/09745AFD-D8F9-462F-BF5B-E866CBD25325">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:18E1DCEC-8EC9-4234-A56D-11EF3AA8DF89">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A4F61E62-1D94-4511-B7A3-D2C56C6931BB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e143046de7980014702a55a6b0058">
    <foafx:homepage></foafx:homepage>
    <foafx:name>nonexpert3</foafx:name>
    <foafx:title>nonexpert3</foafx:title>
    <foafx:lastname>3</foafx:lastname>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    <foafx:firstname>nonexpert</foafx:firstname>
    <rdfs:label>nonexpert3</rdfs:label>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
    <foafx:email>boycer@u.washington.edu</foafx:email>
    <foafx:middlename></foafx:middlename>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C990C802-3E03-4941-BF27-D0ABB28068F3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C990C802-3E03-4941-BF27-D0ABB28068F3"/>
    <ao:exact>glyburide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>C990C802-3E03-4941-BF27-D0ABB28068F3</domeo:uuid>
    <pav:createdOn>2014-07-14 14:11:15 -0400</pav:createdOn>
    <ao:suffix>at week 52 were statistically significant.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307">
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:43C62C1D-C7E6-4C37-A40A-42AC965306C4"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="N321a36df8b4046a68660b97c640eb618"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:77B38702-1D76-480C-B0B1-B21475D8164C"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:30adb140-db74-40d7-a084-0046c4d69196</pav:lineageUri>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/2ff11213-d217-4bb7-81d1-7133062f4625"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C617450-1F44-4F18-B444-ACC7383D721B"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:annotatesResource>
    <pav:previousVersion>urn:domeoclient:uuid:701967fc-74e5-49c3-8c04-8b715684fe00</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:08:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1871BB3-1B3F-4173-A606-3843483F8AAE"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3923697-9CF3-4C48-B7CD-D052D09C0DA2"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-20 22:06:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE177F66-740A-4832-86C6-444F7F7E3E28">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE177F66-740A-4832-86C6-444F7F7E3E28"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>EE177F66-740A-4832-86C6-444F7F7E3E28</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:02:00 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74005337-F273-4F8B-B7D2-B98BE2A52B18">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>whereas ranitidine increased the AUC of risperidone and 9-hydroxyrisperidone combined by 20%</ao:exact>
    <pav:createdOn>2014-07-20 22:11:54 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74005337-F273-4F8B-B7D2-B98BE2A52B18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>74005337-F273-4F8B-B7D2-B98BE2A52B18</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4AB3F0EB-37F3-4B4B-AFCF-6C69F0314EA3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4033ACE4-AA22-470E-BB24-5B38B949FF75"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D0616EF-BE18-4B8B-879A-2CB0C293929C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4490C5F6-212F-4CBC-8F6A-AD57B556EBC2">
    <pav:previousVersion>urn:domeoclient:uuid:4d867608-6034-4082-aeba-08fb4f0d59a4</pav:previousVersion>
    <ao:body rdf:nodeID="N41f7afc058854847b9d1303e5fdc241e"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 21:21:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2CA8D60-E691-4A31-BA4D-BE52E838AF6A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 21:21:42 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1939CDD3-87C8-49DC-A16B-9CE0A40A6331">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>tacrine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8F4575A-6E81-41A7-9180-23E52174F1E7">
    <pav:previousVersion>urn:domeoserver:annotationset:D3FADC53-0CE2-4864-9B1E-954356539008</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:02:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED3121E4-8B7C-4FB3-9B8D-35F3B6C92CD0"/>
    <ao:body rdf:nodeID="N4f451dd750964440ab791f354b7fb25f"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">14</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:02:37 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/39975397-3C66-4E9E-AE43-B41D4A47ACB1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90638CFD-3676-442F-A5C4-0C0D91A67C0A">
    <ao:context rdf:resource="urn:domeoclient:uuid:E21D1443-5FF2-44C6-981C-9FCFB1DA42A3"/>
    <pav:createdOn>2014-07-13 14:57:13 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N03b991762c814bd4b3911658afc6e256"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 14:58:45 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:332ECA06-AD34-474C-AB42-E4F8D696C535</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EB580B9-E1F2-4D5A-BAC7-B74CBB3D79F2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EB580B9-E1F2-4D5A-BAC7-B74CBB3D79F2"/>
    <ao:suffix> in the slow metabolizers, and because steady-state conditions are achieved after 4 to 5 days of dosing in all patients, the recommended dosing regimen of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:22:09 -0400</pav:createdOn>
    <ao:prefix> pharmacokinetics is linear. Because the difference decreases at high doses and is mitigated by the lack of the active </ao:prefix>
    <domeo:uuid>9EB580B9-E1F2-4D5A-BAC7-B74CBB3D79F2</domeo:uuid>
    <ao:exact>5-hydroxymetabolite</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D8403819-0361-487F-8B8A-C5D0191CA73B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/49131E07-9C7D-4E6E-82BF-380178DA4CFA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EDC0F193-125D-47F1-9BF2-6FD1BA33CE0C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AAA91473-653C-480F-9C91-6E28EE5C0D15">
    <pav:createdOn>2014-07-07 09:37:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:0CA3582A-BE38-4247-AAF5-6A6F6DDF5593"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B251B9A8-A616-4200-B88E-BFB7235774F5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EDA670C0-B908-4388-8BB9-AA9D407DF68D">
    <rdfs:label>digoxin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7E04482-9101-4365-BD5F-E1F93FB2EB13">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:050AE3EA-FA24-4A46-84DE-D6F7D32DCEF2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 09:43:37 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AA712FF-F266-46CE-8830-A90C4AE19B77">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4AA712FF-F266-46CE-8830-A90C4AE19B77"/>
    <ao:suffix>is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of risperidone to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, ha</ao:suffix>
    <pav:createdOn>2014-07-14 16:01:16 -0400</pav:createdOn>
    <ao:exact>Risperidone </ao:exact>
    <domeo:uuid>4AA712FF-F266-46CE-8830-A90C4AE19B77</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Metabolism and Drug Interactions: </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4619DA8A-3B4D-4161-8846-E657C8F74F42">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:124B7EBA-78D6-4D17-A8C3-0E0EB5858BEB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:05:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:05:05 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C917B771-FB95-4A3D-B8B5-183FE4B30FF1">
    <domeo:uuid>C917B771-FB95-4A3D-B8B5-183FE4B30FF1</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C917B771-FB95-4A3D-B8B5-183FE4B30FF1"/>
    <ao:exact>azithromycin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:35:37 -0400</pav:createdOn>
    <ao:prefix>, close monitoring for known side effects of </ao:prefix>
    <ao:suffix>, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERSE REACTIONS).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2644C4A-CD71-4BF2-AA84-53F6AEAF17DB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2644C4A-CD71-4BF2-AA84-53F6AEAF17DB"/>
    <domeo:uuid>E2644C4A-CD71-4BF2-AA84-53F6AEAF17DB</domeo:uuid>
    <ao:prefix>. </ao:prefix>
    <pav:createdOn>2014-07-14 14:35:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>. In Japanese subjects,</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F77E3693-4D30-47E9-AEFB-8D6F448334F7">
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:53:04 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BBE3231F-0615-427F-83B8-D983B42AB82D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C09A520-E13B-4BDC-91AE-DCD8B50E4EBA">
    <ao:prefix> half-life and AUC in patients with impaired renal function (n = 14) following a single 200 mg oral dose (Table 7). Plasma concentrations of </ao:prefix>
    <ao:exact>AMT</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C09A520-E13B-4BDC-91AE-DCD8B50E4EBA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> were not determined. A dose adjustment should not be necessary for patients with </ao:suffix>
    <domeo:uuid>8C09A520-E13B-4BDC-91AE-DCD8B50E4EBA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:48:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27E7BF45-C638-4CC1-8D40-4C8CB5A5CB5F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>27E7BF45-C638-4CC1-8D40-4C8CB5A5CB5F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:27E7BF45-C638-4CC1-8D40-4C8CB5A5CB5F"/>
    <ao:suffix>plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concen</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, and </ao:prefix>
    <pav:createdOn>2014-07-14 15:53:13 -0400</pav:createdOn>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8C7CE011-0E6A-4F7B-8D5C-594C5A825005">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D386336B-C8D4-4DEF-A1A2-1A23CAF2EFBC"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F55477B-2C26-44F6-BBEB-B9B47914B0B0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6922</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>metronidazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17F34F7F-E25E-44F5-93C8-01A2B1B1BDD6">
    <ao:exact>5β-tetrahydrolevonorgestrel</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:17F34F7F-E25E-44F5-93C8-01A2B1B1BDD6"/>
    <pav:createdOn>2014-07-20 21:52:06 -0400</pav:createdOn>
    <domeo:uuid>17F34F7F-E25E-44F5-93C8-01A2B1B1BDD6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <ao:suffix> are also present in plasma, along with much smaller amounts of 3α, 5α-tetrahydrolevonorgestrel and 16βhydroxylevonorgestrel. </ao:suffix>
    <ao:prefix> is conjugated at the 17β-OH position to form sulfate conjugates and, to a lesser extent, glucuronide conjugates in plasma. Significant amounts of conjugated and unconjugated 3α, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8661B8B0-3D68-4D28-9DCE-DB3B508D0400">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:14D23C6A-BD1A-40F2-81C2-F0DBB93DC645</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:88666D2A-5D3B-46F7-9326-9197168C6938"/>
    <pav:createdOn>2014-07-14 16:06:47 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N24199442850e4823a622b33a0a3ae19f">
    <domeo:sets rdf:resource="urn:pddi:uuid:68957D9B-ACCE-414F-9A05-BFF679207D36"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C3CED62B-7A1D-4715-BE4B-E10D323C589A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/348ED40D-3D5E-46D3-8B35-2CCEB0540022"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E19F86E4-2875-482D-A744-BA05C600F762"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE25CF3B-9AF9-4457-81F6-F7034B3900E0">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:21:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DBA559A-FC52-400A-AC4C-7F559D51382E"/>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:15578221-1D32-4DCC-92D5-BA56CEE29371">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4C0CD04C-A333-477B-97FA-92306CA5224B"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N45d5ec436c6f4e1d928f4ff303508e5a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:382C65D8-90C4-4FC9-AECE-C467CC36503D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>. This is based on the results from three clinical studies using histamine induced skin wheals and flares coupled with population pharmacokinetic analysis. The size of wheal and flare were significantly larger when </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:382C65D8-90C4-4FC9-AECE-C467CC36503D"/>
    <ao:suffix> was administered with either grapefruit or orange juices compared to water. Based on the literature reports, the same effects may be extrapolated to other fruit juices such as apple juice. The clinical significance of these observations is unknown. In a</ao:suffix>
    <pav:createdOn>2014-07-14 15:31:36 -0400</pav:createdOn>
    <domeo:uuid>382C65D8-90C4-4FC9-AECE-C467CC36503D</domeo:uuid>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:605C3C8F-6ED3-4242-9772-981FED64FB93">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:20BBF6E7-21B7-4808-9376-3BF169E0DA8E"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1ADBB4BB-0B79-4B5A-AB3E-6B67CE15EA39">
    <ao:prefix>. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:exact>The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1ADBB4BB-0B79-4B5A-AB3E-6B67CE15EA39"/>
    <pav:createdOn>2014-07-13 23:58:22 -0400</pav:createdOn>
    <domeo:uuid>1ADBB4BB-0B79-4B5A-AB3E-6B67CE15EA39</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73200C30-2582-473B-BBF0-A8B88C5D08A7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>acetaminophen</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05C4AD4C-EE22-4B10-93F1-58F1F80C036F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05C4AD4C-EE22-4B10-93F1-58F1F80C036F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Coadministration of carbamazepine with nefazodone results in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. Coadministration of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>05C4AD4C-EE22-4B10-93F1-58F1F80C036F</domeo:uuid>
    <pav:createdOn>2014-07-14 13:51:03 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:593206DE-6B60-4404-B7C1-4F46BD29CB6E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EDB43603-7A0A-49AF-B2C6-37B0BF7D79FE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:42:49 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A937B89D-5425-4F4A-8E11-94520EC6C7C8">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EAEE64A7-CF36-45A6-A47C-DC3395498A7F"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DEFF6F71-4DAE-4A00-8C69-0659AFC29CF1">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <rdfs:label>rosiglitazone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CFF0C572-27A1-4744-BBF6-7FCB5B91D54E">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DC8E87C-050D-4499-84A3-7FCA33EAD340">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 20:22:40 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:03353D44-B9A1-4651-BD99-0DC8133875F9"/>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2033976B-F874-4E7B-956B-40B658CA469D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:52:54 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:21EDB578-865D-459F-9D95-9236D1154981"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:68B5D673-3DEA-4E97-834D-35CCF1011A9F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9A3C7EA5-81A2-4747-9EC7-7790912C3041"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A5C6ED3F-F83E-472E-BA65-A7E791BEFCCE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F42DB7E3-2384-440A-A103-1C9D3D952062">
    <domeo:belongsToSet>urn:domeoclient:uuid:E49A2FF1-3433-401B-BC4C-02CCC11D74A4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3B2CCE2C-429A-412B-BBEF-6E686A73C32E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:43:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:674875AE-DCF1-4BBD-9267-E731C58A4C69"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:43:08 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F92D55A-2A47-4519-BDB4-DAD8E8BD588E">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:05C4AD4C-EE22-4B10-93F1-58F1F80C036F"/>
    <ao:body rdf:nodeID="N871c35198bc94f4d8af24ad7242297b7"/>
    <pav:lastSavedOn>2014-07-14 13:51:02 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
    <pav:createdOn>2014-07-14 13:51:03 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E8EAB7E9-C458-4E6E-9AB5-E4A3F099F5EB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED4BC8F1-515A-4681-8194-802B920EB45A">
    <ao:context rdf:resource="urn:domeoclient:uuid:D49C0874-F0CE-46ED-990B-86226E4F2C32"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 00:29:04 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:F1821F89-9333-4E85-BAEE-68D0747727C3</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 00:30:03 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B06ECAA-52F8-419F-A47B-2B99C705DFAF</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479">
    <ao:item rdf:resource="urn:domeoclient:uuid:669E920E-396B-462B-AC4D-481E8F50D445"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5D9BF3D5-3958-4415-B734-388AE452162D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:475E3B29-A953-4362-9AFB-734B47790E99"/>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:09B8A373-C6AA-4951-A8D2-F7AE5D696B36"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:E2FA1722-AFAC-4911-86CB-4E0FB7420FF5</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:4130CB79-C342-4E40-AF40-F141CDBC4513"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:80D806E1-7D43-4654-B166-F2716BEAE049"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:FC056A21-615F-44B8-8E1B-A2A2E8DCB977</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:39:41 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Nae44827563c94e83a6640cc7f48d59be"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:38:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE0BA818-EB34-49AB-8619-92F93C8EF114">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE0BA818-EB34-49AB-8619-92F93C8EF114"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 14:45:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>AE0BA818-EB34-49AB-8619-92F93C8EF114</domeo:uuid>
    <ao:exact>Repeat oral dosing of AVANDIA (8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of digoxin (0.375 mg once daily) in healthy volunteers</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4CF0705-EC2A-4E95-95FD-59BF5CA9A244">
    <domeo:uuid>A4CF0705-EC2A-4E95-95FD-59BF5CA9A244</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4CF0705-EC2A-4E95-95FD-59BF5CA9A244"/>
    <pav:createdOn>2014-07-14 14:28:45 -0400</pav:createdOn>
    <ao:prefix>may be needed when </ao:prefix>
    <ao:exact>gemfibrozil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75881584-7AB7-48E9-BB30-9B332B3D1661">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:75881584-7AB7-48E9-BB30-9B332B3D1661"/>
    <ao:exact>Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <domeo:uuid>75881584-7AB7-48E9-BB30-9B332B3D1661</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:33:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:676D2C9A-DA84-49E3-9398-72BAE4D0F643">
    <domeo:uuid>676D2C9A-DA84-49E3-9398-72BAE4D0F643</domeo:uuid>
    <ao:prefix>is a substrate of the </ao:prefix>
    <pav:createdOn>2014-07-14 15:12:31 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:676D2C9A-DA84-49E3-9398-72BAE4D0F643"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>cytochrome P450 3A4</ao:exact>
    <ao:suffix> (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of tra</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/81422E90-7EE1-49DF-BA32-EAC27947E134">
    <rdfs:label>zidovudine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3535630-AEAB-4817-93D6-0BCC37D4C8A1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-20 20:58:11 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:57:57 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8539392-BAD3-47FB-A09D-AE6A4742CA9C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:188066D2-D8DF-41BA-8D27-20EBE6CC91EC</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7908ABA8-9CF7-4EA8-A4A7-E69CDC721213">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7b51bc9aebaf4e47973df3908df4568c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE65945C-A3A8-4FE9-9507-1BD45BE40703">
    <domeo:uuid>EE65945C-A3A8-4FE9-9507-1BD45BE40703</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE65945C-A3A8-4FE9-9507-1BD45BE40703"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concomitant administration of a single 100 mg dose of sildenafil with 10 mg of atorvastatin did not alter the pharmacokinetics of either sildenafil or atorvastatin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-07 11:17:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:056507AB-98C8-4455-B54E-FE0A47E80095">
    <pav:createdOn>2014-07-14 00:06:46 -0400</pav:createdOn>
    <ao:suffix>(500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>056507AB-98C8-4455-B54E-FE0A47E80095</domeo:uuid>
    <ao:prefix>In 13 normal male volunteers, there was significant increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tolbutamide </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:056507AB-98C8-4455-B54E-FE0A47E80095"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1F3954E2-12AF-4180-9D89-F124A8E8A02F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1F3954E2-12AF-4180-9D89-F124A8E8A02F"/>
    <ao:exact>naphthyloxylactic acid</ao:exact>
    <domeo:uuid>1F3954E2-12AF-4180-9D89-F124A8E8A02F</domeo:uuid>
    <pav:createdOn>2014-07-14 15:11:16 -0400</pav:createdOn>
    <ao:suffix> and glucuronic acid, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <ao:prefix>, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne91dadaeffc442c6a034790e0f269cd5">
    <domeo:sets rdf:resource="urn:pddi:uuid:1849BC60-0B75-40A2-8004-9426E9AAC74C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD5E204D-1584-45B4-B4BC-98D54BB50E09">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:11:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A441F1E-2DC6-402E-97CA-DE8DA2F93DE6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E575BE29-6C29-4B77-852F-5D1C46C0E976">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E575BE29-6C29-4B77-852F-5D1C46C0E976"/>
    <ao:exact>Fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E575BE29-6C29-4B77-852F-5D1C46C0E976</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-13 15:54:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:suffix> 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66989149-6046-43D5-B767-424E2541CB6E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66989149-6046-43D5-B767-424E2541CB6E"/>
    <ao:exact> In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either erythromycin or ketoconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>.</ao:prefix>
    <pav:createdOn>2014-07-14 15:28:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>66989149-6046-43D5-B767-424E2541CB6E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CA3582A-BE38-4247-AAF5-6A6F6DDF5593">
    <ao:prefix>Studies in vitro have shown that </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0CA3582A-BE38-4247-AAF5-6A6F6DDF5593</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0CA3582A-BE38-4247-AAF5-6A6F6DDF5593"/>
    <ao:suffix>is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, &gt; 80-fold for PDE1, &gt; 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5</ao:suffix>
    <ao:exact>sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:37:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndf6b2d8e79714c69865060c2d01ac7d2">
    <domeo:sets rdf:resource="urn:pddi:uuid:CEAF3DDF-3578-401E-9FFB-29D5837D4BF3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74C593C1-62E2-474F-8664-18E528C125D2">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:29AD0FEE-FAB5-46C6-BFD8-B22F52DC9768</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:21:49 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:20:40 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C18DC32B-72B0-425F-BFAC-C5D7EA334268"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2DDFB4C8-AB61-4CDC-BC65-F6A163765F01">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E032555E-3004-4710-AB25-B8EEB5368379"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E73B03BA-3F7F-4BC8-8B72-F12D9213E592">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/29115</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>maalox</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0F3FCB2-5CF9-4BC2-880D-6E9ED081F67E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0F3FCB2-5CF9-4BC2-880D-6E9ED081F67E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:09:19 -0400</pav:createdOn>
    <ao:suffix>or atorvastatin.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>did not alter the pharmacokinetics of either </ao:prefix>
    <domeo:uuid>D0F3FCB2-5CF9-4BC2-880D-6E9ED081F67E</domeo:uuid>
    <ao:exact>sildenafil </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N33edba192600408dbf553278f2d4aa07">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0988428D-F548-48AE-A856-82357493909C">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>tacrine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/90d43cff-af53-450d-97c6-e286a4ddb4c3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:08:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:e9baa0ba-8ace-46bc-ad37-1407aba4cb5c</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5BD6AA8F-46DC-4A84-891D-E3CE8ADADC9D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7f452791-72fe-4919-b04c-8a8bf26edd08"/>
    <pav:createdOn>2014-07-07 08:08:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:226BEBA2-B133-452C-9BB2-14457F46FE68">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:226BEBA2-B133-452C-9BB2-14457F46FE68"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:08:00 -0400</pav:createdOn>
    <ao:exact>Risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <domeo:uuid>226BEBA2-B133-452C-9BB2-14457F46FE68</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:29F63718-A64E-4517-8D3E-B8FC33AB8992">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A244BE56-4C3C-4954-A724-2FC461C7198D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADCC54B3-8D38-4CF2-83B8-A67981B7DBE0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:1794100C-4C38-4154-9980-B12DD6F615EB</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:9EDD1CE4-01B2-4266-8872-6FFCBDEC546E"/>
    <pav:createdOn>2014-07-20 20:33:43 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <ao:body rdf:nodeID="Nc8b17d3c052b4885ab8d16ef8f429f9c"/>
    <pav:lastSavedOn>2014-07-20 20:39:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7446410-AFD6-4534-8BD2-37101F8219A5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:45FEF3E4-BE3C-4ECB-84FB-AC8367F95563"/>
    <pav:createdOn>2014-07-20 20:20:31 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E0D01ED-1C30-4623-9983-1166A668CDD6">
    <ao:suffix>.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:27:11 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E0D01ED-1C30-4623-9983-1166A668CDD6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials</ao:exact>
    <domeo:uuid>6E0D01ED-1C30-4623-9983-1166A668CDD6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1ef72fb593c449afa3c11a4d40536039">
    <domeo:sets rdf:resource="urn:pddi:uuid:D8E62402-0EF8-4B24-B655-35D5F8D2C0B2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD3FEC06-8F5F-42C2-B94E-46D8D2E9A2B2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2EB42C18-3953-48EA-8026-7A33FFBC87D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 15:57:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1A7C521-2B72-4026-944B-55F50A8D98EA">
    <pav:createdOn>2014-07-14 13:48:40 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:847859C6-A442-4975-956B-43362368C298</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:82425C11-949B-43BD-94F1-40D49ACED4BA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 13:51:02 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB06DF4D-0830-462A-9590-A7DAF82A62D4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D8B56A2-F0C4-40E5-8EBE-20A7103FC3D8">
    <ao:suffix>, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving concomitant nitrates [see Contraindications (4)].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8D8B56A2-F0C4-40E5-8EBE-20A7103FC3D8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8D8B56A2-F0C4-40E5-8EBE-20A7103FC3D8</domeo:uuid>
    <ao:prefix>iastolic blood pressure of 8/5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was not different from placebo at 8 hours. Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg doses of </ao:prefix>
    <pav:createdOn>2014-07-07 09:40:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F58C78F-A896-4BA0-B9BC-4EF4857BD7DC">
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:12:53 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:C02DFCCC-9726-44BD-8697-1228625232F8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED1D9799-1C19-467A-AB21-070D2CD81BCC">
    <domeo:uuid>ED1D9799-1C19-467A-AB21-070D2CD81BCC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED1D9799-1C19-467A-AB21-070D2CD81BCC"/>
    <pav:createdOn>2014-07-20 21:58:20 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C0F6572-0B03-4450-B7EF-9E9CAA481758">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 23:11:36 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 23:11:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:b344dc7c-6e63-4256-a61e-8d0aa7e1c056</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N03a5915f704648fd96af232362f7b6e6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:07F67A89-85ED-4E6F-9A6D-3AA7781FF545</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E4E5392-30AB-4DA7-A09E-15821A00FDC6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:EEC5A3A2-87BE-42FE-BBEB-F8F93FAEACE9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/33EB31A8-F03E-4467-A0C6-BDAD2FC08752">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>omeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A9F3111-7009-4BED-AB9C-093B5D4772BC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:43:08 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E49A2FF1-3433-401B-BC4C-02CCC11D74A4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:887679C4-9244-4B68-A45D-6BF938B0A540"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:43:09 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:0C5A3534-75A1-4CAE-9852-B3508570C93E</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:452026D0-6F5C-4DBE-BC29-7C39FA5273F3">
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:452026D0-6F5C-4DBE-BC29-7C39FA5273F3"/>
    <ao:prefix> interfere with conversion of </ao:prefix>
    <domeo:uuid>452026D0-6F5C-4DBE-BC29-7C39FA5273F3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:02:56 -0400</pav:createdOn>
    <ao:suffix>to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients r</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E5BB4968-9DC2-4C81-AFB3-417F6BB7C373">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4">
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D947F3A-2962-4930-9DF0-1A8889511AFE"/>
    <pav:previousVersion>urn:domeoclient:uuid:9490D06B-E361-4A10-99C6-AE05BA8EE70A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:C62C57C9-D3AF-48D4-8F17-2C1140FDF759"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:96D221DE-719C-4624-8E99-AC931D53B9D7"/>
    <pav:createdOn>2014-07-14 14:59:01 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A1C121E-A46B-4DD7-B058-0437DE8B3665"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:D30DECC7-EF99-492F-9ADD-5A6A22F12DC4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:13F23DB7-73C3-47E8-BC40-8D5ADA660830"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:44B7FBED-89E8-4CDE-B257-5546C265C2AF"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:7411787E-8861-4924-A5B0-9D47943208C0"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-14 15:01:19 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N630c6fda3c824c509aabbac504e1a9fd"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92A4787E-9923-49B7-80F4-F4C6B8613CD7">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:14014694-722B-463D-8CFB-283D360F24E7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:50:45 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DCF8DAE-FCDB-4B1F-B2DF-E09F36479DCC">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E253EFE5-32BE-4DA0-9296-CDE33C3C83F6"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 13:41:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2EE3F305-2EE4-48F4-AAF4-65001B891210</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71EE833C-D364-46D8-93C8-22F3A8890CD8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concurrent administration of AVANDIA (2 mg twice daily) and metformin (500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71EE833C-D364-46D8-93C8-22F3A8890CD8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:44:15 -0400</pav:createdOn>
    <domeo:uuid>71EE833C-D364-46D8-93C8-22F3A8890CD8</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2EC590C0-CFE6-4033-B364-76DF5C9CA5E5">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9D38295B-2A04-46C9-A844-42A65BF78753">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D4556CD-CBA3-4E9F-9F20-4D9AA5326ABE">
    <pav:createdOn>2014-07-20 22:16:13 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Fluoxetine (20 mg once daily) and paroxetine (20 mg once daily) have been shown to increase the plasma concentration of risperidone 2.5 to 2.8 fold and 3 to 9 fold, respectively</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D4556CD-CBA3-4E9F-9F20-4D9AA5326ABE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1D4556CD-CBA3-4E9F-9F20-4D9AA5326ABE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:909923E3-7362-4E33-B8B6-C455FD83097A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 14:49:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:89B3E7E4-2FB6-45D2-8E07-F7C9553F5458"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50B4C61F-99FA-48C1-95C6-A8C257EFA76C">
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:55:22 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:664D6307-208B-425F-93A8-7363152E7FFA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F5AB0C8-ED87-493D-9E3F-61FF2F48B317">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1BAF2432-5347-4A9E-85E1-BA882F94973F"/>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:01:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC7FA80F-0DC3-497A-96E9-C184DEC52643">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Co-administration of long-acting </ao:prefix>
    <pav:createdOn>2014-07-14 15:07:06 -0400</pav:createdOn>
    <ao:suffix>at doses greater than or equal to 160 mg/day resulted in increased thioridazine plasma concentrations ranging from 55% to 369% and increased thioridazine metabolite (mesoridazine) concentrations ranging from 33% to 209%.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BC7FA80F-0DC3-497A-96E9-C184DEC52643"/>
    <domeo:uuid>BC7FA80F-0DC3-497A-96E9-C184DEC52643</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-133.txt.html</ao:hasSource>
    <ao:exact>propranolol </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/237818a2-f844-4ad9-9e0e-0168ac7bdfdd">
    <pav:lineageUri>urn:domeoserver:annotationset:84abe5ef-54b1-42df-9d7c-d832206dd6df</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:73B3FB5F-25C5-439F-BCD2-31E69052EA41</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:09:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:09:04 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:f71676c3-fe06-4645-a4e8-0561b8cfcbd4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E05A9B62-0A33-418F-B36D-FC4762F8D912">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N30f61f8684df4351aadb051079336c0c"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:BB790708-0E38-42AE-BEAA-E69185046E54"/>
    <pav:createdOn>2014-07-20 20:30:45 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:38:24 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:3259727D-80E8-48AE-9391-3BA364F092A5</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:706C81F6-D61C-4419-A495-0BDFE8E2F22B">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:706C81F6-D61C-4419-A495-0BDFE8E2F22B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>706C81F6-D61C-4419-A495-0BDFE8E2F22B</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Concomitant administration of a single 100 mg dose of sildenafil with 10 mg of atorvastatin did not alter the pharmacokinetics of either sildenafil or atorvastatin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:16:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2DF9F8A6-090C-4486-823C-DE4004E8D042">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A2944E9F-6997-4CCE-AB8F-859E676FC995"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D61E53E1-37FA-4452-9775-F86A9574E9F5">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>glyburide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:687F59AF-4F7F-4733-B844-220CD26B0990">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:687F59AF-4F7F-4733-B844-220CD26B0990"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 21:59:22 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>687F59AF-4F7F-4733-B844-220CD26B0990</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9B107595-7CC7-4A49-9DC0-75FCE0D45B48">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:81FC10C7-DC44-4F3D-BB68-DA2B5775CD8F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4F20A37A-470E-4A27-BAF2-E2E7367D7BA9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/22B5811C-D2E0-4391-8B65-ABE82AF5FD7A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9F7A5CF9-6F80-47F4-B56C-4AC25415396C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A3090824-4160-44A7-B24C-24AA48263690">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AD3DFA43-4672-4F4D-8C5E-03EBCB6BB722"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C217E92D-6350-4E95-9C85-F1BB7DDCE810"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D809732C-2ED6-481E-87C3-CD8484597163">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BBF62F41-8603-4AE3-8634-2D508DE82EE7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/97834105-E915-4060-8DD0-C6C2CE2A1EF6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne9cb894287954760ab6967444488394b">
    <domeo:sets rdf:resource="urn:pddi:uuid:115ABA0B-F210-4D10-87E7-6B59220014F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/866A3FC9-E44C-46E3-8D5F-286D28F6A4B7">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>Carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FBB30133-3765-4BB2-9353-446C646DB158">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F8A443DF-08F3-4D6F-ADC3-64F330944379"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FFD0C4FB-30B3-4D5F-88DC-625683839E21"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DB05500B-B443-4CC1-967C-7C7A4086F71D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D358E409-61E7-457C-A5D9-5ACD5DED0A00">
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:53:28 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D9B5A79C-FB84-4D6A-9080-E86C010F4D0B"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83AF2611-F71E-4896-90EE-6D866FF99775">
    <domeo:uuid>83AF2611-F71E-4896-90EE-6D866FF99775</domeo:uuid>
    <ao:prefix>, and </ao:prefix>
    <ao:exact>phenobarbital</ao:exact>
    <ao:suffix>) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83AF2611-F71E-4896-90EE-6D866FF99775"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:03:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7E1E892D-B996-4CD8-89D9-6742503DE09F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:79E80761-D219-44E9-8376-D110F53723A0"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6E06164-F47E-4410-8D10-75C1F3E859BA">
    <pav:createdOn>2014-07-14 14:44:43 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:671E5E2E-B23D-4158-81A3-86E7751046B8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">23</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:45:11 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:8A66A3C5-1E5E-4EBF-8342-14A271B60E81</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D67E4EBA-2902-4F1F-B709-6F53A4DE73E0">
    <pav:createdOn>2014-07-14 14:53:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <permissions:permissions rdf:nodeID="N1b8e98df8bce44428786d2838148aca0"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-14 14:53:55 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:9379805F-EC1D-49FD-8C5D-3E99BD213C02"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A8AC2B9A-BAE1-4A95-BC70-E2B929FECD32</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:96FC24C5-FC7C-4873-AD87-FCF9472681C5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F9FD200-00A1-4CDD-9B85-ADB47441530D"/>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/352A0C6D-D279-4B7B-8907-C9270C508918">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydralazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:776DB94C-C517-4073-BB6E-AD34E2C943C8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7498C777-B69C-4843-AAA6-0C05B68090AC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EDA2BA45-98EB-432A-8FB1-8CA7297F16E3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FF01BD0-F6ED-4164-B591-5BB7FEEEC86E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 00:31:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:175A41D6-7C03-45D4-9BC1-0B116037B32C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:914F5EB8-55BD-4DC7-B62B-FB91B57C289C</pav:lineageUri>
    <pav:createdOn>2014-07-14 00:30:37 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7543154-F63A-4A8E-A3EE-4A66E9A5E1B5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4802F4A9-888D-4AC2-9DB3-5D3E4CF38E3E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>magnesium hydroxide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A04A4921-2A3C-45F3-AC1B-B3AC14630075">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A04A4921-2A3C-45F3-AC1B-B3AC14630075"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:06:00 -0400</pav:createdOn>
    <ao:suffix>, but did not alter their pharmacodynamics.</ao:suffix>
    <ao:exact>Co-administration of propranolol with lovastatin or pravastatin, decreased 18% to 23% the AUC of both</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A04A4921-2A3C-45F3-AC1B-B3AC14630075</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9455A366-6768-4BC4-8C0C-BAD815D80B32">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/905AF06F-3E90-47B3-89C2-55A3444BB3E1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5AB35BA-4B97-4F14-97F9-6E876D419EE4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DD889F5-7805-42CF-A30C-5024DA3783AE">
    <pav:lastSavedOn>2014-07-20 22:34:40 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:33:27 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nebb9de1a186b4f3e8a3f0963ecb9f7ca"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:497234FF-3B27-44DF-9D55-C3CA46C0EB1D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF9A07ED-2970-4904-9B8E-EC11A79F00C8"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ED8C3562-5B16-4BF0-9832-820093ED7697">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:82C0520F-2BA6-4B31-93EC-52EAFBA14FAC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F109D515-0B66-4EAC-86BF-ECAAECF21953"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BE812929-7DDC-486F-8296-9FB906175030"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2816B7BF-8F3C-4670-8147-5D5698ACE0F4">
    <ao:suffix>in females. Since therapy should be individualized, no dose adjustments are necessary based on gender alone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>is expressed in adipose tissues, this differentiating characteristic may account, at least in part, for the greater response to </ao:prefix>
    <domeo:uuid>2816B7BF-8F3C-4670-8147-5D5698ACE0F4</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-14 14:18:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2816B7BF-8F3C-4670-8147-5D5698ACE0F4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EA113A4C-9E62-4E18-A11E-423B3714DFB2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/598A98ED-8729-4A91-A1CB-C76461013D4F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4D2232D1-6C3C-4F44-90CF-B8F8A2861D2F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9CED7EB1-D759-40C3-A5BE-250152053AEA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:5EF3BD70-02DA-4C3A-9BD5-86C1A269B710</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:16:38 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 22:16:39 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Na9ee39f346234c349c2dac9ecd75b994"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:36707210-C296-4A75-B0DE-9348B27BB18F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E931211-85E6-4C25-BEBC-A70D9937ED46">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8E931211-85E6-4C25-BEBC-A70D9937ED46</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E931211-85E6-4C25-BEBC-A70D9937ED46"/>
    <pav:createdOn>2014-07-20 22:00:51 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93BB24EB-1586-4941-99D5-2D6960DFF4BA">
    <pav:lastSavedOn>2014-07-13 23:50:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:943B3C2F-578A-415C-B0AC-A08AFFAD1F8C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 23:50:11 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B5BA909-C73E-46FA-9624-82C1B8CDA3B2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B5BA909-C73E-46FA-9624-82C1B8CDA3B2"/>
    <ao:prefix>is 70% (CV=25%). The relative oral bioavailability of </ao:prefix>
    <domeo:uuid>5B5BA909-C73E-46FA-9624-82C1B8CDA3B2</domeo:uuid>
    <pav:createdOn>2014-07-14 15:53:00 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C01C91A1-3910-4E71-8F8D-D7F72516219A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/06EE1461-B811-4FAF-8C18-CA543B3859D1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/644F2F3C-447C-43DA-B43B-96547D66D73E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:038A8C9B-DBAD-4ED4-8716-F8B60581CC86">
    <ao:body rdf:nodeID="N45b8e32cca6a4daa9867c753685d2138"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-13 14:45:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E69164F-0CFB-4629-B36A-A64D4F4BA25A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:D02574BC-8A0B-40CA-A831-E85570571F31</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3268C318-9E0E-42A3-837E-A29259EE9C34">
    <pav:createdOn>2014-07-14 15:55:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D83B6BBF-45AF-4383-A468-BAD13D03381A"/>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7E22EC8-C218-4817-9269-0A8803AD2538">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fexofenadine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42A20FCF-5038-40E2-82E8-F347E1618A10">
    <ao:exact>However, in a pharmacokinetic interaction study in which 12 HIV-1-positive volunteers received a single 300 mg phenytoin dose alone and during steady-state zidovudine conditions (200 mg every 4 hours), no change in phenytoin kinetics was observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>42A20FCF-5038-40E2-82E8-F347E1618A10</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 20:52:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42A20FCF-5038-40E2-82E8-F347E1618A10"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naf299516951c49ffb6fb03be90b40dec">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/69EA206E-14D6-42A6-9850-7107D17DFE73">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E37C4BC-BC85-4FA2-8CBE-51890DA9F6A7">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:05:27 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A0B38CA1-9834-4D6C-BCE5-C86F75D2C876"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:06:35 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/301F2CC2-0DB1-4742-84C5-86AD71F72F84">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluvastatin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N339b58f9dca74a6abdc6d2f122102843">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23C875B1-AA8F-47AD-8210-21D42AC08ED4">
    <ao:exact>Phenytoin</ao:exact>
    <ao:suffix> AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male vol</ao:suffix>
    <domeo:uuid>23C875B1-AA8F-47AD-8210-21D42AC08ED4</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 16:03:12 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:23C875B1-AA8F-47AD-8210-21D42AC08ED4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40661BFA-363F-4758-AC1A-42AFFA1647A6">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:6e22c92c-7297-4e91-ba82-ac1dc0a550ab</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-20 20:20:18 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE47B6A6-3775-4073-AA9C-65980A3ACD8C"/>
    <pav:createdOn>2014-07-20 20:16:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B57524A-5C35-47CE-9D29-5D80E796A669">
    <ao:prefix> oxidation, and direct glucuronidation. It has been estimated that the percentage contributions of these routes to total metabolism are 42%, 41% and 17%, respectively, but with considerable variability between individuals. The four major metabolites are </ao:prefix>
    <ao:exact>propranolol glucuronide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8B57524A-5C35-47CE-9D29-5D80E796A669"/>
    <pav:createdOn>2014-07-14 15:11:11 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, naphthyloxylactic acid and glucuronic acid, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <domeo:uuid>8B57524A-5C35-47CE-9D29-5D80E796A669</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B23B1EBF-3499-4390-B761-2682C8EA921F">
    <domeo:uuid>B23B1EBF-3499-4390-B761-2682C8EA921F</domeo:uuid>
    <pav:createdOn>2014-07-14 13:42:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B23B1EBF-3499-4390-B761-2682C8EA921F"/>
    <ao:prefix>and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <ao:exact>midazolam</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EB81C9F3-C7B9-4496-A2CD-F08DBB75D8E2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C1976E2-C29D-4A23-94A9-9A2B3531BC06">
    <ao:context rdf:resource="urn:domeoclient:uuid:DD379D15-9673-4897-9730-9627C2B862D7"/>
    <pav:createdOn>2014-07-14 14:31:21 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:C174BCA4-061F-41B5-90F6-36B15766499B</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:32:14 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60D77858-A611-4115-8BB1-AF0CC9253AEE">
    <pav:createdOn>2014-07-14 13:59:50 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60D77858-A611-4115-8BB1-AF0CC9253AEE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>(e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical </ao:suffix>
    <ao:prefix>and an inducer of </ao:prefix>
    <ao:exact>CYP2C8 </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>60D77858-A611-4115-8BB1-AF0CC9253AEE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F69FF573-B8E4-4EA9-8CCB-D2780F7E0179">
    <ao:suffix>as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different from placebo or glyburide controls (Table 7).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F69FF573-B8E4-4EA9-8CCB-D2780F7E0179"/>
    <domeo:uuid>F69FF573-B8E4-4EA9-8CCB-D2780F7E0179</domeo:uuid>
    <ao:prefix>. In all 26-week controlled trials, across the recommended dose range, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>AVANDIA </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:09:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1735D1B7-6087-457F-AB69-9E05760B11B3">
    <pav:lastSavedOn>2014-07-20 23:15:46 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:F4E993B2-2405-452F-AF0E-C3CE76EA07A9</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 23:15:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:ACB34A20-F0B5-4EE4-ACC8-901687DDB0F2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A6723E3-B569-4896-8C19-1562EB2F69AB"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N5c7a6d57f7364ae883311f7c67631f83"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88E50021-C9C3-43EB-86E1-D81D2F4ACAD0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1</ao:suffix>
    <ao:prefix>, its major metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:88E50021-C9C3-43EB-86E1-D81D2F4ACAD0"/>
    <pav:createdOn>2014-07-14 15:53:12 -0400</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>88E50021-C9C3-43EB-86E1-D81D2F4ACAD0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54333B22-518F-4D3F-B869-CFF454FC8BBE">
    <pav:createdOn>2014-07-14 15:26:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5B667F9-05E2-4645-9230-F32EA6B4EA69"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB55CED7-33C4-4E9D-8CED-1E430C3CB00F">
    <pav:createdOn>2014-07-14 14:55:23 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:exact>Propranolol does not affect the pharmacokinetics of verapamil and norverapamil</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB55CED7-33C4-4E9D-8CED-1E430C3CB00F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DB55CED7-33C4-4E9D-8CED-1E430C3CB00F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7FCE5626-589F-4F5A-8DD1-081C8F19A770">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:49F1F10C-546C-44F2-A4A0-E7909C0F39F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B089881-295F-41FF-9641-1820771D71BB">
    <ao:body rdf:nodeID="Nd1563ee10a484a7e8d32a96a00c063f9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:104997bb-7cfe-4c6b-bdad-33564d90db31</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 20:29:12 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:29:10 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3D292E9A-7301-4F30-A89D-EBB62CAFFC78"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na0c2e1d3c59d4996b4ba0dd5552b23b6">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:365F830D-0B07-48D1-B187-14FC451BED8E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:365F830D-0B07-48D1-B187-14FC451BED8E"/>
    <domeo:uuid>365F830D-0B07-48D1-B187-14FC451BED8E</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-119.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 13:53:54 -0400</pav:createdOn>
    <ao:prefix>ed or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled 450 patients (n = 229 Synercid; n= 221 Comparator) and Study JRV 305 enrolled 443 patients (n = 221 </ao:prefix>
    <ao:suffix>; n = 222 Comparator). </ao:suffix>
    <ao:exact>Synercid</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5346DFF1-40A0-48DD-834C-F7D65C3815B8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1707E728-3897-48BE-A6F3-60A01593021F">
    <rdfs:label>nifedipine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A119350-B348-4835-AF86-FBC38BCEA446">
    <ao:prefix>plus </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>7A119350-B348-4835-AF86-FBC38BCEA446</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concentrations of 9-hydroxyrisp</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A119350-B348-4835-AF86-FBC38BCEA446"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-14 15:53:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21EDB578-865D-459F-9D95-9236D1154981">
    <ao:exact>Risperidone </ao:exact>
    <ao:suffix>is well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>21EDB578-865D-459F-9D95-9236D1154981</domeo:uuid>
    <pav:createdOn>2014-07-14 15:52:54 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21EDB578-865D-459F-9D95-9236D1154981"/>
    <ao:prefix>Absorption: </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0CA68D01-9113-4C5C-97C2-9150F7BD09B0">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E37BF728-310F-493F-B5BF-0546D1344119"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2D997D5-9E92-45B0-8090-9A0A4C716200">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 16:08:38 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B2D997D5-9E92-45B0-8090-9A0A4C716200"/>
    <ao:exact>risperidone </ao:exact>
    <ao:suffix>due to gender (whether corrected for body weight or not) or race.</ao:suffix>
    <ao:prefix>Race and Gender Effects: No specific pharmacokinetic study was conducted to investigate race and gender effects, but a population pharmacokinetic analysis did not identify important differences in the disposition of </ao:prefix>
    <domeo:uuid>B2D997D5-9E92-45B0-8090-9A0A4C716200</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8165D924-A30A-48EB-B8BB-EB8A774A5D73">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:379E0C95-8345-470E-A3B0-7BC913158B58"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7ACB235-8D9B-4E52-8541-DFCEC757F344">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8E7FCA2-29B2-4398-B95F-2DAEF9F9DF7A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 16:01:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D53567AB-5289-4731-B550-23E90B432F33">
    <ao:exact>Risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Distribution: </ao:prefix>
    <ao:suffix>is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, risperidone is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neit</ao:suffix>
    <domeo:uuid>D53567AB-5289-4731-B550-23E90B432F33</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D53567AB-5289-4731-B550-23E90B432F33"/>
    <pav:createdOn>2014-07-14 15:53:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56BDA5D3-9924-46E2-BA2D-1F2D8C77CDF3">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4F2DD3F-7165-4015-A692-8A7AEEBC58F8"/>
    <pav:previousVersion>urn:domeoserver:annotationset:76AAE184-615C-4489-B09E-1015897F9E1C</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="Na2c77bcc1dfd45d49f97d3575846c80f"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">14</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:30:48 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:30:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDFC99BC-0293-453A-BE1C-C3205EB80DBD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:092AE31E-B6F5-4A0D-915A-AC406DF9800E"/>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:28:20 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:27DF2570-C6A1-4DC3-868B-9419E21C08F6">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:15FF2225-61E8-4C64-ACEE-16EFAE88DFBB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:894D73EE-A600-4C47-AEBD-E8B459A41991">
    <pav:createdOn>2014-07-20 21:21:56 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C1691B5-D52D-4679-91F8-1F3F0A94D187"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 21:22:45 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:34B0CD03-6104-466C-8733-06115032AD32</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FDE992E-5DDB-464A-89E3-9C06D0B1EBE1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 23:59:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF4ACE24-4288-486D-A52C-EF3CE988E132"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68DA08C0-B486-4B49-9C1B-809A3B5C4A25</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C0F4AC67-7BE8-4F09-B20E-85E171343047</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 23:59:38 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8104CD3F-2809-464D-B7A0-56B934F97F82">
    <ao:suffix>had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg ev</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8104CD3F-2809-464D-B7A0-56B934F97F82"/>
    <pav:createdOn>2014-07-14 15:25:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8104CD3F-2809-464D-B7A0-56B934F97F82</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Fexofenadine </ao:exact>
    <ao:prefix>. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FB2355B-FC49-41F0-B1BB-B89F682207E9">
    <domeo:uuid>2FB2355B-FC49-41F0-B1BB-B89F682207E9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2FB2355B-FC49-41F0-B1BB-B89F682207E9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>combination studies, efficacy was demonstrated with no gender differences in glycemic response.</ao:suffix>
    <ao:exact>metformin </ao:exact>
    <pav:createdOn>2014-07-14 14:17:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>improved glycemic control in both males and females. In </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E17E8FCA-4A94-4726-AC39-58A7AB434A41">
    <pav:createdOn>2014-07-14 15:06:19 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Co-administration of propranolol with lovastatin or pravastatin, decreased 18% to 23% the AUC of both</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>E17E8FCA-4A94-4726-AC39-58A7AB434A41</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E17E8FCA-4A94-4726-AC39-58A7AB434A41"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3b49022c53ec42b4adbc277585506e60">
    <domeo:sets rdf:resource="urn:pddi:uuid:1472C09A-E194-42C6-BD9D-5FE42F7C1EA0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03C51E27-B736-4A34-8C86-F7C276D4105F">
    <ao:prefix>does not alter the kinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>diltiazem</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03C51E27-B736-4A34-8C86-F7C276D4105F"/>
    <pav:createdOn>2014-07-14 00:19:14 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21BFCA0F-FA05-477F-A9DB-3C9BCD7A8649">
    <ao:context rdf:resource="urn:domeoclient:uuid:A56F00CB-AF7C-453F-98C0-4F13056D3FFD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:body rdf:nodeID="Nddcf7cf15a454fff9b749a912836fd6b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:59:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:59:19 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:D4DD68FC-37A2-4A54-AE65-4EBA4D154D9F</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:778137C2-B992-489F-9C34-3E57FAD9B734">
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 16:03:21 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 16:03:46 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0A4E36D6-6A02-481C-AF4A-464C53F2BD1E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FEBC010D-01EB-4618-91A9-64C6C13EDFA0">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of other known enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>FEBC010D-01EB-4618-91A9-64C6C13EDFA0</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FEBC010D-01EB-4618-91A9-64C6C13EDFA0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:20:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9AFCED8-4216-4013-843A-1A805A229289">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:15:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3748F22-F64D-4F58-A221-A10B5E5782EC"/>
    <pav:lastSavedOn>2014-07-14 14:15:09 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:5C62A5E1-E846-4FFE-B0D2-F54E63A65412</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E7D11D5-C820-4C62-8576-DC72ED259D95">
    <ao:suffix>was shown to be mediated by increased sensitivity to insulin’s action in the liver, muscle, and adipose tissues. Pharmacological studies in animal models indicate that rosiglitazone inhibits hepatic gluconeogenesis. The expression of the insulin-regulate</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E7D11D5-C820-4C62-8576-DC72ED259D95"/>
    <ao:prefix>In animal models, the antidiabetic activity of </ao:prefix>
    <pav:createdOn>2014-07-14 14:07:34 -0400</pav:createdOn>
    <domeo:uuid>6E7D11D5-C820-4C62-8576-DC72ED259D95</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:069C2CDC-9263-4759-A894-746542B86E88">
    <ao:context rdf:resource="urn:domeoclient:uuid:BB9F17B9-B721-4894-8783-C28EDBC57A75"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0D1C52C0-54DC-43EF-8FAF-634FB7D349E7</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:46:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:97E3F56C-1038-4CC6-A32D-E4165DCD1E93"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/ad23b8b6-7ff4-4fb5-a832-18bcb6092635"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F45B1548-A079-4A32-9741-A5DD89E93ACB"/>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:01BEE98B-AAA6-4FD6-BA64-521EAF70587A</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:256DFC44-CA71-40A7-9682-83DEF643C7DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0EB0A26-D479-42D5-8C52-187EBE17C0A4"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 21:15:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N6472bcee134d42caaec4a9e485365310"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:96D5C991-A5DC-456E-9D64-4DD7B52BE20B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B26D279-9E2C-408C-BCE6-0F2C1BDD11BE"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:08:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86F2F338-DCD6-4C16-8C92-900AF2B1E865">
    <ao:context rdf:resource="urn:domeoclient:uuid:B482F83B-A318-449C-B864-C34A0F7D9EC0"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:28:33 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/64A607CF-3AC2-47A1-A7A5-2B6015F27CE2">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metoclopramide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/02B4E171-BE8F-496F-A3E9-F0BFB5354012">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fexofenadine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB0D1FEC-3C7D-4868-99F4-560643644FD4">
    <pav:lineageUri>urn:domeoserver:annotationset:350326DA-8463-4291-8A23-2C993EC9708D</pav:lineageUri>
    <pav:createdOn>2014-07-14 13:58:22 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <permissions:permissions rdf:nodeID="N7b51bc9aebaf4e47973df3908df4568c"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C6C01F5-90FE-4383-8FBD-7C4886430C84"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:58344963-021B-4687-9C11-13F2008A11CE"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-14 13:58:32 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84D8BA67-F044-4E65-B1CA-791A471C3D57">
    <pav:lineageUri>urn:domeoserver:annotation:B09CE5E7-FECE-43F9-A162-B7D42EF8A2D7</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:59FBA095-B3A8-4E16-B0CC-BCE685195A78"/>
    <pav:createdOn>2014-07-20 20:07:15 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 20:07:17 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FC4BE7C9-BF81-424F-84EF-295509BA81F3</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N096ea8bcb943427bac81c3e3ca9223d4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:EEC5A3A2-87BE-42FE-BBEB-F8F93FAEACE9">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <permissions:permissions rdf:nodeID="Nb7dad43085d247aca0f4cad61fa913de"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:D85AFAA1-5DFA-4385-A376-5CB9FC43B695"/>
    <pav:lineageUri>urn:domeoserver:annotationset:b344dc7c-6e63-4256-a61e-8d0aa7e1c056</pav:lineageUri>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/abe9ddb8-bba8-4a00-9074-e9d4b5418e7a"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:097245F7-D052-4A58-B863-99BF35D5DF65"/>
    <pav:lastSavedOn>2014-07-20 23:11:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:08:49 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E1CE7E20-02F5-410E-839C-E99EA883E19D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C0F6572-0B03-4450-B7EF-9E9CAA481758"/>
    <pav:previousVersion>urn:domeoserver:annotationset:05D78370-862D-4687-8108-2C857A35D1F4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F7EA7C5-B139-423D-ADEB-EDA85A5B27EC">
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:suffix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <domeo:uuid>7F7EA7C5-B139-423D-ADEB-EDA85A5B27EC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F7EA7C5-B139-423D-ADEB-EDA85A5B27EC"/>
    <pav:createdOn>2014-07-13 23:54:59 -0400</pav:createdOn>
    <ao:prefix>AUC following the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F3B4911-C04E-4909-BFC9-7737FBFD0C44">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>3F3B4911-C04E-4909-BFC9-7737FBFD0C44</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F3B4911-C04E-4909-BFC9-7737FBFD0C44"/>
    <pav:createdOn>2014-07-20 22:01:02 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:494E21FB-CA45-4C90-99C7-C526B71F1C26">
    <domeo:uuid>494E21FB-CA45-4C90-99C7-C526B71F1C26</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:494E21FB-CA45-4C90-99C7-C526B71F1C26"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Daily oral dosing of immediate-release paroxetine (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state</ao:exact>
    <ao:suffix>. If anticholinergic effects are seen, the dose of procyclidine should be reduced</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:11:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:702C8EF4-BCF2-415D-A4F0-5F8414627041">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0341E67A-5AAE-4E27-A5C0-2D99A42E6AEA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/51AA2FED-FB36-4809-AE2A-12AE3769C9BA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03353D44-B9A1-4651-BD99-0DC8133875F9">
    <ao:suffix> metabolites have electrophysiologic properties similar to </ao:suffix>
    <domeo:uuid>03353D44-B9A1-4651-BD99-0DC8133875F9</domeo:uuid>
    <pav:createdOn>2014-07-20 20:22:40 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>norpropafenone</ao:exact>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03353D44-B9A1-4651-BD99-0DC8133875F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B083F609-2C02-411B-AC52-4FD5D843A8A0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C62037C9-19A9-4979-9071-880A743D8DF8">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EA0C0AB2-00F6-4796-A890-37A9399E2F18"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F24A797E-0BE2-4406-B36F-3A7E13D5BF18">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7331BE7C-862F-44A7-A182-35BE78245FFE"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BA0AB33-8E5A-4A5A-826E-79EC3567BF12">
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:1439C3B0-F16C-4D45-8F9D-271F7AF1FD58</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:31:14 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0852FDD8-CD18-4C4B-842A-08013BB68121"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F5340A2B-F400-4CF7-AAED-F262BB1C516B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CD3DE6A7-CC9E-4E31-A711-996F488479EB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/30C78047-DE0F-4701-939F-F8B0E15DD34F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13D2860A-FDF4-4C6D-A311-042031531AFB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 20:49:12 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2865C1F-051B-4E10-879D-F2ADD9269128"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 20:48:34 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:7A214A93-2426-48A1-B636-1337A2D9E56A</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7d29e7d10ee84522ae08da83f3722ff2">
    <domeo:sets rdf:resource="urn:pddi:uuid:C62037C9-19A9-4979-9071-880A743D8DF8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CADE04B-1D2F-4F33-A33D-05645A3A1368">
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0F3FCB2-5CF9-4BC2-880D-6E9ED081F67E"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 11:09:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9311462D-06EA-40DB-B3C4-F1141515A293">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8DE0546-D425-4DD3-9B20-F4CBFE8AA67A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:57:00 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:58:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46692380-1BE0-4007-880E-3A3A89ABE2FA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:07:45 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46692380-1BE0-4007-880E-3A3A89ABE2FA"/>
    <ao:suffix>in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>46692380-1BE0-4007-880E-3A3A89ABE2FA</domeo:uuid>
    <ao:prefix>in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A4F793A0-9A25-4129-AAC3-658488064757">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2cf3ff44-7e8c-4e28-a540-768d3157156b">
    <pav:createdOn>2014-07-07 08:08:47 -0400</pav:createdOn>
    <ao:prefix>refore, monitoring of plasma </ao:prefix>
    <ao:exact>theophylline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> concentrations and appropriat</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-83.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2cf3ff44-7e8c-4e28-a540-768d3157156b"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFABF2BE-C0E4-4AD2-A8A4-319D192639C4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:13:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B55C168C-D92C-4A02-8BCE-CC0FFDC09C7C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F175F7AF-622E-4079-BCD1-470178128C83">
    <ao:suffix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of flucon</ao:suffix>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 15:54:45 -0400</pav:createdOn>
    <ao:prefix> AUC and Cmax. There was a mean ± SD decrease in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F175F7AF-622E-4079-BCD1-470178128C83"/>
    <domeo:uuid>F175F7AF-622E-4079-BCD1-470178128C83</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DB9D9E00-DFD4-4A75-B2EA-B98E8D4E08C1">
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF">
    <ao:item rdf:resource="urn:domeoclient:uuid:70468321-8AD6-4EC6-ACD9-3252A6A7E43B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C553B9B3-1DAD-45FD-BA67-C43B6EB873F2"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:65425786-706B-46DA-B512-80709C79E601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9311462D-06EA-40DB-B3C4-F1141515A293"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:227D051B-A8D6-4A42-A3F3-0642743BFC2A"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1B65AAF-5FCC-4501-B613-7B375724DA27"/>
    <permissions:permissions rdf:nodeID="N7bbecddadcbb41d98e7983f324d7a183"/>
    <pav:previousVersion>urn:domeoclient:uuid:B058E044-6257-4B25-A0CE-92932D95D302</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:58:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:56:58 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDB24678-2252-4E22-BEB1-2FE5D20BBEF8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D4AF03D-DEDD-4CEA-97C4-8B14EF87650D">
    <pav:createdOn>2014-07-20 20:22:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>1D4AF03D-DEDD-4CEA-97C4-8B14EF87650D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> SR, the </ao:prefix>
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <ao:suffix> metabolite is usually present in concentrations less than 40% of </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D4AF03D-DEDD-4CEA-97C4-8B14EF87650D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:674875AE-DCF1-4BBD-9267-E731C58A4C69">
    <ao:exact>methotrexate </ao:exact>
    <ao:prefix>; increased serum concentrations of </ao:prefix>
    <ao:suffix>with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. Use of methotrexate with penicillins should be carefully monitored.</ao:suffix>
    <pav:createdOn>2014-07-14 15:43:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:674875AE-DCF1-4BBD-9267-E731C58A4C69"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>674875AE-DCF1-4BBD-9267-E731C58A4C69</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/28493FF7-4279-4623-85D9-CA6D07827A86">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>Erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/913B3678-9CAD-4964-91EE-81C08F9B5770">
    <rdfs:label>nefazodone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/31565</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12ED3AB3-C2AA-44FC-87F6-C455FE6D50A9">
    <ao:body rdf:nodeID="Nfecd980286134b779c9cf8d7c568c38d"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:52:31 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C15C9A48-1F20-4DF1-9116-F2DA550013E6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:52:33 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:A4CAF33B-7EDE-454B-A091-25FEDF0ECA63</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3D070D3C-20D2-4890-A2FD-18296F8E543E</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd60261bfca1a42a9b60300e8876ddc76">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9FF767E9-B3F6-41E0-83F2-C2855FB4973A">
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 15:57:50 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5489E53B-C365-4C9D-BA0A-9FA3E2E4EE43"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8793105D-39F7-4693-A826-2A652E7E4617">
    <pav:lastSavedOn>2014-07-14 14:55:22 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:54:45 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A2C0175E-5534-499F-941C-68D048DA812C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C39C295A-A84B-4762-BFDB-568AB3489ECA">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of other known enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:21:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C39C295A-A84B-4762-BFDB-568AB3489ECA"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>C39C295A-A84B-4762-BFDB-568AB3489ECA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90B4DA79-4F01-467E-93D3-94852D9347E6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:90B4DA79-4F01-467E-93D3-94852D9347E6"/>
    <ao:prefix>and higher </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>90B4DA79-4F01-467E-93D3-94852D9347E6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:02:36 -0400</pav:createdOn>
    <ao:suffix> concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C50757B2-D0A0-4CF4-A459-B2BB72596434">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34716919-5607-440F-9914-55F00D11E133">
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C5CCD1FA-B7FD-4E43-8253-DEFB4379CD47</pav:lineageUri>
    <pav:createdOn>2014-07-14 16:07:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:74B96093-C3F9-4CA0-957A-C0D40AED273C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E235B5A4-5738-4EE1-B721-55F30ABD99C7">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:46:45 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5A86849-E092-43E1-952B-C43B858BFF8A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">25</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:46:09 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:B007B37B-2A74-4AFA-BE1E-EDA76A331AAE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AB0B7AA-F6AE-4D4B-9D5B-567017B8A381">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4F4757D4-A915-4B00-A8C6-82EA8D7F5519</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nb4c9b29313b44df9af1bef7dcb73fcf2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 21:28:01 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:28:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:8A0F6C97-567B-4F64-8F37-7151C79E74A8</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:50322999-A991-4F23-9FD7-0F077D595963"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E7722B2-FB1A-4286-93FE-FF4F1B9944E2">
    <ao:prefix>Concomitant administration of oral contraceptives (</ao:prefix>
    <domeo:uuid>7E7722B2-FB1A-4286-93FE-FF4F1B9944E2</domeo:uuid>
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E7722B2-FB1A-4286-93FE-FF4F1B9944E2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 30 mcg and levonorgestrel 150 mcg) did not affect the pharmacokinetics of sildenafil. Sildenafil had no impact on the plasma levels of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:07:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1E6DC764-6D1F-4200-A5CA-249EE1992D55">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE81CB3B-EBA6-42B3-B93D-9BF9CAEB0E8B">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:23F36509-0614-43F9-924D-7EF7B847092B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:03:09 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CCC6FFC8-D9C8-4E16-80A0-15EBAFCF5797"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:04:22 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6FEC2851-8CD8-4C2B-9A67-94EB8194E2A3">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9364296A-3008-4436-B18B-9519EB15C638">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 </ao:suffix>
    <ao:prefix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of </ao:prefix>
    <pav:createdOn>2014-07-13 15:58:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <domeo:uuid>9364296A-3008-4436-B18B-9519EB15C638</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9364296A-3008-4436-B18B-9519EB15C638"/>
    <ao:exact>fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E316C0F-2E10-4726-8DAA-88A51D60223D">
    <domeo:uuid>8E316C0F-2E10-4726-8DAA-88A51D60223D</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <ao:suffix>may be administered with or without food.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, </ao:prefix>
    <pav:createdOn>2014-07-14 14:12:16 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E316C0F-2E10-4726-8DAA-88A51D60223D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/62ABC094-5576-456A-84FF-7D7CCE8D8FA0">
    <rdfs:label>ritonavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46BDC2C5-99E2-4E4A-BE6B-3805D0C8BFC1">
    <pav:createdOn>2014-07-14 16:02:42 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>and </ao:prefix>
    <ao:suffix> combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46BDC2C5-99E2-4E4A-BE6B-3805D0C8BFC1"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>46BDC2C5-99E2-4E4A-BE6B-3805D0C8BFC1</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72AA2676-2CD7-4866-982E-C23740797310">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72AA2676-2CD7-4866-982E-C23740797310"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>72AA2676-2CD7-4866-982E-C23740797310</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>increase in a dose-proportional manner over the therapeutic dose range (Table 8). The elimination half-life is 3 to 4 hours and is independent of dose.</ao:suffix>
    <ao:prefix>Maximum plasma concentration (Cmax) and the area under the curve (AUC) of </ao:prefix>
    <pav:createdOn>2014-07-14 14:11:49 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7925A81E-6575-4442-A711-93EDD25090C1">
    <ao:exact>Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7925A81E-6575-4442-A711-93EDD25090C1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7925A81E-6575-4442-A711-93EDD25090C1</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 16:06:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A87CD883-8C2E-456D-9F84-A2BE8C243FA4">
    <domeo:uuid>A87CD883-8C2E-456D-9F84-A2BE8C243FA4</domeo:uuid>
    <pav:createdOn>2014-07-07 11:07:44 -0400</pav:createdOn>
    <ao:prefix> 30 mcg and</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A87CD883-8C2E-456D-9F84-A2BE8C243FA4"/>
    <ao:suffix> 150 mcg) did not affect the pharmacokinetics of sildenafil. Sildenafil had no impact on the plasma levels of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> levonorgestrel</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E543F5FB-E68F-4CF2-BF11-544ED3D893E8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F32B7046-21D2-4BEC-97EF-224627866A71">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <domeo:uuid>F32B7046-21D2-4BEC-97EF-224627866A71</domeo:uuid>
    <pav:createdOn>2014-07-13 23:55:13 -0400</pav:createdOn>
    <ao:prefix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F32B7046-21D2-4BEC-97EF-224627866A71"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10B83F24-5357-4E2E-A377-978E3459FEE2">
    <rdfs:label>conivaptan hydrochloride</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/1294548</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F928EAD-02F7-4224-B0C8-AEA4F84AC4A6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:08:08 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>0F928EAD-02F7-4224-B0C8-AEA4F84AC4A6</domeo:uuid>
    <ao:suffix> was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <ao:prefix>and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F928EAD-02F7-4224-B0C8-AEA4F84AC4A6"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CA48B6D-44B8-43E5-9406-172F17271580">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:prefix>. </ao:prefix>
    <pav:createdOn>2014-07-20 20:33:31 -0400</pav:createdOn>
    <domeo:uuid>4CA48B6D-44B8-43E5-9406-172F17271580</domeo:uuid>
    <ao:suffix>. Avoid concomitant use of</ao:suffix>
    <ao:exact>A 100 mg dose of quinidine increased steady state concentrations of propafenone 3-fold</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4CA48B6D-44B8-43E5-9406-172F17271580"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/400e0729-ff42-48b8-b64a-ca4598fee6ba">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:97ed4ebf-e4ad-4f51-924a-e4ccaa98b4ec"/>
    <pav:createdOn>2014-07-07 08:09:17 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:09:17 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:FC4BE7C9-BF81-424F-84EF-295509BA81F3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N28dd54422f4f4b2ebb0d212237efbcd6"/>
    <pav:previousVersion>urn:domeoserver:annotationset:0541454E-686E-463E-8AFA-49ED632C1278</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d5975122-3a09-47fd-8229-08ca67318591</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 20:07:17 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/03687b20-0313-4307-8a9e-7154e2367b29"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84D8BA67-F044-4E65-B1CA-791A471C3D57"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A83FFD59-1BB9-4980-90E2-2C060627CA07"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5124CEA-C04A-4D9B-9B25-05C1B044A10F">
    <ao:exact>Diltiazem </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:suffix>significantly decreases the clearance and increases the t1/2 of quinidine, but quinidine does not alter the kinetics of diltiazem.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-14 00:19:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E5124CEA-C04A-4D9B-9B25-05C1B044A10F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA2AC80A-9C85-4921-B302-367861299DA3">
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:08:05 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E3EEBE7-2F2D-4A17-81E7-D9D0A7640CC4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D85AFAA1-5DFA-4385-A376-5CB9FC43B695">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N21b366bfe4734281ac7eab1c748bccb5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 23:11:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 23:11:57 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8FDE8DEB-89BC-44A8-88B7-9B674C163943"/>
    <pav:lineageUri>urn:domeoserver:annotation:070B3AF8-4B0E-4A68-865D-42A0BC36F145</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:EEC5A3A2-87BE-42FE-BBEB-F8F93FAEACE9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:663FA7F9-D3FD-4437-A28A-EA822FBC208F">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:663FA7F9-D3FD-4437-A28A-EA822FBC208F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>663FA7F9-D3FD-4437-A28A-EA822FBC208F</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 13:46:49 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of Synercid and nifedipine (repeated oral doses) and midazolam (intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2E01D279-897A-4C29-BB74-37F9B70CA5FA">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AD07A6A7-6818-4E84-A90B-5E5BA4AF9F77"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb14a187ff98643d3b3dbb3b1d2382381">
    <domeo:sets rdf:resource="urn:pddi:uuid:C5D00B38-D823-4E74-8F0A-38051CF9F68E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:655AFFCF-6B1A-4B6B-A73D-AABCB594036B">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:188066D2-D8DF-41BA-8D27-20EBE6CC91EC</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E86C5BD9-BD82-42C1-B349-AF9FB6BF1A23"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 20:57:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 20:58:11 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25EA107B-55E7-4F53-82DA-95E6E9308587">
    <pav:createdOn>2014-07-20 22:08:49 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>25EA107B-55E7-4F53-82DA-95E6E9308587</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Amitriptyline did not affect the pharmacokinetics of risperidone or risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25EA107B-55E7-4F53-82DA-95E6E9308587"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:DF431C5E-B3FD-41E4-8BBD-0C3B0F8AC4DB">
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/c7ab95ab-10d2-4e51-bc1b-07d77f1bd0b0"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-39.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N364dd8d23e444a56a1c10120397b20cd"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoserver:annotationset:D7B83B95-77A4-4510-9EA9-C11C56086491</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:9770f851-f52b-436d-b496-4d66f0e28d00</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 23:08:49 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F498AC3-F8F3-4A53-9178-CFF560E40396">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F498AC3-F8F3-4A53-9178-CFF560E40396"/>
    <ao:exact>propafenone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-124.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:49:58 -0400</pav:createdOn>
    <ao:suffix>is increased by more than 200% by co-administration of propranolol.</ao:suffix>
    <ao:prefix>The AUC of </ao:prefix>
    <domeo:uuid>7F498AC3-F8F3-4A53-9178-CFF560E40396</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E4066C2B-1A2B-4EB9-BEDD-5E2051FE9E5C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/159127BA-7F0F-4598-8AFE-AA37CD7B6CA7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6D4FD007-CE5B-43BB-8D19-858E45340D9A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:CFC858C1-4357-4A7E-B3F6-AEC0208DCC3A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/4e5b977f-f237-4cbb-bb63-930b97e76dc9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F711382-433B-491F-BB41-FEA554DAAE64"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:1411cbdb-a3ca-471a-b4a0-a0bde6cf3740</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="N45d5ec436c6f4e1d928f4ff303508e5a"/>
    <pav:lastSavedOn>2014-07-20 23:21:56 -0400</pav:lastSavedOn>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-35.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:b1313b87-cdd8-4c82-a8db-8e478e7d6c5d</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF028FB5-C10E-454B-AB76-0E8AEB2FCCB3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:exact>an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone</ao:exact>
    <pav:createdOn>2014-07-14 14:04:21 -0400</pav:createdOn>
    <domeo:uuid>BF028FB5-C10E-454B-AB76-0E8AEB2FCCB3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF028FB5-C10E-454B-AB76-0E8AEB2FCCB3"/>
    <ao:prefix>and </ao:prefix>
    <ao:suffix>. Therefore, if an inhibitor or an inducer of</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96D221DE-719C-4624-8E99-AC931D53B9D7">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:59:01 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:00:43 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:574D70DE-91DB-41EB-B769-DEB8783E5865"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25311D1B-E6E5-4536-A718-44543B7E8CAC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:202DE2D2-3281-4FD4-9A00-D655AE744EC8</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:44:08 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6484A9BF-2A66-459D-9606-6D96B7FA2AC8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:43:44 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:7CE009CE-9A28-417B-B003-33CDFDB4E8FF</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD6F238F-F381-4959-B940-F521E0242FF1">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FD6F238F-F381-4959-B940-F521E0242FF1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FD6F238F-F381-4959-B940-F521E0242FF1</domeo:uuid>
    <ao:suffix>) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (</ao:suffix>
    <ao:prefix> (</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:12:31 -0400</pav:createdOn>
    <ao:exact>CYP3A4</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F850764-41D1-4729-91C3-3EF7C8510B13">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>metformin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F850764-41D1-4729-91C3-3EF7C8510B13"/>
    <domeo:uuid>7F850764-41D1-4729-91C3-3EF7C8510B13</domeo:uuid>
    <ao:suffix>(500 mg twice daily) in healthy volunteers for 4 days had no effect on the steady-state pharmacokinetics of either metformin or rosiglitazone.</ao:suffix>
    <ao:prefix>(2 mg twice daily) and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:42:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/66E45824-B2E8-422C-8F61-FEE7B9247D49">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
    <rdfs:label>Fluoxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4CAF33B-7EDE-454B-A091-25FEDF0ECA63">
    <pav:lineageUri>urn:domeoserver:annotationset:A799B457-28A6-424B-BA3C-3B3BC8A539CE</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:12ED3AB3-C2AA-44FC-87F6-C455FE6D50A9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2B6559F-B1C1-4C19-BC43-D42428961628"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-14 14:51:49 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:52:30 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N33edba192600408dbf553278f2d4aa07"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5617F774-D0B5-4B59-A464-6F71FBBCCE61"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAFCCD75-1569-4E59-A941-DFB2068CA7A7">
    <pav:createdOn>2014-07-20 20:46:20 -0400</pav:createdOn>
    <ao:exact>GZDV</ao:exact>
    <domeo:uuid>CAFCCD75-1569-4E59-A941-DFB2068CA7A7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAFCCD75-1569-4E59-A941-DFB2068CA7A7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> is </ao:prefix>
    <ao:suffix>. GZDV AUC is about 3-fold greater than the </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5A86849-E092-43E1-952B-C43B858BFF8A">
    <pav:createdOn>2014-07-14 14:46:09 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>A5A86849-E092-43E1-952B-C43B858BFF8A</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5A86849-E092-43E1-952B-C43B858BFF8A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Warfarin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67EC4DE2-C1C6-463E-B7A6-1812ECDCBDED">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:8B4BD89C-2CB8-40C9-A237-62ECA54604FB</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:42:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3EAF9A6-FFDF-4068-A8D8-950A69516F6D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19BCE1B7-AD4F-4E32-95F0-4E990BE5FAEB">
    <pav:createdOn>2014-07-07 11:14:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:19BCE1B7-AD4F-4E32-95F0-4E990BE5FAEB"/>
    <ao:exact>Sildenafil had no impact on the plasma levels of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg)</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>19BCE1B7-AD4F-4E32-95F0-4E990BE5FAEB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E42EC98F-B2CC-41F2-BFF4-65AAE4291D29">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D66CCB4B-8C96-4322-A01D-56F6E42B42A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AA5618D-E659-4A6A-8E7D-926CBB5C8EB6">
    <pav:createdOn>2014-07-14 14:28:17 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:28:52 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:E74D7F41-C3C5-4E58-B5FB-D30661810CA1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:D3E123DC-C427-408F-8E2A-F074C69F1472</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E28C9449-DDBE-45EB-B94F-C720A3460BEC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E28C9449-DDBE-45EB-B94F-C720A3460BEC"/>
    <domeo:uuid>E28C9449-DDBE-45EB-B94F-C720A3460BEC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is conjugated at the 17β-OH position to form sulfate conjugates and, to a lesser extent, glucuronide conjugates in plasma. Significant amounts of </ao:prefix>
    <ao:exact>conjugated and unconjugated 3α</ao:exact>
    <pav:createdOn>2014-07-20 21:52:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2686D0A-82A9-415D-81F8-10EB4F8C507E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <ao:body rdf:nodeID="N9bd963c498b54e20a40da49b124cdf95"/>
    <pav:lastSavedOn>2014-07-20 22:14:39 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:83531713-BD51-4439-A04B-063A78646A82</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:13:37 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C63B787E-B3A4-46FB-85F1-DF955887F744"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:18B1C7B3-45B4-4A32-9EAB-4ECA6CEC6AC3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BBB08782-7AD9-431A-A87A-D5268FE02E4A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8FAE16C3-486C-42CF-BC58-8F7B8D40E38B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6f528b43-e953-4f77-a06d-c893ede78645">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Levonorgestrel</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6f528b43-e953-4f77-a06d-c893ede78645"/>
    <ao:suffix> and its phase I metabolites a</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
    <ao:prefix>nd 16βhydroxylevonorgestrel. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A1179DB-EC75-4FF4-AD92-D72E498ADEFD">
    <domeo:uuid>9A1179DB-EC75-4FF4-AD92-D72E498ADEFD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9A1179DB-EC75-4FF4-AD92-D72E498ADEFD"/>
    <ao:exact>AVANDIA </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:10:53 -0400</pav:createdOn>
    <ao:prefix>Increases in LDL occurred primarily during the first 1 to 2 months of therapy with </ao:prefix>
    <ao:suffix>and LDL levels remained elevated above baseline throughout the trials. In contrast, HDL continued to rise over time. As a result, the LDL/HDL ratio peaked after 2 months of therapy and then appeared to decrease over time. Because of the temporal nature o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/91d3c446-e4c6-4dfe-9626-7d57d7cee2e6">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 08:09:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:b75def36-afcb-4fb2-b905-631321261783"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 08:09:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8401DCE8-4998-4888-BF09-06B17C2FF790">
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:34:03 -0400</pav:createdOn>
    <ao:exact>AVANDIA</ao:exact>
    <ao:prefix>AUC and Cmax slightly increased following coadministration of </ao:prefix>
    <domeo:uuid>8401DCE8-4998-4888-BF09-06B17C2FF790</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8401DCE8-4998-4888-BF09-06B17C2FF790"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F947B7D0-C735-4D70-ADE5-C0152DA0CF7D">
    <pav:previousVersion>urn:domeoclient:uuid:662ac9a4-9184-4f50-aeb5-c3c64969fa45</pav:previousVersion>
    <ao:body rdf:nodeID="Nae33f5e3ba27492db5101afa2edb7115"/>
    <pav:lineageUri>urn:domeoserver:annotationset:57e68989-764c-41a4-8022-c2f4271e1e58</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:303B9247-18E9-4D70-A3C2-D33BACBF928E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:859ABA2E-7C8E-4051-8D7F-DF2DF5EE8EDC"/>
    <pav:createdOn>2014-07-20 22:58:10 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:58:10 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:22C86EF1-01BF-4703-B1EA-9C65647D5BC2">
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:55:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2413F09F-9AD6-4337-8C6A-F897CF9C9EE3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:386783BA-77A0-4DE5-AF5A-F87F3B4A2466">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:386783BA-77A0-4DE5-AF5A-F87F3B4A2466"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> displaces each other from plasma binding sites. </ao:prefix>
    <pav:createdOn>2014-07-14 15:58:07 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>386783BA-77A0-4DE5-AF5A-F87F3B4A2466</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:887679C4-9244-4B68-A45D-6BF938B0A540">
    <pav:createdOn>2014-07-14 15:43:09 -0400</pav:createdOn>
    <ao:suffix>with penicillins should be carefully monitored.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:887679C4-9244-4B68-A45D-6BF938B0A540"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-166.txt.html</ao:hasSource>
    <domeo:uuid>887679C4-9244-4B68-A45D-6BF938B0A540</domeo:uuid>
    <ao:exact>methotrexate </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. Use of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:168928F7-95DE-44CA-A25E-A8A52D80A2FF">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:09:57 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3E02686-0149-4D7A-93A9-D1DC35CBBFD0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Ne05d4a5931ef4188a38efe09250b7bd7"/>
    <pav:createdOn>2014-07-14 15:09:57 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:87C87B25-2788-4E6F-A04F-27F5AF9D1A53</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5977A7EB-C009-460D-9A3A-87A648DE0522</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A978E284-2C0C-4CBD-BAA7-31EB877998F5">
    <pav:createdOn>2014-07-14 16:06:40 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:681C8114-B9B9-45E3-A560-159D848BC479</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4684A74-F0C3-456E-A817-27DCA1288D90"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE47B6A6-3775-4073-AA9C-65980A3ACD8C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE47B6A6-3775-4073-AA9C-65980A3ACD8C"/>
    <domeo:uuid>AE47B6A6-3775-4073-AA9C-65980A3ACD8C</domeo:uuid>
    <ao:suffix> has weaker sodium channel activity but equivalent affinity for beta-receptors).</ao:suffix>
    <pav:createdOn>2014-07-20 20:16:07 -0400</pav:createdOn>
    <ao:prefix>, has similar sodium and calcium channel activity, but about 10 times less beta-blocking activity (</ao:prefix>
    <ao:exact>N-depropylpropafenone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3810A0AD-8340-4F62-9DF9-6542E05DA636">
    <domeo:uuid>3810A0AD-8340-4F62-9DF9-6542E05DA636</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Digitalis</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3810A0AD-8340-4F62-9DF9-6542E05DA636"/>
    <pav:createdOn>2014-07-20 22:50:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>7.3 </ao:prefix>
    <ao:suffix>, </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:535AEF5D-66BD-4A65-B55A-EA4176BB5C40">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:42DD6718-8A82-42A3-BFA9-C146F781139D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80115C95-2CA3-40D8-A6DA-4ED061B28DB2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA6B64F9-AA81-4128-8323-1437004E8AC8"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 22:09:19 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:87b7c298-8ac5-448c-a8b6-3df7ca45b625</pav:previousVersion>
    <ao:body rdf:nodeID="N27b514ff7304434d98ead3edc00a9c66"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:09:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AD3DFA43-4672-4F4D-8C5E-03EBCB6BB722">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8DD620B0-E795-477A-86D5-25C97C5DF945">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:159FA166-31A3-4662-B4D5-FB62E7E7A5E1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8145F723-C130-46D4-81F4-21A84E679258">
    <pav:createdOn>2014-07-14 00:23:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:4194C0E5-1AB0-4F26-B0D9-DAB9B0B19363</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:93F18B89-6C7E-4D12-AE68-BBE16A8D0629"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:DDE9697B-4596-4560-B3CC-D852CBB6AF20</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 00:23:20 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:54B8E090-10E4-49A8-B042-36DB36D30DAC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:772EE157-3C99-41A5-AB25-C59170F8518D"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/14851631-824D-4946-B8D5-9F294AC02788">
    <rdfs:label>ethanol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/448</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33FB62B6-2A11-4637-8FA3-68B0BBD8B517">
    <pav:lastSavedOn>2014-07-14 14:16:05 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:15:57 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:30409CE7-08DE-493D-B7F1-09FA1E072B3D"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C55DC5E6-47B5-44DB-9A36-ED918A3B1E40</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:092BCF3E-DF3B-4915-80EA-F0C495994432">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3B4CE15B-D026-4910-88C7-4C6897125F6B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1924D8FC-CADA-4C33-8CCF-3DE59FEA32FE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0BEB2E3-B860-4F17-9C62-F823B89F9948">
    <pav:createdOn>2014-07-20 20:04:29 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N846a128fdf8744b1817cd0e24f39bdc0"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:38067FFD-3631-467F-B88A-13472691F76E"/>
    <pav:lastSavedOn>2014-07-20 20:04:31 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7636F806-4318-4D68-A436-8A27504D96B6</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1353EFCE-C5CB-4CE7-9955-93F35EC83D57</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4B7B734-D16E-4939-BE06-A0EBD20656D2">
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D57AA31-05E1-414A-82A5-F1465C9BD3A1"/>
    <pav:createdOn>2014-07-14 00:24:08 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:26E4CD1F-B881-44B8-8B69-90C83D34A0FF">
    <domeo:uuid>26E4CD1F-B881-44B8-8B69-90C83D34A0FF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:00:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:26E4CD1F-B881-44B8-8B69-90C83D34A0FF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:suffix>. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in</ao:suffix>
    <ao:exact>Co-administration of propranolol with cimetidine, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7C6FD799-2E15-488B-A8E0-F4974543FE37">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C1CAEC4E-043D-4B2A-8CF1-73FF8E8D3795"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47A6BC6B-5B07-409B-A868-99A2F0862BC2">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N029dc8e7ab7646e5b5c3328761948d80"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:42:54 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 20:42:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4BB71E2C-9151-4B2C-AFD1-E9B1B54CA1E1"/>
    <pav:previousVersion>urn:domeoserver:annotationset:0E11AF88-12B1-4890-8255-D75BE1277FE4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/b10902d8-a1c1-4a82-9df7-b625c8555978">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:af07b0f7-9cc5-4945-b389-197abde3ee14"/>
    <pav:lineageUri>urn:domeoserver:annotationset:e95452ae-ca07-4891-8ea2-e7973a9a03ff</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-07 08:09:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:041167D2-429F-4342-B6B6-12F1268C9179</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 08:09:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1849BC60-0B75-40A2-8004-9426E9AAC74C">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8648DC49-9892-477D-B72A-403D6F34EE07"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:299CDEFF-8F84-4A8F-AC8A-6E57648A52AE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single a</ao:suffix>
    <ao:prefix>, whereas poor </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:299CDEFF-8F84-4A8F-AC8A-6E57648A52AE"/>
    <ao:exact>CYP 2D6</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 16:02:27 -0400</pav:createdOn>
    <domeo:uuid>299CDEFF-8F84-4A8F-AC8A-6E57648A52AE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04AF22FB-0B37-4C7B-9E2C-FD00FDD2A0AC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:53:42 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:80C1776E-DF0D-41B9-94D8-3CC44EA820F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9D638860-02C4-4316-BC23-B315E6826BAD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/704</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>Amitriptyline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11B076B8-D317-4ADD-AD9C-EE6E8BE34C7A">
    <ao:suffix>400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <pav:createdOn>2014-07-14 15:17:04 -0400</pav:createdOn>
    <domeo:uuid>11B076B8-D317-4ADD-AD9C-EE6E8BE34C7A</domeo:uuid>
    <ao:exact>carbamazepine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:prefix>. Following coadministration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:11B076B8-D317-4ADD-AD9C-EE6E8BE34C7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43A63EF4-DDA2-41F8-A24F-8B3A51C5D580">
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B69BFA0-BE22-4A91-823D-BD12B525B6D9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:22:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:21:40 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naadcbe8417e94f6a8391434b13d10206">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:507903E6-DE7C-47BB-8279-84234908AD7B">
    <ao:context rdf:resource="urn:domeoclient:uuid:8F3740DC-54D6-4C60-9FD7-CA88E37567D5"/>
    <pav:createdOn>2014-07-11 23:29:10 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3C4F4974-1D16-456F-8957-6B4A1BA678C2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D5CEEBE8-838A-4DBD-8A5C-057842151596</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-11 23:30:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1871A1A9-1F13-4238-A1E3-D13A2366CD43">
    <pav:createdOn>2014-07-14 14:00:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1871A1A9-1F13-4238-A1E3-D13A2366CD43"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:prefix>. Therefore, if an inhibitor or an inducer of </ao:prefix>
    <ao:exact>CYP2C8 </ao:exact>
    <domeo:uuid>1871A1A9-1F13-4238-A1E3-D13A2366CD43</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6D09FECA-282C-4811-95D2-78A4C3D2CEA8">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>hydralazine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/70C6A666-27EA-4ED8-8D3E-4A5E83DB84D9">
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:326EA6F9-E479-46B9-9608-83693CF9C34F">
    <ao:context rdf:resource="urn:domeoclient:uuid:0EB29FDF-7988-4626-9897-C7B7834893ED"/>
    <pav:createdOn>2014-07-14 15:23:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/30C78047-DE0F-4701-939F-F8B0E15DD34F">
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B3C38113-5A83-4DA6-A0CD-5D747E31779E">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <rdfs:label>metoprolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F1ABBC1F-3808-4691-B77F-6F24BC6C700D">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3DFD7722-40C8-460C-A8C2-D0132D1C418A"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B8CCD6BD-CF10-479E-AEC7-611637783084">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfac35edb7ead4b5a9ded98d0451bb327">
    <domeo:sets rdf:resource="urn:pddi:uuid:0EA9CE52-4F2D-4A64-A9E0-3461B37F97EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:041167D2-429F-4342-B6B6-12F1268C9179">
    <permissions:permissions rdf:nodeID="Nc342f2d7ab90429e8b77b2dceef0bb0d"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DFBF41C-F99E-4FC7-A8C8-9B7AEF3C2D4E"/>
    <pav:lastSavedOn>2014-07-20 23:18:21 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:0cd34311-c0ce-4576-b6ee-033478a250bd</pav:previousVersion>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-30.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:e95452ae-ca07-4891-8ea2-e7973a9a03ff</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/b10902d8-a1c1-4a82-9df7-b625c8555978"/>
    <pav:createdOn>2014-07-07 08:09:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7CE3A2A7-EC7C-497A-B63D-F6ADBA3F9409">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:602EF3D4-D106-43EE-A6EE-4F4B5090174E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF81CE81-E3E7-47BA-ADFC-81174E136A35">
    <domeo:uuid>BF81CE81-E3E7-47BA-ADFC-81174E136A35</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF81CE81-E3E7-47BA-ADFC-81174E136A35"/>
    <ao:suffix>plasma level.</ao:suffix>
    <ao:prefix>resulted in a 70% increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>propranolol </ao:exact>
    <pav:createdOn>2014-07-14 15:09:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D99C623B-2B12-4857-A174-AA5C67D5465F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:776DB94C-C517-4073-BB6E-AD34E2C943C8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63A87F56-A3EC-4533-8029-5C236DE26B7A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">15</pav:versionNumber>
    <ao:body rdf:nodeID="N60f8e9d0c53444c1a5ac586b26fbe949"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1759ABFA-AD7D-4030-AFC4-3E7332B001EF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:32:15 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C174BCA4-061F-41B5-90F6-36B15766499B</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:32:14 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADFB9848-5EF5-4473-9AB3-7135CF730A98">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:37:20 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:1B2D1CB1-AF4A-4392-B9F9-E4972994FD93</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:36:51 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CD4AC815-E106-412D-AE90-606FCC28F77C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD56A5E9-D5CC-4E12-A91A-8C14396A5B06">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:874B7B64-6C2A-4267-AE28-70801AD41B84"/>
    <pav:createdOn>2014-07-14 14:08:56 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2D168BC-003D-4DD7-A72D-9CDBBA1B5D0F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2D168BC-003D-4DD7-A72D-9CDBBA1B5D0F"/>
    <ao:suffix>occurred at about 1 hour. Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and wo</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:53:20 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F2D168BC-003D-4DD7-A72D-9CDBBA1B5D0F</domeo:uuid>
    <ao:prefix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9711f470db104ea5a9984fcab9f0d00c">
    <domeo:sets rdf:resource="urn:pddi:uuid:18030AAA-03FC-4472-BF74-3E3DBAEA79D7"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FEBCD982-7C06-4006-B35D-BFDAFAF94138">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ketoconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4636FE05-5CDD-4C42-ADBC-E5993B315ADE">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FC8ABEC8-05B8-46BD-B102-C903D53DD914"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:f71676c3-fe06-4645-a4e8-0561b8cfcbd4">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>ffect plasma itraconazole or </ao:prefix>
    <pav:createdOn>2014-07-07 08:09:04 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:hasSource>
    <ao:exact>fluvastatin</ao:exact>
    <ao:suffix> levels.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:f71676c3-fe06-4645-a4e8-0561b8cfcbd4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E55A4959-142E-4BAE-B8DC-08D5A8EC79D8">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E55A4959-142E-4BAE-B8DC-08D5A8EC79D8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E55A4959-142E-4BAE-B8DC-08D5A8EC79D8"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in flucon</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Administration of a single oral 200 mg dose of </ao:prefix>
    <pav:createdOn>2014-07-13 15:57:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8897C372-C30C-41C0-89D6-C122DEC1A0B3">
    <rdfs:label>probenecid</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8698</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3908C93B-3FA8-45E2-99DA-EE0516518457">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>VAPRISOL</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E3D8E77-DD6B-4DEE-B1FA-368DAAA52068">
    <pav:createdOn>2014-07-20 21:05:26 -0400</pav:createdOn>
    <ao:exact>Concomitant administration of fluvastatin (40 mg) and itraconazole (100 mg daily x 4 days) does not affect plasma itraconazole or fluvastatin levels</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>7E3D8E77-DD6B-4DEE-B1FA-368DAAA52068</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-191.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7E3D8E77-DD6B-4DEE-B1FA-368DAAA52068"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CCB57B2F-E3A7-4069-B4C7-0471744F8DB2">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3DF675E2-C00D-4F68-BFA2-E7F750F7172B">
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3DF675E2-C00D-4F68-BFA2-E7F750F7172B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <domeo:uuid>3DF675E2-C00D-4F68-BFA2-E7F750F7172B</domeo:uuid>
    <ao:prefix> metabolizers convert it much more slowly. Although extensive metabolizers have lower </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 16:02:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:873CF841-5851-4934-AF20-5A7BBF703196">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:873CF841-5851-4934-AF20-5A7BBF703196"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>873CF841-5851-4934-AF20-5A7BBF703196</domeo:uuid>
    <ao:suffix>, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade.</ao:suffix>
    <pav:createdOn>2014-07-14 14:51:51 -0400</pav:createdOn>
    <ao:exact>quinidine</ao:exact>
    <ao:prefix>is reduced by co-administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61112620-1A34-41CB-9D48-2B9A70FEA7EC">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97E3F56C-1038-4CC6-A32D-E4165DCD1E93">
    <pav:lastSavedOn>2014-07-20 21:14:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 21:08:09 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:c617ed29-a536-4a51-95a3-3f1cbb9e8b61</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D96E7FD7-4D7D-4302-AB4F-1812AB468632"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E5227253-BC22-4A8D-AEB4-CDA2EDD689DE">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F1BA8D36-61EE-49B4-9622-50FCED39E520"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4D2232D1-6C3C-4F44-90CF-B8F8A2861D2F">
    <rdfs:label>zidovudine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7972C0E9-AD08-4562-BB70-4D6882398B5D">
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F4E366F-E035-400F-99C4-EA97163AB922">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:12:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:EF444ECC-4F07-47A1-B3B6-C718307457E2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F6BBFD48-6F27-462B-8DF6-4356DD53EBBF"/>
    <pav:lastSavedOn>2014-07-20 22:13:09 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:17204A88-2ED6-4CE0-9AF8-30CE68A70B8B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/866A3FC9-E44C-46E3-8D5F-286D28F6A4B7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E67B37A8-16A7-427C-AE7A-F0408136624C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78EDBD99-45E4-4D47-A087-446C0E1BD184">
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%. Plasma concentrations of carbamazepine did not appear to be affected</ao:exact>
    <domeo:uuid>78EDBD99-45E4-4D47-A087-446C0E1BD184</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:19:05 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78EDBD99-45E4-4D47-A087-446C0E1BD184"/>
    <ao:suffix>. The dose of</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242">
    <pav:previousVersion>urn:domeoserver:annotationset:B6932D01-199B-4B56-B3A4-5BDB56B6C28E</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F55429F-3B64-4FF6-9A95-6B45519907E4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:911C2380-ED36-4DFE-9977-6B6179B6D95E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B204FD97-C00E-4CC9-9C3C-30F8B0CCFA98"/>
    <permissions:permissions rdf:nodeID="Nd101d7528ec7402e8f4b3642aa022d73"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E384BCF-D1F1-4D7E-84ED-828D7761EBAD"/>
    <pav:lastSavedOn>2014-07-20 22:51:05 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:FB78BFA3-26C0-48E6-A00B-71C81CA3CB84"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-07 08:09:19 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A169EB2C-6279-470C-AE93-A636E8E48071"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DCFDA8C-0C73-4D30-848F-24D5049435C9"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/91d3c446-e4c6-4dfe-9626-7d57d7cee2e6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BBF8E447-EC05-4028-8E62-2FC413F3DD46"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7592b255660847f7b5b785f532133826">
    <domeo:sets rdf:resource="urn:pddi:uuid:0C774389-232F-4134-9E74-3FF3BB994591"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79018A85-E38E-49F7-BFBA-C7041E4DDAC7">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>fexofenadine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>was reduced by 36%. Therefore, to maximize the effects of fexofenadine, it is recommended that fexofenadine hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <domeo:uuid>79018A85-E38E-49F7-BFBA-C7041E4DDAC7</domeo:uuid>
    <pav:createdOn>2014-07-14 15:31:55 -0400</pav:createdOn>
    <ao:prefix>. The clinical significance of these observations is unknown. In addition, based on the population pharmacokinetics analysis of the combined data from grapefruit and orange juices studies with the data from a bioequivalence study, the bioavailability of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:79018A85-E38E-49F7-BFBA-C7041E4DDAC7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BCD0B743-9B84-46D4-AF44-FC27ECC0AA54">
    <rdfs:label>warfarin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:250650BC-CC4F-40A0-BD84-08622DA45BFC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 21:58:08 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:0D9DD421-A8FE-400F-8177-B36F3FFB880C</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D8D6598-02B5-4252-8B43-E1E2CE625D70"/>
    <pav:lastSavedOn>2014-07-20 21:58:22 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N72aff01fc54a44f2ace889a0db58e285"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D62C0A28-17DC-4974-AF1F-92816DD078C0">
    <pav:createdOn>2014-07-20 22:21:57 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>D62C0A28-17DC-4974-AF1F-92816DD078C0</domeo:uuid>
    <ao:exact>Co-administration of other known enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D62C0A28-17DC-4974-AF1F-92816DD078C0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64ED2B68-620C-43AB-8558-FA289B16069E">
    <pav:lineageUri>urn:domeoserver:annotation:3BE7B8C3-56F0-4465-A782-2B6EAF40B20E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E49A2FF1-3433-401B-BC4C-02CCC11D74A4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:43:08 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:99E269C8-B4FC-4C25-9656-24B8639B4E3D"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:43:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F302C840-2655-4D95-A4D4-C15C333402B9">
    <domeo:belongsToSet>urn:domeoclient:uuid:3F482EC3-1EC0-4591-9CE4-4E8266FEEA69</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E0889750-3697-42EF-B875-B3141C060278</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:08:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:07:24 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:50A55843-DBDC-4F66-9F65-1DD94DBEFD6B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84C2CB34-1630-4D81-B99F-BE8565B74420">
    <pav:previousVersion>urn:domeoserver:annotationset:057E0FF7-67D7-4D0E-BA0F-3B21830FA757</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:01:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">12</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 22:01:33 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FEF31AFC-1AB3-45EC-A79F-0519A5C004AC"/>
    <ao:body rdf:nodeID="N390e0365b896402c8a0ab81ab41ae498"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2CE2C23E-F1F5-409E-9AB9-14A060640134">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1F84D1E-3DE5-4DFC-B5D7-A3487C6036D9">
    <domeo:uuid>B1F84D1E-3DE5-4DFC-B5D7-A3487C6036D9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>AUC and Cmax were determined before and after the administration of fluconazole 200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B1F84D1E-3DE5-4DFC-B5D7-A3487C6036D9"/>
    <pav:createdOn>2014-07-13 23:50:08 -0400</pav:createdOn>
    <ao:exact>Cyclosporine </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1E556A4B-CA48-46C7-B173-46522D430C42">
    <rdfs:label>nifedipine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/623EA56C-B196-4E54-A47B-8A3F41918DE3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1472C09A-E194-42C6-BD9D-5FE42F7C1EA0">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2C16108C-E250-4B77-B568-A9E679EF2150"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:27F74D94-835C-4D62-9540-CB940FD4A1A2">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:70F5DAA5-A634-48B4-9423-037A673BE7EF"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0AD41BC2-2669-49F8-A3B8-7D1FC6F2C930">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3E5186B7-14DF-4ADD-A288-50824118ADD2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CE81DAED-A4D7-49B7-B38C-F5F5B55B2A95"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0EBBAAA7-2EBB-45D4-9B88-87543C234DF1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/190B7F86-3784-4EB5-80FD-4CC4C7F36CD5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F019B52A-2B3C-4F08-B43A-567107C07EB8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/26577CC3-4820-4727-8B8E-918F11FB2FF0">
    <rdfs:label>tolbutamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:86DFD58D-9AC9-48B9-A8FF-24D88A8C1436">
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:lastSavedOn>2014-07-20 20:09:04 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N854d10993d994a31bad26326e26417ac"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoclient:uuid:9357ffb2-9886-47be-9601-9c3b5bc1fd5e</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-200.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/2183c61b-5e9b-4050-85f9-2494b8256800"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C3C2FC6-9B5D-4540-A8AC-95984897F9F7"/>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lineageUri>urn:domeoserver:annotationset:817284aa-573d-4596-ba64-5759ad57f2e0</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE8345E7-F989-4625-858B-441DB7D63965">
    <pav:lastSavedOn>2014-07-14 00:31:13 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 00:31:12 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:999B15A4-721B-4EC4-B126-74552C3C9473</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:175A41D6-7C03-45D4-9BC1-0B116037B32C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:295337EC-3B4E-4FE5-BE12-8F076F7CBEF3"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A874C3BD-3499-4877-B489-584D8AE1F205">
    <ao:context rdf:resource="urn:domeoclient:uuid:EBA6A223-96BD-43E6-8FA8-1E6B9A988244"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:11:10 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/88A3C850-58F9-4E63-8C78-7F560C63E678">
    <rdfs:label>nefazodone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/31565</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0D092C2-03F0-4183-B788-4A331F4C4F3A">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0D092C2-03F0-4183-B788-4A331F4C4F3A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <pav:createdOn>2014-07-20 21:59:36 -0400</pav:createdOn>
    <domeo:uuid>D0D092C2-03F0-4183-B788-4A331F4C4F3A</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2C16108C-E250-4B77-B568-A9E679EF2150">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/04E00386-0669-42B9-8251-9F6C313C974B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6B4FFAB2-8E33-4C8E-8C18-152C4A363FCD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AAFF1DBA-4588-4DD0-9479-69F1D385CD4D">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:93F91D34-1594-4D53-A5D8-57FB0319E159"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:24:37 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:527855D9-6DA5-4C98-A6B2-062C81A2568D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:527855D9-6DA5-4C98-A6B2-062C81A2568D"/>
    <ao:prefix>In vitro drug metabolism studies suggest that </ao:prefix>
    <pav:createdOn>2014-07-14 14:23:20 -0400</pav:createdOn>
    <domeo:uuid>527855D9-6DA5-4C98-A6B2-062C81A2568D</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>does not inhibit any of the major P450 enzymes at clinically relevant concentrations. In vitro data demonstrate that rosiglitazone is predominantly metabolized by CYP2C8, and to a lesser extent, 2C9. AVANDIA (4 mg twice daily) was shown to have no clinic</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:67283516-D3C3-4CFB-9AE2-4A7ED9A0D37A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CFF0C572-27A1-4744-BBF6-7FCB5B91D54E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/17B93348-BE16-4BE1-85F4-247BC2076DFA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90E91CE5-FB39-4968-8AF5-B7CDB511BF7F">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 11:07:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7E7722B2-FB1A-4286-93FE-FF4F1B9944E2"/>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45FEF3E4-BE3C-4ECB-84FB-AC8367F95563">
    <domeo:uuid>45FEF3E4-BE3C-4ECB-84FB-AC8367F95563</domeo:uuid>
    <ao:prefix> is slower because the </ao:prefix>
    <ao:exact>5-hydroxy metabolite</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45FEF3E4-BE3C-4ECB-84FB-AC8367F95563"/>
    <ao:suffix> is not formed or is minimally formed. In these patients, the estimated </ao:suffix>
    <pav:createdOn>2014-07-20 20:20:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A745D949-FBDE-4D07-B202-0EAFED08A320">
    <rdfs:label>methadone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A297685E-33BC-4DAD-920B-6220B0319A62">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB0F1F1A-5D16-4DB0-BA65-41402D7709D6"/>
    <pav:createdOn>2014-07-14 00:12:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:334C9BCC-A5B1-43CC-AF7B-DE758417FC61</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4721B9D4-2D04-4C39-9021-EAACA3631195">
    <pav:createdOn>2014-07-20 21:37:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Combined administration of citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4721B9D4-2D04-4C39-9021-EAACA3631195</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4721B9D4-2D04-4C39-9021-EAACA3631195"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-80.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BD99951B-7742-4036-BDF6-EA14EBE73B7F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:758A5759-B1FE-4C19-8285-6C3BCFC63679"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F46E6D59-7A1E-4B67-9077-24555C7124B8">
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:22:51 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2EB9BAEF-6898-4BCD-BCB2-6277D2162332"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA73FD81-BE36-452D-8AF7-36BF7EEACA6C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:body rdf:nodeID="N313ba15db9e4479c94a0571359d64258"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:19BCE1B7-AD4F-4E32-95F0-4E990BE5FAEB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdOn>2014-07-07 11:14:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:00A1E607-7F59-4003-A6F7-2D54D8B6D573</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:14:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:110ED8F7-1F26-4899-9D11-3EE5C6B346E8">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 00:11:20 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:D328F557-C8F8-4D5F-90D2-8348B1E2763C</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 00:08:38 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:82163860-C957-475F-86C9-1232D0DE8CFF"/>
    <pav:lineageUri>urn:domeoserver:annotation:02507873-432F-4FD4-A01E-F24560081906</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19343D9E-0212-4E02-AC1F-6FF9B5873909">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E55A4959-142E-4BAE-B8DC-08D5A8EC79D8"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:createdOn>2014-07-13 15:57:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCB6474C-E1D3-4268-BF2A-E1AFDA289F56">
    <ao:item rdf:resource="urn:domeoclient:uuid:E6381CCF-2191-468D-8649-C27E419DFB61"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:annotatesResource>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:51FC00E7-3901-43AC-B639-A35EFC27FE7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-14 15:33:30 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB833643-1BB9-4375-87DE-96696F930A93"/>
    <pav:lineageUri>urn:domeoserver:annotationset:F8DD3B1A-8183-46C9-BCC9-71FCF468CD96</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N7dd54339975a4ad9998c88f81e3e6d52"/>
    <pav:createdOn>2014-07-14 15:33:12 -0400</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/337C79E0-4E29-4C81-BED4-C97B5A8A4C7D">
    <rdfs:label>synercid</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/135097</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C617450-1F44-4F18-B444-ACC7383D721B">
    <ao:context rdf:resource="urn:domeoclient:uuid:41DD6E21-FEC9-48EA-8EF8-3CDB1DC0A66E"/>
    <pav:lineageUri>urn:domeoserver:annotation:DDD5D591-E5C6-490D-A477-B468F5EAC534</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 22:06:15 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:06:38 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N44a6d2331aa04c548908e159427e6081"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:958E3F8C-5E1F-49A9-99E2-C804B56FE22B">
    <domeo:uuid>958E3F8C-5E1F-49A9-99E2-C804B56FE22B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:958E3F8C-5E1F-49A9-99E2-C804B56FE22B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The mean Cmax and AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-126.txt.html</ao:hasSource>
    <ao:suffix>are increased by 64% and 79%, respectively, by co-administration of propranolol.</ao:suffix>
    <pav:createdOn>2014-07-14 14:53:34 -0400</pav:createdOn>
    <ao:exact>nifedipine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4995119-D6E2-4FDC-AB29-6DB9B00EC5A7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 16:02:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F575DEFA-A914-4145-91C6-A75860A2379B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68D6BA0D-201C-474B-B27F-81160B60D4D6">
    <domeo:uuid>68D6BA0D-201C-474B-B27F-81160B60D4D6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:68D6BA0D-201C-474B-B27F-81160B60D4D6"/>
    <ao:suffix>maintenance therapy, </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In a pharmacokinetic study with patients on </ao:prefix>
    <ao:exact>methadone </ao:exact>
    <pav:createdOn>2014-07-14 15:45:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EFE6A203-A080-452C-8ECD-A3831CD61738">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:271BB10A-D02C-45D2-B46E-982A65CD551A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C160940E-1FC7-4D9E-B418-5292AC237BA4">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/922355A6-4C62-463D-95B6-A969DED9F3ED">
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDF93D23-3CC5-4095-A8C6-54CEAD150DD1">
    <ao:exact>Rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>is approximately 17.6 (30%) liters, based on a population pharmacokinetic analysis. </ao:prefix>
    <ao:suffix>is approximately 99.8% bound to plasma proteins, primarily albumin.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DDF93D23-3CC5-4095-A8C6-54CEAD150DD1</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DDF93D23-3CC5-4095-A8C6-54CEAD150DD1"/>
    <pav:createdOn>2014-07-14 14:12:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:77106F8D-325E-4CD7-8C24-445EA5935113">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8502D74D-66FB-43A8-ADAB-4275537B2C81"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8B869658-C315-4932-8DF4-C5287264BC7B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C403DADA-9061-432C-8227-51655C34C466">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:47:33 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:ABE93F6C-5F65-4524-A0BB-7B775EFCF9DF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:48:59 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B5D8208A-3143-4A78-8D5F-F9BB03AC0E0D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CD08A3C3-5630-42CE-9535-A1B29411B3F6">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:47E6FB67-91E3-434C-9D45-3BFD345EBFB5"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BFD9E549-C79A-46ED-A639-5BC6971D2257">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39DDA238-CF5B-430B-83C9-CC5031E4FE2C">
    <ao:exact>warfarin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 13:54:31 -0400</pav:createdOn>
    <domeo:uuid>39DDA238-CF5B-430B-83C9-CC5031E4FE2C</domeo:uuid>
    <ao:prefix>has been reported to potentiate the anticoagulant effect of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-120.txt.html</ao:hasSource>
    <ao:suffix>and other oral coumarin anticoagulants, resulting in a prolongation of prothrombin time. This possible drug interaction should be considered when FLAGYL (metronidazole) is prescribed for patients on this type of anticoagulant therapy.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:39DDA238-CF5B-430B-83C9-CC5031E4FE2C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:11653357-AEDF-4176-8CA8-A9D150F77446">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8BAEF029-45AB-4A6B-84A1-58ABEFA52BA0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D0B94028-0205-4451-ABA7-C20D5FDBF14A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2221B30-2A29-4C16-9090-4E75B7E0AEDD">
    <domeo:uuid>E2221B30-2A29-4C16-9090-4E75B7E0AEDD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:21:04 -0400</pav:createdOn>
    <ao:exact>Quinupristin/Dalfopristin</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2221B30-2A29-4C16-9090-4E75B7E0AEDD"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:590FE9A8-9B3F-40EB-B85F-003E4A245F10">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:590FE9A8-9B3F-40EB-B85F-003E4A245F10"/>
    <domeo:uuid>590FE9A8-9B3F-40EB-B85F-003E4A245F10</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:exact>In vitro drug metabolism studies reveal that trazodone is a substrate of the cytochrome P450 3A4 (CYP3A4) enzyme and trazodone metabolism can be inhibited by the CYP3A4 inhibitors ketoconazole, ritonavir, and indinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:15:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/55D858DF-A99C-4EF9-A070-F8D97817ADD6">
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD25FC56-73E5-4077-815F-65E4D28AF5F4">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <ao:body rdf:nodeID="Nedbde9ca3aec43a998b001fff9b10e5c"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdOn>2014-07-20 22:11:43 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:11:55 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:DD719F77-8948-4136-9464-45F37BA31C29</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:843B211C-DF94-4460-A2CB-051AE6D64620"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6289A581-10AD-4431-B8B0-158578D2B3F5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6289A581-10AD-4431-B8B0-158578D2B3F5"/>
    <domeo:uuid>6289A581-10AD-4431-B8B0-158578D2B3F5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 21:56:11 -0400</pav:createdOn>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:843B211C-DF94-4460-A2CB-051AE6D64620">
    <ao:exact>whereas ranitidine increased the AUC of risperidone and 9-hydroxyrisperidone combined by 20%</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:843B211C-DF94-4460-A2CB-051AE6D64620"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>843B211C-DF94-4460-A2CB-051AE6D64620</domeo:uuid>
    <ao:prefix>, </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 22:11:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4853D26C-6CBA-4370-9AFD-ADAA1FF19DA6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36707210-C296-4A75-B0DE-9348B27BB18F">
    <ao:exact>Fluoxetine did not affect the plasma concentration of 9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-20 22:16:38 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36707210-C296-4A75-B0DE-9348B27BB18F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>36707210-C296-4A75-B0DE-9348B27BB18F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3e5ad90c-37fb-4eae-983e-46f0fa9638b2">
    <ao:prefix>wn to slow the metabolism of </ao:prefix>
    <ao:exact>carbamazepine</ao:exact>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and increase its serum levels</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3e5ad90c-37fb-4eae-983e-46f0fa9638b2"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-179.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7550A0CE-65C5-40DA-822F-E3D7E7D8562A">
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A57DF30-9529-479A-9A9B-A5D7BF6A7BD0">
    <ao:suffix>(intravenous bolus dose) in healthy volunteers led to elevated plasma concentrations of these drugs. The Cmax increased by 18% and 14% (median values) and the AUC increased by 44% and 33% for nifedipine and midazolam, respectively.</ao:suffix>
    <ao:exact>midazolam </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A57DF30-9529-479A-9A9B-A5D7BF6A7BD0"/>
    <domeo:uuid>4A57DF30-9529-479A-9A9B-A5D7BF6A7BD0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-118.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(repeated oral doses) and </ao:prefix>
    <pav:createdOn>2014-07-14 13:41:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/804BA454-E13F-46DB-8A67-FC57D7F3DF80">
    <rdfs:label>conivaptan</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2335C1EB-2E53-4392-A90A-D97010F2B956">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BFFDABCD-0866-44B8-BB37-FBD8D74E9A04"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BC63BED-1F6A-4D4E-83B9-87707421129A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:71AAB634-BDBC-40EC-A82C-C08EED1A2122"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:07:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:C010EBB7-27BC-43E6-9052-188AE7B53150</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/45BA6A90-636F-49BB-ACEB-5E8181D237B5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C6CB4493-7697-47FA-9633-8F1EBCA4FCB3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:11:16 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1F3954E2-12AF-4180-9D89-F124A8E8A02F"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:599FF10F-7024-475C-ABDD-6FA83ACE9157</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2372E549-CC2F-4FF1-88B9-E8D42F825B2A">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:70BF2DDC-C172-4A34-B8C3-647922E06046"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:bc5ada19-3d47-4d7f-8835-bbbf681e80b6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> Although data are limited, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:bc5ada19-3d47-4d7f-8835-bbbf681e80b6"/>
    <pav:createdOn>2014-07-07 08:09:11 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>methadone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> maintenance therapy in 5 preg</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C30C0D18-0D37-4FCE-8D6F-044D3DB33E6B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:05:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:05:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB7FAB69-6842-4255-BB69-9C81FAA47006"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DA3540C2-CABC-4C9E-B3CA-49DDB86B997D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BE297339-7EC8-4413-A046-9005B63E7AF4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0C8A055F-A38A-4A23-91A5-434066B52D92"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:078B790F-60D6-4853-B6CE-8B560D2343CD">
    <ao:context rdf:resource="urn:domeoclient:uuid:7B175DCD-D292-4747-9C4E-526DBDA5291D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:33:35 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FA5976D-7132-42CC-A1F2-0D4214DFA622">
    <pav:previousVersion>urn:domeoclient:uuid:3A41A1C2-7F92-4464-86CE-B19AA65B1E75</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:06:19 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nb30d19bcc3b443dab681c0a3e0c6605b"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-14 15:06:17 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E17E8FCA-4A94-4726-AC39-58A7AB434A41"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:14D02176-8222-4D2D-85C4-94DA5F6AD211">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DD5735BA-36E3-4565-8CF0-8243BF5BD861"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CECC56F6-DB52-436F-BEF4-449B99F234CB">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/358262</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fosamprenavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:772EE157-3C99-41A5-AB25-C59170F8518D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3B4BF097-852E-4C09-8340-4DF21AA0AE94"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/58B9A07A-8BF3-4F39-9D31-B08A28A103B4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F9704DE-3FF8-4450-98C0-00F719F45601">
    <domeo:uuid>9F9704DE-3FF8-4450-98C0-00F719F45601</domeo:uuid>
    <pav:createdOn>2014-07-14 15:11:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>glucuronic acid</ao:exact>
    <ao:suffix>, and sulfate conjugates of 4-hydroxy propranolol.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F9704DE-3FF8-4450-98C0-00F719F45601"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4F714AD-C2ED-442A-8F74-0D13572896E3">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D32701E-1F86-4999-B744-F0E3FCED3EF0"/>
    <pav:previousVersion>urn:domeoserver:annotationset:50FCED91-5F3D-4068-951D-13F3B60B4C62</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <ao:body rdf:nodeID="N7ec3ab5896e944ba99db39b627fa7fbf"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:25:36 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-14 15:25:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A16A851-1CC1-4290-93A4-E3DBFF45BD03">
    <pav:previousVersion>urn:domeoserver:annotationset:8C4D9771-5D2A-47EB-A2B9-96AD62816EB5</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Ndf33f031f36d44c3bcdde8c88676bb90"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:28:42 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:82DBC37B-E9EC-4E83-A1B6-950725B1D400"/>
    <pav:lastSavedOn>2014-07-14 15:28:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5579062F-331D-4D6D-83E6-2A7AB050CC8E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:14E174B7-26A8-4C12-9F0C-51A555CD8709</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:1ECBDB41-455D-43EA-BA16-FA5E3905DEBD"/>
    <pav:lastSavedOn>2014-07-14 15:14:57 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:12:21 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DD2891CC-9F38-4C9A-B9C3-CE22E16D159F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B2F30803-2A2C-458A-B1EC-C3C7A355106B">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:56CE453B-C31C-494E-98E4-0688E4FE660B"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nce6a27d48e274e5fbd4561f56d487c23">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3149fa67e73b4f3f8b3973b0a9bbb227">
    <domeo:sets rdf:resource="urn:pddi:uuid:F996471B-0832-4AFA-9958-6D0983523181"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28120C08-9093-4E03-AEE4-E77A8FCA5C7F">
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>28120C08-9093-4E03-AEE4-E77A8FCA5C7F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28120C08-9093-4E03-AEE4-E77A8FCA5C7F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 00:28:13 -0400</pav:createdOn>
    <ao:exact>Zonisamide did not inhibit mixed-function liver oxidase enzymes (cytochrome P450), as measured in human liver microsomal preparations, in vitro</ao:exact>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N38335c204bfb4f2f8b927ddfc7719d66">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A227DD21-8C83-4205-9DD9-71AF8DDEDF2E">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B6B30437-03EC-4979-97BB-164CEC453879"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F57D73A8-743F-47BA-B724-496E02303CBD">
    <pav:lastSavedOn>2014-07-14 14:15:09 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:5C62A5E1-E846-4FFE-B0D2-F54E63A65412</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F61456F1-3C46-41AF-8738-36A6475ABE3C"/>
    <pav:createdOn>2014-07-14 14:14:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8FFE4892-8630-4027-9DA3-A52C836A54E8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>digoxin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:193686C3-0953-4EB0-B679-3CD8F00C64D7">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:00:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>193686C3-0953-4EB0-B679-3CD8F00C64D7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:193686C3-0953-4EB0-B679-3CD8F00C64D7"/>
    <ao:exact>Ribavirin has been found to inhibit the phosphorylation of zidovudine in cell culture</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E8A15DD-0969-4FEE-B0C5-095BF99262D7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16145B2E-A4C7-4736-B95B-95CABCAC8A65"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2B3A799F-4AE7-4144-B096-3441B5DA3D2F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6837FB6-9E20-4C81-9D1C-5DE7964FACB9">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:hasSource>
    <domeo:uuid>B6837FB6-9E20-4C81-9D1C-5DE7964FACB9</domeo:uuid>
    <pav:createdOn>2014-07-14 13:58:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>at high doses for extended periods of time. A cause and effect relationship has not been established. Crohn's disease is not an approved indication for FLAGYL.</ao:suffix>
    <ao:exact>metronidazole </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B6837FB6-9E20-4C81-9D1C-5DE7964FACB9"/>
    <ao:prefix>s disease patients are known to have an increased incidence of gastrointestinal and certain extraintestinal cancers. There have been some reports in the medical literature of breast and colon cancer in Crohn's disease patients who have been treated with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F26CC484-4EAA-4D86-AD6F-08AC326B1CEA">
    <pav:createdOn>2014-07-14 14:07:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:BF770148-5A5F-4781-B903-C1E3F639E491"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38166EF0-AD62-493D-84F0-1247DF9E2732">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38166EF0-AD62-493D-84F0-1247DF9E2732"/>
    <domeo:uuid>38166EF0-AD62-493D-84F0-1247DF9E2732</domeo:uuid>
    <ao:exact>aluminum hydroxide</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. Co-administration with </ao:prefix>
    <pav:createdOn>2014-07-14 15:01:04 -0400</pav:createdOn>
    <ao:suffix> gel (1200 mg) may result in a decrease in </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BD7C5FC2-BE60-48C0-8A69-2D4E224E0F98">
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5076EEC9-0A3B-443B-9659-0ADEA006B499">
    <ao:exact>The AUC and Cmax of glipizide (2.5 mg single dose) were significantly increased following the administration of fluconazole in 13 normal male volunteers. There was a mean ± SD increase in AUC of 49% ± 13% (range: 27 to 73%) and an increase in Cmax of 19% ± 23% (range: -11 to 79%)</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5076EEC9-0A3B-443B-9659-0ADEA006B499"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-30.txt.html</ao:hasSource>
    <domeo:uuid>5076EEC9-0A3B-443B-9659-0ADEA006B499</domeo:uuid>
    <pav:createdOn>2014-07-20 23:18:20 -0400</pav:createdOn>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/17B93348-BE16-4BE1-85F4-247BC2076DFA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>diltiazem</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41023C6E-A2FF-4C11-ADD9-A82D4D57F869">
    <ao:body rdf:nodeID="Na859d1b833194e9490a7cbf437f0ffc9"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-14 15:06:37 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:5BB55520-5E21-4EB3-B4A9-93BB19C19780</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:06:35 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8BE3EAC-A77F-4A17-B4C0-BC8BE502CCD2"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:44FC7016-A8BF-41E5-BAB5-BD85F2A46917">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:415FBAF7-A951-4C16-A39E-0E9E7A642ECE"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8B760DD1-5F03-4F94-AE5D-81FF3521C4DA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>methadone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:363FEC73-504B-4213-9F3F-75A8772654FB">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:03421191-39A0-44FB-9848-85E87BF9E5CD"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1544E0E4-4548-47A0-9A95-1B3624CB3D6C">
    <ao:context rdf:resource="urn:domeoclient:uuid:B8CD11F7-E940-4711-8787-A723E351FB40"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:23:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8392E813-0E90-42C8-97AD-FAC2DDFCCB13">
    <pav:createdOn>2014-07-14 15:50:17 -0400</pav:createdOn>
    <domeo:uuid>8392E813-0E90-42C8-97AD-FAC2DDFCCB13</domeo:uuid>
    <ao:exact>Risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8392E813-0E90-42C8-97AD-FAC2DDFCCB13"/>
    <ao:suffix>is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69162B97-85CE-4930-B176-2D9320EFABBE">
    <ao:suffix>AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:prefix>inhibitor, increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>69162B97-85CE-4930-B176-2D9320EFABBE</domeo:uuid>
    <ao:exact>propranolol </ao:exact>
    <pav:createdOn>2014-07-14 14:59:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69162B97-85CE-4930-B176-2D9320EFABBE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:473966E0-AC08-4E1C-86DB-0F8A619103AD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>473966E0-AC08-4E1C-86DB-0F8A619103AD</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:473966E0-AC08-4E1C-86DB-0F8A619103AD"/>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
    <pav:createdOn>2014-07-20 20:29:42 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C1691B5-D52D-4679-91F8-1F3F0A94D187">
    <ao:suffix> and</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9C1691B5-D52D-4679-91F8-1F3F0A94D187</domeo:uuid>
    <pav:createdOn>2014-07-20 21:21:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C1691B5-D52D-4679-91F8-1F3F0A94D187"/>
    <ao:exact>quinupristin/dalfopristin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D947F3A-2962-4930-9DF0-1A8889511AFE">
    <domeo:belongsToSet>urn:domeoserver:annotationset:958A734B-1CD6-4630-BB63-D199264758D4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:00:43 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D0D4CBF3-70A3-4580-93F1-06876D1FC3D1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:329635CE-386E-4F46-8480-7264A536E492"/>
    <pav:createdOn>2014-07-14 14:59:02 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:f35d2bcd-8aef-4bd3-b3f3-7ff045425ac5">
    <pav:createdOn>2014-07-07 08:09:14 -0400</pav:createdOn>
    <ao:prefix>centrations less than 10% of </ao:prefix>
    <ao:suffix>. Inter-Subject Variability </ao:suffix>
    <ao:exact>propafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:f35d2bcd-8aef-4bd3-b3f3-7ff045425ac5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D053F38-6708-453F-93CB-87B91CA4DE34">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7D053F38-6708-453F-93CB-87B91CA4DE34"/>
    <ao:suffix>have occasionally precipitated unpredictable, severe, and occasionally fatal reactions in patients who have received such agents within 14 days. The mechanism of these reactions is unclear, but may be related to a preexisting hyperphenylalaninemia. Some </ao:suffix>
    <pav:createdOn>2014-07-14 15:41:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>oxidase (MAO) inhibitors or those who have recently received such agents. Therapeutic doses of </ao:prefix>
    <domeo:uuid>7D053F38-6708-453F-93CB-87B91CA4DE34</domeo:uuid>
    <ao:exact>meperidine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3665CA43-D65A-44D0-B001-7CFD0D5BD4B3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CAB49B09-00E3-4E2F-97E0-BD24919DE940"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3F4A0740-FAA6-4358-AD68-77F5941EBBC0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FA91E7E-256C-4C5F-9AFD-53B04FADE141">
    <domeo:uuid>1FA91E7E-256C-4C5F-9AFD-53B04FADE141</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1FA91E7E-256C-4C5F-9AFD-53B04FADE141"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>150 mcg).</ao:suffix>
    <ao:prefix> 30 mcg and </ao:prefix>
    <pav:createdOn>2014-07-07 11:08:07 -0400</pav:createdOn>
    <ao:exact>levonorgestrel </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:85DFECD2-7400-4187-BCA1-BCC7ECD3C242">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A0F25B11-F22A-4880-9D67-67D3864B5569"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21DF0E35-5074-44B5-BE2E-39C734C23383">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21DF0E35-5074-44B5-BE2E-39C734C23383"/>
    <ao:exact>ZDV</ao:exact>
    <domeo:uuid>21DF0E35-5074-44B5-BE2E-39C734C23383</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:13:45 -0400</pav:createdOn>
    <ao:prefix> (</ao:prefix>
    <ao:suffix>). Studies which measured cytotoxicity of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:57217751-69E0-486F-A8E0-C5974F060074">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9038129F-73A3-48E1-ADAB-876E955F297E"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E25023F1-C40D-45D7-857F-C13422A84252">
    <ao:suffix>(50 mg) did not potentiate the hypotensive effect of alcohol in healthy volunteers with mean maximum blood alcohol levels of 0.08%.</ao:suffix>
    <domeo:uuid>E25023F1-C40D-45D7-857F-C13422A84252</domeo:uuid>
    <pav:createdOn>2014-07-07 11:10:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E25023F1-C40D-45D7-857F-C13422A84252"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F82C40CD-C485-4144-ADEC-3081C7733E4E">
    <domeo:uuid>F82C40CD-C485-4144-ADEC-3081C7733E4E</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F82C40CD-C485-4144-ADEC-3081C7733E4E"/>
    <ao:exact>Carbamazepine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>induces CYP3A4. Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:16:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED0E8432-9B43-4984-97EA-10003B00C871">
    <ao:body rdf:nodeID="N33e78b1a57564470b5d00009382e1a5f"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F1D8500-6607-4DA2-A342-BE1227AE3A39"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:3259727D-80E8-48AE-9391-3BA364F092A5</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 20:38:24 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 20:30:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FE0C4BF-1A6F-4266-BF6B-E543E8955876">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8FE0C4BF-1A6F-4266-BF6B-E543E8955876"/>
    <ao:exact>FLAGYL</ao:exact>
    <pav:createdOn>2014-07-14 13:58:34 -0400</pav:createdOn>
    <ao:prefix>at high doses for extended periods of time. A cause and effect relationship has not been established. Crohn's disease is not an approved indication for </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-121.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8FE0C4BF-1A6F-4266-BF6B-E543E8955876</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E6FA48B7-725B-45B3-9939-A6DB77634E58">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ADFB3244-7A5F-4302-8C01-8E7FDA866218"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E9935ADA-14AE-44E8-83F1-ED2A61242989"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:32FAEB9E-441A-4E58-9C43-CA1D8B214D83">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A5FC5CFE-5AB6-4A96-838E-8868B4872A95"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:801D676C-691F-4522-9686-C300BF1369B8">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:382B6D84-1C5C-41E1-8D7E-69995B448CD8"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:962AF202-C1C5-4EA9-A24C-C174906D4164">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4F8D42A8-C4C9-4A8A-BE87-A44F1F1B8BA9"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A7AF4C00-2B41-46C2-AC53-3910D6140A9F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:29DA5432-AB0B-44DE-908F-9EE60E838A70">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8CD0860F-CABF-43C6-BD2B-584391B5C379"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4853D26C-6CBA-4370-9AFD-ADAA1FF19DA6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E90C922-200C-441C-B682-73453015A7E3">
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 14:49:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9816C3A2-2987-4FC9-AE3D-5CBD4C691E92"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B4C97892-60FE-45C6-B827-555B44457702">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/40674DF2-4AB0-4B72-BE36-B6179875DC94"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1D2DFDBE-4A91-40A7-B6C8-FD17A4EE70CD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:37B5F832-73BE-483B-9361-B6E3240986C4">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7E6AD2D5-B686-4D85-86B2-9CAB80FCDC51"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82DA41F1-F125-4E08-AD5D-0AA52A705421">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82DA41F1-F125-4E08-AD5D-0AA52A705421"/>
    <ao:suffix>100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <pav:createdOn>2014-07-14 15:17:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>trazodone </ao:exact>
    <domeo:uuid>82DA41F1-F125-4E08-AD5D-0AA52A705421</domeo:uuid>
    <ao:prefix>400 mg/day with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD3C0B1C-DD76-4DC1-B213-3617193F439A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD3C0B1C-DD76-4DC1-B213-3617193F439A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> [see Warnings and Precautions (5.6) and Use in Specific Populations (8.7)]. </ao:suffix>
    <domeo:uuid>AD3C0B1C-DD76-4DC1-B213-3617193F439A</domeo:uuid>
    <ao:prefix> resulted in higher conivaptan exposure than did oral </ao:prefix>
    <pav:createdOn>2014-07-20 23:07:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>conivaptan</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:62E2F222-59F9-4955-BFE9-642A1913EF31">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/965D23DD-3DF3-4804-9EF4-8AC641751517"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AFE2BEFB-C25A-4447-ADC2-3EFF271B8850"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93449bac-6ffe-4b83-b57d-eac1853867c0">
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93449bac-6ffe-4b83-b57d-eac1853867c0"/>
    <ao:exact>hydralazine</ao:exact>
    <ao:suffix>, sulfinpyrazone, oral contrac</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>igoxin, hydrochlorothiazide, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:59974561-254A-4048-89B1-CE33383CA99F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A2B06B88-615B-487A-A99F-2080850CBB13"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B64DF18D-9386-4599-A1E0-A1A56F86D4FA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6066da43d1de4b55811429701da0e26d">
    <domeo:sets rdf:resource="urn:pddi:uuid:3F4078FE-5A50-45B2-9905-FFEEFFDFC638"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AD4F461-D05B-491D-9FDF-1C39784C1963">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Maalox</ao:exact>
    <ao:suffix>® is a registered trademark of Novartis Consumer Healthcare.</ao:suffix>
    <pav:createdOn>2014-07-14 15:22:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4AD4F461-D05B-491D-9FDF-1C39784C1963"/>
    <domeo:uuid>4AD4F461-D05B-491D-9FDF-1C39784C1963</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>1 </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:953C880A-3315-406F-9C98-B28D9ADE5BD7">
    <ao:exact>Coadministration of nelfinavir at steady-state with a single oral dose of azithromycin resulted in increased azithromycin serum concentrations</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:953C880A-3315-406F-9C98-B28D9ADE5BD7"/>
    <pav:createdOn>2014-07-14 15:35:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted (see ADVERS</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>953C880A-3315-406F-9C98-B28D9ADE5BD7</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CABDB1CD-E0B8-4835-A612-75FB6F36823D">
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:53:52 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D53567AB-5289-4731-B550-23E90B432F33"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:83A2282A-89FF-48A9-9224-20D9B674EAD1">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DC205A92-A3B2-4AE1-B4D9-84DD44C4AC75"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:551EB5AD-9916-4F08-A9AF-C986C18F9AA7">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoclient:uuid:3627b43c-169c-41c0-8662-a839fabf2077</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-105.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:4953480f-4108-4568-a18c-d806b07c6b57</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N0368d8d6f0de4d9db37b16f59893a18d"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/87ce4dff-d0b5-41af-a8c9-c30613809c52"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:3807E672-009A-4637-A358-E3ECCE603945"/>
    <pav:lastSavedOn>2014-07-20 23:07:25 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DA56E4A-6ADA-42D3-9A74-5E768F688858">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 09:44:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DA56E4A-6ADA-42D3-9A74-5E768F688858"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5DA56E4A-6ADA-42D3-9A74-5E768F688858</domeo:uuid>
    <ao:prefix>is 105 L, indicating distribution into the tissues. </ao:prefix>
    <ao:exact>Sildenafil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:4619DA8A-3B4D-4161-8846-E657C8F74F42"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41023C6E-A2FF-4C11-ADD9-A82D4D57F869"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7E07A0D-D7D3-4C8F-AB10-8180967EE4D3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C30C0D18-0D37-4FCE-8D6F-044D3DB33E6B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-14 15:05:05 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:2A087E78-389B-4C1E-BE4A-2FEFCD234583"/>
    <pav:previousVersion>urn:domeoserver:annotationset:68A1F2C4-DA9F-4762-B818-3DB3BF7A42DD</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:2FA5976D-7132-42CC-A1F2-0D4214DFA622"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3096A47-93EA-42E0-AB4D-2714032C897B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B3F7C3F1-AE92-43C1-9CA1-E5C138372093"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:lastSavedOn>2014-07-14 15:06:35 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="Na38404111f464e66b88ceb6074215ade"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7657BFC0-26B2-4FF7-96A4-A1862BDF0E64">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-13 14:54:51 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B8739B89-379B-40B4-A540-C9AF6C5A1304"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:E596C216-CC0A-4553-BC0C-DAE5B6F9C589</pav:previousVersion>
    <pav:createdOn>2014-07-13 14:50:17 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6c9b1ae298074402a50d9ec8e3345a6c">
    <domeo:sets rdf:resource="urn:pddi:uuid:7CE9219D-9E90-40F6-9706-415483FC7A28"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C38FFC84-55EB-4952-8F9D-079DC836F634">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:06:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:84206E52-A442-48EC-8693-CC6D827A0B9D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21355386-ce13-4d75-9d67-55843d435567">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:suffix> monotherapy. Upon coadministr</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>8, respectively, compared to </ao:prefix>
    <pav:createdOn>2014-07-07 08:09:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21355386-ce13-4d75-9d67-55843d435567"/>
    <ao:exact>nifedipine</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B47CA244-461F-417D-AE7E-4AE48659142B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:11653357-AEDF-4176-8CA8-A9D150F77446"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49ADF7D8-E82A-4905-A70E-977D1E43AA87">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49ADF7D8-E82A-4905-A70E-977D1E43AA87"/>
    <ao:suffix> treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatm</ao:suffix>
    <ao:prefix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>49ADF7D8-E82A-4905-A70E-977D1E43AA87</domeo:uuid>
    <ao:exact>Fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 14:49:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:917227A6-6882-4EDC-9187-C16EB061E754">
    <pav:createdOn>2014-07-14 15:42:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:917227A6-6882-4EDC-9187-C16EB061E754"/>
    <domeo:uuid>917227A6-6882-4EDC-9187-C16EB061E754</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-165.txt.html</ao:hasSource>
    <ao:prefix>inant manifestations have been hyper-excitability, convulsions, tachycardia, hyperpyrexia, and hypertension. Although it is not known that other narcotics are free of the risk of such reactions, virtually all of the reported reactions have occurred with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. If a narcotic is needed in such patients, a sensitivity test should be performed in which repeated, small, incremental doses of morphine are administered over the course of several hours while the patient's condition and vital signs are under careful o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>meperidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb2729cf9cb4e4e079b4181d2ab55c1ab">
    <domeo:sets rdf:resource="urn:pddi:uuid:98106A81-8770-4585-BCB1-F0C9D05DC91F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8266861F-2C84-490C-8CF3-4B2AD8E9E61F">
    <pav:createdOn>2014-07-14 14:47:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of </ao:prefix>
    <ao:suffix>in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied by increases in gastrointestinal pH.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8266861F-2C84-490C-8CF3-4B2AD8E9E61F"/>
    <domeo:uuid>8266861F-2C84-490C-8CF3-4B2AD8E9E61F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3DB7D0D4-C52D-4FEE-8BAD-5A52C42927C0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metformin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6809</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE40501B-5515-449B-BF8B-E14157E3591E">
    <pav:createdOn>2014-07-14 15:07:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:18A5BB82-A18E-4282-AD00-A5E5846C0059"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:08:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:3F482EC3-1EC0-4591-9CE4-4E8266FEEA69</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:117F9B98-6BBF-4932-89DD-8D6DD6E43D1D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9BF9335-168A-48CA-BF74-27163A0299F6">
    <pav:createdOn>2014-07-20 23:13:26 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D9BF9335-168A-48CA-BF74-27163A0299F6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-33.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>An open-label, randomized, three-way crossover study in 18 healthy subjects assessed the effect of a single 800 mg oral dose of fluconazole on the pharmacokinetics of a single 1200 mg oral dose of azithromycin as well as the effects of azithromycin on the pharmacokinetics of fluconazole. There was no significant pharmacokinetic interaction between fluconazole and azithromycin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>D9BF9335-168A-48CA-BF74-27163A0299F6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5262EE64-9963-44C3-9E5E-21E6A58C8C1E">
    <pav:createdOn>2014-07-14 13:52:54 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7607CDA-5717-4160-8134-A93E0AAD226D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 13:53:55 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:175DE992-5EA0-40AF-8BC8-6F899E0B93D0</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4AE2C32B-4CC0-4775-A826-298273D69C85</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B3EF6E27-3DE7-43FA-9061-1D49CFD57FE0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>furosemide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4603</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F83EE871-5DC8-460E-BAAD-6DB098973963">
    <ao:exact>rosiglitazone </ao:exact>
    <pav:createdOn>2014-07-14 13:59:42 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F83EE871-5DC8-460E-BAAD-6DB098973963"/>
    <domeo:uuid>F83EE871-5DC8-460E-BAAD-6DB098973963</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:suffix>and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>) may increase the AUC of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/525C4ADE-3470-4F7C-85F9-393D25E36BE7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>metoclopramide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48E7C71B-AF8F-43A2-8425-6DEAE82F7EAE">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48E7C71B-AF8F-43A2-8425-6DEAE82F7EAE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>with the long-acting propranolol did not have a significant effect on propranolol’s pharmacokinetics.</ao:suffix>
    <pav:createdOn>2014-07-14 15:01:51 -0400</pav:createdOn>
    <ao:exact>metoclopramide </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Co-administration of </ao:prefix>
    <domeo:uuid>48E7C71B-AF8F-43A2-8425-6DEAE82F7EAE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:76B4C588-B5A5-4B0E-AD4D-463A4754B956">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A2F08077-A14F-4CF3-B2A2-F099B1CD88F0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3672B99A-9372-400C-8697-16605C55A9F9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50A7059B-1B8B-408A-996E-9CF49601F2F8">
    <domeo:uuid>50A7059B-1B8B-408A-996E-9CF49601F2F8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50A7059B-1B8B-408A-996E-9CF49601F2F8"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>The pharmacokinetics of propafenone was not affected by the coadministration of either propranolol or metoprolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:43:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3F767F3-B0B3-4391-BCE6-8ED28C0AE0BA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3F767F3-B0B3-4391-BCE6-8ED28C0AE0BA"/>
    <domeo:uuid>B3F767F3-B0B3-4391-BCE6-8ED28C0AE0BA</domeo:uuid>
    <ao:exact>Concomitant administration of quinidine (50 mg three times daily) with 150 mg immediate-release propafenone three times daily decreased the clearance of propafenone by 60% in EM, making them PM. Steady-state plasma concentrations increased by more that 2-fold for propafenone, and decreased 50% for 5OH-propafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:39:35 -0400</pav:createdOn>
    <ao:prefix> completely inhibit the CYP2D6 hydroxylation metabolic pathway, making all patients, in effect, slow metabolizers [see Clinical Pharmacology (12)]. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11D22EAE-170D-4047-A6B6-AC5C21C9E4CC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:11D22EAE-170D-4047-A6B6-AC5C21C9E4CC"/>
    <ao:prefix>, the incidence of withdrawal symptoms decreased and </ao:prefix>
    <pav:createdOn>2014-07-14 15:46:20 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:suffix>exposure increased to a level comparable to that prior to phenytoin administration.</ao:suffix>
    <domeo:uuid>11D22EAE-170D-4047-A6B6-AC5C21C9E4CC</domeo:uuid>
    <ao:exact>methadone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E62563B-DD9B-423D-B300-7267DA7DFBD5">
    <ao:context rdf:resource="urn:domeoclient:uuid:0D53D99C-6AEB-4A16-A8E3-BF35F707CA3A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Ndf6b2d8e79714c69865060c2d01ac7d2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:3F482EC3-1EC0-4591-9CE4-4E8266FEEA69</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:08:45 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:08:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:C04CDCDF-1C5A-417D-A83C-13CFC86DE361</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C6BCCE9-164B-4614-BFBD-EAD962C58711">
    <ao:exact>Erythromycin (500 mg, single dose) did not affect steady-state plasma levels of fluvastatin (40 mg daily)</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:17:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C6BCCE9-164B-4614-BFBD-EAD962C58711"/>
    <domeo:uuid>1C6BCCE9-164B-4614-BFBD-EAD962C58711</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-192.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D05697EA-857C-4586-A456-C000C9881009">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3665CA43-D65A-44D0-B001-7CFD0D5BD4B3"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/376836F0-CBCC-4524-9B91-2226C8C597DD">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83367</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>atorvastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7649EB48-4659-4BA7-B849-BA342E7DDF8B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:34B63D31-D993-4621-BC19-DCECCF2E1024"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D9A0F52-B812-4C89-AE74-620A9D8CDED9">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7D9A0F52-B812-4C89-AE74-620A9D8CDED9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:06:26 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>7D9A0F52-B812-4C89-AE74-620A9D8CDED9</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE3A4974-29C5-493E-B4DD-B9A5D77AE6AC">
    <ao:exact>AVANDIA</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EE3A4974-29C5-493E-B4DD-B9A5D77AE6AC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Patients with lipid abnormalities were not excluded from clinical trials of </ao:prefix>
    <ao:suffix>. In all 26-week controlled trials, across the recommended dose range, AVANDIA as monotherapy was associated with increases in total cholesterol, LDL, and HDL and decreases in free fatty acids. These changes were statistically significantly different fro</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:09:41 -0400</pav:createdOn>
    <domeo:uuid>EE3A4974-29C5-493E-B4DD-B9A5D77AE6AC</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F0022EA-9BF8-4B51-A11A-901C8CF7EA38">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F0022EA-9BF8-4B51-A11A-901C8CF7EA38"/>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:49:12 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>8F0022EA-9BF8-4B51-A11A-901C8CF7EA38</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28737438-E6F7-4010-A0FB-C1DDF98AB0D9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:29:52 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:F639B167-2183-4B47-BB47-F126C38CD529</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C2A31D3B-5246-42F7-9731-B5E98AC5035F"/>
    <pav:createdOn>2014-07-14 15:29:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDE9A5F8-1276-49D2-B080-F3134B265370">
    <pav:createdOn>2014-07-20 21:52:22 -0400</pav:createdOn>
    <ao:suffix> and 16βhydroxylevonorgestrel. </ao:suffix>
    <domeo:uuid>DDE9A5F8-1276-49D2-B080-F3134B265370</domeo:uuid>
    <ao:exact>5α-tetrahydrolevonorgestrel</ao:exact>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DDE9A5F8-1276-49D2-B080-F3134B265370"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-206.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:894838DF-AC3A-4DFE-9080-DBC82491C758">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:body rdf:nodeID="N5d3464d841024ea7a81fd5414a1a99d8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:01:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:00:38 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:338D89FA-A2F3-4A78-82F4-B1B7A34C002A</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3C1A7E2A-125A-4FE9-B7D5-EAC3E7B561F0"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECD8CAC1-E32D-4DF2-9BAF-DE171A38BDCF">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <ao:exact>chlorpromazine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Co-administration of </ao:prefix>
    <pav:createdOn>2014-07-14 15:09:14 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECD8CAC1-E32D-4DF2-9BAF-DE171A38BDCF"/>
    <ao:suffix>with propranolol resulted in a 70% increase in propranolol plasma level.</ao:suffix>
    <domeo:uuid>ECD8CAC1-E32D-4DF2-9BAF-DE171A38BDCF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/202D8786-7D0E-4F67-8CAB-B7B43704CEB9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78e3cdd5-c0a7-467d-a0d8-fbf5bf7a9a59">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78e3cdd5-c0a7-467d-a0d8-fbf5bf7a9a59"/>
    <ao:exact>warfarin</ao:exact>
    <ao:prefix> receiving the anticoagulant </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>. This interaction should be k</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-87.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17241D6B-945E-4F06-B117-C3A572F5FD80">
    <ao:prefix>In a pharmacokinetic study with patients on methadone maintenance therapy, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>administration (250 mg b.i.d. initially for 1 day followed by 300 mg QD for 3 to 4 days) resulted in an approximately 50% reduction in methadone exposure and withdrawal symptoms occurred concurrently. Upon discontinuation of phenytoin, the incidence of w</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:17241D6B-945E-4F06-B117-C3A572F5FD80"/>
    <ao:exact>phenytoin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:45:44 -0400</pav:createdOn>
    <domeo:uuid>17241D6B-945E-4F06-B117-C3A572F5FD80</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2F78C4F9-208D-499E-A0EF-350D5FDE0322">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydralazine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F262549B-5F75-4AD6-8B52-2A200E9E3368">
    <pav:createdOn>2014-07-20 20:29:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F262549B-5F75-4AD6-8B52-2A200E9E3368"/>
    <ao:exact>Drugs that inhibit CYP2D6 (such as desipramine, paroxetine, ritonavir, sertraline) and CYP3A4 (such as ketoconazole, ritonavir, saquinavir, erythromycin, and grapefruit juice) can be expected to cause increased plasma levels of propafenone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>F262549B-5F75-4AD6-8B52-2A200E9E3368</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05A624D1-7D8F-4A66-8316-E5E33B610293">
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <domeo:uuid>05A624D1-7D8F-4A66-8316-E5E33B610293</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:00:12 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05A624D1-7D8F-4A66-8316-E5E33B610293"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:325ED69B-8C49-4CD2-922D-266C897B186B">
    <ao:prefix>bserved following administration of oral solution from 90 to 240 mg/m2 every 6 hours. Oral bioavailability, terminal half-life, and oral clearance were comparable to adult values. As in adult patients, the major route of elimination was by metabolism to </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:325ED69B-8C49-4CD2-922D-266C897B186B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:49:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:exact>GZDV</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. After intravenous dosing, about 29% of the dose was excreted in the urine unchanged, and about 45% of the dose was excreted as GZDV [see Dosage and Administration (2.1)].</ao:suffix>
    <domeo:uuid>325ED69B-8C49-4CD2-922D-266C897B186B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/176593FF-1570-4712-A4F0-12374F828A42">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <rdfs:label>Fluvoxamine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:661631F1-239C-4984-A953-CCD787046D36">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7003EE0A-5F81-4965-8103-157235E59988"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 15:54:41 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3A3C93D2-9A4D-40D4-B465-EC3B7CF1363B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>sulforidazine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2C3407C-A606-4F0E-BD2A-3D965CC96B06">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:C592D402-62EA-4ABD-B2A0-0603081DB3FA</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:55:22 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:54:46 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C098CF71-98BD-4B5B-976D-9D9611326D7A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C1F3481C-1CD2-429B-8661-06973419C9BA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56AED5B7-A8E4-4C4D-B335-BE7C6BD2440E">
    <ao:suffix>is coadministered.</ao:suffix>
    <ao:prefix>levels rise when </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56AED5B7-A8E4-4C4D-B335-BE7C6BD2440E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-53.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>56AED5B7-A8E4-4C4D-B335-BE7C6BD2440E</domeo:uuid>
    <ao:exact>ketoconazole </ao:exact>
    <pav:createdOn>2014-07-14 00:16:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0E77AEA-B837-4C8E-9F0F-573151C5CB69">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0E77AEA-B837-4C8E-9F0F-573151C5CB69"/>
    <ao:prefix>. </ao:prefix>
    <pav:createdOn>2014-07-14 15:18:48 -0400</pav:createdOn>
    <ao:exact>Following coadministration of carbamazepine 400 mg/day with trazodone 100 mg to 300 mg daily, carbamazepine reduced plasma concentrations of trazodone (as well as mCPP) by 76 and 60%, respectively, compared to pre-carbamazepine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>F0E77AEA-B837-4C8E-9F0F-573151C5CB69</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:08D2F018-1CB7-471A-8D23-B3AA94054D61">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DA3540C2-CABC-4C9E-B3CA-49DDB86B997D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2F7706D-1BF4-41FA-8BEC-1597D569BEA0">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6ED53C36-F6D7-4621-904C-C59BB2CFF28B"/>
    <pav:createdOn>2014-07-13 16:03:15 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 16:03:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:073118E8-782E-429A-A1FF-5CA073116676">
    <ao:suffix>at steady-state with a single oral dose of azithromycin resulted in increased azithromycin serum concentrations. Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known si</ao:suffix>
    <pav:createdOn>2014-07-14 15:34:08 -0400</pav:createdOn>
    <domeo:uuid>073118E8-782E-429A-A1FF-5CA073116676</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-161.txt.html</ao:hasSource>
    <ao:exact>nelfinavir </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:073118E8-782E-429A-A1FF-5CA073116676"/>
    <ao:prefix>Coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F694AA03-BB88-42BA-B7E2-DCBC4770400A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/32C7ABCC-0D31-40BE-936E-A2F53238AF85"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4AF4DAB0-56F4-4096-8D50-E9692309699A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F45B1548-A079-4A32-9741-A5DD89E93ACB">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:64a31bb9-b66f-48d0-999e-7ca9f8a58a09</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-20 21:13:43 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0DECAF4E-8147-452F-868D-93DD30AB6D51</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:c617ed29-a536-4a51-95a3-3f1cbb9e8b61</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3986738E-CF02-432E-808E-10E945DBF10D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-20 21:14:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D63E7F0E-01C8-4159-9D12-DDD9188EE515">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>citalopram</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2556</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39C44C5B-5441-4761-8AF2-0B5F9F25161B">
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:24:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1ACE704-1881-4616-8238-C3E9A98146B9"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68CEE9BB-A652-4D96-B365-474F2E117D8B">
    <ao:prefix>with </ao:prefix>
    <pav:createdOn>2014-07-14 15:09:17 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>propranolol </ao:exact>
    <domeo:uuid>68CEE9BB-A652-4D96-B365-474F2E117D8B</domeo:uuid>
    <ao:suffix>resulted in a 70% increase in propranolol plasma level.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:68CEE9BB-A652-4D96-B365-474F2E117D8B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66D886AA-95C6-4AFC-B94C-687C19B04A6C">
    <pav:lineageUri>urn:domeoserver:annotationset:484f7a0f-bd5e-4f5c-ba77-bd900650692d</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-20 21:50:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:BBEB6B33-EFE4-489D-801E-A793994E27BD"/>
    <pav:previousVersion>urn:domeoclient:uuid:2db7b06e-8839-48c5-9a4d-c982317d8b75</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 21:51:10 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:87B0392E-D172-4B2E-8D81-4517B3E3B75B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7E07A0D-D7D3-4C8F-AB10-8180967EE4D3">
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:05:59 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A5D843E-5611-41DC-83F2-D6FD83E9A8A0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:A0A6C6B2-7F34-4B9F-A1DB-E061DB84B3D9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9ADA95B-A849-4392-9D43-1FB27E3608E3</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:05:06 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/86588D97-4967-4948-A5EF-BCD39B23FD64">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <rdfs:label>avandia</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FCFAA28B-5D98-49DB-9753-32849F1AC225">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3E8F00A1-B0E0-4F93-958E-1FE581EA19EE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/439E7E9D-3CE5-48F4-A17C-0ECECF0D7CFB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15129A73-23CF-455C-AFF8-E6DA6AE86FD9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E1790B3D-22E8-48F8-9BCF-5B21EF0E9EFA"/>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 16:01:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:647CE46D-76F3-4F61-B086-0748D7779113">
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:B702865C-5210-4AC3-9FC5-DC12DE572060</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8619FBA0-A893-4E40-9357-D4E615C15884"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 13:42:35 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:00D8F9AE-3905-4D6D-BFD2-F2D55B2C73F2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/93265AAF-E940-43A2-9770-5A25AAF89D17"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FE50AE67-227F-4CA6-8486-2AC9636E07E1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C8A8132-167F-45D6-970D-50721AE732DA">
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdOn>2014-07-07 09:37:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8594AEA3-40C7-4EFE-A73C-718308321858"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6287B469-D287-4523-8F3E-755BBDB6258A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6287B469-D287-4523-8F3E-755BBDB6258A</domeo:uuid>
    <pav:createdOn>2014-07-14 15:39:02 -0400</pav:createdOn>
    <ao:prefix>reduced the clearance and volume of distribution of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:exact>meperidine </ao:exact>
    <ao:suffix>and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6287B469-D287-4523-8F3E-755BBDB6258A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6ED53C36-F6D7-4621-904C-C59BB2CFF28B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6ED53C36-F6D7-4621-904C-C59BB2CFF28B"/>
    <ao:exact>phenytoin</ao:exact>
    <ao:prefix> AUC was determined after 4 days of </ao:prefix>
    <ao:suffix> dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6ED53C36-F6D7-4621-904C-C59BB2CFF28B</domeo:uuid>
    <pav:createdOn>2014-07-13 16:03:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nacddcbea03f6463ebdb5e7d6d130191b">
    <domeo:sets rdf:resource="urn:pddi:uuid:B47CA244-461F-417D-AE7E-4AE48659142B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:119670BE-D501-429F-9CA2-9EEDB038D28B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F5340A2B-F400-4CF7-AAED-F262BB1C516B"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EAC7703B-47A6-4BE2-8332-4B6F29B85D05">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EAC7703B-47A6-4BE2-8332-4B6F29B85D05"/>
    <ao:prefix>occurred at about 1 hour. Peak concentrations of </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabol</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EAC7703B-47A6-4BE2-8332-4B6F29B85D05</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:53:24 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4A56748-F5DC-4077-A548-565DC9DE900B">
    <ao:prefix>Single oral doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:36:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>F4A56748-F5DC-4077-A548-565DC9DE900B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F4A56748-F5DC-4077-A548-565DC9DE900B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of AVANDIA. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days i</ao:suffix>
    <ao:exact>glimepiride </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:087EAC3A-6E83-4C04-B907-68432A0029EC">
    <pav:previousVersion>urn:domeoserver:annotationset:9551BD57-E803-487A-B670-23EA129D54A7</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:30:42 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0483BE14-7675-4EFA-B6F1-4FC90F932480"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:31:07 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4938761A-449E-4BE2-8AAD-A266E929F425">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3807E672-009A-4637-A358-E3ECCE603945">
    <ao:context rdf:resource="urn:domeoclient:uuid:AD3C0B1C-DD76-4DC1-B213-3617193F439A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 23:07:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:426AB9A1-C3C4-4BFB-A84B-E4DBFD15F2A4</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:551EB5AD-9916-4F08-A9AF-C986C18F9AA7</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 23:07:26 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE8C0E9F-FC4E-49FB-B707-2F0CB03FB060">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:946DC0F8-6735-4931-A702-523CADB1D8D6"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:E596C216-CC0A-4553-BC0C-DAE5B6F9C589</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 14:54:51 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 14:50:26 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38348B3E-8881-4ABD-AD4D-18AF0C140E4C">
    <ao:body rdf:nodeID="N44af7f2436044d1db5190e5afca73344"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 22:32:58 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB60762F-B2C3-41A9-AED8-22C7DC232C2D"/>
    <pav:lastSavedOn>2014-07-20 22:34:40 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C36B0081-C0A1-4A52-ACDD-EAA75F47B005</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F06559E-F01F-4AA8-AC27-A2D667F000FB">
    <ao:suffix>(8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration of AVANDIA.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F06559E-F01F-4AA8-AC27-A2D667F000FB"/>
    <ao:prefix>therapy. Repeat doses of </ao:prefix>
    <pav:createdOn>2014-07-14 14:33:50 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <domeo:uuid>3F06559E-F01F-4AA8-AC27-A2D667F000FB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0852FDD8-CD18-4C4B-842A-08013BB68121">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0852FDD8-CD18-4C4B-842A-08013BB68121"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>may be due to transport-related effects, such as </ao:prefix>
    <ao:suffix>. In vivo animal studies also suggest that in addition to enhancing absorption, </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:31:14 -0400</pav:createdOn>
    <domeo:uuid>0852FDD8-CD18-4C4B-842A-08013BB68121</domeo:uuid>
    <ao:exact>p-glycoprotein</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7dd54339975a4ad9998c88f81e3e6d52">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na32fd67387c54cac9f14b668591c6ea2">
    <domeo:sets rdf:resource="urn:pddi:uuid:7865F088-4856-4644-B7F2-80FFD84F343B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6DCBD3FC-FFAD-4910-91FC-FA2AA684B759">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf4af104f1f014748aa28605d24e13f0c">
    <domeo:sets rdf:resource="urn:pddi:uuid:7C6FD799-2E15-488B-A8E0-F4974543FE37"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:115ABA0B-F210-4D10-87E7-6B59220014F9">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:76B4C588-B5A5-4B0E-AD4D-463A4754B956"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C1CE72E-EE74-438E-B925-8BDDA00E97F1">
    <pav:createdOn>2014-07-14 14:17:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:17:40 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:56CA625B-968A-4312-8B2F-922D691EDB6C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:1F706A03-A24F-4C5B-B78E-4C3F58FD1BDA</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0CC2D660-143E-4B31-820B-162EA1439970">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E4BBBE3C-98BA-4ED1-AABA-93616B3981E9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2D13D6ED-3A49-40AA-85DD-0B424ED2CBF3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:744E0B26-F094-4D3C-8F56-80676DC56DE3">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2C5AB00A-896D-4C1F-908C-7DF79FE2623A"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7169193-484E-459B-9085-BFA94E61FF1B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7169193-484E-459B-9085-BFA94E61FF1B"/>
    <ao:suffix>is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. H</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <domeo:uuid>E7169193-484E-459B-9085-BFA94E61FF1B</domeo:uuid>
    <pav:createdOn>2014-07-14 15:53:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5800632F-7E08-4E2B-834F-32BE7A537D21">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5800632F-7E08-4E2B-834F-32BE7A537D21"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 14:33:00 -0400</pav:createdOn>
    <domeo:uuid>5800632F-7E08-4E2B-834F-32BE7A537D21</domeo:uuid>
    <ao:exact>Gemfibrozil</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD379D15-9673-4897-9730-9627C2B862D7">
    <pav:createdOn>2014-07-14 14:31:21 -0400</pav:createdOn>
    <ao:prefix>AUC by 66%, compared to the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>DD379D15-9673-4897-9730-9627C2B862D7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD379D15-9673-4897-9730-9627C2B862D7"/>
    <ao:suffix>(8 mg) alone [see Drug Interactions (7.1)].4</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7EAB032-76D0-44E7-BD5D-E35A79A707AB">
    <ao:prefix>did not have a significant effect on </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7EAB032-76D0-44E7-BD5D-E35A79A707AB"/>
    <ao:exact>propranolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B7EAB032-76D0-44E7-BD5D-E35A79A707AB</domeo:uuid>
    <pav:createdOn>2014-07-14 15:01:57 -0400</pav:createdOn>
    <ao:suffix>’s pharmacokinetics.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9CBC4AF2-D4D4-43FD-AAA9-24E571ADADC5">
    <rdfs:label>fluvoxamine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42355</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EBDA078-21C6-4A71-B706-8B1CBCC257E6">
    <domeo:uuid>8EBDA078-21C6-4A71-B706-8B1CBCC257E6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 16:03:43 -0400</pav:createdOn>
    <ao:prefix> may cause a decrease in the combined plasma concentrations of </ao:prefix>
    <ao:suffix>and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG I</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8EBDA078-21C6-4A71-B706-8B1CBCC257E6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC58EBE6-613D-43A5-933A-0117FF3BB39D">
    <domeo:uuid>FC58EBE6-613D-43A5-933A-0117FF3BB39D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> treatm</ao:suffix>
    <pav:createdOn>2014-07-13 14:50:31 -0400</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC58EBE6-613D-43A5-933A-0117FF3BB39D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix> decreased very slightly (&lt;5%) in 3 of the 21 subjects after </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/26760B3C-AD77-41F3-A5B4-DEED059D4891">
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DB3DD08-D458-41F9-AAE1-4DFA655290B9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, </ao:prefix>
    <pav:createdOn>2014-07-14 15:12:52 -0400</pav:createdOn>
    <ao:exact>ritonavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5DB3DD08-D458-41F9-AAE1-4DFA655290B9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DB3DD08-D458-41F9-AAE1-4DFA655290B9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <ao:suffix>, and indinavir. The effect of short-term administration of ritonavir (200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of trazodone (50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC inc</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/598A98ED-8729-4A91-A1CB-C76461013D4F">
    <rdfs:label>ribavirin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:667D8415-762A-406F-97E4-8900ACD6EB7C">
    <pav:createdOn>2014-07-14 15:50:40 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DC44CEF6-84D4-4AD8-9FA3-461AB14DBC1C"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4587CD74-C81B-40F7-9B71-84BE5859CD5D">
    <ao:prefix>. </ao:prefix>
    <ao:suffix>, whereas</ao:suffix>
    <domeo:uuid>4587CD74-C81B-40F7-9B71-84BE5859CD5D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4587CD74-C81B-40F7-9B71-84BE5859CD5D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:exact>However, cimetidine did not affect the AUC of risperidone and 9-hydroxyrisperidone combined</ao:exact>
    <pav:createdOn>2014-07-20 22:11:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43177377-6759-44F6-ADFE-4B2D8D998013">
    <pav:lastSavedOn>2014-07-13 16:03:46 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE630A5E-671E-4A0A-8743-2982127399A0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:AF40750A-DF0C-4C52-92C3-D9272B9A10D3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:31D4DCEE-4E59-48CB-BA4B-73174F13EBF0</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-13 16:03:27 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC874544-B44D-467A-ADB4-9DBAC2214DF5">
    <pav:createdOn>2014-07-14 14:12:29 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>is approximately 17.6 (30%) liters, based on a population pharmacokinetic analysis. Rosiglitazone is approximately 99.8% bound to plasma proteins, primarily albumin.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC874544-B44D-467A-ADB4-9DBAC2214DF5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DC874544-B44D-467A-ADB4-9DBAC2214DF5</domeo:uuid>
    <ao:prefix>The mean (CV%) oral volume of distribution (Vss/F) of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A0A9B47-9C50-4714-BBE0-0EE4CB32B680">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:242AFE5F-099E-4E09-913F-71C48733F9EC"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3844856-EB1A-41E8-883A-716B53E41D87">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 23:50:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-13 23:50:41 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B9259B0-DBD5-41CD-88C4-21C8AD25C2E3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F">
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:EA682519-BD73-4855-BCAD-FD5F77F00F2D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C6CB4493-7697-47FA-9633-8F1EBCA4FCB3"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:DF9876E0-07E2-4739-AB7A-AF8DA2A693CF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-14 15:10:37 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:F610AB14-FAD2-4F3A-862C-0B9DA946ED85"/>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="Nea6fe2677e0b488d8a6dde786431e5bd"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:906C71AA-A68D-4B07-9173-8404D6AC0B88"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5895DE06-4E3E-4F22-9346-B9DF978976AC"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6DB0627-5E34-43BF-869B-6EB865E16C2C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9c1c644fe35146ef82890f07aecf9f06">
    <domeo:sets rdf:resource="urn:pddi:uuid:850FBE50-E974-4FC1-9B00-8FFCC23626F6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/a440efa4-9b30-400b-a47f-ef46ebc32fed">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 08:08:48 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:a44e2c8f-4b9e-4967-b8db-c857796f8ffa</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7e0b557d-0dcc-4047-bd64-ba377642295c"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F31802E-7861-4C87-82FB-71DD824528F0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F31802E-7861-4C87-82FB-71DD824528F0"/>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>in patients with mild to severe renal impairment or in hemodialysis-dependent patients compared to subjects with normal renal function. No dosage adjustment is therefore required in such patients receiving AVANDIA. Since metformin is contraindicated in p</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6F31802E-7861-4C87-82FB-71DD824528F0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:20:29 -0400</pav:createdOn>
    <ao:prefix>There are no clinically relevant differences in the pharmacokinetics of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6bd0dcb2-993e-4893-8970-02c95aed2ae7">
    <pav:createdOn>2014-07-07 08:09:04 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6bd0dcb2-993e-4893-8970-02c95aed2ae7"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>rugs, such as probenecid and </ao:prefix>
    <ao:exact>sulfinpyrazone</ao:exact>
    <ao:suffix>, can inhibit renal tubular se</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-36.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AAA0BFC3-A990-495C-8705-283BD6015459">
    <ao:body rdf:nodeID="Nc3bafe31481d42bd80638f2403b51ff6"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:D3FADC53-0CE2-4864-9B1E-954356539008</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:41C35C46-D1D2-43AB-A3B5-675C4DFC616B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">14</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 22:02:37 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 22:02:13 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9D343619-873F-4C32-BE27-8D61199B8221">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fexofenadine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:541AA093-0B25-4A13-A75A-755AF43911C4">
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:452E0148-D89A-4766-9670-95E027356102</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:08:08 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F928EAD-02F7-4224-B0C8-AEA4F84AC4A6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:88998899-DEBD-4168-A53F-878575C09DE8">
    <pav:createdOn>2014-07-14 15:53:09 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:84B677A9-F69E-40FC-BB74-CEA3742E0ACC"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C9B2D52D-D6E7-4ED1-94B9-B83C0AC0E2E1">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C01C91A1-3910-4E71-8F8D-D7F72516219A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF770148-5A5F-4781-B903-C1E3F639E491">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:07:43 -0400</pav:createdOn>
    <ao:prefix>was shown to be mediated by increased sensitivity to insulin’s action in the liver, muscle, and adipose tissues. Pharmacological studies in animal models indicate that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>inhibits hepatic gluconeogenesis. The expression of the insulin-regulated glucose transporter GLUT-4 was increased in adipose tissue. Rosiglitazone did not induce hypoglycemia in animal models of type 2 diabetes and/or impaired glucose tolerance.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BF770148-5A5F-4781-B903-C1E3F639E491"/>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>BF770148-5A5F-4781-B903-C1E3F639E491</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:41939ED2-CEA5-43F8-9BBA-2834749FC3FD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9D343619-873F-4C32-BE27-8D61199B8221"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/41C827FD-34CA-4622-8D55-F71BEBBFC260"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81F532DC-0494-4D7E-A130-DF143CB81B08">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N5501a375535f4b8d90986e0b04d2d37f"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D4DB3901-31B5-4984-B1A2-D06F355747BD"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:A1AD2A47-79BE-4FB3-A352-F642F0288890</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 00:14:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 00:14:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:8E3CE4A5-4812-48D6-86D1-0E8096434689</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1530D396-91D1-4424-839A-534000E05771">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1530D396-91D1-4424-839A-534000E05771"/>
    <ao:prefix> is not expected to substantially inhibit the clearance of drugs that are metabolized by this enzymatic pathway. </ao:prefix>
    <domeo:uuid>1530D396-91D1-4424-839A-534000E05771</domeo:uuid>
    <ao:exact>In drug interaction studies, risperidone did not significantly affect the pharmacokinetics of donepezil and galantamine, which are metabolized by CYP 2D6</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:22:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D444CFE4-5BA6-415B-AEC0-4069CAB94E3E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>methadone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE190217-F3C6-4371-AC6F-C1C99ECD2E87">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:36:20 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:38:08 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:261FBCCB-D709-4392-82BC-685600FA5428</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:0CAF6513-973A-4443-A0D0-3B06DC7D7034"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E19F86E4-2875-482D-A744-BA05C600F762">
    <rdfs:label>fexofenadine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:dbc1a5f3-076e-454b-afe3-a6fd24542dd5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>ak levels for didanosine and </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:09:20 -0400</pav:createdOn>
    <ao:exact>stavudine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:dbc1a5f3-076e-454b-afe3-a6fd24542dd5"/>
    <ao:suffix>, with a more significant decr</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D7651CAF-38C3-4709-BADB-6CD9D6556B63">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D8166BBB-A15B-48C4-9718-6B05BB31B531"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8153F833-F7F6-4312-8191-2A2CCD05FC0A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DFC9F830-AFFF-4613-BB4F-9DF20DEB2196">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E4C8974F-CE04-47B7-8F68-65219E597449"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:08D4CE38-B274-4CA5-A6A7-8A31D9B99ED6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F150AB38-F506-40B5-9C7C-56FFD632EB91"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/26577CC3-4820-4727-8B8E-918F11FB2FF0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:66423F8D-0720-473A-B4A5-689CF6E5120D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A3CB2F68-C804-4347-B155-FCAED657F54C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/25CE3B83-6EBB-4832-B95E-A8BFCA13EF20"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F4ED9D3-5133-4145-9D5D-DE8F072ED4C1">
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:02:00 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N37bb2dfafc68403cadb9ccd1cd3eed4a"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-20 22:02:03 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:AA04C9C9-75B9-4F98-8427-9C284456866B</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE177F66-740A-4832-86C6-444F7F7E3E28"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">13</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/97834105-E915-4060-8DD0-C6C2CE2A1EF6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5F991D5-A0E8-425D-8560-271203F94983">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDC12F8F-B6FD-4140-AF07-018FA4C76974">
    <ao:body rdf:nodeID="Nbb64f5dbd64145708a3f345ed964c801"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 16:01:59 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6AB19158-AAFA-4C25-8F03-75E8E6C7E8A3</pav:lineageUri>
    <pav:createdOn>2014-07-13 16:01:58 -0400</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:CBD0ADB5-CF5F-4CD3-9A18-248A9C9E7CD9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7F2A616-F065-4A8D-B67E-AB840F14B4D8">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F7F2A616-F065-4A8D-B67E-AB840F14B4D8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <ao:exact>rifampin</ao:exact>
    <domeo:uuid>F7F2A616-F065-4A8D-B67E-AB840F14B4D8</domeo:uuid>
    <ao:suffix>) may decrease the AUC of rosiglitazone. Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (1</ao:suffix>
    <ao:prefix>(e.g., </ao:prefix>
    <pav:createdOn>2014-07-14 13:59:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F65794E-6F82-4339-8ACA-530B5350C8E8">
    <ao:context rdf:resource="urn:domeoclient:uuid:76CBD0E6-5C5B-47A4-821F-CDA8BC7E8158"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:03:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5fcb805256024b6f84e541b3996a9dfd">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N29d129f828304189bc961463061538bf">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C36F1196-8714-4AB2-9ECF-693909AC4882">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C36F1196-8714-4AB2-9ECF-693909AC4882"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>C36F1196-8714-4AB2-9ECF-693909AC4882</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:01:09 -0400</pav:createdOn>
    <ao:exact>High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N817023e10c454a1490767ef35bfe38db">
    <domeo:sets rdf:resource="urn:pddi:uuid:B7721270-FC54-491F-8CA7-DA1ED70D0F13"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0B27292-E9F9-4475-AE1C-7EB529AC35EA">
    <ao:suffix>, also called debrisoquin hydroxylase, is the enzyme responsible for metabolism of many neuroleptics, antidepressants, antiarrhythmics, and other drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage o</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0B27292-E9F9-4475-AE1C-7EB529AC35EA"/>
    <ao:exact>CYP 2D6</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 16:01:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>B0B27292-E9F9-4475-AE1C-7EB529AC35EA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7DB5499-620B-464B-9769-D3E961A61EEB">
    <pav:createdOn>2014-07-14 14:49:58 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:B6ACE10A-DE78-4C11-B38C-6109EE0BCFAE</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F498AC3-F8F3-4A53-9178-CFF560E40396"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:16AF6B78-9915-4978-BA10-0534B7220A56</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:51:13 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F395A47F-78F3-4368-9431-23F1650523DF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F395A47F-78F3-4368-9431-23F1650523DF"/>
    <domeo:uuid>F395A47F-78F3-4368-9431-23F1650523DF</domeo:uuid>
    <ao:prefix>A third study evaluated the potential interaction of once weekly dosing of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, flucona</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-13 14:48:52 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:511E4E89-D7AE-48DF-B1A1-5CCC06746637">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2F6CA160-67ED-4743-8B8E-94EF9D64CE96"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:80367BF9-F837-42F7-839C-13E21BD05CDD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A13E9935-F0E6-4CA1-8840-A95120AD10BF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B85C811F-E622-43C2-A98D-FF1E56518D26"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D105817E-0A70-4AF9-BDFB-7AB0429EE1F3">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2244EDD8-BAF4-45A8-B774-B4E11AFFD0D7">
    <rdfs:label>tacrine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10318</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E69078C1-9504-4581-A81D-B6E5B383BBA5">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B1E7DF8A-AC49-4178-B436-08FC96D956FB"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34AE2CE1-80BE-4B8D-A3D3-A7E0231146B3">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 22:11:55 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:DD719F77-8948-4136-9464-45F37BA31C29</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:11:54 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:74005337-F273-4F8B-B7D2-B98BE2A52B18"/>
    <ao:body rdf:nodeID="Naa51f1e6e268497aabb70f572a983c57"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A166D9DF-7636-4C9B-BEB4-D328C9DDD969">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA041D1B-9C2F-4E79-94B7-26F6A29953A8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A143B9D3-083E-40DC-BB2A-069C9BC44AA1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A990CC62-59DF-45EC-A895-B3B17434FC99"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9306A467-0956-4B9D-8BD4-47A748E7F221"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D1127A23-F2D5-4DCB-BA73-F678B5ECDAAB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EC3F6671-AB16-4E9C-8214-0BD363B8166D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FFB6CA12-4FA0-4C81-A4AA-D8A65ECAA5FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB295A84-CC6E-42F0-AF6A-6072389AE082">
    <pav:lastSavedOn>2014-07-20 21:21:42 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E3A0235-DCFD-459A-8F14-2890C2BE937C"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 21:21:08 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:4d867608-6034-4082-aeba-08fb4f0d59a4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N782c06a6a69a49c9a8979e06ad465e56">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:318B26B5-FBEE-495B-B1E1-F1300ABC2C2D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Repeat oral dosing of </ao:prefix>
    <domeo:uuid>318B26B5-FBEE-495B-B1E1-F1300ABC2C2D</domeo:uuid>
    <ao:exact>AVANDIA </ao:exact>
    <pav:createdOn>2014-07-14 14:45:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:318B26B5-FBEE-495B-B1E1-F1300ABC2C2D"/>
    <ao:suffix>(8 mg once daily) for 14 days did not alter the steady-state pharmacokinetics of digoxin (0.375 mg once daily) in healthy volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B164D2E1-3E27-4390-9268-95C1A89A328A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/095CA7ED-42D5-42E2-9549-75DBE58B33C0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/39282B6D-06FA-44D0-907C-957EB7FB7C28"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/064AF908-3A0A-450F-9BFA-F2D49C79BB4D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>meperidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3532DFFB-3D9C-4C29-8E95-67559D564F54">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-13 14:48:52 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F395A47F-78F3-4368-9431-23F1650523DF"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE770B26-EFF8-465C-9F09-8F6D8EE12A07">
    <ao:suffix>(10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>(100 mcg/mL), </ao:prefix>
    <pav:createdOn>2014-07-14 15:55:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>warfarin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE770B26-EFF8-465C-9F09-8F6D8EE12A07"/>
    <domeo:uuid>DE770B26-EFF8-465C-9F09-8F6D8EE12A07</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259">
    <ao:item rdf:resource="urn:domeoclient:uuid:1221383A-AB62-4840-A496-988B305EDC98"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-14 00:19:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:B46F545E-377A-48E6-98B6-FD0397DE5F49</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:39D18119-A5F9-4E38-B9C3-810003206408"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:317005E2-B178-4EE5-8B87-E087CA90B237"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 00:21:15 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E4DEF4EF-010A-4776-AB76-14FB3FB6A27F</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Na7e7a102d34e47f29362325460846201"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5E98D39A-743C-4581-B214-D365FB040563"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF0B7B1E-EA73-4BD2-9FE7-D1E402400807"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76633D97-248B-4FB2-965F-C93E63D6F1C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9F7A5CF9-6F80-47F4-B56C-4AC25415396C">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FA61FE3E-3D69-43BF-96E4-05EE77B8FEB6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7E22EC8-C218-4817-9269-0A8803AD2538"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0E399497-ABC6-4278-8F3B-E80169F841A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:791108D1-BF81-414D-87F1-B5D4A0A7D91E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 00:27:11 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E0D01ED-1C30-4623-9983-1166A668CDD6"/>
    <pav:lastSavedOn>2014-07-14 00:27:12 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:F310F8A9-CACD-4567-B81F-C8DD292E94FF</pav:lineageUri>
    <ao:body rdf:nodeID="Nf0799ccce70343a1b0092e93d503d1a3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:538BC7F1-19AE-4A2B-A488-F62FB7DCFF65</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A53ED7CE-0B72-413D-9DCE-5CE1F14AF03A">
    <domeo:uuid>A53ED7CE-0B72-413D-9DCE-5CE1F14AF03A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A53ED7CE-0B72-413D-9DCE-5CE1F14AF03A"/>
    <ao:suffix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of </ao:prefix>
    <pav:createdOn>2014-07-13 14:36:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:392B0959-5D62-4FA5-9C01-ACBBBB55AE86">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A8E41BB9-C4B7-4A69-906F-3206A3AB67A9"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CE269066-6706-4D6D-B2BD-CAAC90C83EED">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1BEE739F-C465-4D59-950F-BBD38CD4D344"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3986738E-CF02-432E-808E-10E945DBF10D">
    <pav:createdOn>2014-07-20 21:13:43 -0400</pav:createdOn>
    <ao:suffix>-resistant HIV-1 isolate tested in cell culture retained full susceptibility to </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3986738E-CF02-432E-808E-10E945DBF10D"/>
    <domeo:uuid>3986738E-CF02-432E-808E-10E945DBF10D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and reverse transcriptase inhibitors is unlikely because of the different enzyme targets involved. One </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ZDV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FDE8DEB-89BC-44A8-88B7-9B674C163943">
    <pav:createdOn>2014-07-20 23:11:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>8FDE8DEB-89BC-44A8-88B7-9B674C163943</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fluvoxamine and thioridazine should not be coadministered</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8FDE8DEB-89BC-44A8-88B7-9B674C163943"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F069D13E-F4B1-4623-8B81-411C6E9A0C3A">
    <ao:context rdf:resource="urn:domeoclient:uuid:ECD8CAC1-E32D-4DF2-9BAF-DE171A38BDCF"/>
    <pav:createdOn>2014-07-14 15:09:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:E375AB36-B4E1-4B41-B9FB-9C46FCEF3073</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:09:57 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:87C87B25-2788-4E6F-A04F-27F5AF9D1A53</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9976E9AB-FFB4-43A2-811D-03742C2DA427">
    <rdfs:label>azithromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/18631</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C1CAEC4E-043D-4B2A-8CF1-73FF8E8D3795">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/40DA3D3F-0BF9-4A34-85C9-CB703565E2F2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0EE6A646-5E99-48B4-A559-DA3457848C62"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0B38CA1-9834-4D6C-BCE5-C86F75D2C876">
    <ao:exact>Rosiglitazone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A0B38CA1-9834-4D6C-BCE5-C86F75D2C876"/>
    <domeo:uuid>A0B38CA1-9834-4D6C-BCE5-C86F75D2C876</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, a member of the thiazolidinedione class of antidiabetic agents, improves glycemic control by improving insulin sensitivity. Rosiglitazone is a highly selective and potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARγ). In huma</ao:suffix>
    <pav:createdOn>2014-07-14 14:05:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93F91D34-1594-4D53-A5D8-57FB0319E159">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>93F91D34-1594-4D53-A5D8-57FB0319E159</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:93F91D34-1594-4D53-A5D8-57FB0319E159"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:24:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>), which are predominantly metabolized by </ao:prefix>
    <ao:exact>CYP3A4</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:772407C0-472A-4EF2-9082-C74D76A5884F">
    <ao:suffix>(150 mg).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:772407C0-472A-4EF2-9082-C74D76A5884F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 11:09:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>772407C0-472A-4EF2-9082-C74D76A5884F</domeo:uuid>
    <ao:exact>aspirin </ao:exact>
    <ao:prefix>(50 mg) did not potentiate the increase in bleeding time caused by </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8D2ED292-DF73-4222-9489-CD0F5186233C">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:66423F8D-0720-473A-B4A5-689CF6E5120D"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FDDEB300-E784-422D-A16F-6A161F5BD43F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ae21e08a-7338-428a-9d9b-ba327d8add63">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:8f132d8b-8ec4-4488-bf78-60475ab3d167</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:09:15 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:d637dee9-5167-42cc-880c-41448bf7c6c0"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DCA01201-900A-484E-A265-59DB0E1CD1C5</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:09:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FFB6CA12-4FA0-4C81-A4AA-D8A65ECAA5FD">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10ff23ae-618a-437e-af8b-a68b06a4d811">
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:7dc69d20-4aed-4c9f-9940-a84a04c16b52</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:08:48 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:78cb3beb-2fce-4a58-bb25-b7abe617cb72"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:64B0AF47-31CD-4E26-8EC8-498E258CC22C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C8C09E9-486C-451A-91CC-01423F65BFD6">
    <pav:lineageUri>urn:domeoserver:annotation:B0A1FDEC-5745-4542-AF10-65213AA8162E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 13:57:24 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 13:55:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:607F7195-0BA5-4B52-AE2D-5D34139388BA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:AFBD4DF3-2F53-4791-8488-6668A4EB10FD</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B790D350-FD5D-4096-8A96-2248DDAF25DB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix>is started or stopped during treatment with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B790D350-FD5D-4096-8A96-2248DDAF25DB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-122.txt.html</ao:hasSource>
    <domeo:uuid>B790D350-FD5D-4096-8A96-2248DDAF25DB</domeo:uuid>
    <pav:createdOn>2014-07-14 14:00:10 -0400</pav:createdOn>
    <ao:suffix>, changes in diabetes treatment may be needed based upon clinical response. [See Clinical Pharmacology (12.4).] </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42A9228C-7605-4287-9210-CB0702357D4A">
    <pav:createdOn>2014-07-14 14:57:04 -0400</pav:createdOn>
    <ao:prefix>, resulting in increased concentrations of </ao:prefix>
    <ao:exact>diazepam </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <domeo:uuid>42A9228C-7605-4287-9210-CB0702357D4A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42A9228C-7605-4287-9210-CB0702357D4A"/>
    <ao:suffix>and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/839D0558-5E17-4702-AF4E-A5DAB9B8280A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/236474</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fexofenadine hydrochloride</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C41072DB-3941-43B5-9230-4489236E0433">
    <ao:body rdf:nodeID="N1f648381ab624a3696425c03cca38a08"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:79659A32-2EE7-403B-8B6C-54B98F28E027</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">21</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:21:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D62C0A28-17DC-4974-AF1F-92816DD078C0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:createdOn>2014-07-20 22:21:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F8DBE126-C96D-492C-8D5B-06E2619CDEFF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/13CD0FEE-854B-4A27-A144-8605128D6FD0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D4C1CBA4-1E52-47AA-949D-0456A5131A39"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDFF1064-0B94-4251-9EDD-83164C93EC74">
    <pav:createdOn>2014-07-14 14:11:22 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:00C40DBD-DDB8-4667-85A1-845FF6A0EC8D"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:112B1B73-DB37-4023-B62F-FF624A1BA519</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:11:29 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/42D5AEA7-A8A3-481F-BFBD-34546E0CA5FC">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/71CF95C5-95B9-46E5-A0DB-D4F55232760A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65425786-706B-46DA-B512-80709C79E601">
    <ao:body rdf:nodeID="Na549977a732c4c2aa31b77e60ed498b0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:5FC27BC2-08A8-4F93-B114-7BBC12BB7BB0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-14 14:58:06 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 14:58:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7bc5bf00555c458d972c4d6fb8d559fc">
    <domeo:sets rdf:resource="urn:pddi:uuid:F79B0B0D-272A-42BC-A10E-2C99CEB64A33"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:850FBE50-E974-4FC1-9B00-8FFCC23626F6">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1455B528-6F82-492A-8E0B-E305B5A9CD1A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FEC3F002-6EA8-4C3C-A1D3-F7323E6E2CBC">
    <ao:exact>Sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 11:09:46 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>(50 mg) did not potentiate the increase in bleeding time caused by aspirin (150 mg).</ao:suffix>
    <domeo:uuid>FEC3F002-6EA8-4C3C-A1D3-F7323E6E2CBC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FEC3F002-6EA8-4C3C-A1D3-F7323E6E2CBC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BAF2432-5347-4A9E-85E1-BA882F94973F">
    <ao:suffix>. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <pav:createdOn>2014-07-14 16:01:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1BAF2432-5347-4A9E-85E1-BA882F94973F"/>
    <domeo:uuid>1BAF2432-5347-4A9E-85E1-BA882F94973F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>, has similar pharmacological activity as </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31896681-6F81-4411-80C8-7455907DC3A1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>pravastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/42463</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e1d01f6cbaf4eec8c3d6094c69f9238">
    <domeo:sets rdf:resource="urn:pddi:uuid:CD08A3C3-5630-42CE-9535-A1B29411B3F6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A3C8322-C58C-4824-9537-47749E4A77BF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:09:14 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F33B91B1-7A0C-42CF-930F-7D354B2E7667"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4b726c55-6b2f-4746-a732-02879c92a7bf">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-07 08:09:00 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:910d81dd-ca06-45c6-b40e-2d1d4638a212</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1353EFCE-C5CB-4CE7-9955-93F35EC83D57</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 08:09:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7507e0b7-e651-49fe-aa41-4d82d4654521"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F3AC7FF-1FC1-4227-A7A3-E4BE7060A565">
    <pav:createdOn>2014-07-14 16:02:18 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F3AC7FF-1FC1-4227-A7A3-E4BE7060A565"/>
    <ao:suffix>. Extensive CYP 2D6 metabolizers convert risperidone rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations t</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably </ao:prefix>
    <ao:exact>quinidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>2F3AC7FF-1FC1-4227-A7A3-E4BE7060A565</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1996A40-CBAA-47DA-9FCD-A7DB2F8A8CED">
    <ao:context rdf:resource="urn:domeoclient:uuid:C39C295A-A84B-4762-BFDB-568AB3489ECA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nbe5f024e616749648157738ef2ee600a"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:21:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">21</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-20 22:21:35 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:79659A32-2EE7-403B-8B6C-54B98F28E027</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:887DE4D9-4AEB-43CC-8197-17E3F102E6F0">
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:63B80A52-CC3A-4B8F-9431-862133269C24"/>
    <pav:previousVersion>urn:domeoserver:annotationset:00A1E607-7F59-4003-A6F7-2D54D8B6D573</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 11:14:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 11:14:00 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nb415b6b54d3e45778a3be33ebb9d191b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:227D051B-A8D6-4A42-A3F3-0642743BFC2A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:57:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:58:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4F5F3635-63E8-45D6-A1D7-ED0A6A16E7B0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2183c61b-5e9b-4050-85f9-2494b8256800">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:817284aa-573d-4596-ba64-5759ad57f2e0</pav:lineageUri>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:86DFD58D-9AC9-48B9-A8FF-24D88A8C1436</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-07 08:08:48 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:48945067-5b7a-4943-8863-4f1584fdd0f5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:794B5A25-B381-400D-B87D-93B9650232CA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Paroxetine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:hasSource>
    <ao:suffix>produced no genotoxic effects in a battery of 5 in vitro and 2 in vivo assays that included the following: Bacterial mutation assay, mouse lymphoma mutation assay, unscheduled DNA synthesis assay, and tests for cytogenetic aberrations in vivo in mouse bo</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:794B5A25-B381-400D-B87D-93B9650232CA"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>794B5A25-B381-400D-B87D-93B9650232CA</domeo:uuid>
    <pav:createdOn>2014-07-14 00:14:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BDFB4F3B-2B15-4169-8FFE-0B62B9386E3D">
    <rdfs:label>sulfamethazine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72BCE041-A6C2-45DA-9835-BF5DA6159CEF">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:30:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72BCE041-A6C2-45DA-9835-BF5DA6159CEF"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>These studies indicate that ketoconazole or erythromycin coadministration enhances fexofenadine gastrointestinal absorption</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>72BCE041-A6C2-45DA-9835-BF5DA6159CEF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BF05A6E-C3A4-4378-9E7C-D7DCE60F8E50">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A3CD83E0-CE71-4CBB-B7FE-C02843F433A7</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:07:45 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:46692380-1BE0-4007-880E-3A3A89ABE2FA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc342f2d7ab90429e8b77b2dceef0bb0d">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73FC6F4E-B5BF-4EB0-856F-AF5AEB56DC10">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:prefix>:</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>73FC6F4E-B5BF-4EB0-856F-AF5AEB56DC10</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:73FC6F4E-B5BF-4EB0-856F-AF5AEB56DC10"/>
    <ao:exact>There were no significant interactions between risperidone and erythromycin</ao:exact>
    <pav:createdOn>2014-07-20 22:17:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4C62F38B-DB19-420D-9503-7EF687C9BB80">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8214E12-1EB1-4754-9F28-E3075529460F">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:26:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:95FD6F44-4A5A-4BB7-AE18-9BBEAC51F31A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:812A80DB-2E3F-4AE5-A0A5-C63E1DE00DBC">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AFE28430-95D3-4E46-A0DF-E9B20DC549E1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:647A94EA-76ED-4DF0-8B1C-870E35E712AF">
    <ao:exact>but quinidine does not alter the kinetics of diltiazem</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:21:13 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:647A94EA-76ED-4DF0-8B1C-870E35E712AF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid>647A94EA-76ED-4DF0-8B1C-870E35E712AF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BF64C85-A3D3-447B-B78D-B19FFFF57D80">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>In patients well-stabilized on methadone, concomitant administration of rifampin resulted in a marked reduction in serum methadone levels and a concurrent appearance of withdrawal symptoms</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BF64C85-A3D3-447B-B78D-B19FFFF57D80"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:09:03 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9BF64C85-A3D3-447B-B78D-B19FFFF57D80</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-200.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1C2E0D46-5B2F-4381-BBEC-78C2094865A0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fexofenadine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/87636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6F168D68-A400-479A-85FB-7F9FB434D742">
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9076A776-B827-42EA-BAE2-C471214C81D9">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D7651CAF-38C3-4709-BADB-6CD9D6556B63"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F50D9621-2894-4BB2-83B2-3A401583118B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 13:47:11 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:F95340EE-5782-4D4C-872A-6E840CA07FF6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:4CEF400C-B6C5-4833-A3E4-C01598F0F2FA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B23B1EBF-3499-4390-B761-2682C8EA921F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 13:42:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61A16E84-D514-4276-9C32-6E187E5EB7CA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F2E0992-1D21-43B2-8240-EA6485BD1358">
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:20:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D653786A-F069-42B0-91A8-52DBEC720004"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8D7BEDB9-C2C4-4BBE-B683-F8782B5637C1">
    <rdfs:label>rosiglitazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8204760A-0B03-4608-B1B3-EA9D65C0052D">
    <domeo:uuid>8204760A-0B03-4608-B1B3-EA9D65C0052D</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8204760A-0B03-4608-B1B3-EA9D65C0052D"/>
    <ao:exact>Verapamil does not affect the pharmacokinetics of propranolol</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-127.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:56:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C61B6F1-9109-41B3-87A4-E24912A9568C">
    <ao:prefix>. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9</ao:prefix>
    <domeo:uuid>4C61B6F1-9109-41B3-87A4-E24912A9568C</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 16:01:36 -0400</pav:createdOn>
    <ao:suffix>, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C61B6F1-9109-41B3-87A4-E24912A9568C"/>
    <ao:exact>-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCBC813C-26E8-4167-A861-2A127BD4B194">
    <pav:createdOn>2014-07-14 15:52:40 -0400</pav:createdOn>
    <domeo:uuid>BCBC813C-26E8-4167-A861-2A127BD4B194</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:prefix>results from the combined concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BCBC813C-26E8-4167-A861-2A127BD4B194"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4BDB2504-6DC3-4E0E-B8AC-7FC6A9E47198">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>nelfinavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/134527</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC44CEF6-84D4-4AD8-9FA3-461AB14DBC1C">
    <pav:createdOn>2014-07-14 15:50:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC44CEF6-84D4-4AD8-9FA3-461AB14DBC1C"/>
    <ao:suffix>acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-s</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DC44CEF6-84D4-4AD8-9FA3-461AB14DBC1C</domeo:uuid>
    <ao:exact>Risperidone </ao:exact>
    <ao:prefix>is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC9ACC5A-39AC-427B-805F-339CA9F6BDC1">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:CC1C0424-FC1B-479B-BCE8-05649CD69B52</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:47:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:48:59 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5EDBE7EC-DFAA-426E-BB67-42D78AED75C7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na859d1b833194e9490a7cbf437f0ffc9">
    <domeo:sets rdf:resource="urn:pddi:uuid:85DFECD2-7400-4187-BCA1-BCC7ECD3C242"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0368d8d6f0de4d9db37b16f59893a18d">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EEABDB7A-6F26-4D6D-8444-63D448035261">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>lithium</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E3B65C6-5BB3-4446-9E9F-3B0C7A7A1280">
    <ao:context rdf:resource="urn:domeoclient:uuid:42035FD4-F504-4E31-BE05-66C9A2B24E0C"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 13:52:32 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:175DE992-5EA0-40AF-8BC8-6F899E0B93D0</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:BB55A9CD-10A4-4FFC-8073-018B87026D32</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 13:53:55 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD4AC815-E106-412D-AE90-606FCC28F77C">
    <ao:suffix>(8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CD4AC815-E106-412D-AE90-606FCC28F77C</domeo:uuid>
    <pav:createdOn>2014-07-14 14:36:51 -0400</pav:createdOn>
    <ao:exact>AVANDIA </ao:exact>
    <ao:prefix>AUC and Cmax were observed after repeat doses of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CD4AC815-E106-412D-AE90-606FCC28F77C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E236BA8C-C033-4DC5-BC67-703822FB0BAA">
    <ao:exact>risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E236BA8C-C033-4DC5-BC67-703822FB0BAA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E236BA8C-C033-4DC5-BC67-703822FB0BAA</domeo:uuid>
    <ao:prefix> concentrations than poor metabolizers, the pharmacokinetics of </ao:prefix>
    <ao:suffix>and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <pav:createdOn>2014-07-14 16:02:39 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1759ABFA-AD7D-4030-AFC4-3E7332B001EF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Rifampin administration (600 mg once a day), an inducer of CYP2C8, for 6 days is reported to decrease rosiglitazone AUC by 66%, compared to the administration of rosiglitazone (8 mg) alone</ao:exact>
    <ao:suffix> [see Drug Interactions (7.1)].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1759ABFA-AD7D-4030-AFC4-3E7332B001EF"/>
    <domeo:uuid>1759ABFA-AD7D-4030-AFC4-3E7332B001EF</domeo:uuid>
    <pav:createdOn>2014-07-14 14:32:15 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CBF1B031-01B7-4827-BA57-9F45D737B368">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B08ADE6D-20F3-4B69-ACC1-35AE4ED00799"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4802F4A9-888D-4AC2-9DB3-5D3E4CF38E3E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na862c22b02134bcd9aed9f7bd816032f">
    <domeo:sets rdf:resource="urn:pddi:uuid:7FCE5626-589F-4F5A-8DD1-081C8F19A770"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7873A0EC-2F8C-4C58-84D1-48C318DA1582">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Metformin</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>7873A0EC-2F8C-4C58-84D1-48C318DA1582</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7873A0EC-2F8C-4C58-84D1-48C318DA1582"/>
    <pav:createdOn>2014-07-14 14:42:17 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/d40888ba-5671-405a-b36f-800052b7cd47">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:09:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-07 08:09:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:f35d2bcd-8aef-4bd3-b3f3-7ff045425ac5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BBB9E9EA-0471-49FE-A82D-09FF84326065">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9BA3974A-96A6-4596-8631-2C51877A57AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B458216-3F8B-417B-9505-2F5C6BBF2715">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B458216-3F8B-417B-9505-2F5C6BBF2715"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>2B458216-3F8B-417B-9505-2F5C6BBF2715</domeo:uuid>
    <ao:prefix> conjugates of </ao:prefix>
    <ao:exact>4-hydroxy propranolol</ao:exact>
    <pav:createdOn>2014-07-14 15:11:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-135.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:102CC1DC-7EAC-4823-A679-CA0023AEB5B7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:102CC1DC-7EAC-4823-A679-CA0023AEB5B7"/>
    <ao:prefix>.</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%</ao:exact>
    <ao:suffix>. When administering these drugs concurrently, one should be alert for possible excessive</ao:suffix>
    <pav:createdOn>2014-07-20 21:25:21 -0400</pav:createdOn>
    <domeo:uuid>102CC1DC-7EAC-4823-A679-CA0023AEB5B7</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-88.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N294956d67c71431ab563e7c1f7fd19bc">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:85819FE1-23CF-4717-A22F-2427ADC22667">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5E9EC647-C1F0-425B-802C-E52C7B889D3E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E1923CB2-0FF7-4945-8F06-DC30AD67F99D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF56FE4B-6224-4192-A64E-B4B91FF70A51">
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 14:22:57 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:29AD0813-B2C8-4A21-A09B-04904ED8A272"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1E5483B-7558-449D-9B6F-F67BB8FA95E3">
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:52590A14-5FB3-4D4F-96A8-303FF0B2DAF2"/>
    <pav:lastSavedOn>2014-07-14 15:24:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:0E787574-CAFF-45CD-8111-448FFB3DB7D6</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:22:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0AAD930F-D24D-431A-9644-CBA937E6B04F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:67291C71-6522-4DE8-B97A-157EDAA01CB4"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7B0466C-240A-49CD-AE9D-082313F61373">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7B0466C-240A-49CD-AE9D-082313F61373"/>
    <pav:createdOn>2014-07-14 16:03:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D7B0466C-240A-49CD-AE9D-082313F61373</domeo:uuid>
    <ao:suffix>, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest numb</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>quinidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CD3DE6A7-CC9E-4E31-A711-996F488479EB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/25789</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>glimepiride</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4A90553F-7027-4527-AB18-1C3CFDD7F24F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AAA96B2-F8F3-42CA-9919-D8791FDD3499">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>In vitro data indicate ribavirin reduces phosphorylation of lamivudine, stavudine, and zidovudine. However, no pharmacokinetic (e.g., plasma concentrations or intracellular triphosphorylated active metabolite concentrations) or pharmacodynamic (e.g., loss of HIV-1/HCV virologic suppression) interaction was observed when ribavirin and lamivudine (n = 18), stavudine (n = 10), or zidovudine (n = 6) were coadministered as part of a multi-drug regimen to HIV-1/HCV co-infected patients</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0AAA96B2-F8F3-42CA-9919-D8791FDD3499"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0AAA96B2-F8F3-42CA-9919-D8791FDD3499</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 20:57:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E914FB8C-7421-4EC6-96A3-46D1BE508620">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:33:09 -0400</pav:createdOn>
    <ao:exact>Rifampin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E914FB8C-7421-4EC6-96A3-46D1BE508620"/>
    <domeo:uuid>E914FB8C-7421-4EC6-96A3-46D1BE508620</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AF9A31FA-04E9-4956-AFDA-28A7EFE05FB3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/90F08861-0DAB-46CF-B204-46BB26CB3700"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61A16E84-D514-4276-9C32-6E187E5EB7CA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB26F27A-D643-4980-9DBF-B3537C0D3D6C">
    <pav:previousVersion>urn:domeoserver:annotationset:0B0BD6DB-0A1F-4FB4-A424-7B19831EE508</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D4556CD-CBA3-4E9F-9F20-4D9AA5326ABE"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:16:14 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-20 22:16:13 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N61d93039a69c4496b185e4493c8eb49b"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N41f7afc058854847b9d1303e5fdc241e">
    <domeo:sets rdf:resource="urn:pddi:uuid:61CC51D6-2D4C-4BDA-A860-4342A2E6F4BE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F251274-63AC-4938-AFF6-DE7C31B47267">
    <ao:suffix>levels (ALT &gt;2.5X upper limit of normal) at baseline [see Warnings and Precautions (5.6)].</ao:suffix>
    <ao:exact>transaminase </ao:exact>
    <ao:prefix>should not be initiated if the patient exhibits clinical evidence of active liver disease or increased serum </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0F251274-63AC-4938-AFF6-DE7C31B47267</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 14:19:53 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F251274-63AC-4938-AFF6-DE7C31B47267"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5FC2678A-27CB-404F-B580-EF24CFBD2537">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/18899E6B-5B54-47AB-9D1C-6AA4C9C8F517"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/32526DC9-E6DB-4CBA-BD93-0E83C1E6313B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/83BE9B79-8B56-4481-95C5-D5D3B55B72A5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sildenafil</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/905AF06F-3E90-47B3-89C2-55A3444BB3E1">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3DD4B8FD-7B87-4C4C-AAB9-071EC5537F74">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rosiglitazone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EEA72C26-9309-4233-8B8F-C95629C38284">
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9c28ff79-d540-4c8b-8c3d-158f705a60b2">
    <ao:exact>doxazosin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-111.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:09:02 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9c28ff79-d540-4c8b-8c3d-158f705a60b2"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>ectively. In the presence of </ao:prefix>
    <ao:suffix>, AUC and Cmax of nifedipine w</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf72b41c5d78f43c6aabc0824f7839560">
    <domeo:sets rdf:resource="urn:pddi:uuid:57096881-6D9E-449E-910A-528AFFA7AE4D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E7CD0765-E9CB-4A81-8A2E-69BBD346D8F7">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:307E8571-93F7-4F77-9F27-4F5523BEFD29"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C90379C-A4B8-4DFB-954A-60B0D121F2BF">
    <ao:suffix>with nefazodone is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:prefix>and its active metabolite to achieve a therapeutic effect. Coadministration of </ao:prefix>
    <domeo:uuid>3C90379C-A4B8-4DFB-954A-60B0D121F2BF</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3C90379C-A4B8-4DFB-954A-60B0D121F2BF"/>
    <pav:createdOn>2014-07-14 13:48:58 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>carbamazepine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3B23570A-CB5D-4241-8BA5-8AEA1A000F41">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:55E9D065-FCA3-4050-86B5-CA844CAA03FA"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N03b991762c814bd4b3911658afc6e256">
    <domeo:sets rdf:resource="urn:pddi:uuid:ED452DE7-71EF-477E-A633-55ABE405197D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:81FC10C7-DC44-4F3D-BB68-DA2B5775CD8F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E1A0CBEE-CB7F-4544-BCCF-2ADE431F7120"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/81422E90-7EE1-49DF-BA32-EAC27947E134"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C3D2B9B7-F4E4-493F-8CAD-A21CD146CFF3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/07155DEC-567B-4837-8BAA-FD75C9F0234F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E8903495-A0B0-4E81-A534-0B33FFE8CE47"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:09A7681E-3F50-4A35-B373-63963A6D77F6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/963E6827-5B20-4353-8BE7-A491C397BEB4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EDA670C0-B908-4388-8BB9-AA9D407DF68D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:499B3DF8-59D4-4E33-86BC-A4B323D8F805">
    <ao:context rdf:resource="urn:domeoclient:uuid:1FA91E7E-256C-4C5F-9AFD-53B04FADE141"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-07 11:08:07 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27404F63-F3EB-4A7E-B804-35E19E45732A">
    <ao:prefix>s of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-86.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 21:40:54 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:27404F63-F3EB-4A7E-B804-35E19E45732A"/>
    <ao:exact>tacrine</ao:exact>
    <domeo:uuid>27404F63-F3EB-4A7E-B804-35E19E45732A</domeo:uuid>
    <ao:suffix>, although the estimated mean treatment effect was different in each analysis</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4939BE5-4896-48A2-81CD-F3766D80D088">
    <ao:context rdf:resource="urn:domeoclient:uuid:056507AB-98C8-4455-B54E-FE0A47E80095"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 00:08:06 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:4477B066-614B-4766-BF4D-5EE07E18E1DB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:380DADA3-8FF8-4D47-8619-329F423CC3D0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 00:06:46 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N75800d6f8c0c469ca479f5c69726b7fd">
    <domeo:sets rdf:resource="urn:pddi:uuid:B859A639-DEBC-47AF-9A58-931770FF0747"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F8D54F9-05F8-484D-AC39-B03ED5375925">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F8D54F9-05F8-484D-AC39-B03ED5375925"/>
    <pav:createdOn>2014-07-20 20:57:50 -0400</pav:createdOn>
    <ao:suffix> (ZDV-TP). The principal mode of action of ZDV-TP is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. ZDV-TP is a weak inhibitor of the cellular DNA polymerases α and γ and has been report</ao:suffix>
    <domeo:uuid>0F8D54F9-05F8-484D-AC39-B03ED5375925</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>zidovudine triphosphate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/17b187f9-7c97-4316-ab80-f59bd34b0311">
    <pav:lastSavedOn>2014-07-07 08:08:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:ebe61c71-4bd3-4aa1-9a6a-e9cb12d5e1ce</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2cf3ff44-7e8c-4e28-a540-768d3157156b"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:08:47 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:41FADBF6-DB61-48C1-8758-89F516D57C5A</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B7721270-FC54-491F-8CA7-DA1ED70D0F13">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1E325F55-DDB4-4E92-ACA2-3E12A96F014F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6BBFD48-6F27-462B-8DF6-4356DD53EBBF">
    <ao:exact>Lithium</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F6BBFD48-6F27-462B-8DF6-4356DD53EBBF"/>
    <domeo:uuid>F6BBFD48-6F27-462B-8DF6-4356DD53EBBF</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:prefix>7.7 </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:12:38 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N00f4008880d54cc0bb9068f57a1eb096">
    <domeo:sets rdf:resource="urn:pddi:uuid:D6ED373C-75B1-42F4-B99C-2DD071270459"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5544894C-9B0A-4F90-A1EE-CC256DD839CA">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C3CED62B-7A1D-4715-BE4B-E10D323C589A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AA0EF444-9503-4A24-A988-5E01413E3727">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6779</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>mesoridazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43E95240-C15F-4344-A20D-593A76967A8D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ketoconazole</ao:exact>
    <pav:createdOn>2014-07-14 15:25:21 -0400</pav:createdOn>
    <ao:prefix>or </ao:prefix>
    <ao:suffix>. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43E95240-C15F-4344-A20D-593A76967A8D"/>
    <domeo:uuid>43E95240-C15F-4344-A20D-593A76967A8D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N27efbfd403474225b45cac3f0e298393">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15376922-DE98-4B35-89FC-15A1DDE1A8D0">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:25:52 -0400</pav:createdOn>
    <domeo:uuid>15376922-DE98-4B35-89FC-15A1DDE1A8D0</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:15376922-DE98-4B35-89FC-15A1DDE1A8D0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:exact>Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3923697-9CF3-4C48-B7CD-D052D09C0DA2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Na374dc15da8143f1b141afcf942f57cb"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:06:38 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:256E6E7D-4A48-4C42-B3F5-C8241CCFC257</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 22:06:26 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7D9A0F52-B812-4C89-AE74-620A9D8CDED9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38854486-FAD6-4812-AE1A-68BC6BF47203">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>e N-demethylation and hydroxylation, followed by conjugation with sulfate and glucuronic acid. All the circulating metabolites are considerably less potent than parent and, therefore, are not expected to contribute to the insulin-sensitizing activity of </ao:prefix>
    <ao:suffix>.</ao:suffix>
    <ao:exact>rosiglitazone</ao:exact>
    <pav:createdOn>2014-07-14 14:13:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38854486-FAD6-4812-AE1A-68BC6BF47203"/>
    <domeo:uuid>38854486-FAD6-4812-AE1A-68BC6BF47203</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B1216755-C112-4930-9821-BE92F46BB1C3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4A5DB4F5-1EA6-4F76-B578-521E1412F581"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/257936A9-4FFA-4369-85AD-971CFE06D498"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0C774389-232F-4134-9E74-3FF3BB994591">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5573C88B-A725-4BF9-91BD-23656FAD7E82"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDCFEC33-7FC2-43C8-A53F-23F8FE6760DF">
    <pav:lineageUri>urn:domeoserver:annotation:254FFD66-CE46-4AB2-B3F9-72E4812A0BBA</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:45B29599-C983-42A7-A3F1-3DF0980C5720"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 15:02:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:01:54 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:1F4DB871-B0E2-4CBE-B57A-8CC4639877CD</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C09A45A-A18E-40E0-B052-A23D77AAEE39">
    <ao:exact>ethinyl estradiol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C09A45A-A18E-40E0-B052-A23D77AAEE39"/>
    <pav:createdOn>2014-07-13 14:49:01 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>5C09A45A-A18E-40E0-B052-A23D77AAEE39</domeo:uuid>
    <ao:prefix> 300 mg to 21 normal females taking an oral contraceptive containing </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and nore</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BE297339-7EC8-4413-A046-9005B63E7AF4">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF491442-6BC1-4F1D-B36A-0955B91CDFDD">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:44:11 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF491442-6BC1-4F1D-B36A-0955B91CDFDD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>AF491442-6BC1-4F1D-B36A-0955B91CDFDD</domeo:uuid>
    <ao:exact>Carbamazepine can increase alprazolam metabolism and therefore can decrease plasma levels of alprazolam</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-100.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:749A982C-1C6F-4EC5-822D-5846D27D5A06">
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-07-14 15:36:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration.</ao:suffix>
    <domeo:uuid>749A982C-1C6F-4EC5-822D-5846D27D5A06</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:749A982C-1C6F-4EC5-822D-5846D27D5A06"/>
    <ao:exact>meperidine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3AE68A18-97D3-4D92-A348-4A4E6CC91EB7">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3AE68A18-97D3-4D92-A348-4A4E6CC91EB7"/>
    <pav:createdOn>2014-07-14 00:27:32 -0400</pav:createdOn>
    <domeo:uuid>3AE68A18-97D3-4D92-A348-4A4E6CC91EB7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0EB29FDF-7988-4626-9897-C7B7834893ED">
    <pav:createdOn>2014-07-14 15:23:25 -0400</pav:createdOn>
    <ao:prefix>or </ao:prefix>
    <domeo:uuid>0EB29FDF-7988-4626-9897-C7B7834893ED</domeo:uuid>
    <ao:exact>erythromycin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0EB29FDF-7988-4626-9897-C7B7834893ED"/>
    <ao:suffix>led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1659FBB8-F690-4BB3-8312-06E2B7EE26F6">
    <pav:lineageUri>urn:domeoserver:annotationset:FEAD2893-A533-47BD-8016-31A047106ECF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-13 23:54:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 23:56:33 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B68F178E-3014-442D-B3F1-B938781E6609</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F7EA7C5-B139-423D-ADEB-EDA85A5B27EC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0B5A29A-C1BE-4588-AF05-3473FCA807C1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0B5A29A-C1BE-4588-AF05-3473FCA807C1"/>
    <domeo:uuid>E0B5A29A-C1BE-4588-AF05-3473FCA807C1</domeo:uuid>
    <pav:createdOn>2014-07-20 23:00:01 -0400</pav:createdOn>
    <ao:prefix>. </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:exact>Oral conivaptan hydrochloride 40 mg twice daily resulted in a 2-fold increase in the AUC and half-life of amlodipine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5F932699-F716-4A60-BEEA-4E1726615664">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6C19A167-E6AC-4858-AFDA-FA1D45EFE36A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D1B3359F-0727-402B-A293-3F12263E5D17">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:859AAAA8-FD74-4E07-98E4-F05008D361FD">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6694ED24-17DC-41BB-B8F6-A11CB21E936C"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48945067-5b7a-4943-8863-4f1584fdd0f5">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-200.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <ao:suffix> resulted in a marked reductio</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rifampin</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>oncomitant administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48945067-5b7a-4943-8863-4f1584fdd0f5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:224B5795-48A6-41C5-8A03-42E676D48DCD">
    <pav:lastSavedOn>2014-07-20 21:42:27 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-20 21:42:24 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nf84a8c5cae3d490fad803bf7886a02f2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C4E84CA0-FE12-4DA0-967D-F21854C66900</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3918F53-7F45-49FF-A858-9AD333C60994"/>
    <pav:lineageUri>urn:domeoserver:annotation:AEA964B5-C1C9-4CF0-B4D2-222E28D54BA1</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A7A148B1-1E12-4BF3-98A6-C099709CAD1F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:109B2520-9019-4761-A1B4-DCBD1CF3730A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Fexofenadine </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>109B2520-9019-4761-A1B4-DCBD1CF3730A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:109B2520-9019-4761-A1B4-DCBD1CF3730A"/>
    <ao:suffix>has been shown to exhibit minimal (ca. 5%) metabolism. However, coadministration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects. Fexofenadine had no </ao:suffix>
    <pav:createdOn>2014-07-14 15:22:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1453A345-29DC-4B53-BAF4-13DC5D402218">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D876D927-32CF-4C3A-98BB-86C758433B46">
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D876D927-32CF-4C3A-98BB-86C758433B46"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 22:01:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <domeo:uuid>D876D927-32CF-4C3A-98BB-86C758433B46</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B9C1ABD-6DA3-4534-AB68-C1381F046A31">
    <ao:exact>Carbamazepine co-administration decreased the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone by about 50%</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:18:16 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B9C1ABD-6DA3-4534-AB68-C1381F046A31"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2B9C1ABD-6DA3-4534-AB68-C1381F046A31</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32515912-017E-402F-A8DD-F5644EE84E4C">
    <pav:lastSavedOn>2014-07-14 14:12:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:12:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DDF93D23-3CC5-4095-A8C6-54CEAD150DD1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:7120AB7A-7867-43E7-8DC3-5404D7106D51</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:775C4301-4FE3-49A0-9B8D-E000BB081FEA">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7C83C8C9-0D52-4D2F-8890-E9F69B4E65C1"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC8ABEC8-05B8-46BD-B102-C903D53DD914">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4A8C75E0-4929-4A79-9A23-19E6D1E3BA6F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/39975397-3C66-4E9E-AE43-B41D4A47ACB1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B6F0AC6-2C59-43FE-8098-6CAFDC55E355">
    <pav:lineageUri>urn:domeoserver:annotation:85901BC9-65D9-4B64-9FBD-2AAEF3A9AA33</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:39DDA238-CF5B-430B-83C9-CC5031E4FE2C"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:AFBD4DF3-2F53-4791-8488-6668A4EB10FD</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 13:54:31 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 13:57:24 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB568A71-09EF-4AFB-92DE-FD6E050D4815">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/48B4A60C-16C4-47BA-BD76-D3EF7813E856">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77BB8A02-6EBB-4C81-B877-FDAB4DCC276A">
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77BB8A02-6EBB-4C81-B877-FDAB4DCC276A"/>
    <ao:suffix> (see CONTRAINDICATIONS)</ao:suffix>
    <ao:exact>Coadministration of carbamazepine with nefazodone is contraindicated</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 13:51:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>77BB8A02-6EBB-4C81-B877-FDAB4DCC276A</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6ABEE6C3-D942-4DE8-92B1-88B439CECB7A">
    <domeo:uuid>6ABEE6C3-D942-4DE8-92B1-88B439CECB7A</domeo:uuid>
    <pav:createdOn>2014-07-20 22:03:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6ABEE6C3-D942-4DE8-92B1-88B439CECB7A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:75CFE42C-4C0E-47B3-8935-B8E8130DE959">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5F05660B-D46A-4BA4-961D-43D5BA351026"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A3BEEA0E-86E8-41AA-B260-FE3EF9BC49E2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D2BB64D-347B-4107-A2D7-337FA4A2FEA6">
    <ao:exact>zidovudine </ao:exact>
    <ao:suffix>AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <pav:createdOn>2014-07-13 23:54:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1D2BB64D-347B-4107-A2D7-337FA4A2FEA6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D2BB64D-347B-4107-A2D7-337FA4A2FEA6"/>
    <ao:prefix>dose for at least two weeks. There was a significant increase in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0152500B-ECCE-4E95-8F3F-B3FD831A70DF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <domeo:uuid>0152500B-ECCE-4E95-8F3F-B3FD831A70DF</domeo:uuid>
    <ao:exact>The pharmacokinetics of oral conivaptan (20 - 40 mg/day) were unchanged with coadministration of either captopril 25 mg or furosemide up to 80 mg/day</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0152500B-ECCE-4E95-8F3F-B3FD831A70DF"/>
    <pav:createdOn>2014-07-20 23:02:04 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BB64CBF-BDBF-477A-9E52-1B0AD00A4236">
    <domeo:belongsToSet>urn:domeoserver:annotationset:17678A8E-6D15-47A5-AA21-40C60C4E611C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:34:11 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:35:21 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C695803C-F876-4316-8563-FFD22F9C8D2E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:CABE46C4-C26E-435D-88C2-CBF429E23816"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8764870-11A3-4087-A41D-E4F3424A4189">
    <ao:prefix>, a decrease in the dose of </ao:prefix>
    <pav:createdOn>2014-07-14 14:28:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C8764870-11A3-4087-A41D-E4F3424A4189"/>
    <domeo:uuid>C8764870-11A3-4087-A41D-E4F3424A4189</domeo:uuid>
    <ao:exact>rosiglitazone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A9706F29-D8F1-4B81-9647-EFDA6810F208">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ED43869C-D208-4E1F-8C4C-F89CEBB3137C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/226CFA8F-CFF2-405E-93CE-FF82D5380B26"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DA7D24A2-A84E-484F-8A90-E623BCF6CAEE">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Paroxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B8F6771C-52A0-4B9C-8346-18D50BE4F26F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3562135A-39C4-4B5E-A242-6E4334C6A2E6"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:983A278E-ECF2-4B9A-AFCF-4B5E560A3A74">
    <pav:createdOn>2014-07-14 13:59:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F7F2A616-F065-4A8D-B67E-AB840F14B4D8"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F4AC4AAC-8FD6-42DC-9383-46A0396E43CA">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E3E1B937-0F71-4C8D-ABD3-96466229CF3A"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3293CB2D-387F-4DA3-8639-E5F5AB7621E1">
    <pav:lastSavedOn>2014-07-20 22:11:24 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:483E875B-D447-49D9-B73A-93DFCCBD5D97</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4587CD74-C81B-40F7-9B71-84BE5859CD5D"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:11:04 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Ne8a8506dcc5c47d98ffb6a25cc2844ac"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57116A4B-39BB-4561-9279-25F38DD0B1BD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:suffix>had no clinically relevant effect on the steady-state pharmacokinetics of warfarin enantiomers.</ao:suffix>
    <pav:createdOn>2014-07-14 14:46:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57116A4B-39BB-4561-9279-25F38DD0B1BD"/>
    <domeo:uuid>57116A4B-39BB-4561-9279-25F38DD0B1BD</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>Repeat dosing with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/123ECC1A-579E-48AD-A351-32677410E4A7">
    <rdfs:label>erythromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36094B3F-B5BE-42CE-A62A-E38D55F5CC09">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36094B3F-B5BE-42CE-A62A-E38D55F5CC09"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>is contraindicated (see CONTRAINDICATIONS).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-59.txt.html</ao:hasSource>
    <ao:exact>nefazodone </ao:exact>
    <domeo:uuid>36094B3F-B5BE-42CE-A62A-E38D55F5CC09</domeo:uuid>
    <ao:prefix>with </ao:prefix>
    <pav:createdOn>2014-07-14 13:48:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84206E52-A442-48EC-8693-CC6D827A0B9D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>receptors are found in key target tissues for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of </ao:prefix>
    <ao:suffix>nuclear receptors regulates the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In addition, PPARγ-responsive genes also participate in the regulation of fatty acid metabolism.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84206E52-A442-48EC-8693-CC6D827A0B9D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <domeo:uuid>84206E52-A442-48EC-8693-CC6D827A0B9D</domeo:uuid>
    <pav:createdOn>2014-07-14 14:06:50 -0400</pav:createdOn>
    <ao:exact>PPARγ </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne8a8506dcc5c47d98ffb6a25cc2844ac">
    <domeo:sets rdf:resource="urn:pddi:uuid:DB55BFA5-4AA4-4286-8104-20A8FFC75DB7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1943E1F8-418E-4408-A233-6464D5AAFC42">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/71189083-1F17-49A3-8613-19DD6DEAC398"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C1BD8AE6-B90F-4675-B987-BB01261659D6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B94FF46D-C84C-4F87-BF89-23C78F4BAB1E">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:83AA59FA-4D2F-4B83-8719-96BD5A6D4E04"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B77D933-272C-43D1-B39C-FA16DC5AFB1F">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:CDE884CE-74CD-4D68-901D-D6DBEDE41A68</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:34:01 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:35:04 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE2632C4-FA9F-4893-9121-484D938D4E67"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FF212FD2-F441-41B1-94D3-1D82332EECB0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>metformin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6809</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31EC3E3F-B976-4317-A40D-47F4255A0F52">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3C03C37-9341-4769-88AC-6C810EEADDFB">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:80367BF9-F837-42F7-839C-13E21BD05CDD"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:365CE224-B051-4BA8-8FBC-4C0CFA26FB18">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6D7FFEAF-1C15-4AC8-AA51-15D157F2DD93"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:80FE2422-436F-4EC5-B820-9ABD428FF42A">
    <ao:context rdf:resource="urn:domeoclient:uuid:27E7BF45-C638-4CC1-8D40-4C8CB5A5CB5F"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:53:13 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/54668D71-546B-4172-89C5-15BBB76578E1">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdfs:label>ritonavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5573C88B-A725-4BF9-91BD-23656FAD7E82">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B75BEED4-6F7F-4D92-A63A-2E6A65F06DE3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA041D1B-9C2F-4E79-94B7-26F6A29953A8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF35217B-80CC-4C97-BCD6-03C1471E6786">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:46:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:F292101E-84D9-4CC1-A056-EDE2230D7880</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:47:29 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:A83225AF-77D9-4317-AA71-5B8F946798FD</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7C9A255C-5C48-4B77-8F29-21399025C69C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F064491E-496D-4547-8FB0-3C176E7C1090">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F064491E-496D-4547-8FB0-3C176E7C1090"/>
    <domeo:uuid>F064491E-496D-4547-8FB0-3C176E7C1090</domeo:uuid>
    <ao:prefix>were variable and were generally not statistically different from placebo or </ao:prefix>
    <ao:exact>glyburide </ao:exact>
    <ao:suffix>controls.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:11:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7C9A255C-5C48-4B77-8F29-21399025C69C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7C9A255C-5C48-4B77-8F29-21399025C69C"/>
    <ao:prefix>exposure increased to a level comparable to that prior to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7C9A255C-5C48-4B77-8F29-21399025C69C</domeo:uuid>
    <ao:exact>phenytoin </ao:exact>
    <ao:suffix>administration.</ao:suffix>
    <pav:createdOn>2014-07-14 15:46:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CE5412A-076B-48A3-AD53-8E38525CF9CD">
    <ao:suffix>nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone</ao:suffix>
    <ao:prefix>e, is 77%. Neither </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5CE5412A-076B-48A3-AD53-8E38525CF9CD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>5CE5412A-076B-48A3-AD53-8E38525CF9CD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 15:55:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A12A4DCA-3CC3-4FDB-949F-3235381A6DE6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/48B4A60C-16C4-47BA-BD76-D3EF7813E856"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ADC3C789-70F1-4FE1-A8B7-219C2B42A48B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC91A43D-92CC-45A9-93A9-2419C468B150">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/44E86397-C7D3-40F6-888A-3848B98E69A4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A4F793A0-9A25-4129-AAC3-658488064757"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB73AA57-612F-4156-AD04-7AEC495B0653">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:35:55 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E2644C4A-CD71-4BF2-AA84-53F6AEAF17DB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <ao:body rdf:nodeID="Naa05b535cc7247fd95eeb2a1c47c7d81"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:8889F229-1B30-4D8A-A18B-834D12DA9EEB</pav:previousVersion>
    <pav:createdOn>2014-07-14 14:35:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4130CB79-C342-4E40-AF40-F141CDBC4513">
    <pav:lineageUri>urn:domeoserver:annotationset:FC056A21-615F-44B8-8E1B-A2A2E8DCB977</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A962BFAE-763C-4567-8A67-677134BED479</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-14 15:39:28 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:39:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:20B5A5A7-D31A-4292-9911-E6C971147DFB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/159127BA-7F0F-4598-8AFE-AA37CD7B6CA7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F568CD0E-0FFA-473E-A6DE-647C158772D1">
    <pav:createdOn>2014-07-14 14:22:42 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>F568CD0E-0FFA-473E-A6DE-647C158772D1</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F568CD0E-0FFA-473E-A6DE-647C158772D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:exact>Since metformin is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/002AA166-DDBC-4D77-9AD1-BA0DBC4F104D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/abe9ddb8-bba8-4a00-9074-e9d4b5418e7a">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-07 08:08:49 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:398a3d64-9f53-46f5-9f22-befa749ed504"/>
    <pav:lastSavedOn>2014-07-07 08:08:49 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:b344dc7c-6e63-4256-a61e-8d0aa7e1c056</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:EEC5A3A2-87BE-42FE-BBEB-F8F93FAEACE9</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0C56EA4-8A53-4E06-B285-6507BED225BB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0C56EA4-8A53-4E06-B285-6507BED225BB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D0C56EA4-8A53-4E06-B285-6507BED225BB</domeo:uuid>
    <ao:suffix>. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointes</ao:suffix>
    <ao:prefix>The mechanism of these interactions has been evaluated in in vitro, in situ, and in vivo animal models. </ao:prefix>
    <ao:exact>These studies indicate that ketoconazole or erythromycin coadministration enhances fexofenadine gastrointestinal absorption</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:29:54 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2D13D6ED-3A49-40AA-85DD-0B424ED2CBF3">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6106BAF6-6556-420F-8793-84970B7F446A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">18</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:1794100C-4C38-4154-9980-B12DD6F615EB</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DF27214B-1B37-47D3-979C-AE158B7312C8"/>
    <pav:createdOn>2014-07-20 20:34:23 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 20:39:57 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N1ef72fb593c449afa3c11a4d40536039"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nea15e5b3f76c476ab2d07f31f4f99e14">
    <domeo:sets rdf:resource="urn:pddi:uuid:6F99DE8E-D19E-454F-9E62-4CF842716117"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:49D78607-AFB0-4F8D-A21D-6AEC8A8AD9E9">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EED2295A-1A7F-4589-B0BF-68C4164EF36C"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86866714-B907-49D3-B3E9-0F83CD0BFE46">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdOn>2014-07-14 15:53:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:EAC7703B-47A6-4BE2-8332-4B6F29B85D05"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDB43603-7A0A-49AF-B2C6-37B0BF7D79FE">
    <domeo:uuid>EDB43603-7A0A-49AF-B2C6-37B0BF7D79FE</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Effects of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EDB43603-7A0A-49AF-B2C6-37B0BF7D79FE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>on Vision</ao:suffix>
    <ao:exact>REVATIO </ao:exact>
    <pav:createdOn>2014-07-07 09:42:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A1E62784-202B-40C3-9735-5D42D0E5DCF8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C09E880F-9356-4266-BB07-F075BDDEA9AE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4C8C71E7-9E29-483A-B6C4-C10172B513DC"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9306A467-0956-4B9D-8BD4-47A748E7F221">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1576A3E5-6684-42C5-B761-64F15EA02CA8">
    <domeo:belongsToSet>urn:domeoserver:annotationset:68F70384-A9B6-42F6-9F9B-42C1F622FB9E</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 22:18:16 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">17</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nb14a187ff98643d3b3dbb3b1d2382381"/>
    <pav:lastSavedOn>2014-07-20 22:18:17 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B9C1ABD-6DA3-4534-AB68-C1381F046A31"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E04C5790-F82F-48BC-9E6D-FE0ADD65A188</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:ee7fbe62-9486-4bc1-bb47-b88a5d3562ab</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/02D46313-BE5A-4755-A834-E857F809D765">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>gemfibrozil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:244F9F35-C7EB-47DD-AA91-FDBDA904A932">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:244F9F35-C7EB-47DD-AA91-FDBDA904A932"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:39:07 -0400</pav:createdOn>
    <ao:suffix>, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:exact>normeperidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>and also the formation of the metabolite, </ao:prefix>
    <domeo:uuid>244F9F35-C7EB-47DD-AA91-FDBDA904A932</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F3740DC-54D6-4C60-9FD7-CA88E37567D5">
    <domeo:uuid>8F3740DC-54D6-4C60-9FD7-CA88E37567D5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-11 23:29:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F3740DC-54D6-4C60-9FD7-CA88E37567D5"/>
    <ao:exact>Sertraline hydrochloride</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> is supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of sertraline and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypro</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51FC00E7-3901-43AC-B639-A35EFC27FE7A">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:33:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:74CE0CEC-3973-4A94-9B46-F93EE76ADA06"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:CCB6474C-E1D3-4268-BF2A-E1AFDA289F56</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6E0E7CB0-FA1B-4774-9316-D75ABE43E04B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:33:30 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E86C5BD9-BD82-42C1-B349-AF9FB6BF1A23">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E86C5BD9-BD82-42C1-B349-AF9FB6BF1A23"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>). The principal mode of action of ZDV-TP is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. ZDV-TP is a weak inhibitor of the cellular DNA polymerases α and γ and has been reported to be</ao:suffix>
    <domeo:uuid>E86C5BD9-BD82-42C1-B349-AF9FB6BF1A23</domeo:uuid>
    <ao:exact>ZDV-TP</ao:exact>
    <ao:prefix> (</ao:prefix>
    <pav:createdOn>2014-07-20 20:57:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CF3FD43A-6186-4DD6-8BD9-904AAFB33DDE">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FBB30133-3765-4BB2-9353-446C646DB158"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N60f8e9d0c53444c1a5ac586b26fbe949">
    <domeo:sets rdf:resource="urn:pddi:uuid:8165D924-A30A-48EB-B8BB-EB8A774A5D73"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1AEEBD12-7FCB-492B-8DC4-97EADE4AF772">
    <pav:lastSavedOn>2014-07-14 15:25:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 15:25:21 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:43E95240-C15F-4344-A20D-593A76967A8D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:50FCED91-5F3D-4068-951D-13F3B60B4C62</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4ad7ea20-a6d6-4758-8719-7d6e4ddfae7a">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:21355386-ce13-4d75-9d67-55843d435567"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:09:16 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4C0A8888-17AF-4EBF-B532-C29B97C7B8D1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-07 08:09:16 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:98ab1500-3e5b-4e61-b9f0-65c72d1ec4c1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C0158A5-72D1-4C7C-A2DC-9099DD472A99">
    <domeo:uuid>8C0158A5-72D1-4C7C-A2DC-9099DD472A99</domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix>Results of the population pharmacokinetic analysis (n = 716 &lt;65 years; n = 331 ≥65 years) showed that age does not significantly affect the pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C0158A5-72D1-4C7C-A2DC-9099DD472A99"/>
    <pav:createdOn>2014-07-14 14:16:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70BF2DDC-C172-4A34-B8C3-647922E06046">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1240DB80-6D1A-4E93-809B-5C3CCE2A02B6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB568A71-09EF-4AFB-92DE-FD6E050D4815"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13FE2CC3-3AE5-4618-9800-E7722E7FDCA1">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F3AC7FF-1FC1-4227-A7A3-E4BE7060A565"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 16:02:18 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D618A37C-EB11-459E-90AF-386D596129DD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6AAA2938-667F-4834-8FB5-BD1C820B541F">
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-07-07 11:09:35 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E30DB90-3C1D-446F-A8AE-B84FAE8A061B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B207B1E0-73C7-436A-A97E-15D9A6DF068D">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 14:49:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB3A01BA-4FB4-43BD-A2A8-5F83114CC427"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 14:50:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C80C9FF-FE68-4414-86EC-7515CBE8C362">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:03EDFE75-8721-4869-AE7E-F978B2AB8F81"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 16:01:44 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:1B5F2B06-21F8-42C3-889B-D2D7EB10B84E</pav:previousVersion>
    <pav:createdOn>2014-07-14 16:01:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:66CE9C76-A8AD-4556-87A8-949FEF25AEA3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F6733C5-8532-41EB-A15E-1457A5DB5ABB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/30D4FCAA-5252-4450-8869-F5567F8A8C35"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N390e0365b896402c8a0ab81ab41ae498">
    <domeo:sets rdf:resource="urn:pddi:uuid:74CA39C6-8EB5-4F9F-85D2-6ABE503CDDC8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:93917F84-D890-45DF-BD44-79AF04052D3D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/352A0C6D-D279-4B7B-8907-C9270C508918"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EEA72C26-9309-4233-8B8F-C95629C38284"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A2B06B88-615B-487A-A99F-2080850CBB13">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zidovudine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F8BB4F24-0C41-44C2-8CF6-A06DF2F8EEBA">
    <rdfs:label>tolbutamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECFE4B83-555A-4391-AF28-97683C79D6E9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>ECFE4B83-555A-4391-AF28-97683C79D6E9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECFE4B83-555A-4391-AF28-97683C79D6E9"/>
    <ao:suffix>is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells res</ao:suffix>
    <ao:exact>Sildenafil </ao:exact>
    <pav:createdOn>2014-07-07 09:34:47 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd5c8cf74585b465f9873bffa7049709e">
    <domeo:sets rdf:resource="urn:pddi:uuid:9B107595-7CC7-4A49-9DC0-75FCE0D45B48"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5C5FFCB-513F-45F8-BC0B-034F17F0BE3E">
    <pav:createdOn>2014-07-20 20:56:54 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 20:57:10 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC3BDF29-3596-4AC6-90E9-9C0A5E672FA9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nb2614eda862c44c5b4f5f50dcf838f6d"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:4AB9EFB2-30A6-44BD-90C3-6951D971D64F</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91EE9E77-FE27-4232-946E-7304DDE28BD4">
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9EB580B9-E1F2-4D5A-BAC7-B74CBB3D79F2"/>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-20 20:22:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78032DB5-9E69-4584-A595-72EB0760CCB3">
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:29E3CA46-5750-4CD6-B1F0-F9B55F72F92C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:03:01 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E543D5CA-F914-4E78-8EBA-9FD0D5A221A9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E543D5CA-F914-4E78-8EBA-9FD0D5A221A9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:36:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>in 14 healthy adult subjects had no clinically significant effect on the steady-state pharmacokinetics of </ao:prefix>
    <ao:suffix>. No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects.</ao:suffix>
    <ao:exact>AVANDIA</ao:exact>
    <domeo:uuid>E543D5CA-F914-4E78-8EBA-9FD0D5A221A9</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89B3E7E4-2FB6-45D2-8E07-F7C9553F5458">
    <domeo:uuid>89B3E7E4-2FB6-45D2-8E07-F7C9553F5458</domeo:uuid>
    <pav:createdOn>2014-07-13 14:49:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
    <ao:suffix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosi</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89B3E7E4-2FB6-45D2-8E07-F7C9553F5458"/>
    <ao:exact>norethindrone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E4E5392-30AB-4DA7-A09E-15821A00FDC6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E4E5392-30AB-4DA7-A09E-15821A00FDC6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 23:11:36 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-38.txt.html</ao:hasSource>
    <ao:exact>Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>4E4E5392-30AB-4DA7-A09E-15821A00FDC6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndef4eba659bf468abf6cb171ba970895">
    <domeo:sets rdf:resource="urn:pddi:uuid:44FC7016-A8BF-41E5-BAB5-BD85F2A46917"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C5EE8F5A-6782-4DE1-81FD-657FDB6919AF">
    <rdfs:label>midazolam</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76d9d09c-6bdc-47f7-b01f-83ad52fb43f6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 08:09:09 -0400</pav:createdOn>
    <ao:prefix> there was a 50% decrease in </ao:prefix>
    <ao:exact>propafenone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix> plasma concentrations and inc</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:76d9d09c-6bdc-47f7-b01f-83ad52fb43f6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F5CC3A3-C193-4A33-8427-3AA2F7A26581">
    <pav:createdOn>2014-07-14 15:03:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:04:22 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1C268B5-6BC3-4678-A83F-B8577ABEEF6C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:23F36509-0614-43F9-924D-7EF7B847092B</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:934F1FB8-A872-4B6E-9A6D-DD0C3243B8A6">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine in healthy adult subjects</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:934F1FB8-A872-4B6E-9A6D-DD0C3243B8A6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:24:16 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>934F1FB8-A872-4B6E-9A6D-DD0C3243B8A6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED519FB5-4637-4314-B368-FC31635D7532">
    <pav:createdOn>2014-07-14 14:44:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3DB2AB72-A10F-4DB7-861A-EAAEF3E26977"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:8A66A3C5-1E5E-4EBF-8342-14A271B60E81</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">23</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:45:11 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/61DE915B-297C-42B5-BABB-537215239F9E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluoxetine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D68EB7E6-A0B4-4DA3-993E-C98A47021177">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6BF3CF06-11E2-4144-8384-6127B6B5A3A8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/376E2B27-8F0A-4E7C-97F3-F9BCB685288E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:654E908A-332C-4C3B-B9E2-B799EF2947A5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:09:41 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EE3A4974-29C5-493E-B4DD-B9A5D77AE6AC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DA5E3840-738A-4E89-BF0C-B8F2A22C8378">
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D1AE8562-1F62-440F-B6D4-1B8A86AAEEC2">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9F886489-2982-43B9-A82B-7D80D14D47EA"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3D96E2DC-A87B-4014-83BE-3DEAF911375A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0EBBAAA7-2EBB-45D4-9B88-87543C234DF1"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF147165-69C3-434A-84A5-D74FE2899769">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF147165-69C3-434A-84A5-D74FE2899769"/>
    <domeo:uuid>FF147165-69C3-434A-84A5-D74FE2899769</domeo:uuid>
    <pav:createdOn>2014-07-14 14:59:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <ao:exact>CYP450 </ao:exact>
    <ao:prefix>, a non-specific </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4f451dd750964440ab791f354b7fb25f">
    <domeo:sets rdf:resource="urn:pddi:uuid:AD27ECE3-5334-49C3-8D2C-48542FE87542"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5B677EC2-748A-48CB-BB55-1B19898EE258">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>Fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FB594498-B7D8-4AB0-AB51-C710881F5D4D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:17150C68-EA79-4A82-BAEC-4858C6485C47"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/095CA7ED-42D5-42E2-9549-75DBE58B33C0">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6A24B936-8B0E-4B6F-B688-AA294A1068B1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ranitidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1FA48296-5E4E-4511-B607-8CF3EF4D22D0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6915</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>metoclopramide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BFC20C25-3D1C-4C10-A1F3-06D7CEDB5BFF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>stavudine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/59763</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7543154-F63A-4A8E-A3EE-4A66E9A5E1B5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>has been administered to 1,598 individuals during all clinical trials, only some of which were placebo-controlled. During these trials, all events were recorded by the investigators using their own terms. To provide a useful estimate of the proportion of</ao:suffix>
    <ao:exact>Zonisamide </ao:exact>
    <domeo:uuid>E7543154-F63A-4A8E-A3EE-4A66E9A5E1B5</domeo:uuid>
    <pav:createdOn>2014-07-14 00:30:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-58.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7543154-F63A-4A8E-A3EE-4A66E9A5E1B5"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:661131FF-E5A2-4EE3-8C61-BCAF2C9423B9">
    <ao:prefix>, and to a lesser extent, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:661131FF-E5A2-4EE3-8C61-BCAF2C9423B9"/>
    <ao:suffix>. AVANDIA (4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of nifedipine and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>661131FF-E5A2-4EE3-8C61-BCAF2C9423B9</domeo:uuid>
    <ao:exact>2C9</ao:exact>
    <pav:createdOn>2014-07-14 14:23:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E3E1B937-0F71-4C8D-ABD3-96466229CF3A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2BBFE57-E0B3-43DA-81C2-3092EBC29667"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5C965236-9F90-4E18-80C2-DE3F153B1810"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DC71C5C0-05FB-472F-A960-0CA726619223">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E6EA8111-0DC2-4CA6-A00A-591BB946CDB3">
    <rdfs:label>digoxin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDBCBC8C-EA8A-45FE-9E61-B9BF9DF720D0">
    <pav:createdOn>2014-07-14 15:48:47 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:53:44 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:826569BE-2214-48AC-B6FE-A4A3C8124CF1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/49F53E2D-1FA8-470A-8C7C-B9F35EFF552A">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N212e354c6ff64cdbba1a13a8b78e0261">
    <domeo:sets rdf:resource="urn:pddi:uuid:08D2F018-1CB7-471A-8D23-B3AA94054D61"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E738E91E-5D16-4D1B-BBEE-77C0687E598A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:661388CC-A732-4846-810B-CAF99F3D73C2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:42DD6718-8A82-42A3-BFA9-C146F781139D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/84DACE90-8C33-4696-B741-A48617B193E5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5F991D5-A0E8-425D-8560-271203F94983"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B071B771-088E-470A-8A36-C857D4744FE3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 14:37:53 -0400</pav:createdOn>
    <domeo:uuid>B071B771-088E-470A-8A36-C857D4744FE3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B071B771-088E-470A-8A36-C857D4744FE3"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No clinically significant reductions in glimepiride AUC and Cmax were observed after repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult subjects</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B0FF3DD-F960-4681-B093-071C65493026">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Cimetidine reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration</ao:exact>
    <domeo:uuid>3B0FF3DD-F960-4681-B093-071C65493026</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3B0FF3DD-F960-4681-B093-071C65493026"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:39:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:99EC88BD-F1AE-450A-9DF4-E909D77DB021">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2CF922A3-BE6B-40E7-8806-23B5C2924868"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38A0A001-D355-4CD3-B552-546F91524E7F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38A0A001-D355-4CD3-B552-546F91524E7F"/>
    <pav:createdOn>2014-07-13 14:38:22 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>38A0A001-D355-4CD3-B552-546F91524E7F</domeo:uuid>
    <ao:suffix> AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:prefix> or </ao:prefix>
    <ao:exact>levonorgestrel</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:097245F7-D052-4A58-B863-99BF35D5DF65">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:b344dc7c-6e63-4256-a61e-8d0aa7e1c056</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA4D18FA-C7EE-4EDE-8F9D-15957DECEF78"/>
    <pav:previousVersion>urn:domeoclient:uuid:96d6147f-d0f2-48d7-b636-5b3a4ca034f6</pav:previousVersion>
    <ao:body rdf:nodeID="N918ae25eeb754c74aa108442f7840e2a"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:EEC5A3A2-87BE-42FE-BBEB-F8F93FAEACE9</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 23:11:23 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 23:11:23 -0400</pav:lastSavedOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEA0A94C-F5E5-483D-9C00-D034DFD1650B">
    <ao:context rdf:resource="urn:domeoclient:uuid:72BCE041-A6C2-45DA-9835-BF5DA6159CEF"/>
    <pav:previousVersion>urn:domeoserver:annotationset:9C0A517C-F362-4A30-94A9-9E8FE18FBE11</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-14 15:30:22 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <ao:body rdf:nodeID="Nccf0bbb22ab8442e898da5486fd79bd2"/>
    <pav:lastSavedOn>2014-07-14 15:30:20 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/35C3EF52-89AA-4561-B929-7E5A938F81CC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3306C93E-D359-4AAC-9048-F57995B6A419">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E7D11D5-C820-4C62-8576-DC72ED259D95"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:11:15 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-14 14:07:34 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:CE317D62-B542-4FA7-9C11-79A5E8FEDF35</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3CB41909-5F66-4A19-BA0B-5EF367FC95D2">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Amitriptyline</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/704</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd849945786f34cd6ab4fc70f7b44326b">
    <domeo:sets rdf:resource="urn:pddi:uuid:30F74A41-9113-481E-862D-D43B9DFD7A58"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2630D418-D55B-4389-8913-65E1C14B5B03">
    <domeo:uuid>2630D418-D55B-4389-8913-65E1C14B5B03</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-14 15:59:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2630D418-D55B-4389-8913-65E1C14B5B03"/>
    <ao:exact>High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/55492E72-834D-4AF9-B482-28BF12F7DEEB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:44D26FF0-9C88-425F-BD66-8CC2F3CB2B18">
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 21:59:39 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <ao:body rdf:nodeID="N7d68616343aa443db4993b070a61a63e"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:A25A65F2-6DBD-4DD2-A420-A7FFBDA0C111</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0D092C2-03F0-4183-B788-4A331F4C4F3A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:59:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/817AEFDF-49D8-4EA6-B885-2DB25A294791">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3E02686-0149-4D7A-93A9-D1DC35CBBFD0">
    <pav:createdOn>2014-07-14 15:09:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-134.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3E02686-0149-4D7A-93A9-D1DC35CBBFD0"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>D3E02686-0149-4D7A-93A9-D1DC35CBBFD0</domeo:uuid>
    <ao:exact>Co-administration of chlorpromazine with propranolol resulted in a 70% increase in propranolol plasma level</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/931548E6-C126-41DC-9221-7A859EEFDF72">
    <rdfs:label>hydralazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84F64974-6142-4275-AEE1-AF5D2FC01F05">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <domeo:uuid>84F64974-6142-4275-AEE1-AF5D2FC01F05</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:84F64974-6142-4275-AEE1-AF5D2FC01F05"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 21:56:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F53E5468-3974-4391-9325-89ACD826409D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne47ee4ad591c4334923442310380e95b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbe5f024e616749648157738ef2ee600a">
    <domeo:sets rdf:resource="urn:pddi:uuid:B1916EB5-0C06-4808-A0BF-13955B6AAFB9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2BE79849-42A4-447A-9F36-9F940FDA7FD0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/37D76A76-2C1B-4BDC-BFD7-720461A21196"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F8CB0DA6-E11A-42A8-BEA9-D0F8963B1ADE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F7726B9-F827-4F55-856D-E6D8235A718B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:06:35 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F40EE419-3A0B-40B1-A302-921CD072A58A"/>
    <pav:createdOn>2014-07-14 14:06:27 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EBC34EF-32AC-4F0E-884A-83E5DC6BC3E8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the ti</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EBC34EF-32AC-4F0E-884A-83E5DC6BC3E8"/>
    <domeo:uuid>9EBC34EF-32AC-4F0E-884A-83E5DC6BC3E8</domeo:uuid>
    <pav:createdOn>2014-07-07 09:43:48 -0400</pav:createdOn>
    <ao:prefix>is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25–63%). Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When </ao:prefix>
    <ao:exact>REVATIO </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6720E76B-6837-4A9F-BD44-006771D376B2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1E556A4B-CA48-46C7-B173-46522D430C42"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/06B487BC-9C29-4A3A-93F9-5E9E2415AC2C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B049D20-0BF5-4A45-B4CF-1E997279A13C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:39:53 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3C0354CB-25CA-476B-B337-C7C45B4F528A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9793A8EF-A2CE-4A6F-8481-D5F845506091">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C7C6A659-53A2-4E73-A30D-7A8A71B34FA8"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CB6247B4-061D-4F49-B45E-0DBC3F8505C8">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ribavirin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD07A6A7-6818-4E84-A90B-5E5BA4AF9F77">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8C856094-43BD-4D41-A6A8-8E98452DF431"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/64A607CF-3AC2-47A1-A7A5-2B6015F27CE2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69A77863-6B21-463E-B248-090DBEAF2A77">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-14 14:45:59 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:55E86D0B-B096-4EE2-AE98-DE2DF348C9EC</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 14:45:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">24</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:318B26B5-FBEE-495B-B1E1-F1300ABC2C2D"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9ED8E10-DD66-4041-B97A-29FC4BD8C2B2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>PPARγ</ao:exact>
    <ao:prefix>nuclear receptors regulates the transcription of insulin-responsive genes involved in the control of glucose production, transport, and utilization. In addition, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A9ED8E10-DD66-4041-B97A-29FC4BD8C2B2"/>
    <ao:suffix>-responsive genes also participate in the regulation of fatty acid metabolism.</ao:suffix>
    <pav:createdOn>2014-07-14 14:07:05 -0400</pav:createdOn>
    <domeo:uuid>A9ED8E10-DD66-4041-B97A-29FC4BD8C2B2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:41A1276A-CCA6-4B0C-889C-A11B8BDCCC1C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CCDB9DFF-54C5-4FDD-AA1D-77E1E4826197"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D618A37C-EB11-459E-90AF-386D596129DD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:538EFDB0-08D4-4D6E-BFB3-DCDBAE9C60D2">
    <pav:createdOn>2014-07-13 16:03:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of </ao:prefix>
    <domeo:uuid>538EFDB0-08D4-4D6E-BFB3-DCDBAE9C60D2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:538EFDB0-08D4-4D6E-BFB3-DCDBAE9C60D2"/>
    <ao:suffix>. (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>phenytoin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F4392DBE-9713-4D50-A3FB-39E2B4EB12A2">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E540506D-410E-41F8-A76C-03C37390521E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>gzdv</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4D28906-8A23-4ECA-B4D7-2550E551D75C">
    <pav:createdOn>2014-07-14 14:47:46 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E648E53B-93AF-4E1D-82A6-43C9652F2E30</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DD0BF603-5ECF-4DED-BCDD-8E6064A9FB9C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 14:48:59 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B4F32729-CDDF-4DAF-8602-4ADC99476878">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/202807</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>SEPTRA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B0890C2-9185-4AEA-9C8C-872077911D09">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-130.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:02:41 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B0890C2-9185-4AEA-9C8C-872077911D09"/>
    <ao:exact>Co-administration of metoclopramide with the long-acting propranolol did not have a significant effect on propranolol’s pharmacokinetics</ao:exact>
    <domeo:uuid>4B0890C2-9185-4AEA-9C8C-872077911D09</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ACFCFD73-0B90-4146-91B5-FC8207FB5730">
    <ao:suffix>400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either </ao:suffix>
    <pav:createdOn>2014-07-14 15:26:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>500 mg every 8 hours or </ao:prefix>
    <domeo:uuid>ACFCFD73-0B90-4146-91B5-FC8207FB5730</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ACFCFD73-0B90-4146-91B5-FC8207FB5730"/>
    <ao:exact>ketoconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0f71287e8a964e1ab0f0d426af0dbc6d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:222293E7-679B-4BCE-ABED-0516BB481AE7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:F3292A13-BCBA-4E5A-9A82-6518D299C63D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 21:56:13 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N00f4008880d54cc0bb9068f57a1eb096"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6289A581-10AD-4431-B8B0-158578D2B3F5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9f27424c-1720-415d-b02f-d49615582f19</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:d490020d-fbdb-4f4a-8dbb-541406b4038c</pav:previousVersion>
    <pav:createdOn>2014-07-20 21:56:11 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77A78F8D-150E-4242-A11B-185D813450A6">
    <ao:suffix>or erythromycin coadministration enhances fexofenadine gastrointestinal absorption. This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. In vivo animal studies also suggest that in</ao:suffix>
    <pav:createdOn>2014-07-14 15:29:02 -0400</pav:createdOn>
    <domeo:uuid>77A78F8D-150E-4242-A11B-185D813450A6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77A78F8D-150E-4242-A11B-185D813450A6"/>
    <ao:prefix>The mechanism of these interactions has been evaluated in in vitro, in situ, and in vivo animal models. These studies indicate that </ao:prefix>
    <ao:exact>ketoconazole </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E933B203-CB00-48E2-8C18-1203CAA7207A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>captopril</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:61CC51D6-2D4C-4BDA-A860-4342A2E6F4BE">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1E06DCC6-DB44-4449-89AB-342277E90D1A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40CC5EFF-E25A-4261-B9ED-D4A4846C4701">
    <pav:createdOn>2014-07-14 15:55:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:58:51 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:582C14B9-EA64-48C7-8A98-4C13D2417665</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:161CCA94-9344-419F-88FE-0FFF2CBB66A0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10BBD3E6-DB5C-405B-A93D-B8C3F5F8B304">
    <rdfs:label>phenytoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE81DAED-A4D7-49B7-B38C-F5F5B55B2A95">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BE812929-7DDC-486F-8296-9FB906175030">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>normeperidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na549977a732c4c2aa31b77e60ed498b0">
    <domeo:sets rdf:resource="urn:pddi:uuid:E5227253-BC22-4A8D-AEB4-CDA2EDD689DE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:939183D2-85B4-42C3-B5A5-604CACF45D5D">
    <ao:exact>trazodone </ao:exact>
    <pav:createdOn>2014-07-14 15:14:00 -0400</pav:createdOn>
    <domeo:uuid>939183D2-85B4-42C3-B5A5-604CACF45D5D</domeo:uuid>
    <ao:suffix>increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were observed when ritonavir and trazodone were coadministered.</ao:suffix>
    <ao:prefix>(50 mg) has been studied in 10 healthy subjects. The Cmax of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:939183D2-85B4-42C3-B5A5-604CACF45D5D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9272E4C5-F69B-4DAE-8C2F-3915DC3328FC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:11B076B8-D317-4ADD-AD9C-EE6E8BE34C7A"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 15:17:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:50E668E7-0BC8-4343-80A1-DC56C731A3CE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C5FDF9F2-CDBD-44DE-A6BB-F9BB67F0B776">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:520C368B-333A-41CC-AA36-559A10AA578B"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0FFA60EB-5522-42FD-9E90-074DB5BB439F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>digoxin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A2944E9F-6997-4CCE-AB8F-859E676FC995">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0548AE30-FC3F-4664-9E05-3EF1B2774D5F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C955C5EC-C555-48C7-9C21-237661E9CA01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7B2948B4-BF46-4CDA-A5D4-4D7F47132A3C">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5951269F-AC82-4D68-9739-AE4B85A02488"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2334F3FF-B599-4CCC-A4C5-7EBEA16B8EFE">
    <ao:suffix>was about 2 hours longer in patients with liver disease, compared to healthy subjects.</ao:suffix>
    <ao:exact>rosiglitazone </ao:exact>
    <domeo:uuid>2334F3FF-B599-4CCC-A4C5-7EBEA16B8EFE</domeo:uuid>
    <pav:createdOn>2014-07-14 14:18:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>was significantly lower in patients with moderate to severe liver disease (Child-Pugh Class B/C) compared to healthy subjects. As a result, unbound Cmax and AUC0-inf were increased 2- and 3-fold, respectively. Elimination half-life for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2334F3FF-B599-4CCC-A4C5-7EBEA16B8EFE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C53015C-AAF6-411C-AD20-6B65BA28B515">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-115.txt.html</ao:hasSource>
    <ao:exact>Coadministration of nifedipine 10 mg capsule and 60 mg nifedipine coat-core tablet with phenytoin, an inducer of CYP3A4, lowered the AUC and Cmax of nifedipine by approximately 70%</ao:exact>
    <domeo:uuid>9C53015C-AAF6-411C-AD20-6B65BA28B515</domeo:uuid>
    <ao:suffix>. When using</ao:suffix>
    <pav:createdOn>2014-07-20 21:18:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C53015C-AAF6-411C-AD20-6B65BA28B515"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> is metabolized by CYP3A4. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:56CE453B-C31C-494E-98E4-0688E4FE660B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2EC590C0-CFE6-4033-B364-76DF5C9CA5E5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B806BB42-892B-4D38-A04A-45710F0704FF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DB5384EE-1568-408C-8EAC-70006D222747">
    <rdfs:label>ketoconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1e623b7fed294cdd8faaf7fdd37d1350">
    <domeo:sets rdf:resource="urn:pddi:uuid:9076A776-B827-42EA-BAE2-C471214C81D9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:17150C68-EA79-4A82-BAEC-4858C6485C47">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8FFE4892-8630-4027-9DA3-A52C836A54E8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31A9AE8A-52FE-4523-9669-FFCDD9B029C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4B03CBA-F403-488C-B675-09DC0679A7E1">
    <ao:suffix>. In post marketing reports, abrupt cessation of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E4B03CBA-F403-488C-B675-09DC0679A7E1"/>
    <domeo:uuid>E4B03CBA-F403-488C-B675-09DC0679A7E1</domeo:uuid>
    <ao:exact>Orlistat may limit the fraction of propafenone available for absorption</ao:exact>
    <pav:createdOn>2014-07-20 20:42:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:6010B101-D502-4923-8C84-9A4A6BEE20D5">
    <pav:lineageUri>urn:domeoserver:annotationset:73eecd4d-b3fa-49d5-86ef-22223eaafcff</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <permissions:permissions rdf:nodeID="N47247ce965734c51855c3c2f47976467"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/e6b6af29-19bd-4b1b-9f9b-9fed99f42433"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-07 08:09:13 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:26357DD6-B902-4E86-BFA6-ECE08DFF6F2C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:previousVersion>urn:domeoclient:uuid:7dbea824-224a-46c4-94bf-7b308e44a5c2</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-84.txt.html</ao:annotatesResource>
    <rdfs:label>NER Sets</rdfs:label>
    <pav:lastSavedOn>2014-07-20 21:43:13 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0625A4B3-484F-482F-87A8-6C6134C2BEEA">
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 20:47:11 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1DEE22A2-CE94-48E7-8F18-7E31D556F66B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-20 20:46:26 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:b92686cf-78e8-47e8-a8d4-767477cf1b9c</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2865C1F-051B-4E10-879D-F2ADD9269128">
    <ao:prefix>, whereas </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E2865C1F-051B-4E10-879D-F2ADD9269128</domeo:uuid>
    <pav:createdOn>2014-07-20 20:48:34 -0400</pav:createdOn>
    <ao:exact>GZDV</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2865C1F-051B-4E10-879D-F2ADD9269128"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:suffix> elimination was enhanced. A dosage adjustment is recommended for patients undergoing hemodialysis or peritoneal dialysis [see Dosage and Administration (2.4)].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82DBC37B-E9EC-4E83-A1B6-950725B1D400">
    <pav:createdOn>2014-07-14 15:28:42 -0400</pav:createdOn>
    <ao:exact>In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadministered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy adult subjects (n = 24, each study). No differences in adverse events or QTc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either erythromycin or ketoconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82DBC37B-E9EC-4E83-A1B6-950725B1D400"/>
    <domeo:uuid>82DBC37B-E9EC-4E83-A1B6-950725B1D400</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:34BEE349-9FCC-4D10-A8AD-FA0AAEFB32CF">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7F16F9D5-E739-4E80-85D3-C11EC29F5D34"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2BB1BA4D-7A19-4D02-A435-607D0B5CA3BE">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:45B9EFF8-EFE2-45F1-97EE-0C8D41035AE6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0ED2CF13-8DE7-42A5-BF96-CFEBD9F406CB">
    <rdfs:label>procyclidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FACFFF9F-2F17-41D2-B71B-C4596CEA8966">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FACFFF9F-2F17-41D2-B71B-C4596CEA8966"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 21:48:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>FACFFF9F-2F17-41D2-B71B-C4596CEA8966</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine. Methadone disposition was not substantially altered</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1A6F9D8A-2081-4765-88EC-38E393538D19">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>levonorgestrel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7812AE31-F6B2-41E5-AA8F-625441C772B6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/43CA60C2-6C9B-4D6A-B869-369E04D7A0EA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1E398B61-DE44-430D-87A7-BB7089E845A0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nccf0bbb22ab8442e898da5486fd79bd2">
    <domeo:sets rdf:resource="urn:pddi:uuid:AAFD69B3-1F04-4FB8-8C33-681DB759FD8F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8CD11F7-E940-4711-8787-A723E351FB40">
    <ao:prefix>(4 mg twice daily) was shown to have no clinically relevant effect on the pharmacokinetics of </ao:prefix>
    <pav:createdOn>2014-07-14 14:23:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B8CD11F7-E940-4711-8787-A723E351FB40</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and oral contraceptives (ethinyl estradiol and norethindrone), which are predominantly metabolized by CYP3A4.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8CD11F7-E940-4711-8787-A723E351FB40"/>
    <ao:exact>nifedipine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CD71919-DE30-49A3-8A5C-FA0B4875C22B">
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7CD71919-DE30-49A3-8A5C-FA0B4875C22B"/>
    <ao:prefix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>7CD71919-DE30-49A3-8A5C-FA0B4875C22B</domeo:uuid>
    <ao:suffix>and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <pav:createdOn>2014-07-14 16:07:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/36166449-43D4-4B67-9625-65F7B03F08AE">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:520D9F67-2F55-4718-80F2-C1D79EC62CC4">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:08730A23-83FB-4BA4-8466-AACE31D2572D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E0AFC0D-0B0C-4424-A049-69B15D7BBF07">
    <pav:createdOn>2014-07-13 23:50:17 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A605A916-18E6-452E-949B-5B8D210B5340"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 23:50:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F1EF859-21C9-4ACB-A0EC-ACB39F9ED589">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:73892C75-68B3-40A7-B894-3766EFD48411"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">9</pav:versionNumber>
    <ao:body rdf:nodeID="Nf4af104f1f014748aa28605d24e13f0c"/>
    <pav:previousVersion>urn:domeoserver:annotationset:5FCD93D8-A2DD-4F21-A83A-6E286143B89C</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 16:05:39 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 16:05:38 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:206FC580-43B4-45A3-BFF6-05236B7B379B">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:517742CB-4DFD-4C81-AA9E-E37DD1F8D8DB"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B409FE5B-3157-4EDA-99FE-B679ADFE6155">
    <ao:exact>However, there was a 20% increase in valproate peak plasma concentration (Cmax) after concomitant administration of risperidone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 22:14:37 -0400</pav:createdOn>
    <ao:prefix>. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B409FE5B-3157-4EDA-99FE-B679ADFE6155"/>
    <domeo:uuid>B409FE5B-3157-4EDA-99FE-B679ADFE6155</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:12B258BB-8132-4114-90C1-40B5EF57B27D">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D7B37B7F-DC3C-4767-B041-7F3082A40CA9"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5A61AD28-8A5D-4707-957E-22F8C982856A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4579501C-0309-4886-8CFE-F060B2165401"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5DCE183F-DCFB-4FD4-94AB-2458C33F2B26"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16F5AF69-E22D-454C-8AF3-B78E57C68838">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rifampin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N92e452c023c248f4ad47e76fb56e25b3">
    <domeo:sets rdf:resource="urn:pddi:uuid:D6D8F646-EC4F-46FD-96F4-39786D2BF34C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FD2B3E06-3780-4FA7-A32D-61CDBB5F7368">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:038C3C1A-5603-455B-A95F-B047ED42BBD3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:4B06ECAA-52F8-419F-A47B-2B99C705DFAF</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 00:29:08 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 00:30:03 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:CDEAB9DC-E7EA-467D-A0AF-DBF802133350</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1F5EB7B-46D3-4D13-8E55-70EFABCCA7F5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:26:06 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:2022DFF1-A2E9-477C-9185-1F8C1987A9CE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:28:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8EB795BC-BD77-43C1-8598-70A1EBB97152"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DE072DC-2540-4985-9736-6C57CD3C5F15">
    <pav:createdOn>2014-07-20 21:14:30 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8DE072DC-2540-4985-9736-6C57CD3C5F15"/>
    <domeo:uuid>8DE072DC-2540-4985-9736-6C57CD3C5F15</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <ao:exact>ddI</ao:exact>
    <ao:prefix> (</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>) or </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A94D80E8-FAFB-4F33-AAF3-DB15A4A94CD0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C5D00B38-D823-4E74-8F0A-38051CF9F68E">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5F9A68DE-0727-427F-83CE-C3A6D6A73F68"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D11564B1-5BD5-49F7-83D8-CAB91B474732">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:51E86083-BEC2-4E5E-8DF2-7B16E18A94F1"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6cecbe5e-de20-4cba-9280-965e83e490ae">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <pav:createdOn>2014-07-07 08:08:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6cecbe5e-de20-4cba-9280-965e83e490ae"/>
    <ao:exact>omeprazole</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>fluvoxamine, fluoxetine, and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F8A443DF-08F3-4D6F-ADC3-64F330944379">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <rdfs:label>trazodone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4BFA045F-3B46-4F1E-879D-D490C5E15214">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F55477B-2C26-44F6-BBEB-B9B47914B0B0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ED8C0D9A-850C-4757-85F2-860FCD4B2FCB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1a6a42d398c849b080e0f4cc114e34d9">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:139B287C-D55A-466E-A2B3-446B35FF8A98">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Ne1e5fd6232ce4104a298846624b80f49"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:73B3FB5F-25C5-439F-BCD2-31E69052EA41</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-20 21:05:29 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7E7C29E-500F-4496-B978-B8D495F0825D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 21:05:08 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:76C0D748-7883-45EB-A214-C1D0B1F8F267</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/e6b6af29-19bd-4b1b-9f9b-9fed99f42433">
    <pav:createdOn>2014-07-07 08:09:13 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:73eecd4d-b3fa-49d5-86ef-22223eaafcff</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9fa3636a-17b0-41cd-aa8d-1df38f7259ba"/>
    <pav:lastSavedOn>2014-07-07 08:09:13 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6010B101-D502-4923-8C84-9A4A6BEE20D5</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02B3E468-88DF-4A12-9D2D-0D33BD7DF9F0">
    <pav:createdOn>2014-07-13 23:50:23 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C5D054A1-6338-4B7E-A2FB-53E6DAEF0086</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-13 23:50:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B4A87F2E-4A38-4B4E-B891-88DA7284D883</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:557B5FC1-535D-46F4-B99D-C73CC84690A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E7B0DB79-3FAF-4FCC-9881-DAF505046428">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>valproate</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/40254</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:74CE0CEC-3973-4A94-9B46-F93EE76ADA06">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:74CE0CEC-3973-4A94-9B46-F93EE76ADA06"/>
    <ao:prefix>In post-marketing experience, there have been isolated, spontaneous reports of pulmonary changes including pulmonary infiltration and pulmonary fibrosis during </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-160.txt.html</ao:hasSource>
    <ao:exact>mexiletine </ao:exact>
    <domeo:uuid>74CE0CEC-3973-4A94-9B46-F93EE76ADA06</domeo:uuid>
    <pav:createdOn>2014-07-14 15:33:12 -0400</pav:createdOn>
    <ao:suffix>therapy with or without other drugs or diseases that are known to produce pulmonary toxicity. A causal relationship to mexiletine therapy has not been established. In addition, there have been isolated reports of drowsiness, nystagmus, ataxia, dyspepsia,</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CBE82BD6-3D80-4EA4-A8C0-F9D242A9DC3D">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EA682519-BD73-4855-BCAD-FD5F77F00F2D">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:11:11 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:C24F1806-5956-4541-BD19-F5DD927C3969</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:183B71DB-2B7F-4AEB-A0C5-4FECCF83262F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8B57524A-5C35-47CE-9D29-5D80E796A669"/>
    <pav:lastSavedOn>2014-07-14 15:11:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:17D21B8A-6F46-4CC9-8B74-7302D386DA11">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C5D591DD-C00F-4612-BFA3-C8FB0AB29576"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CA401DFE-D04E-487D-96E5-569BC123D98E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3D1CCD2-BB57-4A12-931D-47E61BCC9D1E">
    <ao:prefix>. Thus, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D3D1CCD2-BB57-4A12-931D-47E61BCC9D1E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>can be given with or without meals.</ao:suffix>
    <pav:createdOn>2014-07-14 15:53:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D3D1CCD2-BB57-4A12-931D-47E61BCC9D1E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N64a80a0cff084384905dd430462a15b8">
    <domeo:sets rdf:resource="urn:pddi:uuid:3511A07B-DFE9-43F3-AC17-CF41E3118F01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1BD7B66-E1A8-4245-B56C-28E2BC193620">
    <ao:exact>5-hydroxypropafenone</ao:exact>
    <ao:suffix> which is formed by CYP2D6 and N-depropylpropafenone (norpropafenone) which is formed by both CYP3A4 and CYP1A2. In less than 10% of patients, metabolism of </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B1BD7B66-E1A8-4245-B56C-28E2BC193620"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 20:19:49 -0400</pav:createdOn>
    <domeo:uuid>B1BD7B66-E1A8-4245-B56C-28E2BC193620</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <ao:prefix> into two active metabolites: </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CAB49B09-00E3-4E2F-97E0-BD24919DE940">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <rdfs:label>metoprolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb4c9b29313b44df9af1bef7dcb73fcf2">
    <domeo:sets rdf:resource="urn:pddi:uuid:224B07F7-486B-4365-AD09-7629E350F3CE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2356EE0-FA67-482D-A3CA-AE99BFF1A189">
    <ao:prefix>Therapy with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2356EE0-FA67-482D-A3CA-AE99BFF1A189"/>
    <pav:createdOn>2014-07-14 14:18:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>should not be initiated if the patient exhibits clinical evidence of active liver disease or increased serum transaminase levels (ALT &gt;2.5X upper limit of normal) at baseline [see Warnings and Precautions (5.6)].</ao:suffix>
    <domeo:uuid>F2356EE0-FA67-482D-A3CA-AE99BFF1A189</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA439B2C-7EAF-443F-BEB0-08193CD6CA8B">
    <pav:createdOn>2014-07-20 20:20:13 -0400</pav:createdOn>
    <domeo:uuid>AA439B2C-7EAF-443F-BEB0-08193CD6CA8B</domeo:uuid>
    <ao:prefix> (</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA439B2C-7EAF-443F-BEB0-08193CD6CA8B"/>
    <ao:exact>norpropafenone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-195.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>) which is formed by both CYP3A4 and CYP1A2. In less than 10% of patients, metabolism of </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4C0CD04C-A333-477B-97FA-92306CA5224B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1939CDD3-87C8-49DC-A16B-9CE0A40A6331"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/880C6585-3226-4C5B-ABE2-E5611B0C1FA7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D8E62402-0EF8-4B24-B655-35D5F8D2C0B2">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AD646070-415D-4D07-BF43-60EE661A0C33"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CEC7E92-F5B7-46E3-BF20-C7C846705465">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <ao:suffix> AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>7CEC7E92-F5B7-46E3-BF20-C7C846705465</domeo:uuid>
    <pav:createdOn>2014-07-13 16:03:36 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7CEC7E92-F5B7-46E3-BF20-C7C846705465"/>
    <ao:exact>phenytoin</ao:exact>
    <ao:prefix> AUC. The mean ± SD increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/36412B0E-F568-4AAE-9D6E-E978E2042B20">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C11E308-F44D-4CE2-A61C-6C5825C4A343">
    <pav:createdOn>2014-07-14 00:20:19 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-54.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Diltiazem significantly decreases the clearance and increases the t1/2 of quinidine</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, but</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C11E308-F44D-4CE2-A61C-6C5825C4A343"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:262FFA97-091E-41E6-B55A-C7A7E163D935">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:262FFA97-091E-41E6-B55A-C7A7E163D935"/>
    <ao:exact>CYP 2D6</ao:exact>
    <domeo:uuid>262FFA97-091E-41E6-B55A-C7A7E163D935</domeo:uuid>
    <pav:createdOn>2014-07-14 16:02:08 -0400</pav:createdOn>
    <ao:prefix>, is the enzyme responsible for metabolism of many neuroleptics, antidepressants, antiarrhythmics, and other drugs. </ao:prefix>
    <ao:suffix> is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably quinidine. Exten</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A3E0BFE-EC76-4ACA-9F6B-EE747F04F2F6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5772FFB-759F-46D8-8CA7-C4825EDB14E1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/839D0558-5E17-4702-AF4E-A5DAB9B8280A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1A9AF44C-69E0-40D8-975A-81CD8A5A6F4E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C595A0FB-B219-498E-9571-647F7989874D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DC71C5C0-05FB-472F-A960-0CA726619223"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A6C74EE-C39E-4081-8AFC-14C5523620DA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E1E35BC3-EC58-474D-93D0-609D1D9BA9D4"/>
    <pav:createdOn>2014-07-20 20:44:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-20 20:44:54 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:4EE43374-8BC6-47B5-B10C-618540F54E72</pav:lineageUri>
    <ao:body rdf:nodeID="N98e28009271c40278271cabd38050959"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70F5DAA5-A634-48B4-9423-037A673BE7EF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7BA4F42C-25C2-40C2-91B4-2829B9554361"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1453A345-29DC-4B53-BAF4-13DC5D402218"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F55A34F9-4DAF-462C-B2A0-A6E31F3786AA">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 14:00:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:CA17CC4A-0618-416F-AA84-4F4E0608D189</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B790D350-FD5D-4096-8A96-2248DDAF25DB"/>
    <pav:lastSavedOn>2014-07-14 14:03:20 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:493DA5A2-ABB6-483B-B927-23FF54F9E554</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13172368-8211-4AEC-B9C1-FA5063E37595">
    <pav:lastSavedOn>2014-07-20 20:47:11 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2014-07-20 20:46:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:0AABD01B-CF0E-4F93-81A1-972D2BCC161A"/>
    <pav:previousVersion>urn:domeoclient:uuid:b92686cf-78e8-47e8-a8d4-767477cf1b9c</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:001F5C9E-1FB2-4B0F-886C-4BD244116C8E</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:a0b7b8bd-234a-44b9-863a-5b6a9de05c76</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0EE6A646-5E99-48B4-A559-DA3457848C62">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6879B526-DB29-4CA7-9FF0-AE35DA36F546">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DE52BF1D-256B-46BC-919B-702A4B121CB7"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:710125B6-05F6-4D89-99C4-C24BBC6FC63F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3B7080B4-5D9A-455A-BD5A-4F61B472C0C3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-07 09:41:41 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B75BEED4-6F7F-4D92-A63A-2E6A65F06DE3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ned6aaa04d29143e49eb0b2d2a51f2a37">
    <domeo:sets rdf:resource="urn:pddi:uuid:3594F2D2-3049-4640-B63F-58D76A5291AD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3F4078FE-5A50-45B2-9905-FFEEFFDFC638">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1A9AF44C-69E0-40D8-975A-81CD8A5A6F4E"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B92D7895-B2DA-40B9-957A-6EC78F73694B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:86F67905-BBA0-40B6-AAA6-3DB767E74D53</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:79018A85-E38E-49F7-BFBA-C7041E4DDAC7"/>
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:31:55 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E3064331-2238-4165-A838-B491A0F53C51">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd2a4329a3ed14afc88ff582778865a7c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:937BDF87-2BCF-4A99-B843-DF893A173164">
    <ao:prefix>Fruit juices such as grapefruit, orange and apple may reduce the bioavailability and exposure of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:937BDF87-2BCF-4A99-B843-DF893A173164"/>
    <ao:exact>fexofenadine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. This is based on the results from three clinical studies using histamine induced skin wheals and flares coupled with population pharmacokinetic analysis. The size of wheal and flare were significantly larger when fexofenadine hydrochloride was administ</ao:suffix>
    <domeo:uuid>937BDF87-2BCF-4A99-B843-DF893A173164</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:31:24 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5191BEBF-051B-436E-BC1C-9DB567805CDC">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BD7F19AE-1C7D-4B30-8B3E-92E2A06E2AAB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/97151C04-AE20-4C55-B504-7F805BCE8620"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0C21289C-3482-4415-8AFE-F4EFDE31AFFE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:57D8086A-3900-4A2C-B28D-BE6E3ADEF82C">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A12A4DCA-3CC3-4FDB-949F-3235381A6DE6"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:63571C75-F1CC-422A-AE48-CA4E5FE6C9A5">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EDE6E971-2D9A-4008-B27D-9C6D93AF8CD3"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:93F06F85-9901-4CFD-A872-94ACD592FF32">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:386FC4E1-00E2-46D8-B5B6-402A4B8433CE</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:08FF2C42-9920-45DA-A215-F6C143AE525D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 15:17:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:911C2380-ED36-4DFE-9977-6B6179B6D95E">
    <pav:createdOn>2014-07-20 22:47:26 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:9b9adb60-a447-4aa7-82fc-e4bcf10dd788</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:body rdf:nodeID="N5ed1f6a4669549ceb8ff1dd420708e4d"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C5E5596-217A-4C95-852D-2F0A6CD487EA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-20 22:47:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/d92d8b52-5bc0-4fee-b53e-99da7e496003">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:585C6B99-D509-47B5-B76E-7814527DCE3C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6bd0dcb2-993e-4893-8970-02c95aed2ae7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:09:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:91f910d1-bfe7-4646-b378-0be2e2e1db84</pav:lineageUri>
    <pav:lastSavedOn>2014-07-07 08:09:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:24975FF3-586B-43C2-89BF-1FEC9CAF4D07">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/10BBD3E6-DB5C-405B-A93D-B8C3F5F8B304"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A1B37F80-6B12-460D-B31A-F72AB1A3C675"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE633226-2A2F-4C88-99A8-EE2BD0E3D987">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 15:54:53 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEC64962-88E1-47B5-B8E1-47C8ED38FB33"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7dcd014b-3d57-48c7-9d18-a2b902f5087b">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7dcd014b-3d57-48c7-9d18-a2b902f5087b"/>
    <ao:suffix> metabolism and therefore can </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>  Carbamazepine can increase </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-100.txt.html</ao:hasSource>
    <ao:exact>alprazolam</ao:exact>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1e478010733740ff948b7ffc4db618ac">
    <domeo:sets rdf:resource="urn:pddi:uuid:775C4301-4FE3-49A0-9B8D-E000BB081FEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8EE7E603-E92D-456A-943C-F79CB794C588">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10502</dailymed:activeMoietyRxCUI>
    <rdfs:label>thioridazine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:91E5B85B-68AE-48FA-A50B-1AA605A5B75F">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5F77ABBA-6C09-4F5B-A7E1-B5DCCC0D79D2"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nba2d6a7b7bdd4f3e8fe279af519bb2da">
    <domeo:sets rdf:resource="urn:pddi:uuid:15578221-1D32-4DCC-92D5-BA56CEE29371"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3511A07B-DFE9-43F3-AC17-CF41E3118F01">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0AE89A88-9434-4013-91F8-9E041E2BDF3C"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97ed4ebf-e4ad-4f51-924a-e4ccaa98b4ec">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and Ranitidine Cimetidine an</ao:suffix>
    <pav:createdOn>2014-07-07 08:09:17 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:97ed4ebf-e4ad-4f51-924a-e4ccaa98b4ec"/>
    <ao:exact>Cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xyrisperidone combined. 7.5 </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5AD4974E-C3F7-456C-908E-F7D0BE872FA0">
    <rdfs:label>lamivudine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/68244</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:774A40A6-D325-4431-8107-3273A2B52E71">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3D4F67F0-D7A1-40D9-B299-B2EBB02F8AA9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:38A0A001-D355-4CD3-B552-546F91524E7F"/>
    <pav:createdOn>2014-07-13 14:38:22 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:CA4D6F29-F235-4592-88ED-21FD2B7D3E1E">
    <permissions:permissions rdf:nodeID="N2cd340b9bc36448b8f57313a247bbe98"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4A57C429-7B2E-4810-8892-3F6F01669541"/>
    <pav:lineageUri>urn:domeoserver:annotationset:56608c00-757d-4238-aeae-e22c3322344b</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-100.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:2dfd6153-ce60-4ad0-bb38-2a07961d39bb</pav:previousVersion>
    <pav:lastSavedOn>2014-07-20 22:44:11 -0400</pav:lastSavedOn>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>NER Sets</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/b7910d8b-c30e-4bcc-9b91-04acc5f01d22"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <pav:createdOn>2014-07-07 08:08:48 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4C8C71E7-9E29-483A-B6C4-C10172B513DC">
    <rdfs:label>conivaptan hydrochloride</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/1294548</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B64DF18D-9386-4599-A1E0-A1A56F86D4FA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
    <rdfs:label>Ribavirin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C7C6A659-53A2-4E73-A30D-7A8A71B34FA8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6FEC2851-8CD8-4C2B-9A67-94EB8194E2A3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FD6763FE-BDA1-4A8F-BBC8-FBC3AD2F37CD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:211DE4D6-1280-4905-B502-EB4B87C6FE28">
    <pav:createdOn>2014-07-14 15:42:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:40D75150-06C4-4393-9EEE-CF90A64FC929</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D3740B38-EEB8-4BED-96FC-65982B563AFC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 15:42:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:438B4C67-B651-47C9-A3BC-48E334C9095C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3e8ffe80b8b24c299836da8dd1c622e6">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F6557ED8-784C-4AB8-A6B8-8393D745216A">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3CD46515-2729-43FE-B968-BF2E3ADAD48F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/435797CA-7EFE-43C8-B53B-8F6EC9787B0A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/13BFF386-01D9-401E-9EF8-399F8B314789"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E164B984-DE06-43B6-A297-7FFE20CB56B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <domeo:uuid>E164B984-DE06-43B6-A297-7FFE20CB56B7</domeo:uuid>
    <ao:suffix> and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, talc, and titanium dioxide.</ao:suffix>
    <pav:createdOn>2014-07-11 23:29:39 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E164B984-DE06-43B6-A297-7FFE20CB56B7"/>
    <ao:prefix> equivalent to 25, 50, 100, 150 and 200 mg of </ao:prefix>
    <ao:exact>sertraline</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N683b8e9829854159a33a71d8e1896980">
    <domeo:sets rdf:resource="urn:pddi:uuid:6FF0331F-E778-4CA2-B1B4-5B09969CFE9F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncbaee63d72044c6b905027dcff2a8768">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BFFDABCD-0866-44B8-BB37-FBD8D74E9A04">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/10B83F24-5357-4E2E-A377-978E3459FEE2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/131B4E2A-B685-490F-A204-C1EF6BD31042"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CB63C498-0837-4957-AFAE-EDA3526A0A36">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D1F605EC-7481-42AE-8E6F-BECAFDE18BC7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na7e7a102d34e47f29362325460846201">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:602EF3D4-D106-43EE-A6EE-4F4B5090174E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6A24B936-8B0E-4B6F-B688-AA294A1068B1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B8CCD6BD-CF10-479E-AEC7-611637783084"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1D32611-12A6-484E-AF7D-AD9FF1C038BB">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:24891D4D-D3AB-40C2-B5FC-2FDB82D4C4EA"/>
    <pav:createdOn>2014-07-07 11:09:15 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-07 11:13:15 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:4F72E113-9D6B-4226-966A-8FD6DD55B506</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/518D8A09-6176-424B-A8BD-9AC4F9FDA2B5">
    <rdfs:label>clozapine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2626</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:224B07F7-486B-4365-AD09-7629E350F3CE">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CECDB189-9AA1-46EE-A822-8094A73F55A4"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N83500606875c4ac49853917b26bab232">
    <domeo:sets rdf:resource="urn:pddi:uuid:47BA8C43-7A6B-49AC-B34A-5CB8EC5B559C"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/801CEC80-17A5-4AE1-80D6-25D41A784F6D">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/257936A9-4FFA-4369-85AD-971CFE06D498">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/302285</dailymed:activeMoietyRxCUI>
    <rdfs:label>conivaptan</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/51AA2FED-FB36-4809-AE2A-12AE3769C9BA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diltiazem</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90B9CB8D-53E1-4660-BF50-C1D7A05E574C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-20 20:20:18 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <pav:createdOn>2014-07-20 20:19:49 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:6e22c92c-7297-4e91-ba82-ac1dc0a550ab</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B1BD7B66-E1A8-4245-B56C-28E2BC193620"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4A5DB4F5-1EA6-4F76-B578-521E1412F581">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ketoconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/91761C29-F59A-4EA4-AD3F-2E1447428677">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8690C5F-D60D-43A3-84B0-AA8DFD3C1522">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1F0575F-0EA8-4601-9DA4-60E50A820833"/>
    <pav:lineageUri>urn:domeoserver:annotation:1E11E941-B4DC-497B-8BC3-5A5847020FA9</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-14 00:08:45 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 00:11:20 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:D328F557-C8F8-4D5F-90D2-8348B1E2763C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C955C5EC-C555-48C7-9C21-237661E9CA01">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>aluminum hydroxide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A990CC62-59DF-45EC-A895-B3B17434FC99">
    <rdfs:label>tolbutamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A27C5B12-EBFF-4386-A031-3299F29ADE42">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A27C5B12-EBFF-4386-A031-3299F29ADE42"/>
    <ao:suffix>(50 mg) has been studied in 10 healthy subjects. The Cmax of trazodone increased by 34%, the AUC increased 2.4 fold, the half-life increased by 2.2 fold, and the clearance decreased by 52%. Adverse effects including nausea, hypotension, and syncope were </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(200 mg twice daily, 4 doses) on the pharmacokinetics of a single dose of </ao:prefix>
    <domeo:uuid>A27C5B12-EBFF-4386-A031-3299F29ADE42</domeo:uuid>
    <ao:exact>trazodone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-136.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:13:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/23DE9E1A-4EBE-41EE-854A-6F54E6E9A34D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>didanosine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3364</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0F7756A-4E44-46AB-994A-694CB790B5E5">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:E596C216-CC0A-4553-BC0C-DAE5B6F9C589</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21FB9E6D-4D15-4652-B1DE-B057C40F4A82</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC58EBE6-613D-43A5-933A-0117FF3BB39D"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:9F8679DE-DD80-4E86-BAAA-1BACEDEFBE21</pav:lineageUri>
    <pav:lastSavedOn>2014-07-13 14:54:51 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-13 14:50:31 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DE52BF1D-256B-46BC-919B-702A4B121CB7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FEBCD982-7C06-4006-B35D-BFDAFAF94138"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CCAA2803-5EEB-4AA9-A4D5-E11BEDC5809E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FE461E0-58D7-4E9E-B5DE-69728C3EF270">
    <domeo:uuid>5FE461E0-58D7-4E9E-B5DE-69728C3EF270</domeo:uuid>
    <pav:createdOn>2014-07-14 15:17:13 -0400</pav:createdOn>
    <ao:exact>mCPP</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-137.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FE461E0-58D7-4E9E-B5DE-69728C3EF270"/>
    <ao:suffix>) by 76 and 60%, respectively, compared to pre-carbamazepine values.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(as well as </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N77616acbbb264bf1859fb2fcd89ec43a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CBEB5BFE-AEFC-4265-AAEB-826B3FB400E1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/931548E6-C126-41DC-9221-7A859EEFDF72"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5F414CAA-EF76-4632-85A8-1BB7C9F32B45"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8938DD8-F07C-4CCD-B376-DD381766E6E6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2339FD40-1467-46BB-92DF-54668761E4A9</pav:lineageUri>
    <pav:createdOn>2014-07-07 11:18:25 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7FE1D9CF-5460-48BB-BAA6-538EAE7BE3AA"/>
    <ao:body rdf:nodeID="Nc4c503a13ea148ee8a19cc690b2aa963"/>
    <pav:lastSavedOn>2014-07-07 11:18:20 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D53476D-5323-4EF0-A072-E479B6EA2D79">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 23:01:07 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:exact>VAPRISOL (40 mg/day for 4 days) administered with a single 25 mg dose of warfarin, which undergoes major metabolism by CYP2C9 and minor metabolism by CYP3A, increased the mean S-warfarin AUC and S-warfarin Cmax by 14% and 17%, respectively</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8D53476D-5323-4EF0-A072-E479B6EA2D79"/>
    <domeo:uuid>8D53476D-5323-4EF0-A072-E479B6EA2D79</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. The corresponding</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DB55BFA5-4AA4-4286-8104-20A8FFC75DB7">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E8A6ADD4-6ACC-41F6-96BE-B9C1D83EBEE8"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE0B8B26-849E-41D5-A290-DC147AFC1489">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>PPARγ </ao:exact>
    <ao:suffix>is expressed in adipose tissues, this differentiating characteristic may account, at least in part, for the greater response to AVANDIA in females. Since therapy should be individualized, no dose adjustments are necessary based on gender alone.</ao:suffix>
    <domeo:uuid>FE0B8B26-849E-41D5-A290-DC147AFC1489</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE0B8B26-849E-41D5-A290-DC147AFC1489"/>
    <pav:createdOn>2014-07-14 14:17:55 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>apy studies, a greater therapeutic response was observed in females; however, in more obese patients, gender differences were less evident. For a given body mass index (BMI), females tend to have a greater fat mass than males. Since the molecular target </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A39193A8-6C6E-4F3E-957F-A9D6F24E732E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A39193A8-6C6E-4F3E-957F-A9D6F24E732E"/>
    <ao:suffix>were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-</ao:suffix>
    <pav:createdOn>2014-07-13 23:59:10 -0400</pav:createdOn>
    <ao:exact>theophylline </ao:exact>
    <ao:prefix>The pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A39193A8-6C6E-4F3E-957F-A9D6F24E732E</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A5D843E-5611-41DC-83F2-D6FD83E9A8A0">
    <ao:suffix>or pravastatin, decreased 18% to 23% the AUC of both, but did not alter their pharmacodynamics. Propranolol did not have an effect on the pharmacokinetics of fluvastatin.</ao:suffix>
    <ao:exact>lovastatin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:05:06 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A5D843E-5611-41DC-83F2-D6FD83E9A8A0"/>
    <ao:prefix>with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-132.txt.html</ao:hasSource>
    <domeo:uuid>8A5D843E-5611-41DC-83F2-D6FD83E9A8A0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e5b3080510d486da0935b52aeb9f089">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9FE8874A-3C60-4F7D-9BF2-5BF576C023C3">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/84108</dailymed:activeMoietyRxCUI>
    <rdfs:label>rosiglitazone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:464F68C8-1694-4800-B2DF-F9770157C3FE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concomitant administration of propafenone immediate release tablets and cimetidine in 12 healthy subjects resulted in a 20% increase in steady-state plasma concentrations of propafenone</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>464F68C8-1694-4800-B2DF-F9770157C3FE</domeo:uuid>
    <pav:createdOn>2014-07-20 20:39:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:464F68C8-1694-4800-B2DF-F9770157C3FE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EF1DCCA-C32E-478E-B1D6-13A65B80011A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:11:29 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:createdOn>2014-07-14 14:11:31 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:112B1B73-DB37-4023-B62F-FF624A1BA519</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F064491E-496D-4547-8FB0-3C176E7C1090"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N45709e34b0824899b2e764877caf7505">
    <domeo:sets rdf:resource="urn:pddi:uuid:1B71F769-A5DC-48DD-8815-91370C23B2F4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6df5a60e205f4db6988b80428171e288">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F89A37A6-3CDD-4878-A117-BD9160646C4D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7E92BF1A-B7AB-4B8B-B186-9C6CEE3E8AEC">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7733664F-014A-40F7-A8B3-FE6C7959DD95"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:771E05FA-9239-4B01-8A30-D927BC6F98C3">
    <pav:createdOn>2014-07-20 22:34:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-20 22:34:40 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:475EFF62-7E37-4C7A-A1A3-56FCD2668FE3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A5DB8A62-0702-4B27-8FC6-47B225C594F6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:248FF9F8-6094-427A-9418-E99142CA1A66</pav:lineageUri>
    <ao:body rdf:nodeID="N76b5d3462db647ecae43a10928e0163c"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:21AA3530-DA83-4682-9BA6-2C42908752D7">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:51B200EE-E3FD-44AF-8D8B-E4CDBC02E15E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FF2581E-3442-43CB-AE3F-F76A262F8BDD">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:06:36 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FF2581E-3442-43CB-AE3F-F76A262F8BDD"/>
    <domeo:uuid>4FF2581E-3442-43CB-AE3F-F76A262F8BDD</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>There is a potentially relevant interaction between diazepam and compounds which inhibit certain hepatic enzymes (particularly cytochrome P450 3A and 2C19). Data indicate that these compounds influence the pharmacokinetics of diazepam and may lead to increased and prolonged sedation. At present, this reaction is known to occur with cimetidine, ketoconazole, fluvoxamine, fluoxetine, and omeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-177.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3FD6B834-E969-4A91-B893-083DDDA00DC1">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:63E79435-4988-4364-8897-B91CCDEDCA6A"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F8D2749-4944-45D6-AAF0-8E0A2FC98D19">
    <ao:context rdf:resource="urn:domeoclient:uuid:F997B91A-ADF6-4AD0-BC5A-6BB52A35147D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:19:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F234064E-A4F5-415F-98E1-EB9598123576</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:E0A7E040-C2A3-466D-A330-8114D95E734B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 15:19:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd1751ec5c8694828a93bb4edd0da13b2">
    <domeo:sets rdf:resource="urn:pddi:uuid:7F70F54E-417D-4B2A-9C97-D851FE0D7CD0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/09D66598-5E49-4FAE-8AAE-5AAFEB126BAB">
    <rdfs:label>ranitidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9143</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb954198474ef4c779aa59c3bfccffef8">
    <domeo:sets rdf:resource="urn:pddi:uuid:05223ED7-E009-478C-9BB2-6EACF796798A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N01e02209ea594005984d9711297be9fd">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0665E2A-EBBB-4400-A27A-04D9C66A1F84">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A0665E2A-EBBB-4400-A27A-04D9C66A1F84</domeo:uuid>
    <pav:createdOn>2014-07-20 21:22:58 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A0665E2A-EBBB-4400-A27A-04D9C66A1F84"/>
    <ao:exact>quinupristin/dalfopristin</ao:exact>
    <ao:suffix> with</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-114.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1924D8FC-CADA-4C33-8CCF-3DE59FEA32FE">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4febcca7-67fe-4408-9515-214a0dcf92b5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4febcca7-67fe-4408-9515-214a0dcf92b5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nifedipine</ao:exact>
    <ao:prefix>., increased Cmax and AUC of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-108.txt.html</ao:hasSource>
    <ao:suffix> in healthy volunteers by fact</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-07 08:09:12 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C1BB7C6E-391B-452B-8574-4C2A3EADCEAD">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0CC2D660-143E-4B31-820B-162EA1439970"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3B4BF097-852E-4C09-8340-4DF21AA0AE94">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tolbutamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ned36fdfec9a0487980bc11939410a715">
    <domeo:sets rdf:resource="urn:pddi:uuid:52A4AC2D-AF93-4500-B5EF-7C350351694A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7114F5CD-3259-4ED6-B9FE-B03F8D23A618">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FBE23B10-7F86-4AFB-9AE4-7862FE2BA3F6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/20790BCD-4E13-419C-BA5C-F8EBBD722E56"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/100A9E92-F267-47F8-8748-743E8EE01276">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tolbutamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5B129591-B461-450A-B8CE-4BFAA6262858">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:092BCF3E-DF3B-4915-80EA-F0C495994432"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A005A1C4-8AAD-47D1-B07A-64275878D71E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A005A1C4-8AAD-47D1-B07A-64275878D71E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Chronic administration of clozapine with risperidone may decrease the clearance of risperidone</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-20 22:12:10 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A005A1C4-8AAD-47D1-B07A-64275878D71E</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N70fdf79a395841d48e696610bfb22fac">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F1BA8D36-61EE-49B4-9622-50FCED39E520">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/623EA56C-B196-4E54-A47B-8A3F41918DE3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/90AF96F7-C319-416B-9675-C5BAE512AADA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc8b17d3c052b4885ab8d16ef8f429f9c">
    <domeo:sets rdf:resource="urn:pddi:uuid:4CA4BAD6-2D36-4063-B74A-698BF1BB61C0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A1494F6-227B-4B1A-B07C-55A33FBB1BA8">
    <ao:exact>Coadministration of oral conivaptan hydrochloride 10 mg with ketoconazole 200 mg resulted in 4- and 11-fold increases in Cmax and AUC of conivaptan, respectively</ao:exact>
    <domeo:uuid>8A1494F6-227B-4B1A-B07C-55A33FBB1BA8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A1494F6-227B-4B1A-B07C-55A33FBB1BA8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> [see Contraindications (4.2)]</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:prefix> has not been evaluated. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-20 22:57:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:191FEA6A-791E-4E1A-9D9B-196DA4E5FDEE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7796E5A7-6B35-4FD9-BC0C-1FE7F631A507"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1707E728-3897-48BE-A6F3-60A01593021F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N74bb4a2994994db6aa305ae769890711">
    <domeo:sets rdf:resource="urn:pddi:uuid:8DD620B0-E795-477A-86D5-25C97C5DF945"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62C9AD15-C2E2-40FD-BDF9-997FB03D5443">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6369813F-9844-434B-B66E-FC1EB161F4EE</pav:lineageUri>
    <pav:createdOn>2014-07-14 00:06:55 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:45E70A06-7DB9-4245-A63B-21FFBD6833F0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4477B066-614B-4766-BF4D-5EE07E18E1DB</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 00:08:06 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B15B99CE-DBDC-432A-B3B1-5E3A1BD31AE2">
    <pav:createdOn>2014-07-14 14:23:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:527855D9-6DA5-4C98-A6B2-062C81A2568D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <pav:lastSavedOn>2014-07-14 14:26:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:379A3F4A-D582-4E65-8239-E9BD3AD76AA9</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">11</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFE3AE13-0463-40CC-919F-3A2FF52C336D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B72196C6-8245-4C89-A5FC-0907252FF162"/>
    <pav:createdOn>2014-07-20 21:44:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="Nb6209631558c42d5a9bd83aa4b35ffe3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:10EE7EF0-C3E0-479A-9CEF-39DF8F8D9561</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A88FF26A-4344-4C42-9A0D-4FE418B3CA49</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 21:44:10 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:127B5363-79B2-4079-8128-27356B3C4A96">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 14:35:04 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:127B5363-79B2-4079-8128-27356B3C4A96"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA (2 mg twice daily) taken concomitantly with glyburide (3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on glyburide therapy</ao:exact>
    <ao:suffix>. Repeat doses of</ao:suffix>
    <domeo:uuid>127B5363-79B2-4079-8128-27356B3C4A96</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0CBA1D0E-EE21-43A4-A435-C10B50636A5C">
    <permissions:permissions rdf:nodeID="N275caa8b3dca4dadabc5ca0ea2d25a32"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AE425825-8F21-4D56-A182-F047657EBBED"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/4ea384c1-110a-4f6a-8040-ac8b2e9d26e7"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoserver:annotationset:BD89A66D-D5D9-4485-9C2D-68C3CA3D6BF0</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046de7980014702a55a6b0058"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:831af861-283a-4830-a91e-c36b0a7b18d4</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A9A544F-592E-407F-BACD-ECCDD495C48A"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-113.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:09:08 -0400</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lastSavedOn>2014-07-20 21:33:06 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D080FA0-1886-4F9D-B9FD-CD7D771BC129">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 15:22:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:22:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <ao:body rdf:nodeID="N75800d6f8c0c469ca479f5c69726b7fd"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:40328921-F7C5-45FA-918E-F7579F247671</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1A2A790A-7260-4CC8-B8E3-A2017774498E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A0F25B11-F22A-4880-9D67-67D3864B5569">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/58F2429E-AA5B-4989-BB2D-EFBB6F85E91F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/09745AFD-D8F9-462F-BF5B-E866CBD25325"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/46ED9853-5FFF-4924-89C3-AC277D621356">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/78303A4B-BD0B-46AE-9C10-5390385C9579">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E23049C4-5655-4DDA-A22E-87B5E2B63F9E">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 15:17:09 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:39AB351D-D50D-424F-860D-9F152C179121</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:ACEF28EC-F8D1-4EF0-BDEF-8320C976B6A6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:1FAA27D4-119A-4182-B1D3-9BDF13FE4AC6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 15:18:46 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EC3F6671-AB16-4E9C-8214-0BD363B8166D">
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20B5A5A7-D31A-4292-9911-E6C971147DFB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>20B5A5A7-D31A-4292-9911-E6C971147DFB</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20B5A5A7-D31A-4292-9911-E6C971147DFB"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:39:00 -0400</pav:createdOn>
    <ao:suffix>reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration.</ao:suffix>
    <ao:exact>Cimetidine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9CA222E0-A4FD-47D2-BD23-B1A90DC85E25">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6D6BEBC2-CE25-4FDE-9DAD-E4A5EB041AE4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E5BB4968-9DC2-4C81-AFB3-417F6BB7C373"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4CA4BAD6-2D36-4063-B74A-698BF1BB61C0">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:78166130-A78D-421F-9B32-479B0E71245F"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B5D8208A-3143-4A78-8D5F-F9BB03AC0E0D">
    <domeo:uuid>B5D8208A-3143-4A78-8D5F-F9BB03AC0E0D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ranitidine </ao:exact>
    <pav:createdOn>2014-07-14 14:47:33 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B5D8208A-3143-4A78-8D5F-F9BB03AC0E0D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>(150 mg twice daily for 4 days) did not alter the pharmacokinetics of either single oral or intravenous doses of rosiglitazone in healthy volunteers. These results suggest that the absorption of oral rosiglitazone is not altered in conditions accompanied</ao:suffix>
    <ao:prefix>Pretreatment with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/13737EFC-0D15-4A99-B68E-0E6A4D9BAA39">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:57096881-6D9E-449E-910A-528AFFA7AE4D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2A3F493D-D5D9-42DA-93A9-044EECCA06FE"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3ECBCEF7-04B5-404B-8B20-CB0BDF2CBAA8">
    <pav:createdOn>2014-07-20 21:34:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-112.txt.html</ao:hasSource>
    <ao:exact>clopidrogrel</ao:exact>
    <ao:suffix> was coadministered with </ao:suffix>
    <domeo:uuid>3ECBCEF7-04B5-404B-8B20-CB0BDF2CBAA8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3ECBCEF7-04B5-404B-8B20-CB0BDF2CBAA8"/>
    <ao:prefix>: No clinically significant pharmacodynamic interactions were observed when </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DCC874F-D846-45E7-9105-996551F6946D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DCC874F-D846-45E7-9105-996551F6946D"/>
    <ao:exact>The pharmacokinetics of oral conivaptan (20 - 40 mg/day) were unchanged with coadministration of either captopril 25 mg or furosemide up to 80 mg/day</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-104.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 23:02:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6DCC874F-D846-45E7-9105-996551F6946D</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9FFE004-DD07-481F-94A3-33FF9982C6A6">
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. </ao:prefix>
    <pav:createdOn>2014-07-13 14:44:26 -0400</pav:createdOn>
    <domeo:uuid>A9FFE004-DD07-481F-94A3-33FF9982C6A6</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A9FFE004-DD07-481F-94A3-33FF9982C6A6"/>
    <ao:exact>There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%)</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4294722-E6EA-4B43-BE16-12C1938ECEB6">
    <ao:context rdf:resource="urn:domeoclient:uuid:AA9AF2A8-8489-4A74-A628-6CDCA8F92F96"/>
    <pav:createdOn>2014-07-14 16:07:34 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:074593C6-7986-459D-8413-ADF6B690E6A3</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 16:08:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D96EE18C-074F-4BB7-9249-3A40A7487919">
    <domeo:uuid>D96EE18C-074F-4BB7-9249-3A40A7487919</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D96EE18C-074F-4BB7-9249-3A40A7487919"/>
    <pav:createdOn>2014-07-14 15:55:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydro</ao:suffix>
    <ao:prefix>nor</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:201F90F0-CBAB-4102-8FA5-6A21E5E79DF6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:37C62D90-C747-4727-AE6F-6BFDB983523B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-13 15:58:22 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-13 15:58:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:341B86E6-2AF6-4866-AA44-A744BDD8130A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:DCCFF116-9AF0-48F4-8DC7-635E3824156A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30CF1F0C-3A8D-4951-8D5B-CA8DCC86029F">
    <pav:createdOn>2014-07-14 14:11:29 -0400</pav:createdOn>
    <ao:suffix>were variable and were generally not statistically different from placebo or glyburide controls.</ao:suffix>
    <ao:prefix>The changes in triglycerides during therapy with </ao:prefix>
    <domeo:uuid>30CF1F0C-3A8D-4951-8D5B-CA8DCC86029F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>AVANDIA </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30CF1F0C-3A8D-4951-8D5B-CA8DCC86029F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:574D70DE-91DB-41EB-B769-DEB8783E5865">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:574D70DE-91DB-41EB-B769-DEB8783E5865"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>574D70DE-91DB-41EB-B769-DEB8783E5865</domeo:uuid>
    <ao:exact>propranolol </ao:exact>
    <pav:createdOn>2014-07-14 14:59:01 -0400</pav:createdOn>
    <ao:suffix>with cimetidine, a non-specific CYP450 inhibitor, increased propranolol AUC and Cmax by 46% and 35%, respectively. Co-administration with aluminum hydroxide gel (1200 mg) may result in a decrease in propranolol concentrations.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-129.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Co-administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6D6BEBC2-CE25-4FDE-9DAD-E4A5EB041AE4">
    <rdfs:label>conivaptan hydrochloride</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/1294548</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:624c2187-c1a7-4743-acdc-d6c8320a4c22">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:624c2187-c1a7-4743-acdc-d6c8320a4c22"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>nitrofurantoin</ao:exact>
    <ao:prefix>inistered concomitantly with </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-07 08:08:53 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-35.txt.html</ao:hasSource>
    <ao:suffix>, reduce both the rate and ext</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0309f2de9c0b42f6b9073bbac5aed890">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BBF62F41-8603-4AE3-8634-2D508DE82EE7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N218a3477749d40ab920fd6551d1612be">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/78664986-C827-4183-9367-5D3067C54FED">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/44E86397-C7D3-40F6-888A-3848B98E69A4">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/5487</dailymed:activeMoietyRxCUI>
    <rdfs:label>hydrochlorothiazide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB38C427-0E9E-428B-B6C6-670C77C008B1">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6294BE6-FDE8-4823-A9D1-0BCD1DEE4E9F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6294BE6-FDE8-4823-A9D1-0BCD1DEE4E9F"/>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <domeo:uuid>D6294BE6-FDE8-4823-A9D1-0BCD1DEE4E9F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>The pharmacokinetics of theophylline were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 00:05:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/58BA5753-4787-4141-9D52-6A3A261F3880">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB178C28-C043-4B54-A75F-304283D5ED1D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-14 15:03:10 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:23F36509-0614-43F9-924D-7EF7B847092B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:040F2562-F192-48FD-A7AE-B14DD73235FD"/>
    <pav:lastSavedOn>2014-07-14 15:04:22 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9DD48200-7AB9-4D05-BC85-2B67E8C8D755</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N275caa8b3dca4dadabc5ca0ea2d25a32">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nca1709bb50264c228443737e485a9d77">
    <domeo:sets rdf:resource="urn:pddi:uuid:7BAB0BC2-81F4-4EFE-B350-702384003328"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB069CFF-7092-43EF-95CE-DCF8A6033A3B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CB069CFF-7092-43EF-95CE-DCF8A6033A3B</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:45:35 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-201.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB069CFF-7092-43EF-95CE-DCF8A6033A3B"/>
    <ao:exact>Phenytoin</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A3A23B1E-942D-4B65-8548-D7C819EE74F6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>SEPTRA</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/202807</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2c98e6b6-7366-42e4-b2e6-0c90498bf53f">
    <pav:lastSavedOn>2014-07-07 08:09:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:d3f5505a-0bdb-483b-9bb3-a665aa8fa5b1"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-07 08:09:19 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:b1f5c441-748a-4cd0-a1a5-0253e14e1bf0</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5E26D8B8-3109-4C14-B9D9-36AE9589E7A8</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DAA69266-A17D-4D63-A36B-CBB3BCEC6079">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6AC0E6FE-4192-44D5-A734-64308C0BDF97">
    <rdfs:label>acyclovir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/281</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:59112E47-1755-4B62-A614-6E8FDF1FD005">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B1216755-C112-4930-9821-BE92F46BB1C3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2D618A6F-6ADA-43A4-8A52-4B8158136DD0">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:244F3A12-D743-4F47-87C7-CFA1C1A7E87D"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/93265AAF-E940-43A2-9770-5A25AAF89D17">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72A6487A-7B3C-4EA8-81EC-4050E2715191">
    <domeo:uuid>72A6487A-7B3C-4EA8-81EC-4050E2715191</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72A6487A-7B3C-4EA8-81EC-4050E2715191"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-198.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:48:38 -0400</pav:createdOn>
    <ao:exact>Experimental evidence demonstrated that methadone decreased the AUC and peak levels for didanosine and stavudine, with a more significant decrease for didanosine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7f452791-72fe-4919-b04c-8a8bf26edd08">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> metabolites by nifedipine. Ho</ao:suffix>
    <ao:prefix>of the formation of oxidized </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-110.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-07 08:08:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7f452791-72fe-4919-b04c-8a8bf26edd08"/>
    <ao:exact>irbesartan</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:786018B0-E999-47DC-B4E3-D711FF53726E">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 15:36:22 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 15:38:08 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:261FBCCB-D709-4392-82BC-685600FA5428</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A40B23FD-9121-46E8-83E5-020E18ECCDD7</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C98D591-7244-4E43-B843-98E32DDD9AA0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B07DB1D7-869C-48E9-AE55-E7A4C8B514E0">
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E103D65B-D651-41B3-A813-4810CD52C7ED">
    <ao:suffix>in healthy adult subjects. Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole. In two separate studies in healthy adult subjects, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was coadminis</ao:suffix>
    <ao:prefix>led to increased plasma concentrations of </ao:prefix>
    <pav:createdOn>2014-07-14 15:23:27 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <domeo:uuid>E103D65B-D651-41B3-A813-4810CD52C7ED</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E103D65B-D651-41B3-A813-4810CD52C7ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fexofenadine </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/811F48D7-1FE8-4399-AB5C-2E54D3D018E8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A605A916-18E6-452E-949B-5B8D210B5340">
    <ao:prefix>200 mg daily for 14 days in eight renal transplant patients who had been on </ao:prefix>
    <pav:createdOn>2014-07-13 23:50:17 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A605A916-18E6-452E-949B-5B8D210B5340"/>
    <domeo:uuid>A605A916-18E6-452E-949B-5B8D210B5340</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administ</ao:suffix>
    <ao:exact>cyclosporine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4319A90A-4182-4E21-A4F3-8C189FF40FD0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4319A90A-4182-4E21-A4F3-8C189FF40FD0"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>4319A90A-4182-4E21-A4F3-8C189FF40FD0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Fluoxetine (20 mg once daily) and paroxetine (20 mg once daily) have been shown to increase the plasma concentration of risperidone 2.5 to 2.8 fold and 3 to 9 fold, respectively</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-20 22:16:24 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/644F2F3C-447C-43DA-B43B-96547D66D73E">
    <rdfs:label>levonorgestrel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2B6559F-B1C1-4C19-BC43-D42428961628">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-14 14:51:49 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-14 14:52:31 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:0EF53938-CA77-47B6-BE0B-69600D7CF66A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:A4CAF33B-7EDE-454B-A091-25FEDF0ECA63</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D9142D92-935F-4AC4-BFB7-46C4FD4DAB79</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFD4D56D-7032-40B5-8E9A-3FEC6523482B">
    <ao:suffix>. Sildenafil had no impact on the plasma levels of oral contraceptives (ethinyl estradiol 30 mcg and levonorgestrel 150 mcg).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FFD4D56D-7032-40B5-8E9A-3FEC6523482B"/>
    <ao:prefix> 150 mcg) did not affect the pharmacokinetics of </ao:prefix>
    <domeo:uuid>FFD4D56D-7032-40B5-8E9A-3FEC6523482B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-07 11:07:53 -0400</pav:createdOn>
    <ao:exact>sildenafil</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A244BE56-4C3C-4954-A724-2FC461C7198D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/30CDE530-1807-42E6-80C9-9513AC295DFD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D105817E-0A70-4AF9-BDFB-7AB0429EE1F3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9F886489-2982-43B9-A82B-7D80D14D47EA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A7A148B1-1E12-4BF3-98A6-C099709CAD1F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/913B3678-9CAD-4964-91EE-81C08F9B5770"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb7dad43085d247aca0f4cad61fa913de">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:54028D9B-7715-44BC-A4EA-B8F5F304325B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4B2D19E1-EB91-4410-9409-BE80B2C22924"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FBFC86B4-A0D6-4F79-92F8-D3C079A9337A">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C55792A3-6668-49B5-AC8E-1CBF687DBA52"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/115A7A17-2E6D-4D49-8B23-D10D322D9C8D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>verapamil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11170</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06F5477E-1CBF-4421-B40C-D43DEC150968">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, a decrease in the dose of rosiglitazone may be needed when gemfibrozil is introduced [see Drug Interactions (7.1)].</ao:suffix>
    <domeo:uuid>06F5477E-1CBF-4421-B40C-D43DEC150968</domeo:uuid>
    <pav:createdOn>2014-07-14 14:28:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:06F5477E-1CBF-4421-B40C-D43DEC150968"/>
    <ao:exact>rosiglitazone</ao:exact>
    <ao:prefix>(4 mg once daily) alone. Given the potential for dose-related adverse events with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EE21C792-6535-4C96-B985-F53B187B6033">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:41A1276A-CCA6-4B0C-889C-A11B8BDCCC1C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N04838ef6ea24468f847fbbc01c5777dd">
    <domeo:sets rdf:resource="urn:pddi:uuid:10E0F583-86A2-43D3-A862-AC089113DBC6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:50A17AD3-4F78-41FD-A741-DCA94EC0550F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ABE025E0-E8AE-4F58-B4FE-9A4A51C7E799"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC500AD3-21EB-412A-9942-E54A1FA042B4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:exact>lithium</ao:exact>
    <ao:suffix> (N=13).</ao:suffix>
    <domeo:uuid>CC500AD3-21EB-412A-9942-E54A1FA042B4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC500AD3-21EB-412A-9942-E54A1FA042B4"/>
    <pav:createdOn>2014-07-20 22:12:43 -0400</pav:createdOn>
    <ao:prefix> (3 mg twice daily) did not affect the exposure (AUC) or peak plasma concentrations (Cmax) of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FBE23B10-7F86-4AFB-9AE4-7862FE2BA3F6">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <rdfs:label>avandia</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/261455</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2B3A799F-4AE7-4144-B096-3441B5DA3D2F">
    <rdfs:label>Isoniazid</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N17d9c595ef704daf9c76418c50ad5846">
    <domeo:sets rdf:resource="urn:pddi:uuid:0D2EB67C-B8B2-4A16-BC53-CDEB3818C3CC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ABE025E0-E8AE-4F58-B4FE-9A4A51C7E799">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E5CB698E-5F83-455B-83B0-9FDDCFCEB8BD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D1B3359F-0727-402B-A293-3F12263E5D17"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AAA268A7-D4CA-4EA1-85EE-D6D3F5336DE7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/525C4ADE-3470-4F7C-85F9-393D25E36BE7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BA3C8777-2A2E-476C-8511-99CBFFF4DF20"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:62E91244-FAC3-409B-A2E1-8CAA6E1D2DB0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DE9B7D01-343C-488A-8C0D-DB8926A4CC9F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E73B03BA-3F7F-4BC8-8B72-F12D9213E592"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51429A7F-A009-4AB3-9EA7-6F6DC2EA9519">
    <pav:createdOn>2014-07-14 13:55:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:C51C6F7B-7A2F-4F4B-9664-90D777CC7343"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:A882B3D4-57BA-4FF9-92D1-336A82D24FB1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 13:57:24 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:AFBD4DF3-2F53-4791-8488-6668A4EB10FD</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A6655574-CAED-4C38-930D-891D0187E9E3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7550A0CE-65C5-40DA-822F-E3D7E7D8562A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9D638860-02C4-4316-BC23-B315E6826BAD"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AD3F6DA3-AFE1-4CBA-9D1E-10378C1BEEA4">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propafenone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EB9BAEF-6898-4BCD-BCB2-6277D2162332">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 15:22:51 -0400</pav:createdOn>
    <ao:exact>Erythromycin </ao:exact>
    <domeo:uuid>2EB9BAEF-6898-4BCD-BCB2-6277D2162332</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2EB9BAEF-6898-4BCD-BCB2-6277D2162332"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <ao:prefix>7.2 </ao:prefix>
    <ao:suffix>and Ketoconazole</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3377FF83-DAA0-46E0-8AF0-43B2164B4E45">
    <pav:createdOn>2014-07-20 20:42:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. In 4 patients, administration of</ao:suffix>
    <domeo:uuid>3377FF83-DAA0-46E0-8AF0-43B2164B4E45</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3377FF83-DAA0-46E0-8AF0-43B2164B4E45"/>
    <ao:exact>Concomitant use of propafenone and propranolol in healthy subjects increased propranolol plasma concentrations at steady state by 113%</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3377CE81-F0D9-4690-A732-E96CA8DCBB25">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3377CE81-F0D9-4690-A732-E96CA8DCBB25"/>
    <ao:suffix> (M-2) is the major metabolite and has antiviral activity similar to that of parent drug; however, the concentrations of this metabolite in plasma are low. In vitro studies utilizing human liver microsomes have demonstrated that cytochrome P450 3A (CYP3A</ao:suffix>
    <ao:exact>isopropylthiazole oxidation metabolite</ao:exact>
    <domeo:uuid>3377CE81-F0D9-4690-A732-E96CA8DCBB25</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> metabolites have been identified in human urine and feces. The </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:07:34 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/04B73200-8828-441C-8C58-84D06189FF0B">
    <rdfs:label>paroxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N29d3ffe3ecec44a882abce7db3471bbd">
    <domeo:sets rdf:resource="urn:pddi:uuid:FB594498-B7D8-4AB0-AB51-C710881F5D4D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N47247ce965734c51855c3c2f47976467">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CFD1411-ACED-46D4-87C2-0F32F599E1A7">
    <ao:prefix> (</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-190.txt.html</ao:hasSource>
    <domeo:uuid>1CFD1411-ACED-46D4-87C2-0F32F599E1A7</domeo:uuid>
    <pav:createdOn>2014-07-20 21:07:51 -0400</pav:createdOn>
    <ao:exact>M-2)</ao:exact>
    <ao:suffix> is the major metabolite and has antiviral activity similar to that of parent drug; however, the concentrations of this metabolite in plasma are low. In vitro studies utilizing human liver microsomes have demonstrated that cytochrome P450 3A (CYP3A) is t</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1CFD1411-ACED-46D4-87C2-0F32F599E1A7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5367d44d73484a3898375bc988991f41">
    <domeo:sets rdf:resource="urn:pddi:uuid:29F63718-A64E-4517-8D3E-B8FC33AB8992"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0af8f4a55d1a4368a7bcbec49c0a37de">
    <domeo:sets rdf:resource="urn:pddi:uuid:1B2D1779-276F-413D-AEC9-CC35B60FA0A4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N00cafe36066f4cbe864e30bd79d95492">
    <domeo:sets rdf:resource="urn:pddi:uuid:1C1E067B-34F7-4995-986F-53B80A9D7BC0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E3EEBE7-2F2D-4A17-81E7-D9D0A7640CC4">
    <ao:prefix>had no impact on the plasma levels of oral contraceptives (</ao:prefix>
    <pav:createdOn>2014-07-07 11:08:05 -0400</pav:createdOn>
    <domeo:uuid>0E3EEBE7-2F2D-4A17-81E7-D9D0A7640CC4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E3EEBE7-2F2D-4A17-81E7-D9D0A7640CC4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> 30 mcg and levonorgestrel 150 mcg).</ao:suffix>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/50254AB7-1254-43B8-96CB-C345B4C5D3DC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>fluoxetine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4493</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFA5AD69-5770-4C97-B73E-8AA721042363">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-20 20:42:07 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">20</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:F5664A04-8484-4F32-8704-546030F18A17</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E4B03CBA-F403-488C-B675-09DC0679A7E1"/>
    <pav:createdOn>2014-07-20 20:42:06 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Ne9cb894287954760ab6967444488394b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DDBD1B56-F922-4E62-8E2F-899C899D1700">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5DD10163-B459-4AF1-BDD3-4954A6197369"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8be9ff0857324fe3b692ff141d84d830">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N70f67ef332bf4516ad8d98de856ef63d">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1455B528-6F82-492A-8E0B-E305B5A9CD1A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A7AF4C00-2B41-46C2-AC53-3910D6140A9F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D8A0D55-4F25-48B4-AB24-56A28BB0519B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:083BD2C5-441A-419A-AFA2-28C29EE6EF8F">
    <pav:createdOn>2014-07-14 14:16:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C55DC5E6-47B5-44DB-9A36-ED918A3B1E40</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C0158A5-72D1-4C7C-A2DC-9099DD472A99"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:16:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndf33f031f36d44c3bcdde8c88676bb90">
    <domeo:sets rdf:resource="urn:pddi:uuid:C1D2747D-5BC0-4230-B5F5-982153E6B015"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na5b473601ebc409ba9cc69750f815371">
    <domeo:sets rdf:resource="urn:pddi:uuid:520D9F67-2F55-4718-80F2-C1D79EC62CC4"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D865FC44-06FC-415D-9730-152B1B5EDB2F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>tolbutamide</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA95F2B2-1968-4200-A5BB-7DA23D1DE9D5">
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 14:46:45 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">25</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:B007B37B-2A74-4AFA-BE1E-EDA76A331AAE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:57116A4B-39BB-4561-9279-25F38DD0B1BD"/>
    <pav:createdOn>2014-07-14 14:46:14 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N21b366bfe4734281ac7eab1c748bccb5">
    <domeo:sets rdf:resource="urn:pddi:uuid:7376813C-18F5-4DFB-9351-3C431415603A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:423A0B64-88FB-4E01-A630-2DAE02100296">
    <ao:exact>Zonisamide had no appreciable effect on the steady-state plasma concentrations of phenytoin, carbamazepine, or valproate during clinical trials</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:423A0B64-88FB-4E01-A630-2DAE02100296"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 00:27:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-56.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>423A0B64-88FB-4E01-A630-2DAE02100296</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17BA47FB-892D-4094-B47A-EA05DF25E13B">
    <domeo:uuid>17BA47FB-892D-4094-B47A-EA05DF25E13B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:17BA47FB-892D-4094-B47A-EA05DF25E13B"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:prefix>rapidly into </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone co</ao:suffix>
    <pav:createdOn>2014-07-14 16:02:25 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C6F9E537-6324-4E47-9C8C-2390455D5297">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1964B8DA-FD43-42C9-A983-BE963B06C49B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>stavudine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/59763</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:159FA166-31A3-4662-B4D5-FB62E7E7A5E1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9CBC4AF2-D4D4-43FD-AAA9-24E571ADADC5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3A3C93D2-9A4D-40D4-B465-EC3B7CF1363B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2f99462895f94f928cf2800fa3a48734">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0911aa1822624a159e7a54304e21756c">
    <domeo:sets rdf:resource="urn:pddi:uuid:12B258BB-8132-4114-90C1-40B5EF57B27D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D93AF595-3A2D-476E-B92A-8759D022F862">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EEABDB7A-6F26-4D6D-8444-63D448035261"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/31EC3E3F-B976-4317-A40D-47F4255A0F52"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/31A9AE8A-52FE-4523-9669-FFCDD9B029C0">
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd59af527dda84308958dc429442670e1">
    <domeo:sets rdf:resource="urn:pddi:uuid:7E1E892D-B996-4CD8-89D9-6742503DE09F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B6B30437-03EC-4979-97BB-164CEC453879">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D6FFE1FA-AB9E-493B-B3DF-1B036560AF39"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/23DE9E1A-4EBE-41EE-854A-6F54E6E9A34D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8153F833-F7F6-4312-8191-2A2CCD05FC0A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N72aff01fc54a44f2ace889a0db58e285">
    <domeo:sets rdf:resource="urn:pddi:uuid:54B8E090-10E4-49A8-B042-36DB36D30DAC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EBA0E2A0-D83E-480A-A316-826DCBCA4FEC">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D93AF595-3A2D-476E-B92A-8759D022F862"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N364dd8d23e444a56a1c10120397b20cd">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:307E8571-93F7-4F77-9F27-4F5523BEFD29">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5F53CC33-B5AF-4146-B85C-101051C6ED03"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DB05500B-B443-4CC1-967C-7C7A4086F71D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03EDFE75-8721-4869-AE7E-F978B2AB8F81">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03EDFE75-8721-4869-AE7E-F978B2AB8F81"/>
    <ao:exact>CYP 2D6</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone p</ao:suffix>
    <ao:prefix> by the enzyme, </ao:prefix>
    <pav:createdOn>2014-07-14 16:01:30 -0400</pav:createdOn>
    <domeo:uuid>03EDFE75-8721-4869-AE7E-F978B2AB8F81</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA1F5AD4-3F7F-4E4F-B64D-3D22AA1AAA18">
    <pav:createdOn>2014-07-13 15:55:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA1F5AD4-3F7F-4E4F-B64D-3D22AA1AAA18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> 400 mg to six healthy male volunteers. </ao:prefix>
    <ao:exact>After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%)</ao:exact>
    <domeo:uuid>BA1F5AD4-3F7F-4E4F-B64D-3D22AA1AAA18</domeo:uuid>
    <ao:suffix>. However, the administration of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A071756-83DB-405B-883F-4DC7D8C87B45">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F3738E94-1946-433B-A314-952659477146"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/291D0A52-CE6B-443D-817F-7F1732437012">
    <rdfs:label>propafenone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2933d702d6a642c4a474fdd2c7970ef6">
    <domeo:sets rdf:resource="urn:pddi:uuid:92CF6083-36AD-465E-96EB-9853738CD926"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:789B6118-ED30-46C2-AD27-5E0EBB7D5FE2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(3.75 to 10 mg/day) for 7 days did not alter the mean steady-state 24-hour plasma glucose concentrations in diabetic patients stabilized on </ao:prefix>
    <pav:createdOn>2014-07-14 14:33:44 -0400</pav:createdOn>
    <ao:exact>glyburide </ao:exact>
    <ao:suffix>therapy. Repeat doses of AVANDIA (8 mg once daily) for 8 days in healthy adult Caucasian subjects caused a decrease in glyburide AUC and Cmax of approximately 30%. In Japanese subjects, glyburide AUC and Cmax slightly increased following coadministration</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:789B6118-ED30-46C2-AD27-5E0EBB7D5FE2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>789B6118-ED30-46C2-AD27-5E0EBB7D5FE2</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E6B5106-3F39-4E7E-A2B1-9DD87D37315C">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:00D8F9AE-3905-4D6D-BFD2-F2D55B2C73F2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6ED373C-75B1-42F4-B99C-2DD071270459">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:62E2F222-59F9-4955-BFE9-642A1913EF31"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9850F3BA-C731-4B3D-8137-70A6A3AB0E03">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:350B186B-11EF-4CF9-8194-4572EBEF1AD0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7908ABA8-9CF7-4EA8-A4A7-E69CDC721213"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4A90553F-7027-4527-AB18-1C3CFDD7F24F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2ff11213-d217-4bb7-81d1-7133062f4625">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6cecbe5e-de20-4cba-9280-965e83e490ae"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-07 08:08:57 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:30adb140-db74-40d7-a084-0046c4d69196</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 08:08:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6688CFF6-D7E4-4BDF-8723-93F5EAC30307</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2578F7C2-2B43-4C50-B71D-B6B6D47CD0F8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BF32B3FE-4A0D-4A12-ABEB-F292B848616D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA9AF2A8-8489-4A74-A628-6CDCA8F92F96">
    <ao:suffix>doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:prefix>and its active metabolite decreased by 60% compared to young healthy subjects. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 16:07:34 -0400</pav:createdOn>
    <domeo:uuid>AA9AF2A8-8489-4A74-A628-6CDCA8F92F96</domeo:uuid>
    <ao:exact>Risperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA9AF2A8-8489-4A74-A628-6CDCA8F92F96"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1E35BC3-EC58-474D-93D0-609D1D9BA9D4">
    <ao:suffix>. However, concomitant use of</ao:suffix>
    <pav:createdOn>2014-07-20 20:44:50 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>No significant effects on the pharmacokinetics of propafenone or lidocaine have been seen following their concomitant use in patients</ao:exact>
    <domeo:uuid>E1E35BC3-EC58-474D-93D0-609D1D9BA9D4</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E1E35BC3-EC58-474D-93D0-609D1D9BA9D4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-194.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:89624854-C052-41C5-872A-DDF2A9B14308">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A5ED559-DED3-41B0-8FCD-ED86B82E452D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CECC56F6-DB52-436F-BEF4-449B99F234CB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:54F32B69-C007-4252-9B92-878BB3D2EF90">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1FA48296-5E4E-4511-B607-8CF3EF4D22D0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/14851631-824D-4946-B8D5-9F294AC02788"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C165BA14-BA54-484E-9E3F-F42114C1202A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/25789</dailymed:activeMoietyRxCUI>
    <rdfs:label>glimepiride</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N13260a3323d140649e6eb0540cb689d4">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0F074D3A-ABA0-4A44-BBE4-D1BD0FCFD10C">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/49276</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>doxazosin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7b7c0e745c9242c3aee312a1b920bca5">
    <domeo:sets rdf:resource="urn:pddi:uuid:5544894C-9B0A-4F90-A1EE-CC256DD839CA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08006C31-AEF2-4A53-AB93-23C7606EE4AD">
    <pav:createdOn>2014-07-14 15:31:57 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:08006C31-AEF2-4A53-AB93-23C7606EE4AD"/>
    <ao:prefix>was reduced by 36%. Therefore, to maximize the effects of </ao:prefix>
    <ao:suffix>, it is recommended that fexofenadine hydrochloride tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>08006C31-AEF2-4A53-AB93-23C7606EE4AD</domeo:uuid>
    <ao:exact>fexofenadine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N321a36df8b4046a68660b97c640eb618">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0B670B09-B470-4090-B336-0A14B5F50045">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1408AEC5-B949-4B79-8A3C-772E8B92A892"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D6D715F7-80A0-4EDA-8A61-470841B18BBB"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F109D515-0B66-4EAC-86BF-ECAAECF21953">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8842B8AA-F18A-4534-BB18-6BC1A9090677">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/113BF3F9-340B-4E03-80E2-BB485F290F34"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/145DC160-7ACB-4DE6-A882-0A593AD5428D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5F9A68DE-0727-427F-83CE-C3A6D6A73F68">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E430013B-637D-4FD3-92BB-31423631B5B6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A38F4267-C2F3-4669-9DDA-6CCFCBED3798"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7796E5A7-6B35-4FD9-BC0C-1FE7F631A507">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3443</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diltiazem</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8E02A321-E6BE-48B0-AD2C-FD1D27993FC5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>zonisamide</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfe75f386b3364699a9f957fa8ca3081f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nffd7b94d2f834ff59c9013d306f9f454">
    <domeo:sets rdf:resource="urn:pddi:uuid:801D676C-691F-4522-9686-C300BF1369B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50D09A15-B89D-498F-8E12-6C483F9122F3">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-13 15:54:57 -0400</pav:createdOn>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F89683C5-7B89-4FE1-ADF5-92657120E8C0"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb6209631558c42d5a9bd83aa4b35ffe3">
    <domeo:sets rdf:resource="urn:pddi:uuid:692817DA-3EBC-4B27-8E08-0781E2438FA1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N37e25a0dde23408aaf1e4808d1bf51a2">
    <domeo:sets rdf:resource="urn:pddi:uuid:392B0959-5D62-4FA5-9C01-ACBBBB55AE86"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D99DDD3F-7390-4001-A123-40B454B4F0C9">
    <pav:lineageUri>urn:domeoserver:annotation:D10E6987-944F-4EC1-AD39-561BC6B296FE</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:175DE992-5EA0-40AF-8BC8-6F899E0B93D0</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-14 13:53:54 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-14 13:53:55 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:365F830D-0B07-48D1-B187-14FC451BED8E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D6FFE1FA-AB9E-493B-B3DF-1B036560AF39">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Methadone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7d68616343aa443db4993b070a61a63e">
    <domeo:sets rdf:resource="urn:pddi:uuid:F81CA4F5-9129-4105-ADA2-F29B6192E446"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B08ADE6D-20F3-4B69-ACC1-35AE4ED00799">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F754437E-B6ED-42FE-916D-C298DFEF0B1E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:0739B419-7699-425E-AA16-091CD86AD686</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:1df49f9b-2b76-40aa-97be-a56baece2a0f</pav:lineageUri>
    <pav:lastSavedOn>2014-07-20 20:22:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:502FA972-3333-4B87-BBCC-290F611104F3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-20 20:21:33 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:AA9420F1-DB6C-4737-B69A-22454F6AB38C</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B82DA1FB-FA13-46A0-9259-E6B630A4F4E9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/301F2CC2-0DB1-4742-84C5-86AD71F72F84"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A13AE44B-49B5-4021-B2A3-47BF6869E397"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:618B6E0E-D9D7-430F-BA8F-13E2F205027D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2CE2C23E-F1F5-409E-9AB9-14A060640134"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/115A7A17-2E6D-4D49-8B23-D10D322D9C8D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2C6267E-AE2D-49A6-9562-7DC8679EB032">
    <rdfs:label>propranolol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:421A6913-51A7-43BE-B7F8-F95085E33887">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B9CDC9DC-84A8-452D-8D30-3281FE6EE381"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D61E53E1-37FA-4452-9775-F86A9574E9F5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B5E7563-69FB-47D8-851A-D0622887AAC1">
    <ao:suffix> in 24 healthy male volunteers.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B5E7563-69FB-47D8-851A-D0622887AAC1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-13 15:55:01 -0400</pav:createdOn>
    <domeo:uuid>7B5E7563-69FB-47D8-851A-D0622887AAC1</domeo:uuid>
    <ao:prefix>200 mg) did not affect the bioavailability or pharmacokinetics of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3E1580F0-6D62-4651-9037-2DA6C4DA1825">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinupristin/dalfopristin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ACB1486E-6973-4681-B087-1511A08D51E0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ACD4243C-A1DD-45A7-808E-9CAD9F8689C0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/02B4E171-BE8F-496F-A3E9-F0BFB5354012"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:661388CC-A732-4846-810B-CAF99F3D73C2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/73200C30-2582-473B-BBF0-A8B88C5D08A7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E3238149-ACFD-459C-B1CB-26A84CFCE66C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N41c92df6c10448aabda96bd0b53cf696">
    <domeo:sets rdf:resource="urn:pddi:uuid:FBFC86B4-A0D6-4F79-92F8-D3C079A9337A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6D7FFEAF-1C15-4AC8-AA51-15D157F2DD93">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9850F3BA-C731-4B3D-8137-70A6A3AB0E03"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/35AB51EE-DA9E-438C-824A-1AB8780D6566"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncad08869c6244338a78ed30ed4b2a952">
    <domeo:sets rdf:resource="urn:pddi:uuid:F24A797E-0BE2-4406-B36F-3A7E13D5BF18"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5769AD63-ABC9-4E79-BAF4-A40D4D6698C0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6F168D68-A400-479A-85FB-7F9FB434D742"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0CF5D433-1574-4FBC-B8DD-9393ED93FBEB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F30CD26-B53E-4DF3-978F-C9EBD8AD2A78">
    <ao:prefix>and </ao:prefix>
    <pav:createdOn>2014-07-14 16:07:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F30CD26-B53E-4DF3-978F-C9EBD8AD2A78"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid>3F30CD26-B53E-4DF3-978F-C9EBD8AD2A78</domeo:uuid>
    <ao:suffix> combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DF0B4A2-95DB-440C-80BB-6951AC703786">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DF0B4A2-95DB-440C-80BB-6951AC703786"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Cimetidine reduced the clearance and volume of distribution of meperidine and also the formation of the metabolite, normeperidine, in healthy subjects and thus, caution should be used with concomitant administration</ao:exact>
    <pav:createdOn>2014-07-14 15:39:44 -0400</pav:createdOn>
    <domeo:uuid>0DF0B4A2-95DB-440C-80BB-6951AC703786</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-164.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8479230-F9DA-4188-A1A4-602E8388DCF9">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-3.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-20 21:55:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>No significant interactions with digoxin, hydrochlorothiazide, hydralazine, sulfinpyrazone, oral contraceptives, tolbutamide, or warfarin have been observed</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D8479230-F9DA-4188-A1A4-602E8388DCF9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D8479230-F9DA-4188-A1A4-602E8388DCF9</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DBE6388-DF62-40C2-973C-F3FBD0E27179">
    <ao:context rdf:resource="urn:domeoclient:uuid:E575BE29-6C29-4B77-852F-5D1C46C0E976"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-13 15:54:31 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FDB36BEC-F569-42A4-93B0-C3E233E87D8E</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:B99669A4-12FF-4903-846D-463523BA3C28</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-13 15:55:00 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC205A92-A3B2-4AE1-B4D9-84DD44C4AC75">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BACEEB50-96DF-4265-8FFA-3D5717A1CD80"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E3064331-2238-4165-A838-B491A0F53C51"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1B457ED2-9A9D-4E17-B58C-4A3B0269BEBB">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4F20A37A-470E-4A27-BAF2-E2E7367D7BA9"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F1C62938-6219-4B76-B5EF-ED73F7A5E5F5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E933B203-CB00-48E2-8C18-1203CAA7207A"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/804BA454-E13F-46DB-8A67-FC57D7F3DF80"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A3CB2F68-C804-4347-B155-FCAED657F54C">
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N103a1ca452f14c16ba73a1b81824450b">
    <domeo:sets rdf:resource="urn:pddi:uuid:EFE6A203-A080-452C-8ECD-A3831CD61738"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5DCE183F-DCFB-4FD4-94AB-2458C33F2B26">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>itraconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/28031</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne413ff69319a4499bf0dfe4527d75ef9">
    <domeo:sets rdf:resource="urn:pddi:uuid:0341915A-FEB3-47F5-834B-95B81FE9E127"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/981E2420-F91F-4FCE-8795-6CFD01A871C0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
    <rdfs:label>nifedipine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5a52faba0d9f405d80d8454f3e2d1381">
    <domeo:sets rdf:resource="urn:pddi:uuid:E738E91E-5D16-4D1B-BBEE-77C0687E598A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:67291C71-6522-4DE8-B97A-157EDAA01CB4">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8CF5EBE9-69EE-4D30-BD8E-0DB53AA98915"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EE71BC7A-5DA3-48ED-BAA9-99D54ADB141E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ADFB3244-7A5F-4302-8C01-8E7FDA866218">
    <rdfs:label>trazodone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5F53CC33-B5AF-4146-B85C-101051C6ED03">
    <rdfs:label>meperidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70468321-8AD6-4EC6-ACD9-3252A6A7E43B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:3D484962-4C33-415C-AD6F-1A98F650D378</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 14:58:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2BB84476-421D-44DB-9D68-3E10638DA849"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7839F81D-B7D6-4C2F-B48B-28082D5596EF</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 14:57:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8E780DED-DBF0-4257-9AFB-4C8538DBD2CC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/85207E6C-0847-422E-9BED-B5040130A4EC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2D5FD229-D29F-4031-8F09-640B6C138477"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N71b2e7ae525840e3a4bc660f5fac41e6">
    <domeo:sets rdf:resource="urn:pddi:uuid:744E0B26-F094-4D3C-8F56-80676DC56DE3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D869A491-1E47-4F2C-828D-B6518B4BB664">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D869A491-1E47-4F2C-828D-B6518B4BB664"/>
    <pav:createdOn>2014-07-20 22:48:57 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. In four patients with cardiovascular disease, coadministration of</ao:suffix>
    <domeo:uuid>D869A491-1E47-4F2C-828D-B6518B4BB664</domeo:uuid>
    <ao:exact>In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8C856094-43BD-4D41-A6A8-8E98452DF431">
    <rdfs:label>levodopa</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6375</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neab8265742c74e1191c19a32a4d0a911">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C5D591DD-C00F-4612-BFA3-C8FB0AB29576">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>citalopram</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2556</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd332c3721874471486dbb6ec7374fb1e">
    <domeo:sets rdf:resource="urn:pddi:uuid:CB63C498-0837-4957-AFAE-EDA3526A0A36"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82FC511C-51CF-4E60-8BE9-5C437CB14B89">
    <pav:lastSavedOn>2014-07-13 14:45:42 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:980E7460-3E5A-4BD5-8B5B-2474F4800655</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F034B5E-984A-4C69-A6C9-CF72CF9D5AF9"/>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:3DD2579C-3E3D-4096-B8C8-2A9341E5F2DE</domeo:belongsToSet>
    <pav:createdOn>2014-07-13 14:38:43 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A421213-E3B1-4CA4-9505-3A6E4AC99E2C">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/40254</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>valproate</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na4984cfbb11148429771595086e47c95">
    <domeo:sets rdf:resource="urn:pddi:uuid:F3E6782C-4CBB-4B80-BC69-BEFADA6301A7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8449CB7-E9F9-4DFF-8AEA-90C199A8BFED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Co-administration of other known enzyme inducers (e.g., phenytoin, rifampin, and phenobarbital) with risperidone may cause similar decreases in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-20 22:20:25 -0400</pav:createdOn>
    <domeo:uuid>F8449CB7-E9F9-4DFF-8AEA-90C199A8BFED</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8449CB7-E9F9-4DFF-8AEA-90C199A8BFED"/>
    <ao:prefix> therapy. </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-7.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C646526-BC6E-4925-8245-2EB52CCD51AB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-14 00:12:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C646526-BC6E-4925-8245-2EB52CCD51AB"/>
    <ao:exact>paroxetine </ao:exact>
    <ao:prefix>with </ao:prefix>
    <domeo:uuid>9C646526-BC6E-4925-8245-2EB52CCD51AB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:suffix>significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7E6AD2D5-B686-4D85-86B2-9CAB80FCDC51">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7F75B650-175B-4253-A0D6-4B2CB390E7B8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8D7BEDB9-C2C4-4BBE-B683-F8782B5637C1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42647566-E62B-4C24-8042-AC83B5451B02">
    <pav:lastSavedOn>2014-07-14 15:32:03 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:FA0E6E21-4F7C-4212-B487-AEE73D0A978E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 15:32:01 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:75D661D1-03B9-4B24-9504-59511E2B63BE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D633F54-37C4-4D8B-818B-4FAB7794F558"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc1ece97173d74c82ac0f5e97209f9666">
    <domeo:sets rdf:resource="urn:pddi:uuid:2A0A9B47-9C50-4714-BBE0-0EE4CB32B680"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6A48FF86-3CA3-444A-BD58-31FCA71D16EF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3E76C645-2B57-448B-87FB-30CD72D35828"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DB5384EE-1568-408C-8EAC-70006D222747"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D4C1CBA4-1E52-47AA-949D-0456A5131A39">
    <rdfs:label>nitrofurantoin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7454</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:20BBF6E7-21B7-4808-9376-3BF169E0DA8E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/46ED9853-5FFF-4924-89C3-AC277D621356"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C60BFB14-11B4-4598-82C7-9AAF91D5F7BA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB60762F-B2C3-41A9-AED8-22C7DC232C2D">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>EB60762F-B2C3-41A9-AED8-22C7DC232C2D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-102.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB60762F-B2C3-41A9-AED8-22C7DC232C2D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Absorption of drugs from the stomach may be diminished by metoclopramide (e.g., digoxin), whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-20 22:32:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EA0C0AB2-00F6-4796-A890-37A9399E2F18">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/49B90764-F0CD-4515-A756-3494FEF2D288"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1C89268F-4417-4319-B669-4AB0804C572A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:10E0F583-86A2-43D3-A862-AC089113DBC6">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F1EC62D9-E279-4988-9BAE-78D9A54BFAB6"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3DFD7722-40C8-460C-A8C2-D0132D1C418A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DF6586CD-8A68-410E-9025-EB446B66078C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C1D4E424-6FF6-499D-9316-26826869645E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne2f025d1f9c046a09ac0495a9060ffaf">
    <domeo:sets rdf:resource="urn:pddi:uuid:18EC91BB-1FD8-48E7-A347-AFA8DF68B390"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D3E30071-0826-4BC3-9DFC-799E61F90F77">
    <rdfs:label>ribavirin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9344</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2F5F9699-3D40-44BA-887D-A3C62277F73F">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/16FCEB7D-5C8C-4E0F-AB29-742E59D2D9BC">
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:758A5759-B1FE-4C19-8285-6C3BCFC63679">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1964B8DA-FD43-42C9-A983-BE963B06C49B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D444CFE4-5BA6-415B-AEC0-4069CAB94E3E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:737CC04C-BC04-4880-9190-1A36AE2AEE03">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F694AA03-BB88-42BA-B7E2-DCBC4770400A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA398AA3-ABF6-4755-B6EF-DBD36D20832C">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-14 15:38:30 -0400</pav:createdOn>
    <domeo:uuid>AA398AA3-ABF6-4755-B6EF-DBD36D20832C</domeo:uuid>
    <ao:exact>Plasma concentrations of meperidine and its metabolite, normeperidine, may be increased by acyclovir, thus caution should be used with concomitant administration</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-163.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AA398AA3-ABF6-4755-B6EF-DBD36D20832C"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FE50AE67-227F-4CA6-8486-2AC9636E07E1">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3008</dailymed:activeMoietyRxCUI>
    <rdfs:label>cyclosporine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C60BFB14-11B4-4598-82C7-9AAF91D5F7BA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2cd340b9bc36448b8f57313a247bbe98">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9CBB97FE-955F-436E-A6E1-66ED994C5AB8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/83BE9B79-8B56-4481-95C5-D5D3B55B72A5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/376836F0-CBCC-4524-9B91-2226C8C597DD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4579501C-0309-4886-8CFE-F060B2165401">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluvastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6694ED24-17DC-41BB-B8F6-A11CB21E936C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/20A40E16-59CE-47DE-BAD6-3A072FBAF37A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D8E4BE9A-8C99-4EB9-85AA-F2B14158E2AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D633F54-37C4-4D8B-818B-4FAB7794F558">
    <domeo:uuid>2D633F54-37C4-4D8B-818B-4FAB7794F558</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-139.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-14 15:32:01 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D633F54-37C4-4D8B-818B-4FAB7794F558"/>
    <ao:prefix>, it is recommended that </ao:prefix>
    <ao:exact>fexofenadine hydrochloride</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> tablets should be taken with water [see Clinical Pharmacology (12.3) and Dosage and Administration (2.1)].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc6da84fc58e746cbad8e781a822c1e33">
    <domeo:sets rdf:resource="urn:pddi:uuid:B94FF46D-C84C-4F87-BF89-23C78F4BAB1E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D8166BBB-A15B-48C4-9718-6B05BB31B531">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>hydralazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6FF24A2B-6FD8-4229-A576-9E9C82C2CC47">
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1C89268F-4417-4319-B669-4AB0804C572A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8cf75bc8ad824626a320ae8d8f450db0">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc11d8358a4d54d248d35c7dad963c5cf">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D0B94028-0205-4451-ABA7-C20D5FDBF14A">
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N344d760faf3342c48fe43f1d4b625ff1">
    <domeo:sets rdf:resource="urn:pddi:uuid:D450F3A9-C16A-4A8D-B153-31D8AAB3C25A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3a4e8501d10344c0813d7829b17fa944">
    <domeo:sets rdf:resource="urn:pddi:uuid:2372E549-CC2F-4FF1-88B9-E8D42F825B2A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/32526DC9-E6DB-4CBA-BD93-0E83C1E6313B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>nifedipine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7417</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf34b03160e074b2c97d38c6227503156">
    <domeo:sets rdf:resource="urn:pddi:uuid:1E7BB31A-CBE9-4FD7-BF48-3700BF9BBF6B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3E5186B7-14DF-4ADD-A288-50824118ADD2">
    <rdfs:label>atorvastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83367</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2E88C8E6-71AE-4A0B-8DF1-6C12E874CE1A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C519EEC6-D4FA-4455-AB4B-A212FF7F8D09"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DD267561-23D9-4467-BC42-A0C76F4F087B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98A2D657-E7D0-4451-8886-8EC8C12E22A0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98A2D657-E7D0-4451-8886-8EC8C12E22A0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-109.txt.html</ao:hasSource>
    <ao:exact>Pretreatment of healthy volunteers with 30 mg or 90 mg t.i.d. diltiazem p.o. increased the AUC of nifedipine after a single dose of 20 mg nifedipine by factors of 2.2 and 3.1, respectively. The corresponding Cmax values of nifedipine increased by factors of 2.0 and 1.7, respectively</ao:exact>
    <pav:createdOn>2014-07-20 22:29:23 -0400</pav:createdOn>
    <ao:suffix>. Caution should be exercised when coadministering</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>98A2D657-E7D0-4451-8886-8EC8C12E22A0</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd86d468b84ec4eb5b5b18e7ba7658e46">
    <domeo:sets rdf:resource="urn:pddi:uuid:D90AC6D7-DC03-417E-9804-9B5BDBB189B6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C8BB2325-54B0-4EEE-B527-5720D1F37B99">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>glyburide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4815</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D1F605EC-7481-42AE-8E6F-BECAFDE18BC7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EC9C19E7-72B3-413C-B01C-D35DCBED1545"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7F9EBA0-80D6-45D2-ADEB-4C0C5401BCE2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F1EC62D9-E279-4988-9BAE-78D9A54BFAB6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2EF0A75B-A6F3-4FAA-BE4B-EC253D87AB9C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D2F36F05-9358-4277-AC9A-6BD395B4B1CB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncbeffbe0b8d2406aa37f8b75e2695939">
    <domeo:sets rdf:resource="urn:pddi:uuid:2A071756-83DB-405B-883F-4DC7D8C87B45"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/348ED40D-3D5E-46D3-8B35-2CCEB0540022">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/145DC160-7ACB-4DE6-A882-0A593AD5428D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/39998</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>zonisamide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N03a5915f704648fd96af232362f7b6e6">
    <domeo:sets rdf:resource="urn:pddi:uuid:5FBFD379-47C3-4C8D-B6CE-90A4893F6723"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:415FBAF7-A951-4C16-A39E-0E9E7A642ECE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/78664986-C827-4183-9367-5D3067C54FED"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/36C11962-9D03-476B-98B8-E87892436CE6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:92CF6083-36AD-465E-96EB-9853738CD926">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A7CF6C85-1AF5-4115-A907-CD36383C4136"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7b245890fda94fe388a2cc71a0a98aee">
    <domeo:sets rdf:resource="urn:pddi:uuid:F57F8DB9-3784-491E-9D27-DE3A3D01FF83"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/54828274-B618-479B-AEB1-AFB3F326130E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2556</dailymed:activeMoietyRxCUI>
    <rdfs:label>citalopram</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F575DEFA-A914-4145-91C6-A75860A2379B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F575DEFA-A914-4145-91C6-A75860A2379B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. Extensive </ao:prefix>
    <ao:exact>CYP 2D6</ao:exact>
    <pav:createdOn>2014-07-14 16:02:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> metabolizers convert risperidone rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolize</ao:suffix>
    <domeo:uuid>F575DEFA-A914-4145-91C6-A75860A2379B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0EF53938-CA77-47B6-BE0B-69600D7CF66A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0EF53938-CA77-47B6-BE0B-69600D7CF66A</domeo:uuid>
    <ao:suffix>is reduced by co-administration of quinidine, leading to a two-three fold increased blood concentration and greater degrees of clinical beta-blockade.</ao:suffix>
    <pav:createdOn>2014-07-14 14:51:49 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0EF53938-CA77-47B6-BE0B-69600D7CF66A"/>
    <ao:exact>propranolol </ao:exact>
    <ao:prefix>The metabolism of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-125.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:08730A23-83FB-4BA4-8466-AACE31D2572D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5346DFF1-40A0-48DD-834C-F7D65C3815B8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0769544F-AC1F-41EC-84A8-317A809A4452"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nebdfd63411164caa9296499716f73823">
    <domeo:sets rdf:resource="urn:pddi:uuid:63571C75-F1CC-422A-AE48-CA4E5FE6C9A5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N922d2df3bcc34a7a80cab4ad3c644365">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:47BA8C43-7A6B-49AC-B34A-5CB8EC5B559C">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:08B210AA-3CC1-46FB-A287-17294AF1A1DC"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7331BE7C-862F-44A7-A182-35BE78245FFE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2F78C4F9-208D-499E-A0EF-350D5FDE0322"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AA9B4F45-EE03-4CFE-B335-9128AD3C66D8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F3B8E39B-502B-4887-B0C7-B8251595AADE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AE86C8F9-71A2-4E4D-AA99-632A91F221F6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/801CEC80-17A5-4AE1-80D6-25D41A784F6D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A7CF6C85-1AF5-4115-A907-CD36383C4136">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/33EB31A8-F03E-4467-A0C6-BDAD2FC08752"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B036432F-664F-4181-BF15-84311153EE9E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5d661e46bd5b4ed98f41ecb02694f237">
    <domeo:sets rdf:resource="urn:pddi:uuid:82554599-69C0-4F4F-B23D-1FCD1062BE90"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8C4AAA54-50A3-466F-9BD3-A508BFC15CD4">
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na9ee39f346234c349c2dac9ecd75b994">
    <domeo:sets rdf:resource="urn:pddi:uuid:2FA1215F-246E-4F45-B34F-9369A6E2AA08"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/20A40E16-59CE-47DE-BAD6-3A072FBAF37A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N19d3933a912e48958707027b6db3c98e">
    <domeo:sets rdf:resource="urn:pddi:uuid:898E9B9E-BD79-40E4-839E-56F4FFAC13F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8CD0860F-CABF-43C6-BD2B-584391B5C379">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8027FCAB-832F-43BE-B22A-CCE8D7129E60">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ECBBC132-50C0-4065-A064-62159F7C4836"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd5d62ab8910e4c51987888905565a0aa">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:24602923-6C93-4FB0-829C-2483B51104AD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1A6F9D8A-2081-4765-88EC-38E393538D19"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DAA69266-A17D-4D63-A36B-CBB3BCEC6079"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/22B5811C-D2E0-4391-8B65-ABE82AF5FD7A">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb30d19bcc3b443dab681c0a3e0c6605b">
    <domeo:sets rdf:resource="urn:pddi:uuid:475F1D2C-51BA-49DA-BEE4-57DA6D1E02FC"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4EA5F40D-A7EC-48B8-A791-0B18A7766012">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71D837C7-D687-4607-95FF-4BD95F544864">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A15AE47D-7F27-4107-B092-5B573AE69C02</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lastSavedOn>2014-07-07 09:44:23 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:68CF5698-C118-4B12-BEFA-740B79F38CDF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-07 09:37:57 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CDE41278-0B38-42E0-B1A1-FCA02A6FF966"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7F9EBA0-80D6-45D2-ADEB-4C0C5401BCE2">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DCFDA8C-0C73-4D30-848F-24D5049435C9">
    <ao:context rdf:resource="urn:domeoclient:uuid:3810A0AD-8340-4F62-9DF9-6542E05DA636"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A9E09A34-72E0-4EDA-9932-A792A3983242</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-20 22:50:32 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7d7b48f7-d96b-472a-9f62-f174fb629ca2</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:23C9E12F-CAF2-4684-A56F-345CF01BBF78</pav:previousVersion>
    <pav:createdOn>2014-07-20 22:50:29 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD5BDFD5-73D5-441E-AC12-865C5D80E7A6">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8728A643-E51C-4771-9827-0BE589532B42"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N69d5426d2cbc44a78e5726d3ba0b2620">
    <domeo:sets rdf:resource="urn:pddi:uuid:9E3F4BF7-61B1-449D-AB93-F8E8EF53F25F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA129433-8D22-4EE5-B5AB-8639F127E397">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1B3EE4C-5AD2-4B4A-9B72-D268C4601768</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:2AFE29C5-A524-4FEB-8966-F5513657F510</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lastSavedOn>2014-07-20 20:43:18 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:0779e9c7-f1d4-4081-9099-98336730af35</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:createdOn>2014-07-20 20:43:16 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">23</pav:versionNumber>
    <ao:body rdf:nodeID="N3ad44c112a03453c838563d2fcc7ad77"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6318D475-571D-4887-9A96-F15289C06308"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/435797CA-7EFE-43C8-B53B-8F6EC9787B0A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>cytochrome p450</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ACED3071-EB2E-407D-8147-BA0EBEAA6374">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ED8C0D9A-850C-4757-85F2-860FCD4B2FCB">
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:60A44009-2A71-44FD-B5F4-665D620FC14A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/75FD13B5-0EEA-4E75-B21F-BA39BBFFF746"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4EA5F40D-A7EC-48B8-A791-0B18A7766012"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C1D2747D-5BC0-4230-B5F5-982153E6B015">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6A48FF86-3CA3-444A-BD58-31FCA71D16EF"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D6D715F7-80A0-4EDA-8A61-470841B18BBB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9bd963c498b54e20a40da49b124cdf95">
    <domeo:sets rdf:resource="urn:pddi:uuid:6F023E3E-91F6-4410-BE18-54AC3343B43B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N45b8e32cca6a4daa9867c753685d2138">
    <domeo:sets rdf:resource="urn:pddi:uuid:2F006A75-990B-411A-8E2E-C47907768CA6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd04459bbb6e747fbb916090949b8ce48">
    <domeo:sets rdf:resource="urn:pddi:uuid:48CA2567-4617-464B-9D33-7985EBFDAF1B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CE5758E3-D998-40B9-AC08-851C30EF4865">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfa550ad3d80f4e1d804dc28ca2e4599e">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na50cd6786fd14b68b9a77b3b16a55f26">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndf2d1b8a02d64c33bec77e9ebbb42e63">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8739c95421b74ebda5dbd24a900a36fa">
    <domeo:sets rdf:resource="urn:pddi:uuid:2578F7C2-2B43-4C50-B71D-B6B6D47CD0F8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5E14082A-8F0B-463C-9316-F9DC45C11355">
    <rdfs:label>metoprolol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6918</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf2b2f85e673540c3830d908a4cac008c">
    <domeo:sets rdf:resource="urn:pddi:uuid:85659FB4-58AC-4A68-9866-A7B71CD8E342"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:51B200EE-E3FD-44AF-8D8B-E4CDBC02E15E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/28493FF7-4279-4623-85D9-CA6D07827A86"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0CAA8974-C959-4DCF-ABF8-3C5BCF5DF1A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E43D34D0-FB18-45A5-AF87-E1628BCB7B28">
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/963E6827-5B20-4353-8BE7-A491C397BEB4">
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4028725cae12467a983c4ff5e38c8e9b">
    <domeo:sets rdf:resource="urn:pddi:uuid:1E462ECE-8A32-48E6-9BC8-1DB650956237"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE675E22-D94C-45D9-9698-178FAE508C83">
    <domeo:uuid>DE675E22-D94C-45D9-9698-178FAE508C83</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-128.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-14 14:56:58 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>can inhibit the metabolism of diazepam, resulting in increased concentrations of diazepam and its metabolites. Diazepam does not alter the pharmacokinetics of propranolol.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE675E22-D94C-45D9-9698-178FAE508C83"/>
    <ao:exact>Propranolol </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF0C661E-C375-447A-8975-4589DBCCFA39">
    <ao:prefix>is 99%. Peak plasma concentrations are observed about 1 hour after dosing. Administration of </ao:prefix>
    <ao:exact>rosiglitazone </ao:exact>
    <ao:suffix>with food resulted in no change in overall exposure (AUC), but there was an approximately 28% decrease in Cmax and a delay in Tmax (1.75 hours). These changes are not likely to be clinically significant; therefore, AVANDIA may be administered with or wit</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>AF0C661E-C375-447A-8975-4589DBCCFA39</domeo:uuid>
    <pav:createdOn>2014-07-14 14:12:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF0C661E-C375-447A-8975-4589DBCCFA39"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:379E0C95-8345-470E-A3B0-7BC913158B58">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B32451E8-0A5F-4AB6-ACC3-9321720FC94C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3DD4B8FD-7B87-4C4C-AAB9-071EC5537F74"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F35EA7C7-C6F4-43EC-8A92-8945497CF80F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AC2A4C59-3807-4E20-A0C1-1E6705DD1852"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/65295DE1-5938-47F9-B584-8E32F819BAE4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DAC237E6-032D-4F62-BE59-D442943F6A84">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/05AA0649-FFEE-4563-9292-318B3DFD94BB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DA7D24A2-A84E-484F-8A90-E623BCF6CAEE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3931debc13d94ba2b6e34489f0f2274b">
    <domeo:sets rdf:resource="urn:pddi:uuid:01AC8AFF-3347-4FBB-9ABB-BB103A58CA24"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8539392-BAD3-47FB-A09D-AE6A4742CA9C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8539392-BAD3-47FB-A09D-AE6A4742CA9C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-197.txt.html</ao:hasSource>
    <ao:prefix>). The principal mode of action of </ao:prefix>
    <ao:exact>ZDV-TP</ao:exact>
    <domeo:uuid>E8539392-BAD3-47FB-A09D-AE6A4742CA9C</domeo:uuid>
    <ao:suffix> is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. ZDV-TP is a weak inhibitor of the cellular DNA polymerases α and γ and has been reported to be incorporated into the DNA of cells in cu</ao:suffix>
    <pav:createdOn>2014-07-20 20:57:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1C1E067B-34F7-4995-986F-53B80A9D7BC0">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5801C633-75F0-4348-A5D9-4C7E6BA72BD8"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na3bc410c4ca740e99355b4f1f9778492">
    <domeo:sets rdf:resource="urn:pddi:uuid:6C2CD101-32D2-45E8-8F3A-D793AD011D39"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb577420e51b34dc19666c4dad89edd3d">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0C8A055F-A38A-4A23-91A5-434066B52D92">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N15d729a406ca4b299c35d528bcb67c5d">
    <domeo:sets rdf:resource="urn:pddi:uuid:70E943B1-CBCB-4614-9D7E-5239F04BF723"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0D2EB67C-B8B2-4A16-BC53-CDEB3818C3CC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CBEB5BFE-AEFC-4265-AAEB-826B3FB400E1"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb5fb298ab1714da69f6ab2464a84c775">
    <domeo:sets rdf:resource="urn:pddi:uuid:595D178B-3D2E-43EC-B368-0DFEA77B3E38"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5801C633-75F0-4348-A5D9-4C7E6BA72BD8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/05D1E607-3DD4-4280-9612-FC9DC6B505FA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1C07DDC3-EE07-4A3F-8C17-E728721FB56A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N41022670fd884fa2beac0f3999a0ba44">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:711BBFE1-5E22-4EA8-84F6-6A491A38AC31">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F89A37A6-3CDD-4878-A117-BD9160646C4D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/36412B0E-F568-4AAE-9D6E-E978E2042B20"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B176B227-B65D-45C6-BBB6-3653EC8509DC">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B33B9EF9-2E32-4FD8-8414-49419E121C9B"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C75AF6B7-A8C3-447E-8C18-98595A566BBE">
    <ao:context rdf:resource="urn:domeoclient:uuid:806E7BF4-2821-4AD1-A0EA-EC4A8AC9EE3F"/>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:createdOn>2014-07-14 16:03:35 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45DE64F7-4E3C-4891-BFC6-E966DB8631ED">
    <ao:suffix>and its active metabolite decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <pav:createdOn>2014-07-14 16:07:30 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45DE64F7-4E3C-4891-BFC6-E966DB8631ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>45DE64F7-4E3C-4891-BFC6-E966DB8631ED</domeo:uuid>
    <ao:prefix>Renal Impairment: In patients with moderate to severe renal disease, clearance of the sum of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AAFD69B3-1F04-4FB8-8C33-681DB759FD8F">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:014E2743-74B8-4A2C-9334-6443B4B7EC24"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7bbecddadcbb41d98e7983f324d7a183">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B558C53-5A17-4213-A237-CE3FF4209736">
    <pav:previousVersion>urn:domeoserver:annotationset:E7DBF2A3-812A-4D80-B4D4-E6C5BE950F77</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:52DEC0C9-5A9A-4CD8-A621-36C5793DF7DF"/>
    <pav:createdOn>2014-07-14 16:02:22 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7A164FA7-102A-4ED7-B353-3DC7CEE23ED8</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-14 16:05:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2BCBE7EF-DB49-410E-AD00-F9E8FEB35CC6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/605EB540-8417-4004-AB2E-AF61974DA39A">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>methadone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6813</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/05D1E607-3DD4-4280-9612-FC9DC6B505FA">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>norverapamil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N37bb2dfafc68403cadb9ccd1cd3eed4a">
    <domeo:sets rdf:resource="urn:pddi:uuid:7E92BF1A-B7AB-4B8B-B186-9C6CEE3E8AEC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B33B9EF9-2E32-4FD8-8414-49419E121C9B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/26760B3C-AD77-41F3-A5B4-DEED059D4891"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4938761A-449E-4BE2-8AAD-A266E929F425"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8A9C5576-9FBA-4761-BDC3-D7E95513FE14">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/922355A6-4C62-463D-95B6-A969DED9F3ED"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7B10A6D9-A218-4814-932F-F9FDB15DE4A0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70E943B1-CBCB-4614-9D7E-5239F04BF723">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5A61AD28-8A5D-4707-957E-22F8C982856A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/183ECA96-0948-49B8-8B33-F80FDF74521E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ketoconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3594F2D2-3049-4640-B63F-58D76A5291AD">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:191FEA6A-791E-4E1A-9D9B-196DA4E5FDEE"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39D18119-A5F9-4E38-B9C3-810003206408">
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-14 00:20:21 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-14 00:19:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:D19D3510-DACE-4758-A973-6DDC45A9A259</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C560C9B8-9FA2-408F-B972-9DB873B7DACD</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5A4A433-7D87-4503-98A3-545B5B12BF1D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5786A7D6-0AB4-4D44-B750-6F0EFA06B91D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>paroxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:226D4AE3-0F57-4B88-82B5-27F44F535A40">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A3090824-4160-44A7-B24C-24AA48263690"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2C5AB00A-896D-4C1F-908C-7DF79FE2623A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5B677EC2-748A-48CB-BB55-1B19898EE258"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C5EE8F5A-6782-4DE1-81FD-657FDB6919AF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B036432F-664F-4181-BF15-84311153EE9E">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>diazepam</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC5F6E0D-F3AD-412F-AE0B-36F814BD863D">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ACB1486E-6973-4681-B087-1511A08D51E0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A5C6ED3F-F83E-472E-BA65-A7E791BEFCCE">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8787</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>propranolol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:059304BF-0CE8-4FEB-8E08-B283296A3929">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E7B0DB79-3FAF-4FCC-9881-DAF505046428"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5340CC8B-23A9-4D27-BC47-DDBC410BF494"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65AD7458-085A-4A27-93DB-8F704670EFE4">
    <ao:context rdf:resource="urn:domeoclient:uuid:2F2ABA6C-3921-4F59-9D48-8E02DA9E1084"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">22</pav:versionNumber>
    <pav:lastSavedOn>2014-07-14 14:44:14 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-14 14:42:23 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:A7CF76A0-A5C2-4C16-A32F-635827C3D643</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8542465-9697-4C29-8D46-8AAE9118410F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046de7980014702a55a6b0058</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:86FC473F-1A02-4C28-BEF4-D4C00F469362</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N034a6bda9f8d43aaa246672ca7a5c778">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B859A639-DEBC-47AF-9A58-931770FF0747">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:62E91244-FAC3-409B-A2E1-8CAA6E1D2DB0"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne87c20edd8414a3398cca6b9191a7c1f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5dd91f1e49ea4c199578fbc2c55b3a03">
    <domeo:sets rdf:resource="urn:pddi:uuid:7CE3A2A7-EC7C-497A-B63D-F6ADBA3F9409"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb415b6b54d3e45778a3be33ebb9d191b">
    <domeo:sets rdf:resource="urn:pddi:uuid:C9B2D52D-D6E7-4ED1-94B9-B83C0AC0E2E1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8728A643-E51C-4771-9827-0BE589532B42">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C124B6AE-EBE9-4FA6-BAB5-C51F48134049"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EB81C9F3-C7B9-4496-A2CD-F08DBB75D8E2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E5CB698E-5F83-455B-83B0-9FDDCFCEB8BD">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2403</dailymed:activeMoietyRxCUI>
    <rdfs:label>chlorpromazine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9f130eaba7e640d18ac73156f1aec38e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/39282B6D-06FA-44D0-907C-957EB7FB7C28">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>azithromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/18631</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6D4FD007-CE5B-43BB-8D19-858E45340D9A">
    <rdfs:label>desipramine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3247</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E430013B-637D-4FD3-92BB-31423631B5B6">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:343B1437-F42F-4F35-ADA2-308FBD16B850">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D8403819-0361-487F-8B8A-C5D0191CA73B"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0CAA8974-C959-4DCF-ABF8-3C5BCF5DF1A3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluvastatin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/41127</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N918ae25eeb754c74aa108442f7840e2a">
    <domeo:sets rdf:resource="urn:pddi:uuid:C44B1D22-7C27-4777-B5F4-0311E02D7AC9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EDE6E971-2D9A-4008-B27D-9C6D93AF8CD3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2E7917BC-D9D5-4BE7-B445-15953D34CCA2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5C63E6B4-57F3-4DD0-B058-6040036328ED"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:03421191-39A0-44FB-9848-85E87BF9E5CD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/54668D71-546B-4172-89C5-15BBB76578E1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/291D0A52-CE6B-443D-817F-7F1732437012"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D98EEFB4-8531-4357-AB5B-2ED0A05ABF9D">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:09A7681E-3F50-4A35-B373-63963A6D77F6"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf5c35d09001c43d5b97e8b9df171f49a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N21b1c32ea9ee46a1a14f30025709408b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0AFB1ADC-E666-47CF-A727-DE973B057FC4">
    <rdfs:label>digoxin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3a448a210dbe4cfdbe148633662dd636">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:85D627ED-5BBE-47B6-83B2-9E4657A52CC5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16F5AF69-E22D-454C-8AF3-B78E57C68838"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB38C427-0E9E-428B-B6C6-670C77C008B1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/65295DE1-5938-47F9-B584-8E32F819BAE4">
    <rdfs:label>normeperidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/0</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ED1F9738-C8E2-4846-B93B-CEFA0C5A56DF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/529D9ABE-231C-442F-94F5-98F1E4CC8A1E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C8BB2325-54B0-4EEE-B527-5720D1F37B99"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1240DB80-6D1A-4E93-809B-5C3CCE2A02B6">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>galantamine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N863a31e9e7ba440183166d1f240f501e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5D35D32E-5B0C-47ED-8F3E-49720874CD62">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0AFB1ADC-E666-47CF-A727-DE973B057FC4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4F57AE27-30FC-483E-8AB1-CAA90A44FAD4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfecd980286134b779c9cf8d7c568c38d">
    <domeo:sets rdf:resource="urn:pddi:uuid:91E5B85B-68AE-48FA-A50B-1AA605A5B75F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N029dc8e7ab7646e5b5c3328761948d80">
    <domeo:sets rdf:resource="urn:pddi:uuid:D05697EA-857C-4586-A456-C000C9881009"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F75B650-175B-4253-A0D6-4B2CB390E7B8">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rifampin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N877238f8f2dd4822bb05da4c8b21e6f5">
    <domeo:sets rdf:resource="urn:pddi:uuid:293B762A-D8D3-4D16-8C01-29E558E76F89"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:16E3723C-08FA-4B14-9694-FA8EECC549F3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DFB4CAFA-452A-4113-88AD-9E9CF21546C1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9E5F42A9-6555-4049-9441-6E465188C021"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne6879680ef9d4b0fa5c02e37d538bed9">
    <domeo:sets rdf:resource="urn:pddi:uuid:CD686BD4-A9E6-46B2-9464-CEDAD3442C08"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C55AB560-FFE7-4925-ACA0-D74F8519F26F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/54828274-B618-479B-AEB1-AFB3F326130E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/45BA6A90-636F-49BB-ACEB-5E8181D237B5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7FCDBA82-A0EA-4942-9FE8-ADFC6D2B6FE0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>or </ao:prefix>
    <domeo:uuid>7FCDBA82-A0EA-4942-9FE8-ADFC6D2B6FE0</domeo:uuid>
    <pav:createdOn>2014-07-14 14:42:31 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7FCDBA82-A0EA-4942-9FE8-ADFC6D2B6FE0"/>
    <ao:exact>rosiglitazone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4a6b189e9c4e44ea98c1784cf19afa14">
    <domeo:sets rdf:resource="urn:pddi:uuid:2DF9F8A6-090C-4486-823C-DE4004E8D042"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N00362320461844a3a4d92972d54e9210">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2CF922A3-BE6B-40E7-8806-23B5C2924868">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/126E527F-80E7-4641-B3E9-A725E45D7103"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/371F0C30-80F7-48E7-9370-65B7E8A2226E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9E5F42A9-6555-4049-9441-6E465188C021">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6960</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>midazolam</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ECBBC132-50C0-4065-A064-62159F7C4836">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BDFB4F3B-2B15-4169-8FFE-0B62B9386E3D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B972E3FA-7CD1-4B9E-855F-A6D78A080560"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N996de8fe22cb4259af28e3f72f596cd9">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A8187DCA-CE9D-4347-ACC8-5973A69B1FEE">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:711BBFE1-5E22-4EA8-84F6-6A491A38AC31"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EDA2BA45-98EB-432A-8FB1-8CA7297F16E3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N253b00d205d0427fa74c9ef7ef7862d1">
    <domeo:sets rdf:resource="urn:pddi:uuid:535AEF5D-66BD-4A65-B55A-EA4176BB5C40"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N84d77bbf063246fbae0da3db3228ec8e">
    <domeo:sets rdf:resource="urn:pddi:uuid:F1ABBC1F-3808-4691-B77F-6F24BC6C700D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:18EC91BB-1FD8-48E7-A347-AFA8DF68B390">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A6C6169A-4EFC-42A4-9F91-0CC375DD4F36"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0fcb0f2a1363483889f78397f6a7d570">
    <domeo:sets rdf:resource="urn:pddi:uuid:8C7CE011-0E6A-4F7B-8D5C-594C5A825005"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D894F7F2-3DC5-44D9-AF37-EAD9363B08D4">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf84a8c5cae3d490fad803bf7886a02f2">
    <domeo:sets rdf:resource="urn:pddi:uuid:D0EBB027-3A62-405B-8549-2C1215178F0B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N17aadf86ec0b4905b3bf0d5baabc7523">
    <domeo:sets rdf:resource="urn:pddi:uuid:BD99951B-7742-4036-BDF6-EA14EBE73B7F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5F77ABBA-6C09-4F5B-A7E1-B5DCCC0D79D2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6412A35D-228A-46FC-B733-4EB7F3051BD8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/55492E72-834D-4AF9-B482-28BF12F7DEEB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:b75def36-afcb-4fb2-b905-631321261783">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>TOPROL-XL</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:b75def36-afcb-4fb2-b905-631321261783"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> plus a catecholamine depletor</ao:suffix>
    <pav:createdOn>2014-07-07 08:09:19 -0400</pav:createdOn>
    <ao:prefix>bserve patients treated with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-106.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D1D6680D-FD65-439F-BA94-5952BEE9EBB7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8897C372-C30C-41C0-89D6-C122DEC1A0B3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ECCCCFB0-A5B6-4713-808D-F519ABC2ED7F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CA35FE6E-C43E-4896-BC81-94DC1B97E865">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>hydralazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4F8D42A8-C4C9-4A8A-BE87-A44F1F1B8BA9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9FE8874A-3C60-4F7D-9BF2-5BF576C023C3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FF212FD2-F441-41B1-94D3-1D82332EECB0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7F6733C5-8532-41EB-A15E-1457A5DB5ABB">
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1d4d8f0f004e4a309f4aed1e1f581492">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9BA3974A-96A6-4596-8631-2C51877A57AB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5191BEBF-051B-436E-BC1C-9DB567805CDC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B251B9A8-A616-4200-B88E-BFB7235774F5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F63BB256-FFD8-4275-A145-4E26D6C75211">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lidocaine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ED452DE7-71EF-477E-A633-55ABE405197D">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5E0605EE-B84F-4519-BFA3-80F2CC24B878"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B48B2B6D-FB16-42FF-8AEB-85B7DFCF14A2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/61DE915B-297C-42B5-BABB-537215239F9E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C50757B2-D0A0-4CF4-A459-B2BB72596434"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EF11FADD-9234-456D-8F3B-BF599386DACE">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc1e43c48a40f4d1b85d2b6d133c95ab1">
    <domeo:sets rdf:resource="urn:pddi:uuid:511E4E89-D7AE-48DF-B1A1-5CCC06746637"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb10ef028ac604e7982ef5fd9dac74fd8">
    <domeo:sets rdf:resource="urn:pddi:uuid:57217751-69E0-486F-A8E0-C5974F060074"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5951269F-AC82-4D68-9739-AE4B85A02488">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/817AEFDF-49D8-4EA6-B885-2DB25A294791"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9615C85D-A507-4824-98F2-AF16E6C5176D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/24F0A859-7DFA-45B0-B376-6263F0F252D3">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <rdfs:label>norethindrone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na38404111f464e66b88ceb6074215ade">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd8b9a7b349fe4834beade99986389b04">
    <domeo:sets rdf:resource="urn:pddi:uuid:EBA0E2A0-D83E-480A-A316-826DCBCA4FEC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9f2ee248124b421a829139d7c663ffff">
    <domeo:sets rdf:resource="urn:pddi:uuid:A2317AD6-F2D6-43E2-A50D-0BB94855D542"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:79E80761-D219-44E9-8376-D110F53723A0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/70C6A666-27EA-4ED8-8D3E-4A5E83DB84D9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/24F0A859-7DFA-45B0-B376-6263F0F252D3"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae657714f3b44524889270fa66f8306f">
    <domeo:sets rdf:resource="urn:pddi:uuid:E42EC98F-B2CC-41F2-BFF4-65AAE4291D29"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf0799ccce70343a1b0092e93d503d1a3">
    <domeo:sets rdf:resource="urn:pddi:uuid:378EB634-E0EE-4103-9EFA-D05FA194855C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbecc0bf4d7bd45c0b439430a739b6f7e">
    <domeo:sets rdf:resource="urn:pddi:uuid:C0BD5DF6-AB55-41AD-B946-7F6C6BEB7A4E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/371F0C30-80F7-48E7-9370-65B7E8A2226E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C18DC32B-72B0-425F-BFAC-C5D7EA334268">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>in patients with mild to severe renal impairment or in hemodialysis-dependent patients compared to subjects with normal renal function. No dosage adjustment is therefore required in such patients receiving </ao:prefix>
    <domeo:uuid>C18DC32B-72B0-425F-BFAC-C5D7EA334268</domeo:uuid>
    <pav:createdOn>2014-07-14 14:20:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-123.txt.html</ao:hasSource>
    <ao:suffix>. Since metformin is contraindicated in patients with renal impairment, coadministration of metformin with AVANDIA is contraindicated in these patients.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C18DC32B-72B0-425F-BFAC-C5D7EA334268"/>
    <ao:exact>AVANDIA</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3466f19ff4bd4095a99b7c2ef3295718">
    <domeo:sets rdf:resource="urn:pddi:uuid:52EA4F51-A88B-41B8-9E40-4E1A27AB19EC"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C650BAE-FB6A-404E-AE82-B7B7DEC33989">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <rdfs:label>propafenone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0EA9CE52-4F2D-4A64-A9E0-3461B37F97EF">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8E780DED-DBF0-4257-9AFB-4C8538DBD2CC"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ed1f6a4669549ceb8ff1dd420708e4d">
    <domeo:sets rdf:resource="urn:pddi:uuid:DDBD1B56-F922-4E62-8E2F-899C899D1700"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B806BB42-892B-4D38-A04A-45710F0704FF">
    <rdfs:label>Risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CB5EDDF0-69AF-43EF-9F9D-11FA8690A1B8">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7454</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>nitrofurantoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1E06DCC6-DB44-4449-89AB-342277E90D1A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/981E2420-F91F-4FCE-8795-6CFD01A871C0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3E1580F0-6D62-4651-9037-2DA6C4DA1825"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B1E7DF8A-AC49-4178-B436-08FC96D956FB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/62ABC094-5576-456A-84FF-7D7CCE8D8FA0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D261A21C-057C-4163-82FB-9B9210F534E7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naa05b535cc7247fd95eeb2a1c47c7d81">
    <domeo:sets rdf:resource="urn:pddi:uuid:9FFED551-DACD-47D2-B92F-8CF37055DEE6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1b8e98df8bce44428786d2838148aca0">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N910a0b1e33dc40b6b0bb328996c67ecd">
    <domeo:sets rdf:resource="urn:pddi:uuid:147F3C87-DF3E-4617-812D-E628655927FA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6472bcee134d42caaec4a9e485365310">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7BA4F42C-25C2-40C2-91B4-2829B9554361">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>tolbutamide</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CEAF3DDF-3578-401E-9FFB-29D5837D4BF3">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D3713BE0-3453-4C7B-8754-7AAB6051231F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N232334f29216408497f9ae26eb7f0320">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/77924DDB-A826-427D-89C1-60F26E350FB5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>sulfamethazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N314ddd94861743eb844bca84080dbceb">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N941c92b113e24a84918408aa70bfbc4a">
    <domeo:sets rdf:resource="urn:pddi:uuid:0A3C798B-3140-4B7E-B30E-34637942D510"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N630c6fda3c824c509aabbac504e1a9fd">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8082DF4D-66CB-496A-A4D4-4AD47A172468">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>propafenone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8754</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EC249FC3-5491-4D3D-BE87-557730ECBC72">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2377A11E-B1BA-42FE-AE0B-FE66AB102192"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B4F32729-CDDF-4DAF-8602-4ADC99476878"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:13191346-72D9-47FB-804B-2018EF842C48">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:CBF1B031-01B7-4827-BA57-9F45D737B368"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N44af7f2436044d1db5190e5afca73344">
    <domeo:sets rdf:resource="urn:pddi:uuid:E2CDB4C5-918E-4F6E-AFA2-A00065A974E5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:053950FB-A8F0-4086-BB28-FB762D2C6677">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1CEAFA26-3EE3-48A5-9562-268F8876D4CB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E861E0FF-0822-455F-A4AF-37F3B6D32715"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:52A4AC2D-AF93-4500-B5EF-7C350351694A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A6655574-CAED-4C38-930D-891D0187E9E3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D261A21C-057C-4163-82FB-9B9210F534E7">
    <rdfs:label>trazodone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ned54f3fd89ca4567b2feebb8788c3e81">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3ca2645798234ff6a41894a258dbe992">
    <domeo:sets rdf:resource="urn:pddi:uuid:59112E47-1755-4B62-A614-6E8FDF1FD005"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf776f5ea6f6e47b782d386e888d22445">
    <domeo:sets rdf:resource="urn:pddi:uuid:5F932699-F716-4A60-BEEA-4E1726615664"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B1F6394A-960E-459F-88D8-5DB116AE3D3D">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FA61FE3E-3D69-43BF-96E4-05EE77B8FEB6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf7c1af86405a4f65bc8b78580fbf3cfc">
    <domeo:sets rdf:resource="urn:pddi:uuid:7B2948B4-BF46-4CDA-A5D4-4D7F47132A3C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb14a7acab571481ba2d9f96e5a901269">
    <domeo:sets rdf:resource="urn:pddi:uuid:E4BC4F8D-E61A-4B30-B2B7-F3246B516D4C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N28dd54422f4f4b2ebb0d212237efbcd6">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A5FC5CFE-5AB6-4A96-838E-8868B4872A95">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E43D34D0-FB18-45A5-AF87-E1628BCB7B28"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/71CF95C5-95B9-46E5-A0DB-D4F55232760A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N81de8813ea65411b930986a3392d12d9">
    <domeo:sets rdf:resource="urn:pddi:uuid:206FC580-43B4-45A3-BFF6-05236B7B379B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:530AC122-C796-460B-A40C-269261AAE6F8">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BD2BE18B-848A-4F15-82C9-EFBCFCEB5370"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D386336B-C8D4-4DEF-A1A2-1A23CAF2EFBC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B07DB1D7-869C-48E9-AE55-E7A4C8B514E0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA75BC42-49F0-47ED-B401-D7BF593B7EDE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:014E2743-74B8-4A2C-9334-6443B4B7EC24">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1C2E0D46-5B2F-4381-BBEC-78C2094865A0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/123ECC1A-579E-48AD-A351-32677410E4A7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3562135A-39C4-4B5E-A242-6E4334C6A2E6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7EBC5DE7-FA87-401F-9007-A48970F7C52E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3DB7D0D4-C52D-4FEE-8BAD-5A52C42927C0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:51E86083-BEC2-4E5E-8DF2-7B16E18A94F1">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/09D66598-5E49-4FAE-8AAE-5AAFEB126BAB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/97FDB421-DF71-416B-9F87-503395671080"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nea6fe2677e0b488d8a6dde786431e5bd">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc0c6984492084f55a8a942b9c2af9f80">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ba657e2acdf4c86a74cf89b2ad3e53a">
    <domeo:sets rdf:resource="urn:pddi:uuid:EE21C792-6535-4C96-B985-F53B187B6033"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N76b5d3462db647ecae43a10928e0163c">
    <domeo:sets rdf:resource="urn:pddi:uuid:DE3F8F31-9BEC-4927-8C65-5F24C55EEA57"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N30f61f8684df4351aadb051079336c0c">
    <domeo:sets rdf:resource="urn:pddi:uuid:92FBAE8F-F471-41C9-9B04-B8DC58761B17"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6C19A167-E6AC-4858-AFDA-FA1D45EFE36A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2244EDD8-BAF4-45A8-B774-B4E11AFFD0D7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/619CE452-7F19-4801-A2D1-9376A3FA2F9C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/42D79F9E-1F0E-423B-B507-620DF8808840">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10737</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>trazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:520C368B-333A-41CC-AA36-559A10AA578B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3CB41909-5F66-4A19-BA0B-5EF367FC95D2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D894F7F2-3DC5-44D9-AF37-EAD9363B08D4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb9c2eba4a4f84605b7c88dd5db8aa8ba">
    <domeo:sets rdf:resource="urn:pddi:uuid:119670BE-D501-429F-9CA2-9EEDB038D28B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:34B63D31-D993-4621-BC19-DCECCF2E1024">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3E22CFD1-3023-49EC-8A81-510AC7740021"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/58BA5753-4787-4141-9D52-6A3A261F3880"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:382B6D84-1C5C-41E1-8D7E-69995B448CD8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DEFF6F71-4DAE-4A00-8C69-0659AFC29CF1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/02D46313-BE5A-4755-A834-E857F809D765"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N33e78b1a57564470b5d00009382e1a5f">
    <domeo:sets rdf:resource="urn:pddi:uuid:343B1437-F42F-4F35-ADA2-308FBD16B850"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DF6586CD-8A68-410E-9025-EB446B66078C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ketoconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2f3c2ac49c8345f0bdc7c5d62f4979fa">
    <domeo:sets rdf:resource="urn:pddi:uuid:8027FCAB-832F-43BE-B22A-CCE8D7129E60"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5F05660B-D46A-4BA4-961D-43D5BA351026">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B85C811F-E622-43C2-A98D-FF1E56518D26">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>simvastatin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36567</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AFE2BEFB-C25A-4447-ADC2-3EFF271B8850">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>digoxin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd13194d78f384ed184ffa762c1bb5222">
    <domeo:sets rdf:resource="urn:pddi:uuid:F7A843C9-3689-4284-A39E-306E925D047E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N23787a0bd9f24765a285ee853d2be17d">
    <domeo:sets rdf:resource="urn:pddi:uuid:F3C03C37-9341-4769-88AC-6C810EEADDFB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:293B762A-D8D3-4D16-8C01-29E558E76F89">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6720E76B-6837-4A9F-BD44-006771D376B2"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na1d8e5c332164c2bbf4ea7724814b1b6">
    <domeo:sets rdf:resource="urn:pddi:uuid:BBB9E9EA-0471-49FE-A82D-09FF84326065"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AA9B4F45-EE03-4CFE-B335-9128AD3C66D8">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sulfinpyrazone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10205</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:898E9B9E-BD79-40E4-839E-56F4FFAC13F9">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:350B186B-11EF-4CF9-8194-4572EBEF1AD0"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N21fadbcc68474523a28c65479b569df4">
    <domeo:sets rdf:resource="urn:pddi:uuid:3D96E2DC-A87B-4014-83BE-3DEAF911375A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3FABE034-92E5-4B4C-95BC-8F8BD117B066">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0AC45CA0-F2B5-408C-9905-4A9CFE6B7ECF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AA0EF444-9503-4A24-A988-5E01413E3727"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7FB518E0-065F-4883-8772-40243E88D540">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8241C483-1F0F-4F1E-AFEB-B67E9CA5E1FE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A3A23B1E-942D-4B65-8548-D7C819EE74F6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1A864AE3-EA88-4E3D-BAD5-2178849B6589">
    <rdfs:label>phenytoin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3700f30021b5479b9a9d872c9ab31496">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6af2bf564e2e4ddcbad31de288c88ba5">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:83AA59FA-4D2F-4B83-8719-96BD5A6D4E04">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/166A3DA7-CAA5-4844-B69D-3ADC07E94AF9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3FEDA41F-3483-4B12-A922-A899BF63231C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb5fd903ed1e94c0a81b1d84dd01c76c2">
    <domeo:sets rdf:resource="urn:pddi:uuid:910E78BB-89E3-4CEE-908C-1B6B4C8C7A76"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N886fcd5a02a34130b22fd7556ffbe05b">
    <domeo:sets rdf:resource="urn:pddi:uuid:D6F67B5E-C430-4E32-B343-5355CD86E7C6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne1e5fd6232ce4104a298846624b80f49">
    <domeo:sets rdf:resource="urn:pddi:uuid:3DC3A969-67F2-4B4B-B465-572111454443"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N33aaf95fcebb4c95b67eacc8d5c5b8b5">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc921957da7e84b72841088fba02f0ccc">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/68E2B300-8315-4FD1-B603-AB0DBDAA6D3B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>gemfibrozil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4719</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Necf1faa724754326bdbbfdfaabc842dc">
    <domeo:sets rdf:resource="urn:pddi:uuid:0C69412C-08BB-489E-9EF7-E2E732E0249D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na1c030b014034a0e8a1d714daae53bbb">
    <domeo:sets rdf:resource="urn:pddi:uuid:3DA943FA-B4B7-4998-B325-3B3F66882436"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na2c77bcc1dfd45d49f97d3575846c80f">
    <domeo:sets rdf:resource="urn:pddi:uuid:0DBAE87C-A5F2-4BEB-A373-2EB8F9249D53"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na12e13a2d507409fba2c6a486f5a61b3">
    <domeo:sets rdf:resource="urn:pddi:uuid:FC5F6E0D-F3AD-412F-AE0B-36F814BD863D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N94961683976e440d831a45ca517d1eec">
    <domeo:sets rdf:resource="urn:pddi:uuid:B9688098-0E77-4F0B-9B9B-C40FA96AE9BF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N34d4882dc1cb41288ccf022360c0bd83">
    <domeo:sets rdf:resource="urn:pddi:uuid:D98EEFB4-8531-4357-AB5B-2ED0A05ABF9D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne05d4a5931ef4188a38efe09250b7bd7">
    <domeo:sets rdf:resource="urn:pddi:uuid:50A17AD3-4F78-41FD-A741-DCA94EC0550F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9EADF748-CADC-4023-A087-992834D4FCDE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B6F5B65E-BB4E-4ED0-8C90-DCF7C40D0798"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/811F48D7-1FE8-4399-AB5C-2E54D3D018E8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nedbde9ca3aec43a998b001fff9b10e5c">
    <domeo:sets rdf:resource="urn:pddi:uuid:2F11C456-0E5E-4949-BC6F-F51743F45391"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5E0605EE-B84F-4519-BFA3-80F2CC24B878">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A81E644F-1C28-4C13-AA67-0D9F8F092B13"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9D38295B-2A04-46C9-A844-42A65BF78753"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc4c503a13ea148ee8a19cc690b2aa963">
    <domeo:sets rdf:resource="urn:pddi:uuid:13191346-72D9-47FB-804B-2018EF842C48"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A6C6169A-4EFC-42A4-9F91-0CC375DD4F36">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/69FC2C6F-38BF-4D16-904F-3726979881CF"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/206D43F2-9AC9-4A1A-81B5-B254E7F11CB2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e161b402a834c6e909ac00985455c16">
    <domeo:sets rdf:resource="urn:pddi:uuid:363FEC73-504B-4213-9F3F-75A8772654FB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6eb0bceb25e744819a908c2a8130986a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1f648381ab624a3696425c03cca38a08">
    <domeo:sets rdf:resource="urn:pddi:uuid:A8187DCA-CE9D-4347-ACC8-5973A69B1FEE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N542ef07d8520468aba7e305e324b03ea">
    <domeo:sets rdf:resource="urn:pddi:uuid:8D2ED292-DF73-4222-9489-CD0F5186233C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N03664362b0164e89adb2d328c325ebc3">
    <domeo:sets rdf:resource="urn:pddi:uuid:9793A8EF-A2CE-4A6F-8481-D5F845506091"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2df8e6142fe84b1985266b177dd3859f">
    <domeo:sets rdf:resource="urn:pddi:uuid:91D7CE6B-02D3-45FF-8E3E-11641C822319"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3ad44c112a03453c838563d2fcc7ad77">
    <domeo:sets rdf:resource="urn:pddi:uuid:27DF2570-C6A1-4DC3-868B-9419E21C08F6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3347a17f44024c9db387a170ca0a4959">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2F4CF0DE-41F6-4BE0-9A8F-2FB4F52CE344">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6131B93-FE3F-4D5C-B0AD-F423E8B0B768">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/35C3EF52-89AA-4561-B929-7E5A938F81CC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F8BB4F24-0C41-44C2-8CF6-A06DF2F8EEBA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D66CCB4B-8C96-4322-A01D-56F6E42B42A0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ACED3071-EB2E-407D-8147-BA0EBEAA6374"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/16FCEB7D-5C8C-4E0F-AB29-742E59D2D9BC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N301aca5e8c2e4aa18ec165f51285bf38">
    <domeo:sets rdf:resource="urn:pddi:uuid:E45AB687-4DA6-45DA-9F9D-38B84921AC27"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:75466C36-9AEB-49DC-8789-42264A07B198">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/62ABD731-D72C-41DD-B670-76E0973C1FC5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/86588D97-4967-4948-A5EF-BCD39B23FD64"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7733664F-014A-40F7-A8B3-FE6C7959DD95">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D865FC44-06FC-415D-9730-152B1B5EDB2F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ED8C3562-5B16-4BF0-9832-820093ED7697"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf75db4eb159c4678a094e624986ada8a">
    <domeo:sets rdf:resource="urn:pddi:uuid:F4AC4AAC-8FD6-42DC-9383-46A0396E43CA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3fb93498788c44cb983297e497c80e4d">
    <domeo:sets rdf:resource="urn:pddi:uuid:3821D7D9-A384-4657-A442-EC5C01D153FA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4da253f9c6f34350bf0283171afd03f8">
    <domeo:sets rdf:resource="urn:pddi:uuid:E7CD0765-E9CB-4A81-8A2E-69BBD346D8F7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8DF46239-225C-4774-B0A1-D86F73818C99">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8EE7E603-E92D-456A-943C-F79CB794C588"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/176593FF-1570-4712-A4F0-12374F828A42"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:55E9D065-FCA3-4050-86B5-CA844CAA03FA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2ABA45E5-17F2-4594-AFA1-0512E25679C5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/518D8A09-6176-424B-A8BD-9AC4F9FDA2B5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7dc0c91299cb42c891cb12fc1156f072">
    <domeo:sets rdf:resource="urn:pddi:uuid:A46CDB1D-9E27-4DEF-AEAA-DBA556467619"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbf442b26c2af4b988fdb06eaf8306b39">
    <domeo:sets rdf:resource="urn:pddi:uuid:B2F30803-2A2C-458A-B1EC-C3C7A355106B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4b79c62cfa034843b7859f4ca63e26b8">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8C5B6F2A-C8EE-4A82-B56B-000EE8CC013E">
    <rdfs:label>norethindrone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc93e61e8a7a4401a95d07294264dc54b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5306453341b64d85a92dbf42dd3fa56b">
    <domeo:sets rdf:resource="urn:pddi:uuid:3E23C3B0-0942-4F1B-A258-005D1C03A60D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf4dbd9070fca4064824f0446d137b969">
    <domeo:sets rdf:resource="urn:pddi:uuid:6A356CB5-7309-4F66-96BD-7AD69E3B869C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F6CA160-67ED-4743-8B8E-94EF9D64CE96">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6AC0E6FE-4192-44D5-A734-64308C0BDF97"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/064AF908-3A0A-450F-9BFA-F2D49C79BB4D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naff6134a114a4f2ab2a2e1c3755fbb12">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N12a097a842fd4cf08bb4dfd388c55376">
    <domeo:sets rdf:resource="urn:pddi:uuid:5B129591-B461-450A-B8CE-4BFAA6262858"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb927984741b84931a331a7a4796ac53a">
    <domeo:sets rdf:resource="urn:pddi:uuid:2DDFB4C8-AB61-4CDC-BC65-F6A163765F01"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ef045aae102479dba0ffe9ac6f8aa06">
    <domeo:sets rdf:resource="urn:pddi:uuid:0422EF3C-AE77-4564-B3F5-2957EACA0D46"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N765f970e9eb24c1fb852d0c19141c370">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncb05e923bcb843b281c1088cf60bebe1">
    <domeo:sets rdf:resource="urn:pddi:uuid:0BFD3ECF-0629-4897-AAA5-5FB5ABE39E8E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naa51f1e6e268497aabb70f572a983c57">
    <domeo:sets rdf:resource="urn:pddi:uuid:D11564B1-5BD5-49F7-83D8-CAB91B474732"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FFD0C4FB-30B3-4D5F-88DC-625683839E21">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdfs:label>ritonavir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EED2295A-1A7F-4589-B0BF-68C4164EF36C">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E543F5FB-E68F-4CF2-BF11-544ED3D893E8"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/15EE846D-56EB-4183-91FC-C434E504D22D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6c8ca5a8f7634e68974d0e35a3958b60">
    <domeo:sets rdf:resource="urn:pddi:uuid:F8ACDA4D-F030-445D-BCFB-D87D7EC9400F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N512bb9424f4d4e96b05aad50e8a9ac3a">
    <domeo:sets rdf:resource="urn:pddi:uuid:E69078C1-9504-4581-A81D-B6E5B383BBA5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3b074ea632b640ec948fde4718e6b7c6">
    <domeo:sets rdf:resource="urn:pddi:uuid:962AF202-C1C5-4EA9-A24C-C174906D4164"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N45d1f7deac3a4cebab4d7e707fbda7b2">
    <domeo:sets rdf:resource="urn:pddi:uuid:365CE224-B051-4BA8-8FBC-4C0CFA26FB18"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CECDB189-9AA1-46EE-A822-8094A73F55A4">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B083F609-2C02-411B-AC52-4FD5D843A8A0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0F074D3A-ABA0-4A44-BBE4-D1BD0FCFD10C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BD2BE18B-848A-4F15-82C9-EFBCFCEB5370">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4BDB2504-6DC3-4E0E-B8AC-7FC6A9E47198"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/32854C22-67DF-4D38-8D09-17CDBFBB691E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndd6a9600e1c4404a81d03cfedae0ea61">
    <domeo:sets rdf:resource="urn:pddi:uuid:F43F81A3-9A0E-46EA-A31F-9BBFECC33ACB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4209c4790ff0455b9e16bc53bd59853e">
    <domeo:sets rdf:resource="urn:pddi:uuid:7B148F16-776F-4635-93A8-884E889701FD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N44a6d2331aa04c548908e159427e6081">
    <domeo:sets rdf:resource="urn:pddi:uuid:1B457ED2-9A9D-4E17-B58C-4A3B0269BEBB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2c0e7e8aee8647d3b03f69821bd043b0">
    <domeo:sets rdf:resource="urn:pddi:uuid:A34FB7D9-5215-46FC-9058-F443376565D1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbdd04983f3704d969714245a3ae87fb3">
    <domeo:sets rdf:resource="urn:pddi:uuid:DFC9F830-AFFF-4613-BB4F-9DF20DEB2196"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9D71D4C6-B25C-42A8-8F7F-9B0E2A650305">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/349B2C65-9C79-4D0A-A4BB-47B56BF85AF7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/32BDD969-DCD1-4A82-8447-E9785119F390"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4c9931de075d4c20acfa7ed825afd4ba">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9b38b55a6b0d4693a2814b53a43432d1">
    <domeo:sets rdf:resource="urn:pddi:uuid:D1AE8562-1F62-440F-B6D4-1B8A86AAEEC2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncec5cb4072724aedb8cd8aae5642b089">
    <domeo:sets rdf:resource="urn:pddi:uuid:B8F6771C-52A0-4B9C-8346-18D50BE4F26F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb26c5b0d06e84ea2a441b4200f4adba1">
    <domeo:sets rdf:resource="urn:pddi:uuid:2722CAF7-81B6-4BC0-A47B-F2C238A177B9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neb21cd35a2b542efbeafde327dfb45bb">
    <domeo:sets rdf:resource="urn:pddi:uuid:6879B526-DB29-4CA7-9FF0-AE35DA36F546"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5dbcdebcfb5241e19dc715f17492bc77">
    <domeo:sets rdf:resource="urn:pddi:uuid:F3BCA07A-06BB-4F22-A3A4-F076C15BF4AF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:49F1F10C-546C-44F2-A4A0-E7909C0F39F9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E8EAB7E9-C458-4E6E-9AB5-E4A3F099F5EB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8ED67CAA-C06A-47A2-BAA9-A3A8E79802A9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N37f2b3eadb4b4054bbe380f25a2c7aa0">
    <domeo:sets rdf:resource="urn:pddi:uuid:EBB83A45-A289-45A4-86E3-D9C8DC9DA399"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N89016168d51047e7818270d29905c1f7">
    <domeo:sets rdf:resource="urn:pddi:uuid:3FD6B834-E969-4A91-B893-083DDDA00DC1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N096ea8bcb943427bac81c3e3ca9223d4">
    <domeo:sets rdf:resource="urn:pddi:uuid:50D2384C-A6CF-4368-A352-CA03FF3C56CA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N64e7b9aa3a0a43729b121f8efbe942bc">
    <domeo:sets rdf:resource="urn:pddi:uuid:2335C1EB-2E53-4392-A90A-D97010F2B956"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N23839800323844e08b03916856119ea0">
    <domeo:sets rdf:resource="urn:pddi:uuid:F2F93BCC-1924-4C9E-ABF5-542A48FE6909"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e223151816343aba14e24242a9f71cc">
    <domeo:sets rdf:resource="urn:pddi:uuid:3D526E35-3C47-41BC-B59C-546638F50D9D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb6e0f4138ce54821bff758fce8d7fdc6">
    <domeo:sets rdf:resource="urn:pddi:uuid:530AC122-C796-460B-A40C-269261AAE6F8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N313ba15db9e4479c94a0571359d64258">
    <domeo:sets rdf:resource="urn:pddi:uuid:5E18221F-5E96-4E3E-881C-6DA9000AC86A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc2ade50445eb4d5a941f90ad00b94762">
    <domeo:sets rdf:resource="urn:pddi:uuid:37B5F832-73BE-483B-9361-B6E3240986C4"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8d7d3daa1cce4cd48caf2f0504a14f75">
    <domeo:sets rdf:resource="urn:pddi:uuid:AC6C502B-E088-4AB7-93D3-80FE49A5CA62"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0abd9f58fa9c429985dc171744dc9aab">
    <domeo:sets rdf:resource="urn:pddi:uuid:5405B241-3FC8-4552-99D5-456F4EEE2F8B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N569394208d78439980c576780ff80238">
    <domeo:sets rdf:resource="urn:pddi:uuid:18E1DCEC-8EC9-4234-A56D-11EF3AA8DF89"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9a0d7b0b06714b92af0039486613e2fe">
    <domeo:sets rdf:resource="urn:pddi:uuid:737CC04C-BC04-4880-9190-1A36AE2AEE03"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nca28e3d878bd4fe1a23609a00d14a2da">
    <domeo:sets rdf:resource="urn:pddi:uuid:0B9E38A3-513E-439D-AB4A-0C99491A881F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N19451323bf344750ab441f5ccd3a761a">
    <domeo:sets rdf:resource="urn:pddi:uuid:32FAEB9E-441A-4E58-9C43-CA1D8B214D83"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N66e088b537f54c719a5e08f7a6a43d02">
    <domeo:sets rdf:resource="urn:pddi:uuid:C6BE226D-4378-4938-AFFA-82B2DACBBBED"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N61605ee3260a43b7a1c5ba888beb5eed">
    <domeo:sets rdf:resource="urn:pddi:uuid:C1BB7C6E-391B-452B-8574-4C2A3EADCEAD"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1a394f8933854a15b68866a30e4f6038">
    <domeo:sets rdf:resource="urn:pddi:uuid:A937B89D-5425-4F4A-8E11-94520EC6C7C8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb3696d05db4b43a39754c07c59cf4170">
    <domeo:sets rdf:resource="urn:pddi:uuid:2D618A6F-6ADA-43A4-8A52-4B8158136DD0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N61d93039a69c4496b185e4493c8eb49b">
    <domeo:sets rdf:resource="urn:pddi:uuid:0CA68D01-9113-4C5C-97C2-9150F7BD09B0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7ec3ab5896e944ba99db39b627fa7fbf">
    <domeo:sets rdf:resource="urn:pddi:uuid:B1F6394A-960E-459F-88D8-5DB116AE3D3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E7028888-FEE6-4400-84A4-EB9054028F7F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8E146A6D-284E-4C0F-B6FD-F6D2577C74A8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E8EC5FE2-5508-43D1-806A-88788DEA96D3"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncfd11d69529645278d6554ab5cb7e10f">
    <domeo:sets rdf:resource="urn:pddi:uuid:CE269066-6706-4D6D-B2BD-CAAC90C83EED"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N98e28009271c40278271cabd38050959">
    <domeo:sets rdf:resource="urn:pddi:uuid:812A80DB-2E3F-4AE5-A0A5-C63E1DE00DBC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na027d14f26744d2194672cd4865c14b2">
    <domeo:sets rdf:resource="urn:pddi:uuid:32A6B6DB-4B7D-4DCA-BC66-F25FBA3026EA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N11429616c61f4661b462078e550e606d">
    <domeo:sets rdf:resource="urn:pddi:uuid:49D78607-AFB0-4F8D-A21D-6AEC8A8AD9E9"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2b164d9eece74629b75f1b304d616fdf">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na374dc15da8143f1b141afcf942f57cb">
    <domeo:sets rdf:resource="urn:pddi:uuid:D99C623B-2B12-4857-A174-AA5C67D5465F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5c7a6d57f7364ae883311f7c67631f83">
    <domeo:sets rdf:resource="urn:pddi:uuid:4636FE05-5CDD-4C42-ADBC-E5993B315ADE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na17fcb831e564d9a84eb29add4bac397">
    <domeo:sets rdf:resource="urn:pddi:uuid:2BB1BA4D-7A19-4D02-A435-607D0B5CA3BE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N355c15d5dd264720bb02429757d421cd">
    <domeo:sets rdf:resource="urn:pddi:uuid:57D8086A-3900-4A2C-B28D-BE6E3ADEF82C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8c017f596b2c417085e055b761f9833a">
    <domeo:sets rdf:resource="urn:pddi:uuid:F2270508-35DB-4484-A584-328762624BF8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N03b37d502772494b81b1e7d527ed35e2">
    <domeo:sets rdf:resource="urn:pddi:uuid:11F0264D-23A5-4A18-B0D3-91DA654E6326"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndab2583855c14b7b91e720ba51859bc2">
    <domeo:sets rdf:resource="urn:pddi:uuid:14D02176-8222-4D2D-85C4-94DA5F6AD211"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc082c6fb089048488fb7f0aae5d72642">
    <domeo:sets rdf:resource="urn:pddi:uuid:A227DD21-8C83-4205-9DD9-71AF8DDEDF2E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0a997d57c8be4b85b4411b91651195c3">
    <permissions:accessType>urn:person:uuid:080e143046de7980014702a55a6b0058</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8e6c6bc9e6484b71b0f9e8e0027f944d">
    <domeo:sets rdf:resource="urn:pddi:uuid:316C1128-C3FD-4C92-B42D-A1C6EFB607A3"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae33f5e3ba27492db5101afa2edb7115">
    <domeo:sets rdf:resource="urn:pddi:uuid:9D7D3CBB-49BB-4D03-8CAE-142B4BD512C3"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd1f6dd4d853c4d81ab7df9f745880175">
    <domeo:sets rdf:resource="urn:pddi:uuid:7474E3EA-79D8-4C3B-9FCC-4EFAD31CFA68"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N70372e2d52084e43948d63c14e9f4e51">
    <domeo:sets rdf:resource="urn:pddi:uuid:CF3FD43A-6186-4DD6-8BD9-904AAFB33DDE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nddcf7cf15a454fff9b749a912836fd6b">
    <domeo:sets rdf:resource="urn:pddi:uuid:BC463965-35ED-4517-B542-3922995BCA4F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd0feec6f25de4d2693502401ddf4cf55">
    <domeo:sets rdf:resource="urn:pddi:uuid:0DB30838-4830-49C5-968E-53C2911121DC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N87d7efd1dcee430e8b57f09b04b7753e">
    <domeo:sets rdf:resource="urn:pddi:uuid:ACB7E01C-061A-4238-9522-CEDC267166F6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncad9e603157743999aec11e9f0afb176">
    <domeo:sets rdf:resource="urn:pddi:uuid:34BEE349-9FCC-4D10-A8AD-FA0AAEFB32CF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf40065dd36694b7ca04ebb73584ccdec">
    <domeo:sets rdf:resource="urn:pddi:uuid:83A2282A-89FF-48A9-9224-20D9B674EAD1"/>
  </rdf:Description>
</rdf:RDF>
